data_2m17_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m17 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.794 0.33 . . . . 73.35 111.135 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.5 mt -110.87 109.43 57.5 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.618 0.723 . . . . 73.14 110.907 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 156.48 63.23 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.693 2.262 . . . . 64.55 112.357 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.9 mt -150.51 137.45 13.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 73.51 111.155 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.1 mt -94.91 140.52 16.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 63.44 111.152 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.3 p -126.9 123.14 62.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 74.53 111.089 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.12 119.78 40.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 72.13 110.881 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 16.8 t-105 -121.09 100.92 7.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.258 -0.428 . . . . 75.22 110.912 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.89 -83.53 0.85 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.778 -0.725 . . . . 62.4 112.515 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.68 20.45 1.02 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.693 -0.765 . . . . 70.1 112.459 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -128.43 174.83 9.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.756 0.312 . . . . 72.55 110.896 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -133.07 140.19 47.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 64.24 110.865 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -135.84 118.59 16.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 75.42 110.886 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.6 p -82.36 133.93 35.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 75.01 110.84 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 69.6 t -96.21 131.33 43.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.49 . . . . 72.44 111.137 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.2 p -141.31 93.54 2.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 72.15 111.11 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 173.47 -28.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.462 . . . . 64.31 111.128 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -85.6 150.52 24.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 75.35 110.871 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.89 168.09 18.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 71.23 110.867 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.417 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 44.9 mt-10 -59.04 -21.98 59.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 74.43 110.898 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -68.59 -10.9 58.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 72.24 110.885 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -102.61 -150.47 0.41 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 63.14 110.869 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.65 168.03 20.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 64.1 111.148 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.2 t -63.39 -43.15 98.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 73.32 111.124 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.06 -29.08 69.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.166 -0.47 . . . . 73.11 110.938 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -71.51 -32.67 68.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 74.42 110.845 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.65 -48.82 12.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 74.22 110.924 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.504 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -62.09 -56.09 22.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 73.32 110.89 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -57.6 -22.4 44.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 71.22 110.89 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -77.98 -54.89 5.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 74.11 110.82 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 pp -68.05 -42.13 80.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.148 -0.478 . . . . 74.34 110.92 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.567 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.76 -27.65 42.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 75.34 110.866 179.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.52 -23.62 42.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 75.41 111.155 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.8 mt -76.63 -59.7 2.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 73.43 110.914 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.7 t -135.41 -27.66 1.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 72.11 111.181 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.567 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.95 -177.46 4.8 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 63.33 112.479 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.479 ' CG2' HD23 ' A' ' 39' ' ' LEU . 1.3 p -112.72 138.24 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.856 0.36 . . . . 73.24 111.106 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.584 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.76 150.94 16.49 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.632 0.729 . . . . 74.43 110.875 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -21.59 33.39 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.715 2.277 . . . . 75.25 112.32 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -54.35 -38.79 66.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.429 . . . . 75.13 110.855 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -104.15 -40.58 6.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 71.33 110.889 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.407 ' HG2' HG12 ' A' ' 38' ' ' VAL . 1.9 pp0? -97.28 157.47 15.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 73.42 110.932 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.08 142.94 51.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.435 . . . . 74.31 110.955 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.7 135.9 53.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.246 -0.434 . . . . 63.5 110.885 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.0 -68.29 0.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 62.22 110.972 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.4 61.06 0.66 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.705 -0.76 . . . . 62.54 112.497 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.5 pp -58.96 -18.2 31.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.899 0.381 . . . . 74.34 110.907 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -112.39 144.16 42.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 64.25 110.926 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.0 t -143.85 145.31 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 75.15 111.119 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.0 mttt 54.87 32.51 17.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 75.33 110.858 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.25 -11.3 50.59 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.744 -0.741 . . . . 61.51 112.509 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -81.7 150.88 67.13 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.602 0.715 . . . . 71.51 110.856 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 -32.91 17.85 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.706 2.271 . . . . 63.13 112.351 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 36.78 43.48 0.28 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 74.34 111.074 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.54 -76.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.438 . . . . 65.52 110.896 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -159.36 -37.5 0.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 73.25 110.884 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -66.8 -8.68 30.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 73.4 110.862 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.41 ' HB ' HD22 ' A' ' 64' ' ' LEU . 16.9 t -79.79 145.69 8.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 73.21 111.135 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.9 mttp -90.27 151.44 21.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 75.04 110.858 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.417 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 19.3 mt -49.96 -47.44 52.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 75.35 110.982 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.63 -11.69 85.22 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.732 -0.747 . . . . 64.1 112.473 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.39 -32.16 42.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.783 0.325 . . . . 75.53 111.097 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.41 HD22 ' HB ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -77.82 -23.55 48.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 65.2 110.943 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt 63.12 38.03 11.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 63.44 110.876 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.2 mt -89.66 152.62 21.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 75.42 110.899 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -68.67 160.57 76.41 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.603 0.716 . . . . 71.42 110.899 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -35.0 13.26 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.718 2.278 . . . . 74.33 112.335 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.463 ' O ' ' C ' ' A' ' 70' ' ' THR . 10.5 p30 -78.8 -15.83 57.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 75.31 110.864 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.463 ' C ' ' O ' ' A' ' 69' ' ' ASN . 51.3 m -32.92 121.52 0.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 75.0 111.132 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -92.85 146.49 23.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 75.42 110.913 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.8 mm -116.4 127.46 74.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 74.23 111.087 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 23.2 mtp -99.46 141.68 31.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 74.42 110.89 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.6 mtt -134.74 118.99 17.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 72.32 110.937 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.1 mmm -107.88 123.82 49.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 75.15 110.906 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.79 -155.16 26.32 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.751 -0.738 . . . . 74.35 112.526 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.2 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-O 120.783 0.325 . . . . 73.0 111.164 -179.925 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.804 0.335 . . . . 70.14 111.119 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.4 mt -112.04 109.66 54.57 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.593 0.711 . . . . 74.13 110.89 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 156.6 62.94 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.717 2.278 . . . . 74.03 112.345 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.0 mt -150.45 137.52 13.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 72.12 111.114 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.7 mt -95.14 140.81 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 71.34 111.162 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.3 p -126.92 123.44 62.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 74.12 111.12 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.78 120.9 43.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 75.53 110.931 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 12.9 t-105 -122.04 100.96 7.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.436 . . . . 74.4 110.884 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.79 -83.76 0.78 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.739 -0.744 . . . . 75.15 112.498 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.46 20.17 1.04 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.742 -0.742 . . . . 65.2 112.488 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -128.56 174.24 9.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.784 0.325 . . . . 64.2 110.875 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -132.81 140.5 48.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 75.34 110.902 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -136.67 116.14 12.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 74.2 110.96 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.9 p -81.62 135.03 35.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 65.34 110.854 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.4 t -96.26 140.28 17.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.115 -0.493 . . . . 73.44 111.077 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.5 p -148.66 93.37 2.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 63.44 111.137 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 173.68 -28.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.22 -0.445 . . . . 74.15 111.137 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -86.61 151.92 23.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 75.22 110.908 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.6 169.47 16.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 74.44 110.882 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.409 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 36.3 mt-10 -61.78 -22.09 65.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 72.1 110.854 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -69.87 -10.76 59.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 74.01 110.852 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -100.08 -150.84 0.39 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.452 . . . . 64.12 110.887 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.61 170.58 14.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 75.34 111.176 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.7 t -66.58 -43.79 90.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 73.33 111.135 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.44 -28.66 68.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 72.23 110.925 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -70.07 -35.16 74.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.476 . . . . 73.12 110.844 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.72 -47.82 13.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 63.53 110.911 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.78 -56.71 16.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 74.1 110.892 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.0 -22.41 49.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 73.22 110.924 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -77.16 -55.23 5.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 72.34 110.835 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.4 pp -67.92 -43.14 79.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 72.0 110.942 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.561 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -55.02 -27.34 43.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 74.12 110.876 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.3 -23.78 43.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 74.1 111.159 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.5 mt -76.46 -59.8 2.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 74.12 110.931 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.1 t -135.25 -27.63 1.2 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 72.11 111.135 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.23 -176.63 4.66 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.699 -0.762 . . . . 73.3 112.513 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.468 ' CG2' HD21 ' A' ' 39' ' ' LEU . 1.1 p -112.29 139.73 35.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.835 0.35 . . . . 71.23 111.168 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.609 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.8 149.98 20.55 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.602 0.715 . . . . 74.42 110.927 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -22.02 32.78 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.717 2.278 . . . . 64.22 112.334 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -54.61 -39.06 67.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.443 . . . . 74.12 110.899 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -103.7 -40.46 6.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 75.1 110.87 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.409 ' HG2' HG12 ' A' ' 38' ' ' VAL . 1.5 pp0? -97.57 157.2 16.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 74.25 110.921 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.17 141.32 51.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 74.32 110.908 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.02 135.96 54.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 74.53 110.973 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -76.54 -75.22 0.2 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 75.45 110.916 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.74 60.03 1.48 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.726 -0.75 . . . . 63.2 112.518 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.8 pp -56.8 -22.56 37.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.9 0.381 . . . . 74.24 110.949 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.29 142.43 35.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 73.25 110.932 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.0 t -144.04 144.37 22.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 71.24 111.07 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.1 mmmm 54.3 33.01 17.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 75.34 110.863 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.9 -15.05 45.28 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.718 -0.753 . . . . 73.53 112.462 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -81.08 148.78 64.91 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.538 0.685 . . . . 75.34 110.9 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -35.57 12.53 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.681 2.254 . . . . 64.03 112.366 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 38.14 40.67 0.34 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 72.32 111.136 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -67.81 -76.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 74.11 110.91 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -154.53 -38.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 71.15 110.889 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -73.14 -1.65 18.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 74.14 110.867 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -92.85 148.19 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 73.32 111.168 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.413 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 11.2 mttt -90.75 147.22 23.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 74.22 110.873 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.409 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 17.5 mt -52.47 -38.72 60.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 65.43 110.887 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.77 -17.0 80.29 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.771 -0.728 . . . . 75.11 112.451 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.53 -19.52 33.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.834 0.349 . . . . 72.33 111.128 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -84.44 -20.46 31.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 71.44 110.904 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp 53.89 42.01 31.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 75.42 110.935 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.6 mt -92.79 151.58 19.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.462 . . . . 73.01 110.939 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -68.4 160.01 78.06 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.564 0.697 . . . . 73.22 110.933 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -36.88 10.07 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.68 2.253 . . . . 73.31 112.311 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.471 ' O ' ' C ' ' A' ' 70' ' ' THR . 26.4 m-80 -78.8 -15.79 57.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 75.45 110.897 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.471 ' C ' ' O ' ' A' ' 69' ' ' ASN . 52.0 m -32.43 128.03 0.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 71.52 111.13 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -97.66 146.51 25.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 73.02 110.837 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.0 mm -115.34 128.46 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 75.01 111.167 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 34.4 mtm -100.36 141.76 32.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 74.11 110.883 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.7 mtt -133.21 129.42 37.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 74.2 110.884 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 6.1 mmm -118.6 123.95 46.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.254 -0.43 . . . . 62.14 110.9 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 153.11 -155.23 26.01 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 60.13 112.459 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.794 0.331 . . . . 62.14 111.136 -179.865 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.848 0.356 . . . . 74.23 111.119 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.1 mt -110.86 109.27 57.6 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.625 0.726 . . . . 74.52 110.916 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 156.84 62.27 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.677 2.251 . . . . 72.2 112.308 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.9 mt -150.57 137.51 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 75.12 111.149 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.6 mt -95.03 140.38 16.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 73.54 111.112 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.7 p -127.15 122.91 61.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 73.22 111.133 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.77 122.28 46.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 75.01 110.893 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 17.5 t-105 -122.56 100.52 6.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.24 -0.436 . . . . 75.44 110.89 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.55 -78.75 1.71 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.725 -0.75 . . . . 71.15 112.488 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.11 17.94 0.71 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.727 -0.749 . . . . 74.24 112.508 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -129.94 138.98 51.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.72 0.295 . . . . 73.02 110.93 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -102.98 142.25 34.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 75.33 110.899 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -136.31 119.38 16.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.465 . . . . 74.44 110.94 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.9 p -83.29 131.96 35.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 61.13 110.895 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 66.9 t -93.95 130.94 42.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.485 . . . . 74.52 111.16 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.0 p -141.27 93.08 2.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 74.25 111.137 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 173.23 -28.37 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 72.25 111.14 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -85.11 150.1 25.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.462 . . . . 74.51 110.902 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.71 167.78 18.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 64.31 110.887 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.413 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 35.3 mt-10 -58.81 -21.91 57.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 75.34 110.929 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -68.9 -10.54 57.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.13 -0.487 . . . . 73.33 110.875 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -102.62 -150.76 0.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 73.33 110.867 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.82 167.54 20.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 70.24 111.127 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 82.5 t -63.06 -42.37 96.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 72.54 111.13 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.78 -28.79 69.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.48 . . . . 75.24 110.915 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.01 -32.56 67.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.174 -0.466 . . . . 74.14 110.871 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.59 -48.82 12.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 74.22 110.939 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.502 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.94 -55.78 26.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 71.33 110.929 179.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.6 -22.49 45.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 75.24 110.902 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -77.84 -54.88 5.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 75.45 110.881 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 pp -68.07 -41.96 81.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 74.1 110.927 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.564 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.85 -27.74 44.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 73.42 110.889 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.34 -23.49 43.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.25 -0.432 . . . . 74.33 111.168 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.7 mt -76.76 -59.43 2.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 75.01 110.886 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.6 t -135.47 -28.03 1.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 54.43 111.178 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.59 -177.37 4.35 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.72 -0.752 . . . . 74.35 112.498 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.481 ' CG2' HD21 ' A' ' 39' ' ' LEU . 1.4 p -112.77 137.78 44.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.864 0.364 . . . . 63.34 111.098 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.591 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -53.71 149.95 14.86 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.631 0.729 . . . . 74.24 110.915 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -21.89 32.95 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.695 2.264 . . . . 71.21 112.342 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -54.21 -38.38 65.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 73.13 110.878 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -104.43 -40.3 6.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 75.21 110.885 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.415 ' HG3' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -95.96 157.41 15.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 75.3 110.877 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.09 140.05 52.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 73.44 110.91 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -65.94 135.75 55.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 75.11 110.917 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.4 mp -81.36 -63.51 1.38 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 74.34 110.901 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.91 58.72 0.68 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.703 -0.76 . . . . 65.04 112.483 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.5 pp -60.46 -17.34 44.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 75.54 110.899 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.96 144.15 43.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 72.01 110.885 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.8 p -144.0 144.95 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 74.32 111.132 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt 54.66 32.71 17.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 73.52 110.912 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.78 -12.17 49.42 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.725 -0.75 . . . . 35.33 112.514 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.6 mmtt -81.61 150.6 66.86 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.574 0.702 . . . . 75.43 110.896 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.403 ' O ' ' C ' ' A' ' 55' ' ' ALA . 53.6 Cg_endo -69.83 -32.39 18.39 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.648 2.232 . . . . 72.35 112.302 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 54' ' ' PRO . . . 36.79 43.45 0.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.277 -0.419 . . . . 74.33 111.087 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.46 -78.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 74.13 110.85 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -157.0 -38.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 75.4 110.916 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -64.95 -9.64 22.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 75.03 110.848 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.404 ' HB ' HD21 ' A' ' 64' ' ' LEU . 16.8 t -79.25 145.6 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 73.31 111.133 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.7 mttp -91.0 151.65 20.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 74.42 110.92 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.413 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 20.0 mt -49.66 -47.6 49.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 71.44 110.983 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.68 -11.84 85.05 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.742 -0.742 . . . . 74.33 112.478 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.22 -32.12 43.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.826 0.346 . . . . 72.11 111.125 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.404 HD21 ' HB ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -77.29 -23.91 51.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 73.32 110.9 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp 63.67 37.44 10.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 54.21 110.875 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.2 mt -90.2 152.68 20.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 72.35 110.941 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.61 160.86 74.75 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.558 0.694 . . . . 73.32 110.89 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -35.08 13.24 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.629 2.22 . . . . 74.12 112.319 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.469 ' O ' ' C ' ' A' ' 70' ' ' THR . 68.7 m-20 -78.49 -15.91 58.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 63.33 110.938 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.469 ' C ' ' O ' ' A' ' 69' ' ' ASN . 45.6 m -32.77 122.33 0.36 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.487 . . . . 72.35 111.125 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -93.83 146.24 24.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 75.42 110.899 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 36.2 mm -115.99 131.75 67.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 71.3 111.149 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 46.1 mtm -101.85 142.46 33.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 75.5 110.892 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.9 mtt -133.83 119.29 19.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 73.22 110.88 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.8 mmm -108.42 121.88 45.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 75.24 110.912 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 162.85 -156.7 28.53 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.703 -0.76 . . . . 73.52 112.468 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.7 t . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 120.786 0.326 . . . . 61.24 111.114 -179.823 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.831 0.348 . . . . 72.25 111.111 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -107.79 110.33 62.47 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.597 0.713 . . . . 74.14 110.921 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 156.89 62.01 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.656 2.237 . . . . 73.43 112.287 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.3 mt -150.3 137.15 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.483 . . . . 71.1 111.125 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.6 mt -95.2 140.65 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 74.34 111.126 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.82 122.72 61.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 72.43 111.124 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.97 121.33 44.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 65.32 110.918 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 16.2 t-105 -121.43 100.78 7.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 75.24 110.891 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.59 -83.64 0.96 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.702 -0.761 . . . . 71.23 112.483 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.67 20.68 1.16 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.7 -0.762 . . . . 73.35 112.434 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.28 174.2 9.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.761 0.315 . . . . 73.51 110.944 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -132.93 140.46 47.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.268 -0.424 . . . . 74.33 110.929 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -135.83 116.32 13.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 74.02 110.91 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.3 p -82.51 132.17 35.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 74.14 110.851 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.4 t -94.68 136.93 24.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 74.44 111.12 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.6 p -146.73 93.83 2.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 74.42 111.125 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 172.66 -28.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.219 -0.446 . . . . 75.43 111.136 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -87.64 150.53 23.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 73.43 110.917 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.67 165.56 23.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 70.14 110.883 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.411 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -57.78 -20.75 37.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 75.0 110.878 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.08 -11.9 61.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.179 -0.464 . . . . 74.44 110.854 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -101.06 -148.84 0.37 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.266 -0.425 . . . . 73.55 110.831 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.26 167.47 20.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.191 -0.459 . . . . 74.23 111.166 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.9 t -63.42 -44.05 98.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 74.41 111.094 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.16 -28.39 67.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.457 . . . . 71.13 110.971 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -70.59 -35.52 73.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 60.45 110.857 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 tt -80.4 -47.82 13.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 73.44 110.904 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.493 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.57 -56.69 17.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 73.32 110.886 179.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -57.99 -22.31 48.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 65.01 110.915 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -77.3 -54.93 5.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 73.51 110.839 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.3 pp -68.23 -42.83 79.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 63.31 110.871 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.563 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -55.02 -27.12 41.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 74.1 110.901 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.77 -23.58 42.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 75.25 111.189 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.9 mt -76.7 -59.89 2.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 74.44 110.92 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.1 t -135.4 -27.42 1.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 73.1 111.194 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.563 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.99 -177.95 5.14 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.8 -0.714 . . . . 51.01 112.466 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.472 ' CG2' HD22 ' A' ' 39' ' ' LEU . 1.2 p -112.98 138.7 41.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.899 0.381 . . . . 74.11 111.098 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.596 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.42 151.1 14.74 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.593 0.711 . . . . 74.0 110.932 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 -21.49 33.31 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.68 2.253 . . . . 75.13 112.354 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -54.52 -38.98 67.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 73.13 110.87 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -103.89 -40.45 6.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 75.41 110.847 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.413 ' HG2' HG12 ' A' ' 38' ' ' VAL . 1.7 pp0? -98.11 158.2 15.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 75.14 110.877 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.28 141.37 51.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 75.31 110.902 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.26 135.96 54.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.262 -0.426 . . . . 63.41 110.905 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -76.86 -75.8 0.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 73.3 110.904 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -97.03 60.5 1.13 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.68 -0.772 . . . . 64.12 112.482 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.7 pp -55.4 -24.43 30.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.843 0.354 . . . . 71.44 110.923 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.71 143.42 32.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 72.32 110.892 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.9 p -144.1 143.38 23.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 74.44 111.15 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.0 mttt 54.0 34.19 19.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 74.52 110.905 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.22 -14.98 41.84 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.801 -0.714 . . . . 75.23 112.468 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.8 mmtt -81.67 149.57 64.47 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.537 0.684 . . . . 75.12 110.93 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -35.97 11.75 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.669 2.246 . . . . 73.32 112.334 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 38.97 39.3 0.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 72.04 111.096 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.89 -75.65 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 64.23 110.892 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -154.17 -38.57 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 64.04 110.875 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -72.72 -2.46 20.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 71.33 110.855 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -93.36 148.19 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 74.23 111.137 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.411 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 35.1 mttt -91.39 147.56 22.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 74.33 110.906 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 10.6 mt -51.88 -41.95 62.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 74.53 110.916 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.63 -15.59 80.54 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.76 -0.733 . . . . 73.31 112.462 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.69 -19.94 32.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.839 0.352 . . . . 73.43 111.108 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -83.47 -20.23 34.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 71.41 110.939 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt 53.74 43.02 31.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 74.32 110.816 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 mt -95.48 153.33 17.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 70.34 110.902 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -68.25 159.75 78.87 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.626 0.727 . . . . 75.33 110.872 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -36.77 10.16 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.663 2.242 . . . . 72.23 112.329 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.471 ' O ' ' C ' ' A' ' 70' ' ' THR . 14.8 p30 -78.44 -15.85 58.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 74.5 110.9 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.471 ' C ' ' O ' ' A' ' 69' ' ' ASN . 53.6 m -32.4 125.13 0.31 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 72.44 111.156 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.27 145.83 24.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 75.5 110.919 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.6 mm -115.61 128.36 72.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.27 -0.423 . . . . 74.11 111.126 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 37.0 mtt -99.71 141.74 32.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.478 . . . . 73.21 110.876 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.0 mtt -133.76 118.36 17.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 73.14 110.862 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.0 mmt -106.05 123.07 47.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 73.34 110.887 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.87 -157.16 28.87 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.765 -0.731 . . . . 71.03 112.526 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.3 t . . . . . 0 C--N 1.33 -0.266 0 CA-C-O 120.777 0.322 . . . . 75.22 111.115 -179.893 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.804 0.335 . . . . 75.32 111.116 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.4 mt -110.99 109.54 57.22 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.653 0.739 . . . . 74.43 110.9 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 156.62 62.86 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.685 2.256 . . . . 75.22 112.359 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.8 mt -150.57 137.67 13.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.247 -0.433 . . . . 64.41 111.083 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.8 mt -95.24 140.41 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 74.33 111.116 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.7 p -127.46 123.71 62.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 70.52 111.138 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.21 118.98 38.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.462 . . . . 73.14 110.872 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 10.5 t-105 -122.4 102.56 8.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.205 -0.452 . . . . 64.3 110.906 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.0 -82.84 0.74 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.785 -0.721 . . . . 45.35 112.504 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.77 19.73 0.78 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.73 -0.748 . . . . 55.44 112.464 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -129.08 175.55 8.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.753 0.311 . . . . 63.31 110.941 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -132.92 140.56 47.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 73.01 110.898 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -135.01 120.26 18.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.152 -0.476 . . . . 75.5 110.941 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.4 p -83.53 133.3 34.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.499 . . . . 75.45 110.825 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 73.6 t -95.98 126.83 48.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 74.23 111.169 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.5 p -137.39 92.77 2.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 72.23 111.117 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 174.03 -29.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 74.0 111.162 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -84.92 150.03 25.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 75.13 110.88 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.74 168.18 18.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 72.2 110.875 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.432 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 78.1 mt-10 -59.06 -22.03 60.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 63.23 110.852 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.3 -10.94 58.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.193 -0.458 . . . . 72.32 110.868 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -102.79 -150.14 0.41 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 54.02 110.869 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.03 168.07 20.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 74.03 111.129 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 91.1 t -63.29 -42.92 98.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 72.03 111.126 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.19 -29.47 69.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 74.04 110.907 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -71.06 -32.98 69.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.459 . . . . 62.42 110.863 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.45 -48.95 12.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 74.35 110.871 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.494 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.99 -56.13 22.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 73.31 110.911 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -57.47 -23.01 47.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 74.41 110.913 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -77.27 -55.36 5.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 70.15 110.884 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 pp -67.66 -42.4 82.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.494 . . . . 74.32 110.909 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.569 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.2 tmtt? -54.81 -27.69 43.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 65.34 110.901 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.47 -23.34 43.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.24 -0.436 . . . . 73.14 111.154 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.7 mt -76.85 -59.51 2.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 75.02 110.9 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.8 t -135.27 -27.24 1.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 74.54 111.165 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.569 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.72 -176.86 5.31 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.723 -0.751 . . . . 74.32 112.513 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.477 ' CG2' HD21 ' A' ' 39' ' ' LEU . 1.4 p -112.78 137.16 46.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.845 0.355 . . . . 65.21 111.136 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.589 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -53.48 150.0 13.55 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.561 0.696 . . . . 74.31 110.946 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -21.8 33.19 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.701 2.267 . . . . 64.12 112.37 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.16 -38.09 65.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 72.04 110.868 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -104.95 -40.05 6.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 73.34 110.881 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -96.48 158.31 15.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 73.21 110.895 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.72 140.37 51.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 74.01 110.893 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.32 135.25 54.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 74.2 110.945 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -75.74 -72.17 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 75.53 110.972 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.57 61.61 0.86 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.686 -0.769 . . . . 75.42 112.524 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.5 pp -58.19 -19.22 31.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 74.2 110.948 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.39 144.24 39.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 70.33 110.875 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.9 p -143.8 146.21 21.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 74.34 111.111 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt 54.77 31.92 16.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 72.53 110.914 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.16 -10.91 51.88 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.74 -0.743 . . . . 63.52 112.507 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -81.34 151.07 68.75 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.592 0.711 . . . . 73.14 110.885 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 55' ' ' ALA . 54.1 Cg_endo -69.74 -32.91 17.73 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.683 2.256 . . . . 72.41 112.347 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 54' ' ' PRO . . . 35.98 44.35 0.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 74.3 111.122 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.33 -75.75 0.05 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 75.41 110.869 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.72 -37.53 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 75.3 110.909 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -67.14 -8.99 35.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 71.21 110.884 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.417 ' HB ' HD23 ' A' ' 64' ' ' LEU . 17.7 t -78.61 145.65 9.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 74.32 111.132 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -89.9 151.14 21.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 74.44 110.89 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.432 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 19.8 mt -49.83 -47.42 51.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 73.44 110.909 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.48 -12.02 84.93 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.804 -0.712 . . . . 70.22 112.461 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.14 -32.15 44.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.817 0.341 . . . . 63.14 111.061 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.417 HD23 ' HB ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -77.81 -23.61 49.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 74.44 110.887 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp 63.41 37.49 10.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 74.22 110.95 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.2 mt -89.29 152.32 21.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 74.44 110.987 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.63 160.61 76.03 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.598 0.713 . . . . 72.31 110.882 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -34.85 13.7 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.649 2.232 . . . . 74.24 112.35 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.466 ' O ' ' C ' ' A' ' 70' ' ' THR . 10.5 m120 -78.8 -15.68 58.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 74.31 110.883 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.466 ' C ' ' O ' ' A' ' 69' ' ' ASN . 47.7 m -32.97 120.82 0.36 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 72.12 111.145 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -92.5 146.43 23.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 74.44 110.926 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.0 mm -115.8 128.89 72.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 72.32 111.168 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 44.7 mtm -99.74 141.6 32.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 73.24 110.883 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.8 mtt -131.74 125.72 32.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 74.41 110.876 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -116.01 120.09 37.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 75.54 110.889 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 163.05 -156.41 28.16 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.765 -0.731 . . . . 73.51 112.54 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.754 0.311 . . . . 75.43 111.128 -179.858 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.795 0.331 . . . . 52.3 111.106 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.4 mt -109.15 109.76 60.63 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.609 0.719 . . . . 75.41 110.936 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 156.13 64.07 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.698 2.265 . . . . 72.13 112.343 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.2 mt -150.51 136.08 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 72.44 111.115 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.6 mt -94.87 140.68 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 62.22 111.131 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.7 p -127.33 123.21 61.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 74.0 111.136 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.43 123.21 48.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.485 . . . . 75.44 110.899 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.2 t-105 -124.48 102.88 7.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.441 . . . . 72.24 110.91 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.55 -80.09 1.52 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.745 -0.74 . . . . 64.23 112.493 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.23 17.51 0.69 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.786 -0.721 . . . . 64.41 112.497 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 36.6 mm-40 -130.06 139.19 51.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.751 0.31 . . . . 72.45 110.949 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -103.1 142.06 34.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 72.51 110.903 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -136.28 116.54 13.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 74.31 110.947 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.4 p -82.45 131.2 35.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 75.32 110.88 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.9 t -92.29 138.81 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 73.33 111.136 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 p -148.76 92.42 1.99 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 74.45 111.155 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 173.63 -28.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 74.14 111.158 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -85.78 151.21 24.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 72.35 110.936 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.18 168.54 17.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 74.4 110.863 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.413 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 36.2 mt-10 -60.61 -22.09 63.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 71.41 110.901 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.63 -11.23 60.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.157 -0.474 . . . . 73.4 110.81 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -99.82 -151.15 0.39 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 63.33 110.838 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.64 168.86 17.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 63.01 111.114 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.4 t -65.62 -41.32 90.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 74.53 111.143 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.44 -28.63 69.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.141 -0.482 . . . . 73.11 110.92 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -70.73 -34.92 72.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 64.2 110.859 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 tt -80.76 -47.91 13.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 75.31 110.914 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.64 -56.57 18.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 73.13 110.911 179.812 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.15 -22.45 51.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 73.14 110.943 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -77.29 -55.17 5.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 75.33 110.879 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.3 pp -67.49 -43.45 80.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.141 -0.482 . . . . 73.22 110.902 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.564 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.84 -27.03 39.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 72.34 110.924 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.78 -23.74 41.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 74.34 111.146 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.9 mt -76.46 -59.75 2.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.439 . . . . 74.4 110.859 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.5 t -135.31 -28.07 1.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 74.23 111.163 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.8 -177.58 4.7 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.717 -0.754 . . . . 63.2 112.52 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.481 ' CG2' HD21 ' A' ' 39' ' ' LEU . 1.2 p -112.56 139.22 38.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.861 0.362 . . . . 75.21 111.082 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.592 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.52 150.67 16.55 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.622 0.725 . . . . 74.15 110.88 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.401 ' O ' ' O ' ' A' ' 43' ' ' GLN . 53.5 Cg_endo -69.73 -21.95 32.9 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.653 2.235 . . . . 72.44 112.353 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -54.29 -38.98 66.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 74.43 110.876 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.5 mtt85 -103.97 -40.27 6.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 73.15 110.889 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.406 ' HG2' HG12 ' A' ' 38' ' ' VAL . 1.7 pp0? -98.2 158.7 15.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 74.21 110.916 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.67 141.06 51.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 73.25 110.89 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.64 135.04 53.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 75.34 110.93 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -75.81 -75.57 0.18 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 74.03 110.906 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -96.15 60.34 1.36 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.725 -0.75 . . . . 72.32 112.459 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.8 pp -56.06 -23.85 36.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.905 0.383 . . . . 75.03 110.947 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -104.43 143.4 33.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 72.35 110.888 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.0 p -144.11 143.64 23.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 62.14 111.091 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 54.07 33.82 18.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 74.41 110.854 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.48 -15.04 42.96 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.714 -0.755 . . . . 63.41 112.452 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.6 mmtm -81.61 149.63 64.82 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.636 0.732 . . . . 75.35 110.858 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -35.98 11.71 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.663 2.242 . . . . 71.42 112.354 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 38.92 39.31 0.35 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 62.42 111.115 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.7 -75.47 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 75.22 110.878 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -154.61 -39.51 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 64.35 110.857 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -72.16 -4.11 27.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 64.02 110.875 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.4 t -90.04 147.48 5.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 73.1 111.099 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.485 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 13.4 mttp -90.35 147.13 23.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 74.03 110.933 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.413 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 16.1 mt -51.95 -38.1 55.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 74.03 110.882 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.69 -18.43 79.7 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.753 -0.736 . . . . 62.03 112.455 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.61 -14.89 47.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.857 0.36 . . . . 63.14 111.142 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 60' ' ' LYS . 0.7 OUTLIER -87.17 -18.02 31.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 65.22 110.944 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.16 45.65 23.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 71.04 110.914 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.5 mt -99.02 153.27 18.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 71.52 110.897 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.27 159.81 78.62 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.549 0.69 . . . . 73.53 110.932 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -36.71 10.32 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.707 2.271 . . . . 74.12 112.37 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.44 ' O ' ' C ' ' A' ' 70' ' ' THR . 1.7 m-80 -78.59 -15.81 58.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 63.5 110.872 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.44 ' C ' ' O ' ' A' ' 69' ' ' ASN . 51.8 m -32.63 123.65 0.35 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.475 . . . . 74.24 111.163 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.68 146.26 23.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 74.03 110.856 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.7 mm -115.45 131.83 66.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 71.13 111.115 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 26.5 mtm -104.14 142.04 35.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 74.31 110.866 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 75.0 mtm -134.44 118.6 17.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 75.33 110.91 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.1 mmt -106.2 126.1 51.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 73.32 110.858 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 157.87 -154.65 25.72 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.754 -0.736 . . . . 63.33 112.49 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.795 0.331 . . . . 63.14 111.164 -179.863 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.811 0.339 . . . . 74.43 111.132 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.1 mt -111.71 109.61 55.4 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.681 0.753 . . . . 74.51 110.888 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 156.34 63.61 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.652 2.234 . . . . 65.14 112.331 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.2 mt -150.34 136.81 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 74.13 111.129 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.6 mt -95.2 140.73 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 72.35 111.186 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.6 p -127.1 123.48 62.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 75.12 111.121 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.81 125.72 51.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 73.53 110.876 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.6 t-105 -125.01 100.74 6.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 75.23 110.911 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.22 -79.22 1.71 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.732 -0.747 . . . . 43.5 112.442 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.16 17.46 0.8 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.729 -0.748 . . . . 52.34 112.512 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -129.35 138.59 51.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.742 0.306 . . . . 71.42 110.909 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -102.94 142.28 34.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 73.21 110.94 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -136.69 116.15 12.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 75.22 110.867 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.86 133.87 35.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.086 -0.506 . . . . 62.21 110.858 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 89.7 t -95.71 139.55 18.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.08 -0.509 . . . . 74.43 111.091 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.3 p -149.02 92.91 2.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 71.51 111.151 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 173.67 -28.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 71.21 111.175 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -85.7 151.53 23.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.447 . . . . 74.04 110.919 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.39 168.96 16.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 74.0 110.843 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.411 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 22.5 mt-10 -61.09 -22.37 64.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 73.14 110.892 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.37 -11.33 60.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 75.0 110.856 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -99.94 -151.0 0.39 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 74.21 110.852 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.27 171.57 13.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 74.25 111.148 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.2 t -67.23 -42.02 87.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 74.31 111.153 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.57 -28.96 69.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.481 . . . . 74.34 110.876 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -70.46 -35.05 73.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.434 . . . . 70.13 110.893 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.67 -48.06 13.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 72.33 110.962 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.494 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.45 -56.51 19.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 75.14 110.885 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.2 -22.29 51.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 72.15 110.892 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -77.46 -55.14 5.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 74.31 110.858 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.4 pp -67.67 -43.07 81.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.176 -0.465 . . . . 71.52 110.897 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.565 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.98 -26.91 39.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 74.41 110.883 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -80.02 -23.85 41.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 72.31 111.12 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.1 mt -76.45 -59.85 2.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.456 . . . . 73.33 110.9 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.2 t -135.39 -28.09 1.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 71.11 111.131 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.52 -177.86 4.53 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.699 -0.762 . . . . 64.11 112.502 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.468 ' CG2' HD22 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -113.18 139.57 37.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.898 0.38 . . . . 64.52 111.149 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.594 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.39 151.3 14.19 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.617 0.722 . . . . 73.42 110.898 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -21.42 33.63 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.664 2.243 . . . . 72.43 112.383 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -54.83 -38.88 67.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 74.42 110.821 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 -103.73 -40.47 6.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 75.34 110.865 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -98.29 157.32 16.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 73.13 110.888 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.31 141.11 51.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 65.34 110.907 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.31 135.91 54.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 72.15 110.966 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.0 mp -78.15 -75.09 0.23 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 73.13 110.927 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.13 58.78 1.7 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.724 -0.75 . . . . 75.2 112.446 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.7 pp -55.15 -24.48 26.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.86 0.362 . . . . 73.04 110.905 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.89 143.39 32.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 74.11 110.944 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.7 p -144.25 143.49 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 74.14 111.142 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.6 mttp 54.01 34.04 18.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 75.41 110.934 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.38 -15.11 42.08 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.739 -0.743 . . . . 70.13 112.499 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -81.64 149.47 64.39 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.586 0.708 . . . . 74.02 110.912 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -35.86 11.99 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.705 2.27 . . . . 61.51 112.335 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 38.98 39.51 0.37 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 74.51 111.146 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.31 -74.0 0.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 72.44 110.89 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.402 HD21 ' N ' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -157.45 -36.31 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 74.34 110.889 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.402 ' N ' HD21 ' A' ' 57' ' ' ASN . 4.0 m-20 -75.3 -1.6 24.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 73.14 110.913 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -93.55 147.65 5.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.166 -0.47 . . . . 75.54 111.104 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.407 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 12.9 mttt -89.99 147.2 23.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 75.03 110.85 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 17.3 mt -52.71 -38.3 60.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 74.33 110.895 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.61 -17.21 80.21 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.712 -0.756 . . . . 75.55 112.501 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.39 -20.08 32.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.826 0.346 . . . . 73.44 111.097 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -83.96 -20.02 33.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.435 . . . . 75.34 110.923 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.3 mmtp 52.09 43.91 30.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 74.32 110.904 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.4 mt -95.03 153.12 17.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 75.24 110.898 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.57 159.77 79.87 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.588 0.709 . . . . 73.12 110.876 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 -36.8 10.24 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.699 2.266 . . . . 64.21 112.354 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.447 ' O ' ' C ' ' A' ' 70' ' ' THR . 2.4 m120 -78.45 -15.78 58.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 73.34 110.872 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.447 ' C ' ' O ' ' A' ' 69' ' ' ASN . 51.9 m -32.53 125.01 0.33 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 73.22 111.123 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.93 146.78 24.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 74.4 110.892 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.6 mm -115.17 129.96 70.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 74.02 111.164 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 41.2 mtm -101.01 142.87 31.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.478 . . . . 75.13 110.859 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.1 mtt -135.97 116.88 14.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 75.31 110.912 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 8.7 mmm -105.29 131.39 52.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 71.44 110.894 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 148.64 -151.9 24.02 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.71 -0.757 . . . . 73.23 112.51 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.753 0.311 . . . . 74.42 111.167 -179.932 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.822 0.344 . . . . 71.23 111.1 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.6 mt -111.38 109.37 56.35 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.595 0.712 . . . . 74.05 110.934 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 156.41 63.33 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.651 2.234 . . . . 72.02 112.35 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.3 mt -150.58 137.02 12.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 73.01 111.135 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.1 mt -94.96 140.57 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 73.41 111.134 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.5 p -127.1 122.86 61.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 73.42 111.091 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.66 119.82 40.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 73.34 110.89 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 16.6 t-105 -120.85 100.62 7.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.454 . . . . 72.25 110.944 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.87 -83.39 0.92 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.797 -0.716 . . . . 63.42 112.489 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.57 21.57 1.05 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.772 -0.728 . . . . 61.44 112.501 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -129.28 175.29 8.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.775 0.322 . . . . 73.13 110.904 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -133.19 140.96 47.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 74.52 110.916 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -136.51 119.14 16.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.173 -0.467 . . . . 74.53 110.973 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.2 p -84.13 132.35 34.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 75.12 110.849 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.9 t -94.98 125.98 47.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.069 -0.514 . . . . 75.42 111.138 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.2 p -136.49 93.12 2.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 72.01 111.174 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 173.51 -28.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 73.01 111.113 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -86.12 151.2 23.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.271 -0.422 . . . . 72.44 110.878 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.32 169.33 16.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 71.3 110.815 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.405 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 43.1 mt-10 -61.7 -22.18 65.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.106 -0.497 . . . . 72.1 110.922 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -70.16 -10.69 59.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 74.23 110.871 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -99.2 -150.44 0.37 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 75.02 110.842 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.32 168.53 18.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 74.24 111.144 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.0 t -64.67 -42.85 96.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 70.52 111.137 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.14 -28.47 69.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 73.02 110.9 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -70.81 -35.09 72.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 74.01 110.868 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.64 -47.73 13.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 75.15 110.906 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.499 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.97 -56.8 15.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 73.2 110.867 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -58.19 -22.1 50.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 74.42 110.906 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -77.48 -54.9 5.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 74.43 110.865 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.4 pp -68.28 -43.0 78.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 71.23 110.898 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.567 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -55.08 -26.91 41.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 75.02 110.909 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.82 -23.77 41.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.452 . . . . 73.0 111.141 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.7 mt -76.67 -60.26 2.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.234 -0.439 . . . . 75.24 110.87 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.8 t -135.41 -27.48 1.19 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 72.12 111.181 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.567 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.45 -178.4 4.74 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.759 -0.734 . . . . 70.42 112.521 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.489 ' CG2' HD23 ' A' ' 39' ' ' LEU . 1.2 p -112.91 139.06 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.889 0.376 . . . . 72.41 111.095 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.587 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.53 150.8 16.08 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.66 0.743 . . . . 75.42 110.92 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 -21.64 33.57 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.69 2.26 . . . . 72.55 112.358 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -54.41 -38.89 66.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 63.22 110.874 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.04 -40.52 6.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 74.54 110.865 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.41 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.7 pp0? -97.87 158.27 15.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 74.43 110.929 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.36 141.73 51.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 73.51 110.898 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.36 136.04 54.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.266 -0.425 . . . . 71.41 110.868 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -76.74 -75.91 0.18 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 73.43 110.898 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.26 56.83 1.74 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.735 -0.745 . . . . 54.51 112.473 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.0 pp -50.56 -32.31 18.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.877 0.37 . . . . 71.15 110.933 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.59 146.19 24.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 74.24 110.927 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.5 p -142.37 138.01 29.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 74.41 111.126 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt 54.53 32.2 16.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 74.22 110.893 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.42 -15.57 56.17 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.753 -0.737 . . . . 72.22 112.485 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -80.17 149.79 70.16 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.546 0.688 . . . . 74.23 110.901 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -36.27 11.04 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.729 2.286 . . . . 75.52 112.316 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 39.54 37.05 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 74.03 111.101 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.44 -76.83 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 75.11 110.9 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -153.87 -38.96 0.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 73.44 110.866 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -71.89 -2.61 18.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 73.4 110.882 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -92.93 147.7 5.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 73.15 111.15 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.416 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 15.4 mttp -91.27 147.84 22.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 74.41 110.916 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.405 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 17.6 mt -52.61 -38.45 60.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.248 -0.433 . . . . 64.12 110.907 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.7 -17.29 80.17 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.743 -0.741 . . . . 61.14 112.496 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.28 -19.97 32.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.854 0.359 . . . . 75.24 111.1 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -84.17 -19.27 34.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 61.25 110.944 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt 51.91 43.65 30.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 75.33 110.876 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.5 mt -94.26 152.3 18.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 75.42 110.956 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -68.45 159.79 79.38 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.595 0.712 . . . . 75.13 110.882 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -37.65 8.88 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.703 2.269 . . . . 74.53 112.333 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' A' ' 70' ' ' THR . 14.8 m-20 -78.56 -15.45 58.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 74.41 110.897 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.438 ' C ' ' O ' ' A' ' 69' ' ' ASN . 56.3 m -33.01 126.86 0.32 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.472 . . . . 73.1 111.172 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.78 145.77 25.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 74.21 110.915 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.3 mm -115.5 128.17 72.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 74.11 111.114 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 9.2 mtp -99.76 141.65 32.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 73.22 110.923 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.0 mtt -133.77 117.32 16.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 72.05 110.862 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.7 mmt -105.25 123.28 47.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 75.4 110.849 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 160.3 -157.22 28.56 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.699 -0.762 . . . . 74.21 112.519 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 120.783 0.325 . . . . 74.4 111.135 -179.899 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.796 0.332 . . . . 73.34 111.107 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.95 110.46 63.61 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.603 0.716 . . . . 73.52 110.928 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 156.32 63.58 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.692 2.262 . . . . 63.12 112.337 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 52.6 mt -150.81 136.86 12.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 74.13 111.116 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.5 mt -95.28 140.65 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 73.11 111.159 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.4 p -127.15 123.29 61.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 75.32 111.121 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.11 122.11 46.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 72.14 110.935 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.1 t-105 -123.18 102.89 8.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 75.3 110.899 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.76 -79.68 1.63 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.72 -0.752 . . . . 74.42 112.445 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.34 17.89 0.69 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.773 -0.727 . . . . 63.2 112.547 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -130.0 138.8 51.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.763 0.316 . . . . 62.23 110.928 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -102.71 142.37 33.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 62.52 110.867 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -136.36 116.69 13.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.474 . . . . 73.24 110.923 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.7 p -82.46 132.28 35.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.078 -0.51 . . . . 75.21 110.854 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.8 t -92.96 140.61 16.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 75.24 111.132 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.5 p -151.28 91.54 1.69 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 74.15 111.108 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 173.17 -28.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 75.23 111.132 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -86.53 150.61 24.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 74.02 110.909 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.03 165.6 23.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 74.31 110.828 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.471 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -57.48 -20.55 31.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.5 . . . . 75.42 110.856 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -67.09 -13.2 61.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 71.55 110.874 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -101.91 -145.65 0.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 72.32 110.813 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.28 167.13 22.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 74.21 111.176 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.6 t -62.1 -44.58 99.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 72.15 111.151 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.4 -27.75 67.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 64.42 110.944 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -71.74 -34.5 69.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 75.45 110.878 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 tt -80.16 -47.99 13.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 74.52 110.915 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.46 -55.87 26.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.198 -0.456 . . . . 74.4 110.84 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -57.28 -22.7 43.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 73.52 110.88 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -77.92 -55.37 5.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 73.44 110.875 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 pp -67.09 -43.02 83.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.476 . . . . 73.4 110.938 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.564 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.61 -27.5 39.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 72.41 110.919 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.63 -23.67 42.43 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.474 . . . . 65.31 111.191 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.2 mt -76.49 -59.31 2.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 74.0 110.923 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.6 t -135.02 -28.25 1.19 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 71.43 111.167 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.53 -176.86 5.1 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.73 -0.747 . . . . 65.11 112.532 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.494 ' CG2' HD21 ' A' ' 39' ' ' LEU . 1.3 p -113.09 139.26 39.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.867 0.365 . . . . 75.21 111.115 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.587 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.52 150.25 18.06 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.568 0.699 . . . . 72.05 110.93 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -21.96 32.54 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.713 2.275 . . . . 75.54 112.297 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -54.47 -38.89 66.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 62.41 110.908 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -103.91 -40.31 6.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 74.42 110.892 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.412 ' HG2' HG11 ' A' ' 38' ' ' VAL . 1.9 pp0? -97.35 158.06 15.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 73.52 110.91 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.03 142.52 51.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 75.11 110.928 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.31 135.95 54.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 71.41 110.938 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -77.4 -67.57 0.7 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 64.44 110.907 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.88 61.21 0.61 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.728 -0.748 . . . . 74.31 112.484 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.6 pp -59.2 -17.94 32.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.864 0.364 . . . . 73.32 110.897 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.71 144.16 42.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 74.43 110.904 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.9 p -143.82 145.63 21.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.428 . . . . 74.41 111.115 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp 54.67 32.32 17.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 75.22 110.887 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.25 -11.28 50.64 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.69 -0.767 . . . . 71.54 112.488 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.9 mmtp -81.4 151.45 69.03 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.551 0.691 . . . . 74.22 110.912 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.418 ' O ' ' C ' ' A' ' 55' ' ' ALA . 53.8 Cg_endo -69.68 -32.96 17.84 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.675 2.25 . . . . 75.31 112.349 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 54' ' ' PRO . . . 36.42 43.65 0.25 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 64.21 111.111 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.97 -76.52 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 71.42 110.88 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -159.26 -37.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 73.22 110.922 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -67.4 -8.13 30.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 75.34 110.899 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.0 t -80.2 145.54 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 75.23 111.112 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -90.63 150.82 21.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 75.11 110.898 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.471 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 12.6 mt -51.74 -45.06 63.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 75.15 110.903 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.54 -11.29 85.61 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.75 -0.738 . . . . 71.41 112.473 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.9 -35.25 29.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.805 0.336 . . . . 72.24 111.116 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.424 ' CD1' ' HA ' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -73.13 -24.53 60.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 52.21 110.871 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.8 mmtp 62.38 38.04 13.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 73.15 110.881 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.2 mt -88.85 153.48 21.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 74.21 110.916 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.45 160.3 76.85 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.583 0.706 . . . . 72.52 110.879 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -35.62 12.22 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.678 2.252 . . . . 74.42 112.322 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.448 ' O ' ' C ' ' A' ' 70' ' ' THR . 23.8 p30 -78.8 -15.88 57.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 74.22 110.92 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.448 ' C ' ' O ' ' A' ' 69' ' ' ASN . 55.4 m -32.42 120.13 0.3 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.143 -0.481 . . . . 71.42 111.151 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.72 146.39 23.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 71.52 110.924 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.9 mm -116.97 130.63 71.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 71.05 111.135 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 6.1 mtt -103.91 141.69 35.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 73.44 110.891 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 70.5 mtm -133.99 123.57 24.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.267 -0.424 . . . . 70.35 110.906 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.3 mmm -111.12 124.39 52.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 70.03 110.841 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 164.11 -153.96 24.58 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.716 -0.754 . . . . 61.42 112.45 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.9 t . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 120.838 0.352 . . . . 74.34 111.133 -179.867 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.804 0.335 . . . . 54.42 111.091 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.2 mt -110.79 109.1 57.79 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.621 0.724 . . . . 73.44 110.945 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 156.67 62.86 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.673 2.249 . . . . 70.42 112.34 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.1 mt -150.56 137.3 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.437 . . . . 75.44 111.147 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.1 mt -95.37 140.56 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 72.4 111.146 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.3 p -127.29 122.91 60.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 74.22 111.115 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -107.98 120.19 41.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 74.02 110.907 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.1 t-105 -122.27 100.91 7.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 75.44 110.903 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.91 -83.61 0.77 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.752 -0.737 . . . . 62.44 112.51 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.13 20.38 0.96 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.69 -0.767 . . . . 74.45 112.474 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -129.18 174.9 9.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.771 0.32 . . . . 74.13 110.902 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -132.7 140.64 48.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 62.41 110.934 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -135.92 119.1 16.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 73.24 110.925 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 89.2 p -82.75 136.05 34.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.101 -0.5 . . . . 70.31 110.892 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 87.3 t -98.87 125.23 52.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 74.31 111.108 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.4 p -135.44 93.41 2.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 64.54 111.121 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 173.73 -28.84 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 73.33 111.133 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -84.92 149.85 25.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.222 -0.444 . . . . 71.34 110.893 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.77 167.68 19.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 72.42 110.854 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.428 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 56.1 mt-10 -58.58 -22.39 55.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 74.01 110.887 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.11 -11.54 59.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 70.4 110.905 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -101.63 -150.24 0.4 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 74.3 110.836 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.53 167.57 21.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.462 . . . . 74.22 111.115 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 75.0 t -63.03 -42.26 96.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 72.33 111.143 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.97 -28.72 69.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.491 . . . . 73.15 110.901 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -72.06 -32.78 67.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 52.44 110.878 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.46 -48.93 12.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 70.15 110.917 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.499 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.76 -55.79 26.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 73.31 110.902 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.92 -22.64 49.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 72.33 110.918 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -77.76 -55.11 5.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.453 . . . . 74.3 110.87 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 pp -67.51 -41.93 83.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 75.23 110.915 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.567 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.71 -27.91 44.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 71.22 110.928 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.43 -23.84 42.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.455 . . . . 72.31 111.141 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.7 mt -76.15 -59.48 2.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.446 . . . . 75.51 110.877 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.4 t -135.38 -27.77 1.18 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 73.33 111.147 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.567 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.59 -175.34 4.36 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.766 -0.73 . . . . 53.34 112.495 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.489 ' CG2' HD23 ' A' ' 39' ' ' LEU . 1.4 p -112.56 141.38 28.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.807 0.337 . . . . 74.12 111.17 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.608 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -57.01 149.86 42.68 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.6 0.714 . . . . 74.01 110.885 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -21.4 33.48 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.707 2.272 . . . . 65.23 112.308 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -55.19 -39.25 69.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 71.21 110.835 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.29 -41.42 5.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 72.25 110.891 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.572 HE21 ' N ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -96.12 158.41 15.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 74.35 110.898 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.572 ' N ' HE21 ' A' ' 43' ' ' GLN . 0.0 OUTLIER -130.14 142.45 50.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 73.32 110.902 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.52 136.38 54.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 75.53 110.881 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.2 mp -86.13 -55.26 4.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 75.23 110.877 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.35 52.52 0.97 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.719 -0.753 . . . . 74.24 112.485 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.6 pp -61.67 -16.39 48.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.933 0.397 . . . . 75.51 110.942 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.9 pttt -116.8 143.25 45.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 74.14 110.876 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.6 p -143.73 145.17 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 74.41 111.137 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 55.34 31.52 16.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 74.44 110.924 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.09 -11.17 55.98 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.728 -0.749 . . . . 64.04 112.492 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -81.37 150.98 68.5 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.532 0.682 . . . . 74.14 110.938 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 55' ' ' ALA . 53.6 Cg_endo -69.79 -32.25 18.79 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.691 2.261 . . . . 74.24 112.302 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 54' ' ' PRO . . . 35.99 44.34 0.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.439 . . . . 73.11 111.128 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.08 -79.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 74.43 110.919 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.04 -38.8 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 74.33 110.884 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -64.6 -9.8 21.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 74.33 110.896 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.405 ' HB ' HD21 ' A' ' 64' ' ' LEU . 16.6 t -79.55 145.69 8.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 75.13 111.159 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -91.49 152.25 20.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.446 . . . . 73.44 110.937 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.428 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 20.0 mt -49.86 -47.47 51.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 75.22 110.928 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.72 -11.71 85.18 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.775 -0.726 . . . . 71.11 112.473 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.59 -31.55 41.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.837 0.351 . . . . 71.22 111.076 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.406 HD11 ' HA ' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -78.17 -23.99 47.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 74.12 110.925 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.7 mmtp 63.45 35.84 11.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 73.45 110.875 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.7 mt -87.78 152.88 21.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.439 . . . . 72.22 110.925 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.7 160.44 77.14 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.627 0.727 . . . . 74.44 110.897 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -34.82 13.77 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.657 2.238 . . . . 74.42 112.355 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.467 ' O ' ' C ' ' A' ' 70' ' ' THR . 12.3 m120 -78.81 -16.1 57.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 74.13 110.859 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.467 ' C ' ' O ' ' A' ' 69' ' ' ASN . 49.1 m -32.5 120.17 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 75.12 111.162 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.17 146.68 23.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 71.53 110.891 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.5 mm -115.37 128.95 72.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 74.24 111.147 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 30.8 mtt -99.7 142.67 30.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 72.43 110.865 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.3 mtt -134.08 132.73 40.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 75.35 110.854 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.3 mmt -124.58 123.5 40.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 74.5 110.88 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.13 -155.19 26.02 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.733 -0.746 . . . . 75.1 112.472 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.775 0.321 . . . . 72.24 111.131 -179.836 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.818 0.342 . . . . 74.14 111.112 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.4 mt -112.13 109.68 54.33 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.589 0.709 . . . . 72.33 110.927 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 156.42 63.49 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.689 2.259 . . . . 72.54 112.364 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.8 mt -150.56 137.45 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 75.34 111.134 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.3 mt -95.39 140.65 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 71.15 111.137 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.95 123.28 62.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 72.21 111.108 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.52 120.73 43.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 74.15 110.865 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 17.3 t-105 -123.87 105.03 9.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 74.13 110.878 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.88 -81.81 0.9 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.767 -0.73 . . . . 70.03 112.483 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.04 20.25 0.66 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.782 -0.723 . . . . 73.13 112.513 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -129.13 175.35 8.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.756 0.312 . . . . 74.31 110.947 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -132.74 140.12 47.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 75.51 110.899 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -134.7 116.33 14.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.172 -0.467 . . . . 73.51 110.913 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.0 p -82.93 130.59 35.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.504 . . . . 75.33 110.864 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 91.6 t -91.74 142.0 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 74.14 111.148 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.2 p -151.49 92.31 1.76 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 72.41 111.156 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 173.74 -29.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 64.42 111.148 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -86.25 152.2 22.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 70.43 110.92 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.55 169.75 15.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 75.01 110.851 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.434 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 58.2 mt-10 -61.85 -22.23 65.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 74.22 110.914 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -68.8 -12.05 61.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.17 -0.468 . . . . 75.52 110.887 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -99.78 -150.52 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 73.02 110.88 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.53 171.37 13.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 65.43 111.17 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.8 t -67.69 -40.96 84.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 72.52 111.119 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.19 -29.4 70.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 72.52 110.905 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -70.1 -35.12 73.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 71.41 110.845 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 tt -80.76 -47.67 13.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 74.24 110.938 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.494 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.86 -56.5 18.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 75.14 110.892 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.15 -22.75 52.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.434 . . . . 73.34 110.915 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -76.86 -55.48 5.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 72.0 110.864 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.2 pp -67.29 -43.43 81.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 75.13 110.889 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.567 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.2 tmtt? -54.81 -27.48 42.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 73.31 110.914 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.34 -23.51 43.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 75.03 111.161 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.6 mt -76.65 -59.59 2.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 72.1 110.929 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.7 t -135.01 -27.68 1.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 75.22 111.158 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.567 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.59 -176.68 5.07 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.777 -0.725 . . . . 71.53 112.457 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.496 ' CG2' HD21 ' A' ' 39' ' ' LEU . 1.4 p -112.38 138.54 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.887 0.375 . . . . 73.32 111.144 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.599 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.06 149.75 17.35 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.575 0.703 . . . . 74.11 110.947 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -21.97 32.7 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.669 2.246 . . . . 73.32 112.335 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -53.94 -38.43 64.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 73.11 110.907 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.08 -39.52 6.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 74.43 110.919 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -96.54 158.66 15.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 71.2 110.892 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.02 139.33 52.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 74.54 110.871 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.81 135.45 54.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.257 -0.429 . . . . 75.24 110.898 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.2 mp -77.45 -75.81 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.467 . . . . 73.0 110.907 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.12 59.44 1.68 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.755 -0.736 . . . . 65.43 112.508 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.6 pp -55.83 -24.39 36.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.874 0.369 . . . . 74.25 110.914 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -103.45 143.16 33.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 73.44 110.854 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.4 p -144.19 143.36 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.42 . . . . 74.52 111.126 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.6 mttm 54.04 34.17 19.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 74.25 110.865 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.38 -15.16 41.79 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.741 -0.743 . . . . 74.34 112.47 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -81.56 149.59 64.95 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.557 0.694 . . . . 74.51 110.887 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -36.4 10.85 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.714 2.276 . . . . 70.24 112.344 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 38.4 40.01 0.33 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 71.51 111.075 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -66.94 -74.37 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 74.13 110.865 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -156.54 -37.31 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 75.25 110.87 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -74.67 -2.98 28.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 75.31 110.897 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.3 t -91.15 146.94 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 62.15 111.13 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.467 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 24.6 mttt -89.04 146.55 24.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 73.25 110.943 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.434 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 18.3 mt -52.12 -37.58 54.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.256 -0.429 . . . . 72.44 110.906 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.93 -18.24 79.62 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.748 -0.739 . . . . 71.33 112.47 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.73 -15.56 44.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.883 0.373 . . . . 72.21 111.141 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 60' ' ' LYS . 0.7 OUTLIER -87.04 -18.31 30.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 74.32 110.913 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 49.66 45.08 24.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 73.11 110.924 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.4 mt -97.86 152.99 18.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 65.34 110.923 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.42 159.81 79.15 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.547 0.689 . . . . 75.21 110.911 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -36.57 10.51 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.682 2.255 . . . . 64.04 112.332 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.467 ' O ' ' C ' ' A' ' 70' ' ' THR . 5.0 m120 -78.45 -15.59 58.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 75.22 110.911 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.467 ' C ' ' O ' ' A' ' 69' ' ' ASN . 52.2 m -32.93 125.68 0.34 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 75.21 111.126 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.88 145.29 25.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 74.34 110.887 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.3 mm -115.57 131.9 66.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 74.0 111.14 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.2 mtp -101.99 141.78 34.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 73.11 110.913 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 75.9 mtm -133.47 120.0 20.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 74.33 110.856 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.5 mmt -109.7 123.8 50.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 74.14 110.921 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 162.73 -155.56 26.94 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 72.04 112.48 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.9 t . . . . . 0 C--N 1.33 -0.266 0 CA-C-O 120.8 0.333 . . . . 74.41 111.134 -179.866 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.768 0.318 . . . . 75.33 111.121 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.9 mt -110.49 108.89 58.36 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.665 0.745 . . . . 73.11 110.892 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 156.52 63.05 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.735 2.29 . . . . 74.3 112.33 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.0 mt -150.5 137.24 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 73.35 111.128 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.6 mt -94.96 140.57 16.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 75.33 111.143 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.0 p -127.28 122.88 60.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 74.32 111.153 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -107.31 118.85 37.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 73.1 110.9 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 16.8 t-105 -121.18 101.59 7.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.233 -0.44 . . . . 73.34 110.895 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.48 -83.24 0.79 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.81 -0.71 . . . . 72.14 112.524 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.85 20.55 0.89 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.756 -0.735 . . . . 54.21 112.488 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -129.2 175.83 8.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.711 0.291 . . . . 73.11 110.957 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -132.88 140.78 48.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 73.42 110.903 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -136.62 118.13 14.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.147 -0.479 . . . . 73.34 110.931 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.02 133.94 35.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 73.34 110.856 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.3 t -96.02 126.91 48.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 74.11 111.124 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.1 p -135.94 91.99 2.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 74.33 111.121 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 t 174.62 -29.69 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 75.32 111.125 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -83.4 149.62 26.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 75.03 110.91 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.5 168.01 18.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 75.33 110.844 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.405 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 36.9 mt-10 -59.24 -22.01 60.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 73.53 110.896 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -69.11 -10.7 58.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 71.3 110.873 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -100.89 -150.19 0.39 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 75.0 110.855 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.07 167.99 20.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 75.55 111.141 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.8 t -62.38 -45.02 99.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 73.53 111.158 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.78 -28.54 68.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.475 . . . . 75.44 110.918 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.05 -33.56 70.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 65.45 110.938 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.86 -48.97 11.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 73.1 110.902 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.491 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.4 -56.58 18.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 72.34 110.858 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -58.29 -22.04 51.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 74.44 110.93 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -77.88 -54.93 5.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 74.04 110.854 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.6 pp -67.73 -42.24 82.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 73.41 110.929 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.575 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.88 -27.39 42.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 74.42 110.889 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.77 -23.77 41.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 74.01 111.207 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.9 mt -76.5 -59.94 2.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 64.41 110.896 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.9 t -135.28 -27.62 1.2 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.443 . . . . 74.25 111.162 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.575 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.61 -177.81 4.61 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.729 -0.748 . . . . 72.14 112.532 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.462 ' CG2' HD23 ' A' ' 39' ' ' LEU . 1.3 p -112.66 138.56 41.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.827 0.346 . . . . 75.21 111.145 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.591 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -55.17 151.17 18.45 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.614 0.721 . . . . 71.11 110.903 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -21.61 33.51 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.718 2.279 . . . . 74.2 112.334 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -54.38 -38.91 66.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 75.43 110.869 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -104.14 -40.4 6.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 74.14 110.897 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.411 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.7 pp0? -97.86 158.43 15.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 72.32 110.917 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.64 140.85 51.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 73.14 110.861 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.35 135.75 53.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.461 . . . . 74.05 110.913 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -81.05 -64.39 1.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 73.24 110.91 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.63 56.89 1.64 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.781 -0.723 . . . . 71.33 112.516 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.532 ' CD2' ' C ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -59.72 -13.4 9.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.886 0.374 . . . . 70.43 110.905 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.31 145.97 47.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 73.3 110.903 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.6 p -143.75 144.06 23.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.207 -0.451 . . . . 74.02 111.109 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.2 mttt 54.72 31.14 14.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 73.11 110.907 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.24 -9.99 59.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.763 -0.732 . . . . 70.55 112.485 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -81.04 150.25 68.18 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.576 0.703 . . . . 73.23 110.88 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.411 ' O ' ' C ' ' A' ' 55' ' ' ALA . 53.7 Cg_endo -69.76 -30.53 22.12 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.7 2.267 . . . . 62.12 112.328 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 54' ' ' PRO . . . 35.5 43.28 0.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 53.2 111.102 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.33 -78.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 74.43 110.929 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -157.44 -38.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 75.41 110.845 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -66.12 -8.59 24.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.221 -0.445 . . . . 73.42 110.838 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.4 t -78.79 146.55 7.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 75.52 111.133 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -93.24 151.14 20.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 54.45 110.885 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.405 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 18.9 mt -50.64 -45.64 57.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.264 -0.425 . . . . 74.33 110.882 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.38 -12.02 84.59 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.79 -0.719 . . . . 64.22 112.474 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.14 -33.45 29.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.8 0.333 . . . . 63.02 111.077 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.09 -25.07 60.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 73.33 110.905 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt 62.63 37.75 12.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.218 -0.446 . . . . 73.12 110.891 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.8 mt -91.31 152.98 20.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.266 -0.424 . . . . 75.1 110.928 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -68.7 160.71 75.86 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.589 0.709 . . . . 74.23 110.909 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -35.42 12.61 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.696 2.264 . . . . 74.33 112.356 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.472 ' O ' ' C ' ' A' ' 70' ' ' THR . 8.6 m-20 -78.86 -15.96 57.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 75.03 110.906 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.472 ' C ' ' O ' ' A' ' 69' ' ' ASN . 54.6 m -32.51 124.72 0.33 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 70.52 111.133 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.4 147.0 23.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 74.31 110.859 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.6 mm -116.93 127.5 74.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 74.32 111.128 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.4 mtt -99.22 141.87 31.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 74.24 110.838 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.9 mtt -136.14 117.22 14.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 74.2 110.864 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.4 mmt -106.19 125.78 51.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 74.54 110.863 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 160.26 -155.3 26.42 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.763 -0.732 . . . . 62.12 112.487 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.0 t . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 120.779 0.323 . . . . 74.43 111.163 -179.893 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.792 0.33 . . . . 72.51 111.116 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.9 mt -111.08 109.36 57.11 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.59 0.71 . . . . 75.2 110.865 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 156.05 64.39 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.738 2.292 . . . . 71.34 112.356 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 53.4 mt -150.7 135.96 10.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.452 . . . . 74.21 111.146 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.3 mt -94.24 140.4 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 73.24 111.118 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.9 p -127.34 123.39 61.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 74.21 111.121 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.64 123.01 48.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 71.13 110.866 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.0 t-105 -123.87 100.49 6.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 73.54 110.9 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.23 -80.41 1.3 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.718 -0.753 . . . . 62.42 112.458 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.25 17.24 0.79 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.735 . . . . 71.41 112.48 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -129.89 139.03 51.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.774 0.321 . . . . 64.15 110.943 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -103.07 142.39 34.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 70.23 110.846 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -135.84 117.27 14.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 75.12 110.92 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 82.6 p -81.82 132.6 35.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 62.22 110.829 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 99.9 t -93.31 136.31 25.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 74.45 111.155 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.2 p -147.55 92.38 2.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 74.35 111.145 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 173.51 -28.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 74.42 111.152 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -85.98 150.72 24.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 70.1 110.911 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.81 168.7 17.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.464 . . . . 74.3 110.876 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.43 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 69.9 mt-10 -59.51 -22.14 61.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 63.33 110.893 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.04 -12.57 60.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 72.52 110.883 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -101.97 -148.7 0.38 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 72.24 110.874 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.64 168.28 19.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 74.24 111.13 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 86.9 t -63.02 -45.15 99.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 64.23 111.103 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.8 -27.95 67.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 74.25 110.94 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -71.79 -33.78 68.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.193 -0.458 . . . . 73.0 110.835 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.67 -48.28 12.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 75.51 110.907 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.64 -55.79 26.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 75.0 110.86 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.51 -22.5 44.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 74.41 110.94 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -77.75 -55.06 5.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 74.43 110.891 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 pp -67.76 -42.93 81.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 74.13 110.945 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.571 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.62 -27.53 40.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 73.21 110.923 179.797 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.46 -23.6 42.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.465 . . . . 75.53 111.15 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.2 mt -76.58 -59.15 2.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 74.32 110.958 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.5 t -134.95 -28.09 1.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.444 . . . . 74.32 111.132 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.571 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.79 -176.52 5.21 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.727 -0.749 . . . . 73.12 112.499 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.491 ' CG2' HD23 ' A' ' 39' ' ' LEU . 1.3 p -113.39 138.28 43.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.834 0.349 . . . . 74.31 111.145 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.578 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -53.61 149.94 14.39 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.633 0.73 . . . . 74.41 110.911 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.401 ' O ' ' O ' ' A' ' 43' ' ' GLN . 53.5 Cg_endo -69.78 -21.72 33.01 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.647 2.231 . . . . 64.21 112.373 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -54.06 -38.33 65.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 63.54 110.882 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.76 -40.05 6.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 73.02 110.838 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -96.72 158.05 15.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 65.35 110.876 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.65 140.78 51.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 75.45 110.896 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.72 135.85 54.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.434 . . . . 73.22 110.906 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -75.15 -70.25 0.43 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 74.03 110.911 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -99.73 61.22 0.73 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.708 -0.758 . . . . 62.33 112.455 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.5 pp -57.7 -19.63 28.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.879 0.371 . . . . 71.11 110.929 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.34 144.47 39.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 74.14 110.865 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.7 p -143.83 145.57 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 72.13 111.134 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.9 mttm 54.89 32.24 17.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 73.15 110.892 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.04 -11.16 50.04 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.749 -0.738 . . . . 74.41 112.445 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.0 mmtt -81.3 151.31 69.19 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.581 0.705 . . . . 75.25 110.878 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 55' ' ' ALA . 53.8 Cg_endo -69.81 -32.92 17.43 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.665 2.244 . . . . 71.44 112.313 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 54' ' ' PRO . . . 36.6 43.51 0.27 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 73.14 111.059 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.47 -76.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.203 -0.453 . . . . 72.04 110.919 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -159.47 -37.28 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 43.24 110.913 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.27 -7.8 27.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 73.02 110.9 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.402 ' HB ' HD22 ' A' ' 64' ' ' LEU . 17.6 t -80.52 145.72 8.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 70.23 111.096 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -90.23 151.46 21.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 75.1 110.913 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.43 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 18.6 mt -49.92 -47.62 52.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 75.24 110.924 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.57 -11.95 84.98 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.739 -0.744 . . . . 63.35 112.498 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.04 -32.06 44.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.822 0.344 . . . . 62.14 111.104 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.409 HD11 ' HA ' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -77.83 -23.48 48.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 74.44 110.912 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt 63.39 37.2 10.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 72.3 110.916 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.1 mt -88.79 152.56 21.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 72.43 110.939 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -68.64 160.24 77.85 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.572 0.701 . . . . 74.23 110.878 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -35.54 12.58 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.68 2.254 . . . . 74.12 112.385 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.445 ' O ' ' C ' ' A' ' 70' ' ' THR . 8.2 p30 -78.5 -15.78 58.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 75.25 110.908 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.445 ' C ' ' O ' ' A' ' 69' ' ' ASN . 50.1 m -32.83 119.47 0.32 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 74.4 111.14 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -91.05 146.77 23.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 73.12 110.903 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.3 mm -115.36 129.78 71.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.436 . . . . 74.12 111.106 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 41.3 mtm -101.45 141.65 34.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 74.01 110.875 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.1 mtt -130.78 130.1 43.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 70.42 110.879 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.3 mmt -122.21 127.04 49.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 74.32 110.858 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.88 -150.87 22.52 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.714 -0.755 . . . . 74.4 112.468 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.742 0.306 . . . . 73.53 111.114 -179.851 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.828 0.347 . . . . 73.55 111.131 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 mt -114.45 107.44 51.24 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.628 0.728 . . . . 75.4 110.9 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 156.02 64.43 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.664 2.243 . . . . 64.41 112.364 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.9 mt -150.88 138.63 13.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 72.14 111.102 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.2 mt -95.13 140.72 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 75.44 111.094 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.8 p -126.9 123.24 62.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 74.3 111.142 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.21 118.53 37.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 73.54 110.902 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 17.4 t-105 -120.57 103.77 9.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 73.1 110.938 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.41 -83.26 0.88 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.723 -0.751 . . . . 70.11 112.481 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.06 20.18 0.86 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.678 -0.772 . . . . 71.34 112.448 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -128.84 175.69 8.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.715 0.293 . . . . 75.5 110.932 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -132.79 141.84 48.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 72.43 110.92 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -138.49 116.46 11.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 73.44 110.889 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.21 137.35 35.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 74.12 110.855 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 84.3 t -94.21 142.45 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 60.41 111.141 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.4 p -155.26 90.83 1.29 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 74.43 111.198 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 t 177.11 -31.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 75.54 111.138 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.415 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -88.02 163.67 16.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.44 . . . . 75.31 110.932 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.24 173.96 11.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 73.34 110.862 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.41 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 36.6 mt-10 -63.13 -20.03 65.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.482 . . . . 74.21 110.879 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -69.42 -11.09 60.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 74.45 110.896 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -97.76 -152.08 0.39 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 74.44 110.896 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -137.09 165.3 26.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 63.25 111.143 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 72.6 t -59.04 -43.87 90.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 74.32 111.091 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.56 -30.54 71.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 75.11 110.918 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.413 ' HB3' HD21 ' A' ' 19' ' ' LEU . 5.6 t70 -72.22 -33.85 67.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 54.53 110.864 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.415 ' HA ' ' CD1' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -78.8 -47.89 15.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 65.32 110.889 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -62.75 -54.22 42.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 74.13 110.892 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.49 -22.11 30.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 74.54 110.884 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -77.57 -55.15 5.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 63.21 110.915 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.1 pp -68.45 -42.24 79.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.477 . . . . 73.15 110.872 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.572 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.65 -27.51 40.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 65.04 110.927 179.818 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.62 -23.76 42.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 74.12 111.106 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.8 mt -76.4 -59.9 2.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.42 . . . . 74.23 110.893 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.5 t -135.14 -27.8 1.21 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.203 -0.453 . . . . 73.15 111.111 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.572 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.8 -177.55 4.68 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.778 -0.725 . . . . 41.43 112.486 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.472 ' CG2' HD22 ' A' ' 39' ' ' LEU . 1.3 p -112.7 138.59 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.842 0.353 . . . . 65.42 111.137 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.592 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.78 150.93 16.67 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.632 0.73 . . . . 73.42 110.868 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 -21.7 32.78 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.638 2.225 . . . . 72.33 112.355 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -54.09 -39.14 66.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 74.11 110.872 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.2 mtt85 -104.04 -40.44 6.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 73.33 110.884 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.402 ' HG2' HG12 ' A' ' 38' ' ' VAL . 1.8 pp0? -97.23 157.21 16.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 72.25 110.914 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.83 143.31 50.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 74.12 110.902 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.57 136.1 53.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 75.4 110.908 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.3 mp -86.13 -53.0 5.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 71.03 110.904 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -104.68 53.37 0.68 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.718 -0.754 . . . . 63.55 112.474 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.5 pp -59.67 -17.91 37.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.855 0.359 . . . . 71.55 110.886 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.93 143.13 45.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 72.43 110.91 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.5 p -143.67 145.3 22.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 75.13 111.094 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.92 31.86 16.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 74.5 110.868 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.99 -10.99 56.54 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.756 -0.735 . . . . 72.33 112.494 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -81.62 150.99 67.67 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.61 0.719 . . . . 71.21 110.9 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 55' ' ' ALA . 54.3 Cg_endo -69.73 -32.74 18.1 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.709 2.273 . . . . 75.15 112.353 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 54' ' ' PRO . . . 36.04 44.25 0.25 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 65.02 111.083 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.77 -80.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 64.24 110.918 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -154.65 -39.26 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 72.22 110.886 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.69 -10.39 19.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 74.44 110.864 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.6 t -79.28 146.1 8.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 74.51 111.141 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 14.6 mttt -93.02 152.16 19.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 74.12 110.892 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.41 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 24.3 mt -50.13 -46.56 53.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 74.02 110.939 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.22 -12.02 84.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.742 -0.742 . . . . 70.04 112.435 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.92 -33.1 34.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.883 0.373 . . . . 73.24 111.111 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.23 -24.6 59.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 73.42 110.917 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt 62.95 37.86 11.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 73.41 110.955 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mt -90.76 154.11 19.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 65.44 110.905 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -68.35 160.26 76.62 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.574 0.702 . . . . 74.1 110.929 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 -35.51 12.71 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.68 2.253 . . . . 71.52 112.395 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.459 ' O ' ' C ' ' A' ' 70' ' ' THR . 7.8 m-20 -78.83 -16.32 57.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 73.12 110.94 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.459 ' C ' ' O ' ' A' ' 69' ' ' ASN . 55.5 m -32.45 126.11 0.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 74.4 111.142 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.34 147.5 23.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 73.24 110.874 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.0 mm -117.54 128.64 74.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 75.43 111.168 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 6.5 mtt -99.02 141.87 31.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 74.34 110.863 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.7 mtt -137.03 116.96 13.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 73.23 110.883 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.2 mmm -107.14 126.13 51.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 74.41 110.893 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.83 -155.05 26.19 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.735 . . . . 75.1 112.475 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.3 t . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.764 0.316 . . . . 64.34 111.133 -179.864 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.875 0.369 . . . . 74.43 111.06 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 mt -110.9 108.11 57.74 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.644 0.735 . . . . 74.44 110.911 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 155.72 65.07 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.666 2.244 . . . . 74.33 112.338 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.4 mt -150.95 138.68 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 73.13 111.12 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.1 mt -94.78 140.79 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 72.44 111.109 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.4 p -126.63 123.13 62.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.124 -0.489 . . . . 74.44 111.154 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -107.77 117.38 33.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 73.41 110.863 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 17.9 t-105 -119.84 102.07 8.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 72.31 110.902 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.09 -82.93 0.81 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.748 -0.739 . . . . 54.35 112.505 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.26 19.93 0.83 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.734 -0.745 . . . . 73.23 112.471 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -128.26 175.72 8.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.75 0.31 . . . . 73.34 110.938 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -132.99 141.7 48.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 72.42 110.875 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -138.28 118.38 13.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.16 -0.473 . . . . 73.25 110.938 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.4 p -82.62 135.38 35.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 75.32 110.898 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 62.3 t -94.36 130.58 43.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 72.33 111.13 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.5 p -144.37 90.55 2.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 73.31 111.123 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.8 t 177.68 -32.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 73.13 111.119 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.41 HD21 ' HB3' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -87.86 164.12 16.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 72.21 110.898 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.42 174.82 10.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 74.52 110.877 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -64.8 -20.46 66.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 72.13 110.873 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -67.73 -20.98 65.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 72.32 110.852 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.31 -150.36 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 73.24 110.84 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.97 162.68 33.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 75.33 111.121 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 22.0 t -55.5 -48.53 77.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.45 . . . . 74.33 111.12 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.29 -28.33 69.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 73.53 110.929 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.41 ' HB3' HD21 ' A' ' 19' ' ' LEU . 9.3 t70 -71.56 -36.24 70.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 74.12 110.901 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.402 ' HA ' ' CD1' ' A' ' 19' ' ' LEU . 0.9 OUTLIER -77.2 -47.72 19.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 72.0 110.894 -179.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.486 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -62.47 -55.11 30.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 75.14 110.875 179.83 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -56.62 -22.65 35.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 74.11 110.878 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -76.77 -55.08 5.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 73.43 110.874 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.8 pp -69.01 -41.86 77.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 74.5 110.875 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.571 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.2 tmtt? -54.85 -27.72 44.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 74.1 110.899 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.33 -23.41 43.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.461 . . . . 74.35 111.157 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.5 mt -76.98 -59.77 2.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 73.13 110.915 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.8 t -135.66 -27.64 1.15 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.458 . . . . 71.51 111.176 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.571 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.66 -177.77 4.64 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.704 -0.76 . . . . 74.24 112.506 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.469 ' CG2' HD21 ' A' ' 39' ' ' LEU . 1.3 p -112.31 138.88 39.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.88 0.371 . . . . 73.33 111.159 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.589 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.78 151.04 16.25 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.635 0.731 . . . . 75.33 110.913 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 -21.79 33.09 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.713 2.275 . . . . 74.41 112.318 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -54.17 -39.11 66.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 64.14 110.911 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -104.02 -40.21 6.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 73.52 110.855 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -97.84 157.37 16.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 71.35 110.881 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.06 142.1 51.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 75.23 110.902 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.45 135.95 53.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 72.05 110.916 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.2 mp -85.37 -60.49 2.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 73.45 110.939 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.82 51.63 0.97 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.755 -0.736 . . . . 64.35 112.494 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.6 pp -55.2 -25.45 32.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.909 0.385 . . . . 75.22 110.929 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -107.34 141.76 38.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 75.12 110.88 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.8 t -143.95 144.97 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 63.11 111.113 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 54.34 32.41 16.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 74.25 110.944 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.07 -14.45 49.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.716 -0.755 . . . . 64.22 112.467 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -81.55 148.74 63.04 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.6 0.714 . . . . 72.53 110.866 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.41 ' O ' ' C ' ' A' ' 55' ' ' ALA . 53.5 Cg_endo -69.82 -35.0 13.27 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.696 2.264 . . . . 72.11 112.341 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 54' ' ' PRO . . . 37.39 41.49 0.26 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 75.03 111.132 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.73 -76.89 0.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 71.55 110.885 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -150.98 -39.44 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 75.33 110.892 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -71.96 -2.63 18.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 71.32 110.875 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.78 147.44 5.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 74.14 111.155 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.472 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 30.8 mttt -93.93 149.05 21.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 74.55 110.888 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 17.4 mt -51.98 -39.74 59.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 74.03 110.956 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.13 -16.49 80.56 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.767 -0.73 . . . . 73.01 112.489 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.91 -19.75 31.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.814 0.34 . . . . 64.12 111.096 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -85.05 -18.89 32.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 73.1 110.899 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp 52.31 42.63 31.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 73.1 110.879 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 mt -91.12 153.64 19.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 75.41 110.921 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.47 159.13 82.74 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.6 0.714 . . . . 75.33 110.842 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -37.21 9.56 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.69 2.26 . . . . 75.11 112.339 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.462 ' O ' ' C ' ' A' ' 70' ' ' THR . 11.7 p30 -79.42 -16.31 56.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 64.44 110.856 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.462 ' C ' ' O ' ' A' ' 69' ' ' ASN . 65.8 m -31.77 132.4 0.11 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 63.14 111.144 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.86 145.92 28.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 75.4 110.916 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.5 mm -115.63 128.75 72.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.245 -0.434 . . . . 74.53 111.117 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.2 mtt -99.35 141.45 32.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 74.33 110.918 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.9 mtt -136.65 116.71 13.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 75.43 110.878 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.9 mmm -106.38 127.13 53.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 73.14 110.88 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.98 -155.92 27.08 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.697 -0.764 . . . . 55.14 112.436 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.3 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.768 0.318 . . . . 71.53 111.195 -179.871 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.77 0.319 . . . . 74.32 111.143 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -105.66 109.82 63.58 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.608 0.718 . . . . 63.44 110.934 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 156.46 63.45 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.716 2.277 . . . . 64.55 112.356 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.1 mt -149.98 137.01 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 75.15 111.132 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 mt -95.33 140.58 16.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 73.31 111.134 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.42 123.5 61.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 72.43 111.142 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.35 121.44 45.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 73.45 110.9 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 17.3 t-105 -125.17 106.25 9.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 74.44 110.928 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.16 -81.29 0.86 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.744 -0.741 . . . . 71.34 112.464 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -155.12 19.83 0.56 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.745 -0.741 . . . . 75.41 112.487 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -129.3 175.23 8.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.793 0.33 . . . . 72.2 110.865 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -132.43 140.09 48.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 63.33 110.881 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -134.39 116.13 14.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 63.43 110.979 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.76 131.49 35.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.488 . . . . 74.33 110.858 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 90.4 t -92.79 141.43 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 74.2 111.143 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.3 p -150.58 92.62 1.87 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 75.22 111.142 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 173.29 -28.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 74.22 111.137 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -86.36 150.81 24.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.248 -0.433 . . . . 74.45 110.93 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.67 167.55 19.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 70.11 110.83 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.426 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 40.3 mt-10 -59.41 -22.24 61.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 64.2 110.892 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.0 -11.52 60.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.144 -0.48 . . . . 72.02 110.852 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -100.34 -150.37 0.38 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 75.44 110.837 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.94 170.09 15.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 71.25 111.15 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.8 t -66.1 -43.75 92.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 73.12 111.114 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.4 -28.77 68.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 65.23 110.926 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -69.97 -35.62 74.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 61.1 110.869 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 tt -80.7 -47.94 13.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 75.15 110.903 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.488 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.28 -56.56 19.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 73.4 110.911 179.88 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.19 -22.77 53.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 71.4 110.933 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -76.79 -55.27 5.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 72.33 110.89 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.3 pp -67.73 -43.46 79.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 74.11 110.877 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.566 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.2 tmtt? -54.89 -27.14 40.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 72.24 110.898 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.52 -23.72 42.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.248 -0.433 . . . . 73.51 111.135 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.1 mt -76.59 -59.57 2.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 74.13 110.901 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.9 t -135.09 -28.07 1.2 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 75.03 111.139 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.566 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.03 -177.37 4.85 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.745 -0.741 . . . . 72.44 112.539 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.483 ' CG2' HD23 ' A' ' 39' ' ' LEU . 1.3 p -112.84 138.43 42.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.845 0.355 . . . . 72.4 111.155 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.595 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -53.73 149.72 15.59 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.639 0.733 . . . . 75.35 110.926 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.4 ' O ' ' O ' ' A' ' 43' ' ' GLN . 53.8 Cg_endo -69.78 -21.71 33.01 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.663 2.242 . . . . 72.35 112.335 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -54.19 -38.3 65.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 75.41 110.925 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -104.72 -40.04 6.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 73.42 110.856 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -96.94 158.66 15.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 72.54 110.955 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.37 139.57 52.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 74.1 110.916 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.15 136.08 55.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 72.22 110.92 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -75.83 -74.96 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 74.2 110.915 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -97.52 60.06 1.07 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.731 -0.747 . . . . 72.12 112.464 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.8 pp -54.93 -24.2 22.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.853 0.358 . . . . 74.35 110.944 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.32 143.33 33.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.202 -0.453 . . . . 75.33 110.879 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.9 p -144.13 143.2 23.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 70.55 111.131 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? 54.2 34.06 19.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 73.04 110.912 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.4 -15.18 41.76 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.758 -0.735 . . . . 74.23 112.487 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -81.5 149.28 64.53 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.628 0.727 . . . . 74.53 110.848 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -35.47 12.71 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.698 2.265 . . . . 74.12 112.384 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 38.74 39.61 0.35 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 61.44 111.117 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.49 -75.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.278 -0.419 . . . . 74.54 110.873 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -154.68 -38.63 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 75.43 110.884 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -73.09 -1.98 19.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 73.31 110.819 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -92.71 148.27 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 75.24 111.124 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.433 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 16.6 mttt -91.18 147.28 23.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 72.01 110.924 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.426 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 18.7 mt -52.29 -39.31 60.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.433 . . . . 74.52 110.902 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.66 -16.91 80.34 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.735 -0.745 . . . . 72.32 112.511 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.49 -19.31 33.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.853 0.359 . . . . 73.54 111.093 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -83.79 -19.96 34.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 74.14 110.943 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp 52.87 43.49 31.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 74.24 110.935 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.4 mt -96.19 152.91 18.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 71.32 110.935 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.54 159.81 79.58 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.626 0.727 . . . . 72.53 110.894 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -36.15 11.22 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.645 2.23 . . . . 74.34 112.322 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.463 ' O ' ' C ' ' A' ' 70' ' ' THR . 82.4 m-20 -78.57 -15.72 58.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 71.54 110.868 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.463 ' C ' ' O ' ' A' ' 69' ' ' ASN . 52.8 m -32.58 124.78 0.33 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 74.3 111.128 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.26 146.27 24.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 75.11 110.883 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.3 mm -115.16 129.88 70.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 72.13 111.165 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 6.8 mtp -101.85 141.93 33.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 72.44 110.895 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 78.3 mtm -132.48 125.67 31.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 75.22 110.895 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -115.01 128.9 56.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 74.51 110.886 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 150.84 -151.72 23.67 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.768 -0.729 . . . . 72.11 112.528 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.801 0.334 . . . . 72.43 111.144 -179.884 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.812 0.339 . . . . 73.15 111.105 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 3' ' ' LEU . 0.2 OUTLIER -107.22 111.78 63.17 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.594 0.711 . . . . 72.54 110.925 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 156.28 63.7 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.642 2.228 . . . . 75.05 112.366 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.8 mt -149.87 134.83 10.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 72.44 111.133 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.6 mt -94.28 140.94 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 74.21 111.151 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.26 123.22 61.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 62.32 111.101 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.64 119.06 38.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 73.43 110.906 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.9 t-105 -123.67 105.64 9.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 73.35 110.87 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.82 -81.82 0.9 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.754 -0.736 . . . . 71.02 112.478 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.76 19.92 0.59 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.729 -0.748 . . . . 71.2 112.45 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -129.28 175.85 8.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.738 0.304 . . . . 75.44 110.947 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -132.48 140.83 48.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 74.0 110.916 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -135.79 117.0 14.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 75.3 110.903 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.0 p -83.07 130.89 35.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 73.42 110.839 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.4 t -92.86 135.3 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 74.11 111.12 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.6 p -144.39 92.47 2.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 72.4 111.161 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 173.4 -28.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 72.51 111.161 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -85.94 151.12 24.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 74.04 110.874 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.53 163.47 28.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 71.22 110.85 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.456 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 72.2 mt-10 -55.71 -23.79 30.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.097 -0.501 . . . . 74.15 110.876 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -66.66 -14.01 61.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.467 . . . . 73.2 110.865 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -98.44 -149.77 0.35 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 75.41 110.89 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.8 172.92 11.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 74.44 111.132 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.8 t -68.53 -43.61 83.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 74.31 111.153 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.45 -28.72 68.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 75.33 110.9 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -70.18 -35.82 74.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.189 -0.46 . . . . 73.51 110.838 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 tt -80.61 -47.06 14.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 74.41 110.909 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.498 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -62.09 -56.9 14.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 74.42 110.866 179.814 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -57.8 -22.49 47.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.276 -0.42 . . . . 73.33 110.925 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -77.35 -55.23 5.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 72.31 110.864 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.3 pp -67.78 -43.06 80.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 72.03 110.93 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.567 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -55.01 -27.04 41.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 75.42 110.906 179.829 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.77 -23.54 42.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 70.24 111.121 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.4 mt -76.97 -60.16 2.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.227 -0.442 . . . . 74.2 110.9 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.9 t -134.93 -27.76 1.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 72.13 111.153 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.567 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.83 -177.76 4.84 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.76 -0.734 . . . . 62.32 112.503 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.482 ' CG2' HD23 ' A' ' 39' ' ' LEU . 1.3 p -112.29 139.26 37.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.898 0.38 . . . . 74.55 111.129 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.602 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.61 150.56 17.35 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.599 0.714 . . . . 72.21 110.919 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 -21.92 32.95 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.676 2.251 . . . . 74.35 112.333 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -54.1 -39.04 66.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 71.53 110.928 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -104.25 -40.18 6.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.142 -0.481 . . . . 73.23 110.881 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.424 ' HG2' HG12 ' A' ' 38' ' ' VAL . 1.8 pp0? -97.51 158.16 15.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 75.05 110.91 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.9 141.71 51.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.438 . . . . 75.23 110.907 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.98 134.8 52.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 74.12 110.89 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -75.93 -75.55 0.18 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 75.41 110.898 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.83 59.84 1.47 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.737 -0.744 . . . . 61.11 112.473 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.7 pp -55.56 -23.55 27.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.838 0.351 . . . . 75.14 110.914 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.57 142.23 35.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 65.24 110.929 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 t -143.74 144.27 23.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 71.04 111.097 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.0 mmtm 54.35 33.29 18.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 75.1 110.897 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.48 -14.78 44.43 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.733 -0.746 . . . . 74.13 112.495 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -81.56 149.26 64.24 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.6 0.714 . . . . 75.43 110.886 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -35.69 12.34 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.693 2.262 . . . . 75.41 112.386 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 38.5 40.26 0.37 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.453 . . . . 74.3 111.106 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.34 -75.38 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 74.44 110.881 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -156.38 -37.84 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 64.14 110.91 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -74.41 -1.05 19.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 74.03 110.828 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -93.04 147.81 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 64.21 111.146 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.409 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 5.8 mttp -89.49 146.18 24.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 73.35 110.878 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.456 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 15.9 mt -52.37 -38.39 58.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 72.14 110.884 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.96 -17.2 80.18 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.736 -0.745 . . . . 73.45 112.483 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.22 -19.63 33.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.829 0.347 . . . . 74.31 111.102 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -84.54 -19.53 33.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 63.0 110.907 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp 54.21 42.08 31.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 73.53 110.893 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.9 mt -92.71 152.05 19.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 72.12 110.906 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -68.63 160.18 78.11 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.563 0.696 . . . . 72.21 110.914 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -37.58 8.99 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.663 2.242 . . . . 61.42 112.36 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.481 ' O ' ' C ' ' A' ' 70' ' ' THR . 55.0 m-20 -78.84 -15.92 57.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 64.33 110.877 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.481 ' C ' ' O ' ' A' ' 69' ' ' ASN . 66.9 m -31.31 129.44 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.155 -0.475 . . . . 64.23 111.185 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.87 145.73 26.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 74.1 110.905 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.8 mm -115.61 128.71 72.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 74.52 111.135 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 28.5 mtm -101.33 141.6 33.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 74.2 110.894 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 73.1 mtm -136.2 116.91 13.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 65.11 110.893 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -105.92 127.53 53.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 75.12 110.886 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.65 -154.22 25.27 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.765 -0.731 . . . . 62.54 112.489 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.2 t . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.79 0.328 . . . . 75.1 111.136 -179.829 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.854 0.359 . . . . 65.33 111.083 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.37 108.98 62.51 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.604 0.716 . . . . 74.44 110.936 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 156.33 63.42 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.716 2.277 . . . . 75.31 112.295 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.1 mt -150.4 136.42 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 72.34 111.131 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.5 mt -94.93 140.13 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 73.43 111.119 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.3 p -127.69 123.02 60.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 73.31 111.08 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.89 120.51 42.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 74.45 110.895 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 14.1 t-105 -122.74 102.67 8.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 73.15 110.919 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.0 -78.09 1.71 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.774 -0.727 . . . . 75.4 112.484 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -155.62 18.5 0.5 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.75 -0.738 . . . . 73.23 112.5 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -130.87 139.17 50.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.738 0.304 . . . . 74.53 110.922 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -102.62 142.11 34.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 73.13 110.896 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -136.24 122.14 20.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.494 . . . . 70.3 110.914 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 92.7 p -84.95 133.43 34.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 74.4 110.844 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.5 t -96.37 111.48 26.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 65.41 111.136 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.0 p -124.05 91.42 3.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 74.44 111.174 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 t 174.83 -29.69 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 75.34 111.177 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -83.16 149.76 26.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 74.55 110.947 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.43 168.22 17.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 75.34 110.852 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.414 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 51.8 mt-10 -59.8 -22.16 61.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.477 . . . . 74.42 110.891 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -69.26 -11.34 60.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 70.04 110.868 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -99.52 -149.54 0.36 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 71.22 110.896 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.07 167.46 21.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 64.45 111.131 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.4 t -61.9 -45.69 98.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 73.41 111.129 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.48 -29.15 67.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 75.12 110.914 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -70.69 -34.31 71.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 70.52 110.841 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.74 -48.45 12.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 74.44 110.904 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.484 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.6 -56.79 16.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 73.13 110.894 179.827 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.05 -22.76 51.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 65.44 110.894 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -76.94 -55.16 5.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 75.25 110.922 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 pp -67.59 -42.81 81.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 74.11 110.926 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.574 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.2 tmtt? -54.96 -27.14 41.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 74.42 110.926 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.99 -23.67 41.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 61.24 111.132 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.8 mt -76.96 -60.03 2.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 71.03 110.908 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.1 t -135.45 -27.35 1.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 75.52 111.166 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.574 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.48 -178.75 4.96 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.724 -0.75 . . . . 54.24 112.489 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.493 ' CG2' HD21 ' A' ' 39' ' ' LEU . 1.4 p -113.25 137.96 44.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.885 0.374 . . . . 71.55 111.132 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.588 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -53.95 149.56 17.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.615 0.721 . . . . 73.1 110.919 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -21.59 33.24 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.65 2.234 . . . . 72.44 112.389 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -54.21 -38.35 65.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 73.11 110.883 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -105.05 -39.94 6.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 64.52 110.907 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -95.67 159.4 15.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 75.51 110.905 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.8 137.85 52.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 72.32 110.899 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -66.86 132.66 48.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 71.13 110.917 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.8 mp -83.05 -44.48 15.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 74.14 110.908 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -107.73 39.26 2.96 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.751 -0.738 . . . . 63.44 112.478 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -44.88 -35.02 2.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.905 0.383 . . . . 74.54 110.927 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.85 146.54 33.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 75.34 110.872 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.1 p -143.77 145.69 21.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 75.24 111.11 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.5 mttt 54.91 31.19 15.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.47 . . . . 74.42 110.866 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.64 -10.83 54.9 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.717 -0.754 . . . . 52.54 112.518 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -81.44 149.51 65.23 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.581 0.705 . . . . 74.32 110.881 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -31.69 19.96 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.632 2.221 . . . . 75.23 112.36 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 37.36 41.91 0.28 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 72.25 111.082 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.03 -77.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 74.11 110.885 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.402 HD21 ' N ' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -157.92 -36.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 74.43 110.902 -179.942 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.402 ' N ' HD21 ' A' ' 57' ' ' ASN . 0.2 OUTLIER -68.06 -6.77 24.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 73.24 110.885 179.917 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.6 t -82.14 146.35 7.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.468 . . . . 75.32 111.12 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.2 mttp -94.46 151.61 19.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 74.21 110.871 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.414 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 19.5 mt -50.84 -44.63 59.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 75.1 110.944 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.54 -12.25 84.52 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.753 -0.737 . . . . 62.04 112.504 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.77 -34.42 27.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 65.44 111.097 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.48 -25.22 63.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 74.22 110.91 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp 62.38 36.87 14.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 74.34 110.902 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.2 mt -92.04 152.83 19.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 75.13 110.894 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -68.49 160.99 73.58 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.607 0.717 . . . . 63.21 110.903 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 -35.47 12.69 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.701 2.267 . . . . 65.1 112.381 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.467 ' O ' ' C ' ' A' ' 70' ' ' THR . 23.7 p30 -78.77 -15.73 58.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 65.51 110.909 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.467 ' C ' ' O ' ' A' ' 69' ' ' ASN . 52.4 m -32.53 121.4 0.33 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.174 -0.467 . . . . 74.24 111.124 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -92.85 145.81 24.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 64.12 110.875 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.6 mm -115.74 129.17 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.268 -0.424 . . . . 74.32 111.149 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.6 mtp -101.33 141.92 33.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 73.5 110.891 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 76.5 mtm -135.2 119.62 17.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.438 . . . . 75.31 110.873 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.4 mmt -110.74 123.71 50.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 60.13 110.895 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 163.01 -153.9 24.63 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.756 -0.735 . . . . 71.53 112.508 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.6 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-O 120.81 0.338 . . . . 75.11 111.133 -179.864 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.87 0.367 . . . . 75.04 111.062 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 3' ' ' LEU . 0.2 OUTLIER -107.29 111.72 63.09 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.67 0.748 . . . . 74.1 110.938 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 156.34 63.59 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.713 2.275 . . . . 63.03 112.342 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.8 mt -149.17 135.62 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 75.52 111.143 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.4 mt -94.78 141.0 15.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 74.15 111.15 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.9 p -127.3 123.12 61.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 74.24 111.122 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.65 121.36 44.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 75.54 110.908 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 13.1 t-105 -121.74 100.9 7.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 72.53 110.939 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.01 -83.53 0.91 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.736 -0.745 . . . . 75.01 112.517 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.94 20.43 1.12 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.742 . . . . 64.43 112.497 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -128.01 174.31 9.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.739 0.304 . . . . 73.24 110.926 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -133.06 140.12 47.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 72.35 110.917 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -135.83 115.97 13.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.494 . . . . 73.03 110.901 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.3 p -82.19 133.41 35.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 60.31 110.873 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 91.5 t -96.01 139.72 18.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 71.04 111.123 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.5 p -148.23 93.58 2.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 73.14 111.167 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 173.04 -28.37 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 73.25 111.169 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -86.52 151.78 23.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 74.14 110.944 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.77 163.57 28.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 62.5 110.858 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.446 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 49.0 mt-10 -56.16 -23.34 34.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 75.32 110.872 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -67.84 -12.53 60.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 70.34 110.873 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -99.12 -150.31 0.37 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 71.32 110.842 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.19 171.1 14.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 74.34 111.122 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.6 t -67.3 -43.78 87.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 75.13 111.109 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.77 -28.36 68.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 74.21 110.901 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -70.18 -35.64 74.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.475 . . . . 73.42 110.853 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 tt -80.76 -47.41 13.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 73.43 110.966 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.491 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.7 -56.6 17.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 65.33 110.91 179.81 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -58.09 -22.42 50.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 74.42 110.878 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -77.18 -55.2 5.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 74.44 110.867 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.4 pp -67.93 -43.01 80.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.14 -0.482 . . . . 73.52 110.931 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.564 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.9 -27.2 41.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.45 . . . . 74.35 110.908 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.73 -23.61 42.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.247 -0.433 . . . . 63.35 111.107 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.0 mt -76.59 -59.76 2.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 72.0 110.94 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.3 t -135.14 -27.83 1.2 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 74.54 111.119 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.29 -176.7 4.77 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.718 -0.753 . . . . 42.5 112.505 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.468 ' CG2' HD23 ' A' ' 39' ' ' LEU . 1.1 p -112.43 139.73 35.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.835 0.35 . . . . 75.52 111.16 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.601 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.76 150.2 19.41 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.584 0.707 . . . . 74.52 110.922 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -21.98 32.63 Favored 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.696 2.264 . . . . 71.4 112.308 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -54.42 -39.08 66.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.273 -0.421 . . . . 74.44 110.932 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.2 mtt85 -103.76 -40.73 6.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 73.42 110.906 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -97.29 157.58 15.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 70.13 110.89 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.77 142.18 51.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 74.01 110.923 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.49 136.05 54.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 74.12 110.942 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -77.31 -75.03 0.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 72.42 110.929 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.15 59.23 1.68 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.774 -0.727 . . . . 74.44 112.522 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.8 pp -56.22 -23.06 33.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 73.21 110.906 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -105.95 142.33 35.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 74.01 110.911 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.8 t -143.94 144.33 23.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 73.13 111.119 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.4 mttt 54.27 33.06 17.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 75.21 110.912 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.79 -14.67 46.72 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.728 -0.748 . . . . 72.5 112.504 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -81.56 148.97 63.62 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.597 0.713 . . . . 74.42 110.853 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.403 ' O ' ' C ' ' A' ' 55' ' ' ALA . 53.2 Cg_endo -69.82 -35.49 12.37 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.657 2.238 . . . . 73.43 112.323 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 54' ' ' PRO . . . 38.03 40.69 0.32 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 65.35 111.088 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.02 -76.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 73.11 110.882 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -155.25 -38.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 64.01 110.877 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -73.55 -1.12 17.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 73.13 110.892 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -93.45 148.37 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 74.53 111.159 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.415 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 5.6 mttt -90.32 146.7 24.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 64.41 110.874 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 16.4 mt -52.27 -38.88 59.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.447 . . . . 75.42 110.883 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.89 -17.02 80.28 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.76 -0.733 . . . . 71.14 112.508 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.15 -19.46 34.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.812 0.339 . . . . 64.31 111.128 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -84.83 -19.9 31.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 74.12 110.906 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.9 mmtp 55.13 41.47 31.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 73.22 110.923 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.8 mt -92.38 151.2 20.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 72.23 110.918 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -68.43 160.79 74.28 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.619 0.723 . . . . 65.24 110.944 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -37.09 9.67 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.738 2.292 . . . . 75.25 112.33 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.468 ' O ' ' C ' ' A' ' 70' ' ' THR . 10.5 p-10 -78.81 -15.82 57.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 74.44 110.891 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.468 ' C ' ' O ' ' A' ' 69' ' ' ASN . 53.1 m -31.25 128.96 0.15 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 62.43 111.183 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.49 146.4 25.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.229 -0.441 . . . . 73.24 110.868 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.7 mm -115.38 127.93 72.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 73.2 111.131 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.0 mtp -100.15 141.72 32.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 65.31 110.841 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.8 mtt -134.58 127.5 31.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 73.53 110.871 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -116.97 126.35 52.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 72.13 110.913 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.9 -154.53 25.6 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.75 -0.738 . . . . 63.22 112.51 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.33 -0.264 0 CA-C-O 120.763 0.316 . . . . 75.1 111.101 -179.84 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.877 0.37 . . . . 74.22 111.076 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.7 mt -113.53 107.08 53.61 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.579 0.704 . . . . 62.15 110.917 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 155.68 65.24 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.665 2.243 . . . . 63.01 112.338 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.7 mt -151.0 138.77 13.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 75.15 111.105 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.7 mt -95.02 140.47 16.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 74.41 111.119 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.5 p -126.53 123.0 62.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 70.01 111.139 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.45 118.07 35.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 73.12 110.9 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.9 t-105 -122.87 106.67 11.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 73.32 110.889 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.72 -81.06 0.9 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.744 -0.741 . . . . 74.41 112.469 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -155.98 19.87 0.49 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.72 -0.752 . . . . 54.25 112.466 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -129.34 176.07 8.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.796 0.332 . . . . 72.24 110.902 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -132.51 140.83 48.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 75.1 110.901 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -136.18 119.44 16.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 73.32 110.915 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.6 p -82.89 134.22 35.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.089 -0.505 . . . . 74.15 110.857 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 87.2 t -93.46 132.81 36.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 64.53 111.152 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.4 p -147.28 92.08 2.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 72.34 111.162 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 t 176.99 -31.89 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 73.55 111.133 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.422 HD22 ' HB3' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -87.93 164.32 15.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 75.22 110.931 179.948 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.26 175.17 9.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.448 . . . . 72.33 110.848 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.421 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 35.0 mt-10 -64.52 -20.01 65.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 54.32 110.896 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.94 -11.32 60.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.127 -0.488 . . . . 74.21 110.839 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -95.99 -152.62 0.38 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 74.42 110.848 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.91 165.6 25.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 72.11 111.156 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.9 t -58.69 -44.41 89.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 73.1 111.157 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.88 -30.13 71.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 74.55 110.875 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.422 ' HB3' HD22 ' A' ' 19' ' ' LEU . 3.3 t70 -71.37 -34.97 70.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 74.11 110.875 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.72 -48.03 15.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 74.11 110.902 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.466 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -62.15 -54.73 36.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 72.43 110.902 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -56.36 -22.51 31.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 75.51 110.929 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -77.31 -55.45 5.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 72.13 110.849 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.0 pp -67.68 -43.5 80.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 73.11 110.912 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.567 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.49 -27.17 35.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 74.31 110.882 179.849 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.69 -23.85 42.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 72.32 111.152 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.4 mt -76.36 -59.71 2.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.198 -0.456 . . . . 74.1 110.909 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.5 t -135.21 -28.03 1.18 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.461 . . . . 71.1 111.136 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.567 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.67 -177.51 4.51 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.757 -0.735 . . . . 73.21 112.503 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.48 ' CG2' HD23 ' A' ' 39' ' ' LEU . 1.3 p -112.83 138.71 41.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.883 0.373 . . . . 71.54 111.11 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.58 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.86 150.63 18.18 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.633 0.73 . . . . 61.05 110.852 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -21.76 32.83 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.671 2.247 . . . . 64.41 112.35 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -54.13 -38.93 66.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 74.45 110.902 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -104.29 -40.4 6.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.505 . . . . 73.41 110.836 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.404 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.9 pp0? -97.21 158.09 15.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 73.53 110.876 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.09 141.97 51.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 75.0 110.854 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.05 134.01 51.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 71.35 110.894 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.88 -68.03 0.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 72.32 110.926 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.39 60.03 0.69 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.707 -0.758 . . . . 74.23 112.465 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.6 pp -56.93 -19.81 19.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.86 0.362 . . . . 73.54 110.936 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.65 144.08 41.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 73.42 110.913 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.0 p -143.79 146.1 21.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 73.54 111.146 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.3 mttt 54.78 31.55 15.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 75.52 110.875 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.56 -10.87 54.33 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.71 -0.757 . . . . 34.22 112.502 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.2 mmtm -81.36 150.82 68.21 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.593 0.711 . . . . 72.13 110.869 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 55' ' ' ALA . 53.1 Cg_endo -69.81 -31.98 19.24 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.658 2.239 . . . . 73.45 112.359 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 54' ' ' PRO . . . 35.93 44.63 0.25 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 44.12 111.072 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.32 -76.69 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 70.24 110.92 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -158.61 -37.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 75.14 110.887 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.85 -8.66 30.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 60.2 110.828 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.402 ' HB ' HD22 ' A' ' 64' ' ' LEU . 19.4 t -79.31 147.49 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 74.24 111.149 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.415 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 10.8 mttt -94.78 150.33 20.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 75.44 110.895 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.421 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 25.3 mt -51.42 -42.05 61.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 75.24 110.938 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.12 -13.34 83.33 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.768 -0.729 . . . . 71.43 112.443 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.04 -34.31 22.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.779 0.323 . . . . 54.22 111.066 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -67.84 -24.35 65.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 71.11 110.922 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp 59.88 33.08 21.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 72.44 110.859 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.0 mt -87.72 153.87 21.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.283 -0.417 . . . . 73.34 110.91 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.46 160.41 76.32 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.552 0.692 . . . . 73.24 110.906 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -35.3 12.81 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.641 2.227 . . . . 73.11 112.37 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.452 ' O ' ' C ' ' A' ' 70' ' ' THR . 7.6 p30 -79.15 -16.38 56.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.431 . . . . 73.02 110.886 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.452 ' C ' ' O ' ' A' ' 69' ' ' ASN . 54.9 m -32.08 128.16 0.22 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 73.11 111.163 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.93 147.95 23.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 75.22 110.908 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.6 mm -118.83 127.32 75.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 73.23 111.153 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 62.9 mtp -100.41 141.79 32.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 74.31 110.837 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 73.7 mtm -134.71 117.51 16.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 73.02 110.87 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.2 mmt -105.52 124.56 49.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 72.4 110.866 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.57 -154.69 25.74 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.726 -0.749 . . . . 63.34 112.456 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.5 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.332 . . . . 71.44 111.155 -179.837 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mtt . . . . . 0 C--O 1.23 0.042 0 CA-C-O 120.793 0.33 . . . . 71.33 110.865 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.83 151.43 30.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 73.35 111.135 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.5 mt -110.87 109.43 57.5 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.618 0.723 . . . . 73.14 110.907 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 156.48 63.23 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.693 2.262 . . . . 64.55 112.357 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.9 mt -150.51 137.45 13.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 73.51 111.155 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.1 mt -94.91 140.52 16.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 63.44 111.152 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.3 p -126.9 123.14 62.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 74.53 111.089 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.12 119.78 40.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 72.13 110.881 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 16.8 t-105 -121.09 100.92 7.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.258 -0.428 . . . . 75.22 110.912 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.89 -83.53 0.85 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.778 -0.725 . . . . 62.4 112.515 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.68 20.45 1.02 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.693 -0.765 . . . . 70.1 112.459 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -128.43 174.83 9.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.756 0.312 . . . . 72.55 110.896 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -133.07 140.19 47.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 64.24 110.865 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -135.84 118.59 16.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 75.42 110.886 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.6 p -82.36 133.93 35.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 75.01 110.84 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 69.6 t -96.21 131.33 43.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.49 . . . . 72.44 111.137 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.2 p -141.31 93.54 2.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 72.15 111.11 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 173.47 -28.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.462 . . . . 64.31 111.128 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -85.6 150.52 24.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 75.35 110.871 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.89 168.09 18.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 71.23 110.867 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.417 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 44.9 mt-10 -59.04 -21.98 59.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 74.43 110.898 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -68.59 -10.9 58.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 72.24 110.885 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -102.61 -150.47 0.41 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 63.14 110.869 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.65 168.03 20.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 64.1 111.148 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.2 t -63.39 -43.15 98.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 73.32 111.124 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.06 -29.08 69.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.166 -0.47 . . . . 73.11 110.938 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -71.51 -32.67 68.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 74.42 110.845 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.65 -48.82 12.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 74.22 110.924 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.504 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -62.09 -56.09 22.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 73.32 110.89 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -57.6 -22.4 44.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 71.22 110.89 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -77.98 -54.89 5.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 74.11 110.82 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 pp -68.05 -42.13 80.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.148 -0.478 . . . . 74.34 110.92 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.567 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.76 -27.65 42.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 75.34 110.866 179.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.52 -23.62 42.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 75.41 111.155 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.8 mt -76.63 -59.7 2.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 73.43 110.914 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.7 t -135.41 -27.66 1.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 72.11 111.181 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.567 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.95 -177.46 4.8 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 63.33 112.479 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.479 ' CG2' HD23 ' A' ' 39' ' ' LEU . 1.3 p -112.72 138.24 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.856 0.36 . . . . 73.24 111.106 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.584 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.76 150.94 16.49 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.632 0.729 . . . . 74.43 110.875 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -21.59 33.39 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.715 2.277 . . . . 75.25 112.32 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -54.35 -38.79 66.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.429 . . . . 75.13 110.855 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -104.15 -40.58 6.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 71.33 110.889 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.407 ' HG2' HG12 ' A' ' 38' ' ' VAL . 1.9 pp0? -97.28 157.47 15.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 73.42 110.932 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.08 142.94 51.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.435 . . . . 74.31 110.955 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.7 135.9 53.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.246 -0.434 . . . . 63.5 110.885 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.0 -68.29 0.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 62.22 110.972 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.4 61.06 0.66 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.705 -0.76 . . . . 62.54 112.497 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.5 pp -58.96 -18.2 31.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.899 0.381 . . . . 74.34 110.907 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -112.39 144.16 42.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 64.25 110.926 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.0 t -143.85 145.31 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 75.15 111.119 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.0 mttt 54.87 32.51 17.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 75.33 110.858 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.25 -11.3 50.59 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.744 -0.741 . . . . 61.51 112.509 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -81.7 150.88 67.13 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.602 0.715 . . . . 71.51 110.856 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 -32.91 17.85 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.706 2.271 . . . . 63.13 112.351 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 36.78 43.48 0.28 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 74.34 111.074 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.54 -76.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.438 . . . . 65.52 110.896 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -159.36 -37.5 0.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 73.25 110.884 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -66.8 -8.68 30.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 73.4 110.862 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.41 ' HB ' HD22 ' A' ' 64' ' ' LEU . 16.9 t -79.79 145.69 8.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 73.21 111.135 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.9 mttp -90.27 151.44 21.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 75.04 110.858 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.417 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 19.3 mt -49.96 -47.44 52.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 75.35 110.982 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.63 -11.69 85.22 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.732 -0.747 . . . . 64.1 112.473 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.39 -32.16 42.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.783 0.325 . . . . 75.53 111.097 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.41 HD22 ' HB ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -77.82 -23.55 48.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 65.2 110.943 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt 63.12 38.03 11.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 63.44 110.876 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.2 mt -89.66 152.62 21.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 75.42 110.899 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -68.67 160.57 76.41 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.603 0.716 . . . . 71.42 110.899 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -35.0 13.26 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.718 2.278 . . . . 74.33 112.335 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.463 ' O ' ' C ' ' A' ' 70' ' ' THR . 10.5 p30 -78.8 -15.83 57.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 75.31 110.864 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.463 ' C ' ' O ' ' A' ' 69' ' ' ASN . 51.3 m -32.92 121.52 0.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 75.0 111.132 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -92.85 146.49 23.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 75.42 110.913 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.8 mm -116.4 127.46 74.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 74.23 111.087 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 23.2 mtp -99.46 141.68 31.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 74.42 110.89 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.6 mtt -134.74 118.99 17.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 72.32 110.937 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.1 mmm -107.88 123.82 49.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 75.15 110.906 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.79 -155.16 26.32 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.751 -0.738 . . . . 74.35 112.526 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.2 t -134.19 146.38 50.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.783 0.325 . . . . 73.0 111.164 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -63.22 159.97 16.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 74.32 110.846 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.01 157.56 1.26 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 75.2 110.876 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -89.93 71.05 7.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 74.15 110.919 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -165.9 -118.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 63.15 110.875 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.494 0 O-C-N 124.48 1.112 . . . . 52.32 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.778 0.323 . . . . 75.22 110.887 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.6 151.58 28.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 70.14 111.119 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.4 mt -112.04 109.66 54.57 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.593 0.711 . . . . 74.13 110.89 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 156.6 62.94 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.717 2.278 . . . . 74.03 112.345 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.0 mt -150.45 137.52 13.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 72.12 111.114 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.7 mt -95.14 140.81 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 71.34 111.162 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.3 p -126.92 123.44 62.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 74.12 111.12 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.78 120.9 43.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 75.53 110.931 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 12.9 t-105 -122.04 100.96 7.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.436 . . . . 74.4 110.884 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.79 -83.76 0.78 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.739 -0.744 . . . . 75.15 112.498 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.46 20.17 1.04 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.742 -0.742 . . . . 65.2 112.488 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -128.56 174.24 9.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.784 0.325 . . . . 64.2 110.875 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -132.81 140.5 48.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 75.34 110.902 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -136.67 116.14 12.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 74.2 110.96 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.9 p -81.62 135.03 35.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 65.34 110.854 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.4 t -96.26 140.28 17.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.115 -0.493 . . . . 73.44 111.077 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.5 p -148.66 93.37 2.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 63.44 111.137 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 173.68 -28.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.22 -0.445 . . . . 74.15 111.137 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -86.61 151.92 23.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 75.22 110.908 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.6 169.47 16.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 74.44 110.882 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.409 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 36.3 mt-10 -61.78 -22.09 65.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 72.1 110.854 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -69.87 -10.76 59.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 74.01 110.852 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -100.08 -150.84 0.39 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.452 . . . . 64.12 110.887 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.61 170.58 14.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 75.34 111.176 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.7 t -66.58 -43.79 90.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 73.33 111.135 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.44 -28.66 68.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 72.23 110.925 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -70.07 -35.16 74.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.476 . . . . 73.12 110.844 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.72 -47.82 13.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 63.53 110.911 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.78 -56.71 16.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 74.1 110.892 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.0 -22.41 49.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 73.22 110.924 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -77.16 -55.23 5.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 72.34 110.835 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.4 pp -67.92 -43.14 79.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 72.0 110.942 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.561 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -55.02 -27.34 43.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 74.12 110.876 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.3 -23.78 43.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 74.1 111.159 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.5 mt -76.46 -59.8 2.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 74.12 110.931 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.1 t -135.25 -27.63 1.2 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 72.11 111.135 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.23 -176.63 4.66 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.699 -0.762 . . . . 73.3 112.513 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.468 ' CG2' HD21 ' A' ' 39' ' ' LEU . 1.1 p -112.29 139.73 35.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.835 0.35 . . . . 71.23 111.168 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.609 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.8 149.98 20.55 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.602 0.715 . . . . 74.42 110.927 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -22.02 32.78 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.717 2.278 . . . . 64.22 112.334 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -54.61 -39.06 67.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.443 . . . . 74.12 110.899 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -103.7 -40.46 6.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 75.1 110.87 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.409 ' HG2' HG12 ' A' ' 38' ' ' VAL . 1.5 pp0? -97.57 157.2 16.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 74.25 110.921 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.17 141.32 51.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 74.32 110.908 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.02 135.96 54.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 74.53 110.973 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -76.54 -75.22 0.2 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 75.45 110.916 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.74 60.03 1.48 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.726 -0.75 . . . . 63.2 112.518 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.8 pp -56.8 -22.56 37.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.9 0.381 . . . . 74.24 110.949 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.29 142.43 35.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 73.25 110.932 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.0 t -144.04 144.37 22.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 71.24 111.07 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.1 mmmm 54.3 33.01 17.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 75.34 110.863 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.9 -15.05 45.28 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.718 -0.753 . . . . 73.53 112.462 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -81.08 148.78 64.91 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.538 0.685 . . . . 75.34 110.9 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -35.57 12.53 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.681 2.254 . . . . 64.03 112.366 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 38.14 40.67 0.34 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 72.32 111.136 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -67.81 -76.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 74.11 110.91 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -154.53 -38.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 71.15 110.889 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -73.14 -1.65 18.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 74.14 110.867 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -92.85 148.19 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 73.32 111.168 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.413 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 11.2 mttt -90.75 147.22 23.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 74.22 110.873 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.409 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 17.5 mt -52.47 -38.72 60.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 65.43 110.887 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.77 -17.0 80.29 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.771 -0.728 . . . . 75.11 112.451 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.53 -19.52 33.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.834 0.349 . . . . 72.33 111.128 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -84.44 -20.46 31.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 71.44 110.904 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp 53.89 42.01 31.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 75.42 110.935 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.6 mt -92.79 151.58 19.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.462 . . . . 73.01 110.939 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -68.4 160.01 78.06 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.564 0.697 . . . . 73.22 110.933 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -36.88 10.07 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.68 2.253 . . . . 73.31 112.311 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.471 ' O ' ' C ' ' A' ' 70' ' ' THR . 26.4 m-80 -78.8 -15.79 57.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 75.45 110.897 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.471 ' C ' ' O ' ' A' ' 69' ' ' ASN . 52.0 m -32.43 128.03 0.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 71.52 111.13 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -97.66 146.51 25.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 73.02 110.837 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.0 mm -115.34 128.46 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 75.01 111.167 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 34.4 mtm -100.36 141.76 32.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 74.11 110.883 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.7 mtt -133.21 129.42 37.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 74.2 110.884 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 6.1 mmm -118.6 123.95 46.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.254 -0.43 . . . . 62.14 110.9 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 153.11 -155.23 26.01 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 60.13 112.459 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.0 t -133.32 139.86 47.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.794 0.331 . . . . 62.14 111.136 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.401 ' HA ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -93.55 147.46 22.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.444 . . . . 73.43 110.894 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -55.87 174.55 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 75.42 110.894 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -104.91 86.65 2.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 71.23 110.892 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 90' ' ' NH2 . 0.3 OUTLIER -172.55 179.64 2.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 73.42 110.887 -179.8 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' NH2 . . . . . 0.504 ' N ' ' OG ' ' A' ' 81' ' ' SER . . . . . . . . 0 C--N 1.325 -0.499 0 O-C-N 124.504 1.128 . . . . 64.14 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.804 0.335 . . . . 65.05 110.845 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.57 151.34 22.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 74.23 111.119 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.1 mt -110.86 109.27 57.6 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.625 0.726 . . . . 74.52 110.916 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 156.84 62.27 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.677 2.251 . . . . 72.2 112.308 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.9 mt -150.57 137.51 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 75.12 111.149 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.6 mt -95.03 140.38 16.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 73.54 111.112 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.7 p -127.15 122.91 61.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 73.22 111.133 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.77 122.28 46.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 75.01 110.893 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 17.5 t-105 -122.56 100.52 6.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.24 -0.436 . . . . 75.44 110.89 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.55 -78.75 1.71 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.725 -0.75 . . . . 71.15 112.488 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.11 17.94 0.71 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.727 -0.749 . . . . 74.24 112.508 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -129.94 138.98 51.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.72 0.295 . . . . 73.02 110.93 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -102.98 142.25 34.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 75.33 110.899 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -136.31 119.38 16.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.465 . . . . 74.44 110.94 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.9 p -83.29 131.96 35.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 61.13 110.895 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 66.9 t -93.95 130.94 42.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.485 . . . . 74.52 111.16 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.0 p -141.27 93.08 2.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 74.25 111.137 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 173.23 -28.37 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 72.25 111.14 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -85.11 150.1 25.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.462 . . . . 74.51 110.902 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.71 167.78 18.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 64.31 110.887 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.413 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 35.3 mt-10 -58.81 -21.91 57.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 75.34 110.929 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -68.9 -10.54 57.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.13 -0.487 . . . . 73.33 110.875 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -102.62 -150.76 0.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 73.33 110.867 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.82 167.54 20.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 70.24 111.127 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 82.5 t -63.06 -42.37 96.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 72.54 111.13 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.78 -28.79 69.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.48 . . . . 75.24 110.915 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.01 -32.56 67.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.174 -0.466 . . . . 74.14 110.871 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.59 -48.82 12.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 74.22 110.939 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.502 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.94 -55.78 26.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 71.33 110.929 179.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.6 -22.49 45.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 75.24 110.902 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -77.84 -54.88 5.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 75.45 110.881 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 pp -68.07 -41.96 81.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 74.1 110.927 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.564 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.85 -27.74 44.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 73.42 110.889 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.34 -23.49 43.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.25 -0.432 . . . . 74.33 111.168 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.7 mt -76.76 -59.43 2.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 75.01 110.886 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.6 t -135.47 -28.03 1.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 54.43 111.178 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.59 -177.37 4.35 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.72 -0.752 . . . . 74.35 112.498 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.481 ' CG2' HD21 ' A' ' 39' ' ' LEU . 1.4 p -112.77 137.78 44.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.864 0.364 . . . . 63.34 111.098 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.591 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -53.71 149.95 14.86 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.631 0.729 . . . . 74.24 110.915 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -21.89 32.95 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.695 2.264 . . . . 71.21 112.342 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -54.21 -38.38 65.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 73.13 110.878 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -104.43 -40.3 6.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 75.21 110.885 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.415 ' HG3' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -95.96 157.41 15.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 75.3 110.877 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.09 140.05 52.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 73.44 110.91 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -65.94 135.75 55.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 75.11 110.917 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.4 mp -81.36 -63.51 1.38 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 74.34 110.901 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.91 58.72 0.68 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.703 -0.76 . . . . 65.04 112.483 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.5 pp -60.46 -17.34 44.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 75.54 110.899 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.96 144.15 43.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 72.01 110.885 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.8 p -144.0 144.95 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 74.32 111.132 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt 54.66 32.71 17.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 73.52 110.912 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.78 -12.17 49.42 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.725 -0.75 . . . . 35.33 112.514 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.6 mmtt -81.61 150.6 66.86 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.574 0.702 . . . . 75.43 110.896 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.403 ' O ' ' C ' ' A' ' 55' ' ' ALA . 53.6 Cg_endo -69.83 -32.39 18.39 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.648 2.232 . . . . 72.35 112.302 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 54' ' ' PRO . . . 36.79 43.45 0.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.277 -0.419 . . . . 74.33 111.087 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.46 -78.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 74.13 110.85 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -157.0 -38.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 75.4 110.916 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -64.95 -9.64 22.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 75.03 110.848 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.404 ' HB ' HD21 ' A' ' 64' ' ' LEU . 16.8 t -79.25 145.6 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 73.31 111.133 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.7 mttp -91.0 151.65 20.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 74.42 110.92 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.413 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 20.0 mt -49.66 -47.6 49.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 71.44 110.983 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.68 -11.84 85.05 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.742 -0.742 . . . . 74.33 112.478 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.22 -32.12 43.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.826 0.346 . . . . 72.11 111.125 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.404 HD21 ' HB ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -77.29 -23.91 51.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 73.32 110.9 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp 63.67 37.44 10.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 54.21 110.875 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.2 mt -90.2 152.68 20.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 72.35 110.941 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.61 160.86 74.75 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.558 0.694 . . . . 73.32 110.89 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -35.08 13.24 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.629 2.22 . . . . 74.12 112.319 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.469 ' O ' ' C ' ' A' ' 70' ' ' THR . 68.7 m-20 -78.49 -15.91 58.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 63.33 110.938 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.469 ' C ' ' O ' ' A' ' 69' ' ' ASN . 45.6 m -32.77 122.33 0.36 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.487 . . . . 72.35 111.125 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -93.83 146.24 24.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 75.42 110.899 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 36.2 mm -115.99 131.75 67.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 71.3 111.149 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 46.1 mtm -101.85 142.46 33.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 75.5 110.892 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.9 mtt -133.83 119.29 19.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 73.22 110.88 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.8 mmm -108.42 121.88 45.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 75.24 110.912 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 162.85 -156.7 28.53 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.703 -0.76 . . . . 73.52 112.468 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.7 t -133.58 147.2 51.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.786 0.326 . . . . 61.24 111.114 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.87 159.35 25.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 74.3 110.879 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -82.1 179.44 7.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 72.25 110.907 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 63.37 162.59 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.464 . . . . 74.11 110.915 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.7 166.64 16.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 73.42 110.864 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.492 0 O-C-N 124.552 1.158 . . . . 72.13 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mmt . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.801 0.334 . . . . 75.01 110.89 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.74 147.09 23.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 72.25 111.111 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -107.79 110.33 62.47 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.597 0.713 . . . . 74.14 110.921 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 156.89 62.01 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.656 2.237 . . . . 73.43 112.287 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.3 mt -150.3 137.15 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.483 . . . . 71.1 111.125 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.6 mt -95.2 140.65 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 74.34 111.126 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.82 122.72 61.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 72.43 111.124 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.97 121.33 44.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 65.32 110.918 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 16.2 t-105 -121.43 100.78 7.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 75.24 110.891 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.59 -83.64 0.96 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.702 -0.761 . . . . 71.23 112.483 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.67 20.68 1.16 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.7 -0.762 . . . . 73.35 112.434 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.28 174.2 9.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.761 0.315 . . . . 73.51 110.944 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -132.93 140.46 47.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.268 -0.424 . . . . 74.33 110.929 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -135.83 116.32 13.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 74.02 110.91 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.3 p -82.51 132.17 35.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 74.14 110.851 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.4 t -94.68 136.93 24.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 74.44 111.12 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.6 p -146.73 93.83 2.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 74.42 111.125 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 172.66 -28.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.219 -0.446 . . . . 75.43 111.136 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -87.64 150.53 23.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 73.43 110.917 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.67 165.56 23.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 70.14 110.883 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.411 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -57.78 -20.75 37.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 75.0 110.878 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.08 -11.9 61.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.179 -0.464 . . . . 74.44 110.854 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -101.06 -148.84 0.37 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.266 -0.425 . . . . 73.55 110.831 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.26 167.47 20.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.191 -0.459 . . . . 74.23 111.166 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.9 t -63.42 -44.05 98.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 74.41 111.094 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.16 -28.39 67.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.457 . . . . 71.13 110.971 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -70.59 -35.52 73.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 60.45 110.857 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 tt -80.4 -47.82 13.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 73.44 110.904 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.493 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.57 -56.69 17.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 73.32 110.886 179.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -57.99 -22.31 48.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 65.01 110.915 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -77.3 -54.93 5.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 73.51 110.839 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.3 pp -68.23 -42.83 79.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 63.31 110.871 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.563 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -55.02 -27.12 41.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 74.1 110.901 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.77 -23.58 42.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 75.25 111.189 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.9 mt -76.7 -59.89 2.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 74.44 110.92 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.1 t -135.4 -27.42 1.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 73.1 111.194 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.563 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.99 -177.95 5.14 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.8 -0.714 . . . . 51.01 112.466 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.472 ' CG2' HD22 ' A' ' 39' ' ' LEU . 1.2 p -112.98 138.7 41.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.899 0.381 . . . . 74.11 111.098 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.596 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.42 151.1 14.74 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.593 0.711 . . . . 74.0 110.932 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 -21.49 33.31 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.68 2.253 . . . . 75.13 112.354 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -54.52 -38.98 67.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 73.13 110.87 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -103.89 -40.45 6.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 75.41 110.847 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.413 ' HG2' HG12 ' A' ' 38' ' ' VAL . 1.7 pp0? -98.11 158.2 15.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 75.14 110.877 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.28 141.37 51.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 75.31 110.902 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.26 135.96 54.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.262 -0.426 . . . . 63.41 110.905 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -76.86 -75.8 0.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 73.3 110.904 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -97.03 60.5 1.13 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.68 -0.772 . . . . 64.12 112.482 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.7 pp -55.4 -24.43 30.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.843 0.354 . . . . 71.44 110.923 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.71 143.42 32.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 72.32 110.892 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.9 p -144.1 143.38 23.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 74.44 111.15 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.0 mttt 54.0 34.19 19.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 74.52 110.905 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.22 -14.98 41.84 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.801 -0.714 . . . . 75.23 112.468 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.8 mmtt -81.67 149.57 64.47 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.537 0.684 . . . . 75.12 110.93 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -35.97 11.75 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.669 2.246 . . . . 73.32 112.334 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 38.97 39.3 0.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 72.04 111.096 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.89 -75.65 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 64.23 110.892 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -154.17 -38.57 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 64.04 110.875 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -72.72 -2.46 20.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 71.33 110.855 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -93.36 148.19 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 74.23 111.137 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.411 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 35.1 mttt -91.39 147.56 22.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 74.33 110.906 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 10.6 mt -51.88 -41.95 62.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 74.53 110.916 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.63 -15.59 80.54 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.76 -0.733 . . . . 73.31 112.462 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.69 -19.94 32.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.839 0.352 . . . . 73.43 111.108 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -83.47 -20.23 34.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 71.41 110.939 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt 53.74 43.02 31.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 74.32 110.816 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 mt -95.48 153.33 17.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 70.34 110.902 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -68.25 159.75 78.87 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.626 0.727 . . . . 75.33 110.872 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -36.77 10.16 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.663 2.242 . . . . 72.23 112.329 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.471 ' O ' ' C ' ' A' ' 70' ' ' THR . 14.8 p30 -78.44 -15.85 58.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 74.5 110.9 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.471 ' C ' ' O ' ' A' ' 69' ' ' ASN . 53.6 m -32.4 125.13 0.31 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 72.44 111.156 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.27 145.83 24.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 75.5 110.919 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.6 mm -115.61 128.36 72.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.27 -0.423 . . . . 74.11 111.126 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 37.0 mtt -99.71 141.74 32.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.478 . . . . 73.21 110.876 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.0 mtt -133.76 118.36 17.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 73.14 110.862 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.0 mmt -106.05 123.07 47.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 73.34 110.887 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.87 -157.16 28.87 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.765 -0.731 . . . . 71.03 112.526 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.3 t -134.27 148.89 50.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.777 0.322 . . . . 75.22 111.115 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -67.39 154.84 40.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 75.33 110.866 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -74.85 175.57 7.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 73.24 110.896 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.29 -43.57 98.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 75.03 110.855 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 55.07 -108.11 0.42 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 74.44 110.886 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.464 0 O-C-N 124.465 1.103 . . . . 72.44 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 mtt . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.825 0.345 . . . . 74.32 110.871 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.73 151.54 23.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 75.32 111.116 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.4 mt -110.99 109.54 57.22 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.653 0.739 . . . . 74.43 110.9 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 156.62 62.86 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.685 2.256 . . . . 75.22 112.359 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.8 mt -150.57 137.67 13.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.247 -0.433 . . . . 64.41 111.083 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.8 mt -95.24 140.41 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 74.33 111.116 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.7 p -127.46 123.71 62.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 70.52 111.138 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.21 118.98 38.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.462 . . . . 73.14 110.872 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 10.5 t-105 -122.4 102.56 8.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.205 -0.452 . . . . 64.3 110.906 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.0 -82.84 0.74 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.785 -0.721 . . . . 45.35 112.504 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.77 19.73 0.78 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.73 -0.748 . . . . 55.44 112.464 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -129.08 175.55 8.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.753 0.311 . . . . 63.31 110.941 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -132.92 140.56 47.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 73.01 110.898 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -135.01 120.26 18.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.152 -0.476 . . . . 75.5 110.941 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.4 p -83.53 133.3 34.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.499 . . . . 75.45 110.825 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 73.6 t -95.98 126.83 48.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 74.23 111.169 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.5 p -137.39 92.77 2.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 72.23 111.117 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 174.03 -29.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 74.0 111.162 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -84.92 150.03 25.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 75.13 110.88 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.74 168.18 18.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 72.2 110.875 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.432 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 78.1 mt-10 -59.06 -22.03 60.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 63.23 110.852 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.3 -10.94 58.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.193 -0.458 . . . . 72.32 110.868 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -102.79 -150.14 0.41 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 54.02 110.869 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.03 168.07 20.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 74.03 111.129 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 91.1 t -63.29 -42.92 98.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 72.03 111.126 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.19 -29.47 69.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 74.04 110.907 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -71.06 -32.98 69.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.459 . . . . 62.42 110.863 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.45 -48.95 12.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 74.35 110.871 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.494 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.99 -56.13 22.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 73.31 110.911 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -57.47 -23.01 47.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 74.41 110.913 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -77.27 -55.36 5.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 70.15 110.884 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 pp -67.66 -42.4 82.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.494 . . . . 74.32 110.909 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.569 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.2 tmtt? -54.81 -27.69 43.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 65.34 110.901 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.47 -23.34 43.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.24 -0.436 . . . . 73.14 111.154 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.7 mt -76.85 -59.51 2.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 75.02 110.9 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.8 t -135.27 -27.24 1.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 74.54 111.165 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.569 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.72 -176.86 5.31 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.723 -0.751 . . . . 74.32 112.513 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.477 ' CG2' HD21 ' A' ' 39' ' ' LEU . 1.4 p -112.78 137.16 46.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.845 0.355 . . . . 65.21 111.136 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.589 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -53.48 150.0 13.55 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.561 0.696 . . . . 74.31 110.946 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -21.8 33.19 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.701 2.267 . . . . 64.12 112.37 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.16 -38.09 65.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 72.04 110.868 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -104.95 -40.05 6.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 73.34 110.881 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -96.48 158.31 15.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 73.21 110.895 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.72 140.37 51.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 74.01 110.893 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.32 135.25 54.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 74.2 110.945 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -75.74 -72.17 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 75.53 110.972 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.57 61.61 0.86 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.686 -0.769 . . . . 75.42 112.524 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.5 pp -58.19 -19.22 31.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 74.2 110.948 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.39 144.24 39.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 70.33 110.875 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.9 p -143.8 146.21 21.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 74.34 111.111 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt 54.77 31.92 16.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 72.53 110.914 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.16 -10.91 51.88 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.74 -0.743 . . . . 63.52 112.507 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -81.34 151.07 68.75 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.592 0.711 . . . . 73.14 110.885 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 55' ' ' ALA . 54.1 Cg_endo -69.74 -32.91 17.73 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.683 2.256 . . . . 72.41 112.347 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 54' ' ' PRO . . . 35.98 44.35 0.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 74.3 111.122 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.33 -75.75 0.05 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 75.41 110.869 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.72 -37.53 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 75.3 110.909 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -67.14 -8.99 35.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 71.21 110.884 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.417 ' HB ' HD23 ' A' ' 64' ' ' LEU . 17.7 t -78.61 145.65 9.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 74.32 111.132 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -89.9 151.14 21.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 74.44 110.89 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.432 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 19.8 mt -49.83 -47.42 51.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 73.44 110.909 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.48 -12.02 84.93 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.804 -0.712 . . . . 70.22 112.461 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.14 -32.15 44.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.817 0.341 . . . . 63.14 111.061 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.417 HD23 ' HB ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -77.81 -23.61 49.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 74.44 110.887 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp 63.41 37.49 10.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 74.22 110.95 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.2 mt -89.29 152.32 21.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 74.44 110.987 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.63 160.61 76.03 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.598 0.713 . . . . 72.31 110.882 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -34.85 13.7 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.649 2.232 . . . . 74.24 112.35 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.466 ' O ' ' C ' ' A' ' 70' ' ' THR . 10.5 m120 -78.8 -15.68 58.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 74.31 110.883 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.466 ' C ' ' O ' ' A' ' 69' ' ' ASN . 47.7 m -32.97 120.82 0.36 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 72.12 111.145 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -92.5 146.43 23.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 74.44 110.926 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.0 mm -115.8 128.89 72.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 72.32 111.168 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 44.7 mtm -99.74 141.6 32.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 73.24 110.883 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.8 mtt -131.74 125.72 32.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 74.41 110.876 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -116.01 120.09 37.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 75.54 110.889 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 163.05 -156.41 28.16 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.765 -0.731 . . . . 73.51 112.54 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.3 t -133.96 144.85 49.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.754 0.311 . . . . 75.43 111.128 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.7 157.51 20.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 75.25 110.943 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -73.27 177.0 5.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 74.21 110.895 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.87 99.7 4.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 70.33 110.854 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.6 ' OG ' ' N ' ' A' ' 90' ' ' NH2 . 1.4 t -177.94 -103.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 73.55 110.834 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' NH2 . . . . . 0.6 ' N ' ' OG ' ' A' ' 81' ' ' SER . . . . . . . . 0 C--N 1.325 -0.474 0 O-C-N 124.513 1.133 . . . . 51.32 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.773 0.321 . . . . 73.13 110.87 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.5 148.79 35.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 52.3 111.106 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.4 mt -109.15 109.76 60.63 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.609 0.719 . . . . 75.41 110.936 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 156.13 64.07 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.698 2.265 . . . . 72.13 112.343 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.2 mt -150.51 136.08 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 72.44 111.115 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.6 mt -94.87 140.68 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 62.22 111.131 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.7 p -127.33 123.21 61.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 74.0 111.136 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.43 123.21 48.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.485 . . . . 75.44 110.899 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.2 t-105 -124.48 102.88 7.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.441 . . . . 72.24 110.91 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.55 -80.09 1.52 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.745 -0.74 . . . . 64.23 112.493 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.23 17.51 0.69 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.786 -0.721 . . . . 64.41 112.497 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 36.6 mm-40 -130.06 139.19 51.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.751 0.31 . . . . 72.45 110.949 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -103.1 142.06 34.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 72.51 110.903 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -136.28 116.54 13.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 74.31 110.947 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.4 p -82.45 131.2 35.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 75.32 110.88 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.9 t -92.29 138.81 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 73.33 111.136 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 p -148.76 92.42 1.99 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 74.45 111.155 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 173.63 -28.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 74.14 111.158 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -85.78 151.21 24.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 72.35 110.936 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.18 168.54 17.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 74.4 110.863 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.413 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 36.2 mt-10 -60.61 -22.09 63.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 71.41 110.901 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.63 -11.23 60.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.157 -0.474 . . . . 73.4 110.81 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -99.82 -151.15 0.39 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 63.33 110.838 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.64 168.86 17.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 63.01 111.114 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.4 t -65.62 -41.32 90.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 74.53 111.143 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.44 -28.63 69.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.141 -0.482 . . . . 73.11 110.92 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -70.73 -34.92 72.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 64.2 110.859 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 tt -80.76 -47.91 13.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 75.31 110.914 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.64 -56.57 18.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 73.13 110.911 179.812 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.15 -22.45 51.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 73.14 110.943 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -77.29 -55.17 5.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 75.33 110.879 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.3 pp -67.49 -43.45 80.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.141 -0.482 . . . . 73.22 110.902 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.564 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.84 -27.03 39.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 72.34 110.924 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.78 -23.74 41.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 74.34 111.146 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.9 mt -76.46 -59.75 2.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.439 . . . . 74.4 110.859 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.5 t -135.31 -28.07 1.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 74.23 111.163 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.8 -177.58 4.7 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.717 -0.754 . . . . 63.2 112.52 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.481 ' CG2' HD21 ' A' ' 39' ' ' LEU . 1.2 p -112.56 139.22 38.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.861 0.362 . . . . 75.21 111.082 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.592 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.52 150.67 16.55 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.622 0.725 . . . . 74.15 110.88 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.401 ' O ' ' O ' ' A' ' 43' ' ' GLN . 53.5 Cg_endo -69.73 -21.95 32.9 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.653 2.235 . . . . 72.44 112.353 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -54.29 -38.98 66.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 74.43 110.876 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.5 mtt85 -103.97 -40.27 6.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 73.15 110.889 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.406 ' HG2' HG12 ' A' ' 38' ' ' VAL . 1.7 pp0? -98.2 158.7 15.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 74.21 110.916 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.67 141.06 51.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 73.25 110.89 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.64 135.04 53.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 75.34 110.93 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -75.81 -75.57 0.18 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 74.03 110.906 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -96.15 60.34 1.36 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.725 -0.75 . . . . 72.32 112.459 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.8 pp -56.06 -23.85 36.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.905 0.383 . . . . 75.03 110.947 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -104.43 143.4 33.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 72.35 110.888 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.0 p -144.11 143.64 23.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 62.14 111.091 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 54.07 33.82 18.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 74.41 110.854 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.48 -15.04 42.96 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.714 -0.755 . . . . 63.41 112.452 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.6 mmtm -81.61 149.63 64.82 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.636 0.732 . . . . 75.35 110.858 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -35.98 11.71 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.663 2.242 . . . . 71.42 112.354 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 38.92 39.31 0.35 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 62.42 111.115 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.7 -75.47 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 75.22 110.878 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -154.61 -39.51 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 64.35 110.857 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -72.16 -4.11 27.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 64.02 110.875 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.4 t -90.04 147.48 5.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 73.1 111.099 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.485 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 13.4 mttp -90.35 147.13 23.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 74.03 110.933 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.413 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 16.1 mt -51.95 -38.1 55.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 74.03 110.882 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.69 -18.43 79.7 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.753 -0.736 . . . . 62.03 112.455 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.61 -14.89 47.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.857 0.36 . . . . 63.14 111.142 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 60' ' ' LYS . 0.7 OUTLIER -87.17 -18.02 31.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 65.22 110.944 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.16 45.65 23.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 71.04 110.914 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.5 mt -99.02 153.27 18.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 71.52 110.897 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.27 159.81 78.62 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.549 0.69 . . . . 73.53 110.932 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -36.71 10.32 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.707 2.271 . . . . 74.12 112.37 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.44 ' O ' ' C ' ' A' ' 70' ' ' THR . 1.7 m-80 -78.59 -15.81 58.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 63.5 110.872 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.44 ' C ' ' O ' ' A' ' 69' ' ' ASN . 51.8 m -32.63 123.65 0.35 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.475 . . . . 74.24 111.163 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.68 146.26 23.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 74.03 110.856 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.7 mm -115.45 131.83 66.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 71.13 111.115 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 26.5 mtm -104.14 142.04 35.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 74.31 110.866 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 75.0 mtm -134.44 118.6 17.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 75.33 110.91 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.1 mmt -106.2 126.1 51.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 73.32 110.858 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 157.87 -154.65 25.72 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.754 -0.736 . . . . 63.33 112.49 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 t -134.99 150.4 50.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.795 0.331 . . . . 63.14 111.164 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.17 153.45 43.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 72.15 110.842 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -63.06 179.28 0.4 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 75.51 110.865 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -144.17 77.08 1.53 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 75.31 110.904 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.852 ' OG ' ' N ' ' A' ' 90' ' ' NH2 . 0.7 OUTLIER -172.35 -125.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 73.34 110.865 -179.797 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' NH2 . . . . . 0.852 ' N ' ' OG ' ' A' ' 81' ' ' SER . . . . . . . . 0 C--N 1.324 -0.511 0 O-C-N 124.512 1.133 . . . . 35.44 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.77 0.319 . . . . 71.23 110.876 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.26 151.3 26.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.426 . . . . 74.43 111.132 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.1 mt -111.71 109.61 55.4 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.681 0.753 . . . . 74.51 110.888 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 156.34 63.61 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.652 2.234 . . . . 65.14 112.331 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.2 mt -150.34 136.81 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 74.13 111.129 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.6 mt -95.2 140.73 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 72.35 111.186 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.6 p -127.1 123.48 62.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 75.12 111.121 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.81 125.72 51.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 73.53 110.876 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.6 t-105 -125.01 100.74 6.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 75.23 110.911 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.22 -79.22 1.71 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.732 -0.747 . . . . 43.5 112.442 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.16 17.46 0.8 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.729 -0.748 . . . . 52.34 112.512 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -129.35 138.59 51.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.742 0.306 . . . . 71.42 110.909 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -102.94 142.28 34.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 73.21 110.94 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -136.69 116.15 12.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 75.22 110.867 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.86 133.87 35.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.086 -0.506 . . . . 62.21 110.858 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 89.7 t -95.71 139.55 18.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.08 -0.509 . . . . 74.43 111.091 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.3 p -149.02 92.91 2.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 71.51 111.151 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 173.67 -28.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 71.21 111.175 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -85.7 151.53 23.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.447 . . . . 74.04 110.919 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.39 168.96 16.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 74.0 110.843 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.411 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 22.5 mt-10 -61.09 -22.37 64.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 73.14 110.892 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.37 -11.33 60.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 75.0 110.856 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -99.94 -151.0 0.39 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 74.21 110.852 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.27 171.57 13.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 74.25 111.148 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.2 t -67.23 -42.02 87.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 74.31 111.153 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.57 -28.96 69.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.481 . . . . 74.34 110.876 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -70.46 -35.05 73.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.434 . . . . 70.13 110.893 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.67 -48.06 13.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 72.33 110.962 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.494 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.45 -56.51 19.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 75.14 110.885 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.2 -22.29 51.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 72.15 110.892 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -77.46 -55.14 5.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 74.31 110.858 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.4 pp -67.67 -43.07 81.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.176 -0.465 . . . . 71.52 110.897 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.565 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.98 -26.91 39.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 74.41 110.883 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -80.02 -23.85 41.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 72.31 111.12 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.1 mt -76.45 -59.85 2.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.456 . . . . 73.33 110.9 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.2 t -135.39 -28.09 1.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 71.11 111.131 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.52 -177.86 4.53 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.699 -0.762 . . . . 64.11 112.502 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.474 ' HB ' ' HB3' ' A' ' 78' ' ' ARG . 1.0 OUTLIER -113.18 139.57 37.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.898 0.38 . . . . 64.52 111.149 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.594 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.39 151.3 14.19 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.617 0.722 . . . . 73.42 110.898 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -21.42 33.63 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.664 2.243 . . . . 72.43 112.383 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -54.83 -38.88 67.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 74.42 110.821 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 -103.73 -40.47 6.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 75.34 110.865 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -98.29 157.32 16.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 73.13 110.888 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.31 141.11 51.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 65.34 110.907 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.31 135.91 54.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 72.15 110.966 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.0 mp -78.15 -75.09 0.23 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 73.13 110.927 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.13 58.78 1.7 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.724 -0.75 . . . . 75.2 112.446 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.7 pp -55.15 -24.48 26.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.86 0.362 . . . . 73.04 110.905 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.89 143.39 32.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 74.11 110.944 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.7 p -144.25 143.49 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 74.14 111.142 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.6 mttp 54.01 34.04 18.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 75.41 110.934 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.38 -15.11 42.08 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.739 -0.743 . . . . 70.13 112.499 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -81.64 149.47 64.39 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.586 0.708 . . . . 74.02 110.912 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -35.86 11.99 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.705 2.27 . . . . 61.51 112.335 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 38.98 39.51 0.37 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 74.51 111.146 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.31 -74.0 0.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 72.44 110.89 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.402 HD21 ' N ' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -157.45 -36.31 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 74.34 110.889 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.402 ' N ' HD21 ' A' ' 57' ' ' ASN . 4.0 m-20 -75.3 -1.6 24.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 73.14 110.913 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -93.55 147.65 5.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.166 -0.47 . . . . 75.54 111.104 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.407 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 12.9 mttt -89.99 147.2 23.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 75.03 110.85 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 17.3 mt -52.71 -38.3 60.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 74.33 110.895 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.61 -17.21 80.21 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.712 -0.756 . . . . 75.55 112.501 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.39 -20.08 32.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.826 0.346 . . . . 73.44 111.097 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -83.96 -20.02 33.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.435 . . . . 75.34 110.923 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.3 mmtp 52.09 43.91 30.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 74.32 110.904 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.4 mt -95.03 153.12 17.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 75.24 110.898 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.57 159.77 79.87 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.588 0.709 . . . . 73.12 110.876 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 -36.8 10.24 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.699 2.266 . . . . 64.21 112.354 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.447 ' O ' ' C ' ' A' ' 70' ' ' THR . 2.4 m120 -78.45 -15.78 58.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 73.34 110.872 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.447 ' C ' ' O ' ' A' ' 69' ' ' ASN . 51.9 m -32.53 125.01 0.33 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 73.22 111.123 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.93 146.78 24.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 74.4 110.892 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.6 mm -115.17 129.96 70.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 74.02 111.164 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 41.2 mtm -101.01 142.87 31.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.478 . . . . 75.13 110.859 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.1 mtt -135.97 116.88 14.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 75.31 110.912 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 8.7 mmm -105.29 131.39 52.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 71.44 110.894 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 148.64 -151.9 24.02 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.71 -0.757 . . . . 73.23 112.51 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 t -133.06 134.59 44.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.753 0.311 . . . . 74.42 111.167 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.474 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -89.14 151.72 22.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 74.33 110.893 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -81.02 88.41 5.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 74.43 110.914 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -72.62 137.21 45.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 74.32 110.854 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 57.09 -142.08 0.76 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 75.13 110.832 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.511 0 O-C-N 124.56 1.163 . . . . 64.51 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 mtt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.785 0.326 . . . . 71.41 110.872 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.38 151.34 27.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 71.23 111.1 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.6 mt -111.38 109.37 56.35 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.595 0.712 . . . . 74.05 110.934 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 156.41 63.33 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.651 2.234 . . . . 72.02 112.35 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.3 mt -150.58 137.02 12.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 73.01 111.135 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.1 mt -94.96 140.57 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 73.41 111.134 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.5 p -127.1 122.86 61.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 73.42 111.091 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.66 119.82 40.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 73.34 110.89 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 16.6 t-105 -120.85 100.62 7.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.454 . . . . 72.25 110.944 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.87 -83.39 0.92 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.797 -0.716 . . . . 63.42 112.489 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.57 21.57 1.05 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.772 -0.728 . . . . 61.44 112.501 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -129.28 175.29 8.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.775 0.322 . . . . 73.13 110.904 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -133.19 140.96 47.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 74.52 110.916 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -136.51 119.14 16.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.173 -0.467 . . . . 74.53 110.973 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.2 p -84.13 132.35 34.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 75.12 110.849 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.9 t -94.98 125.98 47.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.069 -0.514 . . . . 75.42 111.138 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.2 p -136.49 93.12 2.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 72.01 111.174 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 173.51 -28.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 73.01 111.113 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -86.12 151.2 23.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.271 -0.422 . . . . 72.44 110.878 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.32 169.33 16.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 71.3 110.815 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.405 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 43.1 mt-10 -61.7 -22.18 65.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.106 -0.497 . . . . 72.1 110.922 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -70.16 -10.69 59.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 74.23 110.871 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -99.2 -150.44 0.37 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 75.02 110.842 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.32 168.53 18.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 74.24 111.144 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.0 t -64.67 -42.85 96.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 70.52 111.137 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.14 -28.47 69.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 73.02 110.9 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -70.81 -35.09 72.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 74.01 110.868 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.64 -47.73 13.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 75.15 110.906 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.499 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.97 -56.8 15.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 73.2 110.867 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -58.19 -22.1 50.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 74.42 110.906 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -77.48 -54.9 5.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 74.43 110.865 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.4 pp -68.28 -43.0 78.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 71.23 110.898 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.567 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -55.08 -26.91 41.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 75.02 110.909 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.82 -23.77 41.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.452 . . . . 73.0 111.141 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.7 mt -76.67 -60.26 2.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.234 -0.439 . . . . 75.24 110.87 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.8 t -135.41 -27.48 1.19 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 72.12 111.181 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.567 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.45 -178.4 4.74 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.759 -0.734 . . . . 70.42 112.521 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.489 ' CG2' HD23 ' A' ' 39' ' ' LEU . 1.2 p -112.91 139.06 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.889 0.376 . . . . 72.41 111.095 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.587 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.53 150.8 16.08 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.66 0.743 . . . . 75.42 110.92 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 -21.64 33.57 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.69 2.26 . . . . 72.55 112.358 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -54.41 -38.89 66.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 63.22 110.874 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.04 -40.52 6.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 74.54 110.865 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.41 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.7 pp0? -97.87 158.27 15.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 74.43 110.929 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.36 141.73 51.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 73.51 110.898 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.36 136.04 54.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.266 -0.425 . . . . 71.41 110.868 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -76.74 -75.91 0.18 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 73.43 110.898 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.26 56.83 1.74 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.735 -0.745 . . . . 54.51 112.473 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.0 pp -50.56 -32.31 18.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.877 0.37 . . . . 71.15 110.933 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.59 146.19 24.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 74.24 110.927 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.5 p -142.37 138.01 29.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 74.41 111.126 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt 54.53 32.2 16.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 74.22 110.893 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.42 -15.57 56.17 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.753 -0.737 . . . . 72.22 112.485 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -80.17 149.79 70.16 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.546 0.688 . . . . 74.23 110.901 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -36.27 11.04 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.729 2.286 . . . . 75.52 112.316 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 39.54 37.05 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 74.03 111.101 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.44 -76.83 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 75.11 110.9 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -153.87 -38.96 0.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 73.44 110.866 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -71.89 -2.61 18.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 73.4 110.882 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -92.93 147.7 5.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 73.15 111.15 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.416 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 15.4 mttp -91.27 147.84 22.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 74.41 110.916 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.405 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 17.6 mt -52.61 -38.45 60.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.248 -0.433 . . . . 64.12 110.907 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.7 -17.29 80.17 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.743 -0.741 . . . . 61.14 112.496 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.28 -19.97 32.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.854 0.359 . . . . 75.24 111.1 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -84.17 -19.27 34.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 61.25 110.944 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt 51.91 43.65 30.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 75.33 110.876 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.5 mt -94.26 152.3 18.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 75.42 110.956 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -68.45 159.79 79.38 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.595 0.712 . . . . 75.13 110.882 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -37.65 8.88 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.703 2.269 . . . . 74.53 112.333 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' A' ' 70' ' ' THR . 14.8 m-20 -78.56 -15.45 58.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 74.41 110.897 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.438 ' C ' ' O ' ' A' ' 69' ' ' ASN . 56.3 m -33.01 126.86 0.32 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.472 . . . . 73.1 111.172 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.78 145.77 25.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 74.21 110.915 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.3 mm -115.5 128.17 72.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 74.11 111.114 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 9.2 mtp -99.76 141.65 32.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 73.22 110.923 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.0 mtt -133.77 117.32 16.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 72.05 110.862 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.7 mmt -105.25 123.28 47.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 75.4 110.849 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 160.3 -157.22 28.56 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.699 -0.762 . . . . 74.21 112.519 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 t -134.21 149.3 50.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.783 0.325 . . . . 74.4 111.135 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -66.4 153.34 43.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 75.5 110.827 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -69.53 -174.29 0.68 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 73.15 110.876 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -60.38 -32.15 71.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 74.35 110.868 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 58.57 -173.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 54.13 110.896 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.513 0 O-C-N 124.537 1.148 . . . . 31.43 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.758 0.313 . . . . 75.54 110.907 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.19 146.56 33.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 73.34 111.107 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.95 110.46 63.61 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.603 0.716 . . . . 73.52 110.928 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 156.32 63.58 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.692 2.262 . . . . 63.12 112.337 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 52.6 mt -150.81 136.86 12.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 74.13 111.116 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.5 mt -95.28 140.65 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 73.11 111.159 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.4 p -127.15 123.29 61.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 75.32 111.121 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.11 122.11 46.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 72.14 110.935 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.1 t-105 -123.18 102.89 8.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 75.3 110.899 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.76 -79.68 1.63 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.72 -0.752 . . . . 74.42 112.445 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.34 17.89 0.69 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.773 -0.727 . . . . 63.2 112.547 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -130.0 138.8 51.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.763 0.316 . . . . 62.23 110.928 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -102.71 142.37 33.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 62.52 110.867 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -136.36 116.69 13.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.474 . . . . 73.24 110.923 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.7 p -82.46 132.28 35.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.078 -0.51 . . . . 75.21 110.854 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.8 t -92.96 140.61 16.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 75.24 111.132 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.5 p -151.28 91.54 1.69 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 74.15 111.108 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 173.17 -28.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 75.23 111.132 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -86.53 150.61 24.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 74.02 110.909 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.03 165.6 23.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 74.31 110.828 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.471 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -57.48 -20.55 31.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.5 . . . . 75.42 110.856 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -67.09 -13.2 61.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 71.55 110.874 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -101.91 -145.65 0.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 72.32 110.813 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.28 167.13 22.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 74.21 111.176 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.6 t -62.1 -44.58 99.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 72.15 111.151 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.4 -27.75 67.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 64.42 110.944 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -71.74 -34.5 69.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 75.45 110.878 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 tt -80.16 -47.99 13.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 74.52 110.915 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.46 -55.87 26.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.198 -0.456 . . . . 74.4 110.84 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -57.28 -22.7 43.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 73.52 110.88 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -77.92 -55.37 5.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 73.44 110.875 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 pp -67.09 -43.02 83.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.476 . . . . 73.4 110.938 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.564 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.61 -27.5 39.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 72.41 110.919 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.63 -23.67 42.43 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.474 . . . . 65.31 111.191 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.2 mt -76.49 -59.31 2.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 74.0 110.923 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.6 t -135.02 -28.25 1.19 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 71.43 111.167 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.53 -176.86 5.1 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.73 -0.747 . . . . 65.11 112.532 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.494 ' CG2' HD21 ' A' ' 39' ' ' LEU . 1.3 p -113.09 139.26 39.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.867 0.365 . . . . 75.21 111.115 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.587 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.52 150.25 18.06 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.568 0.699 . . . . 72.05 110.93 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -21.96 32.54 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.713 2.275 . . . . 75.54 112.297 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -54.47 -38.89 66.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 62.41 110.908 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -103.91 -40.31 6.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 74.42 110.892 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.412 ' HG2' HG11 ' A' ' 38' ' ' VAL . 1.9 pp0? -97.35 158.06 15.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 73.52 110.91 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.03 142.52 51.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 75.11 110.928 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.31 135.95 54.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 71.41 110.938 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -77.4 -67.57 0.7 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 64.44 110.907 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.88 61.21 0.61 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.728 -0.748 . . . . 74.31 112.484 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.6 pp -59.2 -17.94 32.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.864 0.364 . . . . 73.32 110.897 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.71 144.16 42.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 74.43 110.904 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.9 p -143.82 145.63 21.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.428 . . . . 74.41 111.115 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp 54.67 32.32 17.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 75.22 110.887 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.25 -11.28 50.64 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.69 -0.767 . . . . 71.54 112.488 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.9 mmtp -81.4 151.45 69.03 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.551 0.691 . . . . 74.22 110.912 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.418 ' O ' ' C ' ' A' ' 55' ' ' ALA . 53.8 Cg_endo -69.68 -32.96 17.84 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.675 2.25 . . . . 75.31 112.349 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 54' ' ' PRO . . . 36.42 43.65 0.25 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 64.21 111.111 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.97 -76.52 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 71.42 110.88 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -159.26 -37.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 73.22 110.922 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -67.4 -8.13 30.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 75.34 110.899 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.0 t -80.2 145.54 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 75.23 111.112 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -90.63 150.82 21.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 75.11 110.898 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.471 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 12.6 mt -51.74 -45.06 63.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 75.15 110.903 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.54 -11.29 85.61 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.75 -0.738 . . . . 71.41 112.473 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.9 -35.25 29.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.805 0.336 . . . . 72.24 111.116 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.424 ' CD1' ' HA ' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -73.13 -24.53 60.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 52.21 110.871 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.8 mmtp 62.38 38.04 13.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 73.15 110.881 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.2 mt -88.85 153.48 21.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 74.21 110.916 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.45 160.3 76.85 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.583 0.706 . . . . 72.52 110.879 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -35.62 12.22 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.678 2.252 . . . . 74.42 112.322 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.448 ' O ' ' C ' ' A' ' 70' ' ' THR . 23.8 p30 -78.8 -15.88 57.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 74.22 110.92 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.448 ' C ' ' O ' ' A' ' 69' ' ' ASN . 55.4 m -32.42 120.13 0.3 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.143 -0.481 . . . . 71.42 111.151 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.72 146.39 23.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 71.52 110.924 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.9 mm -116.97 130.63 71.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 71.05 111.135 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 6.1 mtt -103.91 141.69 35.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 73.44 110.891 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 70.5 mtm -133.99 123.57 24.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.267 -0.424 . . . . 70.35 110.906 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.3 mmm -111.12 124.39 52.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 70.03 110.841 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 164.11 -153.96 24.58 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.716 -0.754 . . . . 61.42 112.45 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.9 t -134.47 143.68 47.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.838 0.352 . . . . 74.34 111.133 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -63.72 158.75 20.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 74.21 110.878 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -84.43 140.93 31.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.465 . . . . 63.43 110.894 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -64.73 -31.81 73.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 73.31 110.904 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.6 t -80.4 -63.59 1.38 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.134 -0.485 . . . . 74.12 110.874 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.478 0 O-C-N 124.487 1.117 . . . . 52.05 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.8 0.334 . . . . 74.44 110.868 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.72 151.36 19.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 54.42 111.091 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.2 mt -110.79 109.1 57.79 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.621 0.724 . . . . 73.44 110.945 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 156.67 62.86 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.673 2.249 . . . . 70.42 112.34 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.1 mt -150.56 137.3 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.437 . . . . 75.44 111.147 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.1 mt -95.37 140.56 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 72.4 111.146 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.3 p -127.29 122.91 60.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 74.22 111.115 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -107.98 120.19 41.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 74.02 110.907 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.1 t-105 -122.27 100.91 7.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 75.44 110.903 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.91 -83.61 0.77 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.752 -0.737 . . . . 62.44 112.51 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.13 20.38 0.96 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.69 -0.767 . . . . 74.45 112.474 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -129.18 174.9 9.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.771 0.32 . . . . 74.13 110.902 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -132.7 140.64 48.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 62.41 110.934 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -135.92 119.1 16.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 73.24 110.925 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 89.2 p -82.75 136.05 34.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.101 -0.5 . . . . 70.31 110.892 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 87.3 t -98.87 125.23 52.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 74.31 111.108 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.4 p -135.44 93.41 2.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 64.54 111.121 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 173.73 -28.84 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 73.33 111.133 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -84.92 149.85 25.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.222 -0.444 . . . . 71.34 110.893 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.77 167.68 19.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 72.42 110.854 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.428 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 56.1 mt-10 -58.58 -22.39 55.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 74.01 110.887 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.11 -11.54 59.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 70.4 110.905 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -101.63 -150.24 0.4 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 74.3 110.836 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.53 167.57 21.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.462 . . . . 74.22 111.115 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 75.0 t -63.03 -42.26 96.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 72.33 111.143 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.97 -28.72 69.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.491 . . . . 73.15 110.901 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -72.06 -32.78 67.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 52.44 110.878 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.46 -48.93 12.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 70.15 110.917 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.499 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.76 -55.79 26.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 73.31 110.902 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.92 -22.64 49.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 72.33 110.918 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -77.76 -55.11 5.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.453 . . . . 74.3 110.87 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 pp -67.51 -41.93 83.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 75.23 110.915 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.567 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.71 -27.91 44.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 71.22 110.928 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.43 -23.84 42.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.455 . . . . 72.31 111.141 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.7 mt -76.15 -59.48 2.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.446 . . . . 75.51 110.877 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.4 t -135.38 -27.77 1.18 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 73.33 111.147 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.567 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.59 -175.34 4.36 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.766 -0.73 . . . . 53.34 112.495 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.489 ' CG2' HD23 ' A' ' 39' ' ' LEU . 1.4 p -112.56 141.38 28.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.807 0.337 . . . . 74.12 111.17 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.608 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -57.01 149.86 42.68 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.6 0.714 . . . . 74.01 110.885 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -21.4 33.48 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.707 2.272 . . . . 65.23 112.308 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -55.19 -39.25 69.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 71.21 110.835 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.29 -41.42 5.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 72.25 110.891 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.572 HE21 ' N ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -96.12 158.41 15.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 74.35 110.898 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.572 ' N ' HE21 ' A' ' 43' ' ' GLN . 0.0 OUTLIER -130.14 142.45 50.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 73.32 110.902 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.52 136.38 54.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 75.53 110.881 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.2 mp -86.13 -55.26 4.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 75.23 110.877 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.35 52.52 0.97 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.719 -0.753 . . . . 74.24 112.485 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.6 pp -61.67 -16.39 48.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.933 0.397 . . . . 75.51 110.942 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.9 pttt -116.8 143.25 45.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 74.14 110.876 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.6 p -143.73 145.17 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 74.41 111.137 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 55.34 31.52 16.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 74.44 110.924 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.09 -11.17 55.98 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.728 -0.749 . . . . 64.04 112.492 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -81.37 150.98 68.5 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.532 0.682 . . . . 74.14 110.938 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 55' ' ' ALA . 53.6 Cg_endo -69.79 -32.25 18.79 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.691 2.261 . . . . 74.24 112.302 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 54' ' ' PRO . . . 35.99 44.34 0.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.439 . . . . 73.11 111.128 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.08 -79.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 74.43 110.919 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.04 -38.8 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 74.33 110.884 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -64.6 -9.8 21.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 74.33 110.896 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.405 ' HB ' HD21 ' A' ' 64' ' ' LEU . 16.6 t -79.55 145.69 8.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 75.13 111.159 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -91.49 152.25 20.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.446 . . . . 73.44 110.937 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.428 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 20.0 mt -49.86 -47.47 51.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 75.22 110.928 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.72 -11.71 85.18 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.775 -0.726 . . . . 71.11 112.473 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.59 -31.55 41.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.837 0.351 . . . . 71.22 111.076 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.406 HD11 ' HA ' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -78.17 -23.99 47.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 74.12 110.925 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.7 mmtp 63.45 35.84 11.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 73.45 110.875 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.7 mt -87.78 152.88 21.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.439 . . . . 72.22 110.925 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.7 160.44 77.14 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.627 0.727 . . . . 74.44 110.897 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -34.82 13.77 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.657 2.238 . . . . 74.42 112.355 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.467 ' O ' ' C ' ' A' ' 70' ' ' THR . 12.3 m120 -78.81 -16.1 57.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 74.13 110.859 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.467 ' C ' ' O ' ' A' ' 69' ' ' ASN . 49.1 m -32.5 120.17 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 75.12 111.162 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.17 146.68 23.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 71.53 110.891 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.5 mm -115.37 128.95 72.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 74.24 111.147 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 30.8 mtt -99.7 142.67 30.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 72.43 110.865 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.3 mtt -134.08 132.73 40.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 75.35 110.854 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.3 mmt -124.58 123.5 40.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 74.5 110.88 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.13 -155.19 26.02 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.733 -0.746 . . . . 75.1 112.472 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 t -132.73 135.41 45.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.775 0.321 . . . . 72.24 111.131 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.429 ' HA ' HG22 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -93.17 147.83 22.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 74.22 110.867 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -54.46 167.35 0.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 74.25 110.858 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.34 108.15 19.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 72.32 110.877 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.1 m -78.58 -141.44 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 61.01 110.817 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.481 0 O-C-N 124.494 1.121 . . . . 31.22 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mtt . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.815 0.341 . . . . 71.14 110.83 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.1 151.47 20.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 74.14 111.112 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.4 mt -112.13 109.68 54.33 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.589 0.709 . . . . 72.33 110.927 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 156.42 63.49 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.689 2.259 . . . . 72.54 112.364 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.8 mt -150.56 137.45 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 75.34 111.134 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.3 mt -95.39 140.65 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 71.15 111.137 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.95 123.28 62.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 72.21 111.108 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.52 120.73 43.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 74.15 110.865 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 17.3 t-105 -123.87 105.03 9.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 74.13 110.878 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.88 -81.81 0.9 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.767 -0.73 . . . . 70.03 112.483 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.04 20.25 0.66 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.782 -0.723 . . . . 73.13 112.513 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -129.13 175.35 8.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.756 0.312 . . . . 74.31 110.947 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -132.74 140.12 47.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 75.51 110.899 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -134.7 116.33 14.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.172 -0.467 . . . . 73.51 110.913 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.0 p -82.93 130.59 35.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.504 . . . . 75.33 110.864 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 91.6 t -91.74 142.0 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 74.14 111.148 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.2 p -151.49 92.31 1.76 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 72.41 111.156 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 173.74 -29.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 64.42 111.148 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -86.25 152.2 22.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 70.43 110.92 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.55 169.75 15.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 75.01 110.851 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.434 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 58.2 mt-10 -61.85 -22.23 65.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 74.22 110.914 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -68.8 -12.05 61.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.17 -0.468 . . . . 75.52 110.887 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -99.78 -150.52 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 73.02 110.88 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.53 171.37 13.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 65.43 111.17 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.8 t -67.69 -40.96 84.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 72.52 111.119 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.19 -29.4 70.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 72.52 110.905 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -70.1 -35.12 73.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 71.41 110.845 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 tt -80.76 -47.67 13.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 74.24 110.938 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.494 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.86 -56.5 18.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 75.14 110.892 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.15 -22.75 52.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.434 . . . . 73.34 110.915 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -76.86 -55.48 5.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 72.0 110.864 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.2 pp -67.29 -43.43 81.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 75.13 110.889 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.567 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.2 tmtt? -54.81 -27.48 42.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 73.31 110.914 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.34 -23.51 43.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 75.03 111.161 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.6 mt -76.65 -59.59 2.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 72.1 110.929 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.7 t -135.01 -27.68 1.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 75.22 111.158 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.567 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.59 -176.68 5.07 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.777 -0.725 . . . . 71.53 112.457 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.496 ' CG2' HD21 ' A' ' 39' ' ' LEU . 1.4 p -112.38 138.54 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.887 0.375 . . . . 73.32 111.144 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.599 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.06 149.75 17.35 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.575 0.703 . . . . 74.11 110.947 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -21.97 32.7 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.669 2.246 . . . . 73.32 112.335 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -53.94 -38.43 64.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 73.11 110.907 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.08 -39.52 6.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 74.43 110.919 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -96.54 158.66 15.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 71.2 110.892 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.02 139.33 52.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 74.54 110.871 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.81 135.45 54.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.257 -0.429 . . . . 75.24 110.898 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.2 mp -77.45 -75.81 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.467 . . . . 73.0 110.907 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.12 59.44 1.68 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.755 -0.736 . . . . 65.43 112.508 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.6 pp -55.83 -24.39 36.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.874 0.369 . . . . 74.25 110.914 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -103.45 143.16 33.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 73.44 110.854 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.4 p -144.19 143.36 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.42 . . . . 74.52 111.126 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.6 mttm 54.04 34.17 19.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 74.25 110.865 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.38 -15.16 41.79 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.741 -0.743 . . . . 74.34 112.47 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -81.56 149.59 64.95 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.557 0.694 . . . . 74.51 110.887 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -36.4 10.85 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.714 2.276 . . . . 70.24 112.344 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 38.4 40.01 0.33 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 71.51 111.075 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -66.94 -74.37 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 74.13 110.865 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -156.54 -37.31 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 75.25 110.87 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -74.67 -2.98 28.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 75.31 110.897 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.3 t -91.15 146.94 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 62.15 111.13 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.467 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 24.6 mttt -89.04 146.55 24.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 73.25 110.943 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.434 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 18.3 mt -52.12 -37.58 54.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.256 -0.429 . . . . 72.44 110.906 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.93 -18.24 79.62 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.748 -0.739 . . . . 71.33 112.47 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.73 -15.56 44.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.883 0.373 . . . . 72.21 111.141 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 60' ' ' LYS . 0.7 OUTLIER -87.04 -18.31 30.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 74.32 110.913 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 49.66 45.08 24.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 73.11 110.924 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.4 mt -97.86 152.99 18.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 65.34 110.923 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.42 159.81 79.15 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.547 0.689 . . . . 75.21 110.911 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -36.57 10.51 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.682 2.255 . . . . 64.04 112.332 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.467 ' O ' ' C ' ' A' ' 70' ' ' THR . 5.0 m120 -78.45 -15.59 58.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 75.22 110.911 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.467 ' C ' ' O ' ' A' ' 69' ' ' ASN . 52.2 m -32.93 125.68 0.34 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 75.21 111.126 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.88 145.29 25.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 74.34 110.887 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.3 mm -115.57 131.9 66.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 74.0 111.14 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.2 mtp -101.99 141.78 34.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 73.11 110.913 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 75.9 mtm -133.47 120.0 20.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 74.33 110.856 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.5 mmt -109.7 123.8 50.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 74.14 110.921 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 162.73 -155.56 26.94 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 72.04 112.48 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.9 t -134.09 144.04 48.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.8 0.333 . . . . 74.41 111.134 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -64.22 156.05 29.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 75.21 110.889 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -81.38 141.94 33.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 74.22 110.852 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.625 ' O ' ' N ' ' A' ' 90' ' ' NH2 . 0.2 OUTLIER 58.27 89.02 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 63.31 110.877 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.76 -38.32 0.12 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 62.25 110.895 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' NH2 . . . . . 0.625 ' N ' ' O ' ' A' ' 80' ' ' GLU . . . . . . . . 0 C--N 1.324 -0.513 0 O-C-N 124.55 1.156 . . . . 35.12 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.78 0.324 . . . . 74.21 110.864 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.8 151.13 21.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 75.33 111.121 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.9 mt -110.49 108.89 58.36 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.665 0.745 . . . . 73.11 110.892 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 156.52 63.05 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.735 2.29 . . . . 74.3 112.33 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.0 mt -150.5 137.24 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 73.35 111.128 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.6 mt -94.96 140.57 16.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 75.33 111.143 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.0 p -127.28 122.88 60.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 74.32 111.153 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -107.31 118.85 37.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 73.1 110.9 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 16.8 t-105 -121.18 101.59 7.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.233 -0.44 . . . . 73.34 110.895 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.48 -83.24 0.79 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.81 -0.71 . . . . 72.14 112.524 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.85 20.55 0.89 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.756 -0.735 . . . . 54.21 112.488 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -129.2 175.83 8.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.711 0.291 . . . . 73.11 110.957 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -132.88 140.78 48.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 73.42 110.903 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -136.62 118.13 14.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.147 -0.479 . . . . 73.34 110.931 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.02 133.94 35.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 73.34 110.856 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.3 t -96.02 126.91 48.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 74.11 111.124 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.1 p -135.94 91.99 2.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 74.33 111.121 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 t 174.62 -29.69 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 75.32 111.125 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -83.4 149.62 26.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 75.03 110.91 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.5 168.01 18.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 75.33 110.844 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.405 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 36.9 mt-10 -59.24 -22.01 60.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 73.53 110.896 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -69.11 -10.7 58.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 71.3 110.873 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -100.89 -150.19 0.39 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 75.0 110.855 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.07 167.99 20.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 75.55 111.141 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.8 t -62.38 -45.02 99.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 73.53 111.158 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.78 -28.54 68.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.475 . . . . 75.44 110.918 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.05 -33.56 70.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 65.45 110.938 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.86 -48.97 11.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 73.1 110.902 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.491 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.4 -56.58 18.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 72.34 110.858 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -58.29 -22.04 51.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 74.44 110.93 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -77.88 -54.93 5.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 74.04 110.854 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.6 pp -67.73 -42.24 82.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 73.41 110.929 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.575 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.88 -27.39 42.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 74.42 110.889 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.77 -23.77 41.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 74.01 111.207 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.9 mt -76.5 -59.94 2.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 64.41 110.896 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.9 t -135.28 -27.62 1.2 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.443 . . . . 74.25 111.162 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.575 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.61 -177.81 4.61 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.729 -0.748 . . . . 72.14 112.532 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.462 ' CG2' HD23 ' A' ' 39' ' ' LEU . 1.3 p -112.66 138.56 41.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.827 0.346 . . . . 75.21 111.145 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.591 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -55.17 151.17 18.45 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.614 0.721 . . . . 71.11 110.903 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -21.61 33.51 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.718 2.279 . . . . 74.2 112.334 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -54.38 -38.91 66.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 75.43 110.869 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -104.14 -40.4 6.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 74.14 110.897 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.411 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.7 pp0? -97.86 158.43 15.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 72.32 110.917 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.64 140.85 51.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 73.14 110.861 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.35 135.75 53.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.461 . . . . 74.05 110.913 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -81.05 -64.39 1.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 73.24 110.91 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.63 56.89 1.64 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.781 -0.723 . . . . 71.33 112.516 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.532 ' CD2' ' C ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -59.72 -13.4 9.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.886 0.374 . . . . 70.43 110.905 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.31 145.97 47.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 73.3 110.903 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.6 p -143.75 144.06 23.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.207 -0.451 . . . . 74.02 111.109 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.2 mttt 54.72 31.14 14.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 73.11 110.907 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.24 -9.99 59.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.763 -0.732 . . . . 70.55 112.485 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -81.04 150.25 68.18 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.576 0.703 . . . . 73.23 110.88 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.411 ' O ' ' C ' ' A' ' 55' ' ' ALA . 53.7 Cg_endo -69.76 -30.53 22.12 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.7 2.267 . . . . 62.12 112.328 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 54' ' ' PRO . . . 35.5 43.28 0.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 53.2 111.102 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.33 -78.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 74.43 110.929 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -157.44 -38.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 75.41 110.845 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -66.12 -8.59 24.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.221 -0.445 . . . . 73.42 110.838 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.4 t -78.79 146.55 7.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 75.52 111.133 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -93.24 151.14 20.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 54.45 110.885 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.405 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 18.9 mt -50.64 -45.64 57.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.264 -0.425 . . . . 74.33 110.882 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.38 -12.02 84.59 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.79 -0.719 . . . . 64.22 112.474 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.14 -33.45 29.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.8 0.333 . . . . 63.02 111.077 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.09 -25.07 60.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 73.33 110.905 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt 62.63 37.75 12.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.218 -0.446 . . . . 73.12 110.891 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.8 mt -91.31 152.98 20.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.266 -0.424 . . . . 75.1 110.928 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -68.7 160.71 75.86 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.589 0.709 . . . . 74.23 110.909 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -35.42 12.61 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.696 2.264 . . . . 74.33 112.356 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.472 ' O ' ' C ' ' A' ' 70' ' ' THR . 8.6 m-20 -78.86 -15.96 57.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 75.03 110.906 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.472 ' C ' ' O ' ' A' ' 69' ' ' ASN . 54.6 m -32.51 124.72 0.33 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 70.52 111.133 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.4 147.0 23.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 74.31 110.859 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.6 mm -116.93 127.5 74.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 74.32 111.128 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.4 mtt -99.22 141.87 31.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 74.24 110.838 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.9 mtt -136.14 117.22 14.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 74.2 110.864 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.4 mmt -106.19 125.78 51.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 74.54 110.863 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 160.26 -155.3 26.42 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.763 -0.732 . . . . 62.12 112.487 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.0 t -134.52 147.82 50.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.779 0.323 . . . . 74.43 111.163 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -64.95 157.0 29.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 71.2 110.849 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.56 165.69 0.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 74.52 110.89 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.03 148.89 43.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 65.42 110.905 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.3 p -152.11 -165.58 2.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 73.22 110.882 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.472 0 O-C-N 124.508 1.13 . . . . 72.14 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mtt . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.774 0.321 . . . . 71.43 110.879 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.42 151.46 23.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 72.51 111.116 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.9 mt -111.08 109.36 57.11 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.59 0.71 . . . . 75.2 110.865 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 156.05 64.39 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.738 2.292 . . . . 71.34 112.356 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 53.4 mt -150.7 135.96 10.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.452 . . . . 74.21 111.146 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.3 mt -94.24 140.4 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 73.24 111.118 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.9 p -127.34 123.39 61.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 74.21 111.121 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.64 123.01 48.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 71.13 110.866 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.0 t-105 -123.87 100.49 6.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 73.54 110.9 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.23 -80.41 1.3 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.718 -0.753 . . . . 62.42 112.458 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.25 17.24 0.79 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.735 . . . . 71.41 112.48 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -129.89 139.03 51.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.774 0.321 . . . . 64.15 110.943 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -103.07 142.39 34.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 70.23 110.846 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -135.84 117.27 14.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 75.12 110.92 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 82.6 p -81.82 132.6 35.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 62.22 110.829 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 99.9 t -93.31 136.31 25.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 74.45 111.155 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.2 p -147.55 92.38 2.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 74.35 111.145 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 173.51 -28.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 74.42 111.152 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -85.98 150.72 24.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 70.1 110.911 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.81 168.7 17.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.464 . . . . 74.3 110.876 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.43 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 69.9 mt-10 -59.51 -22.14 61.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 63.33 110.893 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.04 -12.57 60.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 72.52 110.883 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -101.97 -148.7 0.38 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 72.24 110.874 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.64 168.28 19.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 74.24 111.13 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 86.9 t -63.02 -45.15 99.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 64.23 111.103 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.8 -27.95 67.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 74.25 110.94 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -71.79 -33.78 68.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.193 -0.458 . . . . 73.0 110.835 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.67 -48.28 12.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 75.51 110.907 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.64 -55.79 26.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 75.0 110.86 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.51 -22.5 44.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 74.41 110.94 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -77.75 -55.06 5.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 74.43 110.891 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 pp -67.76 -42.93 81.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 74.13 110.945 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.571 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.62 -27.53 40.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 73.21 110.923 179.797 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.46 -23.6 42.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.465 . . . . 75.53 111.15 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.2 mt -76.58 -59.15 2.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 74.32 110.958 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.5 t -134.95 -28.09 1.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.444 . . . . 74.32 111.132 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.571 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.79 -176.52 5.21 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.727 -0.749 . . . . 73.12 112.499 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.491 ' CG2' HD23 ' A' ' 39' ' ' LEU . 1.3 p -113.39 138.28 43.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.834 0.349 . . . . 74.31 111.145 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.578 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -53.61 149.94 14.39 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.633 0.73 . . . . 74.41 110.911 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.401 ' O ' ' O ' ' A' ' 43' ' ' GLN . 53.5 Cg_endo -69.78 -21.72 33.01 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.647 2.231 . . . . 64.21 112.373 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -54.06 -38.33 65.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 63.54 110.882 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.76 -40.05 6.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 73.02 110.838 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -96.72 158.05 15.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 65.35 110.876 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.65 140.78 51.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 75.45 110.896 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.72 135.85 54.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.434 . . . . 73.22 110.906 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -75.15 -70.25 0.43 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 74.03 110.911 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -99.73 61.22 0.73 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.708 -0.758 . . . . 62.33 112.455 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.5 pp -57.7 -19.63 28.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.879 0.371 . . . . 71.11 110.929 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.34 144.47 39.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 74.14 110.865 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.7 p -143.83 145.57 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 72.13 111.134 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.9 mttm 54.89 32.24 17.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 73.15 110.892 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.04 -11.16 50.04 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.749 -0.738 . . . . 74.41 112.445 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.0 mmtt -81.3 151.31 69.19 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.581 0.705 . . . . 75.25 110.878 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 55' ' ' ALA . 53.8 Cg_endo -69.81 -32.92 17.43 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.665 2.244 . . . . 71.44 112.313 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 54' ' ' PRO . . . 36.6 43.51 0.27 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 73.14 111.059 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.47 -76.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.203 -0.453 . . . . 72.04 110.919 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -159.47 -37.28 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 43.24 110.913 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.27 -7.8 27.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 73.02 110.9 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.402 ' HB ' HD22 ' A' ' 64' ' ' LEU . 17.6 t -80.52 145.72 8.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 70.23 111.096 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -90.23 151.46 21.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 75.1 110.913 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.43 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 18.6 mt -49.92 -47.62 52.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 75.24 110.924 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.57 -11.95 84.98 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.739 -0.744 . . . . 63.35 112.498 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.04 -32.06 44.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.822 0.344 . . . . 62.14 111.104 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.409 HD11 ' HA ' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -77.83 -23.48 48.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 74.44 110.912 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt 63.39 37.2 10.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 72.3 110.916 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.1 mt -88.79 152.56 21.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 72.43 110.939 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -68.64 160.24 77.85 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.572 0.701 . . . . 74.23 110.878 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -35.54 12.58 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.68 2.254 . . . . 74.12 112.385 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.445 ' O ' ' C ' ' A' ' 70' ' ' THR . 8.2 p30 -78.5 -15.78 58.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 75.25 110.908 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.445 ' C ' ' O ' ' A' ' 69' ' ' ASN . 50.1 m -32.83 119.47 0.32 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 74.4 111.14 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -91.05 146.77 23.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 73.12 110.903 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.3 mm -115.36 129.78 71.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.436 . . . . 74.12 111.106 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 41.3 mtm -101.45 141.65 34.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 74.01 110.875 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.1 mtt -130.78 130.1 43.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 70.42 110.879 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.3 mmt -122.21 127.04 49.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 74.32 110.858 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.88 -150.87 22.52 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.714 -0.755 . . . . 74.4 112.468 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 t -132.92 125.17 29.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.742 0.306 . . . . 73.53 111.114 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.486 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -83.82 148.22 27.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 73.13 110.836 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -69.68 -172.49 0.5 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.465 . . . . 74.33 110.905 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -98.1 -59.29 1.79 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 71.24 110.884 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.9 t -135.39 -40.27 0.73 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.098 -0.501 . . . . 74.4 110.854 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.497 0 O-C-N 124.519 1.137 . . . . 62.14 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mmt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.781 0.324 . . . . 72.43 110.872 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.73 151.34 22.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 73.55 111.131 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 mt -114.45 107.44 51.24 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.628 0.728 . . . . 75.4 110.9 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 156.02 64.43 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.664 2.243 . . . . 64.41 112.364 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.9 mt -150.88 138.63 13.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 72.14 111.102 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.2 mt -95.13 140.72 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 75.44 111.094 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.8 p -126.9 123.24 62.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 74.3 111.142 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.21 118.53 37.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 73.54 110.902 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 17.4 t-105 -120.57 103.77 9.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 73.1 110.938 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.41 -83.26 0.88 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.723 -0.751 . . . . 70.11 112.481 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.06 20.18 0.86 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.678 -0.772 . . . . 71.34 112.448 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -128.84 175.69 8.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.715 0.293 . . . . 75.5 110.932 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -132.79 141.84 48.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 72.43 110.92 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -138.49 116.46 11.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 73.44 110.889 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.21 137.35 35.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 74.12 110.855 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 84.3 t -94.21 142.45 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 60.41 111.141 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.4 p -155.26 90.83 1.29 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 74.43 111.198 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 t 177.11 -31.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 75.54 111.138 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.415 ' CD1' ' HA ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -88.02 163.67 16.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.44 . . . . 75.31 110.932 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.24 173.96 11.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 73.34 110.862 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.41 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 36.6 mt-10 -63.13 -20.03 65.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.482 . . . . 74.21 110.879 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -69.42 -11.09 60.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 74.45 110.896 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -97.76 -152.08 0.39 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 74.44 110.896 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -137.09 165.3 26.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 63.25 111.143 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 72.6 t -59.04 -43.87 90.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 74.32 111.091 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.56 -30.54 71.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 75.11 110.918 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.413 ' HB3' HD21 ' A' ' 19' ' ' LEU . 5.6 t70 -72.22 -33.85 67.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 54.53 110.864 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.415 ' HA ' ' CD1' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -78.8 -47.89 15.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 65.32 110.889 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -62.75 -54.22 42.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 74.13 110.892 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.49 -22.11 30.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 74.54 110.884 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -77.57 -55.15 5.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 63.21 110.915 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.1 pp -68.45 -42.24 79.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.477 . . . . 73.15 110.872 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.572 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.65 -27.51 40.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 65.04 110.927 179.818 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.62 -23.76 42.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 74.12 111.106 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.8 mt -76.4 -59.9 2.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.42 . . . . 74.23 110.893 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.5 t -135.14 -27.8 1.21 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.203 -0.453 . . . . 73.15 111.111 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.572 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.8 -177.55 4.68 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.778 -0.725 . . . . 41.43 112.486 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.472 ' CG2' HD22 ' A' ' 39' ' ' LEU . 1.3 p -112.7 138.59 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.842 0.353 . . . . 65.42 111.137 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.592 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.78 150.93 16.67 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.632 0.73 . . . . 73.42 110.868 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 -21.7 32.78 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.638 2.225 . . . . 72.33 112.355 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -54.09 -39.14 66.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 74.11 110.872 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.2 mtt85 -104.04 -40.44 6.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 73.33 110.884 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.402 ' HG2' HG12 ' A' ' 38' ' ' VAL . 1.8 pp0? -97.23 157.21 16.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 72.25 110.914 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.83 143.31 50.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 74.12 110.902 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.57 136.1 53.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 75.4 110.908 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.3 mp -86.13 -53.0 5.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 71.03 110.904 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -104.68 53.37 0.68 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.718 -0.754 . . . . 63.55 112.474 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.5 pp -59.67 -17.91 37.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.855 0.359 . . . . 71.55 110.886 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.93 143.13 45.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 72.43 110.91 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.5 p -143.67 145.3 22.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 75.13 111.094 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.92 31.86 16.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 74.5 110.868 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.99 -10.99 56.54 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.756 -0.735 . . . . 72.33 112.494 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -81.62 150.99 67.67 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.61 0.719 . . . . 71.21 110.9 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 55' ' ' ALA . 54.3 Cg_endo -69.73 -32.74 18.1 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.709 2.273 . . . . 75.15 112.353 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 54' ' ' PRO . . . 36.04 44.25 0.25 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 65.02 111.083 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.77 -80.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 64.24 110.918 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -154.65 -39.26 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 72.22 110.886 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.69 -10.39 19.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 74.44 110.864 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.6 t -79.28 146.1 8.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 74.51 111.141 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 14.6 mttt -93.02 152.16 19.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 74.12 110.892 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.41 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 24.3 mt -50.13 -46.56 53.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 74.02 110.939 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.22 -12.02 84.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.742 -0.742 . . . . 70.04 112.435 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.92 -33.1 34.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.883 0.373 . . . . 73.24 111.111 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.23 -24.6 59.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 73.42 110.917 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt 62.95 37.86 11.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 73.41 110.955 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mt -90.76 154.11 19.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 65.44 110.905 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -68.35 160.26 76.62 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.574 0.702 . . . . 74.1 110.929 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 -35.51 12.71 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.68 2.253 . . . . 71.52 112.395 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.459 ' O ' ' C ' ' A' ' 70' ' ' THR . 7.8 m-20 -78.83 -16.32 57.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 73.12 110.94 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.459 ' C ' ' O ' ' A' ' 69' ' ' ASN . 55.5 m -32.45 126.11 0.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 74.4 111.142 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.34 147.5 23.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 73.24 110.874 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.0 mm -117.54 128.64 74.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 75.43 111.168 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 6.5 mtt -99.02 141.87 31.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 74.34 110.863 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.7 mtt -137.03 116.96 13.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 73.23 110.883 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.2 mmm -107.14 126.13 51.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 74.41 110.893 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.83 -155.05 26.19 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.735 . . . . 75.1 112.475 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.3 t -134.65 143.83 47.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.764 0.316 . . . . 64.34 111.133 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -61.72 159.56 13.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 74.52 110.891 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -52.07 157.25 1.36 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 74.21 110.853 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -165.46 32.0 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 73.52 110.877 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.6 t -168.5 -128.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 72.51 110.86 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.454 0 O-C-N 124.504 1.128 . . . . 74.21 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.77 0.319 . . . . 73.1 110.848 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.39 146.7 39.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 74.43 111.06 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 mt -110.9 108.11 57.74 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.644 0.735 . . . . 74.44 110.911 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 155.72 65.07 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.666 2.244 . . . . 74.33 112.338 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.4 mt -150.95 138.68 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 73.13 111.12 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.1 mt -94.78 140.79 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 72.44 111.109 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.4 p -126.63 123.13 62.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.124 -0.489 . . . . 74.44 111.154 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -107.77 117.38 33.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 73.41 110.863 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 17.9 t-105 -119.84 102.07 8.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 72.31 110.902 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.09 -82.93 0.81 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.748 -0.739 . . . . 54.35 112.505 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.26 19.93 0.83 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.734 -0.745 . . . . 73.23 112.471 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -128.26 175.72 8.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.75 0.31 . . . . 73.34 110.938 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -132.99 141.7 48.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 72.42 110.875 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -138.28 118.38 13.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.16 -0.473 . . . . 73.25 110.938 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.4 p -82.62 135.38 35.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 75.32 110.898 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 62.3 t -94.36 130.58 43.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 72.33 111.13 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.5 p -144.37 90.55 2.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 73.31 111.123 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.8 t 177.68 -32.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 73.13 111.119 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.41 HD21 ' HB3' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -87.86 164.12 16.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 72.21 110.898 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.42 174.82 10.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 74.52 110.877 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -64.8 -20.46 66.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 72.13 110.873 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -67.73 -20.98 65.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 72.32 110.852 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.31 -150.36 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 73.24 110.84 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.97 162.68 33.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 75.33 111.121 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 22.0 t -55.5 -48.53 77.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.45 . . . . 74.33 111.12 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.29 -28.33 69.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 73.53 110.929 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.41 ' HB3' HD21 ' A' ' 19' ' ' LEU . 9.3 t70 -71.56 -36.24 70.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 74.12 110.901 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.402 ' HA ' ' CD1' ' A' ' 19' ' ' LEU . 0.9 OUTLIER -77.2 -47.72 19.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 72.0 110.894 -179.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.486 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -62.47 -55.11 30.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 75.14 110.875 179.83 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -56.62 -22.65 35.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 74.11 110.878 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -76.77 -55.08 5.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 73.43 110.874 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.8 pp -69.01 -41.86 77.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 74.5 110.875 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.571 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.2 tmtt? -54.85 -27.72 44.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 74.1 110.899 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.33 -23.41 43.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.461 . . . . 74.35 111.157 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.5 mt -76.98 -59.77 2.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 73.13 110.915 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.8 t -135.66 -27.64 1.15 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.458 . . . . 71.51 111.176 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.571 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.66 -177.77 4.64 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.704 -0.76 . . . . 74.24 112.506 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.469 ' CG2' HD21 ' A' ' 39' ' ' LEU . 1.3 p -112.31 138.88 39.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.88 0.371 . . . . 73.33 111.159 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.589 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.78 151.04 16.25 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.635 0.731 . . . . 75.33 110.913 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 -21.79 33.09 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.713 2.275 . . . . 74.41 112.318 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -54.17 -39.11 66.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 64.14 110.911 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -104.02 -40.21 6.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 73.52 110.855 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -97.84 157.37 16.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 71.35 110.881 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.06 142.1 51.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 75.23 110.902 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.45 135.95 53.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 72.05 110.916 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.2 mp -85.37 -60.49 2.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 73.45 110.939 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.82 51.63 0.97 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.755 -0.736 . . . . 64.35 112.494 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.6 pp -55.2 -25.45 32.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.909 0.385 . . . . 75.22 110.929 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -107.34 141.76 38.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 75.12 110.88 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.8 t -143.95 144.97 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 63.11 111.113 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 54.34 32.41 16.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 74.25 110.944 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.07 -14.45 49.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.716 -0.755 . . . . 64.22 112.467 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -81.55 148.74 63.04 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.6 0.714 . . . . 72.53 110.866 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.41 ' O ' ' C ' ' A' ' 55' ' ' ALA . 53.5 Cg_endo -69.82 -35.0 13.27 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.696 2.264 . . . . 72.11 112.341 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 54' ' ' PRO . . . 37.39 41.49 0.26 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 75.03 111.132 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.73 -76.89 0.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 71.55 110.885 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -150.98 -39.44 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 75.33 110.892 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -71.96 -2.63 18.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 71.32 110.875 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.78 147.44 5.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 74.14 111.155 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.472 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 30.8 mttt -93.93 149.05 21.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 74.55 110.888 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 17.4 mt -51.98 -39.74 59.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 74.03 110.956 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.13 -16.49 80.56 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.767 -0.73 . . . . 73.01 112.489 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.91 -19.75 31.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.814 0.34 . . . . 64.12 111.096 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -85.05 -18.89 32.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 73.1 110.899 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp 52.31 42.63 31.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 73.1 110.879 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 mt -91.12 153.64 19.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 75.41 110.921 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.47 159.13 82.74 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.6 0.714 . . . . 75.33 110.842 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -37.21 9.56 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.69 2.26 . . . . 75.11 112.339 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.462 ' O ' ' C ' ' A' ' 70' ' ' THR . 11.7 p30 -79.42 -16.31 56.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 64.44 110.856 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.462 ' C ' ' O ' ' A' ' 69' ' ' ASN . 65.8 m -31.77 132.4 0.11 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 63.14 111.144 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.86 145.92 28.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 75.4 110.916 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.5 mm -115.63 128.75 72.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.245 -0.434 . . . . 74.53 111.117 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.2 mtt -99.35 141.45 32.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 74.33 110.918 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.9 mtt -136.65 116.71 13.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 75.43 110.878 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.9 mmm -106.38 127.13 53.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 73.14 110.88 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.98 -155.92 27.08 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.697 -0.764 . . . . 55.14 112.436 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.3 t -134.71 146.59 49.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.768 0.318 . . . . 71.53 111.195 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -64.12 160.58 17.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 74.1 110.848 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.79 177.97 5.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 73.33 110.88 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -130.14 -48.99 1.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 72.2 110.883 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.19 162.84 13.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 75.34 110.874 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.489 0 O-C-N 124.494 1.121 . . . . 71.3 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mtt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.771 0.319 . . . . 72.14 110.86 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.0 145.46 26.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 74.32 111.143 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -105.66 109.82 63.58 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.608 0.718 . . . . 63.44 110.934 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 156.46 63.45 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.716 2.277 . . . . 64.55 112.356 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.1 mt -149.98 137.01 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 75.15 111.132 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 mt -95.33 140.58 16.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 73.31 111.134 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.42 123.5 61.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 72.43 111.142 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.35 121.44 45.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 73.45 110.9 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 17.3 t-105 -125.17 106.25 9.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 74.44 110.928 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.16 -81.29 0.86 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.744 -0.741 . . . . 71.34 112.464 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -155.12 19.83 0.56 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.745 -0.741 . . . . 75.41 112.487 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -129.3 175.23 8.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.793 0.33 . . . . 72.2 110.865 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -132.43 140.09 48.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 63.33 110.881 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -134.39 116.13 14.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 63.43 110.979 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.76 131.49 35.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.488 . . . . 74.33 110.858 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 90.4 t -92.79 141.43 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 74.2 111.143 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.3 p -150.58 92.62 1.87 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 75.22 111.142 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 173.29 -28.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 74.22 111.137 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -86.36 150.81 24.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.248 -0.433 . . . . 74.45 110.93 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.67 167.55 19.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 70.11 110.83 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.426 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 40.3 mt-10 -59.41 -22.24 61.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 64.2 110.892 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.0 -11.52 60.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.144 -0.48 . . . . 72.02 110.852 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -100.34 -150.37 0.38 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 75.44 110.837 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.94 170.09 15.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 71.25 111.15 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.8 t -66.1 -43.75 92.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 73.12 111.114 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.4 -28.77 68.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 65.23 110.926 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -69.97 -35.62 74.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 61.1 110.869 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 tt -80.7 -47.94 13.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 75.15 110.903 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.488 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.28 -56.56 19.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 73.4 110.911 179.88 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.19 -22.77 53.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 71.4 110.933 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -76.79 -55.27 5.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 72.33 110.89 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.3 pp -67.73 -43.46 79.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 74.11 110.877 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.566 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.2 tmtt? -54.89 -27.14 40.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 72.24 110.898 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.52 -23.72 42.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.248 -0.433 . . . . 73.51 111.135 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.1 mt -76.59 -59.57 2.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 74.13 110.901 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.9 t -135.09 -28.07 1.2 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 75.03 111.139 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.566 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.03 -177.37 4.85 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.745 -0.741 . . . . 72.44 112.539 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 78' ' ' ARG . 1.3 p -112.84 138.43 42.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.845 0.355 . . . . 72.4 111.155 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.595 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -53.73 149.72 15.59 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.639 0.733 . . . . 75.35 110.926 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.4 ' O ' ' O ' ' A' ' 43' ' ' GLN . 53.8 Cg_endo -69.78 -21.71 33.01 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.663 2.242 . . . . 72.35 112.335 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -54.19 -38.3 65.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 75.41 110.925 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -104.72 -40.04 6.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 73.42 110.856 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -96.94 158.66 15.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 72.54 110.955 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.37 139.57 52.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 74.1 110.916 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.15 136.08 55.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 72.22 110.92 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -75.83 -74.96 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 74.2 110.915 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -97.52 60.06 1.07 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.731 -0.747 . . . . 72.12 112.464 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.8 pp -54.93 -24.2 22.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.853 0.358 . . . . 74.35 110.944 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.32 143.33 33.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.202 -0.453 . . . . 75.33 110.879 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.9 p -144.13 143.2 23.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 70.55 111.131 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? 54.2 34.06 19.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 73.04 110.912 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.4 -15.18 41.76 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.758 -0.735 . . . . 74.23 112.487 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -81.5 149.28 64.53 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.628 0.727 . . . . 74.53 110.848 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -35.47 12.71 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.698 2.265 . . . . 74.12 112.384 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 38.74 39.61 0.35 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 61.44 111.117 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.49 -75.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.278 -0.419 . . . . 74.54 110.873 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -154.68 -38.63 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 75.43 110.884 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -73.09 -1.98 19.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 73.31 110.819 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -92.71 148.27 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 75.24 111.124 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.433 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 16.6 mttt -91.18 147.28 23.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 72.01 110.924 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.426 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 18.7 mt -52.29 -39.31 60.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.433 . . . . 74.52 110.902 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.66 -16.91 80.34 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.735 -0.745 . . . . 72.32 112.511 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.49 -19.31 33.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.853 0.359 . . . . 73.54 111.093 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -83.79 -19.96 34.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 74.14 110.943 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp 52.87 43.49 31.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 74.24 110.935 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.4 mt -96.19 152.91 18.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 71.32 110.935 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.54 159.81 79.58 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.626 0.727 . . . . 72.53 110.894 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -36.15 11.22 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.645 2.23 . . . . 74.34 112.322 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.463 ' O ' ' C ' ' A' ' 70' ' ' THR . 82.4 m-20 -78.57 -15.72 58.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 71.54 110.868 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.463 ' C ' ' O ' ' A' ' 69' ' ' ASN . 52.8 m -32.58 124.78 0.33 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 74.3 111.128 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.26 146.27 24.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 75.11 110.883 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.3 mm -115.16 129.88 70.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 72.13 111.165 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 6.8 mtp -101.85 141.93 33.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 72.44 110.895 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 78.3 mtm -132.48 125.67 31.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 75.22 110.895 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -115.01 128.9 56.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 74.51 110.886 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 150.84 -151.72 23.67 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.768 -0.729 . . . . 72.11 112.528 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 t -133.02 134.42 44.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.801 0.334 . . . . 72.43 111.144 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.493 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -92.1 149.09 21.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 75.22 110.901 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -60.45 -175.16 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 72.5 110.893 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -99.22 88.61 3.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.484 . . . . 73.4 110.893 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.01 168.63 21.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 65.34 110.897 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.507 0 O-C-N 124.518 1.136 . . . . 32.21 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mtt . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.787 0.327 . . . . 74.3 110.889 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.54 137.07 37.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 73.15 111.105 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 3' ' ' LEU . 0.2 OUTLIER -107.22 111.78 63.17 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.594 0.711 . . . . 72.54 110.925 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 156.28 63.7 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.642 2.228 . . . . 75.05 112.366 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.8 mt -149.87 134.83 10.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 72.44 111.133 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.6 mt -94.28 140.94 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 74.21 111.151 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.26 123.22 61.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 62.32 111.101 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.64 119.06 38.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 73.43 110.906 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.9 t-105 -123.67 105.64 9.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 73.35 110.87 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.82 -81.82 0.9 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.754 -0.736 . . . . 71.02 112.478 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.76 19.92 0.59 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.729 -0.748 . . . . 71.2 112.45 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -129.28 175.85 8.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.738 0.304 . . . . 75.44 110.947 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -132.48 140.83 48.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 74.0 110.916 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -135.79 117.0 14.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 75.3 110.903 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.0 p -83.07 130.89 35.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 73.42 110.839 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.4 t -92.86 135.3 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 74.11 111.12 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.6 p -144.39 92.47 2.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 72.4 111.161 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 173.4 -28.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 72.51 111.161 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -85.94 151.12 24.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 74.04 110.874 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.53 163.47 28.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 71.22 110.85 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.456 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 72.2 mt-10 -55.71 -23.79 30.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.097 -0.501 . . . . 74.15 110.876 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -66.66 -14.01 61.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.467 . . . . 73.2 110.865 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -98.44 -149.77 0.35 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 75.41 110.89 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.8 172.92 11.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 74.44 111.132 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.8 t -68.53 -43.61 83.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 74.31 111.153 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.45 -28.72 68.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 75.33 110.9 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -70.18 -35.82 74.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.189 -0.46 . . . . 73.51 110.838 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 tt -80.61 -47.06 14.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 74.41 110.909 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.498 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -62.09 -56.9 14.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 74.42 110.866 179.814 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -57.8 -22.49 47.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.276 -0.42 . . . . 73.33 110.925 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -77.35 -55.23 5.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 72.31 110.864 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.3 pp -67.78 -43.06 80.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 72.03 110.93 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.567 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -55.01 -27.04 41.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 75.42 110.906 179.829 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.77 -23.54 42.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 70.24 111.121 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.4 mt -76.97 -60.16 2.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.227 -0.442 . . . . 74.2 110.9 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.9 t -134.93 -27.76 1.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 72.13 111.153 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.567 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.83 -177.76 4.84 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.76 -0.734 . . . . 62.32 112.503 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.482 ' CG2' HD23 ' A' ' 39' ' ' LEU . 1.3 p -112.29 139.26 37.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.898 0.38 . . . . 74.55 111.129 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.602 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.61 150.56 17.35 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.599 0.714 . . . . 72.21 110.919 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 -21.92 32.95 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.676 2.251 . . . . 74.35 112.333 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -54.1 -39.04 66.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 71.53 110.928 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -104.25 -40.18 6.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.142 -0.481 . . . . 73.23 110.881 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.424 ' HG2' HG12 ' A' ' 38' ' ' VAL . 1.8 pp0? -97.51 158.16 15.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 75.05 110.91 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.9 141.71 51.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.438 . . . . 75.23 110.907 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.98 134.8 52.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 74.12 110.89 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -75.93 -75.55 0.18 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 75.41 110.898 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.83 59.84 1.47 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.737 -0.744 . . . . 61.11 112.473 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.7 pp -55.56 -23.55 27.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.838 0.351 . . . . 75.14 110.914 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.57 142.23 35.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 65.24 110.929 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 t -143.74 144.27 23.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 71.04 111.097 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.0 mmtm 54.35 33.29 18.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 75.1 110.897 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.48 -14.78 44.43 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.733 -0.746 . . . . 74.13 112.495 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -81.56 149.26 64.24 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.6 0.714 . . . . 75.43 110.886 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -35.69 12.34 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.693 2.262 . . . . 75.41 112.386 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 38.5 40.26 0.37 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.453 . . . . 74.3 111.106 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.34 -75.38 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 74.44 110.881 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -156.38 -37.84 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 64.14 110.91 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -74.41 -1.05 19.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 74.03 110.828 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -93.04 147.81 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 64.21 111.146 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.409 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 5.8 mttp -89.49 146.18 24.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 73.35 110.878 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.456 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 15.9 mt -52.37 -38.39 58.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 72.14 110.884 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.96 -17.2 80.18 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.736 -0.745 . . . . 73.45 112.483 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.22 -19.63 33.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.829 0.347 . . . . 74.31 111.102 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -84.54 -19.53 33.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 63.0 110.907 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp 54.21 42.08 31.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 73.53 110.893 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.9 mt -92.71 152.05 19.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 72.12 110.906 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -68.63 160.18 78.11 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.563 0.696 . . . . 72.21 110.914 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -37.58 8.99 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.663 2.242 . . . . 61.42 112.36 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.481 ' O ' ' C ' ' A' ' 70' ' ' THR . 55.0 m-20 -78.84 -15.92 57.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 64.33 110.877 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.481 ' C ' ' O ' ' A' ' 69' ' ' ASN . 66.9 m -31.31 129.44 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.155 -0.475 . . . . 64.23 111.185 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.87 145.73 26.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 74.1 110.905 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.8 mm -115.61 128.71 72.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 74.52 111.135 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 28.5 mtm -101.33 141.6 33.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 74.2 110.894 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 73.1 mtm -136.2 116.91 13.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 65.11 110.893 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -105.92 127.53 53.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 75.12 110.886 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.65 -154.22 25.27 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.765 -0.731 . . . . 62.54 112.489 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.2 t -134.84 146.22 49.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.79 0.328 . . . . 75.1 111.136 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.22 158.04 24.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 75.45 110.877 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.7 ' OE1' ' N ' ' A' ' 90' ' ' NH2 . 5.0 pt-20 -51.15 133.68 27.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 72.43 110.885 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -57.42 -32.85 67.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 71.51 110.844 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.51 -14.36 0.11 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.491 . . . . 74.41 110.833 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' NH2 . . . . . 0.7 ' N ' ' OE1' ' A' ' 79' ' ' GLU . . . . . . . . 0 C--N 1.324 -0.514 0 O-C-N 124.493 1.12 . . . . 54.21 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.8 mmt . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.75 0.31 . . . . 72.31 110.882 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.43 148.27 29.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 65.33 111.083 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.37 108.98 62.51 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.604 0.716 . . . . 74.44 110.936 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 156.33 63.42 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.716 2.277 . . . . 75.31 112.295 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.1 mt -150.4 136.42 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 72.34 111.131 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.5 mt -94.93 140.13 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 73.43 111.119 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.3 p -127.69 123.02 60.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 73.31 111.08 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.89 120.51 42.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 74.45 110.895 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 14.1 t-105 -122.74 102.67 8.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 73.15 110.919 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.0 -78.09 1.71 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.774 -0.727 . . . . 75.4 112.484 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -155.62 18.5 0.5 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.75 -0.738 . . . . 73.23 112.5 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -130.87 139.17 50.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.738 0.304 . . . . 74.53 110.922 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -102.62 142.11 34.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 73.13 110.896 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -136.24 122.14 20.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.494 . . . . 70.3 110.914 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 92.7 p -84.95 133.43 34.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 74.4 110.844 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.5 t -96.37 111.48 26.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 65.41 111.136 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.0 p -124.05 91.42 3.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 74.44 111.174 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 t 174.83 -29.69 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 75.34 111.177 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -83.16 149.76 26.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 74.55 110.947 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.43 168.22 17.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 75.34 110.852 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.414 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 51.8 mt-10 -59.8 -22.16 61.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.477 . . . . 74.42 110.891 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -69.26 -11.34 60.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 70.04 110.868 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -99.52 -149.54 0.36 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 71.22 110.896 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.07 167.46 21.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 64.45 111.131 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.4 t -61.9 -45.69 98.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 73.41 111.129 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.48 -29.15 67.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 75.12 110.914 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -70.69 -34.31 71.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 70.52 110.841 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.74 -48.45 12.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 74.44 110.904 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.484 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.6 -56.79 16.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 73.13 110.894 179.827 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.05 -22.76 51.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 65.44 110.894 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -76.94 -55.16 5.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 75.25 110.922 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 pp -67.59 -42.81 81.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 74.11 110.926 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.574 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.2 tmtt? -54.96 -27.14 41.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 74.42 110.926 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.99 -23.67 41.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 61.24 111.132 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.8 mt -76.96 -60.03 2.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 71.03 110.908 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.1 t -135.45 -27.35 1.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 75.52 111.166 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.574 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.48 -178.75 4.96 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.724 -0.75 . . . . 54.24 112.489 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.493 ' CG2' HD21 ' A' ' 39' ' ' LEU . 1.4 p -113.25 137.96 44.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.885 0.374 . . . . 71.55 111.132 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.588 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -53.95 149.56 17.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.615 0.721 . . . . 73.1 110.919 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -21.59 33.24 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.65 2.234 . . . . 72.44 112.389 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -54.21 -38.35 65.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 73.11 110.883 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -105.05 -39.94 6.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 64.52 110.907 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -95.67 159.4 15.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 75.51 110.905 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.8 137.85 52.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 72.32 110.899 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -66.86 132.66 48.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 71.13 110.917 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.8 mp -83.05 -44.48 15.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 74.14 110.908 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -107.73 39.26 2.96 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.751 -0.738 . . . . 63.44 112.478 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -44.88 -35.02 2.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.905 0.383 . . . . 74.54 110.927 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.85 146.54 33.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 75.34 110.872 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.1 p -143.77 145.69 21.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 75.24 111.11 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.5 mttt 54.91 31.19 15.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.47 . . . . 74.42 110.866 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.64 -10.83 54.9 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.717 -0.754 . . . . 52.54 112.518 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -81.44 149.51 65.23 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.581 0.705 . . . . 74.32 110.881 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -31.69 19.96 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.632 2.221 . . . . 75.23 112.36 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 37.36 41.91 0.28 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 72.25 111.082 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.03 -77.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 74.11 110.885 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.402 HD21 ' N ' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -157.92 -36.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 74.43 110.902 -179.942 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.402 ' N ' HD21 ' A' ' 57' ' ' ASN . 0.2 OUTLIER -68.06 -6.77 24.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 73.24 110.885 179.917 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.6 t -82.14 146.35 7.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.468 . . . . 75.32 111.12 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.2 mttp -94.46 151.61 19.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 74.21 110.871 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.414 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 19.5 mt -50.84 -44.63 59.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 75.1 110.944 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.54 -12.25 84.52 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.753 -0.737 . . . . 62.04 112.504 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.77 -34.42 27.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 65.44 111.097 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.48 -25.22 63.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 74.22 110.91 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp 62.38 36.87 14.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 74.34 110.902 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.2 mt -92.04 152.83 19.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 75.13 110.894 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -68.49 160.99 73.58 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.607 0.717 . . . . 63.21 110.903 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 -35.47 12.69 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.701 2.267 . . . . 65.1 112.381 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.467 ' O ' ' C ' ' A' ' 70' ' ' THR . 23.7 p30 -78.77 -15.73 58.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 65.51 110.909 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.467 ' C ' ' O ' ' A' ' 69' ' ' ASN . 52.4 m -32.53 121.4 0.33 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.174 -0.467 . . . . 74.24 111.124 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -92.85 145.81 24.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 64.12 110.875 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.6 mm -115.74 129.17 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.268 -0.424 . . . . 74.32 111.149 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.6 mtp -101.33 141.92 33.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 73.5 110.891 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 76.5 mtm -135.2 119.62 17.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.438 . . . . 75.31 110.873 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.4 mmt -110.74 123.71 50.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 60.13 110.895 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 163.01 -153.9 24.63 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.756 -0.735 . . . . 71.53 112.508 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.6 t -134.17 142.12 47.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.81 0.338 . . . . 75.11 111.133 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -61.59 160.33 11.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 73.32 110.846 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.04 138.81 24.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 53.54 110.91 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 58.33 -172.12 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 65.44 110.864 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -108.5 -29.14 8.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.488 . . . . 75.21 110.829 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.505 0 O-C-N 124.495 1.122 . . . . 74.43 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mtm . . . . . 0 N--CA 1.458 -0.062 0 CA-C-O 120.749 0.309 . . . . 74.22 110.889 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.24 137.06 50.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 75.04 111.062 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 3' ' ' LEU . 0.2 OUTLIER -107.29 111.72 63.09 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.67 0.748 . . . . 74.1 110.938 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 156.34 63.59 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.713 2.275 . . . . 63.03 112.342 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.8 mt -149.17 135.62 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 75.52 111.143 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.4 mt -94.78 141.0 15.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 74.15 111.15 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.9 p -127.3 123.12 61.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 74.24 111.122 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.65 121.36 44.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 75.54 110.908 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 13.1 t-105 -121.74 100.9 7.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 72.53 110.939 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.01 -83.53 0.91 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.736 -0.745 . . . . 75.01 112.517 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.94 20.43 1.12 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.742 . . . . 64.43 112.497 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -128.01 174.31 9.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.739 0.304 . . . . 73.24 110.926 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -133.06 140.12 47.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 72.35 110.917 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -135.83 115.97 13.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.494 . . . . 73.03 110.901 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.3 p -82.19 133.41 35.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 60.31 110.873 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 91.5 t -96.01 139.72 18.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 71.04 111.123 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.5 p -148.23 93.58 2.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 73.14 111.167 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 173.04 -28.37 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 73.25 111.169 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -86.52 151.78 23.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 74.14 110.944 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.77 163.57 28.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 62.5 110.858 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.446 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 49.0 mt-10 -56.16 -23.34 34.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 75.32 110.872 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -67.84 -12.53 60.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 70.34 110.873 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -99.12 -150.31 0.37 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 71.32 110.842 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.19 171.1 14.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 74.34 111.122 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.6 t -67.3 -43.78 87.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 75.13 111.109 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.77 -28.36 68.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 74.21 110.901 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -70.18 -35.64 74.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.475 . . . . 73.42 110.853 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 tt -80.76 -47.41 13.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 73.43 110.966 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.491 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.7 -56.6 17.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 65.33 110.91 179.81 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -58.09 -22.42 50.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 74.42 110.878 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -77.18 -55.2 5.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 74.44 110.867 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.4 pp -67.93 -43.01 80.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.14 -0.482 . . . . 73.52 110.931 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.564 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.9 -27.2 41.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.45 . . . . 74.35 110.908 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.73 -23.61 42.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.247 -0.433 . . . . 63.35 111.107 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.0 mt -76.59 -59.76 2.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 72.0 110.94 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.3 t -135.14 -27.83 1.2 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 74.54 111.119 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.29 -176.7 4.77 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.718 -0.753 . . . . 42.5 112.505 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.468 ' CG2' HD23 ' A' ' 39' ' ' LEU . 1.1 p -112.43 139.73 35.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.835 0.35 . . . . 75.52 111.16 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.601 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.76 150.2 19.41 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.584 0.707 . . . . 74.52 110.922 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -21.98 32.63 Favored 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.696 2.264 . . . . 71.4 112.308 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -54.42 -39.08 66.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.273 -0.421 . . . . 74.44 110.932 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.2 mtt85 -103.76 -40.73 6.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 73.42 110.906 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -97.29 157.58 15.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 70.13 110.89 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.77 142.18 51.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 74.01 110.923 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.49 136.05 54.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 74.12 110.942 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -77.31 -75.03 0.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 72.42 110.929 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.15 59.23 1.68 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.774 -0.727 . . . . 74.44 112.522 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.8 pp -56.22 -23.06 33.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 73.21 110.906 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -105.95 142.33 35.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 74.01 110.911 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.8 t -143.94 144.33 23.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 73.13 111.119 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.4 mttt 54.27 33.06 17.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 75.21 110.912 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.79 -14.67 46.72 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.728 -0.748 . . . . 72.5 112.504 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -81.56 148.97 63.62 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.597 0.713 . . . . 74.42 110.853 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.403 ' O ' ' C ' ' A' ' 55' ' ' ALA . 53.2 Cg_endo -69.82 -35.49 12.37 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.657 2.238 . . . . 73.43 112.323 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 54' ' ' PRO . . . 38.03 40.69 0.32 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 65.35 111.088 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.02 -76.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 73.11 110.882 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -155.25 -38.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 64.01 110.877 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -73.55 -1.12 17.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 73.13 110.892 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -93.45 148.37 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 74.53 111.159 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.415 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 5.6 mttt -90.32 146.7 24.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 64.41 110.874 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 16.4 mt -52.27 -38.88 59.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.447 . . . . 75.42 110.883 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.89 -17.02 80.28 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.76 -0.733 . . . . 71.14 112.508 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.15 -19.46 34.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.812 0.339 . . . . 64.31 111.128 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -84.83 -19.9 31.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 74.12 110.906 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.9 mmtp 55.13 41.47 31.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 73.22 110.923 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.8 mt -92.38 151.2 20.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 72.23 110.918 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -68.43 160.79 74.28 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.619 0.723 . . . . 65.24 110.944 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -37.09 9.67 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.738 2.292 . . . . 75.25 112.33 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.468 ' O ' ' C ' ' A' ' 70' ' ' THR . 10.5 p-10 -78.81 -15.82 57.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 74.44 110.891 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.468 ' C ' ' O ' ' A' ' 69' ' ' ASN . 53.1 m -31.25 128.96 0.15 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 62.43 111.183 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.49 146.4 25.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.229 -0.441 . . . . 73.24 110.868 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.7 mm -115.38 127.93 72.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 73.2 111.131 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.0 mtp -100.15 141.72 32.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 65.31 110.841 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.8 mtt -134.58 127.5 31.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 73.53 110.871 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -116.97 126.35 52.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 72.13 110.913 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.9 -154.53 25.6 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.75 -0.738 . . . . 63.22 112.51 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 t -133.52 140.12 47.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.763 0.316 . . . . 75.1 111.101 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.403 ' HA ' HG22 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -93.88 150.34 20.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 70.11 110.907 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.12 174.55 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 75.43 110.901 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.17 -59.55 4.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 75.11 110.858 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.2 t -67.62 -104.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 72.31 110.889 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.452 0 O-C-N 124.447 1.092 . . . . 45.14 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.76 0.314 . . . . 73.21 110.864 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.76 150.98 29.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 74.22 111.076 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.7 mt -113.53 107.08 53.61 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.579 0.704 . . . . 62.15 110.917 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 155.68 65.24 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.665 2.243 . . . . 63.01 112.338 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.7 mt -151.0 138.77 13.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 75.15 111.105 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.7 mt -95.02 140.47 16.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 74.41 111.119 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.5 p -126.53 123.0 62.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 70.01 111.139 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.45 118.07 35.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 73.12 110.9 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.9 t-105 -122.87 106.67 11.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 73.32 110.889 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.72 -81.06 0.9 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.744 -0.741 . . . . 74.41 112.469 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -155.98 19.87 0.49 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.72 -0.752 . . . . 54.25 112.466 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -129.34 176.07 8.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.796 0.332 . . . . 72.24 110.902 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -132.51 140.83 48.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 75.1 110.901 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -136.18 119.44 16.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 73.32 110.915 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.6 p -82.89 134.22 35.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.089 -0.505 . . . . 74.15 110.857 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 87.2 t -93.46 132.81 36.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 64.53 111.152 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.4 p -147.28 92.08 2.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 72.34 111.162 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 t 176.99 -31.89 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 73.55 111.133 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.422 HD22 ' HB3' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -87.93 164.32 15.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 75.22 110.931 179.948 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.26 175.17 9.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.448 . . . . 72.33 110.848 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.421 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 35.0 mt-10 -64.52 -20.01 65.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 54.32 110.896 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.94 -11.32 60.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.127 -0.488 . . . . 74.21 110.839 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -95.99 -152.62 0.38 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 74.42 110.848 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.91 165.6 25.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 72.11 111.156 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.9 t -58.69 -44.41 89.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 73.1 111.157 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.88 -30.13 71.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 74.55 110.875 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.422 ' HB3' HD22 ' A' ' 19' ' ' LEU . 3.3 t70 -71.37 -34.97 70.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 74.11 110.875 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.72 -48.03 15.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 74.11 110.902 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.466 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -62.15 -54.73 36.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 72.43 110.902 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -56.36 -22.51 31.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 75.51 110.929 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -77.31 -55.45 5.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 72.13 110.849 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.0 pp -67.68 -43.5 80.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 73.11 110.912 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.567 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.49 -27.17 35.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 74.31 110.882 179.849 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.69 -23.85 42.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 72.32 111.152 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.4 mt -76.36 -59.71 2.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.198 -0.456 . . . . 74.1 110.909 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.5 t -135.21 -28.03 1.18 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.461 . . . . 71.1 111.136 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.567 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.67 -177.51 4.51 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.757 -0.735 . . . . 73.21 112.503 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.48 ' CG2' HD23 ' A' ' 39' ' ' LEU . 1.3 p -112.83 138.71 41.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.883 0.373 . . . . 71.54 111.11 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.58 ' CD1' ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.86 150.63 18.18 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.633 0.73 . . . . 61.05 110.852 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -21.76 32.83 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.671 2.247 . . . . 64.41 112.35 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -54.13 -38.93 66.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 74.45 110.902 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -104.29 -40.4 6.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.505 . . . . 73.41 110.836 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.404 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.9 pp0? -97.21 158.09 15.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 73.53 110.876 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.09 141.97 51.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 75.0 110.854 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.05 134.01 51.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 71.35 110.894 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.88 -68.03 0.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 72.32 110.926 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.39 60.03 0.69 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.707 -0.758 . . . . 74.23 112.465 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.6 pp -56.93 -19.81 19.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.86 0.362 . . . . 73.54 110.936 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.65 144.08 41.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 73.42 110.913 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.0 p -143.79 146.1 21.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 73.54 111.146 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.3 mttt 54.78 31.55 15.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 75.52 110.875 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.56 -10.87 54.33 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.71 -0.757 . . . . 34.22 112.502 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.2 mmtm -81.36 150.82 68.21 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.593 0.711 . . . . 72.13 110.869 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 55' ' ' ALA . 53.1 Cg_endo -69.81 -31.98 19.24 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.658 2.239 . . . . 73.45 112.359 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 54' ' ' PRO . . . 35.93 44.63 0.25 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 44.12 111.072 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.32 -76.69 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 70.24 110.92 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -158.61 -37.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 75.14 110.887 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.85 -8.66 30.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 60.2 110.828 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.402 ' HB ' HD22 ' A' ' 64' ' ' LEU . 19.4 t -79.31 147.49 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 74.24 111.149 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.415 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 10.8 mttt -94.78 150.33 20.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 75.44 110.895 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.421 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 25.3 mt -51.42 -42.05 61.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 75.24 110.938 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.12 -13.34 83.33 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.768 -0.729 . . . . 71.43 112.443 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.04 -34.31 22.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.779 0.323 . . . . 54.22 111.066 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -67.84 -24.35 65.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 71.11 110.922 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp 59.88 33.08 21.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 72.44 110.859 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.0 mt -87.72 153.87 21.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.283 -0.417 . . . . 73.34 110.91 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.46 160.41 76.32 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.552 0.692 . . . . 73.24 110.906 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -35.3 12.81 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.641 2.227 . . . . 73.11 112.37 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.452 ' O ' ' C ' ' A' ' 70' ' ' THR . 7.6 p30 -79.15 -16.38 56.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.431 . . . . 73.02 110.886 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.452 ' C ' ' O ' ' A' ' 69' ' ' ASN . 54.9 m -32.08 128.16 0.22 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 73.11 111.163 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.93 147.95 23.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 75.22 110.908 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.6 mm -118.83 127.32 75.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 73.23 111.153 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 62.9 mtp -100.41 141.79 32.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 74.31 110.837 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 73.7 mtm -134.71 117.51 16.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 73.02 110.87 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.2 mmt -105.52 124.56 49.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 72.4 110.866 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.57 -154.69 25.74 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.726 -0.749 . . . . 63.34 112.456 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.5 t -135.15 144.16 46.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.332 . . . . 71.44 111.155 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -60.99 160.55 9.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 74.31 110.838 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.04 143.72 13.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 74.23 110.896 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -82.91 -55.05 4.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 74.24 110.906 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -176.81 11.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 53.45 110.9 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.477 0 O-C-N 124.519 1.137 . . . . 70.45 . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.737 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.794 0.33 . . . . 73.35 111.135 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.5 mt -110.87 109.43 57.5 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.618 0.723 . . . . 73.14 110.907 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 156.48 63.23 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.693 2.262 . . . . 43.22 112.357 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 28' ' ' LEU . 42.9 mt -150.51 137.45 13.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 73.51 111.155 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.718 HD12 ' HA ' ' A' ' 69' ' ' ASN . 4.1 mt -94.91 140.52 16.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 63.44 111.152 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.83 HG21 HD13 ' A' ' 32' ' ' LEU . 8.3 p -126.9 123.14 62.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 61.52 111.089 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.12 119.78 40.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 65.52 110.881 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 16.8 t-105 -121.09 100.92 7.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.258 -0.428 . . . . 75.22 110.912 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.89 -83.53 0.85 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.778 -0.725 . . . . 34.02 112.515 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.68 20.45 1.02 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.693 -0.765 . . . . 70.1 112.459 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -128.43 174.83 9.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.756 0.312 . . . . 72.55 110.896 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -133.07 140.19 47.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 64.24 110.865 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -135.84 118.59 16.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 75.42 110.886 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.6 p -82.36 133.93 35.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 75.01 110.84 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.54 HG21 HD23 ' A' ' 32' ' ' LEU . 69.6 t -96.21 131.33 43.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.49 . . . . 72.44 111.137 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.2 p -141.31 93.54 2.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 52.03 111.11 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.602 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.7 OUTLIER 173.47 -28.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.462 . . . . 61.43 111.128 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.737 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.9 mm? -85.6 150.52 24.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 74.03 110.871 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.549 ' C ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.89 168.09 18.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 55.13 110.867 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.41 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 44.9 mt-10 -59.04 -21.98 59.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 63.42 110.898 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -68.59 -10.9 58.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 63.31 110.885 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.458 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.5 m-20 -102.61 -150.47 0.41 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 63.14 110.869 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.504 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -135.65 168.03 20.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 64.1 111.148 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.621 HG22 HD11 ' A' ' 64' ' ' LEU . 94.2 t -63.39 -43.15 98.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 73.32 111.124 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.407 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -61.06 -29.08 69.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.166 -0.47 . . . . 64.32 110.938 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.561 ' HB3' HD11 ' A' ' 19' ' ' LEU . 2.0 t0 -71.51 -32.67 68.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 74.42 110.845 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.642 HD23 HD23 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -80.65 -48.82 12.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 72.31 110.924 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.514 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -62.09 -56.09 22.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 71.24 110.89 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -57.6 -22.4 44.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 71.22 110.89 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.602 ' CZ ' HG21 ' A' ' 18' ' ' THR . 40.3 t80 -77.98 -54.89 5.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 73.43 110.82 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.83 HD13 HG21 ' A' ' 7' ' ' VAL . 2.5 pp -68.05 -42.13 80.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.148 -0.478 . . . . 60.0 110.92 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.568 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.76 -27.65 42.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 75.34 110.866 179.869 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.499 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.52 -23.62 42.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 75.15 111.155 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.432 HD11 ' CE1' ' A' ' 31' ' ' PHE . 13.8 mt -76.63 -59.7 2.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 73.43 110.914 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.7 t -135.41 -27.66 1.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 72.11 111.181 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.568 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.95 -177.46 4.8 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 55.3 112.479 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.878 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.3 p -112.72 138.24 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.856 0.36 . . . . 73.24 111.106 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.979 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.76 150.94 16.49 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.632 0.729 . . . . 74.43 110.875 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -21.59 33.39 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.715 2.277 . . . . 72.14 112.32 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -54.35 -38.79 66.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.429 . . . . 75.13 110.855 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.441 ' H ' HD23 ' A' ' 39' ' ' LEU . 2.6 mpt_? -104.15 -40.58 6.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 71.33 110.889 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.878 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.9 pp0? -97.28 157.47 15.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 73.42 110.932 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.08 142.94 51.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.435 . . . . 74.31 110.955 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.408 HD22 ' N ' ' A' ' 45' ' ' LEU . 3.7 mm? -67.7 135.9 53.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.246 -0.434 . . . . 61.45 110.885 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.748 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.0 mm? -78.0 -68.29 0.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 60.24 110.972 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.4 61.06 0.66 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.705 -0.76 . . . . 62.54 112.497 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.58 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 4.5 pp -58.96 -18.2 31.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.899 0.381 . . . . 72.43 110.907 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -112.39 144.16 42.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 64.25 110.926 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.876 HG21 HD11 ' A' ' 66' ' ' LEU . 43.0 t -143.85 145.31 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 75.15 111.119 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.0 mttt 54.87 32.51 17.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 75.33 110.858 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.25 -11.3 50.59 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.744 -0.741 . . . . 61.51 112.509 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -81.7 150.88 67.13 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.602 0.715 . . . . 71.51 110.856 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 -32.91 17.85 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.706 2.271 . . . . 54.51 112.351 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 36.78 43.48 0.28 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 74.34 111.074 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.54 -76.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.438 . . . . 65.52 110.896 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -159.36 -37.5 0.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 72.21 110.884 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -66.8 -8.68 30.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 73.4 110.862 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.575 HG21 ' HA ' ' A' ' 55' ' ' ALA . 16.9 t -79.79 145.69 8.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 73.21 111.135 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 18.9 mttp -90.27 151.44 21.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 75.04 110.858 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.549 HD12 ' C ' ' A' ' 20' ' ' SER . 19.3 mt -49.96 -47.44 52.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 75.35 110.982 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.63 -11.69 85.22 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.732 -0.747 . . . . 63.4 112.473 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.39 -32.16 42.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.783 0.325 . . . . 61.33 111.097 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.621 HD11 HG22 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -77.82 -23.55 48.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 65.2 110.943 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt 63.12 38.03 11.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 62.45 110.876 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.876 HD11 HG21 ' A' ' 50' ' ' VAL . 4.2 mt -89.66 152.62 21.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 75.42 110.899 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -68.67 160.57 76.41 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.603 0.716 . . . . 65.03 110.899 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -35.0 13.26 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.718 2.278 . . . . 74.13 112.335 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.718 ' HA ' HD12 ' A' ' 6' ' ' ILE . 10.5 p30 -78.8 -15.83 57.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 72.33 110.864 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.663 HG21 HD13 ' A' ' 66' ' ' LEU . 51.3 m -32.92 121.52 0.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 72.32 111.132 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -92.85 146.49 23.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 61.23 110.913 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.8 mm -116.4 127.46 74.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 74.23 111.087 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 23.2 mtp -99.46 141.68 31.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 63.54 110.89 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.6 mtt -134.74 118.99 17.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 72.32 110.937 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.748 ' CG ' HD21 ' A' ' 46' ' ' LEU . 4.1 mmm -107.88 123.82 49.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 74.23 110.906 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.79 -155.16 26.32 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.751 -0.738 . . . . 73.54 112.526 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.2 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-O 120.783 0.325 . . . . 73.0 111.164 -179.925 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.743 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.804 0.335 . . . . 70.14 111.119 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.404 HD23 ' HD2' ' A' ' 4' ' ' PRO . 2.4 mt -112.04 109.66 54.57 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.593 0.711 . . . . 63.52 110.89 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.404 ' HD2' HD23 ' A' ' 3' ' ' LEU . 54.1 Cg_endo -69.75 156.6 62.94 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.717 2.278 . . . . 74.03 112.345 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.547 ' HB ' HD21 ' A' ' 28' ' ' LEU . 28.0 mt -150.45 137.52 13.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 71.13 111.114 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.653 HD12 ' HA ' ' A' ' 69' ' ' ASN . 4.7 mt -95.14 140.81 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 60.35 111.162 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.823 HG21 HD13 ' A' ' 32' ' ' LEU . 8.3 p -126.92 123.44 62.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 72.03 111.12 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.78 120.9 43.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 71.34 110.931 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 12.9 t-105 -122.04 100.96 7.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.436 . . . . 73.12 110.884 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.79 -83.76 0.78 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.739 -0.744 . . . . 75.15 112.498 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.46 20.17 1.04 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.742 -0.742 . . . . 65.2 112.488 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -128.56 174.24 9.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.784 0.325 . . . . 63.2 110.875 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -132.81 140.5 48.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 75.34 110.902 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -136.67 116.14 12.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 74.2 110.96 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.9 p -81.62 135.03 35.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 65.34 110.854 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.518 HG21 HD23 ' A' ' 32' ' ' LEU . 97.4 t -96.26 140.28 17.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.115 -0.493 . . . . 73.44 111.077 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.5 p -148.66 93.37 2.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 63.44 111.137 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.749 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 1.0 OUTLIER 173.68 -28.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.22 -0.445 . . . . 74.15 111.137 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.743 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.7 mm? -86.61 151.92 23.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 75.22 110.908 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.416 ' O ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.6 169.47 16.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 61.22 110.882 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.413 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 36.3 mt-10 -61.78 -22.09 65.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 63.05 110.854 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -69.87 -10.76 59.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 74.01 110.852 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.417 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.6 m-20 -100.08 -150.84 0.39 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.452 . . . . 64.12 110.887 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.41 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -132.61 170.58 14.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 63.11 111.176 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.938 HG22 HD11 ' A' ' 64' ' ' LEU . 11.7 t -66.58 -43.79 90.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 72.31 111.135 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.44 -28.66 68.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 72.23 110.925 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.478 ' HB3' HD11 ' A' ' 19' ' ' LEU . 17.0 t0 -70.07 -35.16 74.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.476 . . . . 64.2 110.844 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.665 HD12 ' CB ' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -80.72 -47.82 13.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 63.53 110.911 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.717 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.78 -56.71 16.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 73.2 110.892 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.0 -22.41 49.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 73.22 110.924 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.749 ' CZ ' HG21 ' A' ' 18' ' ' THR . 40.0 t80 -77.16 -55.23 5.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 70.33 110.835 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.823 HD13 HG21 ' A' ' 7' ' ' VAL . 2.4 pp -67.92 -43.14 79.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 72.0 110.942 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.567 ' N ' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -55.02 -27.34 43.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 72.23 110.876 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.493 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.3 -23.78 43.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 65.23 111.159 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.424 HD11 ' CE1' ' A' ' 31' ' ' PHE . 12.5 mt -76.46 -59.8 2.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 54.54 110.931 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.1 t -135.25 -27.63 1.2 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 65.54 111.135 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.562 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.23 -176.63 4.66 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.699 -0.762 . . . . 54.3 112.513 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.857 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.1 p -112.29 139.73 35.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.835 0.35 . . . . 62.31 111.168 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.973 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.8 149.98 20.55 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.602 0.715 . . . . 74.42 110.927 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -22.02 32.78 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.717 2.278 . . . . 64.22 112.334 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -54.61 -39.06 67.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.443 . . . . 74.12 110.899 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.431 ' H ' HD23 ' A' ' 39' ' ' LEU . 4.0 mpt_? -103.7 -40.46 6.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 75.1 110.87 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.857 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.5 pp0? -97.57 157.2 16.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 74.25 110.921 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.17 141.32 51.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 74.32 110.908 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.02 135.96 54.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 74.53 110.973 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.74 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.0 mm? -76.54 -75.22 0.2 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 75.45 110.916 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.74 60.03 1.48 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.726 -0.75 . . . . 55.31 112.518 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.649 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 3.8 pp -56.8 -22.56 37.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.9 0.381 . . . . 74.22 110.949 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.428 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -106.29 142.43 35.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 71.13 110.932 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.898 HG11 HD21 ' A' ' 66' ' ' LEU . 21.0 t -144.04 144.37 22.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 71.24 111.07 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.449 ' HG2' HG12 ' A' ' 50' ' ' VAL . 2.1 mmmm 54.3 33.01 17.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 75.34 110.863 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.9 -15.05 45.28 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.718 -0.753 . . . . 71.23 112.462 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -81.08 148.78 64.91 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.538 0.685 . . . . 75.32 110.9 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.428 ' HA ' ' HB3' ' A' ' 49' ' ' LYS . 53.8 Cg_endo -69.71 -35.57 12.53 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.681 2.254 . . . . 64.03 112.366 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 38.14 40.67 0.34 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 61.34 111.136 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -67.81 -76.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 63.02 110.91 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -154.53 -38.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 71.15 110.889 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -73.14 -1.65 18.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 74.14 110.867 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -92.85 148.19 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 62.51 111.168 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.41 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 11.2 mttt -90.75 147.22 23.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 62.55 110.873 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 20' ' ' SER . 17.5 mt -52.47 -38.72 60.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 54.41 110.887 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.77 -17.0 80.29 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.771 -0.728 . . . . 62.3 112.451 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.53 -19.52 33.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.834 0.349 . . . . 72.33 111.128 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.938 HD11 HG22 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -84.44 -20.46 31.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 71.44 110.904 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp 53.89 42.01 31.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 74.32 110.935 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.898 HD21 HG11 ' A' ' 50' ' ' VAL . 3.6 mt -92.79 151.58 19.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.462 . . . . 52.33 110.939 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -68.4 160.01 78.06 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.564 0.697 . . . . 71.43 110.933 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -36.88 10.07 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.68 2.253 . . . . 73.31 112.311 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.653 ' HA ' HD12 ' A' ' 6' ' ' ILE . 26.4 m-80 -78.8 -15.79 57.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 75.45 110.897 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.75 HG21 HD22 ' A' ' 66' ' ' LEU . 52.0 m -32.43 128.03 0.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 60.4 111.13 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -97.66 146.51 25.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 73.02 110.837 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.0 mm -115.34 128.46 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 74.33 111.167 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 34.4 mtm -100.36 141.76 32.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 74.11 110.883 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.7 mtt -133.21 129.42 37.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 71.21 110.884 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.74 ' CG ' HD21 ' A' ' 46' ' ' LEU . 6.1 mmm -118.6 123.95 46.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.254 -0.43 . . . . 52.0 110.9 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 153.11 -155.23 26.01 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 60.05 112.459 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.794 0.331 . . . . 52.42 111.136 -179.865 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.74 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.848 0.356 . . . . 62.42 111.119 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.407 HD23 ' HD2' ' A' ' 4' ' ' PRO . 2.1 mt -110.86 109.27 57.6 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.625 0.726 . . . . 64.41 110.916 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.407 ' HD2' HD23 ' A' ' 3' ' ' LEU . 53.5 Cg_endo -69.77 156.84 62.27 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.677 2.251 . . . . 72.2 112.308 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.44 ' HB ' HD21 ' A' ' 28' ' ' LEU . 42.9 mt -150.57 137.51 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 53.21 111.149 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.715 HD12 ' HA ' ' A' ' 69' ' ' ASN . 3.6 mt -95.03 140.38 16.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 73.44 111.112 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.83 HG21 HD13 ' A' ' 32' ' ' LEU . 8.7 p -127.15 122.91 61.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 73.22 111.133 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.77 122.28 46.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 73.51 110.893 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 17.5 t-105 -122.56 100.52 6.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.24 -0.436 . . . . 75.44 110.89 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.55 -78.75 1.71 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.725 -0.75 . . . . 71.15 112.488 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.11 17.94 0.71 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.727 -0.749 . . . . 74.24 112.508 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -129.94 138.98 51.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.72 0.295 . . . . 73.02 110.93 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -102.98 142.25 34.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 63.52 110.899 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -136.31 119.38 16.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.465 . . . . 74.44 110.94 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.9 p -83.29 131.96 35.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 52.51 110.895 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.546 HG21 HD23 ' A' ' 32' ' ' LEU . 66.9 t -93.95 130.94 42.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.485 . . . . 74.52 111.16 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.0 p -141.27 93.08 2.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 72.45 111.137 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.575 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.8 OUTLIER 173.23 -28.37 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 72.25 111.14 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.74 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.9 mm? -85.11 150.1 25.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.462 . . . . 33.15 110.902 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.563 ' C ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.71 167.78 18.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 64.31 110.887 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.406 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 35.3 mt-10 -58.81 -21.91 57.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 64.12 110.929 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -68.9 -10.54 57.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.13 -0.487 . . . . 73.33 110.875 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.473 ' HB2' HD12 ' A' ' 19' ' ' LEU . 2.1 m-20 -102.62 -150.76 0.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 73.33 110.867 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.489 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -135.82 167.54 20.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 55.25 111.127 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.61 HG21 HD21 ' A' ' 64' ' ' LEU . 82.5 t -63.06 -42.37 96.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 63.54 111.13 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.424 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -61.78 -28.79 69.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.48 . . . . 73.04 110.915 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.594 ' HB3' HD11 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -72.01 -32.56 67.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.174 -0.466 . . . . 71.45 110.871 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.65 HD23 HD23 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -80.59 -48.82 12.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 73.53 110.939 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.512 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.94 -55.78 26.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 71.33 110.929 179.783 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.6 -22.49 45.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 75.24 110.902 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.575 ' CZ ' HG21 ' A' ' 18' ' ' THR . 54.6 t80 -77.84 -54.88 5.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 75.45 110.881 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.83 HD13 HG21 ' A' ' 7' ' ' VAL . 2.5 pp -68.07 -41.96 81.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 74.1 110.927 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.564 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.85 -27.74 44.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 73.42 110.889 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.34 -23.49 43.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.25 -0.432 . . . . 64.55 111.168 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.7 mt -76.76 -59.43 2.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 64.3 110.886 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.6 t -135.47 -28.03 1.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 54.43 111.178 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.59 -177.37 4.35 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.72 -0.752 . . . . 51.22 112.498 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.848 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.4 p -112.77 137.78 44.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.864 0.364 . . . . 63.34 111.098 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.975 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -53.71 149.95 14.86 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.631 0.729 . . . . 71.31 110.915 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -21.89 32.95 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.695 2.264 . . . . 64.21 112.342 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -54.21 -38.38 65.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 73.13 110.878 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.42 ' H ' HD23 ' A' ' 39' ' ' LEU . 2.7 mpt_? -104.43 -40.3 6.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 75.21 110.885 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.848 ' HG2' HG13 ' A' ' 38' ' ' VAL . 2.3 pp0? -95.96 157.41 15.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 75.3 110.877 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.09 140.05 52.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 64.52 110.91 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.624 HD22 HE22 ' A' ' 43' ' ' GLN . 3.6 mm? -65.94 135.75 55.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 75.11 110.917 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.684 HD11 ' CG ' ' A' ' 75' ' ' MET . 6.4 mp -81.36 -63.51 1.38 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 74.34 110.901 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.91 58.72 0.68 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.703 -0.76 . . . . 65.04 112.483 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.568 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 4.5 pp -60.46 -17.34 44.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 75.54 110.899 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.96 144.15 43.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 72.01 110.885 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.893 HG21 HD21 ' A' ' 66' ' ' LEU . 11.8 p -144.0 144.95 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 70.14 111.132 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.636 ' HG2' HG22 ' A' ' 50' ' ' VAL . 11.7 mmtt 54.66 32.71 17.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 65.11 110.912 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.78 -12.17 49.42 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.725 -0.75 . . . . 21.23 112.514 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.6 mmtt -81.61 150.6 66.86 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.574 0.702 . . . . 75.43 110.896 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.403 ' O ' ' C ' ' A' ' 55' ' ' ALA . 53.6 Cg_endo -69.83 -32.39 18.39 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.648 2.232 . . . . 62.25 112.302 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.579 ' HA ' HG21 ' A' ' 59' ' ' VAL . . . 36.79 43.45 0.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.277 -0.419 . . . . 44.41 111.087 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.46 -78.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 71.32 110.85 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -157.0 -38.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 62.31 110.916 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -64.95 -9.64 22.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 71.32 110.848 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.579 HG21 ' HA ' ' A' ' 55' ' ' ALA . 16.8 t -79.25 145.6 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 73.31 111.133 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 25.7 mttp -91.0 151.65 20.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 61.03 110.92 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.563 HD12 ' C ' ' A' ' 20' ' ' SER . 20.0 mt -49.66 -47.6 49.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 71.44 110.983 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.68 -11.84 85.05 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.742 -0.742 . . . . 55.34 112.478 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.22 -32.12 43.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.826 0.346 . . . . 72.02 111.125 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.61 HD21 HG21 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -77.29 -23.91 51.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 54.24 110.9 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp 63.67 37.44 10.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 54.11 110.875 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.893 HD21 HG21 ' A' ' 50' ' ' VAL . 5.2 mt -90.2 152.68 20.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 65.14 110.941 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.61 160.86 74.75 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.558 0.694 . . . . 73.03 110.89 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -35.08 13.24 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.629 2.22 . . . . 74.12 112.319 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.715 ' HA ' HD12 ' A' ' 6' ' ' ILE . 68.7 m-20 -78.49 -15.91 58.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 51.44 110.938 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.707 HG21 HD13 ' A' ' 66' ' ' LEU . 45.6 m -32.77 122.33 0.36 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.487 . . . . 72.35 111.125 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -93.83 146.24 24.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 70.24 110.899 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 36.2 mm -115.99 131.75 67.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 61.14 111.149 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.531 ' HB3' HD13 ' A' ' 46' ' ' LEU . 46.1 mtm -101.85 142.46 33.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 75.13 110.892 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.9 mtt -133.83 119.29 19.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 61.12 110.88 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.684 ' CG ' HD11 ' A' ' 46' ' ' LEU . 2.8 mmm -108.42 121.88 45.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 75.24 110.912 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 162.85 -156.7 28.53 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.703 -0.76 . . . . 72.14 112.468 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.7 t . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 120.786 0.326 . . . . 61.24 111.114 -179.823 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.736 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.831 0.348 . . . . 41.4 111.111 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.522 HD23 ' HD2' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -107.79 110.33 62.47 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.597 0.713 . . . . 62.24 110.921 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.522 ' HD2' HD23 ' A' ' 3' ' ' LEU . 53.2 Cg_endo -69.83 156.89 62.01 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.656 2.237 . . . . 72.14 112.287 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.549 ' HB ' HD21 ' A' ' 28' ' ' LEU . 40.3 mt -150.3 137.15 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.483 . . . . 70.33 111.125 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.692 HD12 ' HA ' ' A' ' 69' ' ' ASN . 4.6 mt -95.2 140.65 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 74.02 111.126 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.801 HG21 HD13 ' A' ' 32' ' ' LEU . 7.3 p -126.82 122.72 61.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 53.34 111.124 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.97 121.33 44.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 61.2 110.918 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 16.2 t-105 -121.43 100.78 7.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 75.24 110.891 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.59 -83.64 0.96 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.702 -0.761 . . . . 71.23 112.483 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.67 20.68 1.16 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.7 -0.762 . . . . 61.31 112.434 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.28 174.2 9.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.761 0.315 . . . . 73.51 110.944 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -132.93 140.46 47.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.268 -0.424 . . . . 74.25 110.929 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.506 ' CD2' HG21 ' A' ' 36' ' ' THR . 38.2 m-85 -135.83 116.32 13.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 74.02 110.91 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.3 p -82.51 132.17 35.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 74.14 110.851 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.551 HG21 HD23 ' A' ' 32' ' ' LEU . 96.4 t -94.68 136.93 24.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 74.44 111.12 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.6 p -146.73 93.83 2.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 74.42 111.125 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.666 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.7 OUTLIER 172.66 -28.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.219 -0.446 . . . . 75.43 111.136 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.736 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.8 mm? -87.64 150.53 23.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 65.41 110.917 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.67 165.56 23.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 65.54 110.883 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -57.78 -20.75 37.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 71.01 110.878 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.08 -11.9 61.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.179 -0.464 . . . . 74.44 110.854 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.431 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.7 m-20 -101.06 -148.84 0.37 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.266 -0.425 . . . . 73.55 110.831 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.26 167.47 20.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.191 -0.459 . . . . 74.23 111.166 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.939 HG22 HD11 ' A' ' 64' ' ' LEU . 15.9 t -63.42 -44.05 98.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 61.54 111.094 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.16 -28.39 67.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.457 . . . . 63.35 110.971 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.498 ' HB3' HD11 ' A' ' 19' ' ' LEU . 12.5 t0 -70.59 -35.52 73.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 54.32 110.857 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.693 HD12 ' CB ' ' A' ' 19' ' ' LEU . 1.2 tt -80.4 -47.82 13.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 45.14 110.904 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.747 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.57 -56.69 17.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 73.32 110.886 179.861 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -57.99 -22.31 48.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 63.44 110.915 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.666 ' CZ ' HG21 ' A' ' 18' ' ' THR . 64.8 t80 -77.3 -54.93 5.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 73.51 110.839 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.801 HD13 HG21 ' A' ' 7' ' ' VAL . 2.3 pp -68.23 -42.83 79.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 63.31 110.871 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.562 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -55.02 -27.12 41.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 74.1 110.901 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.503 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.77 -23.58 42.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 75.25 111.189 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.9 mt -76.7 -59.89 2.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 74.44 110.92 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.506 HG21 ' CD2' ' A' ' 14' ' ' TYR . 3.1 t -135.4 -27.42 1.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 73.1 111.194 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.562 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.99 -177.95 5.14 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.8 -0.714 . . . . 51.01 112.466 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.861 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.2 p -112.98 138.7 41.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.899 0.381 . . . . 74.11 111.098 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.963 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.42 151.1 14.74 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.593 0.711 . . . . 71.3 110.932 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 54.1 Cg_endo -69.78 -21.49 33.31 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.68 2.253 . . . . 73.42 112.354 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -54.52 -38.98 67.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 73.13 110.87 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.438 ' H ' HD23 ' A' ' 39' ' ' LEU . 8.8 mpt_? -103.89 -40.45 6.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 73.11 110.847 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.861 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.7 pp0? -98.11 158.2 15.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 75.14 110.877 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.28 141.37 51.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 75.31 110.902 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.26 135.96 54.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.262 -0.426 . . . . 63.41 110.905 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.736 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.1 mm? -76.86 -75.8 0.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 73.3 110.904 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -97.03 60.5 1.13 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.68 -0.772 . . . . 64.12 112.482 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.645 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 3.7 pp -55.4 -24.43 30.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.843 0.354 . . . . 64.22 110.923 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.421 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -103.71 143.42 32.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 72.32 110.892 179.845 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.763 HG21 HD21 ' A' ' 66' ' ' LEU . 14.9 p -144.1 143.38 23.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 73.12 111.15 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.0 mttt 54.0 34.19 19.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 44.32 110.905 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.22 -14.98 41.84 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.801 -0.714 . . . . 52.24 112.468 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.8 mmtt -81.67 149.57 64.47 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.537 0.684 . . . . 60.4 110.93 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.421 ' HA ' ' HB3' ' A' ' 49' ' ' LYS . 53.9 Cg_endo -69.73 -35.97 11.75 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.669 2.246 . . . . 73.32 112.334 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.645 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 38.97 39.3 0.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 34.12 111.096 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.89 -75.65 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 64.23 110.892 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -154.17 -38.57 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 64.04 110.875 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -72.72 -2.46 20.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 64.0 110.855 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.555 ' O ' HG23 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -93.36 148.19 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 74.23 111.137 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.408 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 35.1 mttt -91.39 147.56 22.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 64.1 110.906 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.407 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 10.6 mt -51.88 -41.95 62.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 70.15 110.916 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.63 -15.59 80.54 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.76 -0.733 . . . . 72.2 112.462 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.69 -19.94 32.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.839 0.352 . . . . 64.3 111.108 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.939 HD11 HG22 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -83.47 -20.23 34.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 70.12 110.939 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt 53.74 43.02 31.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 53.23 110.816 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.763 HD21 HG21 ' A' ' 50' ' ' VAL . 3.3 mt -95.48 153.33 17.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 70.34 110.902 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -68.25 159.75 78.87 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.626 0.727 . . . . 73.22 110.872 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -36.77 10.16 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.663 2.242 . . . . 72.23 112.329 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.692 ' HA ' HD12 ' A' ' 6' ' ' ILE . 14.8 p30 -78.44 -15.85 58.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 74.5 110.9 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.636 HG21 HD13 ' A' ' 66' ' ' LEU . 53.6 m -32.4 125.13 0.31 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 72.44 111.156 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.27 145.83 24.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 70.21 110.919 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.6 mm -115.61 128.36 72.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.27 -0.423 . . . . 71.32 111.126 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 37.0 mtt -99.71 141.74 32.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.478 . . . . 73.21 110.876 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.0 mtt -133.76 118.36 17.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 73.14 110.862 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.736 ' CG ' HD21 ' A' ' 46' ' ' LEU . 3.0 mmt -106.05 123.07 47.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 61.33 110.887 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.87 -157.16 28.87 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.765 -0.731 . . . . 62.34 112.526 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.3 t . . . . . 0 C--N 1.33 -0.266 0 CA-C-O 120.777 0.322 . . . . 55.54 111.115 -179.893 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.748 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.804 0.335 . . . . 72.2 111.116 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.4 mt -110.99 109.54 57.22 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.653 0.739 . . . . 74.12 110.9 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 156.62 62.86 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.685 2.256 . . . . 75.22 112.359 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.443 ' HB ' HD21 ' A' ' 28' ' ' LEU . 37.8 mt -150.57 137.67 13.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.247 -0.433 . . . . 64.41 111.083 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.694 HD12 ' HA ' ' A' ' 69' ' ' ASN . 3.8 mt -95.24 140.41 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 74.33 111.116 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.838 HG21 HD13 ' A' ' 32' ' ' LEU . 8.7 p -127.46 123.71 62.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 64.03 111.138 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.21 118.98 38.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.462 . . . . 73.14 110.872 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 10.5 t-105 -122.4 102.56 8.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.205 -0.452 . . . . 63.1 110.906 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.0 -82.84 0.74 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.785 -0.721 . . . . 34.23 112.504 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.77 19.73 0.78 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.73 -0.748 . . . . 55.44 112.464 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -129.08 175.55 8.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.753 0.311 . . . . 63.31 110.941 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -132.92 140.56 47.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 54.34 110.898 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -135.01 120.26 18.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.152 -0.476 . . . . 75.42 110.941 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.4 p -83.53 133.3 34.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.499 . . . . 75.45 110.825 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.541 HG21 ' CD2' ' A' ' 32' ' ' LEU . 73.6 t -95.98 126.83 48.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 74.23 111.169 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.5 p -137.39 92.77 2.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 54.32 111.117 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.563 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.9 OUTLIER 174.03 -29.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 74.0 111.162 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.748 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.8 mm? -84.92 150.03 25.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 75.13 110.88 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.558 ' C ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.74 168.18 18.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 72.04 110.875 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.432 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 78.1 mt-10 -59.06 -22.03 60.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 63.23 110.852 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.3 -10.94 58.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.193 -0.458 . . . . 72.32 110.868 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.444 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.9 m-20 -102.79 -150.14 0.41 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 53.44 110.869 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.564 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -136.03 168.07 20.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 73.13 111.129 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.613 HG22 HD11 ' A' ' 64' ' ' LEU . 91.1 t -63.29 -42.92 98.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 61.03 111.126 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.403 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -61.19 -29.47 69.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 74.04 110.907 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.566 ' HB3' HD11 ' A' ' 19' ' ' LEU . 4.1 t0 -71.06 -32.98 69.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.459 . . . . 62.42 110.863 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.674 HD23 HD23 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -80.45 -48.95 12.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 74.35 110.871 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.509 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.99 -56.13 22.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 73.31 110.911 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -57.47 -23.01 47.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 74.41 110.913 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.563 ' CZ ' HG21 ' A' ' 18' ' ' THR . 52.5 t80 -77.27 -55.36 5.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 70.15 110.884 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.838 HD13 HG21 ' A' ' 7' ' ' VAL . 2.5 pp -67.66 -42.4 82.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.494 . . . . 62.42 110.909 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.572 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.2 tmtt? -54.81 -27.69 43.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 65.34 110.901 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.518 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.47 -23.34 43.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.24 -0.436 . . . . 73.12 111.154 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.7 mt -76.85 -59.51 2.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 41.22 110.9 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.8 t -135.27 -27.24 1.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 73.31 111.165 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.572 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.72 -176.86 5.31 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.723 -0.751 . . . . 74.32 112.513 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.873 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.4 p -112.78 137.16 46.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.845 0.355 . . . . 45.53 111.136 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.947 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -53.48 150.0 13.55 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.561 0.696 . . . . 43.02 110.946 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -21.8 33.19 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.701 2.267 . . . . 64.12 112.37 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.16 -38.09 65.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 62.44 110.868 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.423 ' H ' HD23 ' A' ' 39' ' ' LEU . 3.1 mpt_? -104.95 -40.05 6.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 63.15 110.881 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.873 ' HG2' HG13 ' A' ' 38' ' ' VAL . 2.3 pp0? -96.48 158.31 15.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 63.31 110.895 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.72 140.37 51.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 73.41 110.893 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.671 HD22 HE22 ' A' ' 43' ' ' GLN . 3.7 mm? -66.32 135.25 54.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 74.2 110.945 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.746 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.0 mm? -75.74 -72.17 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 65.3 110.972 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.57 61.61 0.86 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.686 -0.769 . . . . 53.24 112.524 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.583 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 4.5 pp -58.19 -19.22 31.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 72.1 110.948 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.39 144.24 39.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 70.24 110.875 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.783 HG21 HD21 ' A' ' 66' ' ' LEU . 10.9 p -143.8 146.21 21.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 74.34 111.111 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt 54.77 31.92 16.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 72.53 110.914 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.16 -10.91 51.88 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.74 -0.743 . . . . 63.52 112.507 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -81.34 151.07 68.75 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.592 0.711 . . . . 73.14 110.885 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 55' ' ' ALA . 54.1 Cg_endo -69.74 -32.91 17.73 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.683 2.256 . . . . 71.21 112.347 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.585 ' HA ' HG21 ' A' ' 59' ' ' VAL . . . 35.98 44.35 0.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 74.3 111.122 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.33 -75.75 0.05 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 75.41 110.869 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.72 -37.53 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 75.3 110.909 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -67.14 -8.99 35.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 71.21 110.884 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.585 HG21 ' HA ' ' A' ' 55' ' ' ALA . 17.7 t -78.61 145.65 9.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 74.32 111.132 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -89.9 151.14 21.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 74.04 110.89 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.558 HD12 ' C ' ' A' ' 20' ' ' SER . 19.8 mt -49.83 -47.42 51.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 51.24 110.909 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.48 -12.02 84.93 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.804 -0.712 . . . . 50.41 112.461 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.14 -32.15 44.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.817 0.341 . . . . 63.14 111.061 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.613 HD11 HG22 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -77.81 -23.61 49.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 71.53 110.887 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp 63.41 37.49 10.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 64.31 110.95 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.783 HD21 HG21 ' A' ' 50' ' ' VAL . 4.2 mt -89.29 152.32 21.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 65.55 110.987 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.63 160.61 76.03 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.598 0.713 . . . . 72.31 110.882 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -34.85 13.7 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.649 2.232 . . . . 64.35 112.35 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.694 ' HA ' HD12 ' A' ' 6' ' ' ILE . 10.5 m120 -78.8 -15.68 58.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 74.31 110.883 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.66 HG21 HD13 ' A' ' 66' ' ' LEU . 47.7 m -32.97 120.82 0.36 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 61.01 111.145 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -92.5 146.43 23.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 63.34 110.926 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.0 mm -115.8 128.89 72.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 52.54 111.168 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 44.7 mtm -99.74 141.6 32.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 64.11 110.883 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.8 mtt -131.74 125.72 32.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 74.41 110.876 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.746 ' CG ' HD21 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -116.01 120.09 37.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 74.31 110.889 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 163.05 -156.41 28.16 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.765 -0.731 . . . . 73.51 112.54 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.754 0.311 . . . . 51.11 111.128 -179.858 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.744 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.795 0.331 . . . . 43.22 111.106 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.413 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 3.4 mt -109.15 109.76 60.63 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.609 0.719 . . . . 72.04 110.936 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 53.8 Cg_endo -69.79 156.13 64.07 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.698 2.265 . . . . 71.13 112.343 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.557 ' HB ' HD21 ' A' ' 28' ' ' LEU . 36.2 mt -150.51 136.08 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 62.12 111.115 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.716 HD12 ' HA ' ' A' ' 69' ' ' ASN . 3.6 mt -94.87 140.68 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 60.43 111.131 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.848 HG21 HD13 ' A' ' 32' ' ' LEU . 7.7 p -127.33 123.21 61.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 74.0 111.136 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.43 123.21 48.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.485 . . . . 52.33 110.899 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.2 t-105 -124.48 102.88 7.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.441 . . . . 72.24 110.91 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.55 -80.09 1.52 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.745 -0.74 . . . . 61.22 112.493 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.23 17.51 0.69 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.786 -0.721 . . . . 64.41 112.497 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 36.6 mm-40 -130.06 139.19 51.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.751 0.31 . . . . 64.53 110.949 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -103.1 142.06 34.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 72.51 110.903 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.634 ' CD1' HG21 ' A' ' 36' ' ' THR . 76.4 m-85 -136.28 116.54 13.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 61.2 110.947 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.4 p -82.45 131.2 35.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 61.44 110.88 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.562 HG21 HD23 ' A' ' 32' ' ' LEU . 85.9 t -92.29 138.81 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 72.33 111.136 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 p -148.76 92.42 1.99 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 74.45 111.155 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.655 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.9 OUTLIER 173.63 -28.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 63.25 111.158 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.744 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.8 mm? -85.78 151.21 24.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 65.24 110.936 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.18 168.54 17.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 74.4 110.863 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.414 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 36.2 mt-10 -60.61 -22.09 63.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 62.33 110.901 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.63 -11.23 60.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.157 -0.474 . . . . 73.4 110.81 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.415 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.5 m-20 -99.82 -151.15 0.39 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 61.1 110.838 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.64 168.86 17.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 61.41 111.114 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.961 HG22 HD11 ' A' ' 64' ' ' LEU . 12.4 t -65.62 -41.32 90.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 74.53 111.143 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.44 -28.63 69.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.141 -0.482 . . . . 72.01 110.92 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.519 ' HB3' HD11 ' A' ' 19' ' ' LEU . 19.6 t0 -70.73 -34.92 72.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 64.2 110.859 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.68 HD12 ' CB ' ' A' ' 19' ' ' LEU . 1.2 tt -80.76 -47.91 13.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 74.13 110.914 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.751 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.64 -56.57 18.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 73.13 110.911 179.812 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.15 -22.45 51.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 73.14 110.943 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.655 ' CZ ' HG21 ' A' ' 18' ' ' THR . 55.2 t80 -77.29 -55.17 5.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 74.21 110.879 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.848 HD13 HG21 ' A' ' 7' ' ' VAL . 2.3 pp -67.49 -43.45 80.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.141 -0.482 . . . . 64.25 110.902 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.579 ' N ' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -54.84 -27.03 39.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 71.11 110.924 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.46 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.78 -23.74 41.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 74.34 111.146 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.9 mt -76.46 -59.75 2.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.439 . . . . 74.4 110.859 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.634 HG21 ' CD1' ' A' ' 14' ' ' TYR . 3.5 t -135.31 -28.07 1.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 74.23 111.163 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.8 -177.58 4.7 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.717 -0.754 . . . . 63.2 112.52 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.898 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.2 p -112.56 139.22 38.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.861 0.362 . . . . 51.24 111.082 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.978 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.52 150.67 16.55 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.622 0.725 . . . . 74.15 110.88 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 53.5 Cg_endo -69.73 -21.95 32.9 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.653 2.235 . . . . 71.21 112.353 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -54.29 -38.98 66.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 63.55 110.876 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.421 ' H ' HD23 ' A' ' 39' ' ' LEU . 5.5 mtt85 -103.97 -40.27 6.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 62.52 110.889 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.898 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.7 pp0? -98.2 158.7 15.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 74.2 110.916 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.67 141.06 51.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 73.25 110.89 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.64 135.04 53.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 74.24 110.93 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.737 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.1 mm? -75.81 -75.57 0.18 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 74.03 110.906 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -96.15 60.34 1.36 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.725 -0.75 . . . . 72.32 112.459 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.635 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 3.8 pp -56.06 -23.85 36.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.905 0.383 . . . . 72.35 110.947 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.407 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -104.43 143.4 33.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 61.53 110.888 179.836 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.757 HG21 HD21 ' A' ' 66' ' ' LEU . 13.0 p -144.11 143.64 23.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 51.33 111.091 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.719 ' HG2' HG22 ' A' ' 50' ' ' VAL . 0.2 OUTLIER 54.07 33.82 18.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 72.11 110.854 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.48 -15.04 42.96 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.714 -0.755 . . . . 51.33 112.452 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.6 mmtm -81.61 149.63 64.82 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.636 0.732 . . . . 54.41 110.858 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.407 ' HA ' ' HB3' ' A' ' 49' ' ' LYS . 53.8 Cg_endo -69.73 -35.98 11.71 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.663 2.242 . . . . 71.42 112.354 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 38.92 39.31 0.35 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 41.4 111.115 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.7 -75.47 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 75.22 110.878 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -154.61 -39.51 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 64.35 110.857 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -72.16 -4.11 27.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 54.41 110.875 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.615 ' O ' HG23 ' A' ' 25' ' ' VAL . 1.4 t -90.04 147.48 5.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 73.1 111.099 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.485 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 13.4 mttp -90.35 147.13 23.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 74.03 110.933 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.414 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 16.1 mt -51.95 -38.1 55.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 71.34 110.882 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.69 -18.43 79.7 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.753 -0.736 . . . . 41.23 112.455 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.61 -14.89 47.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.857 0.36 . . . . 63.14 111.142 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.961 HD11 HG22 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -87.17 -18.02 31.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 64.3 110.944 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.16 45.65 23.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 64.11 110.914 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.757 HD21 HG21 ' A' ' 50' ' ' VAL . 3.5 mt -99.02 153.27 18.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 71.52 110.897 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.27 159.81 78.62 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.549 0.69 . . . . 63.33 110.932 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -36.71 10.32 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.707 2.271 . . . . 52.22 112.37 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.716 ' HA ' HD12 ' A' ' 6' ' ' ILE . 1.7 m-80 -78.59 -15.81 58.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 62.02 110.872 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.655 HG21 HD13 ' A' ' 66' ' ' LEU . 51.8 m -32.63 123.65 0.35 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.475 . . . . 51.2 111.163 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.68 146.26 23.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 72.04 110.856 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.7 mm -115.45 131.83 66.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 63.52 111.115 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 26.5 mtm -104.14 142.04 35.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 62.24 110.866 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 75.0 mtm -134.44 118.6 17.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 65.32 110.91 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.737 ' CG ' HD21 ' A' ' 46' ' ' LEU . 2.1 mmt -106.2 126.1 51.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 73.32 110.858 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' A' ' 43' ' ' GLN . . . 157.87 -154.65 25.72 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.754 -0.736 . . . . 63.33 112.49 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.795 0.331 . . . . 63.03 111.164 -179.863 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.746 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.811 0.339 . . . . 63.21 111.132 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.412 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 4.1 mt -111.71 109.61 55.4 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.681 0.753 . . . . 74.51 110.888 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 53.7 Cg_endo -69.75 156.34 63.61 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.652 2.234 . . . . 65.14 112.331 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.538 ' HB ' HD21 ' A' ' 28' ' ' LEU . 30.2 mt -150.34 136.81 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 62.32 111.129 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.711 HD12 ' HA ' ' A' ' 69' ' ' ASN . 3.6 mt -95.2 140.73 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 54.35 111.186 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.853 HG21 HD13 ' A' ' 32' ' ' LEU . 8.6 p -127.1 123.48 62.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 64.35 111.121 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.81 125.72 51.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 72.15 110.876 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.6 t-105 -125.01 100.74 6.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 73.12 110.911 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.22 -79.22 1.71 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.732 -0.747 . . . . 43.5 112.442 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.16 17.46 0.8 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.729 -0.748 . . . . 52.34 112.512 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -129.35 138.59 51.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.742 0.306 . . . . 70.02 110.909 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -102.94 142.28 34.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 73.21 110.94 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.58 ' CG ' HG21 ' A' ' 36' ' ' THR . 79.7 m-85 -136.69 116.15 12.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 75.22 110.867 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.86 133.87 35.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.086 -0.506 . . . . 53.23 110.858 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.529 HG21 HD23 ' A' ' 32' ' ' LEU . 89.7 t -95.71 139.55 18.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.08 -0.509 . . . . 74.41 111.091 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.3 p -149.02 92.91 2.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 71.51 111.151 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.712 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.8 OUTLIER 173.67 -28.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 44.34 111.175 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.746 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.7 mm? -85.7 151.53 23.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.447 . . . . 64.55 110.919 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.423 ' O ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.39 168.96 16.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 74.0 110.843 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.417 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 22.5 mt-10 -61.09 -22.37 64.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 71.2 110.892 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.37 -11.33 60.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 75.0 110.856 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.402 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.6 m-20 -99.94 -151.0 0.39 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 74.21 110.852 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -133.27 171.57 13.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 62.14 111.148 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.954 HG22 HD11 ' A' ' 64' ' ' LEU . 11.2 t -67.23 -42.02 87.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 63.12 111.153 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.57 -28.96 69.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.481 . . . . 74.34 110.876 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.496 ' HB3' HD11 ' A' ' 19' ' ' LEU . 10.1 t0 -70.46 -35.05 73.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.434 . . . . 70.13 110.893 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.661 HD23 HD23 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -80.67 -48.06 13.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 72.33 110.962 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.775 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.45 -56.51 19.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 61.44 110.885 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.2 -22.29 51.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 45.31 110.892 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.712 ' CZ ' HG21 ' A' ' 18' ' ' THR . 50.8 t80 -77.46 -55.14 5.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 63.21 110.858 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.853 HD13 HG21 ' A' ' 7' ' ' VAL . 2.4 pp -67.67 -43.07 81.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.176 -0.465 . . . . 64.22 110.897 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.564 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.98 -26.91 39.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 45.55 110.883 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.478 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -80.02 -23.85 41.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 72.31 111.12 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.405 HD11 ' CE2' ' A' ' 31' ' ' PHE . 13.1 mt -76.45 -59.85 2.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.456 . . . . 70.42 110.9 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.58 HG21 ' CG ' ' A' ' 14' ' ' TYR . 4.2 t -135.39 -28.09 1.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 71.11 111.131 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.52 -177.86 4.53 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.699 -0.762 . . . . 64.11 112.502 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.859 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.0 OUTLIER -113.18 139.57 37.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.898 0.38 . . . . 64.52 111.149 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 1.001 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.39 151.3 14.19 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.617 0.722 . . . . 71.04 110.898 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 53.9 Cg_endo -69.74 -21.42 33.63 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.664 2.243 . . . . 72.43 112.383 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -54.83 -38.88 67.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 74.42 110.821 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.426 ' H ' HD23 ' A' ' 39' ' ' LEU . 1.8 mtt-85 -103.73 -40.47 6.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 64.15 110.865 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.859 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.7 pp0? -98.29 157.32 16.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 73.13 110.888 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.31 141.11 51.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 64.04 110.907 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.406 HD22 ' N ' ' A' ' 45' ' ' LEU . 3.7 mm? -67.31 135.91 54.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 62.43 110.966 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.796 HD11 ' HG2' ' A' ' 75' ' ' MET . 7.0 mp -78.15 -75.09 0.23 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 73.13 110.927 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.13 58.78 1.7 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.724 -0.75 . . . . 75.12 112.446 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.649 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 3.7 pp -55.15 -24.48 26.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.86 0.362 . . . . 73.04 110.905 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.411 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -103.89 143.39 32.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 72.44 110.944 179.807 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.787 HG21 HD21 ' A' ' 66' ' ' LEU . 14.7 p -144.25 143.49 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 74.14 111.142 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.6 mttp 54.01 34.04 18.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 72.21 110.934 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.38 -15.11 42.08 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.739 -0.743 . . . . 70.13 112.499 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -81.64 149.47 64.39 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.586 0.708 . . . . 62.11 110.912 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.411 ' HA ' ' HB3' ' A' ' 49' ' ' LYS . 54.4 Cg_endo -69.72 -35.86 11.99 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.705 2.27 . . . . 61.51 112.335 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 38.98 39.51 0.37 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 61.42 111.146 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.31 -74.0 0.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 72.44 110.89 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.416 HD22 ' N ' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -157.45 -36.31 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 74.34 110.889 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.416 ' N ' HD22 ' A' ' 57' ' ' ASN . 4.0 m-20 -75.3 -1.6 24.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 72.41 110.913 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -93.55 147.65 5.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.166 -0.47 . . . . 72.22 111.104 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.407 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 12.9 mttt -89.99 147.2 23.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 70.33 110.85 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.423 HD12 ' O ' ' A' ' 20' ' ' SER . 17.3 mt -52.71 -38.3 60.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 72.32 110.895 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.61 -17.21 80.21 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.712 -0.756 . . . . 75.55 112.501 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.39 -20.08 32.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.826 0.346 . . . . 73.44 111.097 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.954 HD11 HG22 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -83.96 -20.02 33.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.435 . . . . 75.34 110.923 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.3 mmtp 52.09 43.91 30.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 74.11 110.904 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.787 HD21 HG21 ' A' ' 50' ' ' VAL . 3.4 mt -95.03 153.12 17.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 70.15 110.898 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.57 159.77 79.87 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.588 0.709 . . . . 71.23 110.876 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 -36.8 10.24 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.699 2.266 . . . . 60.4 112.354 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.711 ' HA ' HD12 ' A' ' 6' ' ' ILE . 2.4 m120 -78.45 -15.78 58.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 72.23 110.872 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.652 HG21 HD13 ' A' ' 66' ' ' LEU . 51.9 m -32.53 125.01 0.33 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 73.22 111.123 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.93 146.78 24.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 70.32 110.892 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.6 mm -115.17 129.96 70.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 74.02 111.164 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.487 ' CB ' HD13 ' A' ' 46' ' ' LEU . 41.2 mtm -101.01 142.87 31.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.478 . . . . 74.23 110.859 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.1 mtt -135.97 116.88 14.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 75.31 110.912 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.796 ' HG2' HD11 ' A' ' 46' ' ' LEU . 8.7 mmm -105.29 131.39 52.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 55.13 110.894 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 148.64 -151.9 24.02 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.71 -0.757 . . . . 73.23 112.51 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.753 0.311 . . . . 70.15 111.167 -179.932 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.745 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.822 0.344 . . . . 63.44 111.1 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.421 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 2.6 mt -111.38 109.37 56.35 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.595 0.712 . . . . 41.42 110.934 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 53.7 Cg_endo -69.8 156.41 63.33 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.651 2.234 . . . . 72.02 112.35 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.544 ' HB ' HD21 ' A' ' 28' ' ' LEU . 31.3 mt -150.58 137.02 12.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 73.01 111.135 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.648 HD12 ' HA ' ' A' ' 69' ' ' ASN . 5.1 mt -94.96 140.57 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 72.54 111.134 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.855 HG21 HD13 ' A' ' 32' ' ' LEU . 7.5 p -127.1 122.86 61.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 73.42 111.091 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.66 119.82 40.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 73.34 110.89 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 16.6 t-105 -120.85 100.62 7.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.454 . . . . 61.43 110.944 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.87 -83.39 0.92 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.797 -0.716 . . . . 63.42 112.489 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.57 21.57 1.05 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.772 -0.728 . . . . 61.23 112.501 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -129.28 175.29 8.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.775 0.322 . . . . 73.13 110.904 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -133.19 140.96 47.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 74.52 110.916 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.466 ' CD2' HG21 ' A' ' 36' ' ' THR . 41.3 m-85 -136.51 119.14 16.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.173 -0.467 . . . . 74.53 110.973 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.2 p -84.13 132.35 34.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 62.22 110.849 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.553 HG21 HD23 ' A' ' 32' ' ' LEU . 95.9 t -94.98 125.98 47.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.069 -0.514 . . . . 45.14 111.138 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.2 p -136.49 93.12 2.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 52.41 111.174 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.712 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.8 OUTLIER 173.51 -28.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 70.22 111.113 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.745 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.8 mm? -86.12 151.2 23.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.271 -0.422 . . . . 70.52 110.878 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.438 ' O ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.32 169.33 16.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 70.5 110.815 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.412 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 43.1 mt-10 -61.7 -22.18 65.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.106 -0.497 . . . . 72.1 110.922 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -70.16 -10.69 59.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 74.23 110.871 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.403 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.5 m-20 -99.2 -150.44 0.37 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 75.02 110.842 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.32 168.53 18.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 71.42 111.144 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.975 HG22 HD11 ' A' ' 64' ' ' LEU . 13.0 t -64.67 -42.85 96.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 64.2 111.137 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.14 -28.47 69.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 73.02 110.9 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.49 ' HB3' HD11 ' A' ' 19' ' ' LEU . 19.9 t0 -70.81 -35.09 72.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 73.12 110.868 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.667 HD12 ' CB ' ' A' ' 19' ' ' LEU . 0.9 OUTLIER -80.64 -47.73 13.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 75.15 110.906 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.755 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.97 -56.8 15.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 73.2 110.867 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -58.19 -22.1 50.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 74.42 110.906 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.712 ' CZ ' HG21 ' A' ' 18' ' ' THR . 54.0 t80 -77.48 -54.9 5.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 74.43 110.865 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.855 HD13 HG21 ' A' ' 7' ' ' VAL . 2.4 pp -68.28 -43.0 78.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 71.23 110.898 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.569 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -55.08 -26.91 41.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 74.12 110.909 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.82 -23.77 41.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.452 . . . . 62.22 111.141 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.7 mt -76.67 -60.26 2.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.234 -0.439 . . . . 72.4 110.87 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.466 HG21 ' CD2' ' A' ' 14' ' ' TYR . 2.8 t -135.41 -27.48 1.19 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 61.43 111.181 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.569 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.45 -178.4 4.74 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.759 -0.734 . . . . 70.42 112.521 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.875 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.2 p -112.91 139.06 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.889 0.376 . . . . 71.53 111.095 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.991 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.53 150.8 16.08 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.66 0.743 . . . . 75.42 110.92 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 53.9 Cg_endo -69.68 -21.64 33.57 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.69 2.26 . . . . 53.0 112.358 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -54.41 -38.89 66.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 53.25 110.874 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.432 ' H ' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -104.04 -40.52 6.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 63.1 110.865 -179.902 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.875 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.7 pp0? -97.87 158.27 15.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 73.44 110.929 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.36 141.73 51.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 73.51 110.898 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.36 136.04 54.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.266 -0.425 . . . . 40.42 110.868 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.723 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.1 mm? -76.74 -75.91 0.18 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 62.4 110.898 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.26 56.83 1.74 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.735 -0.745 . . . . 52.35 112.473 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.646 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 4.0 pp -50.56 -32.31 18.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.877 0.37 . . . . 63.52 110.933 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.527 ' N ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -95.59 146.19 24.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 72.25 110.927 179.802 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.705 HG21 ' CD2' ' A' ' 66' ' ' LEU . 8.5 p -142.37 138.01 29.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 74.41 111.126 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt 54.53 32.2 16.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 73.25 110.893 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.42 -15.57 56.17 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.753 -0.737 . . . . 42.43 112.485 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -80.17 149.79 70.16 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.546 0.688 . . . . 72.44 110.901 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -36.27 11.04 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.729 2.286 . . . . 70.43 112.316 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 39.54 37.05 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 71.24 111.101 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.44 -76.83 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 74.45 110.9 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -153.87 -38.96 0.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 71.13 110.866 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -71.89 -2.61 18.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 73.4 110.882 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.58 ' O ' HG23 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -92.93 147.7 5.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 71.55 111.15 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.415 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 15.4 mttp -91.27 147.84 22.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 74.41 110.916 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.438 HD12 ' O ' ' A' ' 20' ' ' SER . 17.6 mt -52.61 -38.45 60.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.248 -0.433 . . . . 51.51 110.907 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.7 -17.29 80.17 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.743 -0.741 . . . . 61.14 112.496 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.28 -19.97 32.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.854 0.359 . . . . 75.24 111.1 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.975 HD11 HG22 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -84.17 -19.27 34.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 55.32 110.944 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt 51.91 43.65 30.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 71.44 110.876 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.705 ' CD2' HG21 ' A' ' 50' ' ' VAL . 3.5 mt -94.26 152.3 18.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 71.25 110.956 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -68.45 159.79 79.38 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.595 0.712 . . . . 74.12 110.882 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -37.65 8.88 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.703 2.269 . . . . 74.53 112.333 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.648 ' HA ' HD12 ' A' ' 6' ' ' ILE . 14.8 m-20 -78.56 -15.45 58.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 74.41 110.897 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.611 HG21 HD13 ' A' ' 66' ' ' LEU . 56.3 m -33.01 126.86 0.32 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.472 . . . . 73.1 111.172 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.78 145.77 25.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 74.21 110.915 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.3 mm -115.5 128.17 72.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 73.22 111.114 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 9.2 mtp -99.76 141.65 32.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 53.44 110.923 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.0 mtt -133.77 117.32 16.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 72.05 110.862 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.723 ' CG ' HD21 ' A' ' 46' ' ' LEU . 2.7 mmt -105.25 123.28 47.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 71.44 110.849 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 160.3 -157.22 28.56 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.699 -0.762 . . . . 74.21 112.519 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 120.783 0.325 . . . . 65.22 111.135 -179.899 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.731 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.796 0.332 . . . . 73.34 111.107 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.545 HD23 ' HD2' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -106.95 110.46 63.61 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.603 0.716 . . . . 73.52 110.928 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.545 ' HD2' HD23 ' A' ' 3' ' ' LEU . 53.7 Cg_endo -69.79 156.32 63.58 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.692 2.262 . . . . 63.12 112.337 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.474 ' HB ' HD21 ' A' ' 28' ' ' LEU . 52.6 mt -150.81 136.86 12.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 74.13 111.116 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.712 HD12 ' HA ' ' A' ' 69' ' ' ASN . 3.5 mt -95.28 140.65 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 64.33 111.159 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.831 HG21 HD13 ' A' ' 32' ' ' LEU . 8.4 p -127.15 123.29 61.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 75.32 111.121 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.11 122.11 46.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 72.14 110.935 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.1 t-105 -123.18 102.89 8.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 75.3 110.899 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.76 -79.68 1.63 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.72 -0.752 . . . . 74.42 112.445 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.34 17.89 0.69 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.773 -0.727 . . . . 63.2 112.547 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -130.0 138.8 51.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.763 0.316 . . . . 62.23 110.928 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -102.71 142.37 33.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 62.52 110.867 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.542 ' CD1' HG21 ' A' ' 36' ' ' THR . 80.1 m-85 -136.36 116.69 13.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.474 . . . . 73.14 110.923 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.7 p -82.46 132.28 35.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.078 -0.51 . . . . 50.32 110.854 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.544 HG21 HD23 ' A' ' 32' ' ' LEU . 85.8 t -92.96 140.61 16.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 71.4 111.132 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.5 p -151.28 91.54 1.69 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 35.44 111.108 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.436 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.7 OUTLIER 173.17 -28.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 62.24 111.132 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.731 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.4 mm? -86.53 150.61 24.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 73.3 110.909 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.462 ' C ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -132.03 165.6 23.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 64.22 110.828 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.465 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -57.48 -20.55 31.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.5 . . . . 75.42 110.856 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -67.09 -13.2 61.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 71.55 110.874 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.406 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.8 m-20 -101.91 -145.65 0.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 72.32 110.813 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -138.28 167.13 22.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 72.34 111.176 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.639 HG22 HD11 ' A' ' 64' ' ' LEU . 97.6 t -62.1 -44.58 99.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 52.21 111.151 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.424 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -60.4 -27.75 67.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 64.42 110.944 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.477 ' HB3' HD11 ' A' ' 19' ' ' LEU . 3.2 t0 -71.74 -34.5 69.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 72.02 110.878 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.682 HD12 ' HB3' ' A' ' 19' ' ' LEU . 1.1 tt -80.16 -47.99 13.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 74.52 110.915 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.517 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.46 -55.87 26.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.198 -0.456 . . . . 74.4 110.84 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -57.28 -22.7 43.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 73.52 110.88 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.46 ' O ' HG22 ' A' ' 34' ' ' THR . 70.5 t80 -77.92 -55.37 5.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 44.25 110.875 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.831 HD13 HG21 ' A' ' 7' ' ' VAL . 2.5 pp -67.09 -43.02 83.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.476 . . . . 73.4 110.938 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.582 ' N ' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -54.61 -27.5 39.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 64.42 110.919 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.46 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.63 -23.67 42.43 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.474 . . . . 65.31 111.191 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.2 mt -76.49 -59.31 2.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 63.11 110.923 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.542 HG21 ' CD1' ' A' ' 14' ' ' TYR . 4.6 t -135.02 -28.25 1.19 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 71.43 111.167 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.53 -176.86 5.1 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.73 -0.747 . . . . 65.11 112.532 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.88 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.3 p -113.09 139.26 39.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.867 0.365 . . . . 64.03 111.115 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.993 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.52 150.25 18.06 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.568 0.699 . . . . 72.05 110.93 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -21.96 32.54 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.713 2.275 . . . . 75.54 112.297 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -54.47 -38.89 66.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 42.12 110.908 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.416 ' H ' HD23 ' A' ' 39' ' ' LEU . 3.9 mpt_? -103.91 -40.31 6.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 61.1 110.892 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.88 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.9 pp0? -97.35 158.06 15.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 64.22 110.91 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.03 142.52 51.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 75.11 110.928 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.31 135.95 54.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 71.41 110.938 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.752 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.1 mm? -77.4 -67.57 0.7 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 61.44 110.907 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.88 61.21 0.61 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.728 -0.748 . . . . 71.12 112.484 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.578 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 4.6 pp -59.2 -17.94 32.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.864 0.364 . . . . 73.32 110.897 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.71 144.16 42.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 74.43 110.904 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.781 HG21 HD21 ' A' ' 66' ' ' LEU . 10.9 p -143.82 145.63 21.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.428 . . . . 74.34 111.115 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.551 ' HG2' HG22 ' A' ' 50' ' ' VAL . 19.7 mmtp 54.67 32.32 17.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 64.35 110.887 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.25 -11.28 50.64 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.69 -0.767 . . . . 45.1 112.488 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.9 mmtp -81.4 151.45 69.03 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.551 0.691 . . . . 74.22 110.912 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.418 ' O ' ' C ' ' A' ' 55' ' ' ALA . 53.8 Cg_endo -69.68 -32.96 17.84 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.675 2.25 . . . . 75.31 112.349 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.601 ' HA ' HG21 ' A' ' 59' ' ' VAL . . . 36.42 43.65 0.25 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 64.11 111.111 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.97 -76.52 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 71.42 110.88 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -159.26 -37.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 73.22 110.922 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -67.4 -8.13 30.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 75.34 110.899 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.601 HG21 ' HA ' ' A' ' 55' ' ' ALA . 17.0 t -80.2 145.54 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 50.4 111.112 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -90.63 150.82 21.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 51.13 110.898 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.527 ' HA ' HD12 ' A' ' 64' ' ' LEU . 12.6 mt -51.74 -45.06 63.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 72.42 110.903 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.54 -11.29 85.61 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.75 -0.738 . . . . 51.21 112.473 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.9 -35.25 29.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.805 0.336 . . . . 64.54 111.116 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.639 HD11 HG22 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -73.13 -24.53 60.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 52.21 110.871 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.8 mmtp 62.38 38.04 13.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 52.54 110.881 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.781 HD21 HG21 ' A' ' 50' ' ' VAL . 4.2 mt -88.85 153.48 21.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 74.21 110.916 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.45 160.3 76.85 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.583 0.706 . . . . 61.14 110.879 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -35.62 12.22 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.678 2.252 . . . . 62.01 112.322 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.712 ' HA ' HD12 ' A' ' 6' ' ' ILE . 23.8 p30 -78.8 -15.88 57.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 64.31 110.92 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.617 HG21 HD13 ' A' ' 66' ' ' LEU . 55.4 m -32.42 120.13 0.3 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.143 -0.481 . . . . 61.41 111.151 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.72 146.39 23.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 71.52 110.924 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.9 mm -116.97 130.63 71.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 62.11 111.135 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 6.1 mtt -103.91 141.69 35.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 62.42 110.891 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 70.5 mtm -133.99 123.57 24.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.267 -0.424 . . . . 70.35 110.906 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.752 ' CG ' HD21 ' A' ' 46' ' ' LEU . 1.3 mmm -111.12 124.39 52.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 64.44 110.841 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 164.11 -153.96 24.58 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.716 -0.754 . . . . 53.21 112.45 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.9 t . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 120.838 0.352 . . . . 72.4 111.133 -179.867 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.738 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.804 0.335 . . . . 52.34 111.091 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.2 mt -110.79 109.1 57.79 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.621 0.724 . . . . 53.54 110.945 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 156.67 62.86 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.673 2.249 . . . . 70.42 112.34 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.458 ' HB ' HD21 ' A' ' 28' ' ' LEU . 38.1 mt -150.56 137.3 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.437 . . . . 75.44 111.147 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.723 HD12 ' HA ' ' A' ' 69' ' ' ASN . 4.1 mt -95.37 140.56 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 72.4 111.146 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.808 HG21 HD13 ' A' ' 32' ' ' LEU . 8.3 p -127.29 122.91 60.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 74.22 111.115 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -107.98 120.19 41.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 74.02 110.907 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.1 t-105 -122.27 100.91 7.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 75.11 110.903 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.91 -83.61 0.77 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.752 -0.737 . . . . 54.11 112.51 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.13 20.38 0.96 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.69 -0.767 . . . . 71.1 112.474 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -129.18 174.9 9.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.771 0.32 . . . . 72.41 110.902 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -132.7 140.64 48.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 55.4 110.934 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -135.92 119.1 16.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 71.35 110.925 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 89.2 p -82.75 136.05 34.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.101 -0.5 . . . . 61.42 110.892 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.527 HG21 HD23 ' A' ' 32' ' ' LEU . 87.3 t -98.87 125.23 52.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 72.31 111.108 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.4 p -135.44 93.41 2.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 63.34 111.121 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.573 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.9 OUTLIER 173.73 -28.84 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 73.14 111.133 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.738 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.9 mm? -84.92 149.85 25.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.222 -0.444 . . . . 63.11 110.893 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.572 ' C ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.77 167.68 19.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 72.42 110.854 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.43 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 56.1 mt-10 -58.58 -22.39 55.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 55.15 110.887 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.11 -11.54 59.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 70.4 110.905 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.447 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.9 m-20 -101.63 -150.24 0.4 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 60.43 110.836 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.487 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -136.53 167.57 21.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.462 . . . . 74.22 111.115 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.625 HG21 HD21 ' A' ' 64' ' ' LEU . 75.0 t -63.03 -42.26 96.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 70.54 111.143 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.417 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -61.97 -28.72 69.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.491 . . . . 70.34 110.901 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.576 ' HB3' HD11 ' A' ' 19' ' ' LEU . 1.2 t0 -72.06 -32.78 67.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 52.44 110.878 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.685 HD23 HD23 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -80.46 -48.93 12.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 53.03 110.917 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.76 -55.79 26.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 72.43 110.902 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.92 -22.64 49.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 72.33 110.918 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.573 ' CZ ' HG21 ' A' ' 18' ' ' THR . 44.5 t80 -77.76 -55.11 5.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.453 . . . . 64.34 110.87 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.808 HD13 HG21 ' A' ' 7' ' ' VAL . 2.8 pp -67.51 -41.93 83.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 60.41 110.915 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.569 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.71 -27.91 44.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 53.1 110.928 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.43 -23.84 42.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.455 . . . . 72.31 111.141 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.441 HD11 ' CE1' ' A' ' 31' ' ' PHE . 13.7 mt -76.15 -59.48 2.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.446 . . . . 75.44 110.877 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.4 t -135.38 -27.77 1.18 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 71.43 111.147 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.569 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.59 -175.34 4.36 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.766 -0.73 . . . . 53.34 112.495 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.726 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.4 p -112.56 141.38 28.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.807 0.337 . . . . 52.21 111.17 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 1.001 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -57.01 149.86 42.68 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.6 0.714 . . . . 74.01 110.885 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -21.4 33.48 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.707 2.272 . . . . 63.14 112.308 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -55.19 -39.25 69.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 71.21 110.835 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.423 ' H ' HD23 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -104.29 -41.42 5.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 72.25 110.891 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.726 ' HG2' HG13 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -96.12 158.41 15.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 61.11 110.898 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.603 ' N ' HE21 ' A' ' 43' ' ' GLN . 0.0 OUTLIER -130.14 142.45 50.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 64.44 110.902 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.52 136.38 54.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 54.43 110.881 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.734 HD11 ' CG ' ' A' ' 75' ' ' MET . 6.2 mp -86.13 -55.26 4.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 62.33 110.877 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.35 52.52 0.97 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.719 -0.753 . . . . 71.14 112.485 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.584 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 4.6 pp -61.67 -16.39 48.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.933 0.397 . . . . 75.51 110.942 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.9 pttt -116.8 143.25 45.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 72.13 110.876 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.988 HG21 HD21 ' A' ' 66' ' ' LEU . 10.6 p -143.73 145.17 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 74.41 111.137 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 55.34 31.52 16.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 71.14 110.924 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.09 -11.17 55.98 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.728 -0.749 . . . . 64.04 112.492 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -81.37 150.98 68.5 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.532 0.682 . . . . 74.14 110.938 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 55' ' ' ALA . 53.6 Cg_endo -69.79 -32.25 18.79 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.691 2.261 . . . . 74.24 112.302 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.591 ' HA ' HG21 ' A' ' 59' ' ' VAL . . . 35.99 44.34 0.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.439 . . . . 42.21 111.128 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.08 -79.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 74.43 110.919 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.04 -38.8 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 54.13 110.884 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -64.6 -9.8 21.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 74.33 110.896 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.591 HG21 ' HA ' ' A' ' 55' ' ' ALA . 16.6 t -79.55 145.69 8.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 73.41 111.159 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 29.8 mttt -91.49 152.25 20.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.446 . . . . 63.4 110.937 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.572 HD12 ' C ' ' A' ' 20' ' ' SER . 20.0 mt -49.86 -47.47 51.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 75.22 110.928 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.72 -11.71 85.18 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.775 -0.726 . . . . 51.41 112.473 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.59 -31.55 41.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.837 0.351 . . . . 52.51 111.076 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.625 HD21 HG21 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -78.17 -23.99 47.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 74.12 110.925 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.7 mmtp 63.45 35.84 11.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 72.03 110.875 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.988 HD21 HG21 ' A' ' 50' ' ' VAL . 4.7 mt -87.78 152.88 21.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.439 . . . . 64.13 110.925 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.7 160.44 77.14 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.627 0.727 . . . . 74.44 110.897 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -34.82 13.77 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.657 2.238 . . . . 74.42 112.355 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.723 ' HA ' HD12 ' A' ' 6' ' ' ILE . 12.3 m120 -78.81 -16.1 57.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 74.13 110.859 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.698 HG21 HD13 ' A' ' 66' ' ' LEU . 49.1 m -32.5 120.17 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 71.1 111.162 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.17 146.68 23.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 71.53 110.891 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.5 mm -115.37 128.95 72.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 72.55 111.147 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 30.8 mtt -99.7 142.67 30.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 72.43 110.865 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.3 mtt -134.08 132.73 40.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 72.0 110.854 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.734 ' CG ' HD11 ' A' ' 46' ' ' LEU . 2.3 mmt -124.58 123.5 40.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 74.5 110.88 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.13 -155.19 26.02 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.733 -0.746 . . . . 61.33 112.472 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.775 0.321 . . . . 72.24 111.131 -179.836 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.734 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.818 0.342 . . . . 64.05 111.112 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.663 HD12 ' HG2' ' A' ' 21' ' ' GLU . 4.4 mt -112.13 109.68 54.33 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.589 0.709 . . . . 72.33 110.927 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 156.42 63.49 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.689 2.259 . . . . 72.54 112.364 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.554 ' HB ' HD21 ' A' ' 28' ' ' LEU . 33.8 mt -150.56 137.45 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 72.44 111.134 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.681 HD12 ' HA ' ' A' ' 69' ' ' ASN . 4.3 mt -95.39 140.65 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 63.23 111.137 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.813 HG21 HD13 ' A' ' 32' ' ' LEU . 7.3 p -126.95 123.28 62.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 51.44 111.108 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.52 120.73 43.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 70.23 110.865 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 17.3 t-105 -123.87 105.03 9.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 74.13 110.878 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.88 -81.81 0.9 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.767 -0.73 . . . . 70.03 112.483 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.04 20.25 0.66 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.782 -0.723 . . . . 62.25 112.513 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -129.13 175.35 8.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.756 0.312 . . . . 74.31 110.947 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -132.74 140.12 47.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 75.51 110.899 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.528 ' CD2' HG21 ' A' ' 36' ' ' THR . 47.4 m-85 -134.7 116.33 14.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.172 -0.467 . . . . 73.51 110.913 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.0 p -82.93 130.59 35.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.504 . . . . 75.33 110.864 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.556 HG21 HD23 ' A' ' 32' ' ' LEU . 91.6 t -91.74 142.0 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 74.14 111.148 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.2 p -151.49 92.31 1.76 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 63.21 111.156 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.688 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.8 OUTLIER 173.74 -29.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 63.23 111.148 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.734 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.6 mm? -86.25 152.2 22.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 54.34 110.92 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.427 ' O ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.55 169.75 15.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 75.01 110.851 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.663 ' HG2' HD12 ' A' ' 3' ' ' LEU . 58.2 mt-10 -61.85 -22.23 65.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 63.12 110.914 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -68.8 -12.05 61.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.17 -0.468 . . . . 75.52 110.887 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.412 ' HB2' HD12 ' A' ' 19' ' ' LEU . 2.0 m-20 -99.78 -150.52 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 71.33 110.88 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -132.53 171.37 13.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 64.14 111.17 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.929 HG22 HD11 ' A' ' 64' ' ' LEU . 11.8 t -67.69 -40.96 84.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 72.52 111.119 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.19 -29.4 70.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 72.52 110.905 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.47 ' HB3' HD11 ' A' ' 19' ' ' LEU . 19.0 t0 -70.1 -35.12 73.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 71.41 110.845 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.689 HD12 ' CB ' ' A' ' 19' ' ' LEU . 1.2 tt -80.76 -47.67 13.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 51.24 110.938 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.771 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.86 -56.5 18.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 62.44 110.892 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.15 -22.75 52.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.434 . . . . 64.51 110.915 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.688 ' CZ ' HG21 ' A' ' 18' ' ' THR . 59.9 t80 -76.86 -55.48 5.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 64.25 110.864 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.813 HD13 HG21 ' A' ' 7' ' ' VAL . 2.2 pp -67.29 -43.43 81.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 75.13 110.889 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.571 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.2 tmtt? -54.81 -27.48 42.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 73.31 110.914 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.503 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.34 -23.51 43.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 75.03 111.161 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.6 mt -76.65 -59.59 2.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 53.44 110.929 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.528 HG21 ' CD2' ' A' ' 14' ' ' TYR . 2.7 t -135.01 -27.68 1.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 75.22 111.158 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.571 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.59 -176.68 5.07 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.777 -0.725 . . . . 62.01 112.457 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.883 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.4 p -112.38 138.54 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.887 0.375 . . . . 73.32 111.144 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.983 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.06 149.75 17.35 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.575 0.703 . . . . 74.1 110.947 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -21.97 32.7 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.669 2.246 . . . . 41.22 112.335 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -53.94 -38.43 64.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 61.35 110.907 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.408 ' H ' HD23 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -105.08 -39.52 6.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 63.35 110.919 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.883 ' HG2' HG13 ' A' ' 38' ' ' VAL . 2.3 pp0? -96.54 158.66 15.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 71.2 110.892 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.02 139.33 52.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 73.15 110.871 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.663 HD22 HE22 ' A' ' 43' ' ' GLN . 3.7 mm? -65.81 135.45 54.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.257 -0.429 . . . . 73.4 110.898 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.735 HD11 ' CG ' ' A' ' 75' ' ' MET . 7.2 mp -77.45 -75.81 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.467 . . . . 73.0 110.907 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.12 59.44 1.68 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.755 -0.736 . . . . 64.51 112.508 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.64 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 3.6 pp -55.83 -24.39 36.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.874 0.369 . . . . 74.25 110.914 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.423 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 1.9 pttt -103.45 143.16 33.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 73.44 110.854 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.8 HG21 HD21 ' A' ' 66' ' ' LEU . 14.4 p -144.19 143.36 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.42 . . . . 51.25 111.126 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.6 mttm 54.04 34.17 19.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 74.21 110.865 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.38 -15.16 41.79 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.741 -0.743 . . . . 74.34 112.47 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -81.56 149.59 64.95 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.557 0.694 . . . . 72.22 110.887 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.423 ' HA ' ' HB3' ' A' ' 49' ' ' LYS . 53.8 Cg_endo -69.77 -36.4 10.85 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.714 2.276 . . . . 65.2 112.344 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 38.4 40.01 0.33 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 71.51 111.075 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -66.94 -74.37 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 71.5 110.865 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.401 HD22 ' N ' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -156.54 -37.31 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 71.1 110.87 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.401 ' N ' HD22 ' A' ' 57' ' ' ASN . 56.4 m-20 -74.67 -2.98 28.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 75.31 110.897 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.597 ' O ' HG23 ' A' ' 25' ' ' VAL . 1.3 t -91.15 146.94 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 61.43 111.13 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.465 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 24.6 mttt -89.04 146.55 24.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 70.33 110.943 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.438 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 18.3 mt -52.12 -37.58 54.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.256 -0.429 . . . . 52.4 110.906 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.93 -18.24 79.62 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.748 -0.739 . . . . 71.33 112.47 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.73 -15.56 44.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.883 0.373 . . . . 53.03 111.141 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.929 HD11 HG22 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -87.04 -18.31 30.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 71.22 110.913 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 49.66 45.08 24.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 73.11 110.924 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.8 HD21 HG21 ' A' ' 50' ' ' VAL . 3.4 mt -97.86 152.99 18.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 65.34 110.923 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.42 159.81 79.15 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.547 0.689 . . . . 63.41 110.911 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -36.57 10.51 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.682 2.255 . . . . 64.04 112.332 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.681 ' HA ' HD12 ' A' ' 6' ' ' ILE . 5.0 m120 -78.45 -15.59 58.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 75.22 110.911 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.649 HG21 HD13 ' A' ' 66' ' ' LEU . 52.2 m -32.93 125.68 0.34 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 74.14 111.126 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.88 145.29 25.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 74.34 110.887 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.3 mm -115.57 131.9 66.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 62.31 111.14 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.2 mtp -101.99 141.78 34.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 71.24 110.913 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 75.9 mtm -133.47 120.0 20.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 74.33 110.856 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.735 ' CG ' HD11 ' A' ' 46' ' ' LEU . 1.5 mmt -109.7 123.8 50.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 74.14 110.921 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 162.73 -155.56 26.94 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 70.34 112.48 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.9 t . . . . . 0 C--N 1.33 -0.266 0 CA-C-O 120.8 0.333 . . . . 74.41 111.134 -179.866 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.74 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.768 0.318 . . . . 40.53 111.121 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.409 HD23 ' HD2' ' A' ' 4' ' ' PRO . 1.9 mt -110.49 108.89 58.36 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.665 0.745 . . . . 73.11 110.892 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.409 ' HD2' HD23 ' A' ' 3' ' ' LEU . 53.6 Cg_endo -69.8 156.52 63.05 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.735 2.29 . . . . 65.21 112.33 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.461 ' HB ' HD21 ' A' ' 28' ' ' LEU . 39.0 mt -150.5 137.24 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 62.45 111.128 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.69 HD12 ' HA ' ' A' ' 69' ' ' ASN . 4.6 mt -94.96 140.57 16.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 75.33 111.143 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.814 HG21 HD13 ' A' ' 32' ' ' LEU . 8.0 p -127.28 122.88 60.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 74.31 111.153 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -107.31 118.85 37.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 73.1 110.9 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 16.8 t-105 -121.18 101.59 7.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.233 -0.44 . . . . 73.34 110.895 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.48 -83.24 0.79 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.81 -0.71 . . . . 72.14 112.524 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.85 20.55 0.89 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.756 -0.735 . . . . 54.21 112.488 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -129.2 175.83 8.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.711 0.291 . . . . 61.55 110.957 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -132.88 140.78 48.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 73.42 110.903 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -136.62 118.13 14.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.147 -0.479 . . . . 73.34 110.931 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.02 133.94 35.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 73.34 110.856 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.532 HG21 HD23 ' A' ' 32' ' ' LEU . 86.3 t -96.02 126.91 48.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 74.11 111.124 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.1 p -135.94 91.99 2.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 74.33 111.121 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.659 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 1.2 t 174.62 -29.69 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 75.32 111.125 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.74 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.9 mm? -83.4 149.62 26.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 74.3 110.91 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.518 ' C ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.5 168.01 18.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 72.12 110.844 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.401 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 36.9 mt-10 -59.24 -22.01 60.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 62.43 110.896 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -69.11 -10.7 58.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 71.3 110.873 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.465 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.5 m-20 -100.89 -150.19 0.39 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 74.55 110.855 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -137.07 167.99 20.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 75.55 111.141 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.941 HG22 HD11 ' A' ' 64' ' ' LEU . 41.8 t -62.38 -45.02 99.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 73.53 111.158 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -60.78 -28.54 68.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.475 . . . . 71.33 110.918 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.567 ' HB3' HD11 ' A' ' 19' ' ' LEU . 0.7 OUTLIER -71.05 -33.56 70.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 43.15 110.938 179.792 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.689 HD23 HD23 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -80.86 -48.97 11.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 64.31 110.902 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.592 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.4 -56.58 18.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 72.34 110.858 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -58.29 -22.04 51.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 62.01 110.93 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.659 ' CZ ' HG21 ' A' ' 18' ' ' THR . 44.9 t80 -77.88 -54.93 5.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 65.41 110.854 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.814 HD13 HG21 ' A' ' 7' ' ' VAL . 2.6 pp -67.73 -42.24 82.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 54.45 110.929 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.577 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.88 -27.39 42.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 70.44 110.889 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.484 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.77 -23.77 41.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 74.01 111.207 179.925 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.416 HD11 ' CE2' ' A' ' 31' ' ' PHE . 13.9 mt -76.5 -59.94 2.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 52.32 110.896 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.9 t -135.28 -27.62 1.2 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.443 . . . . 74.25 111.162 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.577 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.61 -177.81 4.61 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.729 -0.748 . . . . 72.14 112.532 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.89 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.3 p -112.66 138.56 41.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.827 0.346 . . . . 64.0 111.145 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.967 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -55.17 151.17 18.45 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.614 0.721 . . . . 71.11 110.903 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -21.61 33.51 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.718 2.279 . . . . 74.2 112.334 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -54.38 -38.91 66.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 75.43 110.869 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.447 ' H ' HD23 ' A' ' 39' ' ' LEU . 3.1 mpt_? -104.14 -40.4 6.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 74.14 110.897 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.89 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.7 pp0? -97.86 158.43 15.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 72.32 110.917 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.64 140.85 51.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 71.42 110.861 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 45' ' ' LEU . 3.8 mm? -67.35 135.75 53.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.461 . . . . 74.05 110.913 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.742 HD21 ' CG ' ' A' ' 75' ' ' MET . 3.8 mm? -81.05 -64.39 1.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 63.42 110.91 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.63 56.89 1.64 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.781 -0.723 . . . . 71.33 112.516 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.805 ' C ' HD22 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -59.72 -13.4 9.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.886 0.374 . . . . 52.33 110.905 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.514 ' N ' HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -122.31 145.97 47.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 54.14 110.903 179.851 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.924 HG21 HD21 ' A' ' 66' ' ' LEU . 9.6 p -143.75 144.06 23.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.207 -0.451 . . . . 74.02 111.109 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.2 mttt 54.72 31.14 14.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 73.11 110.907 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.24 -9.99 59.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.763 -0.732 . . . . 70.55 112.485 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -81.04 150.25 68.18 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.576 0.703 . . . . 64.23 110.88 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.411 ' O ' ' C ' ' A' ' 55' ' ' ALA . 53.7 Cg_endo -69.76 -30.53 22.12 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.7 2.267 . . . . 62.12 112.328 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.62 ' HA ' HG21 ' A' ' 59' ' ' VAL . . . 35.5 43.28 0.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 53.2 111.102 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.33 -78.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 70.34 110.929 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -157.44 -38.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 72.54 110.845 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -66.12 -8.59 24.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.221 -0.445 . . . . 73.42 110.838 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.62 HG21 ' HA ' ' A' ' 55' ' ' ALA . 21.4 t -78.79 146.55 7.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 32.4 111.133 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 28.8 mttt -93.24 151.14 20.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 54.23 110.885 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.54 ' HA ' HD12 ' A' ' 64' ' ' LEU . 18.9 mt -50.64 -45.64 57.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.264 -0.425 . . . . 64.32 110.882 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.38 -12.02 84.59 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.79 -0.719 . . . . 52.33 112.474 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.14 -33.45 29.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.8 0.333 . . . . 53.22 111.077 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.941 HD11 HG22 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -73.09 -25.07 60.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 64.41 110.905 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt 62.63 37.75 12.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.218 -0.446 . . . . 72.53 110.891 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.924 HD21 HG21 ' A' ' 50' ' ' VAL . 5.8 mt -91.31 152.98 20.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.266 -0.424 . . . . 75.1 110.928 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -68.7 160.71 75.86 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.589 0.709 . . . . 70.41 110.909 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -35.42 12.61 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.696 2.264 . . . . 72.12 112.356 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.69 ' HA ' HD12 ' A' ' 6' ' ' ILE . 8.6 m-20 -78.86 -15.96 57.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 71.1 110.906 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.472 ' C ' ' O ' ' A' ' 69' ' ' ASN . 54.6 m -32.51 124.72 0.33 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 70.52 111.133 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.4 147.0 23.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 74.31 110.859 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.6 mm -116.93 127.5 74.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 74.32 111.128 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.4 mtt -99.22 141.87 31.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 74.24 110.838 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.9 mtt -136.14 117.22 14.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 74.2 110.864 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.742 ' CG ' HD21 ' A' ' 46' ' ' LEU . 1.4 mmt -106.19 125.78 51.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 55.31 110.863 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 160.26 -155.3 26.42 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.763 -0.732 . . . . 62.12 112.487 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.0 t . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 120.779 0.323 . . . . 74.43 111.163 -179.893 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.737 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.792 0.33 . . . . 72.51 111.116 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.411 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 3.9 mt -111.08 109.36 57.11 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.59 0.71 . . . . 65.02 110.865 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 53.9 Cg_endo -69.74 156.05 64.39 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.738 2.292 . . . . 71.34 112.356 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.431 ' HB ' HD21 ' A' ' 28' ' ' LEU . 53.4 mt -150.7 135.96 10.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.452 . . . . 62.42 111.146 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.697 HD12 ' HA ' ' A' ' 69' ' ' ASN . 3.3 mt -94.24 140.4 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 73.24 111.118 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.831 HG21 HD13 ' A' ' 32' ' ' LEU . 8.9 p -127.34 123.39 61.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 63.43 111.121 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.64 123.01 48.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 71.13 110.866 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.0 t-105 -123.87 100.49 6.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 73.54 110.9 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.23 -80.41 1.3 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.718 -0.753 . . . . 54.54 112.458 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.25 17.24 0.79 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.735 . . . . 61.43 112.48 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -129.89 139.03 51.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.774 0.321 . . . . 64.15 110.943 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -103.07 142.39 34.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 70.23 110.846 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -135.84 117.27 14.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 75.12 110.92 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 82.6 p -81.82 132.6 35.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 45.43 110.829 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.545 HG21 HD23 ' A' ' 32' ' ' LEU . 99.9 t -93.31 136.31 25.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 74.45 111.155 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.2 p -147.55 92.38 2.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 74.35 111.145 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.488 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.7 OUTLIER 173.51 -28.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 74.42 111.152 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.737 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.6 mm? -85.98 150.72 24.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 63.24 110.911 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.545 ' C ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.81 168.7 17.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.464 . . . . 74.3 110.876 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.426 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 69.9 mt-10 -59.51 -22.14 61.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 52.1 110.893 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.04 -12.57 60.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 61.21 110.883 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.423 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.9 m-20 -101.97 -148.7 0.38 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 72.24 110.874 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.499 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -136.64 168.28 19.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 71.42 111.13 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.601 HG21 HD21 ' A' ' 64' ' ' LEU . 86.9 t -63.02 -45.15 99.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 63.22 111.103 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.422 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -59.8 -27.95 67.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 65.43 110.94 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.537 ' HB3' HD11 ' A' ' 19' ' ' LEU . 2.3 t0 -71.79 -33.78 68.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.193 -0.458 . . . . 54.44 110.835 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.657 HD12 ' HB3' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -80.67 -48.28 12.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 75.51 110.907 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.503 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.64 -55.79 26.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 74.53 110.86 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.51 -22.5 44.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 74.04 110.94 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.488 ' CZ ' HG21 ' A' ' 18' ' ' THR . 45.8 t80 -77.75 -55.06 5.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 73.33 110.891 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.831 HD13 HG21 ' A' ' 7' ' ' VAL . 2.5 pp -67.76 -42.93 81.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 74.13 110.945 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.582 ' N ' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -54.62 -27.53 40.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 63.42 110.923 179.797 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.46 -23.6 42.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.465 . . . . 75.53 111.15 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.2 mt -76.58 -59.15 2.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 74.32 110.958 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.5 t -134.95 -28.09 1.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.444 . . . . 64.21 111.132 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.573 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.79 -176.52 5.21 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.727 -0.749 . . . . 63.25 112.499 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.864 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.3 p -113.39 138.28 43.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.834 0.349 . . . . 74.31 111.145 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.97 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -53.61 149.94 14.39 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.633 0.73 . . . . 74.41 110.911 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.401 ' O ' ' O ' ' A' ' 43' ' ' GLN . 53.5 Cg_endo -69.78 -21.72 33.01 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.647 2.231 . . . . 64.02 112.373 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -54.06 -38.33 65.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 63.54 110.882 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.42 ' H ' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -104.76 -40.05 6.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 73.02 110.838 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.864 ' HG2' HG13 ' A' ' 38' ' ' VAL . 2.2 pp0? -96.72 158.05 15.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 65.35 110.876 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.65 140.78 51.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 73.33 110.896 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.652 HD22 HE22 ' A' ' 43' ' ' GLN . 3.7 mm? -66.72 135.85 54.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.434 . . . . 71.15 110.906 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.738 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.0 mm? -75.15 -70.25 0.43 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 61.21 110.911 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -99.73 61.22 0.73 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.708 -0.758 . . . . 62.33 112.455 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.587 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 4.5 pp -57.7 -19.63 28.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.879 0.371 . . . . 54.24 110.929 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.34 144.47 39.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 74.14 110.865 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.979 HG21 HD21 ' A' ' 66' ' ' LEU . 9.7 p -143.83 145.57 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 62.15 111.134 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.9 mttm 54.89 32.24 17.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 62.42 110.892 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.04 -11.16 50.04 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.749 -0.738 . . . . 72.44 112.445 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.0 mmtt -81.3 151.31 69.19 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.581 0.705 . . . . 75.25 110.878 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 55' ' ' ALA . 53.8 Cg_endo -69.81 -32.92 17.43 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.665 2.244 . . . . 71.44 112.313 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.588 ' HA ' HG21 ' A' ' 59' ' ' VAL . . . 36.6 43.51 0.27 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 73.14 111.059 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.47 -76.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.203 -0.453 . . . . 72.04 110.919 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -159.47 -37.28 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 43.24 110.913 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.27 -7.8 27.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 73.02 110.9 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.588 HG21 ' HA ' ' A' ' 55' ' ' ALA . 17.6 t -80.52 145.72 8.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 70.23 111.096 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -90.23 151.46 21.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 72.31 110.913 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.545 HD12 ' C ' ' A' ' 20' ' ' SER . 18.6 mt -49.92 -47.62 52.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 74.21 110.924 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.57 -11.95 84.98 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.739 -0.744 . . . . 42.25 112.498 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.04 -32.06 44.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.822 0.344 . . . . 62.14 111.104 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.601 HD21 HG21 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -77.83 -23.48 48.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 72.31 110.912 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt 63.39 37.2 10.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 72.25 110.916 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.979 HD21 HG21 ' A' ' 50' ' ' VAL . 6.1 mt -88.79 152.56 21.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 63.41 110.939 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -68.64 160.24 77.85 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.572 0.701 . . . . 71.42 110.878 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -35.54 12.58 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.68 2.254 . . . . 74.12 112.385 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.697 ' HA ' HD12 ' A' ' 6' ' ' ILE . 8.2 p30 -78.5 -15.78 58.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 71.52 110.908 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.445 ' C ' ' O ' ' A' ' 69' ' ' ASN . 50.1 m -32.83 119.47 0.32 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 61.5 111.14 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -91.05 146.77 23.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 71.55 110.903 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.3 mm -115.36 129.78 71.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.436 . . . . 74.12 111.106 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 41.3 mtm -101.45 141.65 34.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 74.01 110.875 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.1 mtt -130.78 130.1 43.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 64.44 110.879 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.738 ' CG ' HD21 ' A' ' 46' ' ' LEU . 2.3 mmt -122.21 127.04 49.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 72.4 110.858 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.88 -150.87 22.52 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.714 -0.755 . . . . 74.4 112.468 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.742 0.306 . . . . 73.53 111.114 -179.851 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.678 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.828 0.347 . . . . 54.4 111.131 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.411 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 2.7 mt -114.45 107.44 51.24 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.628 0.728 . . . . 75.4 110.9 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 53.8 Cg_endo -69.76 156.02 64.43 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.664 2.243 . . . . 61.4 112.364 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.94 HD12 HD22 ' A' ' 28' ' ' LEU . 19.9 mt -150.88 138.63 13.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 72.14 111.102 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.622 HD12 ' HA ' ' A' ' 69' ' ' ASN . 5.2 mt -95.13 140.72 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 71.51 111.094 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.766 HG21 HD13 ' A' ' 32' ' ' LEU . 8.8 p -126.9 123.24 62.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 70.11 111.142 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.21 118.53 37.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 64.4 110.902 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 17.4 t-105 -120.57 103.77 9.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 70.44 110.938 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.41 -83.26 0.88 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.723 -0.751 . . . . 70.11 112.481 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.06 20.18 0.86 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.678 -0.772 . . . . 71.34 112.448 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -128.84 175.69 8.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.715 0.293 . . . . 75.33 110.932 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -132.79 141.84 48.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 72.43 110.92 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -138.49 116.46 11.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 73.44 110.889 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.21 137.35 35.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 73.24 110.855 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.499 HG21 HD23 ' A' ' 32' ' ' LEU . 84.3 t -94.21 142.45 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 51.42 111.141 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.4 HG23 ' O ' ' A' ' 16' ' ' VAL . 6.4 p -155.26 90.83 1.29 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 74.43 111.198 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.671 HG21 ' CE1' ' A' ' 31' ' ' PHE . 1.8 t 177.11 -31.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 75.54 111.138 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.797 ' CB ' HD12 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -88.02 163.67 16.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.44 . . . . 74.22 110.932 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.24 173.96 11.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 73.34 110.862 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.419 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 36.6 mt-10 -63.13 -20.03 65.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.482 . . . . 73.5 110.879 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -69.42 -11.09 60.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 54.35 110.896 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.676 ' HB2' HD23 ' A' ' 19' ' ' LEU . 6.0 m-20 -97.76 -152.08 0.39 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 74.44 110.896 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -137.09 165.3 26.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 53.23 111.143 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.603 HG22 HD11 ' A' ' 64' ' ' LEU . 72.6 t -59.04 -43.87 90.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 74.32 111.091 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.42 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -63.56 -30.54 71.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 75.11 110.918 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.591 ' HB3' HD21 ' A' ' 19' ' ' LEU . 5.6 t70 -72.22 -33.85 67.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 54.53 110.864 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.94 HD22 HD12 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -78.8 -47.89 15.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 63.53 110.889 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.477 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -62.75 -54.22 42.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 74.13 110.892 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.49 -22.11 30.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 70.41 110.884 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.671 ' CE1' HG21 ' A' ' 18' ' ' THR . 61.0 t80 -77.57 -55.15 5.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 63.21 110.915 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.766 HD13 HG21 ' A' ' 7' ' ' VAL . 2.1 pp -68.45 -42.24 79.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.477 . . . . 62.35 110.872 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.574 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.65 -27.51 40.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 64.42 110.927 179.818 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.62 -23.76 42.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 63.54 111.106 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.8 mt -76.4 -59.9 2.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.42 . . . . 72.52 110.893 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.5 t -135.14 -27.8 1.21 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.203 -0.453 . . . . 73.15 111.111 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.574 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.8 -177.55 4.68 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.778 -0.725 . . . . 41.43 112.486 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.876 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.3 p -112.7 138.59 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.842 0.353 . . . . 64.41 111.137 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.952 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.78 150.93 16.67 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.632 0.73 . . . . 71.52 110.868 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 53.7 Cg_endo -69.83 -21.7 32.78 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.638 2.225 . . . . 55.33 112.355 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -54.09 -39.14 66.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 74.11 110.872 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.446 ' H ' HD23 ' A' ' 39' ' ' LEU . 23.2 mtt85 -104.04 -40.44 6.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 70.21 110.884 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.876 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.8 pp0? -97.23 157.21 16.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 72.25 110.914 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.83 143.31 50.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 74.12 110.902 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.413 HD22 ' N ' ' A' ' 45' ' ' LEU . 3.7 mm? -67.57 136.1 53.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 73.5 110.908 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.724 HD11 ' CG ' ' A' ' 75' ' ' MET . 6.3 mp -86.13 -53.0 5.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 52.51 110.904 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -104.68 53.37 0.68 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.718 -0.754 . . . . 63.55 112.474 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.58 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 4.5 pp -59.67 -17.91 37.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.855 0.359 . . . . 71.55 110.886 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.93 143.13 45.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 72.43 110.91 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.793 HG21 HD21 ' A' ' 66' ' ' LEU . 11.5 p -143.67 145.3 22.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 74.42 111.094 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.92 31.86 16.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 72.43 110.868 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.99 -10.99 56.54 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.756 -0.735 . . . . 61.44 112.494 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -81.62 150.99 67.67 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.61 0.719 . . . . 64.04 110.9 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 55' ' ' ALA . 54.3 Cg_endo -69.73 -32.74 18.1 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.709 2.273 . . . . 42.04 112.353 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.625 ' HA ' HG21 ' A' ' 59' ' ' VAL . . . 36.04 44.25 0.25 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 65.02 111.083 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.77 -80.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 64.24 110.918 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -154.65 -39.26 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 72.22 110.886 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.69 -10.39 19.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 74.44 110.864 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.625 HG21 ' HA ' ' A' ' 55' ' ' ALA . 16.6 t -79.28 146.1 8.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 74.51 111.141 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 14.6 mttt -93.02 152.16 19.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 74.12 110.892 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.539 ' CD1' HD13 ' A' ' 28' ' ' LEU . 24.3 mt -50.13 -46.56 53.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 74.02 110.939 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.22 -12.02 84.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.742 -0.742 . . . . 70.04 112.435 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.92 -33.1 34.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.883 0.373 . . . . 52.12 111.111 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.603 HD11 HG22 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -74.23 -24.6 59.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 73.42 110.917 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt 62.95 37.86 11.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 73.41 110.955 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.793 HD21 HG21 ' A' ' 50' ' ' VAL . 4.5 mt -90.76 154.11 19.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 65.44 110.905 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -68.35 160.26 76.62 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.574 0.702 . . . . 74.1 110.929 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 -35.51 12.71 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.68 2.253 . . . . 53.25 112.395 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.622 ' HA ' HD12 ' A' ' 6' ' ' ILE . 7.8 m-20 -78.83 -16.32 57.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 73.12 110.94 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.665 HG21 HD13 ' A' ' 66' ' ' LEU . 55.5 m -32.45 126.11 0.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 74.4 111.142 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.34 147.5 23.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 73.12 110.874 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.0 mm -117.54 128.64 74.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 75.34 111.168 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.406 ' HB3' HD13 ' A' ' 46' ' ' LEU . 6.5 mtt -99.02 141.87 31.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 74.34 110.863 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.7 mtt -137.03 116.96 13.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 71.53 110.883 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.724 ' CG ' HD11 ' A' ' 46' ' ' LEU . 4.2 mmm -107.14 126.13 51.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 74.41 110.893 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.83 -155.05 26.19 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.735 . . . . 75.1 112.475 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.3 t . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.764 0.316 . . . . 61.0 111.133 -179.864 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.697 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.875 0.369 . . . . 73.33 111.06 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.409 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 3.3 mt -110.9 108.11 57.74 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.644 0.735 . . . . 74.44 110.911 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 53.8 Cg_endo -69.81 155.72 65.07 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.666 2.244 . . . . 64.31 112.338 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.866 HD12 HD22 ' A' ' 28' ' ' LEU . 17.4 mt -150.95 138.68 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 73.13 111.12 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.552 HD12 ' HA ' ' A' ' 69' ' ' ASN . 6.1 mt -94.78 140.79 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 72.44 111.109 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.789 HG21 HD13 ' A' ' 32' ' ' LEU . 8.4 p -126.63 123.13 62.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.124 -0.489 . . . . 62.01 111.154 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -107.77 117.38 33.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 72.4 110.863 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 17.9 t-105 -119.84 102.07 8.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 70.12 110.902 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.09 -82.93 0.81 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.748 -0.739 . . . . 51.0 112.505 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.26 19.93 0.83 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.734 -0.745 . . . . 73.23 112.471 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -128.26 175.72 8.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.75 0.31 . . . . 73.34 110.938 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -132.99 141.7 48.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 72.42 110.875 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -138.28 118.38 13.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.16 -0.473 . . . . 63.43 110.938 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.4 p -82.62 135.38 35.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 75.32 110.898 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.526 HG21 ' CD2' ' A' ' 32' ' ' LEU . 62.3 t -94.36 130.58 43.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 64.35 111.13 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.5 p -144.37 90.55 2.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 73.31 111.123 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.764 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 2.8 t 177.68 -32.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 73.13 111.119 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.785 HD13 ' HA ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -87.86 164.12 16.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 61.11 110.898 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.42 174.82 10.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 74.52 110.877 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.404 ' HG2' HD12 ' A' ' 3' ' ' LEU . 37.8 mt-10 -64.8 -20.46 66.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 63.53 110.873 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -67.73 -20.98 65.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 72.32 110.852 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.663 ' HB2' HD23 ' A' ' 19' ' ' LEU . 1.5 m-20 -85.31 -150.36 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 73.24 110.84 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.97 162.68 33.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 75.33 111.121 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.011 HG22 HD11 ' A' ' 64' ' ' LEU . 22.0 t -55.5 -48.53 77.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.45 . . . . 74.23 111.12 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.403 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -61.29 -28.33 69.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 61.2 110.929 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.558 ' HB3' HD21 ' A' ' 19' ' ' LEU . 9.3 t70 -71.56 -36.24 70.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 74.12 110.901 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.866 HD22 HD12 ' A' ' 5' ' ' ILE . 0.9 OUTLIER -77.2 -47.72 19.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 72.0 110.894 -179.959 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.536 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -62.47 -55.11 30.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 73.02 110.875 179.83 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -56.62 -22.65 35.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 73.23 110.878 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.764 ' CZ ' HG21 ' A' ' 18' ' ' THR . 42.7 t80 -76.77 -55.08 5.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 73.43 110.874 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.789 HD13 HG21 ' A' ' 7' ' ' VAL . 1.8 pp -69.01 -41.86 77.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 73.35 110.875 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.569 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.2 tmtt? -54.85 -27.72 44.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 73.34 110.899 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.519 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.33 -23.41 43.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.461 . . . . 74.35 111.157 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.5 mt -76.98 -59.77 2.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 73.13 110.915 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.8 t -135.66 -27.64 1.15 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.458 . . . . 64.02 111.176 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.569 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.66 -177.77 4.64 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.704 -0.76 . . . . 73.34 112.506 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.884 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.3 p -112.31 138.88 39.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.88 0.371 . . . . 73.33 111.159 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.984 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.78 151.04 16.25 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.635 0.731 . . . . 75.33 110.913 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 53.3 Cg_endo -69.74 -21.79 33.09 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.713 2.275 . . . . 72.43 112.318 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -54.17 -39.11 66.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 63.43 110.911 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.425 ' H ' HD23 ' A' ' 39' ' ' LEU . 4.2 mpt_? -104.02 -40.21 6.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 73.52 110.855 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.884 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.7 pp0? -97.84 157.37 16.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 55.42 110.881 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.06 142.1 51.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 74.45 110.902 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 45' ' ' LEU . 3.7 mm? -67.45 135.95 53.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 64.21 110.916 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.733 HD11 ' CG ' ' A' ' 75' ' ' MET . 6.2 mp -85.37 -60.49 2.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 73.45 110.939 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.82 51.63 0.97 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.755 -0.736 . . . . 64.35 112.494 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.651 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 3.6 pp -55.2 -25.45 32.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.909 0.385 . . . . 75.22 110.929 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.414 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -107.34 141.76 38.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 41.3 110.88 179.832 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.977 HG21 HD11 ' A' ' 66' ' ' LEU . 23.8 t -143.95 144.97 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 61.13 111.113 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.554 ' HG2' HG12 ' A' ' 50' ' ' VAL . 0.4 OUTLIER 54.34 32.41 16.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 74.25 110.944 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.07 -14.45 49.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.716 -0.755 . . . . 64.22 112.467 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -81.55 148.74 63.04 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.6 0.714 . . . . 63.53 110.866 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.414 ' HA ' ' HB3' ' A' ' 49' ' ' LYS . 53.5 Cg_endo -69.82 -35.0 13.27 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.696 2.264 . . . . 52.22 112.341 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.651 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 37.39 41.49 0.26 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 75.03 111.132 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.73 -76.89 0.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 71.55 110.885 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -150.98 -39.44 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 63.33 110.892 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -71.96 -2.63 18.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 71.32 110.875 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.566 ' O ' HG23 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -95.78 147.44 5.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 62.03 111.155 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.473 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 30.8 mttt -93.93 149.05 21.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 74.55 110.888 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.666 ' CD1' HD13 ' A' ' 28' ' ' LEU . 17.4 mt -51.98 -39.74 59.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 74.03 110.956 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.13 -16.49 80.56 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.767 -0.73 . . . . 53.54 112.489 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.91 -19.75 31.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.814 0.34 . . . . 61.31 111.096 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.011 HD11 HG22 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -85.05 -18.89 32.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 73.1 110.899 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp 52.31 42.63 31.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 62.13 110.879 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.977 HD11 HG21 ' A' ' 50' ' ' VAL . 3.3 mt -91.12 153.64 19.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 75.41 110.921 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.47 159.13 82.74 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.6 0.714 . . . . 65.22 110.842 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -37.21 9.56 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.69 2.26 . . . . 75.11 112.339 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.552 ' HA ' HD12 ' A' ' 6' ' ' ILE . 11.7 p30 -79.42 -16.31 56.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 64.44 110.856 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.634 HG21 HD13 ' A' ' 66' ' ' LEU . 65.8 m -31.77 132.4 0.11 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 52.32 111.144 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.86 145.92 28.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 74.15 110.916 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.5 mm -115.63 128.75 72.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.245 -0.434 . . . . 62.03 111.117 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.2 mtt -99.35 141.45 32.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 71.24 110.918 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.9 mtt -136.65 116.71 13.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 75.43 110.878 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.733 ' CG ' HD11 ' A' ' 46' ' ' LEU . 3.9 mmm -106.38 127.13 53.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 73.11 110.88 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.98 -155.92 27.08 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.697 -0.764 . . . . 55.14 112.436 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.3 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.768 0.318 . . . . 71.53 111.195 -179.871 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.733 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.77 0.319 . . . . 74.32 111.143 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.447 HD23 ' HG3' ' A' ' 21' ' ' GLU . 1.7 mm? -105.66 109.82 63.58 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.608 0.718 . . . . 63.44 110.934 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 156.46 63.45 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.716 2.277 . . . . 50.52 112.356 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.551 ' HB ' HD21 ' A' ' 28' ' ' LEU . 29.1 mt -149.98 137.01 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 75.15 111.132 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.669 HD12 ' HA ' ' A' ' 69' ' ' ASN . 3.7 mt -95.33 140.58 16.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 73.31 111.134 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.807 HG21 HD13 ' A' ' 32' ' ' LEU . 7.6 p -127.42 123.5 61.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 72.34 111.142 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.35 121.44 45.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 73.45 110.9 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 17.3 t-105 -125.17 106.25 9.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 74.12 110.928 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.16 -81.29 0.86 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.744 -0.741 . . . . 71.34 112.464 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -155.12 19.83 0.56 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.745 -0.741 . . . . 75.41 112.487 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -129.3 175.23 8.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.793 0.33 . . . . 72.2 110.865 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -132.43 140.09 48.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 63.33 110.881 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.55 ' CG ' HG21 ' A' ' 36' ' ' THR . 50.0 m-85 -134.39 116.13 14.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 63.43 110.979 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.76 131.49 35.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.488 . . . . 74.11 110.858 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.539 HG21 HD23 ' A' ' 32' ' ' LEU . 90.4 t -92.79 141.43 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 64.44 111.143 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.3 p -150.58 92.62 1.87 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 75.22 111.142 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.685 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.8 OUTLIER 173.29 -28.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 73.02 111.137 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.733 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.8 mm? -86.36 150.81 24.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.248 -0.433 . . . . 65.52 110.93 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.67 167.55 19.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 51.23 110.83 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.447 ' HG3' HD23 ' A' ' 3' ' ' LEU . 40.3 mt-10 -59.41 -22.24 61.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 52.44 110.892 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.0 -11.52 60.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.144 -0.48 . . . . 72.02 110.852 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.415 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.5 m-20 -100.34 -150.37 0.38 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 75.44 110.837 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.418 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -132.94 170.09 15.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 64.04 111.15 -179.892 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.974 HG22 HD11 ' A' ' 64' ' ' LEU . 12.8 t -66.1 -43.75 92.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 62.04 111.114 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.4 -28.77 68.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 62.31 110.926 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.477 ' HB3' HD11 ' A' ' 19' ' ' LEU . 9.1 t0 -69.97 -35.62 74.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 61.1 110.869 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.664 HD12 ' HB3' ' A' ' 19' ' ' LEU . 1.2 tt -80.7 -47.94 13.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 74.31 110.903 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.735 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.28 -56.56 19.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 73.4 110.911 179.88 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.19 -22.77 53.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 71.4 110.933 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.685 ' CZ ' HG21 ' A' ' 18' ' ' THR . 49.0 t80 -76.79 -55.27 5.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 71.51 110.89 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.807 HD13 HG21 ' A' ' 7' ' ' VAL . 2.3 pp -67.73 -43.46 79.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 74.11 110.877 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.566 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.2 tmtt? -54.89 -27.14 40.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 70.0 110.898 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.502 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.52 -23.72 42.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.248 -0.433 . . . . 70.31 111.135 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.1 mt -76.59 -59.57 2.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 52.45 110.901 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.55 HG21 ' CG ' ' A' ' 14' ' ' TYR . 2.9 t -135.09 -28.07 1.2 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 74.42 111.139 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.566 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.03 -177.37 4.85 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.745 -0.741 . . . . 63.12 112.539 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.855 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.3 p -112.84 138.43 42.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.845 0.355 . . . . 72.4 111.155 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.925 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -53.73 149.72 15.59 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.639 0.733 . . . . 75.35 110.926 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.4 ' O ' ' O ' ' A' ' 43' ' ' GLN . 53.8 Cg_endo -69.78 -21.71 33.01 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.663 2.242 . . . . 72.35 112.335 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -54.19 -38.3 65.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 62.52 110.925 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.418 ' H ' HD23 ' A' ' 39' ' ' LEU . 1.3 mpt_? -104.72 -40.04 6.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 73.42 110.856 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.855 ' HG2' HG13 ' A' ' 38' ' ' VAL . 2.3 pp0? -96.94 158.66 15.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 72.54 110.955 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.37 139.57 52.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 63.34 110.916 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.682 HD22 HE22 ' A' ' 43' ' ' GLN . 3.8 mm? -66.15 136.08 55.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 72.22 110.92 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.761 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.1 mm? -75.83 -74.96 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 60.14 110.915 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -97.52 60.06 1.07 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.731 -0.747 . . . . 43.22 112.464 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.646 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 3.8 pp -54.93 -24.2 22.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.853 0.358 . . . . 74.35 110.944 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.421 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -104.32 143.33 33.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.202 -0.453 . . . . 71.34 110.879 179.813 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.76 HG21 HD21 ' A' ' 66' ' ' LEU . 14.9 p -144.13 143.2 23.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 60.51 111.131 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.642 ' HG2' HG22 ' A' ' 50' ' ' VAL . 10.0 mmpt? 54.2 34.06 19.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 60.21 110.912 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.4 -15.18 41.76 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.758 -0.735 . . . . 74.23 112.487 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -81.5 149.28 64.53 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.628 0.727 . . . . 74.53 110.848 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.421 ' HA ' ' HB3' ' A' ' 49' ' ' LYS . 54.0 Cg_endo -69.72 -35.47 12.71 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.698 2.265 . . . . 74.12 112.384 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 38.74 39.61 0.35 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 42.14 111.117 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.49 -75.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.278 -0.419 . . . . 74.54 110.873 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -154.68 -38.63 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 75.43 110.884 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -73.09 -1.98 19.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 73.31 110.819 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.58 ' O ' HG23 ' A' ' 25' ' ' VAL . 0.8 OUTLIER -92.71 148.27 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 75.24 111.124 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.431 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 16.6 mttt -91.18 147.28 23.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 70.35 110.924 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.43 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 18.7 mt -52.29 -39.31 60.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.433 . . . . 74.52 110.902 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.66 -16.91 80.34 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.735 -0.745 . . . . 71.34 112.511 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.49 -19.31 33.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.853 0.359 . . . . 73.35 111.093 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.974 HD11 HG22 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -83.79 -19.96 34.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 74.14 110.943 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp 52.87 43.49 31.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 62.42 110.935 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.76 HD21 HG21 ' A' ' 50' ' ' VAL . 3.4 mt -96.19 152.91 18.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 71.32 110.935 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.54 159.81 79.58 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.626 0.727 . . . . 72.53 110.894 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -36.15 11.22 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.645 2.23 . . . . 74.3 112.322 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.669 ' HA ' HD12 ' A' ' 6' ' ' ILE . 82.4 m-20 -78.57 -15.72 58.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 55.53 110.868 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.628 HG21 HD13 ' A' ' 66' ' ' LEU . 52.8 m -32.58 124.78 0.33 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 74.3 111.128 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.26 146.27 24.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 60.33 110.883 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.3 mm -115.16 129.88 70.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 64.45 111.165 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 6.8 mtp -101.85 141.93 33.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 72.44 110.895 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 78.3 mtm -132.48 125.67 31.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 71.32 110.895 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.761 ' CG ' HD21 ' A' ' 46' ' ' LEU . 0.4 OUTLIER -115.01 128.9 56.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 65.41 110.886 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 150.84 -151.72 23.67 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.768 -0.729 . . . . 72.11 112.528 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.801 0.334 . . . . 72.43 111.144 -179.884 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.812 0.339 . . . . 72.15 111.105 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 3' ' ' LEU . 0.2 OUTLIER -107.22 111.78 63.17 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.594 0.711 . . . . 54.42 110.925 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 156.28 63.7 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.642 2.228 . . . . 75.05 112.366 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.528 ' HB ' HD21 ' A' ' 28' ' ' LEU . 30.8 mt -149.87 134.83 10.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 72.21 111.133 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.61 HD12 ' HA ' ' A' ' 69' ' ' ASN . 4.6 mt -94.28 140.94 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 72.23 111.151 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.848 HG21 HD13 ' A' ' 32' ' ' LEU . 7.3 p -127.26 123.22 61.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 62.32 111.101 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.64 119.06 38.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 73.43 110.906 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.9 t-105 -123.67 105.64 9.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 73.23 110.87 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.82 -81.82 0.9 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.754 -0.736 . . . . 71.02 112.478 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.76 19.92 0.59 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.729 -0.748 . . . . 52.34 112.45 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -129.28 175.85 8.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.738 0.304 . . . . 75.44 110.947 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -132.48 140.83 48.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 74.0 110.916 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.53 ' CG ' HG21 ' A' ' 36' ' ' THR . 53.7 m-85 -135.79 117.0 14.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 75.3 110.903 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.0 p -83.07 130.89 35.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 50.45 110.839 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.581 HG21 HD23 ' A' ' 32' ' ' LEU . 96.4 t -92.86 135.3 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 74.11 111.12 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.6 p -144.39 92.47 2.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 72.4 111.161 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.654 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.8 OUTLIER 173.4 -28.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 72.51 111.161 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.67 ' HB3' HD12 ' A' ' 28' ' ' LEU . 1.6 mm? -85.94 151.12 24.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 74.04 110.874 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.53 163.47 28.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 52.21 110.85 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.459 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 72.2 mt-10 -55.71 -23.79 30.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.097 -0.501 . . . . 43.24 110.876 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -66.66 -14.01 61.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.467 . . . . 64.32 110.865 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.419 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.7 m-20 -98.44 -149.77 0.35 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 75.41 110.89 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.54 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -132.8 172.92 11.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 74.44 111.132 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.93 HG22 HD11 ' A' ' 64' ' ' LEU . 10.8 t -68.53 -43.61 83.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 74.31 111.153 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.45 -28.72 68.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 74.24 110.9 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.489 ' HB3' HD11 ' A' ' 19' ' ' LEU . 9.5 t0 -70.18 -35.82 74.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.189 -0.46 . . . . 73.51 110.838 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.67 HD12 ' HB3' ' A' ' 19' ' ' LEU . 1.1 tt -80.61 -47.06 14.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 73.54 110.909 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.754 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -62.09 -56.9 14.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 74.42 110.866 179.814 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -57.8 -22.49 47.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.276 -0.42 . . . . 73.33 110.925 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.654 ' CZ ' HG21 ' A' ' 18' ' ' THR . 62.5 t80 -77.35 -55.23 5.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 44.33 110.864 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.848 HD13 HG21 ' A' ' 7' ' ' VAL . 2.3 pp -67.78 -43.06 80.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 65.14 110.93 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.565 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -55.01 -27.04 41.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 55.12 110.906 179.829 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.489 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.77 -23.54 42.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 70.24 111.121 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.4 mt -76.97 -60.16 2.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.227 -0.442 . . . . 72.24 110.9 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.53 HG21 ' CG ' ' A' ' 14' ' ' TYR . 2.9 t -134.93 -27.76 1.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 53.24 111.153 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.83 -177.76 4.84 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.76 -0.734 . . . . 61.42 112.503 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.869 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.3 p -112.29 139.26 37.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.898 0.38 . . . . 72.02 111.129 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.969 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.61 150.56 17.35 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.599 0.714 . . . . 72.13 110.919 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 -21.92 32.95 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.676 2.251 . . . . 64.23 112.333 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -54.1 -39.04 66.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 71.53 110.928 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.434 ' H ' HD23 ' A' ' 39' ' ' LEU . 5.8 mpt_? -104.25 -40.18 6.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.142 -0.481 . . . . 61.53 110.881 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.869 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.8 pp0? -97.51 158.16 15.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 73.43 110.91 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.9 141.71 51.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.438 . . . . 75.23 110.907 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.98 134.8 52.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 74.12 110.89 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.735 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.0 mm? -75.93 -75.55 0.18 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 75.41 110.898 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.83 59.84 1.47 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.737 -0.744 . . . . 61.11 112.473 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.656 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 3.7 pp -55.56 -23.55 27.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.838 0.351 . . . . 70.25 110.914 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.422 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -105.57 142.23 35.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 65.23 110.929 179.808 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.943 HG21 HD11 ' A' ' 66' ' ' LEU . 21.8 t -143.74 144.27 23.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 71.04 111.097 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.651 ' HG2' HG12 ' A' ' 50' ' ' VAL . 16.0 mmtm 54.35 33.29 18.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 71.45 110.897 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.48 -14.78 44.43 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.733 -0.746 . . . . 74.13 112.495 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -81.56 149.26 64.24 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.6 0.714 . . . . 73.52 110.886 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.422 ' HA ' ' HB3' ' A' ' 49' ' ' LYS . 54.1 Cg_endo -69.7 -35.69 12.34 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.693 2.262 . . . . 73.32 112.386 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.656 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 38.5 40.26 0.37 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.453 . . . . 74.3 111.106 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.34 -75.38 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 74.44 110.881 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -156.38 -37.84 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 64.14 110.91 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -74.41 -1.05 19.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 74.03 110.828 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.573 ' O ' HG23 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -93.04 147.81 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 52.42 111.146 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.408 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 5.8 mttp -89.49 146.18 24.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 65.25 110.878 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 15.9 mt -52.37 -38.39 58.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 62.31 110.884 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.96 -17.2 80.18 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.736 -0.745 . . . . 65.42 112.483 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.22 -19.63 33.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.829 0.347 . . . . 74.31 111.102 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.93 HD11 HG22 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -84.54 -19.53 33.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 25.34 110.907 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp 54.21 42.08 31.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 73.13 110.893 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.943 HD11 HG21 ' A' ' 50' ' ' VAL . 3.9 mt -92.71 152.05 19.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 61.23 110.906 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -68.63 160.18 78.11 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.563 0.696 . . . . 61.32 110.914 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -37.58 8.99 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.663 2.242 . . . . 61.42 112.36 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.61 ' HA ' HD12 ' A' ' 6' ' ' ILE . 55.0 m-20 -78.84 -15.92 57.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 64.33 110.877 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.701 HG21 HD13 ' A' ' 66' ' ' LEU . 66.9 m -31.31 129.44 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.155 -0.475 . . . . 63.12 111.185 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.87 145.73 26.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 61.03 110.905 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.8 mm -115.61 128.71 72.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 74.52 111.135 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 28.5 mtm -101.33 141.6 33.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 73.02 110.894 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 73.1 mtm -136.2 116.91 13.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 62.32 110.893 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.735 ' CG ' HD21 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -105.92 127.53 53.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 75.12 110.886 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.65 -154.22 25.27 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.765 -0.731 . . . . 62.54 112.489 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.2 t . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.79 0.328 . . . . 64.31 111.136 -179.829 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.753 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.854 0.359 . . . . 44.53 111.083 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.502 HD12 ' HG2' ' A' ' 21' ' ' GLU . 1.0 OUTLIER -107.37 108.98 62.51 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.604 0.716 . . . . 74.44 110.936 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 156.33 63.42 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.716 2.277 . . . . 74.51 112.295 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.477 ' HB ' HD21 ' A' ' 28' ' ' LEU . 38.1 mt -150.4 136.42 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 70.31 111.131 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.703 HD12 ' HA ' ' A' ' 69' ' ' ASN . 3.5 mt -94.93 140.13 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 73.43 111.119 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.883 HG21 HD13 ' A' ' 32' ' ' LEU . 8.3 p -127.69 123.02 60.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 72.42 111.08 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.89 120.51 42.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 73.33 110.895 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 14.1 t-105 -122.74 102.67 8.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 73.15 110.919 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.0 -78.09 1.71 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.774 -0.727 . . . . 54.42 112.484 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -155.62 18.5 0.5 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.75 -0.738 . . . . 73.23 112.5 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -130.87 139.17 50.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.738 0.304 . . . . 74.53 110.922 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -102.62 142.11 34.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 73.13 110.896 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.605 ' CD1' HG21 ' A' ' 36' ' ' THR . 82.6 m-85 -136.24 122.14 20.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.494 . . . . 70.3 110.914 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 92.7 p -84.95 133.43 34.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 51.52 110.844 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.592 HG21 HD23 ' A' ' 32' ' ' LEU . 85.5 t -96.37 111.48 26.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 51.41 111.136 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.0 p -124.05 91.42 3.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 74.44 111.174 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.618 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 1.2 t 174.83 -29.69 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 71.03 111.177 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.753 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.9 mm? -83.16 149.76 26.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 60.42 110.947 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.524 ' C ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.43 168.22 17.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 71.2 110.852 -179.885 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.502 ' HG2' HD12 ' A' ' 3' ' ' LEU . 51.8 mt-10 -59.8 -22.16 61.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.477 . . . . 74.42 110.891 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -69.26 -11.34 60.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 70.04 110.868 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.442 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.5 m-20 -99.52 -149.54 0.36 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 54.33 110.896 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.485 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -138.07 167.46 21.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 64.45 111.131 -179.878 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.973 HG22 HD11 ' A' ' 64' ' ' LEU . 41.4 t -61.9 -45.69 98.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 73.41 111.129 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.48 -29.15 67.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 73.34 110.914 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.553 ' HB3' HD11 ' A' ' 19' ' ' LEU . 1.3 t0 -70.69 -34.31 71.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 70.52 110.841 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.695 HD23 HD23 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -80.74 -48.45 12.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 71.42 110.904 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.592 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.6 -56.79 16.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 73.13 110.894 179.827 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.05 -22.76 51.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 65.44 110.894 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.618 ' CZ ' HG21 ' A' ' 18' ' ' THR . 58.7 t80 -76.94 -55.16 5.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 75.25 110.922 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.883 HD13 HG21 ' A' ' 7' ' ' VAL . 2.5 pp -67.59 -42.81 81.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 74.11 110.926 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.571 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.2 tmtt? -54.96 -27.14 41.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 74.34 110.926 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.99 -23.67 41.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 60.05 111.132 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.8 mt -76.96 -60.03 2.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 61.21 110.908 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.605 HG21 ' CD1' ' A' ' 14' ' ' TYR . 5.1 t -135.45 -27.35 1.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 75.52 111.166 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.571 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.48 -178.75 4.96 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.724 -0.75 . . . . 54.24 112.489 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.85 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.4 p -113.25 137.96 44.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.885 0.374 . . . . 30.44 111.132 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.984 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -53.95 149.56 17.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.615 0.721 . . . . 53.24 110.919 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -21.59 33.24 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.65 2.234 . . . . 72.44 112.389 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -54.21 -38.35 65.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 71.1 110.883 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.408 ' H ' HD23 ' A' ' 39' ' ' LEU . 2.7 mpt_? -105.05 -39.94 6.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 64.45 110.907 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.85 ' HG2' HG13 ' A' ' 38' ' ' VAL . 2.4 pp0? -95.67 159.4 15.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 75.51 110.905 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.8 137.85 52.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 63.55 110.899 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.64 HD22 HE22 ' A' ' 43' ' ' GLN . 3.4 mm? -66.86 132.66 48.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 71.13 110.917 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.738 HD11 ' CG ' ' A' ' 75' ' ' MET . 5.8 mp -83.05 -44.48 15.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 73.11 110.908 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -107.73 39.26 2.96 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.751 -0.738 . . . . 44.35 112.478 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.516 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 0.5 OUTLIER -44.88 -35.02 2.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.905 0.383 . . . . 70.41 110.927 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.85 146.54 33.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 55.5 110.872 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.675 HG21 HD21 ' A' ' 66' ' ' LEU . 14.1 p -143.77 145.69 21.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 71.12 111.11 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.5 mttt 54.91 31.19 15.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.47 . . . . 74.42 110.866 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.64 -10.83 54.9 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.717 -0.754 . . . . 52.54 112.518 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -81.44 149.51 65.23 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.581 0.705 . . . . 72.14 110.881 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -31.69 19.96 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.632 2.221 . . . . 75.23 112.36 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.609 ' HA ' HG21 ' A' ' 59' ' ' VAL . . . 37.36 41.91 0.28 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 51.11 111.082 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.03 -77.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 64.53 110.885 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.417 HD22 ' N ' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -157.92 -36.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 74.43 110.902 -179.942 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.417 ' N ' HD22 ' A' ' 57' ' ' ASN . 0.2 OUTLIER -68.06 -6.77 24.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 73.24 110.885 179.917 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.609 HG21 ' HA ' ' A' ' 55' ' ' ALA . 17.6 t -82.14 146.35 7.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.468 . . . . 55.15 111.12 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.2 mttp -94.46 151.61 19.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 74.11 110.871 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.553 ' HA ' HD12 ' A' ' 64' ' ' LEU . 19.5 mt -50.84 -44.63 59.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 71.45 110.944 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.54 -12.25 84.52 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.753 -0.737 . . . . 62.04 112.504 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.77 -34.42 27.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 65.44 111.097 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.973 HD11 HG22 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -70.48 -25.22 63.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 72.44 110.91 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp 62.38 36.87 14.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 61.53 110.902 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.675 HD21 HG21 ' A' ' 50' ' ' VAL . 4.2 mt -92.04 152.83 19.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 75.13 110.894 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -68.49 160.99 73.58 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.607 0.717 . . . . 63.21 110.903 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 -35.47 12.69 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.701 2.267 . . . . 42.32 112.381 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.703 ' HA ' HD12 ' A' ' 6' ' ' ILE . 23.7 p30 -78.77 -15.73 58.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 64.11 110.909 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.643 HG21 HD13 ' A' ' 66' ' ' LEU . 52.4 m -32.53 121.4 0.33 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.174 -0.467 . . . . 74.24 111.124 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -92.85 145.81 24.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 62.22 110.875 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.6 mm -115.74 129.17 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.268 -0.424 . . . . 74.32 111.149 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.455 ' CB ' HD13 ' A' ' 46' ' ' LEU . 4.6 mtp -101.33 141.92 33.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 73.33 110.891 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 76.5 mtm -135.2 119.62 17.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.438 . . . . 75.31 110.873 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.738 ' CG ' HD11 ' A' ' 46' ' ' LEU . 1.4 mmt -110.74 123.71 50.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 53.32 110.895 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 163.01 -153.9 24.63 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.756 -0.735 . . . . 71.53 112.508 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.6 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-O 120.81 0.338 . . . . 62.21 111.133 -179.864 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.87 0.367 . . . . 44.23 111.062 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 3' ' ' LEU . 0.2 OUTLIER -107.29 111.72 63.09 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.67 0.748 . . . . 62.23 110.938 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.412 ' O ' HD12 ' A' ' 3' ' ' LEU . 53.9 Cg_endo -69.77 156.34 63.59 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.713 2.275 . . . . 62.42 112.342 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.543 ' HB ' HD21 ' A' ' 28' ' ' LEU . 23.8 mt -149.17 135.62 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 74.1 111.143 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.633 HD12 ' HA ' ' A' ' 69' ' ' ASN . 4.4 mt -94.78 141.0 15.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 64.02 111.15 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.833 HG21 HD13 ' A' ' 32' ' ' LEU . 7.9 p -127.3 123.12 61.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 64.13 111.122 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.65 121.36 44.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 73.32 110.908 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 13.1 t-105 -121.74 100.9 7.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 71.42 110.939 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.01 -83.53 0.91 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.736 -0.745 . . . . 75.01 112.517 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.94 20.43 1.12 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.742 . . . . 64.43 112.497 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -128.01 174.31 9.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.739 0.304 . . . . 72.22 110.926 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -133.06 140.12 47.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 72.35 110.917 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.521 ' CD2' HG21 ' A' ' 36' ' ' THR . 38.7 m-85 -135.83 115.97 13.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.494 . . . . 73.03 110.901 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.3 p -82.19 133.41 35.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 60.31 110.873 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.521 HG21 HD23 ' A' ' 32' ' ' LEU . 91.5 t -96.01 139.72 18.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 54.43 111.123 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.5 p -148.23 93.58 2.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 73.14 111.167 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.682 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.8 OUTLIER 173.04 -28.37 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 73.25 111.169 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.657 ' HB3' HD12 ' A' ' 28' ' ' LEU . 1.7 mm? -86.52 151.78 23.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 72.35 110.944 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.77 163.57 28.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 62.5 110.858 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.448 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 49.0 mt-10 -56.16 -23.34 34.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 72.52 110.872 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -67.84 -12.53 60.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 70.34 110.873 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.405 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.6 m-20 -99.12 -150.31 0.37 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 71.04 110.842 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -132.19 171.1 14.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 74.34 111.122 -179.881 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.946 HG22 HD11 ' A' ' 64' ' ' LEU . 11.6 t -67.3 -43.78 87.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 73.4 111.109 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.77 -28.36 68.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 73.52 110.901 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.494 ' HB3' HD11 ' A' ' 19' ' ' LEU . 17.3 t0 -70.18 -35.64 74.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.475 . . . . 73.42 110.853 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.673 HD23 HD23 ' A' ' 32' ' ' LEU . 1.2 tt -80.76 -47.41 13.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 44.14 110.966 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.77 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.7 -56.6 17.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 42.13 110.91 179.81 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -58.09 -22.42 50.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 73.42 110.878 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.682 ' CZ ' HG21 ' A' ' 18' ' ' THR . 56.4 t80 -77.18 -55.2 5.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 74.44 110.867 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.833 HD13 HG21 ' A' ' 7' ' ' VAL . 2.4 pp -67.93 -43.01 80.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.14 -0.482 . . . . 73.52 110.931 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.564 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.9 -27.2 41.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.45 . . . . 74.35 110.908 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.73 -23.61 42.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.247 -0.433 . . . . 54.45 111.107 179.968 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.0 mt -76.59 -59.76 2.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 70.4 110.94 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.521 HG21 ' CD2' ' A' ' 14' ' ' TYR . 3.3 t -135.14 -27.83 1.2 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 74.54 111.119 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.29 -176.7 4.77 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.718 -0.753 . . . . 42.5 112.505 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.88 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.1 p -112.43 139.73 35.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.835 0.35 . . . . 75.52 111.16 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.983 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.76 150.2 19.41 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.584 0.707 . . . . 74.52 110.922 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -21.98 32.63 Favored 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.696 2.264 . . . . 71.4 112.308 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -54.42 -39.08 66.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.273 -0.421 . . . . 74.44 110.932 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.413 ' H ' HD23 ' A' ' 39' ' ' LEU . 9.2 mtt85 -103.76 -40.73 6.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 73.42 110.906 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.88 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.6 pp0? -97.29 157.58 15.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 65.13 110.89 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.77 142.18 51.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 72.13 110.923 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.49 136.05 54.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 74.12 110.942 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.743 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.0 mm? -77.31 -75.03 0.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 72.42 110.929 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.15 59.23 1.68 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.774 -0.727 . . . . 70.25 112.522 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.645 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 3.8 pp -56.22 -23.06 33.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 73.21 110.906 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.417 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 2.0 pttt -105.95 142.33 35.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 72.5 110.911 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.871 HG11 HD21 ' A' ' 66' ' ' LEU . 20.8 t -143.94 144.33 23.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 73.13 111.119 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.596 ' HG3' HG12 ' A' ' 50' ' ' VAL . 18.4 mttt 54.27 33.06 17.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 75.21 110.912 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.79 -14.67 46.72 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.728 -0.748 . . . . 72.5 112.504 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -81.56 148.97 63.62 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.597 0.713 . . . . 71.21 110.853 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.417 ' HA ' ' HB3' ' A' ' 49' ' ' LYS . 53.2 Cg_endo -69.82 -35.49 12.37 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.657 2.238 . . . . 64.34 112.323 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.645 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 38.03 40.69 0.32 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 61.2 111.088 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.02 -76.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 72.31 110.882 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -155.25 -38.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 61.31 110.877 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -73.55 -1.12 17.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 73.13 110.892 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.572 ' O ' HG23 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -93.45 148.37 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 70.03 111.159 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.414 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 5.6 mttt -90.32 146.7 24.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 60.34 110.874 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.448 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 16.4 mt -52.27 -38.88 59.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.447 . . . . 75.42 110.883 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.89 -17.02 80.28 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.76 -0.733 . . . . 33.21 112.508 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.15 -19.46 34.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.812 0.339 . . . . 64.31 111.128 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.946 HD11 HG22 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -84.83 -19.9 31.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 74.12 110.906 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.9 mmtp 55.13 41.47 31.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 65.21 110.923 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.871 HD21 HG11 ' A' ' 50' ' ' VAL . 3.8 mt -92.38 151.2 20.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 72.23 110.918 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -68.43 160.79 74.28 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.619 0.723 . . . . 65.24 110.944 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -37.09 9.67 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.738 2.292 . . . . 72.12 112.33 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.633 ' HA ' HD12 ' A' ' 6' ' ' ILE . 10.5 p-10 -78.81 -15.82 57.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 70.12 110.891 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.749 HG21 HD22 ' A' ' 66' ' ' LEU . 53.1 m -31.25 128.96 0.15 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 62.4 111.183 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.49 146.4 25.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.229 -0.441 . . . . 63.22 110.868 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.7 mm -115.38 127.93 72.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 73.2 111.131 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.0 mtp -100.15 141.72 32.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 65.31 110.841 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.8 mtt -134.58 127.5 31.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 73.53 110.871 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.743 ' CG ' HD21 ' A' ' 46' ' ' LEU . 0.3 OUTLIER -116.97 126.35 52.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 72.13 110.913 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.9 -154.53 25.6 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.75 -0.738 . . . . 63.22 112.51 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.33 -0.264 0 CA-C-O 120.763 0.316 . . . . 75.1 111.101 -179.84 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.691 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.877 0.37 . . . . 72.03 111.076 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.416 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 1.7 mt -113.53 107.08 53.61 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.579 0.704 . . . . 62.15 110.917 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 53.7 Cg_endo -69.78 155.68 65.24 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.665 2.243 . . . . 55.35 112.338 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.962 HD12 HD22 ' A' ' 28' ' ' LEU . 20.7 mt -151.0 138.77 13.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 75.15 111.105 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.615 HD12 ' HA ' ' A' ' 69' ' ' ASN . 4.7 mt -95.02 140.47 16.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 74.41 111.119 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.829 HG21 HD13 ' A' ' 32' ' ' LEU . 7.5 p -126.53 123.0 62.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 70.01 111.139 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.45 118.07 35.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 63.11 110.9 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.9 t-105 -122.87 106.67 11.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 73.32 110.889 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.72 -81.06 0.9 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.744 -0.741 . . . . 74.41 112.469 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -155.98 19.87 0.49 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.72 -0.752 . . . . 54.25 112.466 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -129.34 176.07 8.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.796 0.332 . . . . 52.41 110.902 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -132.51 140.83 48.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 70.01 110.901 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -136.18 119.44 16.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 73.32 110.915 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.6 p -82.89 134.22 35.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.089 -0.505 . . . . 64.32 110.857 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.535 HG21 HD23 ' A' ' 32' ' ' LEU . 87.2 t -93.46 132.81 36.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 64.53 111.152 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.4 p -147.28 92.08 2.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 71.54 111.162 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.679 HG21 ' CE1' ' A' ' 31' ' ' PHE . 1.8 t 176.99 -31.89 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 73.55 111.133 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.788 ' CB ' HD12 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -87.93 164.32 15.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 75.22 110.931 179.948 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.449 ' O ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -136.26 175.17 9.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.448 . . . . 52.0 110.848 -179.895 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.424 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 35.0 mt-10 -64.52 -20.01 65.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 54.32 110.896 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.94 -11.32 60.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.127 -0.488 . . . . 32.03 110.839 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.687 ' HB2' HD23 ' A' ' 19' ' ' LEU . 1.6 m-20 -95.99 -152.62 0.38 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 74.42 110.848 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -136.91 165.6 25.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 61.21 111.156 -179.882 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.978 HG22 HD11 ' A' ' 64' ' ' LEU . 37.9 t -58.69 -44.41 89.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 73.1 111.157 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.407 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -63.88 -30.13 71.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 61.4 110.875 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.577 ' HB3' HD21 ' A' ' 19' ' ' LEU . 3.3 t70 -71.37 -34.97 70.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 60.43 110.875 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.962 HD22 HD12 ' A' ' 5' ' ' ILE . 0.6 OUTLIER -78.72 -48.03 15.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 63.42 110.902 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.557 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -62.15 -54.73 36.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 72.43 110.902 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -56.36 -22.51 31.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 75.51 110.929 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.679 ' CE1' HG21 ' A' ' 18' ' ' THR . 56.3 t80 -77.31 -55.45 5.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 72.13 110.849 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.829 HD13 HG21 ' A' ' 7' ' ' VAL . 2.0 pp -67.68 -43.5 80.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 73.11 110.912 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.569 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.49 -27.17 35.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 74.31 110.882 179.849 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.69 -23.85 42.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 63.15 111.152 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.4 mt -76.36 -59.71 2.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.198 -0.456 . . . . 74.1 110.909 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.5 t -135.21 -28.03 1.18 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.461 . . . . 61.24 111.136 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.569 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.67 -177.51 4.51 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.757 -0.735 . . . . 55.32 112.503 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.882 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.3 p -112.83 138.71 41.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.883 0.373 . . . . 65.05 111.11 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.987 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.86 150.63 18.18 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.633 0.73 . . . . 55.22 110.852 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -21.76 32.83 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.671 2.247 . . . . 63.24 112.35 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -54.13 -38.93 66.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 74.45 110.902 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.422 ' H ' HD23 ' A' ' 39' ' ' LEU . 6.6 mpt_? -104.29 -40.4 6.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.505 . . . . 70.32 110.836 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.882 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.9 pp0? -97.21 158.09 15.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 64.1 110.876 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.09 141.97 51.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 75.0 110.854 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.406 HD22 ' N ' ' A' ' 45' ' ' LEU . 3.7 mm? -67.05 134.01 51.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 65.41 110.894 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.745 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.1 mm? -74.88 -68.03 0.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 64.13 110.926 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.39 60.03 0.69 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.707 -0.758 . . . . 24.1 112.465 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.598 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 4.6 pp -56.93 -19.81 19.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.86 0.362 . . . . 73.54 110.936 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.65 144.08 41.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 73.42 110.913 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.79 HG21 HD21 ' A' ' 66' ' ' LEU . 11.0 p -143.79 146.1 21.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 73.54 111.146 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.3 mttt 54.78 31.55 15.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 75.52 110.875 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.56 -10.87 54.33 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.71 -0.757 . . . . 34.22 112.502 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.2 mmtm -81.36 150.82 68.21 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.593 0.711 . . . . 72.13 110.869 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 55' ' ' ALA . 53.1 Cg_endo -69.81 -31.98 19.24 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.658 2.239 . . . . 73.45 112.359 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.638 ' HA ' HG21 ' A' ' 59' ' ' VAL . . . 35.93 44.63 0.25 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 44.12 111.072 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.32 -76.69 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 70.24 110.92 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -158.61 -37.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 73.33 110.887 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.85 -8.66 30.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 60.2 110.828 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.638 HG21 ' HA ' ' A' ' 55' ' ' ALA . 19.4 t -79.31 147.49 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 73.33 111.149 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.42 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 10.8 mttt -94.78 150.33 20.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 71.32 110.895 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.623 ' HA ' HD12 ' A' ' 64' ' ' LEU . 25.3 mt -51.42 -42.05 61.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 75.24 110.938 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.12 -13.34 83.33 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.768 -0.729 . . . . 71.43 112.443 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.04 -34.31 22.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.779 0.323 . . . . 54.22 111.066 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.978 HD11 HG22 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -67.84 -24.35 65.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 61.43 110.922 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp 59.88 33.08 21.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 72.44 110.859 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.79 HD21 HG21 ' A' ' 50' ' ' VAL . 5.0 mt -87.72 153.87 21.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.283 -0.417 . . . . 72.5 110.91 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.46 160.41 76.32 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.552 0.692 . . . . 73.24 110.906 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -35.3 12.81 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.641 2.227 . . . . 53.34 112.37 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.615 ' HA ' HD12 ' A' ' 6' ' ' ILE . 7.6 p30 -79.15 -16.38 56.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.431 . . . . 73.02 110.886 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.527 HG21 HD13 ' A' ' 66' ' ' LEU . 54.9 m -32.08 128.16 0.22 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 63.21 111.163 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.93 147.95 23.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 64.42 110.908 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.6 mm -118.83 127.32 75.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 63.44 111.153 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 62.9 mtp -100.41 141.79 32.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 61.02 110.837 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 73.7 mtm -134.71 117.51 16.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 71.13 110.87 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.745 ' CG ' HD21 ' A' ' 46' ' ' LEU . 2.2 mmt -105.52 124.56 49.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 72.4 110.866 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.57 -154.69 25.74 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.726 -0.749 . . . . 62.11 112.456 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.5 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.332 . . . . 71.44 111.155 -179.837 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mtt . . . . . 0 C--O 1.23 0.042 0 CA-C-O 120.793 0.33 . . . . 71.33 110.865 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.737 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . -79.83 151.43 30.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 73.35 111.135 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.5 mt -110.87 109.43 57.5 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.618 0.723 . . . . 73.14 110.907 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 156.48 63.23 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.693 2.262 . . . . 43.22 112.357 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 28' ' ' LEU . 42.9 mt -150.51 137.45 13.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 73.51 111.155 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.718 HD12 ' HA ' ' A' ' 69' ' ' ASN . 4.1 mt -94.91 140.52 16.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 63.44 111.152 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.83 HG21 HD13 ' A' ' 32' ' ' LEU . 8.3 p -126.9 123.14 62.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 61.52 111.089 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.12 119.78 40.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 65.52 110.881 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 16.8 t-105 -121.09 100.92 7.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.258 -0.428 . . . . 75.22 110.912 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.89 -83.53 0.85 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.778 -0.725 . . . . 34.02 112.515 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.68 20.45 1.02 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.693 -0.765 . . . . 70.1 112.459 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -128.43 174.83 9.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.756 0.312 . . . . 72.55 110.896 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -133.07 140.19 47.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 64.24 110.865 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -135.84 118.59 16.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 75.42 110.886 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.6 p -82.36 133.93 35.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 75.01 110.84 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.54 HG21 HD23 ' A' ' 32' ' ' LEU . 69.6 t -96.21 131.33 43.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.49 . . . . 72.44 111.137 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.2 p -141.31 93.54 2.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 52.03 111.11 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.602 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.7 OUTLIER 173.47 -28.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.462 . . . . 61.43 111.128 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.737 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.9 mm? -85.6 150.52 24.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 74.03 110.871 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.549 ' C ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.89 168.09 18.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 55.13 110.867 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.41 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 44.9 mt-10 -59.04 -21.98 59.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 63.42 110.898 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -68.59 -10.9 58.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 63.31 110.885 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.458 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.5 m-20 -102.61 -150.47 0.41 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 63.14 110.869 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.504 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -135.65 168.03 20.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 64.1 111.148 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.621 HG22 HD11 ' A' ' 64' ' ' LEU . 94.2 t -63.39 -43.15 98.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 73.32 111.124 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.407 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -61.06 -29.08 69.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.166 -0.47 . . . . 64.32 110.938 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.561 ' HB3' HD11 ' A' ' 19' ' ' LEU . 2.0 t0 -71.51 -32.67 68.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 74.42 110.845 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.642 HD23 HD23 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -80.65 -48.82 12.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 72.31 110.924 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.514 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -62.09 -56.09 22.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 71.24 110.89 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -57.6 -22.4 44.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 71.22 110.89 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.602 ' CZ ' HG21 ' A' ' 18' ' ' THR . 40.3 t80 -77.98 -54.89 5.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 73.43 110.82 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.83 HD13 HG21 ' A' ' 7' ' ' VAL . 2.5 pp -68.05 -42.13 80.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.148 -0.478 . . . . 60.0 110.92 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.568 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.76 -27.65 42.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 75.34 110.866 179.869 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.499 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.52 -23.62 42.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 75.15 111.155 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.432 HD11 ' CE1' ' A' ' 31' ' ' PHE . 13.8 mt -76.63 -59.7 2.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 73.43 110.914 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.7 t -135.41 -27.66 1.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 72.11 111.181 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.568 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.95 -177.46 4.8 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 55.3 112.479 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.878 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.3 p -112.72 138.24 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.856 0.36 . . . . 73.24 111.106 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.979 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.76 150.94 16.49 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.632 0.729 . . . . 74.43 110.875 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -21.59 33.39 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.715 2.277 . . . . 72.14 112.32 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -54.35 -38.79 66.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.429 . . . . 75.13 110.855 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.441 ' H ' HD23 ' A' ' 39' ' ' LEU . 2.6 mpt_? -104.15 -40.58 6.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 71.33 110.889 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.878 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.9 pp0? -97.28 157.47 15.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 73.42 110.932 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.08 142.94 51.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.435 . . . . 74.31 110.955 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.408 HD22 ' N ' ' A' ' 45' ' ' LEU . 3.7 mm? -67.7 135.9 53.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.246 -0.434 . . . . 61.45 110.885 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.748 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.0 mm? -78.0 -68.29 0.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 60.24 110.972 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.4 61.06 0.66 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.705 -0.76 . . . . 62.54 112.497 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.58 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 4.5 pp -58.96 -18.2 31.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.899 0.381 . . . . 72.43 110.907 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -112.39 144.16 42.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 64.25 110.926 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.876 HG21 HD11 ' A' ' 66' ' ' LEU . 43.0 t -143.85 145.31 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 75.15 111.119 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.0 mttt 54.87 32.51 17.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 75.33 110.858 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.25 -11.3 50.59 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.744 -0.741 . . . . 61.51 112.509 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -81.7 150.88 67.13 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.602 0.715 . . . . 71.51 110.856 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 -32.91 17.85 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.706 2.271 . . . . 54.51 112.351 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 36.78 43.48 0.28 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 74.34 111.074 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.54 -76.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.438 . . . . 65.52 110.896 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -159.36 -37.5 0.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 72.21 110.884 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -66.8 -8.68 30.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 73.4 110.862 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.575 HG21 ' HA ' ' A' ' 55' ' ' ALA . 16.9 t -79.79 145.69 8.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 73.21 111.135 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 18.9 mttp -90.27 151.44 21.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 75.04 110.858 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.549 HD12 ' C ' ' A' ' 20' ' ' SER . 19.3 mt -49.96 -47.44 52.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 75.35 110.982 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.63 -11.69 85.22 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.732 -0.747 . . . . 63.4 112.473 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.39 -32.16 42.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.783 0.325 . . . . 61.33 111.097 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.621 HD11 HG22 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -77.82 -23.55 48.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 65.2 110.943 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt 63.12 38.03 11.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 62.45 110.876 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.876 HD11 HG21 ' A' ' 50' ' ' VAL . 4.2 mt -89.66 152.62 21.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 75.42 110.899 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -68.67 160.57 76.41 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.603 0.716 . . . . 65.03 110.899 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -35.0 13.26 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.718 2.278 . . . . 74.13 112.335 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.718 ' HA ' HD12 ' A' ' 6' ' ' ILE . 10.5 p30 -78.8 -15.83 57.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 72.33 110.864 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.663 HG21 HD13 ' A' ' 66' ' ' LEU . 51.3 m -32.92 121.52 0.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 72.32 111.132 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -92.85 146.49 23.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 61.23 110.913 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.8 mm -116.4 127.46 74.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 74.23 111.087 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 23.2 mtp -99.46 141.68 31.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 63.54 110.89 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.6 mtt -134.74 118.99 17.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 72.32 110.937 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.748 ' CG ' HD21 ' A' ' 46' ' ' LEU . 4.1 mmm -107.88 123.82 49.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 74.23 110.906 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.79 -155.16 26.32 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.751 -0.738 . . . . 73.54 112.526 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.2 t -134.19 146.38 50.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.783 0.325 . . . . 73.0 111.164 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -63.22 159.97 16.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 74.32 110.846 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.01 157.56 1.26 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 72.24 110.876 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -89.93 71.05 7.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 74.15 110.919 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -165.9 -118.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 63.15 110.875 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.494 0 O-C-N 124.48 1.112 . . . . 22.43 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.778 0.323 . . . . 75.22 110.887 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.743 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . -80.6 151.58 28.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 70.14 111.119 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.404 HD23 ' HD2' ' A' ' 4' ' ' PRO . 2.4 mt -112.04 109.66 54.57 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.593 0.711 . . . . 63.52 110.89 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.404 ' HD2' HD23 ' A' ' 3' ' ' LEU . 54.1 Cg_endo -69.75 156.6 62.94 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.717 2.278 . . . . 74.03 112.345 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.547 ' HB ' HD21 ' A' ' 28' ' ' LEU . 28.0 mt -150.45 137.52 13.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 71.13 111.114 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.653 HD12 ' HA ' ' A' ' 69' ' ' ASN . 4.7 mt -95.14 140.81 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 60.35 111.162 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.823 HG21 HD13 ' A' ' 32' ' ' LEU . 8.3 p -126.92 123.44 62.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 72.03 111.12 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.78 120.9 43.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 71.34 110.931 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 12.9 t-105 -122.04 100.96 7.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.436 . . . . 73.12 110.884 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.79 -83.76 0.78 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.739 -0.744 . . . . 75.15 112.498 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.46 20.17 1.04 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.742 -0.742 . . . . 65.2 112.488 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -128.56 174.24 9.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.784 0.325 . . . . 63.2 110.875 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -132.81 140.5 48.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 75.34 110.902 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -136.67 116.14 12.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 74.2 110.96 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.9 p -81.62 135.03 35.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 65.34 110.854 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.518 HG21 HD23 ' A' ' 32' ' ' LEU . 97.4 t -96.26 140.28 17.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.115 -0.493 . . . . 73.44 111.077 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.5 p -148.66 93.37 2.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 63.44 111.137 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.749 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 1.0 OUTLIER 173.68 -28.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.22 -0.445 . . . . 74.15 111.137 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.743 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.7 mm? -86.61 151.92 23.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 75.22 110.908 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.416 ' O ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.6 169.47 16.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 61.22 110.882 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.413 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 36.3 mt-10 -61.78 -22.09 65.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 63.05 110.854 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -69.87 -10.76 59.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 74.01 110.852 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.417 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.6 m-20 -100.08 -150.84 0.39 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.452 . . . . 64.12 110.887 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.41 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -132.61 170.58 14.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 63.11 111.176 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.938 HG22 HD11 ' A' ' 64' ' ' LEU . 11.7 t -66.58 -43.79 90.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 72.31 111.135 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.44 -28.66 68.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 72.23 110.925 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.478 ' HB3' HD11 ' A' ' 19' ' ' LEU . 17.0 t0 -70.07 -35.16 74.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.476 . . . . 64.2 110.844 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.665 HD12 ' CB ' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -80.72 -47.82 13.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 63.53 110.911 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.717 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.78 -56.71 16.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 73.2 110.892 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.0 -22.41 49.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 73.22 110.924 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.749 ' CZ ' HG21 ' A' ' 18' ' ' THR . 40.0 t80 -77.16 -55.23 5.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 70.33 110.835 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.823 HD13 HG21 ' A' ' 7' ' ' VAL . 2.4 pp -67.92 -43.14 79.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 72.0 110.942 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.567 ' N ' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -55.02 -27.34 43.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 72.23 110.876 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.493 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.3 -23.78 43.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 65.23 111.159 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.424 HD11 ' CE1' ' A' ' 31' ' ' PHE . 12.5 mt -76.46 -59.8 2.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 54.54 110.931 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.1 t -135.25 -27.63 1.2 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 65.54 111.135 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.562 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.23 -176.63 4.66 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.699 -0.762 . . . . 54.3 112.513 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.857 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.1 p -112.29 139.73 35.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.835 0.35 . . . . 62.31 111.168 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.973 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.8 149.98 20.55 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.602 0.715 . . . . 74.42 110.927 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -22.02 32.78 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.717 2.278 . . . . 64.22 112.334 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -54.61 -39.06 67.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.443 . . . . 74.12 110.899 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.431 ' H ' HD23 ' A' ' 39' ' ' LEU . 4.0 mpt_? -103.7 -40.46 6.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 75.1 110.87 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.857 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.5 pp0? -97.57 157.2 16.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 74.25 110.921 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.17 141.32 51.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 74.32 110.908 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.02 135.96 54.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 74.53 110.973 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.74 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.0 mm? -76.54 -75.22 0.2 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 75.45 110.916 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.74 60.03 1.48 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.726 -0.75 . . . . 55.31 112.518 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.649 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 3.8 pp -56.8 -22.56 37.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.9 0.381 . . . . 74.22 110.949 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.428 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -106.29 142.43 35.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 71.13 110.932 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.898 HG11 HD21 ' A' ' 66' ' ' LEU . 21.0 t -144.04 144.37 22.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 71.24 111.07 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.449 ' HG2' HG12 ' A' ' 50' ' ' VAL . 2.1 mmmm 54.3 33.01 17.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 75.34 110.863 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.9 -15.05 45.28 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.718 -0.753 . . . . 71.23 112.462 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -81.08 148.78 64.91 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.538 0.685 . . . . 75.32 110.9 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.428 ' HA ' ' HB3' ' A' ' 49' ' ' LYS . 53.8 Cg_endo -69.71 -35.57 12.53 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.681 2.254 . . . . 64.03 112.366 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 38.14 40.67 0.34 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 61.34 111.136 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -67.81 -76.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 63.02 110.91 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -154.53 -38.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 71.15 110.889 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -73.14 -1.65 18.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 74.14 110.867 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -92.85 148.19 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 62.51 111.168 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.41 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 11.2 mttt -90.75 147.22 23.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 62.55 110.873 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 20' ' ' SER . 17.5 mt -52.47 -38.72 60.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 54.41 110.887 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.77 -17.0 80.29 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.771 -0.728 . . . . 62.3 112.451 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.53 -19.52 33.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.834 0.349 . . . . 72.33 111.128 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.938 HD11 HG22 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -84.44 -20.46 31.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 71.44 110.904 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp 53.89 42.01 31.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 74.32 110.935 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.898 HD21 HG11 ' A' ' 50' ' ' VAL . 3.6 mt -92.79 151.58 19.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.462 . . . . 52.33 110.939 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -68.4 160.01 78.06 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.564 0.697 . . . . 71.43 110.933 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -36.88 10.07 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.68 2.253 . . . . 73.31 112.311 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.653 ' HA ' HD12 ' A' ' 6' ' ' ILE . 26.4 m-80 -78.8 -15.79 57.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 75.45 110.897 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.75 HG21 HD22 ' A' ' 66' ' ' LEU . 52.0 m -32.43 128.03 0.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 60.4 111.13 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -97.66 146.51 25.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 73.02 110.837 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.0 mm -115.34 128.46 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 74.33 111.167 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 34.4 mtm -100.36 141.76 32.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 74.11 110.883 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.7 mtt -133.21 129.42 37.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 71.21 110.884 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.74 ' CG ' HD21 ' A' ' 46' ' ' LEU . 6.1 mmm -118.6 123.95 46.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.254 -0.43 . . . . 52.0 110.9 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 153.11 -155.23 26.01 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 60.05 112.459 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.0 t -133.32 139.86 47.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.794 0.331 . . . . 52.42 111.136 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.477 ' HA ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -93.55 147.46 22.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.444 . . . . 73.43 110.894 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -55.87 174.55 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 75.42 110.894 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -104.91 86.65 2.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 61.43 110.892 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.748 ' HG ' ' N ' ' A' ' 90' ' ' NH2 . 0.3 OUTLIER -172.55 179.64 2.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 73.42 110.887 -179.8 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' NH2 . . . . . 0.748 ' N ' ' HG ' ' A' ' 81' ' ' SER . . . . . . . . 0 C--N 1.325 -0.499 0 O-C-N 124.504 1.128 . . . . 64.14 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.804 0.335 . . . . 65.05 110.845 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.74 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . -88.57 151.34 22.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 62.42 111.119 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.407 HD23 ' HD2' ' A' ' 4' ' ' PRO . 2.1 mt -110.86 109.27 57.6 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.625 0.726 . . . . 64.41 110.916 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.407 ' HD2' HD23 ' A' ' 3' ' ' LEU . 53.5 Cg_endo -69.77 156.84 62.27 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.677 2.251 . . . . 72.2 112.308 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.44 ' HB ' HD21 ' A' ' 28' ' ' LEU . 42.9 mt -150.57 137.51 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 53.21 111.149 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.715 HD12 ' HA ' ' A' ' 69' ' ' ASN . 3.6 mt -95.03 140.38 16.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 73.44 111.112 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.83 HG21 HD13 ' A' ' 32' ' ' LEU . 8.7 p -127.15 122.91 61.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 73.22 111.133 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.77 122.28 46.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 73.51 110.893 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 17.5 t-105 -122.56 100.52 6.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.24 -0.436 . . . . 75.44 110.89 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.55 -78.75 1.71 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.725 -0.75 . . . . 71.15 112.488 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.11 17.94 0.71 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.727 -0.749 . . . . 74.24 112.508 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -129.94 138.98 51.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.72 0.295 . . . . 73.02 110.93 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -102.98 142.25 34.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 63.52 110.899 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -136.31 119.38 16.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.465 . . . . 74.44 110.94 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.9 p -83.29 131.96 35.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 52.51 110.895 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.546 HG21 HD23 ' A' ' 32' ' ' LEU . 66.9 t -93.95 130.94 42.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.485 . . . . 74.52 111.16 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.0 p -141.27 93.08 2.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 72.45 111.137 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.575 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.8 OUTLIER 173.23 -28.37 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 72.25 111.14 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.74 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.9 mm? -85.11 150.1 25.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.462 . . . . 33.15 110.902 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.563 ' C ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.71 167.78 18.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 64.31 110.887 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.406 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 35.3 mt-10 -58.81 -21.91 57.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 64.12 110.929 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -68.9 -10.54 57.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.13 -0.487 . . . . 73.33 110.875 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.473 ' HB2' HD12 ' A' ' 19' ' ' LEU . 2.1 m-20 -102.62 -150.76 0.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 73.33 110.867 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.489 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -135.82 167.54 20.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 55.25 111.127 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.61 HG21 HD21 ' A' ' 64' ' ' LEU . 82.5 t -63.06 -42.37 96.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 63.54 111.13 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.424 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -61.78 -28.79 69.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.48 . . . . 73.04 110.915 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.594 ' HB3' HD11 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -72.01 -32.56 67.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.174 -0.466 . . . . 71.45 110.871 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.65 HD23 HD23 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -80.59 -48.82 12.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 73.53 110.939 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.512 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.94 -55.78 26.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 71.33 110.929 179.783 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.6 -22.49 45.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 75.24 110.902 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.575 ' CZ ' HG21 ' A' ' 18' ' ' THR . 54.6 t80 -77.84 -54.88 5.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 75.45 110.881 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.83 HD13 HG21 ' A' ' 7' ' ' VAL . 2.5 pp -68.07 -41.96 81.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 74.1 110.927 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.564 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.85 -27.74 44.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 73.42 110.889 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.34 -23.49 43.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.25 -0.432 . . . . 64.55 111.168 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.7 mt -76.76 -59.43 2.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 64.3 110.886 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.6 t -135.47 -28.03 1.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 54.43 111.178 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.59 -177.37 4.35 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.72 -0.752 . . . . 51.22 112.498 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.848 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.4 p -112.77 137.78 44.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.864 0.364 . . . . 63.34 111.098 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.975 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -53.71 149.95 14.86 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.631 0.729 . . . . 71.31 110.915 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -21.89 32.95 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.695 2.264 . . . . 64.21 112.342 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -54.21 -38.38 65.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 73.13 110.878 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.42 ' H ' HD23 ' A' ' 39' ' ' LEU . 2.7 mpt_? -104.43 -40.3 6.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 75.21 110.885 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.848 ' HG2' HG13 ' A' ' 38' ' ' VAL . 2.3 pp0? -95.96 157.41 15.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 75.3 110.877 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.09 140.05 52.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 64.52 110.91 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.624 HD22 HE22 ' A' ' 43' ' ' GLN . 3.6 mm? -65.94 135.75 55.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 75.11 110.917 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.684 HD11 ' CG ' ' A' ' 75' ' ' MET . 6.4 mp -81.36 -63.51 1.38 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 74.34 110.901 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.91 58.72 0.68 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.703 -0.76 . . . . 65.04 112.483 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.568 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 4.5 pp -60.46 -17.34 44.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 75.54 110.899 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.96 144.15 43.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 72.01 110.885 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.893 HG21 HD21 ' A' ' 66' ' ' LEU . 11.8 p -144.0 144.95 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 70.14 111.132 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.636 ' HG2' HG22 ' A' ' 50' ' ' VAL . 11.7 mmtt 54.66 32.71 17.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 65.11 110.912 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.78 -12.17 49.42 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.725 -0.75 . . . . 21.23 112.514 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.6 mmtt -81.61 150.6 66.86 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.574 0.702 . . . . 75.43 110.896 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.403 ' O ' ' C ' ' A' ' 55' ' ' ALA . 53.6 Cg_endo -69.83 -32.39 18.39 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.648 2.232 . . . . 62.25 112.302 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.579 ' HA ' HG21 ' A' ' 59' ' ' VAL . . . 36.79 43.45 0.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.277 -0.419 . . . . 44.41 111.087 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.46 -78.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 71.32 110.85 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -157.0 -38.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 62.31 110.916 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -64.95 -9.64 22.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 71.32 110.848 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.579 HG21 ' HA ' ' A' ' 55' ' ' ALA . 16.8 t -79.25 145.6 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 73.31 111.133 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 25.7 mttp -91.0 151.65 20.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 61.03 110.92 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.563 HD12 ' C ' ' A' ' 20' ' ' SER . 20.0 mt -49.66 -47.6 49.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 71.44 110.983 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.68 -11.84 85.05 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.742 -0.742 . . . . 55.34 112.478 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.22 -32.12 43.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.826 0.346 . . . . 72.02 111.125 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.61 HD21 HG21 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -77.29 -23.91 51.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 54.24 110.9 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp 63.67 37.44 10.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 54.11 110.875 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.893 HD21 HG21 ' A' ' 50' ' ' VAL . 5.2 mt -90.2 152.68 20.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 65.14 110.941 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.61 160.86 74.75 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.558 0.694 . . . . 73.03 110.89 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -35.08 13.24 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.629 2.22 . . . . 74.12 112.319 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.715 ' HA ' HD12 ' A' ' 6' ' ' ILE . 68.7 m-20 -78.49 -15.91 58.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 51.44 110.938 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.707 HG21 HD13 ' A' ' 66' ' ' LEU . 45.6 m -32.77 122.33 0.36 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.487 . . . . 72.35 111.125 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -93.83 146.24 24.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 70.24 110.899 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 36.2 mm -115.99 131.75 67.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 61.14 111.149 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.531 ' HB3' HD13 ' A' ' 46' ' ' LEU . 46.1 mtm -101.85 142.46 33.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 75.13 110.892 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.9 mtt -133.83 119.29 19.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 61.12 110.88 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.684 ' CG ' HD11 ' A' ' 46' ' ' LEU . 2.8 mmm -108.42 121.88 45.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 75.24 110.912 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 162.85 -156.7 28.53 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.703 -0.76 . . . . 72.14 112.468 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.7 t -133.58 147.2 51.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.786 0.326 . . . . 61.24 111.114 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.87 159.35 25.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 74.3 110.879 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -82.1 179.44 7.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 72.25 110.907 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 63.37 162.59 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.464 . . . . 74.11 110.915 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.7 166.64 16.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 72.21 110.864 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.492 0 O-C-N 124.552 1.158 . . . . 72.13 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mmt . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.801 0.334 . . . . 74.13 110.89 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.736 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . -94.74 147.09 23.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 41.4 111.111 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.522 HD23 ' HD2' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -107.79 110.33 62.47 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.597 0.713 . . . . 62.24 110.921 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.522 ' HD2' HD23 ' A' ' 3' ' ' LEU . 53.2 Cg_endo -69.83 156.89 62.01 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.656 2.237 . . . . 72.14 112.287 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.549 ' HB ' HD21 ' A' ' 28' ' ' LEU . 40.3 mt -150.3 137.15 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.483 . . . . 70.33 111.125 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.692 HD12 ' HA ' ' A' ' 69' ' ' ASN . 4.6 mt -95.2 140.65 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 74.02 111.126 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.801 HG21 HD13 ' A' ' 32' ' ' LEU . 7.3 p -126.82 122.72 61.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 53.34 111.124 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.97 121.33 44.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 61.2 110.918 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 16.2 t-105 -121.43 100.78 7.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 75.24 110.891 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.59 -83.64 0.96 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.702 -0.761 . . . . 71.23 112.483 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.67 20.68 1.16 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.7 -0.762 . . . . 61.31 112.434 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.28 174.2 9.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.761 0.315 . . . . 73.51 110.944 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -132.93 140.46 47.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.268 -0.424 . . . . 74.25 110.929 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.506 ' CD2' HG21 ' A' ' 36' ' ' THR . 38.2 m-85 -135.83 116.32 13.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 74.02 110.91 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.3 p -82.51 132.17 35.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 74.14 110.851 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.551 HG21 HD23 ' A' ' 32' ' ' LEU . 96.4 t -94.68 136.93 24.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 74.44 111.12 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.6 p -146.73 93.83 2.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 74.42 111.125 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.666 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.7 OUTLIER 172.66 -28.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.219 -0.446 . . . . 75.43 111.136 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.736 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.8 mm? -87.64 150.53 23.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 65.41 110.917 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.67 165.56 23.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 65.54 110.883 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -57.78 -20.75 37.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 71.01 110.878 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.08 -11.9 61.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.179 -0.464 . . . . 74.44 110.854 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.431 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.7 m-20 -101.06 -148.84 0.37 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.266 -0.425 . . . . 73.55 110.831 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.26 167.47 20.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.191 -0.459 . . . . 74.23 111.166 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.939 HG22 HD11 ' A' ' 64' ' ' LEU . 15.9 t -63.42 -44.05 98.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 61.54 111.094 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.16 -28.39 67.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.457 . . . . 63.35 110.971 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.498 ' HB3' HD11 ' A' ' 19' ' ' LEU . 12.5 t0 -70.59 -35.52 73.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 54.32 110.857 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.693 HD12 ' CB ' ' A' ' 19' ' ' LEU . 1.2 tt -80.4 -47.82 13.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 45.14 110.904 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.747 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.57 -56.69 17.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 73.32 110.886 179.861 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -57.99 -22.31 48.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 63.44 110.915 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.666 ' CZ ' HG21 ' A' ' 18' ' ' THR . 64.8 t80 -77.3 -54.93 5.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 73.51 110.839 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.801 HD13 HG21 ' A' ' 7' ' ' VAL . 2.3 pp -68.23 -42.83 79.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 63.31 110.871 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.562 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -55.02 -27.12 41.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 74.1 110.901 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.503 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.77 -23.58 42.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 75.25 111.189 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.9 mt -76.7 -59.89 2.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 74.44 110.92 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.506 HG21 ' CD2' ' A' ' 14' ' ' TYR . 3.1 t -135.4 -27.42 1.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 73.1 111.194 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.562 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.99 -177.95 5.14 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.8 -0.714 . . . . 51.01 112.466 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.861 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.2 p -112.98 138.7 41.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.899 0.381 . . . . 74.11 111.098 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.963 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.42 151.1 14.74 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.593 0.711 . . . . 71.3 110.932 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 54.1 Cg_endo -69.78 -21.49 33.31 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.68 2.253 . . . . 73.42 112.354 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -54.52 -38.98 67.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 73.13 110.87 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.438 ' H ' HD23 ' A' ' 39' ' ' LEU . 8.8 mpt_? -103.89 -40.45 6.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 73.11 110.847 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.861 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.7 pp0? -98.11 158.2 15.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 75.14 110.877 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.28 141.37 51.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 75.31 110.902 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.26 135.96 54.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.262 -0.426 . . . . 63.41 110.905 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.736 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.1 mm? -76.86 -75.8 0.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 73.3 110.904 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -97.03 60.5 1.13 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.68 -0.772 . . . . 64.12 112.482 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.645 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 3.7 pp -55.4 -24.43 30.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.843 0.354 . . . . 64.22 110.923 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.421 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -103.71 143.42 32.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 72.32 110.892 179.845 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.763 HG21 HD21 ' A' ' 66' ' ' LEU . 14.9 p -144.1 143.38 23.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 73.12 111.15 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.0 mttt 54.0 34.19 19.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 44.32 110.905 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.22 -14.98 41.84 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.801 -0.714 . . . . 52.24 112.468 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.8 mmtt -81.67 149.57 64.47 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.537 0.684 . . . . 60.4 110.93 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.421 ' HA ' ' HB3' ' A' ' 49' ' ' LYS . 53.9 Cg_endo -69.73 -35.97 11.75 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.669 2.246 . . . . 73.32 112.334 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.645 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 38.97 39.3 0.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 34.12 111.096 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.89 -75.65 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 64.23 110.892 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -154.17 -38.57 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 64.04 110.875 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -72.72 -2.46 20.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 64.0 110.855 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.555 ' O ' HG23 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -93.36 148.19 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 74.23 111.137 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.408 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 35.1 mttt -91.39 147.56 22.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 64.1 110.906 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.407 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 10.6 mt -51.88 -41.95 62.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 70.15 110.916 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.63 -15.59 80.54 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.76 -0.733 . . . . 72.2 112.462 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.69 -19.94 32.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.839 0.352 . . . . 64.3 111.108 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.939 HD11 HG22 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -83.47 -20.23 34.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 70.12 110.939 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt 53.74 43.02 31.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 53.23 110.816 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.763 HD21 HG21 ' A' ' 50' ' ' VAL . 3.3 mt -95.48 153.33 17.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 70.34 110.902 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -68.25 159.75 78.87 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.626 0.727 . . . . 73.22 110.872 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -36.77 10.16 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.663 2.242 . . . . 72.23 112.329 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.692 ' HA ' HD12 ' A' ' 6' ' ' ILE . 14.8 p30 -78.44 -15.85 58.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 74.5 110.9 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.636 HG21 HD13 ' A' ' 66' ' ' LEU . 53.6 m -32.4 125.13 0.31 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 72.44 111.156 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.27 145.83 24.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 70.21 110.919 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.6 mm -115.61 128.36 72.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.27 -0.423 . . . . 71.32 111.126 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 37.0 mtt -99.71 141.74 32.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.478 . . . . 73.21 110.876 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.0 mtt -133.76 118.36 17.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 73.14 110.862 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.736 ' CG ' HD21 ' A' ' 46' ' ' LEU . 3.0 mmt -106.05 123.07 47.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 61.33 110.887 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.87 -157.16 28.87 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.765 -0.731 . . . . 62.34 112.526 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.3 t -134.27 148.89 50.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.777 0.322 . . . . 55.54 111.115 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -67.39 154.84 40.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 73.11 110.866 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.452 ' HG3' HD11 ' A' ' 39' ' ' LEU . 41.6 mt-10 -74.85 175.57 7.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 73.24 110.896 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.29 -43.57 98.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 74.33 110.855 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 55.07 -108.11 0.42 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 71.22 110.886 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.464 0 O-C-N 124.465 1.103 . . . . 2.13 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 mtt . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.825 0.345 . . . . 74.32 110.871 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.748 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . -85.73 151.54 23.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 72.2 111.116 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.4 mt -110.99 109.54 57.22 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.653 0.739 . . . . 74.12 110.9 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 156.62 62.86 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.685 2.256 . . . . 75.22 112.359 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.443 ' HB ' HD21 ' A' ' 28' ' ' LEU . 37.8 mt -150.57 137.67 13.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.247 -0.433 . . . . 64.41 111.083 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.694 HD12 ' HA ' ' A' ' 69' ' ' ASN . 3.8 mt -95.24 140.41 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 74.33 111.116 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.838 HG21 HD13 ' A' ' 32' ' ' LEU . 8.7 p -127.46 123.71 62.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 64.03 111.138 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.21 118.98 38.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.462 . . . . 73.14 110.872 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 10.5 t-105 -122.4 102.56 8.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.205 -0.452 . . . . 63.1 110.906 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.0 -82.84 0.74 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.785 -0.721 . . . . 34.23 112.504 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.77 19.73 0.78 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.73 -0.748 . . . . 55.44 112.464 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -129.08 175.55 8.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.753 0.311 . . . . 63.31 110.941 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -132.92 140.56 47.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 54.34 110.898 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -135.01 120.26 18.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.152 -0.476 . . . . 75.42 110.941 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.4 p -83.53 133.3 34.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.499 . . . . 75.45 110.825 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.541 HG21 ' CD2' ' A' ' 32' ' ' LEU . 73.6 t -95.98 126.83 48.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 74.23 111.169 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.5 p -137.39 92.77 2.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 54.32 111.117 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.563 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.9 OUTLIER 174.03 -29.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 74.0 111.162 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.748 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.8 mm? -84.92 150.03 25.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 75.13 110.88 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.558 ' C ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.74 168.18 18.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 72.04 110.875 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.432 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 78.1 mt-10 -59.06 -22.03 60.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 63.23 110.852 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.3 -10.94 58.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.193 -0.458 . . . . 72.32 110.868 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.444 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.9 m-20 -102.79 -150.14 0.41 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 53.44 110.869 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.564 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -136.03 168.07 20.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 73.13 111.129 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.613 HG22 HD11 ' A' ' 64' ' ' LEU . 91.1 t -63.29 -42.92 98.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 61.03 111.126 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.403 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -61.19 -29.47 69.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 74.04 110.907 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.566 ' HB3' HD11 ' A' ' 19' ' ' LEU . 4.1 t0 -71.06 -32.98 69.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.459 . . . . 62.42 110.863 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.674 HD23 HD23 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -80.45 -48.95 12.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 74.35 110.871 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.509 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.99 -56.13 22.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 73.31 110.911 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -57.47 -23.01 47.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 74.41 110.913 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.563 ' CZ ' HG21 ' A' ' 18' ' ' THR . 52.5 t80 -77.27 -55.36 5.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 70.15 110.884 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.838 HD13 HG21 ' A' ' 7' ' ' VAL . 2.5 pp -67.66 -42.4 82.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.494 . . . . 62.42 110.909 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.572 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.2 tmtt? -54.81 -27.69 43.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 65.34 110.901 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.518 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.47 -23.34 43.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.24 -0.436 . . . . 73.12 111.154 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.7 mt -76.85 -59.51 2.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 41.22 110.9 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.8 t -135.27 -27.24 1.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 73.31 111.165 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.572 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.72 -176.86 5.31 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.723 -0.751 . . . . 74.32 112.513 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.873 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.4 p -112.78 137.16 46.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.845 0.355 . . . . 45.53 111.136 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.947 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -53.48 150.0 13.55 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.561 0.696 . . . . 43.02 110.946 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -21.8 33.19 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.701 2.267 . . . . 64.12 112.37 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.16 -38.09 65.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 62.44 110.868 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.423 ' H ' HD23 ' A' ' 39' ' ' LEU . 3.1 mpt_? -104.95 -40.05 6.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 63.15 110.881 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.873 ' HG2' HG13 ' A' ' 38' ' ' VAL . 2.3 pp0? -96.48 158.31 15.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 63.31 110.895 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.72 140.37 51.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 73.41 110.893 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.671 HD22 HE22 ' A' ' 43' ' ' GLN . 3.7 mm? -66.32 135.25 54.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 74.2 110.945 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.746 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.0 mm? -75.74 -72.17 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 65.3 110.972 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.57 61.61 0.86 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.686 -0.769 . . . . 53.24 112.524 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.583 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 4.5 pp -58.19 -19.22 31.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 72.1 110.948 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.39 144.24 39.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 70.24 110.875 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.783 HG21 HD21 ' A' ' 66' ' ' LEU . 10.9 p -143.8 146.21 21.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 74.34 111.111 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt 54.77 31.92 16.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 72.53 110.914 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.16 -10.91 51.88 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.74 -0.743 . . . . 63.52 112.507 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -81.34 151.07 68.75 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.592 0.711 . . . . 73.14 110.885 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 55' ' ' ALA . 54.1 Cg_endo -69.74 -32.91 17.73 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.683 2.256 . . . . 71.21 112.347 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.585 ' HA ' HG21 ' A' ' 59' ' ' VAL . . . 35.98 44.35 0.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 74.3 111.122 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.33 -75.75 0.05 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 75.41 110.869 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.72 -37.53 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 75.3 110.909 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -67.14 -8.99 35.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 71.21 110.884 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.585 HG21 ' HA ' ' A' ' 55' ' ' ALA . 17.7 t -78.61 145.65 9.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 74.32 111.132 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -89.9 151.14 21.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 74.04 110.89 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.558 HD12 ' C ' ' A' ' 20' ' ' SER . 19.8 mt -49.83 -47.42 51.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 51.24 110.909 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.48 -12.02 84.93 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.804 -0.712 . . . . 50.41 112.461 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.14 -32.15 44.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.817 0.341 . . . . 63.14 111.061 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.613 HD11 HG22 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -77.81 -23.61 49.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 71.53 110.887 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp 63.41 37.49 10.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 64.31 110.95 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.783 HD21 HG21 ' A' ' 50' ' ' VAL . 4.2 mt -89.29 152.32 21.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 65.55 110.987 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.63 160.61 76.03 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.598 0.713 . . . . 72.31 110.882 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -34.85 13.7 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.649 2.232 . . . . 64.35 112.35 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.694 ' HA ' HD12 ' A' ' 6' ' ' ILE . 10.5 m120 -78.8 -15.68 58.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 74.31 110.883 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.66 HG21 HD13 ' A' ' 66' ' ' LEU . 47.7 m -32.97 120.82 0.36 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 61.01 111.145 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -92.5 146.43 23.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 63.34 110.926 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.0 mm -115.8 128.89 72.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 52.54 111.168 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 44.7 mtm -99.74 141.6 32.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 64.11 110.883 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.8 mtt -131.74 125.72 32.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 74.41 110.876 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.746 ' CG ' HD21 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -116.01 120.09 37.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 74.31 110.889 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 163.05 -156.41 28.16 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.765 -0.731 . . . . 73.51 112.54 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.3 t -133.96 144.85 49.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.754 0.311 . . . . 51.11 111.128 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.7 157.51 20.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 75.25 110.943 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.412 ' HB3' HD11 ' A' ' 39' ' ' LEU . 4.4 pt-20 -73.27 177.0 5.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 74.21 110.895 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.87 99.7 4.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 64.23 110.854 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.829 ' HG ' ' N ' ' A' ' 90' ' ' NH2 . 1.4 t -177.94 -103.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 72.42 110.834 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' NH2 . . . . . 0.829 ' N ' ' HG ' ' A' ' 81' ' ' SER . . . . . . . . 0 C--N 1.325 -0.474 0 O-C-N 124.513 1.133 . . . . 44.11 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.773 0.321 . . . . 73.13 110.87 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.744 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . -113.5 148.79 35.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 43.22 111.106 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.413 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 3.4 mt -109.15 109.76 60.63 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.609 0.719 . . . . 72.04 110.936 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 53.8 Cg_endo -69.79 156.13 64.07 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.698 2.265 . . . . 71.13 112.343 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.557 ' HB ' HD21 ' A' ' 28' ' ' LEU . 36.2 mt -150.51 136.08 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 62.12 111.115 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.716 HD12 ' HA ' ' A' ' 69' ' ' ASN . 3.6 mt -94.87 140.68 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 60.43 111.131 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.848 HG21 HD13 ' A' ' 32' ' ' LEU . 7.7 p -127.33 123.21 61.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 74.0 111.136 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.43 123.21 48.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.485 . . . . 52.33 110.899 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.2 t-105 -124.48 102.88 7.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.441 . . . . 72.24 110.91 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.55 -80.09 1.52 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.745 -0.74 . . . . 61.22 112.493 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.23 17.51 0.69 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.786 -0.721 . . . . 64.41 112.497 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 36.6 mm-40 -130.06 139.19 51.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.751 0.31 . . . . 64.53 110.949 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -103.1 142.06 34.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 72.51 110.903 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.634 ' CD1' HG21 ' A' ' 36' ' ' THR . 76.4 m-85 -136.28 116.54 13.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 61.2 110.947 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.4 p -82.45 131.2 35.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 61.44 110.88 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.562 HG21 HD23 ' A' ' 32' ' ' LEU . 85.9 t -92.29 138.81 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 72.33 111.136 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 p -148.76 92.42 1.99 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 74.45 111.155 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.655 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.9 OUTLIER 173.63 -28.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 63.25 111.158 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.744 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.8 mm? -85.78 151.21 24.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 65.24 110.936 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.18 168.54 17.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 74.4 110.863 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.414 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 36.2 mt-10 -60.61 -22.09 63.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 62.33 110.901 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.63 -11.23 60.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.157 -0.474 . . . . 73.4 110.81 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.415 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.5 m-20 -99.82 -151.15 0.39 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 61.1 110.838 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.64 168.86 17.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 61.41 111.114 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.961 HG22 HD11 ' A' ' 64' ' ' LEU . 12.4 t -65.62 -41.32 90.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 74.53 111.143 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.44 -28.63 69.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.141 -0.482 . . . . 72.01 110.92 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.519 ' HB3' HD11 ' A' ' 19' ' ' LEU . 19.6 t0 -70.73 -34.92 72.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 64.2 110.859 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.68 HD12 ' CB ' ' A' ' 19' ' ' LEU . 1.2 tt -80.76 -47.91 13.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 74.13 110.914 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.751 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.64 -56.57 18.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 73.13 110.911 179.812 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.15 -22.45 51.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 73.14 110.943 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.655 ' CZ ' HG21 ' A' ' 18' ' ' THR . 55.2 t80 -77.29 -55.17 5.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 74.21 110.879 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.848 HD13 HG21 ' A' ' 7' ' ' VAL . 2.3 pp -67.49 -43.45 80.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.141 -0.482 . . . . 64.25 110.902 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.579 ' N ' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -54.84 -27.03 39.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 71.11 110.924 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.46 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.78 -23.74 41.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 74.34 111.146 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.9 mt -76.46 -59.75 2.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.439 . . . . 74.4 110.859 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.634 HG21 ' CD1' ' A' ' 14' ' ' TYR . 3.5 t -135.31 -28.07 1.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 74.23 111.163 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.8 -177.58 4.7 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.717 -0.754 . . . . 63.2 112.52 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.898 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.2 p -112.56 139.22 38.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.861 0.362 . . . . 51.24 111.082 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.978 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.52 150.67 16.55 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.622 0.725 . . . . 74.15 110.88 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 53.5 Cg_endo -69.73 -21.95 32.9 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.653 2.235 . . . . 71.21 112.353 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -54.29 -38.98 66.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 63.55 110.876 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.421 ' H ' HD23 ' A' ' 39' ' ' LEU . 5.5 mtt85 -103.97 -40.27 6.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 62.52 110.889 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.898 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.7 pp0? -98.2 158.7 15.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 74.2 110.916 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.67 141.06 51.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 73.25 110.89 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.64 135.04 53.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 74.24 110.93 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.737 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.1 mm? -75.81 -75.57 0.18 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 74.03 110.906 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -96.15 60.34 1.36 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.725 -0.75 . . . . 72.32 112.459 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.635 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 3.8 pp -56.06 -23.85 36.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.905 0.383 . . . . 72.35 110.947 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.407 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -104.43 143.4 33.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 61.53 110.888 179.836 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.757 HG21 HD21 ' A' ' 66' ' ' LEU . 13.0 p -144.11 143.64 23.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 51.33 111.091 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.719 ' HG2' HG22 ' A' ' 50' ' ' VAL . 0.2 OUTLIER 54.07 33.82 18.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 72.11 110.854 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.48 -15.04 42.96 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.714 -0.755 . . . . 51.33 112.452 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.6 mmtm -81.61 149.63 64.82 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.636 0.732 . . . . 54.41 110.858 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.407 ' HA ' ' HB3' ' A' ' 49' ' ' LYS . 53.8 Cg_endo -69.73 -35.98 11.71 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.663 2.242 . . . . 71.42 112.354 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 38.92 39.31 0.35 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 41.4 111.115 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.7 -75.47 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 75.22 110.878 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -154.61 -39.51 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 64.35 110.857 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -72.16 -4.11 27.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 54.41 110.875 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.615 ' O ' HG23 ' A' ' 25' ' ' VAL . 1.4 t -90.04 147.48 5.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 73.1 111.099 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.485 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 13.4 mttp -90.35 147.13 23.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 74.03 110.933 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.414 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 16.1 mt -51.95 -38.1 55.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 71.34 110.882 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.69 -18.43 79.7 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.753 -0.736 . . . . 41.23 112.455 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.61 -14.89 47.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.857 0.36 . . . . 63.14 111.142 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.961 HD11 HG22 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -87.17 -18.02 31.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 64.3 110.944 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.16 45.65 23.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 64.11 110.914 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.757 HD21 HG21 ' A' ' 50' ' ' VAL . 3.5 mt -99.02 153.27 18.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 71.52 110.897 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.27 159.81 78.62 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.549 0.69 . . . . 63.33 110.932 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -36.71 10.32 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.707 2.271 . . . . 52.22 112.37 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.716 ' HA ' HD12 ' A' ' 6' ' ' ILE . 1.7 m-80 -78.59 -15.81 58.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 62.02 110.872 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.655 HG21 HD13 ' A' ' 66' ' ' LEU . 51.8 m -32.63 123.65 0.35 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.475 . . . . 51.2 111.163 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.68 146.26 23.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 72.04 110.856 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.7 mm -115.45 131.83 66.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 63.52 111.115 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 26.5 mtm -104.14 142.04 35.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 62.24 110.866 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 75.0 mtm -134.44 118.6 17.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 65.32 110.91 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.737 ' CG ' HD21 ' A' ' 46' ' ' LEU . 2.1 mmt -106.2 126.1 51.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 73.32 110.858 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' A' ' 43' ' ' GLN . . . 157.87 -154.65 25.72 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.754 -0.736 . . . . 63.33 112.49 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 t -134.99 150.4 50.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.795 0.331 . . . . 63.03 111.164 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.17 153.45 43.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 63.4 110.842 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -63.06 179.28 0.4 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 75.51 110.865 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -144.17 77.08 1.53 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 75.31 110.904 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . 1.075 ' HG ' ' N ' ' A' ' 90' ' ' NH2 . 0.7 OUTLIER -172.35 -125.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 73.34 110.865 -179.797 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' NH2 . . . . . 1.075 ' N ' ' HG ' ' A' ' 81' ' ' SER . . . . . . . . 0 C--N 1.324 -0.511 0 O-C-N 124.512 1.133 . . . . 35.44 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.77 0.319 . . . . 71.23 110.876 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.746 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . -82.26 151.3 26.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.426 . . . . 63.21 111.132 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.412 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 4.1 mt -111.71 109.61 55.4 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.681 0.753 . . . . 74.51 110.888 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 53.7 Cg_endo -69.75 156.34 63.61 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.652 2.234 . . . . 65.14 112.331 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.538 ' HB ' HD21 ' A' ' 28' ' ' LEU . 30.2 mt -150.34 136.81 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 62.32 111.129 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.711 HD12 ' HA ' ' A' ' 69' ' ' ASN . 3.6 mt -95.2 140.73 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 54.35 111.186 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.853 HG21 HD13 ' A' ' 32' ' ' LEU . 8.6 p -127.1 123.48 62.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 64.35 111.121 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.81 125.72 51.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 72.15 110.876 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.6 t-105 -125.01 100.74 6.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 73.12 110.911 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.22 -79.22 1.71 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.732 -0.747 . . . . 43.5 112.442 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.16 17.46 0.8 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.729 -0.748 . . . . 52.34 112.512 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -129.35 138.59 51.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.742 0.306 . . . . 70.02 110.909 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -102.94 142.28 34.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 73.21 110.94 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.58 ' CG ' HG21 ' A' ' 36' ' ' THR . 79.7 m-85 -136.69 116.15 12.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 75.22 110.867 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.86 133.87 35.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.086 -0.506 . . . . 53.23 110.858 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.529 HG21 HD23 ' A' ' 32' ' ' LEU . 89.7 t -95.71 139.55 18.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.08 -0.509 . . . . 74.41 111.091 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.3 p -149.02 92.91 2.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 71.51 111.151 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.712 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.8 OUTLIER 173.67 -28.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 44.34 111.175 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.746 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.7 mm? -85.7 151.53 23.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.447 . . . . 64.55 110.919 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.423 ' O ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.39 168.96 16.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 74.0 110.843 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.417 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 22.5 mt-10 -61.09 -22.37 64.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 71.2 110.892 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.37 -11.33 60.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 75.0 110.856 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.402 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.6 m-20 -99.94 -151.0 0.39 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 74.21 110.852 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -133.27 171.57 13.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 62.14 111.148 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.954 HG22 HD11 ' A' ' 64' ' ' LEU . 11.2 t -67.23 -42.02 87.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 63.12 111.153 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.57 -28.96 69.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.481 . . . . 74.34 110.876 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.496 ' HB3' HD11 ' A' ' 19' ' ' LEU . 10.1 t0 -70.46 -35.05 73.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.434 . . . . 70.13 110.893 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.661 HD23 HD23 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -80.67 -48.06 13.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 72.33 110.962 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.775 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.45 -56.51 19.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 61.44 110.885 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.2 -22.29 51.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 45.31 110.892 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.712 ' CZ ' HG21 ' A' ' 18' ' ' THR . 50.8 t80 -77.46 -55.14 5.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 63.21 110.858 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.853 HD13 HG21 ' A' ' 7' ' ' VAL . 2.4 pp -67.67 -43.07 81.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.176 -0.465 . . . . 64.22 110.897 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.564 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.98 -26.91 39.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 45.55 110.883 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.478 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -80.02 -23.85 41.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 72.31 111.12 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.405 HD11 ' CE2' ' A' ' 31' ' ' PHE . 13.1 mt -76.45 -59.85 2.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.456 . . . . 70.42 110.9 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.58 HG21 ' CG ' ' A' ' 14' ' ' TYR . 4.2 t -135.39 -28.09 1.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 71.11 111.131 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.52 -177.86 4.53 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.699 -0.762 . . . . 64.11 112.502 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.859 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.0 OUTLIER -113.18 139.57 37.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.898 0.38 . . . . 64.52 111.149 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 1.001 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.39 151.3 14.19 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.617 0.722 . . . . 71.04 110.898 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 53.9 Cg_endo -69.74 -21.42 33.63 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.664 2.243 . . . . 72.43 112.383 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -54.83 -38.88 67.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 74.42 110.821 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.426 ' H ' HD23 ' A' ' 39' ' ' LEU . 1.8 mtt-85 -103.73 -40.47 6.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 64.15 110.865 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.859 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.7 pp0? -98.29 157.32 16.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 73.13 110.888 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.31 141.11 51.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 64.04 110.907 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.406 HD22 ' N ' ' A' ' 45' ' ' LEU . 3.7 mm? -67.31 135.91 54.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 62.43 110.966 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.796 HD11 ' HG2' ' A' ' 75' ' ' MET . 7.0 mp -78.15 -75.09 0.23 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 73.13 110.927 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.13 58.78 1.7 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.724 -0.75 . . . . 75.12 112.446 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.649 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 3.7 pp -55.15 -24.48 26.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.86 0.362 . . . . 73.04 110.905 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.411 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -103.89 143.39 32.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 72.44 110.944 179.807 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.787 HG21 HD21 ' A' ' 66' ' ' LEU . 14.7 p -144.25 143.49 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 74.14 111.142 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.6 mttp 54.01 34.04 18.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 72.21 110.934 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.38 -15.11 42.08 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.739 -0.743 . . . . 70.13 112.499 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -81.64 149.47 64.39 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.586 0.708 . . . . 62.11 110.912 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.411 ' HA ' ' HB3' ' A' ' 49' ' ' LYS . 54.4 Cg_endo -69.72 -35.86 11.99 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.705 2.27 . . . . 61.51 112.335 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 38.98 39.51 0.37 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 61.42 111.146 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.31 -74.0 0.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 72.44 110.89 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.416 HD22 ' N ' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -157.45 -36.31 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 74.34 110.889 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.416 ' N ' HD22 ' A' ' 57' ' ' ASN . 4.0 m-20 -75.3 -1.6 24.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 72.41 110.913 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -93.55 147.65 5.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.166 -0.47 . . . . 72.22 111.104 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.407 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 12.9 mttt -89.99 147.2 23.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 70.33 110.85 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.423 HD12 ' O ' ' A' ' 20' ' ' SER . 17.3 mt -52.71 -38.3 60.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 72.32 110.895 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.61 -17.21 80.21 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.712 -0.756 . . . . 75.55 112.501 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.39 -20.08 32.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.826 0.346 . . . . 73.44 111.097 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.954 HD11 HG22 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -83.96 -20.02 33.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.435 . . . . 75.34 110.923 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.3 mmtp 52.09 43.91 30.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 74.11 110.904 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.787 HD21 HG21 ' A' ' 50' ' ' VAL . 3.4 mt -95.03 153.12 17.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 70.15 110.898 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.57 159.77 79.87 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.588 0.709 . . . . 71.23 110.876 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 -36.8 10.24 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.699 2.266 . . . . 60.4 112.354 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.711 ' HA ' HD12 ' A' ' 6' ' ' ILE . 2.4 m120 -78.45 -15.78 58.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 72.23 110.872 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.652 HG21 HD13 ' A' ' 66' ' ' LEU . 51.9 m -32.53 125.01 0.33 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 73.22 111.123 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.93 146.78 24.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 70.32 110.892 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.6 mm -115.17 129.96 70.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 74.02 111.164 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.487 ' CB ' HD13 ' A' ' 46' ' ' LEU . 41.2 mtm -101.01 142.87 31.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.478 . . . . 74.23 110.859 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.1 mtt -135.97 116.88 14.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 75.31 110.912 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.796 ' HG2' HD11 ' A' ' 46' ' ' LEU . 8.7 mmm -105.29 131.39 52.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 55.13 110.894 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 148.64 -151.9 24.02 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.71 -0.757 . . . . 73.23 112.51 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 t -133.06 134.59 44.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.753 0.311 . . . . 70.15 111.167 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.507 ' HA ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -89.14 151.72 22.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 74.33 110.893 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.529 ' HG3' HD11 ' A' ' 39' ' ' LEU . 36.1 mt-10 -81.02 88.41 5.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 74.43 110.914 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -72.62 137.21 45.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 74.32 110.854 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 57.09 -142.08 0.76 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 75.13 110.832 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.511 0 O-C-N 124.56 1.163 . . . . 64.51 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 mtt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.785 0.326 . . . . 71.41 110.872 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.745 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . -81.38 151.34 27.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 63.44 111.1 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.421 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 2.6 mt -111.38 109.37 56.35 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.595 0.712 . . . . 41.42 110.934 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 53.7 Cg_endo -69.8 156.41 63.33 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.651 2.234 . . . . 72.02 112.35 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.544 ' HB ' HD21 ' A' ' 28' ' ' LEU . 31.3 mt -150.58 137.02 12.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 73.01 111.135 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.648 HD12 ' HA ' ' A' ' 69' ' ' ASN . 5.1 mt -94.96 140.57 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 72.54 111.134 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.855 HG21 HD13 ' A' ' 32' ' ' LEU . 7.5 p -127.1 122.86 61.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 73.42 111.091 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.66 119.82 40.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 73.34 110.89 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 16.6 t-105 -120.85 100.62 7.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.454 . . . . 61.43 110.944 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.87 -83.39 0.92 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.797 -0.716 . . . . 63.42 112.489 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.57 21.57 1.05 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.772 -0.728 . . . . 61.23 112.501 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -129.28 175.29 8.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.775 0.322 . . . . 73.13 110.904 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -133.19 140.96 47.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 74.52 110.916 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.466 ' CD2' HG21 ' A' ' 36' ' ' THR . 41.3 m-85 -136.51 119.14 16.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.173 -0.467 . . . . 74.53 110.973 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.2 p -84.13 132.35 34.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 62.22 110.849 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.553 HG21 HD23 ' A' ' 32' ' ' LEU . 95.9 t -94.98 125.98 47.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.069 -0.514 . . . . 45.14 111.138 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.2 p -136.49 93.12 2.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 52.41 111.174 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.712 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.8 OUTLIER 173.51 -28.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 70.22 111.113 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.745 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.8 mm? -86.12 151.2 23.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.271 -0.422 . . . . 70.52 110.878 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.438 ' O ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.32 169.33 16.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 70.5 110.815 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.412 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 43.1 mt-10 -61.7 -22.18 65.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.106 -0.497 . . . . 72.1 110.922 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -70.16 -10.69 59.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 74.23 110.871 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.403 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.5 m-20 -99.2 -150.44 0.37 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 75.02 110.842 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.32 168.53 18.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 71.42 111.144 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.975 HG22 HD11 ' A' ' 64' ' ' LEU . 13.0 t -64.67 -42.85 96.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 64.2 111.137 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.14 -28.47 69.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 73.02 110.9 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.49 ' HB3' HD11 ' A' ' 19' ' ' LEU . 19.9 t0 -70.81 -35.09 72.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 73.12 110.868 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.667 HD12 ' CB ' ' A' ' 19' ' ' LEU . 0.9 OUTLIER -80.64 -47.73 13.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 75.15 110.906 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.755 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.97 -56.8 15.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 73.2 110.867 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -58.19 -22.1 50.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 74.42 110.906 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.712 ' CZ ' HG21 ' A' ' 18' ' ' THR . 54.0 t80 -77.48 -54.9 5.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 74.43 110.865 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.855 HD13 HG21 ' A' ' 7' ' ' VAL . 2.4 pp -68.28 -43.0 78.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 71.23 110.898 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.569 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -55.08 -26.91 41.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 74.12 110.909 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.82 -23.77 41.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.452 . . . . 62.22 111.141 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.7 mt -76.67 -60.26 2.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.234 -0.439 . . . . 72.4 110.87 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.466 HG21 ' CD2' ' A' ' 14' ' ' TYR . 2.8 t -135.41 -27.48 1.19 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 61.43 111.181 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.569 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.45 -178.4 4.74 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.759 -0.734 . . . . 70.42 112.521 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.875 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.2 p -112.91 139.06 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.889 0.376 . . . . 71.53 111.095 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.991 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.53 150.8 16.08 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.66 0.743 . . . . 75.42 110.92 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 53.9 Cg_endo -69.68 -21.64 33.57 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.69 2.26 . . . . 53.0 112.358 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -54.41 -38.89 66.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 53.25 110.874 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.432 ' H ' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -104.04 -40.52 6.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 63.1 110.865 -179.902 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.875 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.7 pp0? -97.87 158.27 15.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 73.44 110.929 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.36 141.73 51.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 73.51 110.898 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.36 136.04 54.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.266 -0.425 . . . . 40.42 110.868 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.723 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.1 mm? -76.74 -75.91 0.18 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 62.4 110.898 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.26 56.83 1.74 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.735 -0.745 . . . . 52.35 112.473 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.646 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 4.0 pp -50.56 -32.31 18.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.877 0.37 . . . . 63.52 110.933 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.527 ' N ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -95.59 146.19 24.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 72.25 110.927 179.802 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.705 HG21 ' CD2' ' A' ' 66' ' ' LEU . 8.5 p -142.37 138.01 29.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 74.41 111.126 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt 54.53 32.2 16.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 73.25 110.893 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.42 -15.57 56.17 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.753 -0.737 . . . . 42.43 112.485 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -80.17 149.79 70.16 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.546 0.688 . . . . 72.44 110.901 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -36.27 11.04 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.729 2.286 . . . . 70.43 112.316 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 39.54 37.05 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 71.24 111.101 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.44 -76.83 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 74.45 110.9 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -153.87 -38.96 0.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 71.13 110.866 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -71.89 -2.61 18.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 73.4 110.882 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.58 ' O ' HG23 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -92.93 147.7 5.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 71.55 111.15 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.415 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 15.4 mttp -91.27 147.84 22.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 74.41 110.916 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.438 HD12 ' O ' ' A' ' 20' ' ' SER . 17.6 mt -52.61 -38.45 60.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.248 -0.433 . . . . 51.51 110.907 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.7 -17.29 80.17 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.743 -0.741 . . . . 61.14 112.496 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.28 -19.97 32.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.854 0.359 . . . . 75.24 111.1 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.975 HD11 HG22 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -84.17 -19.27 34.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 55.32 110.944 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt 51.91 43.65 30.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 71.44 110.876 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.705 ' CD2' HG21 ' A' ' 50' ' ' VAL . 3.5 mt -94.26 152.3 18.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 71.25 110.956 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -68.45 159.79 79.38 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.595 0.712 . . . . 74.12 110.882 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -37.65 8.88 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.703 2.269 . . . . 74.53 112.333 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.648 ' HA ' HD12 ' A' ' 6' ' ' ILE . 14.8 m-20 -78.56 -15.45 58.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 74.41 110.897 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.611 HG21 HD13 ' A' ' 66' ' ' LEU . 56.3 m -33.01 126.86 0.32 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.472 . . . . 73.1 111.172 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.78 145.77 25.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 74.21 110.915 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.3 mm -115.5 128.17 72.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 73.22 111.114 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 9.2 mtp -99.76 141.65 32.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 53.44 110.923 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.0 mtt -133.77 117.32 16.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 72.05 110.862 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.723 ' CG ' HD21 ' A' ' 46' ' ' LEU . 2.7 mmt -105.25 123.28 47.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 71.44 110.849 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 160.3 -157.22 28.56 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.699 -0.762 . . . . 74.21 112.519 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 t -134.21 149.3 50.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.783 0.325 . . . . 65.22 111.135 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -66.4 153.34 43.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 75.5 110.827 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -69.53 -174.29 0.68 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 73.15 110.876 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -60.38 -32.15 71.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 71.32 110.868 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 58.57 -173.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 54.13 110.896 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.513 0 O-C-N 124.537 1.148 . . . . 31.43 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.758 0.313 . . . . 73.0 110.907 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.731 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . -79.19 146.56 33.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 73.34 111.107 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.545 HD23 ' HD2' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -106.95 110.46 63.61 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.603 0.716 . . . . 73.52 110.928 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.545 ' HD2' HD23 ' A' ' 3' ' ' LEU . 53.7 Cg_endo -69.79 156.32 63.58 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.692 2.262 . . . . 63.12 112.337 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.474 ' HB ' HD21 ' A' ' 28' ' ' LEU . 52.6 mt -150.81 136.86 12.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 74.13 111.116 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.712 HD12 ' HA ' ' A' ' 69' ' ' ASN . 3.5 mt -95.28 140.65 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 64.33 111.159 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.831 HG21 HD13 ' A' ' 32' ' ' LEU . 8.4 p -127.15 123.29 61.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 75.32 111.121 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.11 122.11 46.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 72.14 110.935 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.1 t-105 -123.18 102.89 8.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 75.3 110.899 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.76 -79.68 1.63 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.72 -0.752 . . . . 74.42 112.445 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.34 17.89 0.69 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.773 -0.727 . . . . 63.2 112.547 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -130.0 138.8 51.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.763 0.316 . . . . 62.23 110.928 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -102.71 142.37 33.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 62.52 110.867 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.542 ' CD1' HG21 ' A' ' 36' ' ' THR . 80.1 m-85 -136.36 116.69 13.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.474 . . . . 73.14 110.923 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.7 p -82.46 132.28 35.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.078 -0.51 . . . . 50.32 110.854 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.544 HG21 HD23 ' A' ' 32' ' ' LEU . 85.8 t -92.96 140.61 16.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 71.4 111.132 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.5 p -151.28 91.54 1.69 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 35.44 111.108 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.436 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.7 OUTLIER 173.17 -28.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 62.24 111.132 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.731 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.4 mm? -86.53 150.61 24.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 73.3 110.909 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.462 ' C ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -132.03 165.6 23.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 64.22 110.828 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.465 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -57.48 -20.55 31.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.5 . . . . 75.42 110.856 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -67.09 -13.2 61.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 71.55 110.874 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.406 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.8 m-20 -101.91 -145.65 0.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 72.32 110.813 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -138.28 167.13 22.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 72.34 111.176 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.639 HG22 HD11 ' A' ' 64' ' ' LEU . 97.6 t -62.1 -44.58 99.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 52.21 111.151 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.424 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -60.4 -27.75 67.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 64.42 110.944 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.477 ' HB3' HD11 ' A' ' 19' ' ' LEU . 3.2 t0 -71.74 -34.5 69.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 72.02 110.878 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.682 HD12 ' HB3' ' A' ' 19' ' ' LEU . 1.1 tt -80.16 -47.99 13.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 74.52 110.915 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.517 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.46 -55.87 26.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.198 -0.456 . . . . 74.4 110.84 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -57.28 -22.7 43.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 73.52 110.88 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.46 ' O ' HG22 ' A' ' 34' ' ' THR . 70.5 t80 -77.92 -55.37 5.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 44.25 110.875 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.831 HD13 HG21 ' A' ' 7' ' ' VAL . 2.5 pp -67.09 -43.02 83.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.476 . . . . 73.4 110.938 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.582 ' N ' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -54.61 -27.5 39.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 64.42 110.919 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.46 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.63 -23.67 42.43 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.474 . . . . 65.31 111.191 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.2 mt -76.49 -59.31 2.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 63.11 110.923 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.542 HG21 ' CD1' ' A' ' 14' ' ' TYR . 4.6 t -135.02 -28.25 1.19 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 71.43 111.167 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.53 -176.86 5.1 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.73 -0.747 . . . . 65.11 112.532 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.88 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.3 p -113.09 139.26 39.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.867 0.365 . . . . 64.03 111.115 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.993 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.52 150.25 18.06 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.568 0.699 . . . . 72.05 110.93 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -21.96 32.54 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.713 2.275 . . . . 75.54 112.297 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -54.47 -38.89 66.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 42.12 110.908 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.416 ' H ' HD23 ' A' ' 39' ' ' LEU . 3.9 mpt_? -103.91 -40.31 6.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 61.1 110.892 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.88 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.9 pp0? -97.35 158.06 15.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 64.22 110.91 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.03 142.52 51.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 75.11 110.928 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.31 135.95 54.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 71.41 110.938 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.752 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.1 mm? -77.4 -67.57 0.7 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 61.44 110.907 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.88 61.21 0.61 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.728 -0.748 . . . . 71.12 112.484 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.578 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 4.6 pp -59.2 -17.94 32.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.864 0.364 . . . . 73.32 110.897 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.71 144.16 42.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 74.43 110.904 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.781 HG21 HD21 ' A' ' 66' ' ' LEU . 10.9 p -143.82 145.63 21.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.428 . . . . 74.34 111.115 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.551 ' HG2' HG22 ' A' ' 50' ' ' VAL . 19.7 mmtp 54.67 32.32 17.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 64.35 110.887 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.25 -11.28 50.64 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.69 -0.767 . . . . 45.1 112.488 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.9 mmtp -81.4 151.45 69.03 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.551 0.691 . . . . 74.22 110.912 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.418 ' O ' ' C ' ' A' ' 55' ' ' ALA . 53.8 Cg_endo -69.68 -32.96 17.84 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.675 2.25 . . . . 75.31 112.349 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.601 ' HA ' HG21 ' A' ' 59' ' ' VAL . . . 36.42 43.65 0.25 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 64.11 111.111 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.97 -76.52 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 71.42 110.88 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -159.26 -37.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 73.22 110.922 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -67.4 -8.13 30.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 75.34 110.899 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.601 HG21 ' HA ' ' A' ' 55' ' ' ALA . 17.0 t -80.2 145.54 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 50.4 111.112 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -90.63 150.82 21.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 51.13 110.898 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.527 ' HA ' HD12 ' A' ' 64' ' ' LEU . 12.6 mt -51.74 -45.06 63.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 72.42 110.903 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.54 -11.29 85.61 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.75 -0.738 . . . . 51.21 112.473 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.9 -35.25 29.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.805 0.336 . . . . 64.54 111.116 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.639 HD11 HG22 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -73.13 -24.53 60.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 52.21 110.871 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.8 mmtp 62.38 38.04 13.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 52.54 110.881 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.781 HD21 HG21 ' A' ' 50' ' ' VAL . 4.2 mt -88.85 153.48 21.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 74.21 110.916 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.45 160.3 76.85 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.583 0.706 . . . . 61.14 110.879 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -35.62 12.22 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.678 2.252 . . . . 62.01 112.322 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.712 ' HA ' HD12 ' A' ' 6' ' ' ILE . 23.8 p30 -78.8 -15.88 57.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 64.31 110.92 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.617 HG21 HD13 ' A' ' 66' ' ' LEU . 55.4 m -32.42 120.13 0.3 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.143 -0.481 . . . . 61.41 111.151 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.72 146.39 23.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 71.52 110.924 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.9 mm -116.97 130.63 71.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 62.11 111.135 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 6.1 mtt -103.91 141.69 35.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 62.42 110.891 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 70.5 mtm -133.99 123.57 24.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.267 -0.424 . . . . 70.35 110.906 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.752 ' CG ' HD21 ' A' ' 46' ' ' LEU . 1.3 mmm -111.12 124.39 52.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 64.44 110.841 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 164.11 -153.96 24.58 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.716 -0.754 . . . . 53.21 112.45 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.9 t -134.47 143.68 47.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.838 0.352 . . . . 72.4 111.133 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -63.72 158.75 20.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 74.21 110.878 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -84.43 140.93 31.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.465 . . . . 63.43 110.894 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -64.73 -31.81 73.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 73.31 110.904 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.6 t -80.4 -63.59 1.38 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.134 -0.485 . . . . 71.01 110.874 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.478 0 O-C-N 124.487 1.117 . . . . 25.2 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.8 0.334 . . . . 61.44 110.868 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.738 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . -94.72 151.36 19.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 52.34 111.091 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.2 mt -110.79 109.1 57.79 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.621 0.724 . . . . 53.54 110.945 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 156.67 62.86 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.673 2.249 . . . . 70.42 112.34 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.458 ' HB ' HD21 ' A' ' 28' ' ' LEU . 38.1 mt -150.56 137.3 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.437 . . . . 75.44 111.147 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.723 HD12 ' HA ' ' A' ' 69' ' ' ASN . 4.1 mt -95.37 140.56 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 72.4 111.146 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.808 HG21 HD13 ' A' ' 32' ' ' LEU . 8.3 p -127.29 122.91 60.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 74.22 111.115 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -107.98 120.19 41.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 74.02 110.907 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.1 t-105 -122.27 100.91 7.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 75.11 110.903 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.91 -83.61 0.77 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.752 -0.737 . . . . 54.11 112.51 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.13 20.38 0.96 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.69 -0.767 . . . . 71.1 112.474 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -129.18 174.9 9.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.771 0.32 . . . . 72.41 110.902 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -132.7 140.64 48.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 55.4 110.934 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -135.92 119.1 16.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 71.35 110.925 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 89.2 p -82.75 136.05 34.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.101 -0.5 . . . . 61.42 110.892 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.527 HG21 HD23 ' A' ' 32' ' ' LEU . 87.3 t -98.87 125.23 52.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 72.31 111.108 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.4 p -135.44 93.41 2.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 63.34 111.121 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.573 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.9 OUTLIER 173.73 -28.84 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 73.14 111.133 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.738 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.9 mm? -84.92 149.85 25.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.222 -0.444 . . . . 63.11 110.893 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.572 ' C ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.77 167.68 19.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 72.42 110.854 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.43 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 56.1 mt-10 -58.58 -22.39 55.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 55.15 110.887 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.11 -11.54 59.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 70.4 110.905 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.447 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.9 m-20 -101.63 -150.24 0.4 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 60.43 110.836 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.487 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -136.53 167.57 21.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.462 . . . . 74.22 111.115 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.625 HG21 HD21 ' A' ' 64' ' ' LEU . 75.0 t -63.03 -42.26 96.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 70.54 111.143 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.417 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -61.97 -28.72 69.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.491 . . . . 70.34 110.901 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.576 ' HB3' HD11 ' A' ' 19' ' ' LEU . 1.2 t0 -72.06 -32.78 67.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 52.44 110.878 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.685 HD23 HD23 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -80.46 -48.93 12.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 53.03 110.917 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.76 -55.79 26.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 72.43 110.902 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.92 -22.64 49.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 72.33 110.918 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.573 ' CZ ' HG21 ' A' ' 18' ' ' THR . 44.5 t80 -77.76 -55.11 5.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.453 . . . . 64.34 110.87 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.808 HD13 HG21 ' A' ' 7' ' ' VAL . 2.8 pp -67.51 -41.93 83.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 60.41 110.915 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.569 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.71 -27.91 44.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 53.1 110.928 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.43 -23.84 42.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.455 . . . . 72.31 111.141 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.441 HD11 ' CE1' ' A' ' 31' ' ' PHE . 13.7 mt -76.15 -59.48 2.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.446 . . . . 75.44 110.877 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.4 t -135.38 -27.77 1.18 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 71.43 111.147 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.569 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.59 -175.34 4.36 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.766 -0.73 . . . . 53.34 112.495 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.726 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.4 p -112.56 141.38 28.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.807 0.337 . . . . 52.21 111.17 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 1.001 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -57.01 149.86 42.68 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.6 0.714 . . . . 74.01 110.885 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -21.4 33.48 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.707 2.272 . . . . 63.14 112.308 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -55.19 -39.25 69.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 71.21 110.835 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.423 ' H ' HD23 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -104.29 -41.42 5.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 72.25 110.891 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.726 ' HG2' HG13 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -96.12 158.41 15.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 61.11 110.898 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.603 ' N ' HE21 ' A' ' 43' ' ' GLN . 0.0 OUTLIER -130.14 142.45 50.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 64.44 110.902 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.52 136.38 54.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 54.43 110.881 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.734 HD11 ' CG ' ' A' ' 75' ' ' MET . 6.2 mp -86.13 -55.26 4.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 62.33 110.877 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.35 52.52 0.97 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.719 -0.753 . . . . 71.14 112.485 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.584 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 4.6 pp -61.67 -16.39 48.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.933 0.397 . . . . 75.51 110.942 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.9 pttt -116.8 143.25 45.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 72.13 110.876 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.988 HG21 HD21 ' A' ' 66' ' ' LEU . 10.6 p -143.73 145.17 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 74.41 111.137 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 55.34 31.52 16.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 71.14 110.924 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.09 -11.17 55.98 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.728 -0.749 . . . . 64.04 112.492 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -81.37 150.98 68.5 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.532 0.682 . . . . 74.14 110.938 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 55' ' ' ALA . 53.6 Cg_endo -69.79 -32.25 18.79 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.691 2.261 . . . . 74.24 112.302 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.591 ' HA ' HG21 ' A' ' 59' ' ' VAL . . . 35.99 44.34 0.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.439 . . . . 42.21 111.128 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.08 -79.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 74.43 110.919 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.04 -38.8 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 54.13 110.884 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -64.6 -9.8 21.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 74.33 110.896 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.591 HG21 ' HA ' ' A' ' 55' ' ' ALA . 16.6 t -79.55 145.69 8.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 73.41 111.159 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 29.8 mttt -91.49 152.25 20.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.446 . . . . 63.4 110.937 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.572 HD12 ' C ' ' A' ' 20' ' ' SER . 20.0 mt -49.86 -47.47 51.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 75.22 110.928 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.72 -11.71 85.18 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.775 -0.726 . . . . 51.41 112.473 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.59 -31.55 41.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.837 0.351 . . . . 52.51 111.076 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.625 HD21 HG21 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -78.17 -23.99 47.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 74.12 110.925 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.7 mmtp 63.45 35.84 11.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 72.03 110.875 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.988 HD21 HG21 ' A' ' 50' ' ' VAL . 4.7 mt -87.78 152.88 21.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.439 . . . . 64.13 110.925 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.7 160.44 77.14 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.627 0.727 . . . . 74.44 110.897 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -34.82 13.77 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.657 2.238 . . . . 74.42 112.355 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.723 ' HA ' HD12 ' A' ' 6' ' ' ILE . 12.3 m120 -78.81 -16.1 57.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 74.13 110.859 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.698 HG21 HD13 ' A' ' 66' ' ' LEU . 49.1 m -32.5 120.17 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 71.1 111.162 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.17 146.68 23.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 71.53 110.891 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.5 mm -115.37 128.95 72.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 72.55 111.147 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 30.8 mtt -99.7 142.67 30.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 72.43 110.865 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.3 mtt -134.08 132.73 40.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 72.0 110.854 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.734 ' CG ' HD11 ' A' ' 46' ' ' LEU . 2.3 mmt -124.58 123.5 40.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 74.5 110.88 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.13 -155.19 26.02 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.733 -0.746 . . . . 61.33 112.472 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 t -132.73 135.41 45.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.775 0.321 . . . . 72.24 111.131 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.522 ' HA ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -93.17 147.83 22.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 62.31 110.867 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.441 ' H ' HD11 ' A' ' 39' ' ' LEU . 21.6 pt-20 -54.46 167.35 0.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 74.25 110.858 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.34 108.15 19.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 72.32 110.877 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.1 m -78.58 -141.44 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 43.54 110.817 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.481 0 O-C-N 124.494 1.121 . . . . 21.41 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mtt . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.815 0.341 . . . . 71.14 110.83 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.734 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . -91.1 151.47 20.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 64.05 111.112 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.663 HD12 ' HG2' ' A' ' 21' ' ' GLU . 4.4 mt -112.13 109.68 54.33 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.589 0.709 . . . . 72.33 110.927 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 156.42 63.49 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.689 2.259 . . . . 72.54 112.364 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.554 ' HB ' HD21 ' A' ' 28' ' ' LEU . 33.8 mt -150.56 137.45 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 72.44 111.134 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.681 HD12 ' HA ' ' A' ' 69' ' ' ASN . 4.3 mt -95.39 140.65 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 63.23 111.137 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.813 HG21 HD13 ' A' ' 32' ' ' LEU . 7.3 p -126.95 123.28 62.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 51.44 111.108 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.52 120.73 43.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 70.23 110.865 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 17.3 t-105 -123.87 105.03 9.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 74.13 110.878 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.88 -81.81 0.9 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.767 -0.73 . . . . 70.03 112.483 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.04 20.25 0.66 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.782 -0.723 . . . . 62.25 112.513 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -129.13 175.35 8.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.756 0.312 . . . . 74.31 110.947 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -132.74 140.12 47.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 75.51 110.899 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.528 ' CD2' HG21 ' A' ' 36' ' ' THR . 47.4 m-85 -134.7 116.33 14.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.172 -0.467 . . . . 73.51 110.913 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.0 p -82.93 130.59 35.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.504 . . . . 75.33 110.864 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.556 HG21 HD23 ' A' ' 32' ' ' LEU . 91.6 t -91.74 142.0 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 74.14 111.148 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.2 p -151.49 92.31 1.76 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 63.21 111.156 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.688 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.8 OUTLIER 173.74 -29.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 63.23 111.148 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.734 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.6 mm? -86.25 152.2 22.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 54.34 110.92 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.427 ' O ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.55 169.75 15.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 75.01 110.851 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.663 ' HG2' HD12 ' A' ' 3' ' ' LEU . 58.2 mt-10 -61.85 -22.23 65.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 63.12 110.914 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -68.8 -12.05 61.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.17 -0.468 . . . . 75.52 110.887 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.412 ' HB2' HD12 ' A' ' 19' ' ' LEU . 2.0 m-20 -99.78 -150.52 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 71.33 110.88 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -132.53 171.37 13.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 64.14 111.17 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.929 HG22 HD11 ' A' ' 64' ' ' LEU . 11.8 t -67.69 -40.96 84.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 72.52 111.119 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.19 -29.4 70.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 72.52 110.905 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.47 ' HB3' HD11 ' A' ' 19' ' ' LEU . 19.0 t0 -70.1 -35.12 73.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 71.41 110.845 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.689 HD12 ' CB ' ' A' ' 19' ' ' LEU . 1.2 tt -80.76 -47.67 13.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 51.24 110.938 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.771 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.86 -56.5 18.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 62.44 110.892 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.15 -22.75 52.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.434 . . . . 64.51 110.915 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.688 ' CZ ' HG21 ' A' ' 18' ' ' THR . 59.9 t80 -76.86 -55.48 5.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 64.25 110.864 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.813 HD13 HG21 ' A' ' 7' ' ' VAL . 2.2 pp -67.29 -43.43 81.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 75.13 110.889 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.571 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.2 tmtt? -54.81 -27.48 42.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 73.31 110.914 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.503 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.34 -23.51 43.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 75.03 111.161 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.6 mt -76.65 -59.59 2.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 53.44 110.929 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.528 HG21 ' CD2' ' A' ' 14' ' ' TYR . 2.7 t -135.01 -27.68 1.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 75.22 111.158 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.571 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.59 -176.68 5.07 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.777 -0.725 . . . . 62.01 112.457 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.883 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.4 p -112.38 138.54 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.887 0.375 . . . . 73.32 111.144 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.983 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.06 149.75 17.35 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.575 0.703 . . . . 74.1 110.947 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -21.97 32.7 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.669 2.246 . . . . 41.22 112.335 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -53.94 -38.43 64.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 61.35 110.907 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.408 ' H ' HD23 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -105.08 -39.52 6.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 63.35 110.919 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.883 ' HG2' HG13 ' A' ' 38' ' ' VAL . 2.3 pp0? -96.54 158.66 15.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 71.2 110.892 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.02 139.33 52.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 73.15 110.871 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.663 HD22 HE22 ' A' ' 43' ' ' GLN . 3.7 mm? -65.81 135.45 54.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.257 -0.429 . . . . 73.4 110.898 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.735 HD11 ' CG ' ' A' ' 75' ' ' MET . 7.2 mp -77.45 -75.81 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.467 . . . . 73.0 110.907 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.12 59.44 1.68 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.755 -0.736 . . . . 64.51 112.508 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.64 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 3.6 pp -55.83 -24.39 36.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.874 0.369 . . . . 74.25 110.914 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.423 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 1.9 pttt -103.45 143.16 33.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 73.44 110.854 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.8 HG21 HD21 ' A' ' 66' ' ' LEU . 14.4 p -144.19 143.36 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.42 . . . . 51.25 111.126 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.6 mttm 54.04 34.17 19.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 74.21 110.865 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.38 -15.16 41.79 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.741 -0.743 . . . . 74.34 112.47 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -81.56 149.59 64.95 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.557 0.694 . . . . 72.22 110.887 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.423 ' HA ' ' HB3' ' A' ' 49' ' ' LYS . 53.8 Cg_endo -69.77 -36.4 10.85 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.714 2.276 . . . . 65.2 112.344 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 38.4 40.01 0.33 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 71.51 111.075 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -66.94 -74.37 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 71.5 110.865 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.401 HD22 ' N ' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -156.54 -37.31 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 71.1 110.87 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.401 ' N ' HD22 ' A' ' 57' ' ' ASN . 56.4 m-20 -74.67 -2.98 28.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 75.31 110.897 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.597 ' O ' HG23 ' A' ' 25' ' ' VAL . 1.3 t -91.15 146.94 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 61.43 111.13 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.465 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 24.6 mttt -89.04 146.55 24.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 70.33 110.943 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.438 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 18.3 mt -52.12 -37.58 54.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.256 -0.429 . . . . 52.4 110.906 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.93 -18.24 79.62 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.748 -0.739 . . . . 71.33 112.47 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.73 -15.56 44.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.883 0.373 . . . . 53.03 111.141 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.929 HD11 HG22 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -87.04 -18.31 30.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 71.22 110.913 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 49.66 45.08 24.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 73.11 110.924 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.8 HD21 HG21 ' A' ' 50' ' ' VAL . 3.4 mt -97.86 152.99 18.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 65.34 110.923 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.42 159.81 79.15 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.547 0.689 . . . . 63.41 110.911 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -36.57 10.51 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.682 2.255 . . . . 64.04 112.332 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.681 ' HA ' HD12 ' A' ' 6' ' ' ILE . 5.0 m120 -78.45 -15.59 58.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 75.22 110.911 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.649 HG21 HD13 ' A' ' 66' ' ' LEU . 52.2 m -32.93 125.68 0.34 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 74.14 111.126 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.88 145.29 25.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 74.34 110.887 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.3 mm -115.57 131.9 66.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 62.31 111.14 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.2 mtp -101.99 141.78 34.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 71.24 110.913 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 75.9 mtm -133.47 120.0 20.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 74.33 110.856 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.735 ' CG ' HD11 ' A' ' 46' ' ' LEU . 1.5 mmt -109.7 123.8 50.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 74.14 110.921 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 162.73 -155.56 26.94 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 70.34 112.48 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.9 t -134.09 144.04 48.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.8 0.333 . . . . 74.41 111.134 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -64.22 156.05 29.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 75.13 110.889 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -81.38 141.94 33.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 74.22 110.852 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.625 ' O ' ' N ' ' A' ' 90' ' ' NH2 . 0.2 OUTLIER 58.27 89.02 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 63.31 110.877 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.76 -38.32 0.12 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 53.13 110.895 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' NH2 . . . . . 0.625 ' N ' ' O ' ' A' ' 80' ' ' GLU . . . . . . . . 0 C--N 1.324 -0.513 0 O-C-N 124.55 1.156 . . . . 35.12 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.78 0.324 . . . . 74.21 110.864 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.74 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . -90.8 151.13 21.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 40.53 111.121 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.409 HD23 ' HD2' ' A' ' 4' ' ' PRO . 1.9 mt -110.49 108.89 58.36 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.665 0.745 . . . . 73.11 110.892 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.409 ' HD2' HD23 ' A' ' 3' ' ' LEU . 53.6 Cg_endo -69.8 156.52 63.05 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.735 2.29 . . . . 65.21 112.33 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.461 ' HB ' HD21 ' A' ' 28' ' ' LEU . 39.0 mt -150.5 137.24 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 62.45 111.128 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.69 HD12 ' HA ' ' A' ' 69' ' ' ASN . 4.6 mt -94.96 140.57 16.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 75.33 111.143 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.814 HG21 HD13 ' A' ' 32' ' ' LEU . 8.0 p -127.28 122.88 60.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 74.31 111.153 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -107.31 118.85 37.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 73.1 110.9 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 16.8 t-105 -121.18 101.59 7.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.233 -0.44 . . . . 73.34 110.895 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.48 -83.24 0.79 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.81 -0.71 . . . . 72.14 112.524 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.85 20.55 0.89 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.756 -0.735 . . . . 54.21 112.488 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -129.2 175.83 8.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.711 0.291 . . . . 61.55 110.957 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -132.88 140.78 48.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 73.42 110.903 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -136.62 118.13 14.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.147 -0.479 . . . . 73.34 110.931 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.02 133.94 35.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 73.34 110.856 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.532 HG21 HD23 ' A' ' 32' ' ' LEU . 86.3 t -96.02 126.91 48.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 74.11 111.124 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.1 p -135.94 91.99 2.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 74.33 111.121 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.659 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 1.2 t 174.62 -29.69 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 75.32 111.125 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.74 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.9 mm? -83.4 149.62 26.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 74.3 110.91 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.518 ' C ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.5 168.01 18.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 72.12 110.844 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.401 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 36.9 mt-10 -59.24 -22.01 60.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 62.43 110.896 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -69.11 -10.7 58.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 71.3 110.873 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.465 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.5 m-20 -100.89 -150.19 0.39 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 74.55 110.855 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -137.07 167.99 20.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 75.55 111.141 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.941 HG22 HD11 ' A' ' 64' ' ' LEU . 41.8 t -62.38 -45.02 99.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 73.53 111.158 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -60.78 -28.54 68.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.475 . . . . 71.33 110.918 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.567 ' HB3' HD11 ' A' ' 19' ' ' LEU . 0.7 OUTLIER -71.05 -33.56 70.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 43.15 110.938 179.792 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.689 HD23 HD23 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -80.86 -48.97 11.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 64.31 110.902 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.592 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.4 -56.58 18.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 72.34 110.858 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -58.29 -22.04 51.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 62.01 110.93 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.659 ' CZ ' HG21 ' A' ' 18' ' ' THR . 44.9 t80 -77.88 -54.93 5.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 65.41 110.854 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.814 HD13 HG21 ' A' ' 7' ' ' VAL . 2.6 pp -67.73 -42.24 82.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 54.45 110.929 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.577 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.88 -27.39 42.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 70.44 110.889 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.484 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.77 -23.77 41.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 74.01 111.207 179.925 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.416 HD11 ' CE2' ' A' ' 31' ' ' PHE . 13.9 mt -76.5 -59.94 2.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 52.32 110.896 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.9 t -135.28 -27.62 1.2 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.443 . . . . 74.25 111.162 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.577 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.61 -177.81 4.61 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.729 -0.748 . . . . 72.14 112.532 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.89 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.3 p -112.66 138.56 41.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.827 0.346 . . . . 64.0 111.145 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.967 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -55.17 151.17 18.45 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.614 0.721 . . . . 71.11 110.903 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -21.61 33.51 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.718 2.279 . . . . 74.2 112.334 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -54.38 -38.91 66.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 75.43 110.869 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.447 ' H ' HD23 ' A' ' 39' ' ' LEU . 3.1 mpt_? -104.14 -40.4 6.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 74.14 110.897 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.89 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.7 pp0? -97.86 158.43 15.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 72.32 110.917 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.64 140.85 51.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 71.42 110.861 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 45' ' ' LEU . 3.8 mm? -67.35 135.75 53.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.461 . . . . 74.05 110.913 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.742 HD21 ' CG ' ' A' ' 75' ' ' MET . 3.8 mm? -81.05 -64.39 1.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 63.42 110.91 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.63 56.89 1.64 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.781 -0.723 . . . . 71.33 112.516 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.805 ' C ' HD22 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -59.72 -13.4 9.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.886 0.374 . . . . 52.33 110.905 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.514 ' N ' HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -122.31 145.97 47.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 54.14 110.903 179.851 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.924 HG21 HD21 ' A' ' 66' ' ' LEU . 9.6 p -143.75 144.06 23.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.207 -0.451 . . . . 74.02 111.109 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.2 mttt 54.72 31.14 14.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 73.11 110.907 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.24 -9.99 59.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.763 -0.732 . . . . 70.55 112.485 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -81.04 150.25 68.18 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.576 0.703 . . . . 64.23 110.88 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.411 ' O ' ' C ' ' A' ' 55' ' ' ALA . 53.7 Cg_endo -69.76 -30.53 22.12 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.7 2.267 . . . . 62.12 112.328 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.62 ' HA ' HG21 ' A' ' 59' ' ' VAL . . . 35.5 43.28 0.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 53.2 111.102 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.33 -78.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 70.34 110.929 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -157.44 -38.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 72.54 110.845 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -66.12 -8.59 24.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.221 -0.445 . . . . 73.42 110.838 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.62 HG21 ' HA ' ' A' ' 55' ' ' ALA . 21.4 t -78.79 146.55 7.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 32.4 111.133 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 28.8 mttt -93.24 151.14 20.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 54.23 110.885 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.54 ' HA ' HD12 ' A' ' 64' ' ' LEU . 18.9 mt -50.64 -45.64 57.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.264 -0.425 . . . . 64.32 110.882 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.38 -12.02 84.59 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.79 -0.719 . . . . 52.33 112.474 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.14 -33.45 29.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.8 0.333 . . . . 53.22 111.077 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.941 HD11 HG22 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -73.09 -25.07 60.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 64.41 110.905 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt 62.63 37.75 12.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.218 -0.446 . . . . 72.53 110.891 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.924 HD21 HG21 ' A' ' 50' ' ' VAL . 5.8 mt -91.31 152.98 20.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.266 -0.424 . . . . 75.1 110.928 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -68.7 160.71 75.86 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.589 0.709 . . . . 70.41 110.909 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -35.42 12.61 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.696 2.264 . . . . 72.12 112.356 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.69 ' HA ' HD12 ' A' ' 6' ' ' ILE . 8.6 m-20 -78.86 -15.96 57.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 71.1 110.906 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.472 ' C ' ' O ' ' A' ' 69' ' ' ASN . 54.6 m -32.51 124.72 0.33 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 70.52 111.133 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.4 147.0 23.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 74.31 110.859 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.6 mm -116.93 127.5 74.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 74.32 111.128 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.4 mtt -99.22 141.87 31.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 74.24 110.838 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.9 mtt -136.14 117.22 14.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 74.2 110.864 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.742 ' CG ' HD21 ' A' ' 46' ' ' LEU . 1.4 mmt -106.19 125.78 51.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 55.31 110.863 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 160.26 -155.3 26.42 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.763 -0.732 . . . . 62.12 112.487 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.0 t -134.52 147.82 50.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.779 0.323 . . . . 74.43 111.163 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -64.95 157.0 29.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 50.51 110.849 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.56 165.69 0.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 74.31 110.89 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.03 148.89 43.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 65.42 110.905 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.3 p -152.11 -165.58 2.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 62.54 110.882 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.472 0 O-C-N 124.508 1.13 . . . . 72.14 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mtt . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.774 0.321 . . . . 71.43 110.879 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.737 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . -85.42 151.46 23.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 72.51 111.116 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.411 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 3.9 mt -111.08 109.36 57.11 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.59 0.71 . . . . 65.02 110.865 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 53.9 Cg_endo -69.74 156.05 64.39 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.738 2.292 . . . . 71.34 112.356 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.431 ' HB ' HD21 ' A' ' 28' ' ' LEU . 53.4 mt -150.7 135.96 10.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.452 . . . . 62.42 111.146 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.697 HD12 ' HA ' ' A' ' 69' ' ' ASN . 3.3 mt -94.24 140.4 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 73.24 111.118 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.831 HG21 HD13 ' A' ' 32' ' ' LEU . 8.9 p -127.34 123.39 61.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 63.43 111.121 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.64 123.01 48.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 71.13 110.866 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.0 t-105 -123.87 100.49 6.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 73.54 110.9 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.23 -80.41 1.3 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.718 -0.753 . . . . 54.54 112.458 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.25 17.24 0.79 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.735 . . . . 61.43 112.48 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -129.89 139.03 51.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.774 0.321 . . . . 64.15 110.943 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -103.07 142.39 34.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 70.23 110.846 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -135.84 117.27 14.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 75.12 110.92 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 82.6 p -81.82 132.6 35.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 45.43 110.829 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.545 HG21 HD23 ' A' ' 32' ' ' LEU . 99.9 t -93.31 136.31 25.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 74.45 111.155 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.2 p -147.55 92.38 2.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 74.35 111.145 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.488 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.7 OUTLIER 173.51 -28.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 74.42 111.152 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.737 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.6 mm? -85.98 150.72 24.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 63.24 110.911 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.545 ' C ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.81 168.7 17.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.464 . . . . 74.3 110.876 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.426 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 69.9 mt-10 -59.51 -22.14 61.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 52.1 110.893 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.04 -12.57 60.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 61.21 110.883 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.423 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.9 m-20 -101.97 -148.7 0.38 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 72.24 110.874 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.499 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -136.64 168.28 19.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 71.42 111.13 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.601 HG21 HD21 ' A' ' 64' ' ' LEU . 86.9 t -63.02 -45.15 99.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 63.22 111.103 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.422 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -59.8 -27.95 67.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 65.43 110.94 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.537 ' HB3' HD11 ' A' ' 19' ' ' LEU . 2.3 t0 -71.79 -33.78 68.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.193 -0.458 . . . . 54.44 110.835 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.657 HD12 ' HB3' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -80.67 -48.28 12.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 75.51 110.907 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.503 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.64 -55.79 26.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 74.53 110.86 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.51 -22.5 44.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 74.04 110.94 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.488 ' CZ ' HG21 ' A' ' 18' ' ' THR . 45.8 t80 -77.75 -55.06 5.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 73.33 110.891 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.831 HD13 HG21 ' A' ' 7' ' ' VAL . 2.5 pp -67.76 -42.93 81.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 74.13 110.945 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.582 ' N ' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -54.62 -27.53 40.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 63.42 110.923 179.797 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.46 -23.6 42.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.465 . . . . 75.53 111.15 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.2 mt -76.58 -59.15 2.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 74.32 110.958 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.5 t -134.95 -28.09 1.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.444 . . . . 64.21 111.132 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.573 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.79 -176.52 5.21 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.727 -0.749 . . . . 63.25 112.499 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.864 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.3 p -113.39 138.28 43.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.834 0.349 . . . . 74.31 111.145 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.97 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -53.61 149.94 14.39 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.633 0.73 . . . . 74.41 110.911 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.401 ' O ' ' O ' ' A' ' 43' ' ' GLN . 53.5 Cg_endo -69.78 -21.72 33.01 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.647 2.231 . . . . 64.02 112.373 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -54.06 -38.33 65.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 63.54 110.882 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.42 ' H ' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -104.76 -40.05 6.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 73.02 110.838 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.864 ' HG2' HG13 ' A' ' 38' ' ' VAL . 2.2 pp0? -96.72 158.05 15.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 65.35 110.876 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.65 140.78 51.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 73.33 110.896 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.652 HD22 HE22 ' A' ' 43' ' ' GLN . 3.7 mm? -66.72 135.85 54.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.434 . . . . 71.15 110.906 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.738 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.0 mm? -75.15 -70.25 0.43 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 61.21 110.911 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -99.73 61.22 0.73 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.708 -0.758 . . . . 62.33 112.455 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.587 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 4.5 pp -57.7 -19.63 28.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.879 0.371 . . . . 54.24 110.929 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.34 144.47 39.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 74.14 110.865 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.979 HG21 HD21 ' A' ' 66' ' ' LEU . 9.7 p -143.83 145.57 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 62.15 111.134 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.9 mttm 54.89 32.24 17.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 62.42 110.892 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.04 -11.16 50.04 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.749 -0.738 . . . . 72.44 112.445 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.0 mmtt -81.3 151.31 69.19 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.581 0.705 . . . . 75.25 110.878 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 55' ' ' ALA . 53.8 Cg_endo -69.81 -32.92 17.43 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.665 2.244 . . . . 71.44 112.313 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.588 ' HA ' HG21 ' A' ' 59' ' ' VAL . . . 36.6 43.51 0.27 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 73.14 111.059 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.47 -76.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.203 -0.453 . . . . 72.04 110.919 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -159.47 -37.28 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 43.24 110.913 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.27 -7.8 27.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 73.02 110.9 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.588 HG21 ' HA ' ' A' ' 55' ' ' ALA . 17.6 t -80.52 145.72 8.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 70.23 111.096 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -90.23 151.46 21.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 72.31 110.913 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.545 HD12 ' C ' ' A' ' 20' ' ' SER . 18.6 mt -49.92 -47.62 52.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 74.21 110.924 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.57 -11.95 84.98 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.739 -0.744 . . . . 42.25 112.498 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.04 -32.06 44.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.822 0.344 . . . . 62.14 111.104 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.601 HD21 HG21 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -77.83 -23.48 48.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 72.31 110.912 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt 63.39 37.2 10.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 72.25 110.916 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.979 HD21 HG21 ' A' ' 50' ' ' VAL . 6.1 mt -88.79 152.56 21.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 63.41 110.939 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -68.64 160.24 77.85 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.572 0.701 . . . . 71.42 110.878 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -35.54 12.58 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.68 2.254 . . . . 74.12 112.385 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.697 ' HA ' HD12 ' A' ' 6' ' ' ILE . 8.2 p30 -78.5 -15.78 58.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 71.52 110.908 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.445 ' C ' ' O ' ' A' ' 69' ' ' ASN . 50.1 m -32.83 119.47 0.32 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 61.5 111.14 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -91.05 146.77 23.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 71.55 110.903 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.3 mm -115.36 129.78 71.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.436 . . . . 74.12 111.106 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 41.3 mtm -101.45 141.65 34.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 74.01 110.875 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.1 mtt -130.78 130.1 43.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 64.44 110.879 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.738 ' CG ' HD21 ' A' ' 46' ' ' LEU . 2.3 mmt -122.21 127.04 49.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 72.4 110.858 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.88 -150.87 22.52 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.714 -0.755 . . . . 74.4 112.468 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 t -132.92 125.17 29.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.742 0.306 . . . . 73.53 111.114 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.513 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -83.82 148.22 27.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 72.35 110.836 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -69.68 -172.49 0.5 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.465 . . . . 74.33 110.905 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -98.1 -59.29 1.79 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 71.24 110.884 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.9 t -135.39 -40.27 0.73 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.098 -0.501 . . . . 74.4 110.854 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.497 0 O-C-N 124.519 1.137 . . . . 41.24 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mmt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.781 0.324 . . . . 72.43 110.872 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.678 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . -101.73 151.34 22.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 54.4 111.131 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.411 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 2.7 mt -114.45 107.44 51.24 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.628 0.728 . . . . 75.4 110.9 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 53.8 Cg_endo -69.76 156.02 64.43 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.664 2.243 . . . . 61.4 112.364 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.94 HD12 HD22 ' A' ' 28' ' ' LEU . 19.9 mt -150.88 138.63 13.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 72.14 111.102 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.622 HD12 ' HA ' ' A' ' 69' ' ' ASN . 5.2 mt -95.13 140.72 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 71.51 111.094 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.766 HG21 HD13 ' A' ' 32' ' ' LEU . 8.8 p -126.9 123.24 62.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 70.11 111.142 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.21 118.53 37.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 64.4 110.902 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 17.4 t-105 -120.57 103.77 9.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 70.44 110.938 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.41 -83.26 0.88 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.723 -0.751 . . . . 70.11 112.481 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.06 20.18 0.86 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.678 -0.772 . . . . 71.34 112.448 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -128.84 175.69 8.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.715 0.293 . . . . 75.33 110.932 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -132.79 141.84 48.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 72.43 110.92 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -138.49 116.46 11.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 73.44 110.889 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.21 137.35 35.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 73.24 110.855 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.499 HG21 HD23 ' A' ' 32' ' ' LEU . 84.3 t -94.21 142.45 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 51.42 111.141 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.4 HG23 ' O ' ' A' ' 16' ' ' VAL . 6.4 p -155.26 90.83 1.29 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 74.43 111.198 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.671 HG21 ' CE1' ' A' ' 31' ' ' PHE . 1.8 t 177.11 -31.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 75.54 111.138 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.797 ' CB ' HD12 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -88.02 163.67 16.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.44 . . . . 74.22 110.932 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.24 173.96 11.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 73.34 110.862 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.419 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 36.6 mt-10 -63.13 -20.03 65.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.482 . . . . 73.5 110.879 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -69.42 -11.09 60.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 54.35 110.896 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.676 ' HB2' HD23 ' A' ' 19' ' ' LEU . 6.0 m-20 -97.76 -152.08 0.39 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 74.44 110.896 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -137.09 165.3 26.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 53.23 111.143 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.603 HG22 HD11 ' A' ' 64' ' ' LEU . 72.6 t -59.04 -43.87 90.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 74.32 111.091 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.42 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -63.56 -30.54 71.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 75.11 110.918 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.591 ' HB3' HD21 ' A' ' 19' ' ' LEU . 5.6 t70 -72.22 -33.85 67.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 54.53 110.864 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.94 HD22 HD12 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -78.8 -47.89 15.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 63.53 110.889 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.477 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -62.75 -54.22 42.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 74.13 110.892 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.49 -22.11 30.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 70.41 110.884 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.671 ' CE1' HG21 ' A' ' 18' ' ' THR . 61.0 t80 -77.57 -55.15 5.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 63.21 110.915 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.766 HD13 HG21 ' A' ' 7' ' ' VAL . 2.1 pp -68.45 -42.24 79.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.477 . . . . 62.35 110.872 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.574 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.65 -27.51 40.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 64.42 110.927 179.818 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.62 -23.76 42.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 63.54 111.106 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.8 mt -76.4 -59.9 2.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.42 . . . . 72.52 110.893 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.5 t -135.14 -27.8 1.21 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.203 -0.453 . . . . 73.15 111.111 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.574 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.8 -177.55 4.68 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.778 -0.725 . . . . 41.43 112.486 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.876 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.3 p -112.7 138.59 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.842 0.353 . . . . 64.41 111.137 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.952 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.78 150.93 16.67 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.632 0.73 . . . . 71.52 110.868 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 53.7 Cg_endo -69.83 -21.7 32.78 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.638 2.225 . . . . 55.33 112.355 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -54.09 -39.14 66.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 74.11 110.872 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.446 ' H ' HD23 ' A' ' 39' ' ' LEU . 23.2 mtt85 -104.04 -40.44 6.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 70.21 110.884 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.876 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.8 pp0? -97.23 157.21 16.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 72.25 110.914 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.83 143.31 50.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 74.12 110.902 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.413 HD22 ' N ' ' A' ' 45' ' ' LEU . 3.7 mm? -67.57 136.1 53.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 73.5 110.908 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.724 HD11 ' CG ' ' A' ' 75' ' ' MET . 6.3 mp -86.13 -53.0 5.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 52.51 110.904 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -104.68 53.37 0.68 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.718 -0.754 . . . . 63.55 112.474 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.58 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 4.5 pp -59.67 -17.91 37.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.855 0.359 . . . . 71.55 110.886 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.93 143.13 45.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 72.43 110.91 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.793 HG21 HD21 ' A' ' 66' ' ' LEU . 11.5 p -143.67 145.3 22.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 74.42 111.094 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.92 31.86 16.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 72.43 110.868 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.99 -10.99 56.54 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.756 -0.735 . . . . 61.44 112.494 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -81.62 150.99 67.67 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.61 0.719 . . . . 64.04 110.9 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 55' ' ' ALA . 54.3 Cg_endo -69.73 -32.74 18.1 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.709 2.273 . . . . 42.04 112.353 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.625 ' HA ' HG21 ' A' ' 59' ' ' VAL . . . 36.04 44.25 0.25 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 65.02 111.083 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.77 -80.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 64.24 110.918 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -154.65 -39.26 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 72.22 110.886 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.69 -10.39 19.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 74.44 110.864 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.625 HG21 ' HA ' ' A' ' 55' ' ' ALA . 16.6 t -79.28 146.1 8.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 74.51 111.141 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 14.6 mttt -93.02 152.16 19.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 74.12 110.892 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.539 ' CD1' HD13 ' A' ' 28' ' ' LEU . 24.3 mt -50.13 -46.56 53.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 74.02 110.939 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.22 -12.02 84.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.742 -0.742 . . . . 70.04 112.435 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.92 -33.1 34.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.883 0.373 . . . . 52.12 111.111 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.603 HD11 HG22 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -74.23 -24.6 59.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 73.42 110.917 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt 62.95 37.86 11.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 73.41 110.955 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.793 HD21 HG21 ' A' ' 50' ' ' VAL . 4.5 mt -90.76 154.11 19.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 65.44 110.905 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -68.35 160.26 76.62 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.574 0.702 . . . . 74.1 110.929 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 -35.51 12.71 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.68 2.253 . . . . 53.25 112.395 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.622 ' HA ' HD12 ' A' ' 6' ' ' ILE . 7.8 m-20 -78.83 -16.32 57.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 73.12 110.94 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.665 HG21 HD13 ' A' ' 66' ' ' LEU . 55.5 m -32.45 126.11 0.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 74.4 111.142 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.34 147.5 23.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 73.12 110.874 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.0 mm -117.54 128.64 74.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 75.34 111.168 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.406 ' HB3' HD13 ' A' ' 46' ' ' LEU . 6.5 mtt -99.02 141.87 31.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 74.34 110.863 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.7 mtt -137.03 116.96 13.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 71.53 110.883 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.724 ' CG ' HD11 ' A' ' 46' ' ' LEU . 4.2 mmm -107.14 126.13 51.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 74.41 110.893 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.83 -155.05 26.19 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.735 . . . . 75.1 112.475 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.3 t -134.65 143.83 47.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.764 0.316 . . . . 61.0 111.133 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -61.72 159.56 13.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 74.52 110.891 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -52.07 157.25 1.36 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 74.21 110.853 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -165.46 32.0 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 73.52 110.877 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.6 t -168.5 -128.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 72.51 110.86 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.454 0 O-C-N 124.504 1.128 . . . . 32.3 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.77 0.319 . . . . 73.1 110.848 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.697 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . -113.39 146.7 39.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 73.33 111.06 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.409 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 3.3 mt -110.9 108.11 57.74 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.644 0.735 . . . . 74.44 110.911 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 53.8 Cg_endo -69.81 155.72 65.07 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.666 2.244 . . . . 64.31 112.338 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.866 HD12 HD22 ' A' ' 28' ' ' LEU . 17.4 mt -150.95 138.68 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 73.13 111.12 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.552 HD12 ' HA ' ' A' ' 69' ' ' ASN . 6.1 mt -94.78 140.79 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 72.44 111.109 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.789 HG21 HD13 ' A' ' 32' ' ' LEU . 8.4 p -126.63 123.13 62.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.124 -0.489 . . . . 62.01 111.154 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -107.77 117.38 33.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 72.4 110.863 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 17.9 t-105 -119.84 102.07 8.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 70.12 110.902 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.09 -82.93 0.81 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.748 -0.739 . . . . 51.0 112.505 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.26 19.93 0.83 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.734 -0.745 . . . . 73.23 112.471 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -128.26 175.72 8.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.75 0.31 . . . . 73.34 110.938 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -132.99 141.7 48.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 72.42 110.875 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -138.28 118.38 13.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.16 -0.473 . . . . 63.43 110.938 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.4 p -82.62 135.38 35.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 75.32 110.898 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.526 HG21 ' CD2' ' A' ' 32' ' ' LEU . 62.3 t -94.36 130.58 43.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 64.35 111.13 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.5 p -144.37 90.55 2.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 73.31 111.123 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.764 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 2.8 t 177.68 -32.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 73.13 111.119 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.785 HD13 ' HA ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -87.86 164.12 16.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 61.11 110.898 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.42 174.82 10.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 74.52 110.877 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.404 ' HG2' HD12 ' A' ' 3' ' ' LEU . 37.8 mt-10 -64.8 -20.46 66.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 63.53 110.873 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -67.73 -20.98 65.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 72.32 110.852 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.663 ' HB2' HD23 ' A' ' 19' ' ' LEU . 1.5 m-20 -85.31 -150.36 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 73.24 110.84 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.97 162.68 33.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 75.33 111.121 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.011 HG22 HD11 ' A' ' 64' ' ' LEU . 22.0 t -55.5 -48.53 77.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.45 . . . . 74.23 111.12 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.403 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -61.29 -28.33 69.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 61.2 110.929 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.558 ' HB3' HD21 ' A' ' 19' ' ' LEU . 9.3 t70 -71.56 -36.24 70.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 74.12 110.901 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.866 HD22 HD12 ' A' ' 5' ' ' ILE . 0.9 OUTLIER -77.2 -47.72 19.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 72.0 110.894 -179.959 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.536 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -62.47 -55.11 30.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 73.02 110.875 179.83 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -56.62 -22.65 35.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 73.23 110.878 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.764 ' CZ ' HG21 ' A' ' 18' ' ' THR . 42.7 t80 -76.77 -55.08 5.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 73.43 110.874 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.789 HD13 HG21 ' A' ' 7' ' ' VAL . 1.8 pp -69.01 -41.86 77.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 73.35 110.875 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.569 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.2 tmtt? -54.85 -27.72 44.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 73.34 110.899 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.519 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.33 -23.41 43.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.461 . . . . 74.35 111.157 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.5 mt -76.98 -59.77 2.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 73.13 110.915 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.8 t -135.66 -27.64 1.15 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.458 . . . . 64.02 111.176 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.569 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.66 -177.77 4.64 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.704 -0.76 . . . . 73.34 112.506 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.884 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.3 p -112.31 138.88 39.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.88 0.371 . . . . 73.33 111.159 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.984 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.78 151.04 16.25 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.635 0.731 . . . . 75.33 110.913 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 53.3 Cg_endo -69.74 -21.79 33.09 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.713 2.275 . . . . 72.43 112.318 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -54.17 -39.11 66.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 63.43 110.911 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.425 ' H ' HD23 ' A' ' 39' ' ' LEU . 4.2 mpt_? -104.02 -40.21 6.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 73.52 110.855 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.884 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.7 pp0? -97.84 157.37 16.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 55.42 110.881 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.06 142.1 51.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 74.45 110.902 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 45' ' ' LEU . 3.7 mm? -67.45 135.95 53.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 64.21 110.916 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.733 HD11 ' CG ' ' A' ' 75' ' ' MET . 6.2 mp -85.37 -60.49 2.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 73.45 110.939 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.82 51.63 0.97 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.755 -0.736 . . . . 64.35 112.494 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.651 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 3.6 pp -55.2 -25.45 32.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.909 0.385 . . . . 75.22 110.929 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.414 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -107.34 141.76 38.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 41.3 110.88 179.832 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.977 HG21 HD11 ' A' ' 66' ' ' LEU . 23.8 t -143.95 144.97 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 61.13 111.113 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.554 ' HG2' HG12 ' A' ' 50' ' ' VAL . 0.4 OUTLIER 54.34 32.41 16.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 74.25 110.944 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.07 -14.45 49.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.716 -0.755 . . . . 64.22 112.467 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -81.55 148.74 63.04 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.6 0.714 . . . . 63.53 110.866 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.414 ' HA ' ' HB3' ' A' ' 49' ' ' LYS . 53.5 Cg_endo -69.82 -35.0 13.27 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.696 2.264 . . . . 52.22 112.341 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.651 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 37.39 41.49 0.26 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 75.03 111.132 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.73 -76.89 0.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 71.55 110.885 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -150.98 -39.44 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 63.33 110.892 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -71.96 -2.63 18.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 71.32 110.875 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.566 ' O ' HG23 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -95.78 147.44 5.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 62.03 111.155 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.473 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 30.8 mttt -93.93 149.05 21.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 74.55 110.888 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.666 ' CD1' HD13 ' A' ' 28' ' ' LEU . 17.4 mt -51.98 -39.74 59.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 74.03 110.956 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.13 -16.49 80.56 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.767 -0.73 . . . . 53.54 112.489 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.91 -19.75 31.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.814 0.34 . . . . 61.31 111.096 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.011 HD11 HG22 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -85.05 -18.89 32.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 73.1 110.899 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp 52.31 42.63 31.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 62.13 110.879 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.977 HD11 HG21 ' A' ' 50' ' ' VAL . 3.3 mt -91.12 153.64 19.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 75.41 110.921 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.47 159.13 82.74 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.6 0.714 . . . . 65.22 110.842 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -37.21 9.56 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.69 2.26 . . . . 75.11 112.339 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.552 ' HA ' HD12 ' A' ' 6' ' ' ILE . 11.7 p30 -79.42 -16.31 56.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 64.44 110.856 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.634 HG21 HD13 ' A' ' 66' ' ' LEU . 65.8 m -31.77 132.4 0.11 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 52.32 111.144 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.86 145.92 28.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 74.15 110.916 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.5 mm -115.63 128.75 72.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.245 -0.434 . . . . 62.03 111.117 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.2 mtt -99.35 141.45 32.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 71.24 110.918 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.9 mtt -136.65 116.71 13.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 75.43 110.878 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.733 ' CG ' HD11 ' A' ' 46' ' ' LEU . 3.9 mmm -106.38 127.13 53.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 73.11 110.88 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.98 -155.92 27.08 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.697 -0.764 . . . . 55.14 112.436 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.3 t -134.71 146.59 49.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.768 0.318 . . . . 71.53 111.195 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -64.12 160.58 17.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 70.21 110.848 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.79 177.97 5.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 61.44 110.88 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -130.14 -48.99 1.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 72.2 110.883 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.19 162.84 13.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 75.34 110.874 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.489 0 O-C-N 124.494 1.121 . . . . 71.3 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mtt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.771 0.319 . . . . 71.32 110.86 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.733 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . -87.0 145.46 26.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 74.32 111.143 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.447 HD23 ' HG3' ' A' ' 21' ' ' GLU . 1.7 mm? -105.66 109.82 63.58 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.608 0.718 . . . . 63.44 110.934 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 156.46 63.45 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.716 2.277 . . . . 50.52 112.356 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.551 ' HB ' HD21 ' A' ' 28' ' ' LEU . 29.1 mt -149.98 137.01 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 75.15 111.132 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.669 HD12 ' HA ' ' A' ' 69' ' ' ASN . 3.7 mt -95.33 140.58 16.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 73.31 111.134 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.807 HG21 HD13 ' A' ' 32' ' ' LEU . 7.6 p -127.42 123.5 61.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 72.34 111.142 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.35 121.44 45.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 73.45 110.9 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 17.3 t-105 -125.17 106.25 9.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 74.12 110.928 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.16 -81.29 0.86 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.744 -0.741 . . . . 71.34 112.464 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -155.12 19.83 0.56 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.745 -0.741 . . . . 75.41 112.487 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -129.3 175.23 8.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.793 0.33 . . . . 72.2 110.865 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -132.43 140.09 48.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 63.33 110.881 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.55 ' CG ' HG21 ' A' ' 36' ' ' THR . 50.0 m-85 -134.39 116.13 14.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 63.43 110.979 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.76 131.49 35.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.488 . . . . 74.11 110.858 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.539 HG21 HD23 ' A' ' 32' ' ' LEU . 90.4 t -92.79 141.43 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 64.44 111.143 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.3 p -150.58 92.62 1.87 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 75.22 111.142 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.685 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.8 OUTLIER 173.29 -28.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 73.02 111.137 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.733 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.8 mm? -86.36 150.81 24.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.248 -0.433 . . . . 65.52 110.93 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.67 167.55 19.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 51.23 110.83 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.447 ' HG3' HD23 ' A' ' 3' ' ' LEU . 40.3 mt-10 -59.41 -22.24 61.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 52.44 110.892 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.0 -11.52 60.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.144 -0.48 . . . . 72.02 110.852 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.415 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.5 m-20 -100.34 -150.37 0.38 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 75.44 110.837 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.418 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -132.94 170.09 15.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 64.04 111.15 -179.892 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.974 HG22 HD11 ' A' ' 64' ' ' LEU . 12.8 t -66.1 -43.75 92.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 62.04 111.114 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.4 -28.77 68.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 62.31 110.926 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.477 ' HB3' HD11 ' A' ' 19' ' ' LEU . 9.1 t0 -69.97 -35.62 74.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 61.1 110.869 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.664 HD12 ' HB3' ' A' ' 19' ' ' LEU . 1.2 tt -80.7 -47.94 13.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 74.31 110.903 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.735 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.28 -56.56 19.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 73.4 110.911 179.88 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.19 -22.77 53.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 71.4 110.933 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.685 ' CZ ' HG21 ' A' ' 18' ' ' THR . 49.0 t80 -76.79 -55.27 5.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 71.51 110.89 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.807 HD13 HG21 ' A' ' 7' ' ' VAL . 2.3 pp -67.73 -43.46 79.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 74.11 110.877 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.566 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.2 tmtt? -54.89 -27.14 40.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 70.0 110.898 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.502 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.52 -23.72 42.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.248 -0.433 . . . . 70.31 111.135 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.1 mt -76.59 -59.57 2.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 52.45 110.901 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.55 HG21 ' CG ' ' A' ' 14' ' ' TYR . 2.9 t -135.09 -28.07 1.2 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 74.42 111.139 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.566 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.03 -177.37 4.85 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.745 -0.741 . . . . 63.12 112.539 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.855 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.3 p -112.84 138.43 42.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.845 0.355 . . . . 72.4 111.155 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.925 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -53.73 149.72 15.59 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.639 0.733 . . . . 75.35 110.926 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.4 ' O ' ' O ' ' A' ' 43' ' ' GLN . 53.8 Cg_endo -69.78 -21.71 33.01 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.663 2.242 . . . . 72.35 112.335 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -54.19 -38.3 65.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 62.52 110.925 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.418 ' H ' HD23 ' A' ' 39' ' ' LEU . 1.3 mpt_? -104.72 -40.04 6.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 73.42 110.856 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.855 ' HG2' HG13 ' A' ' 38' ' ' VAL . 2.3 pp0? -96.94 158.66 15.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 72.54 110.955 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.37 139.57 52.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 63.34 110.916 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.682 HD22 HE22 ' A' ' 43' ' ' GLN . 3.8 mm? -66.15 136.08 55.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 72.22 110.92 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.761 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.1 mm? -75.83 -74.96 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 60.14 110.915 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -97.52 60.06 1.07 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.731 -0.747 . . . . 43.22 112.464 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.646 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 3.8 pp -54.93 -24.2 22.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.853 0.358 . . . . 74.35 110.944 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.421 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -104.32 143.33 33.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.202 -0.453 . . . . 71.34 110.879 179.813 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.76 HG21 HD21 ' A' ' 66' ' ' LEU . 14.9 p -144.13 143.2 23.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 60.51 111.131 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.642 ' HG2' HG22 ' A' ' 50' ' ' VAL . 10.0 mmpt? 54.2 34.06 19.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 60.21 110.912 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.4 -15.18 41.76 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.758 -0.735 . . . . 74.23 112.487 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -81.5 149.28 64.53 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.628 0.727 . . . . 74.53 110.848 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.421 ' HA ' ' HB3' ' A' ' 49' ' ' LYS . 54.0 Cg_endo -69.72 -35.47 12.71 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.698 2.265 . . . . 74.12 112.384 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 38.74 39.61 0.35 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 42.14 111.117 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.49 -75.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.278 -0.419 . . . . 74.54 110.873 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -154.68 -38.63 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 75.43 110.884 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -73.09 -1.98 19.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 73.31 110.819 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.58 ' O ' HG23 ' A' ' 25' ' ' VAL . 0.8 OUTLIER -92.71 148.27 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 75.24 111.124 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.431 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 16.6 mttt -91.18 147.28 23.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 70.35 110.924 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.43 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 18.7 mt -52.29 -39.31 60.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.433 . . . . 74.52 110.902 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.66 -16.91 80.34 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.735 -0.745 . . . . 71.34 112.511 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.49 -19.31 33.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.853 0.359 . . . . 73.35 111.093 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.974 HD11 HG22 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -83.79 -19.96 34.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 74.14 110.943 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp 52.87 43.49 31.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 62.42 110.935 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.76 HD21 HG21 ' A' ' 50' ' ' VAL . 3.4 mt -96.19 152.91 18.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 71.32 110.935 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.54 159.81 79.58 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.626 0.727 . . . . 72.53 110.894 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -36.15 11.22 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.645 2.23 . . . . 74.3 112.322 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.669 ' HA ' HD12 ' A' ' 6' ' ' ILE . 82.4 m-20 -78.57 -15.72 58.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 55.53 110.868 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.628 HG21 HD13 ' A' ' 66' ' ' LEU . 52.8 m -32.58 124.78 0.33 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 74.3 111.128 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.26 146.27 24.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 60.33 110.883 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.3 mm -115.16 129.88 70.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 64.45 111.165 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 6.8 mtp -101.85 141.93 33.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 72.44 110.895 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 78.3 mtm -132.48 125.67 31.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 71.32 110.895 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.761 ' CG ' HD21 ' A' ' 46' ' ' LEU . 0.4 OUTLIER -115.01 128.9 56.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 65.41 110.886 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 150.84 -151.72 23.67 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.768 -0.729 . . . . 72.11 112.528 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 t -133.02 134.42 44.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.801 0.334 . . . . 72.43 111.144 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.517 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -92.1 149.09 21.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 75.22 110.901 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -60.45 -175.16 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 65.11 110.893 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -99.22 88.61 3.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.484 . . . . 73.4 110.893 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.01 168.63 21.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 65.34 110.897 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.507 0 O-C-N 124.518 1.136 . . . . 32.21 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mtt . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.787 0.327 . . . . 74.01 110.889 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.54 137.07 37.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 72.15 111.105 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 3' ' ' LEU . 0.2 OUTLIER -107.22 111.78 63.17 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.594 0.711 . . . . 54.42 110.925 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 156.28 63.7 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.642 2.228 . . . . 75.05 112.366 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.528 ' HB ' HD21 ' A' ' 28' ' ' LEU . 30.8 mt -149.87 134.83 10.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 72.21 111.133 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.61 HD12 ' HA ' ' A' ' 69' ' ' ASN . 4.6 mt -94.28 140.94 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 72.23 111.151 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.848 HG21 HD13 ' A' ' 32' ' ' LEU . 7.3 p -127.26 123.22 61.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 62.32 111.101 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.64 119.06 38.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 73.43 110.906 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.9 t-105 -123.67 105.64 9.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 73.23 110.87 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.82 -81.82 0.9 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.754 -0.736 . . . . 71.02 112.478 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.76 19.92 0.59 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.729 -0.748 . . . . 52.34 112.45 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -129.28 175.85 8.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.738 0.304 . . . . 75.44 110.947 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -132.48 140.83 48.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 74.0 110.916 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.53 ' CG ' HG21 ' A' ' 36' ' ' THR . 53.7 m-85 -135.79 117.0 14.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 75.3 110.903 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.0 p -83.07 130.89 35.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 50.45 110.839 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.581 HG21 HD23 ' A' ' 32' ' ' LEU . 96.4 t -92.86 135.3 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 74.11 111.12 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.6 p -144.39 92.47 2.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 72.4 111.161 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.654 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.8 OUTLIER 173.4 -28.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 72.51 111.161 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.67 ' HB3' HD12 ' A' ' 28' ' ' LEU . 1.6 mm? -85.94 151.12 24.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 74.04 110.874 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.53 163.47 28.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 52.21 110.85 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.459 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 72.2 mt-10 -55.71 -23.79 30.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.097 -0.501 . . . . 43.24 110.876 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -66.66 -14.01 61.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.467 . . . . 64.32 110.865 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.419 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.7 m-20 -98.44 -149.77 0.35 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 75.41 110.89 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.54 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -132.8 172.92 11.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 74.44 111.132 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.93 HG22 HD11 ' A' ' 64' ' ' LEU . 10.8 t -68.53 -43.61 83.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 74.31 111.153 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.45 -28.72 68.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 74.24 110.9 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.489 ' HB3' HD11 ' A' ' 19' ' ' LEU . 9.5 t0 -70.18 -35.82 74.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.189 -0.46 . . . . 73.51 110.838 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.67 HD12 ' HB3' ' A' ' 19' ' ' LEU . 1.1 tt -80.61 -47.06 14.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 73.54 110.909 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.754 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -62.09 -56.9 14.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 74.42 110.866 179.814 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -57.8 -22.49 47.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.276 -0.42 . . . . 73.33 110.925 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.654 ' CZ ' HG21 ' A' ' 18' ' ' THR . 62.5 t80 -77.35 -55.23 5.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 44.33 110.864 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.848 HD13 HG21 ' A' ' 7' ' ' VAL . 2.3 pp -67.78 -43.06 80.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 65.14 110.93 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.565 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -55.01 -27.04 41.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 55.12 110.906 179.829 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.489 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.77 -23.54 42.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 70.24 111.121 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.4 mt -76.97 -60.16 2.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.227 -0.442 . . . . 72.24 110.9 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.53 HG21 ' CG ' ' A' ' 14' ' ' TYR . 2.9 t -134.93 -27.76 1.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 53.24 111.153 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.83 -177.76 4.84 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.76 -0.734 . . . . 61.42 112.503 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.869 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.3 p -112.29 139.26 37.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.898 0.38 . . . . 72.02 111.129 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.969 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.61 150.56 17.35 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.599 0.714 . . . . 72.13 110.919 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 -21.92 32.95 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.676 2.251 . . . . 64.23 112.333 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -54.1 -39.04 66.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 71.53 110.928 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.434 ' H ' HD23 ' A' ' 39' ' ' LEU . 5.8 mpt_? -104.25 -40.18 6.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.142 -0.481 . . . . 61.53 110.881 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.869 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.8 pp0? -97.51 158.16 15.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 73.43 110.91 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.9 141.71 51.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.438 . . . . 75.23 110.907 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.98 134.8 52.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 74.12 110.89 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.735 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.0 mm? -75.93 -75.55 0.18 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 75.41 110.898 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.83 59.84 1.47 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.737 -0.744 . . . . 61.11 112.473 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.656 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 3.7 pp -55.56 -23.55 27.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.838 0.351 . . . . 70.25 110.914 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.422 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -105.57 142.23 35.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 65.23 110.929 179.808 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.943 HG21 HD11 ' A' ' 66' ' ' LEU . 21.8 t -143.74 144.27 23.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 71.04 111.097 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.651 ' HG2' HG12 ' A' ' 50' ' ' VAL . 16.0 mmtm 54.35 33.29 18.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 71.45 110.897 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.48 -14.78 44.43 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.733 -0.746 . . . . 74.13 112.495 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -81.56 149.26 64.24 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.6 0.714 . . . . 73.52 110.886 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.422 ' HA ' ' HB3' ' A' ' 49' ' ' LYS . 54.1 Cg_endo -69.7 -35.69 12.34 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.693 2.262 . . . . 73.32 112.386 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.656 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 38.5 40.26 0.37 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.453 . . . . 74.3 111.106 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.34 -75.38 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 74.44 110.881 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -156.38 -37.84 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 64.14 110.91 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -74.41 -1.05 19.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 74.03 110.828 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.573 ' O ' HG23 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -93.04 147.81 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 52.42 111.146 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.408 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 5.8 mttp -89.49 146.18 24.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 65.25 110.878 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 15.9 mt -52.37 -38.39 58.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 62.31 110.884 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.96 -17.2 80.18 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.736 -0.745 . . . . 65.42 112.483 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.22 -19.63 33.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.829 0.347 . . . . 74.31 111.102 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.93 HD11 HG22 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -84.54 -19.53 33.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 25.34 110.907 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp 54.21 42.08 31.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 73.13 110.893 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.943 HD11 HG21 ' A' ' 50' ' ' VAL . 3.9 mt -92.71 152.05 19.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 61.23 110.906 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -68.63 160.18 78.11 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.563 0.696 . . . . 61.32 110.914 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -37.58 8.99 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.663 2.242 . . . . 61.42 112.36 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.61 ' HA ' HD12 ' A' ' 6' ' ' ILE . 55.0 m-20 -78.84 -15.92 57.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 64.33 110.877 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.701 HG21 HD13 ' A' ' 66' ' ' LEU . 66.9 m -31.31 129.44 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.155 -0.475 . . . . 63.12 111.185 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.87 145.73 26.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 61.03 110.905 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.8 mm -115.61 128.71 72.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 74.52 111.135 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 28.5 mtm -101.33 141.6 33.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 73.02 110.894 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 73.1 mtm -136.2 116.91 13.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 62.32 110.893 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.735 ' CG ' HD21 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -105.92 127.53 53.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 75.12 110.886 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.65 -154.22 25.27 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.765 -0.731 . . . . 62.54 112.489 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.2 t -134.84 146.22 49.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.79 0.328 . . . . 64.31 111.136 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.22 158.04 24.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 75.45 110.877 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.7 ' OE1' ' N ' ' A' ' 90' ' ' NH2 . 5.0 pt-20 -51.15 133.68 27.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 72.43 110.885 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -57.42 -32.85 67.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 71.51 110.844 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.51 -14.36 0.11 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.491 . . . . 74.41 110.833 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' NH2 . . . . . 0.7 ' N ' ' OE1' ' A' ' 79' ' ' GLU . . . . . . . . 0 C--N 1.324 -0.514 0 O-C-N 124.493 1.12 . . . . 10.43 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.8 mmt . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.75 0.31 . . . . 72.31 110.882 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.753 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . -81.43 148.27 29.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 44.53 111.083 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.502 HD12 ' HG2' ' A' ' 21' ' ' GLU . 1.0 OUTLIER -107.37 108.98 62.51 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.604 0.716 . . . . 74.44 110.936 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 156.33 63.42 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.716 2.277 . . . . 74.51 112.295 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.477 ' HB ' HD21 ' A' ' 28' ' ' LEU . 38.1 mt -150.4 136.42 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 70.31 111.131 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.703 HD12 ' HA ' ' A' ' 69' ' ' ASN . 3.5 mt -94.93 140.13 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 73.43 111.119 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.883 HG21 HD13 ' A' ' 32' ' ' LEU . 8.3 p -127.69 123.02 60.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 72.42 111.08 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.89 120.51 42.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 73.33 110.895 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 14.1 t-105 -122.74 102.67 8.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 73.15 110.919 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.0 -78.09 1.71 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.774 -0.727 . . . . 54.42 112.484 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -155.62 18.5 0.5 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.75 -0.738 . . . . 73.23 112.5 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -130.87 139.17 50.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.738 0.304 . . . . 74.53 110.922 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -102.62 142.11 34.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 73.13 110.896 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.605 ' CD1' HG21 ' A' ' 36' ' ' THR . 82.6 m-85 -136.24 122.14 20.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.494 . . . . 70.3 110.914 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 92.7 p -84.95 133.43 34.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 51.52 110.844 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.592 HG21 HD23 ' A' ' 32' ' ' LEU . 85.5 t -96.37 111.48 26.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 51.41 111.136 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.0 p -124.05 91.42 3.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 74.44 111.174 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.618 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 1.2 t 174.83 -29.69 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 71.03 111.177 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.753 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.9 mm? -83.16 149.76 26.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 60.42 110.947 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.524 ' C ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.43 168.22 17.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 71.2 110.852 -179.885 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.502 ' HG2' HD12 ' A' ' 3' ' ' LEU . 51.8 mt-10 -59.8 -22.16 61.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.477 . . . . 74.42 110.891 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -69.26 -11.34 60.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 70.04 110.868 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.442 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.5 m-20 -99.52 -149.54 0.36 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 54.33 110.896 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.485 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -138.07 167.46 21.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 64.45 111.131 -179.878 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.973 HG22 HD11 ' A' ' 64' ' ' LEU . 41.4 t -61.9 -45.69 98.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 73.41 111.129 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.48 -29.15 67.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 73.34 110.914 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.553 ' HB3' HD11 ' A' ' 19' ' ' LEU . 1.3 t0 -70.69 -34.31 71.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 70.52 110.841 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.695 HD23 HD23 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -80.74 -48.45 12.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 71.42 110.904 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.592 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.6 -56.79 16.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 73.13 110.894 179.827 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.05 -22.76 51.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 65.44 110.894 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.618 ' CZ ' HG21 ' A' ' 18' ' ' THR . 58.7 t80 -76.94 -55.16 5.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 75.25 110.922 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.883 HD13 HG21 ' A' ' 7' ' ' VAL . 2.5 pp -67.59 -42.81 81.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 74.11 110.926 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.571 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.2 tmtt? -54.96 -27.14 41.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 74.34 110.926 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.99 -23.67 41.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 60.05 111.132 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.8 mt -76.96 -60.03 2.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 61.21 110.908 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.605 HG21 ' CD1' ' A' ' 14' ' ' TYR . 5.1 t -135.45 -27.35 1.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 75.52 111.166 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.571 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.48 -178.75 4.96 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.724 -0.75 . . . . 54.24 112.489 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.85 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.4 p -113.25 137.96 44.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.885 0.374 . . . . 30.44 111.132 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.984 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -53.95 149.56 17.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.615 0.721 . . . . 53.24 110.919 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -21.59 33.24 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.65 2.234 . . . . 72.44 112.389 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -54.21 -38.35 65.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 71.1 110.883 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.408 ' H ' HD23 ' A' ' 39' ' ' LEU . 2.7 mpt_? -105.05 -39.94 6.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 64.45 110.907 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.85 ' HG2' HG13 ' A' ' 38' ' ' VAL . 2.4 pp0? -95.67 159.4 15.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 75.51 110.905 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.8 137.85 52.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 63.55 110.899 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.64 HD22 HE22 ' A' ' 43' ' ' GLN . 3.4 mm? -66.86 132.66 48.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 71.13 110.917 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.738 HD11 ' CG ' ' A' ' 75' ' ' MET . 5.8 mp -83.05 -44.48 15.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 73.11 110.908 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -107.73 39.26 2.96 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.751 -0.738 . . . . 44.35 112.478 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.516 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 0.5 OUTLIER -44.88 -35.02 2.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.905 0.383 . . . . 70.41 110.927 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.85 146.54 33.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 55.5 110.872 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.675 HG21 HD21 ' A' ' 66' ' ' LEU . 14.1 p -143.77 145.69 21.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 71.12 111.11 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.5 mttt 54.91 31.19 15.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.47 . . . . 74.42 110.866 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.64 -10.83 54.9 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.717 -0.754 . . . . 52.54 112.518 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -81.44 149.51 65.23 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.581 0.705 . . . . 72.14 110.881 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -31.69 19.96 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.632 2.221 . . . . 75.23 112.36 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.609 ' HA ' HG21 ' A' ' 59' ' ' VAL . . . 37.36 41.91 0.28 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 51.11 111.082 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.03 -77.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 64.53 110.885 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.417 HD22 ' N ' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -157.92 -36.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 74.43 110.902 -179.942 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.417 ' N ' HD22 ' A' ' 57' ' ' ASN . 0.2 OUTLIER -68.06 -6.77 24.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 73.24 110.885 179.917 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.609 HG21 ' HA ' ' A' ' 55' ' ' ALA . 17.6 t -82.14 146.35 7.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.468 . . . . 55.15 111.12 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.2 mttp -94.46 151.61 19.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 74.11 110.871 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.553 ' HA ' HD12 ' A' ' 64' ' ' LEU . 19.5 mt -50.84 -44.63 59.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 71.45 110.944 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.54 -12.25 84.52 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.753 -0.737 . . . . 62.04 112.504 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.77 -34.42 27.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 65.44 111.097 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.973 HD11 HG22 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -70.48 -25.22 63.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 72.44 110.91 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp 62.38 36.87 14.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 61.53 110.902 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.675 HD21 HG21 ' A' ' 50' ' ' VAL . 4.2 mt -92.04 152.83 19.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 75.13 110.894 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -68.49 160.99 73.58 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.607 0.717 . . . . 63.21 110.903 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 -35.47 12.69 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.701 2.267 . . . . 42.32 112.381 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.703 ' HA ' HD12 ' A' ' 6' ' ' ILE . 23.7 p30 -78.77 -15.73 58.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 64.11 110.909 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.643 HG21 HD13 ' A' ' 66' ' ' LEU . 52.4 m -32.53 121.4 0.33 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.174 -0.467 . . . . 74.24 111.124 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -92.85 145.81 24.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 62.22 110.875 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.6 mm -115.74 129.17 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.268 -0.424 . . . . 74.32 111.149 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.455 ' CB ' HD13 ' A' ' 46' ' ' LEU . 4.6 mtp -101.33 141.92 33.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 73.33 110.891 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 76.5 mtm -135.2 119.62 17.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.438 . . . . 75.31 110.873 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.738 ' CG ' HD11 ' A' ' 46' ' ' LEU . 1.4 mmt -110.74 123.71 50.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 53.32 110.895 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 163.01 -153.9 24.63 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.756 -0.735 . . . . 71.53 112.508 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.6 t -134.17 142.12 47.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.81 0.338 . . . . 62.21 111.133 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -61.59 160.33 11.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 73.32 110.846 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.04 138.81 24.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 53.54 110.91 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 58.33 -172.12 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 61.5 110.864 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -108.5 -29.14 8.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.488 . . . . 75.21 110.829 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.505 0 O-C-N 124.495 1.122 . . . . 65.12 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mtm . . . . . 0 N--CA 1.458 -0.062 0 CA-C-O 120.749 0.309 . . . . 74.22 110.889 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.24 137.06 50.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 44.23 111.062 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 3' ' ' LEU . 0.2 OUTLIER -107.29 111.72 63.09 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.67 0.748 . . . . 62.23 110.938 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.412 ' O ' HD12 ' A' ' 3' ' ' LEU . 53.9 Cg_endo -69.77 156.34 63.59 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.713 2.275 . . . . 62.42 112.342 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.543 ' HB ' HD21 ' A' ' 28' ' ' LEU . 23.8 mt -149.17 135.62 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 74.1 111.143 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.633 HD12 ' HA ' ' A' ' 69' ' ' ASN . 4.4 mt -94.78 141.0 15.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 64.02 111.15 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.833 HG21 HD13 ' A' ' 32' ' ' LEU . 7.9 p -127.3 123.12 61.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 64.13 111.122 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.65 121.36 44.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 73.32 110.908 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 13.1 t-105 -121.74 100.9 7.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 71.42 110.939 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.01 -83.53 0.91 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.736 -0.745 . . . . 75.01 112.517 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.94 20.43 1.12 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.742 . . . . 64.43 112.497 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -128.01 174.31 9.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.739 0.304 . . . . 72.22 110.926 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -133.06 140.12 47.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 72.35 110.917 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.521 ' CD2' HG21 ' A' ' 36' ' ' THR . 38.7 m-85 -135.83 115.97 13.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.494 . . . . 73.03 110.901 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.3 p -82.19 133.41 35.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 60.31 110.873 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.521 HG21 HD23 ' A' ' 32' ' ' LEU . 91.5 t -96.01 139.72 18.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 54.43 111.123 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.5 p -148.23 93.58 2.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 73.14 111.167 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.682 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.8 OUTLIER 173.04 -28.37 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 73.25 111.169 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.657 ' HB3' HD12 ' A' ' 28' ' ' LEU . 1.7 mm? -86.52 151.78 23.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 72.35 110.944 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.77 163.57 28.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 62.5 110.858 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.448 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 49.0 mt-10 -56.16 -23.34 34.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 72.52 110.872 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -67.84 -12.53 60.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 70.34 110.873 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.405 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.6 m-20 -99.12 -150.31 0.37 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 71.04 110.842 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -132.19 171.1 14.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 74.34 111.122 -179.881 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.946 HG22 HD11 ' A' ' 64' ' ' LEU . 11.6 t -67.3 -43.78 87.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 73.4 111.109 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.77 -28.36 68.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 73.52 110.901 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.494 ' HB3' HD11 ' A' ' 19' ' ' LEU . 17.3 t0 -70.18 -35.64 74.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.475 . . . . 73.42 110.853 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.673 HD23 HD23 ' A' ' 32' ' ' LEU . 1.2 tt -80.76 -47.41 13.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 44.14 110.966 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.77 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.7 -56.6 17.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 42.13 110.91 179.81 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -58.09 -22.42 50.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 73.42 110.878 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.682 ' CZ ' HG21 ' A' ' 18' ' ' THR . 56.4 t80 -77.18 -55.2 5.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 74.44 110.867 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.833 HD13 HG21 ' A' ' 7' ' ' VAL . 2.4 pp -67.93 -43.01 80.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.14 -0.482 . . . . 73.52 110.931 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.564 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.9 -27.2 41.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.45 . . . . 74.35 110.908 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.73 -23.61 42.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.247 -0.433 . . . . 54.45 111.107 179.968 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.0 mt -76.59 -59.76 2.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 70.4 110.94 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.521 HG21 ' CD2' ' A' ' 14' ' ' TYR . 3.3 t -135.14 -27.83 1.2 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 74.54 111.119 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.29 -176.7 4.77 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.718 -0.753 . . . . 42.5 112.505 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.88 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.1 p -112.43 139.73 35.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.835 0.35 . . . . 75.52 111.16 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.983 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.76 150.2 19.41 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.584 0.707 . . . . 74.52 110.922 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -21.98 32.63 Favored 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.696 2.264 . . . . 71.4 112.308 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -54.42 -39.08 66.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.273 -0.421 . . . . 74.44 110.932 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.413 ' H ' HD23 ' A' ' 39' ' ' LEU . 9.2 mtt85 -103.76 -40.73 6.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 73.42 110.906 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.88 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.6 pp0? -97.29 157.58 15.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 65.13 110.89 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.77 142.18 51.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 72.13 110.923 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.49 136.05 54.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 74.12 110.942 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.743 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.0 mm? -77.31 -75.03 0.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 72.42 110.929 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.15 59.23 1.68 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.774 -0.727 . . . . 70.25 112.522 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.645 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 3.8 pp -56.22 -23.06 33.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 73.21 110.906 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.417 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 2.0 pttt -105.95 142.33 35.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 72.5 110.911 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.871 HG11 HD21 ' A' ' 66' ' ' LEU . 20.8 t -143.94 144.33 23.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 73.13 111.119 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.596 ' HG3' HG12 ' A' ' 50' ' ' VAL . 18.4 mttt 54.27 33.06 17.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 75.21 110.912 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.79 -14.67 46.72 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.728 -0.748 . . . . 72.5 112.504 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -81.56 148.97 63.62 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.597 0.713 . . . . 71.21 110.853 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.417 ' HA ' ' HB3' ' A' ' 49' ' ' LYS . 53.2 Cg_endo -69.82 -35.49 12.37 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.657 2.238 . . . . 64.34 112.323 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.645 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 38.03 40.69 0.32 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 61.2 111.088 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.02 -76.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 72.31 110.882 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -155.25 -38.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 61.31 110.877 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -73.55 -1.12 17.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 73.13 110.892 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.572 ' O ' HG23 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -93.45 148.37 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 70.03 111.159 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.414 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 5.6 mttt -90.32 146.7 24.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 60.34 110.874 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.448 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 16.4 mt -52.27 -38.88 59.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.447 . . . . 75.42 110.883 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.89 -17.02 80.28 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.76 -0.733 . . . . 33.21 112.508 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.15 -19.46 34.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.812 0.339 . . . . 64.31 111.128 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.946 HD11 HG22 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -84.83 -19.9 31.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 74.12 110.906 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.9 mmtp 55.13 41.47 31.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 65.21 110.923 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.871 HD21 HG11 ' A' ' 50' ' ' VAL . 3.8 mt -92.38 151.2 20.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 72.23 110.918 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -68.43 160.79 74.28 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.619 0.723 . . . . 65.24 110.944 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -37.09 9.67 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.738 2.292 . . . . 72.12 112.33 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.633 ' HA ' HD12 ' A' ' 6' ' ' ILE . 10.5 p-10 -78.81 -15.82 57.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 70.12 110.891 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.749 HG21 HD22 ' A' ' 66' ' ' LEU . 53.1 m -31.25 128.96 0.15 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 62.4 111.183 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.49 146.4 25.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.229 -0.441 . . . . 63.22 110.868 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.7 mm -115.38 127.93 72.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 73.2 111.131 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.0 mtp -100.15 141.72 32.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 65.31 110.841 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.8 mtt -134.58 127.5 31.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 73.53 110.871 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.743 ' CG ' HD21 ' A' ' 46' ' ' LEU . 0.3 OUTLIER -116.97 126.35 52.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 72.13 110.913 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.9 -154.53 25.6 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.75 -0.738 . . . . 63.22 112.51 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 t -133.52 140.12 47.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.763 0.316 . . . . 75.1 111.101 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.479 ' HA ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -93.88 150.34 20.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 64.1 110.907 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.12 174.55 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 75.43 110.901 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.17 -59.55 4.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 65.31 110.858 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.2 t -67.62 -104.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 64.24 110.889 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.452 0 O-C-N 124.447 1.092 . . . . 45.14 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.76 0.314 . . . . 73.21 110.864 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.691 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . -80.76 150.98 29.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 72.03 111.076 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.416 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 1.7 mt -113.53 107.08 53.61 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.579 0.704 . . . . 62.15 110.917 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 53.7 Cg_endo -69.78 155.68 65.24 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.665 2.243 . . . . 55.35 112.338 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.962 HD12 HD22 ' A' ' 28' ' ' LEU . 20.7 mt -151.0 138.77 13.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 75.15 111.105 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.615 HD12 ' HA ' ' A' ' 69' ' ' ASN . 4.7 mt -95.02 140.47 16.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 74.41 111.119 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.829 HG21 HD13 ' A' ' 32' ' ' LEU . 7.5 p -126.53 123.0 62.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 70.01 111.139 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.45 118.07 35.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 63.11 110.9 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.9 t-105 -122.87 106.67 11.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 73.32 110.889 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.72 -81.06 0.9 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.744 -0.741 . . . . 74.41 112.469 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -155.98 19.87 0.49 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.72 -0.752 . . . . 54.25 112.466 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -129.34 176.07 8.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.796 0.332 . . . . 52.41 110.902 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -132.51 140.83 48.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 70.01 110.901 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -136.18 119.44 16.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 73.32 110.915 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.6 p -82.89 134.22 35.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.089 -0.505 . . . . 64.32 110.857 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.535 HG21 HD23 ' A' ' 32' ' ' LEU . 87.2 t -93.46 132.81 36.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 64.53 111.152 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.4 p -147.28 92.08 2.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 71.54 111.162 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.679 HG21 ' CE1' ' A' ' 31' ' ' PHE . 1.8 t 176.99 -31.89 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 73.55 111.133 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.788 ' CB ' HD12 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -87.93 164.32 15.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 75.22 110.931 179.948 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.449 ' O ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -136.26 175.17 9.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.448 . . . . 52.0 110.848 -179.895 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.424 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 35.0 mt-10 -64.52 -20.01 65.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 54.32 110.896 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.94 -11.32 60.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.127 -0.488 . . . . 32.03 110.839 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.687 ' HB2' HD23 ' A' ' 19' ' ' LEU . 1.6 m-20 -95.99 -152.62 0.38 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 74.42 110.848 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -136.91 165.6 25.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 61.21 111.156 -179.882 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.978 HG22 HD11 ' A' ' 64' ' ' LEU . 37.9 t -58.69 -44.41 89.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 73.1 111.157 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.407 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -63.88 -30.13 71.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 61.4 110.875 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.577 ' HB3' HD21 ' A' ' 19' ' ' LEU . 3.3 t70 -71.37 -34.97 70.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 60.43 110.875 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.962 HD22 HD12 ' A' ' 5' ' ' ILE . 0.6 OUTLIER -78.72 -48.03 15.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 63.42 110.902 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.557 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -62.15 -54.73 36.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 72.43 110.902 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -56.36 -22.51 31.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 75.51 110.929 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.679 ' CE1' HG21 ' A' ' 18' ' ' THR . 56.3 t80 -77.31 -55.45 5.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 72.13 110.849 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.829 HD13 HG21 ' A' ' 7' ' ' VAL . 2.0 pp -67.68 -43.5 80.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 73.11 110.912 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.569 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.49 -27.17 35.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 74.31 110.882 179.849 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.69 -23.85 42.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 63.15 111.152 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.4 mt -76.36 -59.71 2.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.198 -0.456 . . . . 74.1 110.909 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.5 t -135.21 -28.03 1.18 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.461 . . . . 61.24 111.136 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.569 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.67 -177.51 4.51 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.757 -0.735 . . . . 55.32 112.503 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.882 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.3 p -112.83 138.71 41.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.883 0.373 . . . . 65.05 111.11 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.987 HD13 ' H ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.86 150.63 18.18 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.633 0.73 . . . . 55.22 110.852 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -21.76 32.83 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.671 2.247 . . . . 63.24 112.35 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -54.13 -38.93 66.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 74.45 110.902 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.422 ' H ' HD23 ' A' ' 39' ' ' LEU . 6.6 mpt_? -104.29 -40.4 6.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.505 . . . . 70.32 110.836 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.882 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.9 pp0? -97.21 158.09 15.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 64.1 110.876 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.09 141.97 51.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 75.0 110.854 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.406 HD22 ' N ' ' A' ' 45' ' ' LEU . 3.7 mm? -67.05 134.01 51.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 65.41 110.894 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.745 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.1 mm? -74.88 -68.03 0.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 64.13 110.926 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.39 60.03 0.69 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.707 -0.758 . . . . 24.1 112.465 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.598 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 4.6 pp -56.93 -19.81 19.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.86 0.362 . . . . 73.54 110.936 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.65 144.08 41.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 73.42 110.913 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.79 HG21 HD21 ' A' ' 66' ' ' LEU . 11.0 p -143.79 146.1 21.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 73.54 111.146 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.3 mttt 54.78 31.55 15.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 75.52 110.875 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.56 -10.87 54.33 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.71 -0.757 . . . . 34.22 112.502 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.2 mmtm -81.36 150.82 68.21 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.593 0.711 . . . . 72.13 110.869 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 55' ' ' ALA . 53.1 Cg_endo -69.81 -31.98 19.24 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.658 2.239 . . . . 73.45 112.359 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.638 ' HA ' HG21 ' A' ' 59' ' ' VAL . . . 35.93 44.63 0.25 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 44.12 111.072 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.32 -76.69 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 70.24 110.92 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -158.61 -37.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 73.33 110.887 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.85 -8.66 30.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 60.2 110.828 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.638 HG21 ' HA ' ' A' ' 55' ' ' ALA . 19.4 t -79.31 147.49 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 73.33 111.149 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.42 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 10.8 mttt -94.78 150.33 20.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 71.32 110.895 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.623 ' HA ' HD12 ' A' ' 64' ' ' LEU . 25.3 mt -51.42 -42.05 61.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 75.24 110.938 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.12 -13.34 83.33 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.768 -0.729 . . . . 71.43 112.443 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.04 -34.31 22.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.779 0.323 . . . . 54.22 111.066 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.978 HD11 HG22 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -67.84 -24.35 65.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 61.43 110.922 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp 59.88 33.08 21.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 72.44 110.859 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.79 HD21 HG21 ' A' ' 50' ' ' VAL . 5.0 mt -87.72 153.87 21.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.283 -0.417 . . . . 72.5 110.91 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.46 160.41 76.32 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.552 0.692 . . . . 73.24 110.906 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -35.3 12.81 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.641 2.227 . . . . 53.34 112.37 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.615 ' HA ' HD12 ' A' ' 6' ' ' ILE . 7.6 p30 -79.15 -16.38 56.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.431 . . . . 73.02 110.886 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.527 HG21 HD13 ' A' ' 66' ' ' LEU . 54.9 m -32.08 128.16 0.22 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 63.21 111.163 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.93 147.95 23.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 64.42 110.908 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.6 mm -118.83 127.32 75.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 63.44 111.153 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 62.9 mtp -100.41 141.79 32.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 61.02 110.837 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 73.7 mtm -134.71 117.51 16.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 71.13 110.87 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.745 ' CG ' HD21 ' A' ' 46' ' ' LEU . 2.2 mmt -105.52 124.56 49.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 72.4 110.866 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.57 -154.69 25.74 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.726 -0.749 . . . . 62.11 112.456 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.5 t -135.15 144.16 46.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.332 . . . . 71.44 111.155 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -60.99 160.55 9.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 71.43 110.838 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.04 143.72 13.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 62.15 110.896 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -82.91 -55.05 4.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 54.54 110.906 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -176.81 11.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 50.55 110.9 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.477 0 O-C-N 124.519 1.137 . . . . 20.44 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.737 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.794 0.33 . . . . 73.349999999999994 111.135 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.5 mt -110.87 109.43 57.5 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.618 0.723 . . . . 73.140000000000001 110.907 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 156.48 63.23 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.693 2.262 . . . . 43.219999999999999 112.357 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 28' ' ' LEU . 42.9 mt -150.51 137.45 13.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 73.510000000000005 111.155 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.718 HD12 ' HA ' ' A' ' 69' ' ' ASN . 4.1 mt -94.91 140.52 16.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 63.439999999999998 111.152 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.83 HG21 HD13 ' A' ' 32' ' ' LEU . 8.3 p -126.9 123.14 62.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 61.520000000000003 111.089 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.12 119.78 40.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 65.519999999999996 110.881 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 16.8 t-105 -121.09 100.92 7.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.258 -0.428 . . . . 75.219999999999999 110.912 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.89 -83.53 0.85 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.778 -0.725 . . . . 34.020000000000003 112.515 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.68 20.45 1.02 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.693 -0.765 . . . . 70.099999999999994 112.459 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -128.43 174.83 9.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.756 0.312 . . . . 72.549999999999997 110.896 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -133.07 140.19 47.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 64.239999999999995 110.865 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -135.84 118.59 16.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 75.420000000000002 110.886 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.6 p -82.36 133.93 35.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 75.010000000000005 110.84 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.54 HG21 HD23 ' A' ' 32' ' ' LEU . 69.6 t -96.21 131.33 43.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.49 . . . . 72.439999999999998 111.137 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.2 p -141.31 93.54 2.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 52.030000000000001 111.11 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.602 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.7 OUTLIER 173.47 -28.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.462 . . . . 61.43 111.128 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.737 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.9 mm? -85.6 150.52 24.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 74.030000000000001 110.871 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.549 ' C ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.89 168.09 18.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 55.130000000000003 110.867 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.41 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 44.9 mt-10 -59.04 -21.98 59.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 63.420000000000002 110.898 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -68.59 -10.9 58.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 63.310000000000002 110.885 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.458 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.5 m-20 -102.61 -150.47 0.41 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 63.140000000000001 110.869 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.504 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -135.65 168.03 20.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 64.099999999999994 111.148 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.621 HG22 HD11 ' A' ' 64' ' ' LEU . 94.2 t -63.39 -43.15 98.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 73.319999999999993 111.124 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.407 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -61.06 -29.08 69.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.166 -0.47 . . . . 64.319999999999993 110.938 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.561 ' HB3' HD11 ' A' ' 19' ' ' LEU . 2.0 t0 -71.51 -32.67 68.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 74.420000000000002 110.845 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.642 HD23 HD23 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -80.65 -48.82 12.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 72.310000000000002 110.924 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.514 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -62.09 -56.09 22.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 71.239999999999995 110.89 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -57.6 -22.4 44.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 71.219999999999999 110.89 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.602 ' CZ ' HG21 ' A' ' 18' ' ' THR . 40.3 t80 -77.98 -54.89 5.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 73.430000000000007 110.82 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.83 HD13 HG21 ' A' ' 7' ' ' VAL . 2.5 pp -68.05 -42.13 80.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.148 -0.478 . . . . 60.0 110.92 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.568 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.76 -27.65 42.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 75.340000000000003 110.866 179.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.499 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.52 -23.62 42.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 75.150000000000006 111.155 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.432 HD11 ' CE1' ' A' ' 31' ' ' PHE . 13.8 mt -76.63 -59.7 2.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 73.430000000000007 110.914 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.7 t -135.41 -27.66 1.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 72.109999999999999 111.181 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.568 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.95 -177.46 4.8 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 55.299999999999997 112.479 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.878 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.3 p -112.72 138.24 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.856 0.36 . . . . 73.239999999999995 111.106 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.979 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.76 150.94 16.49 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.632 0.729 . . . . 74.430000000000007 110.875 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -21.59 33.39 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.715 2.277 . . . . 72.140000000000001 112.32 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -54.35 -38.79 66.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.429 . . . . 75.129999999999995 110.855 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.441 ' H ' HD23 ' A' ' 39' ' ' LEU . 2.6 mpt_? -104.15 -40.58 6.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 71.329999999999998 110.889 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.878 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.9 pp0? -97.28 157.47 15.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 73.420000000000002 110.932 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.08 142.94 51.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.435 . . . . 74.310000000000002 110.955 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.408 ' N ' HD22 ' A' ' 45' ' ' LEU . 3.7 mm? -67.7 135.9 53.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.246 -0.434 . . . . 61.450000000000003 110.885 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.748 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.0 mm? -78.0 -68.29 0.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 60.240000000000002 110.972 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.4 61.06 0.66 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.705 -0.76 . . . . 62.539999999999999 112.497 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.58 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 4.5 pp -58.96 -18.2 31.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.899 0.381 . . . . 72.430000000000007 110.907 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -112.39 144.16 42.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 64.25 110.926 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.876 HG21 HD11 ' A' ' 66' ' ' LEU . 43.0 t -143.85 145.31 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 75.150000000000006 111.119 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.0 mttt 54.87 32.51 17.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 75.329999999999998 110.858 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.25 -11.3 50.59 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.744 -0.741 . . . . 61.509999999999998 112.509 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -81.7 150.88 67.13 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.602 0.715 . . . . 71.510000000000005 110.856 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 -32.91 17.85 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.706 2.271 . . . . 54.509999999999998 112.351 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 36.78 43.48 0.28 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 74.340000000000003 111.074 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.54 -76.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.438 . . . . 65.519999999999996 110.896 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -159.36 -37.5 0.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 72.209999999999994 110.884 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -66.8 -8.68 30.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 73.400000000000006 110.862 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.575 HG21 ' HA ' ' A' ' 55' ' ' ALA . 16.9 t -79.79 145.69 8.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 73.209999999999994 111.135 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 18.9 mttp -90.27 151.44 21.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 75.040000000000006 110.858 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.549 HD12 ' C ' ' A' ' 20' ' ' SER . 19.3 mt -49.96 -47.44 52.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 75.349999999999994 110.982 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.63 -11.69 85.22 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.732 -0.747 . . . . 63.399999999999999 112.473 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.39 -32.16 42.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.783 0.325 . . . . 61.329999999999998 111.097 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.621 HD11 HG22 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -77.82 -23.55 48.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 65.200000000000003 110.943 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt 63.12 38.03 11.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 62.450000000000003 110.876 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.876 HD11 HG21 ' A' ' 50' ' ' VAL . 4.2 mt -89.66 152.62 21.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 75.420000000000002 110.899 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -68.67 160.57 76.41 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.603 0.716 . . . . 65.030000000000001 110.899 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -35.0 13.26 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.718 2.278 . . . . 74.129999999999995 112.335 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.718 ' HA ' HD12 ' A' ' 6' ' ' ILE . 10.5 p30 -78.8 -15.83 57.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 72.329999999999998 110.864 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.663 HG21 HD13 ' A' ' 66' ' ' LEU . 51.3 m -32.92 121.52 0.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 72.319999999999993 111.132 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -92.85 146.49 23.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 61.229999999999997 110.913 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.8 mm -116.4 127.46 74.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 74.230000000000004 111.087 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 23.2 mtp -99.46 141.68 31.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 63.539999999999999 110.89 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.6 mtt -134.74 118.99 17.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 72.319999999999993 110.937 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.748 ' CG ' HD21 ' A' ' 46' ' ' LEU . 4.1 mmm -107.88 123.82 49.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 74.230000000000004 110.906 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.79 -155.16 26.32 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.751 -0.738 . . . . 73.540000000000006 112.526 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.2 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-O 120.783 0.325 . . . . 73.0 111.164 -179.925 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.743 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.804 0.335 . . . . 70.140000000000001 111.119 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.404 HD23 ' HD2' ' A' ' 4' ' ' PRO . 2.4 mt -112.04 109.66 54.57 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.593 0.711 . . . . 63.520000000000003 110.89 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.404 ' HD2' HD23 ' A' ' 3' ' ' LEU . 54.1 Cg_endo -69.75 156.6 62.94 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.717 2.278 . . . . 74.030000000000001 112.345 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.547 ' HB ' HD21 ' A' ' 28' ' ' LEU . 28.0 mt -150.45 137.52 13.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 71.129999999999995 111.114 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.653 HD12 ' HA ' ' A' ' 69' ' ' ASN . 4.7 mt -95.14 140.81 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 60.350000000000001 111.162 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.823 HG21 HD13 ' A' ' 32' ' ' LEU . 8.3 p -126.92 123.44 62.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 72.030000000000001 111.12 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.78 120.9 43.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 71.340000000000003 110.931 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 12.9 t-105 -122.04 100.96 7.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.436 . . . . 73.120000000000005 110.884 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.79 -83.76 0.78 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.739 -0.744 . . . . 75.150000000000006 112.498 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.46 20.17 1.04 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.742 -0.742 . . . . 65.200000000000003 112.488 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -128.56 174.24 9.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.784 0.325 . . . . 63.200000000000003 110.875 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -132.81 140.5 48.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 75.340000000000003 110.902 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -136.67 116.14 12.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 74.200000000000003 110.96 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.9 p -81.62 135.03 35.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 65.340000000000003 110.854 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.518 HG21 HD23 ' A' ' 32' ' ' LEU . 97.4 t -96.26 140.28 17.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.115 -0.493 . . . . 73.439999999999998 111.077 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.5 p -148.66 93.37 2.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 63.439999999999998 111.137 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.749 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 1.0 OUTLIER 173.68 -28.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.22 -0.445 . . . . 74.150000000000006 111.137 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.743 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.7 mm? -86.61 151.92 23.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 75.219999999999999 110.908 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.416 ' O ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.6 169.47 16.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 61.219999999999999 110.882 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.413 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 36.3 mt-10 -61.78 -22.09 65.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 63.049999999999997 110.854 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -69.87 -10.76 59.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 74.010000000000005 110.852 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.417 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.6 m-20 -100.08 -150.84 0.39 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.452 . . . . 64.120000000000005 110.887 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.41 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -132.61 170.58 14.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 63.109999999999999 111.176 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.938 HG22 HD11 ' A' ' 64' ' ' LEU . 11.7 t -66.58 -43.79 90.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 72.310000000000002 111.135 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.44 -28.66 68.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 72.230000000000004 110.925 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.478 ' HB3' HD11 ' A' ' 19' ' ' LEU . 17.0 t0 -70.07 -35.16 74.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.476 . . . . 64.200000000000003 110.844 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.665 HD12 ' CB ' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -80.72 -47.82 13.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 63.530000000000001 110.911 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.717 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.78 -56.71 16.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 73.200000000000003 110.892 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.0 -22.41 49.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 73.219999999999999 110.924 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.749 ' CZ ' HG21 ' A' ' 18' ' ' THR . 40.0 t80 -77.16 -55.23 5.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 70.329999999999998 110.835 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.823 HD13 HG21 ' A' ' 7' ' ' VAL . 2.4 pp -67.92 -43.14 79.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 72.0 110.942 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.567 ' N ' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -55.02 -27.34 43.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 72.230000000000004 110.876 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.493 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.3 -23.78 43.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 65.230000000000004 111.159 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.424 HD11 ' CE1' ' A' ' 31' ' ' PHE . 12.5 mt -76.46 -59.8 2.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 54.539999999999999 110.931 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.1 t -135.25 -27.63 1.2 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 65.540000000000006 111.135 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.562 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.23 -176.63 4.66 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.699 -0.762 . . . . 54.299999999999997 112.513 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.857 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.1 p -112.29 139.73 35.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.835 0.35 . . . . 62.310000000000002 111.168 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.973 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.8 149.98 20.55 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.602 0.715 . . . . 74.420000000000002 110.927 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -22.02 32.78 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.717 2.278 . . . . 64.219999999999999 112.334 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -54.61 -39.06 67.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.443 . . . . 74.120000000000005 110.899 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.431 ' H ' HD23 ' A' ' 39' ' ' LEU . 4.0 mpt_? -103.7 -40.46 6.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 75.099999999999994 110.87 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.857 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.5 pp0? -97.57 157.2 16.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 74.25 110.921 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.17 141.32 51.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 74.319999999999993 110.908 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.02 135.96 54.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 74.530000000000001 110.973 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.74 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.0 mm? -76.54 -75.22 0.2 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 75.450000000000003 110.916 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.74 60.03 1.48 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.726 -0.75 . . . . 55.310000000000002 112.518 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.649 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 3.8 pp -56.8 -22.56 37.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.9 0.381 . . . . 74.219999999999999 110.949 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.428 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -106.29 142.43 35.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 71.129999999999995 110.932 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.898 HG11 HD21 ' A' ' 66' ' ' LEU . 21.0 t -144.04 144.37 22.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 71.239999999999995 111.07 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.449 ' HG2' HG12 ' A' ' 50' ' ' VAL . 2.1 mmmm 54.3 33.01 17.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 75.340000000000003 110.863 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.9 -15.05 45.28 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.718 -0.753 . . . . 71.230000000000004 112.462 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -81.08 148.78 64.91 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.538 0.685 . . . . 75.319999999999993 110.9 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.428 ' HA ' ' HB3' ' A' ' 49' ' ' LYS . 53.8 Cg_endo -69.71 -35.57 12.53 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.681 2.254 . . . . 64.030000000000001 112.366 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 38.14 40.67 0.34 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 61.340000000000003 111.136 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -67.81 -76.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 63.020000000000003 110.91 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -154.53 -38.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 71.150000000000006 110.889 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -73.14 -1.65 18.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 74.140000000000001 110.867 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -92.85 148.19 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 62.509999999999998 111.168 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.41 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 11.2 mttt -90.75 147.22 23.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 62.549999999999997 110.873 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 20' ' ' SER . 17.5 mt -52.47 -38.72 60.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 54.409999999999997 110.887 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.77 -17.0 80.29 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.771 -0.728 . . . . 62.299999999999997 112.451 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.53 -19.52 33.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.834 0.349 . . . . 72.329999999999998 111.128 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.938 HD11 HG22 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -84.44 -20.46 31.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 71.439999999999998 110.904 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp 53.89 42.01 31.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 74.319999999999993 110.935 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.898 HD21 HG11 ' A' ' 50' ' ' VAL . 3.6 mt -92.79 151.58 19.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.462 . . . . 52.329999999999998 110.939 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -68.4 160.01 78.06 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.564 0.697 . . . . 71.430000000000007 110.933 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -36.88 10.07 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.68 2.253 . . . . 73.310000000000002 112.311 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.653 ' HA ' HD12 ' A' ' 6' ' ' ILE . 26.4 m-80 -78.8 -15.79 57.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 75.450000000000003 110.897 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.75 HG21 HD22 ' A' ' 66' ' ' LEU . 52.0 m -32.43 128.03 0.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 60.399999999999999 111.13 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -97.66 146.51 25.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 73.019999999999996 110.837 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.0 mm -115.34 128.46 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 74.329999999999998 111.167 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 34.4 mtm -100.36 141.76 32.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 74.109999999999999 110.883 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.7 mtt -133.21 129.42 37.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 71.209999999999994 110.884 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.74 ' CG ' HD21 ' A' ' 46' ' ' LEU . 6.1 mmm -118.6 123.95 46.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.254 -0.43 . . . . 52.0 110.9 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 153.11 -155.23 26.01 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 60.049999999999997 112.459 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.794 0.331 . . . . 52.420000000000002 111.136 -179.865 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.74 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.848 0.356 . . . . 62.420000000000002 111.119 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.407 HD23 ' HD2' ' A' ' 4' ' ' PRO . 2.1 mt -110.86 109.27 57.6 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.625 0.726 . . . . 64.409999999999997 110.916 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.407 ' HD2' HD23 ' A' ' 3' ' ' LEU . 53.5 Cg_endo -69.77 156.84 62.27 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.677 2.251 . . . . 72.200000000000003 112.308 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.44 ' HB ' HD21 ' A' ' 28' ' ' LEU . 42.9 mt -150.57 137.51 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 53.210000000000001 111.149 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.715 HD12 ' HA ' ' A' ' 69' ' ' ASN . 3.6 mt -95.03 140.38 16.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 73.439999999999998 111.112 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.83 HG21 HD13 ' A' ' 32' ' ' LEU . 8.7 p -127.15 122.91 61.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 73.219999999999999 111.133 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.77 122.28 46.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 73.510000000000005 110.893 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 17.5 t-105 -122.56 100.52 6.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.24 -0.436 . . . . 75.439999999999998 110.89 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.55 -78.75 1.71 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.725 -0.75 . . . . 71.150000000000006 112.488 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.11 17.94 0.71 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.727 -0.749 . . . . 74.239999999999995 112.508 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -129.94 138.98 51.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.72 0.295 . . . . 73.019999999999996 110.93 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -102.98 142.25 34.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 63.520000000000003 110.899 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -136.31 119.38 16.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.465 . . . . 74.439999999999998 110.94 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.9 p -83.29 131.96 35.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 52.509999999999998 110.895 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.546 HG21 HD23 ' A' ' 32' ' ' LEU . 66.9 t -93.95 130.94 42.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.485 . . . . 74.519999999999996 111.16 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.0 p -141.27 93.08 2.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 72.450000000000003 111.137 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.575 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.8 OUTLIER 173.23 -28.37 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 72.25 111.14 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.74 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.9 mm? -85.11 150.1 25.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.462 . . . . 33.149999999999999 110.902 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.563 ' C ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.71 167.78 18.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 64.310000000000002 110.887 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.406 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 35.3 mt-10 -58.81 -21.91 57.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 64.120000000000005 110.929 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -68.9 -10.54 57.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.13 -0.487 . . . . 73.329999999999998 110.875 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.473 ' HB2' HD12 ' A' ' 19' ' ' LEU . 2.1 m-20 -102.62 -150.76 0.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 73.329999999999998 110.867 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.489 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -135.82 167.54 20.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 55.25 111.127 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.61 HG21 HD21 ' A' ' 64' ' ' LEU . 82.5 t -63.06 -42.37 96.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 63.539999999999999 111.13 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.424 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -61.78 -28.79 69.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.48 . . . . 73.040000000000006 110.915 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.594 ' HB3' HD11 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -72.01 -32.56 67.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.174 -0.466 . . . . 71.450000000000003 110.871 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.65 HD23 HD23 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -80.59 -48.82 12.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 73.530000000000001 110.939 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.512 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.94 -55.78 26.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 71.329999999999998 110.929 179.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.6 -22.49 45.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 75.239999999999995 110.902 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.575 ' CZ ' HG21 ' A' ' 18' ' ' THR . 54.6 t80 -77.84 -54.88 5.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 75.450000000000003 110.881 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.83 HD13 HG21 ' A' ' 7' ' ' VAL . 2.5 pp -68.07 -41.96 81.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 74.099999999999994 110.927 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.564 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.85 -27.74 44.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 73.420000000000002 110.889 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.34 -23.49 43.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.25 -0.432 . . . . 64.549999999999997 111.168 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.7 mt -76.76 -59.43 2.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 64.299999999999997 110.886 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.6 t -135.47 -28.03 1.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 54.43 111.178 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.59 -177.37 4.35 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.72 -0.752 . . . . 51.219999999999999 112.498 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.848 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.4 p -112.77 137.78 44.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.864 0.364 . . . . 63.340000000000003 111.098 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.975 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -53.71 149.95 14.86 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.631 0.729 . . . . 71.310000000000002 110.915 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -21.89 32.95 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.695 2.264 . . . . 64.209999999999994 112.342 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -54.21 -38.38 65.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 73.129999999999995 110.878 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.42 ' H ' HD23 ' A' ' 39' ' ' LEU . 2.7 mpt_? -104.43 -40.3 6.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 75.209999999999994 110.885 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.848 ' HG2' HG13 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -95.96 157.41 15.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 75.299999999999997 110.877 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.09 140.05 52.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 64.519999999999996 110.91 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.403 ' N ' HD22 ' A' ' 45' ' ' LEU . 3.6 mm? -65.94 135.75 55.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 75.109999999999999 110.917 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.684 HD11 ' CG ' ' A' ' 75' ' ' MET . 6.4 mp -81.36 -63.51 1.38 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 74.340000000000003 110.901 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.91 58.72 0.68 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.703 -0.76 . . . . 65.040000000000006 112.483 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.568 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 4.5 pp -60.46 -17.34 44.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 75.540000000000006 110.899 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.96 144.15 43.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 72.010000000000005 110.885 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.893 HG21 HD21 ' A' ' 66' ' ' LEU . 11.8 p -144.0 144.95 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 70.140000000000001 111.132 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.636 ' HG2' HG22 ' A' ' 50' ' ' VAL . 11.7 mmtt 54.66 32.71 17.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 65.109999999999999 110.912 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.78 -12.17 49.42 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.725 -0.75 . . . . 21.23 112.514 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.6 mmtt -81.61 150.6 66.86 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.574 0.702 . . . . 75.430000000000007 110.896 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.403 ' O ' ' C ' ' A' ' 55' ' ' ALA . 53.6 Cg_endo -69.83 -32.39 18.39 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.648 2.232 . . . . 62.25 112.302 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.579 ' HA ' HG21 ' A' ' 59' ' ' VAL . . . 36.79 43.45 0.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.277 -0.419 . . . . 44.409999999999997 111.087 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.46 -78.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 71.319999999999993 110.85 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -157.0 -38.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 62.310000000000002 110.916 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -64.95 -9.64 22.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 71.319999999999993 110.848 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.579 HG21 ' HA ' ' A' ' 55' ' ' ALA . 16.8 t -79.25 145.6 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 73.310000000000002 111.133 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 25.7 mttp -91.0 151.65 20.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 61.030000000000001 110.92 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.563 HD12 ' C ' ' A' ' 20' ' ' SER . 20.0 mt -49.66 -47.6 49.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 71.439999999999998 110.983 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.68 -11.84 85.05 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.742 -0.742 . . . . 55.340000000000003 112.478 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.22 -32.12 43.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.826 0.346 . . . . 72.019999999999996 111.125 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.61 HD21 HG21 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -77.29 -23.91 51.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 54.240000000000002 110.9 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp 63.67 37.44 10.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 54.109999999999999 110.875 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.893 HD21 HG21 ' A' ' 50' ' ' VAL . 5.2 mt -90.2 152.68 20.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 65.140000000000001 110.941 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.61 160.86 74.75 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.558 0.694 . . . . 73.030000000000001 110.89 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -35.08 13.24 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.629 2.22 . . . . 74.120000000000005 112.319 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.715 ' HA ' HD12 ' A' ' 6' ' ' ILE . 68.7 m-20 -78.49 -15.91 58.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 51.439999999999998 110.938 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.707 HG21 HD13 ' A' ' 66' ' ' LEU . 45.6 m -32.77 122.33 0.36 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.487 . . . . 72.349999999999994 111.125 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -93.83 146.24 24.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 70.239999999999995 110.899 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 36.2 mm -115.99 131.75 67.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 61.140000000000001 111.149 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.531 ' HB3' HD13 ' A' ' 46' ' ' LEU . 46.1 mtm -101.85 142.46 33.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 75.129999999999995 110.892 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.9 mtt -133.83 119.29 19.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 61.119999999999997 110.88 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.684 ' CG ' HD11 ' A' ' 46' ' ' LEU . 2.8 mmm -108.42 121.88 45.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 75.239999999999995 110.912 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 162.85 -156.7 28.53 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.703 -0.76 . . . . 72.140000000000001 112.468 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.7 t . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 120.786 0.326 . . . . 61.240000000000002 111.114 -179.823 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.736 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.831 0.348 . . . . 41.399999999999999 111.111 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.522 HD23 ' HD2' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -107.79 110.33 62.47 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.597 0.713 . . . . 62.240000000000002 110.921 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.522 ' HD2' HD23 ' A' ' 3' ' ' LEU . 53.2 Cg_endo -69.83 156.89 62.01 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.656 2.237 . . . . 72.140000000000001 112.287 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.549 ' HB ' HD21 ' A' ' 28' ' ' LEU . 40.3 mt -150.3 137.15 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.483 . . . . 70.329999999999998 111.125 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.692 HD12 ' HA ' ' A' ' 69' ' ' ASN . 4.6 mt -95.2 140.65 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 74.019999999999996 111.126 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.801 HG21 HD13 ' A' ' 32' ' ' LEU . 7.3 p -126.82 122.72 61.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 53.340000000000003 111.124 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.97 121.33 44.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 61.200000000000003 110.918 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 16.2 t-105 -121.43 100.78 7.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 75.239999999999995 110.891 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.59 -83.64 0.96 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.702 -0.761 . . . . 71.230000000000004 112.483 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.67 20.68 1.16 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.7 -0.762 . . . . 61.310000000000002 112.434 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.28 174.2 9.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.761 0.315 . . . . 73.510000000000005 110.944 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -132.93 140.46 47.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.268 -0.424 . . . . 74.25 110.929 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.506 ' CD2' HG21 ' A' ' 36' ' ' THR . 38.2 m-85 -135.83 116.32 13.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 74.019999999999996 110.91 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.3 p -82.51 132.17 35.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 74.140000000000001 110.851 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.551 HG21 HD23 ' A' ' 32' ' ' LEU . 96.4 t -94.68 136.93 24.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 74.439999999999998 111.12 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.6 p -146.73 93.83 2.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 74.420000000000002 111.125 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.666 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.7 OUTLIER 172.66 -28.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.219 -0.446 . . . . 75.430000000000007 111.136 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.736 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.8 mm? -87.64 150.53 23.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 65.409999999999997 110.917 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.67 165.56 23.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 65.540000000000006 110.883 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -57.78 -20.75 37.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 71.010000000000005 110.878 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.08 -11.9 61.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.179 -0.464 . . . . 74.439999999999998 110.854 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.431 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.7 m-20 -101.06 -148.84 0.37 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.266 -0.425 . . . . 73.549999999999997 110.831 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.26 167.47 20.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.191 -0.459 . . . . 74.230000000000004 111.166 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.939 HG22 HD11 ' A' ' 64' ' ' LEU . 15.9 t -63.42 -44.05 98.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 61.539999999999999 111.094 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.16 -28.39 67.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.457 . . . . 63.350000000000001 110.971 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.498 ' HB3' HD11 ' A' ' 19' ' ' LEU . 12.5 t0 -70.59 -35.52 73.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 54.32 110.857 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.693 HD12 ' CB ' ' A' ' 19' ' ' LEU . 1.2 tt -80.4 -47.82 13.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 45.140000000000001 110.904 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.747 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.57 -56.69 17.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 73.319999999999993 110.886 179.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -57.99 -22.31 48.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 63.439999999999998 110.915 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.666 ' CZ ' HG21 ' A' ' 18' ' ' THR . 64.8 t80 -77.3 -54.93 5.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 73.510000000000005 110.839 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.801 HD13 HG21 ' A' ' 7' ' ' VAL . 2.3 pp -68.23 -42.83 79.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 63.310000000000002 110.871 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.562 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -55.02 -27.12 41.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 74.099999999999994 110.901 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.503 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.77 -23.58 42.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 75.25 111.189 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.9 mt -76.7 -59.89 2.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 74.439999999999998 110.92 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.506 HG21 ' CD2' ' A' ' 14' ' ' TYR . 3.1 t -135.4 -27.42 1.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 73.099999999999994 111.194 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.562 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.99 -177.95 5.14 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.8 -0.714 . . . . 51.009999999999998 112.466 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.861 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.2 p -112.98 138.7 41.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.899 0.381 . . . . 74.109999999999999 111.098 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.963 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.42 151.1 14.74 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.593 0.711 . . . . 71.299999999999997 110.932 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 54.1 Cg_endo -69.78 -21.49 33.31 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.68 2.253 . . . . 73.420000000000002 112.354 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -54.52 -38.98 67.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 73.129999999999995 110.87 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.438 ' H ' HD23 ' A' ' 39' ' ' LEU . 8.8 mpt_? -103.89 -40.45 6.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 73.109999999999999 110.847 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.861 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.7 pp0? -98.11 158.2 15.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 75.140000000000001 110.877 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.28 141.37 51.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 75.310000000000002 110.902 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.26 135.96 54.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.262 -0.426 . . . . 63.409999999999997 110.905 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.736 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.1 mm? -76.86 -75.8 0.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 73.299999999999997 110.904 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -97.03 60.5 1.13 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.68 -0.772 . . . . 64.120000000000005 112.482 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.645 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 3.7 pp -55.4 -24.43 30.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.843 0.354 . . . . 64.219999999999999 110.923 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.421 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -103.71 143.42 32.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 72.319999999999993 110.892 179.845 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.763 HG21 HD21 ' A' ' 66' ' ' LEU . 14.9 p -144.1 143.38 23.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 73.120000000000005 111.15 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.0 mttt 54.0 34.19 19.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 44.32 110.905 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.22 -14.98 41.84 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.801 -0.714 . . . . 52.240000000000002 112.468 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.8 mmtt -81.67 149.57 64.47 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.537 0.684 . . . . 60.399999999999999 110.93 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.421 ' HA ' ' HB3' ' A' ' 49' ' ' LYS . 53.9 Cg_endo -69.73 -35.97 11.75 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.669 2.246 . . . . 73.319999999999993 112.334 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.645 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 38.97 39.3 0.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 34.119999999999997 111.096 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.89 -75.65 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 64.230000000000004 110.892 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -154.17 -38.57 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 64.040000000000006 110.875 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -72.72 -2.46 20.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 64.0 110.855 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.555 ' O ' HG23 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -93.36 148.19 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 74.230000000000004 111.137 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.408 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 35.1 mttt -91.39 147.56 22.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 64.099999999999994 110.906 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.407 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 10.6 mt -51.88 -41.95 62.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 70.150000000000006 110.916 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.63 -15.59 80.54 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.76 -0.733 . . . . 72.200000000000003 112.462 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.69 -19.94 32.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.839 0.352 . . . . 64.299999999999997 111.108 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.939 HD11 HG22 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -83.47 -20.23 34.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 70.120000000000005 110.939 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt 53.74 43.02 31.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 53.229999999999997 110.816 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.763 HD21 HG21 ' A' ' 50' ' ' VAL . 3.3 mt -95.48 153.33 17.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 70.340000000000003 110.902 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -68.25 159.75 78.87 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.626 0.727 . . . . 73.219999999999999 110.872 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -36.77 10.16 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.663 2.242 . . . . 72.230000000000004 112.329 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.692 ' HA ' HD12 ' A' ' 6' ' ' ILE . 14.8 p30 -78.44 -15.85 58.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 74.5 110.9 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.636 HG21 HD13 ' A' ' 66' ' ' LEU . 53.6 m -32.4 125.13 0.31 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 72.439999999999998 111.156 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.27 145.83 24.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 70.209999999999994 110.919 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.6 mm -115.61 128.36 72.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.27 -0.423 . . . . 71.319999999999993 111.126 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 37.0 mtt -99.71 141.74 32.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.478 . . . . 73.209999999999994 110.876 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.0 mtt -133.76 118.36 17.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 73.140000000000001 110.862 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.736 ' CG ' HD21 ' A' ' 46' ' ' LEU . 3.0 mmt -106.05 123.07 47.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 61.329999999999998 110.887 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.87 -157.16 28.87 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.765 -0.731 . . . . 62.340000000000003 112.526 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.3 t . . . . . 0 C--N 1.33 -0.266 0 CA-C-O 120.777 0.322 . . . . 55.539999999999999 111.115 -179.893 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.748 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.804 0.335 . . . . 72.200000000000003 111.116 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.4 mt -110.99 109.54 57.22 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.653 0.739 . . . . 74.120000000000005 110.9 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 156.62 62.86 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.685 2.256 . . . . 75.219999999999999 112.359 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.443 ' HB ' HD21 ' A' ' 28' ' ' LEU . 37.8 mt -150.57 137.67 13.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.247 -0.433 . . . . 64.409999999999997 111.083 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.694 HD12 ' HA ' ' A' ' 69' ' ' ASN . 3.8 mt -95.24 140.41 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 74.329999999999998 111.116 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.838 HG21 HD13 ' A' ' 32' ' ' LEU . 8.7 p -127.46 123.71 62.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 64.030000000000001 111.138 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.21 118.98 38.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.462 . . . . 73.140000000000001 110.872 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 10.5 t-105 -122.4 102.56 8.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.205 -0.452 . . . . 63.100000000000001 110.906 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.0 -82.84 0.74 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.785 -0.721 . . . . 34.229999999999997 112.504 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.77 19.73 0.78 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.73 -0.748 . . . . 55.439999999999998 112.464 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -129.08 175.55 8.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.753 0.311 . . . . 63.310000000000002 110.941 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -132.92 140.56 47.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 54.340000000000003 110.898 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -135.01 120.26 18.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.152 -0.476 . . . . 75.420000000000002 110.941 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.4 p -83.53 133.3 34.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.499 . . . . 75.450000000000003 110.825 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.541 HG21 ' CD2' ' A' ' 32' ' ' LEU . 73.6 t -95.98 126.83 48.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 74.230000000000004 111.169 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.5 p -137.39 92.77 2.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 54.32 111.117 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.563 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.9 OUTLIER 174.03 -29.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 74.0 111.162 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.748 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.8 mm? -84.92 150.03 25.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 75.129999999999995 110.88 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.558 ' C ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.74 168.18 18.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 72.040000000000006 110.875 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.432 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 78.1 mt-10 -59.06 -22.03 60.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 63.229999999999997 110.852 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.3 -10.94 58.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.193 -0.458 . . . . 72.319999999999993 110.868 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.444 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.9 m-20 -102.79 -150.14 0.41 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 53.439999999999998 110.869 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.564 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -136.03 168.07 20.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 73.129999999999995 111.129 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.613 HG22 HD11 ' A' ' 64' ' ' LEU . 91.1 t -63.29 -42.92 98.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 61.030000000000001 111.126 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.403 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -61.19 -29.47 69.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 74.040000000000006 110.907 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.566 ' HB3' HD11 ' A' ' 19' ' ' LEU . 4.1 t0 -71.06 -32.98 69.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.459 . . . . 62.420000000000002 110.863 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.674 HD23 HD23 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -80.45 -48.95 12.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 74.349999999999994 110.871 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.509 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.99 -56.13 22.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 73.310000000000002 110.911 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -57.47 -23.01 47.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 74.409999999999997 110.913 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.563 ' CZ ' HG21 ' A' ' 18' ' ' THR . 52.5 t80 -77.27 -55.36 5.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 70.150000000000006 110.884 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.838 HD13 HG21 ' A' ' 7' ' ' VAL . 2.5 pp -67.66 -42.4 82.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.494 . . . . 62.420000000000002 110.909 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.572 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.2 tmtt? -54.81 -27.69 43.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 65.340000000000003 110.901 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.518 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.47 -23.34 43.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.24 -0.436 . . . . 73.120000000000005 111.154 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.7 mt -76.85 -59.51 2.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 41.219999999999999 110.9 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.8 t -135.27 -27.24 1.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 73.310000000000002 111.165 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.572 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.72 -176.86 5.31 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.723 -0.751 . . . . 74.319999999999993 112.513 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.873 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.4 p -112.78 137.16 46.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.845 0.355 . . . . 45.530000000000001 111.136 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.947 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -53.48 150.0 13.55 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.561 0.696 . . . . 43.020000000000003 110.946 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -21.8 33.19 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.701 2.267 . . . . 64.120000000000005 112.37 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.16 -38.09 65.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 62.439999999999998 110.868 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.423 ' H ' HD23 ' A' ' 39' ' ' LEU . 3.1 mpt_? -104.95 -40.05 6.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 63.149999999999999 110.881 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.873 ' HG2' HG13 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -96.48 158.31 15.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 63.310000000000002 110.895 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.72 140.37 51.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 73.409999999999997 110.893 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.32 135.25 54.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 74.200000000000003 110.945 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.746 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.0 mm? -75.74 -72.17 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 65.299999999999997 110.972 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.57 61.61 0.86 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.686 -0.769 . . . . 53.240000000000002 112.524 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.583 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 4.5 pp -58.19 -19.22 31.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 72.099999999999994 110.948 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.39 144.24 39.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 70.239999999999995 110.875 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.783 HG21 HD21 ' A' ' 66' ' ' LEU . 10.9 p -143.8 146.21 21.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 74.340000000000003 111.111 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt 54.77 31.92 16.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 72.530000000000001 110.914 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.16 -10.91 51.88 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.74 -0.743 . . . . 63.520000000000003 112.507 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -81.34 151.07 68.75 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.592 0.711 . . . . 73.140000000000001 110.885 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 55' ' ' ALA . 54.1 Cg_endo -69.74 -32.91 17.73 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.683 2.256 . . . . 71.209999999999994 112.347 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.585 ' HA ' HG21 ' A' ' 59' ' ' VAL . . . 35.98 44.35 0.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 74.299999999999997 111.122 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.33 -75.75 0.05 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 75.409999999999997 110.869 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.72 -37.53 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 75.299999999999997 110.909 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -67.14 -8.99 35.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 71.209999999999994 110.884 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.585 HG21 ' HA ' ' A' ' 55' ' ' ALA . 17.7 t -78.61 145.65 9.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 74.319999999999993 111.132 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -89.9 151.14 21.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 74.040000000000006 110.89 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.558 HD12 ' C ' ' A' ' 20' ' ' SER . 19.8 mt -49.83 -47.42 51.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 51.240000000000002 110.909 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.48 -12.02 84.93 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.804 -0.712 . . . . 50.409999999999997 112.461 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.14 -32.15 44.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.817 0.341 . . . . 63.140000000000001 111.061 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.613 HD11 HG22 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -77.81 -23.61 49.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 71.530000000000001 110.887 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp 63.41 37.49 10.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 64.310000000000002 110.95 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.783 HD21 HG21 ' A' ' 50' ' ' VAL . 4.2 mt -89.29 152.32 21.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 65.549999999999997 110.987 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.63 160.61 76.03 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.598 0.713 . . . . 72.310000000000002 110.882 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -34.85 13.7 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.649 2.232 . . . . 64.349999999999994 112.35 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.694 ' HA ' HD12 ' A' ' 6' ' ' ILE . 10.5 m120 -78.8 -15.68 58.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 74.310000000000002 110.883 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.66 HG21 HD13 ' A' ' 66' ' ' LEU . 47.7 m -32.97 120.82 0.36 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 61.009999999999998 111.145 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -92.5 146.43 23.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 63.340000000000003 110.926 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.0 mm -115.8 128.89 72.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 52.539999999999999 111.168 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 44.7 mtm -99.74 141.6 32.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 64.109999999999999 110.883 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.8 mtt -131.74 125.72 32.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 74.409999999999997 110.876 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.746 ' CG ' HD21 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -116.01 120.09 37.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 74.310000000000002 110.889 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 163.05 -156.41 28.16 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.765 -0.731 . . . . 73.510000000000005 112.54 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.754 0.311 . . . . 51.109999999999999 111.128 -179.858 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.744 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.795 0.331 . . . . 43.219999999999999 111.106 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.413 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 3.4 mt -109.15 109.76 60.63 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.609 0.719 . . . . 72.040000000000006 110.936 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 53.8 Cg_endo -69.79 156.13 64.07 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.698 2.265 . . . . 71.129999999999995 112.343 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.557 ' HB ' HD21 ' A' ' 28' ' ' LEU . 36.2 mt -150.51 136.08 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 62.119999999999997 111.115 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.716 HD12 ' HA ' ' A' ' 69' ' ' ASN . 3.6 mt -94.87 140.68 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 60.43 111.131 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.848 HG21 HD13 ' A' ' 32' ' ' LEU . 7.7 p -127.33 123.21 61.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 74.0 111.136 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.43 123.21 48.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.485 . . . . 52.329999999999998 110.899 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.2 t-105 -124.48 102.88 7.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.441 . . . . 72.239999999999995 110.91 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.55 -80.09 1.52 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.745 -0.74 . . . . 61.219999999999999 112.493 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.23 17.51 0.69 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.786 -0.721 . . . . 64.409999999999997 112.497 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 36.6 mm-40 -130.06 139.19 51.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.751 0.31 . . . . 64.530000000000001 110.949 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -103.1 142.06 34.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 72.510000000000005 110.903 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.634 ' CD1' HG21 ' A' ' 36' ' ' THR . 76.4 m-85 -136.28 116.54 13.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 61.200000000000003 110.947 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.4 p -82.45 131.2 35.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 61.439999999999998 110.88 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.562 HG21 HD23 ' A' ' 32' ' ' LEU . 85.9 t -92.29 138.81 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 72.329999999999998 111.136 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 p -148.76 92.42 1.99 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 74.450000000000003 111.155 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.655 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.9 OUTLIER 173.63 -28.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 63.25 111.158 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.744 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.8 mm? -85.78 151.21 24.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 65.239999999999995 110.936 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.18 168.54 17.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 74.400000000000006 110.863 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.414 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 36.2 mt-10 -60.61 -22.09 63.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 62.329999999999998 110.901 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.63 -11.23 60.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.157 -0.474 . . . . 73.400000000000006 110.81 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.415 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.5 m-20 -99.82 -151.15 0.39 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 61.100000000000001 110.838 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.64 168.86 17.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 61.409999999999997 111.114 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.961 HG22 HD11 ' A' ' 64' ' ' LEU . 12.4 t -65.62 -41.32 90.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 74.530000000000001 111.143 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.44 -28.63 69.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.141 -0.482 . . . . 72.010000000000005 110.92 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.519 ' HB3' HD11 ' A' ' 19' ' ' LEU . 19.6 t0 -70.73 -34.92 72.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 64.200000000000003 110.859 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.68 HD12 ' CB ' ' A' ' 19' ' ' LEU . 1.2 tt -80.76 -47.91 13.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 74.129999999999995 110.914 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.751 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.64 -56.57 18.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 73.129999999999995 110.911 179.812 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.15 -22.45 51.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 73.140000000000001 110.943 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.655 ' CZ ' HG21 ' A' ' 18' ' ' THR . 55.2 t80 -77.29 -55.17 5.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 74.209999999999994 110.879 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.848 HD13 HG21 ' A' ' 7' ' ' VAL . 2.3 pp -67.49 -43.45 80.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.141 -0.482 . . . . 64.25 110.902 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.579 ' N ' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -54.84 -27.03 39.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 71.109999999999999 110.924 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.46 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.78 -23.74 41.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 74.340000000000003 111.146 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.9 mt -76.46 -59.75 2.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.439 . . . . 74.400000000000006 110.859 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.634 HG21 ' CD1' ' A' ' 14' ' ' TYR . 3.5 t -135.31 -28.07 1.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 74.230000000000004 111.163 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.8 -177.58 4.7 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.717 -0.754 . . . . 63.200000000000003 112.52 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.898 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.2 p -112.56 139.22 38.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.861 0.362 . . . . 51.240000000000002 111.082 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.978 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.52 150.67 16.55 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.622 0.725 . . . . 74.150000000000006 110.88 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 53.5 Cg_endo -69.73 -21.95 32.9 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.653 2.235 . . . . 71.209999999999994 112.353 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -54.29 -38.98 66.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 63.549999999999997 110.876 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.421 ' H ' HD23 ' A' ' 39' ' ' LEU . 5.5 mtt85 -103.97 -40.27 6.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 62.520000000000003 110.889 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.898 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.7 pp0? -98.2 158.7 15.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 74.200000000000003 110.916 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.67 141.06 51.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 73.25 110.89 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.64 135.04 53.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 74.239999999999995 110.93 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.737 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.1 mm? -75.81 -75.57 0.18 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 74.030000000000001 110.906 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -96.15 60.34 1.36 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.725 -0.75 . . . . 72.319999999999993 112.459 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.635 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 3.8 pp -56.06 -23.85 36.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.905 0.383 . . . . 72.349999999999994 110.947 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.407 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -104.43 143.4 33.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 61.530000000000001 110.888 179.836 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.757 HG21 HD21 ' A' ' 66' ' ' LEU . 13.0 p -144.11 143.64 23.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 51.329999999999998 111.091 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.719 ' HG2' HG22 ' A' ' 50' ' ' VAL . 0.2 OUTLIER 54.07 33.82 18.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 72.109999999999999 110.854 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.48 -15.04 42.96 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.714 -0.755 . . . . 51.329999999999998 112.452 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.6 mmtm -81.61 149.63 64.82 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.636 0.732 . . . . 54.409999999999997 110.858 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.407 ' HA ' ' HB3' ' A' ' 49' ' ' LYS . 53.8 Cg_endo -69.73 -35.98 11.71 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.663 2.242 . . . . 71.420000000000002 112.354 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 38.92 39.31 0.35 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 41.399999999999999 111.115 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.7 -75.47 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 75.219999999999999 110.878 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -154.61 -39.51 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 64.349999999999994 110.857 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -72.16 -4.11 27.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 54.409999999999997 110.875 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.615 ' O ' HG23 ' A' ' 25' ' ' VAL . 1.4 t -90.04 147.48 5.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 73.099999999999994 111.099 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.485 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 13.4 mttp -90.35 147.13 23.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 74.030000000000001 110.933 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.414 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 16.1 mt -51.95 -38.1 55.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 71.340000000000003 110.882 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.69 -18.43 79.7 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.753 -0.736 . . . . 41.229999999999997 112.455 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.61 -14.89 47.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.857 0.36 . . . . 63.140000000000001 111.142 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.961 HD11 HG22 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -87.17 -18.02 31.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 64.299999999999997 110.944 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.16 45.65 23.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 64.109999999999999 110.914 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.757 HD21 HG21 ' A' ' 50' ' ' VAL . 3.5 mt -99.02 153.27 18.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 71.519999999999996 110.897 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.27 159.81 78.62 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.549 0.69 . . . . 63.329999999999998 110.932 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -36.71 10.32 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.707 2.271 . . . . 52.219999999999999 112.37 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.716 ' HA ' HD12 ' A' ' 6' ' ' ILE . 1.7 m-80 -78.59 -15.81 58.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 62.020000000000003 110.872 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.655 HG21 HD13 ' A' ' 66' ' ' LEU . 51.8 m -32.63 123.65 0.35 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.475 . . . . 51.200000000000003 111.163 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.68 146.26 23.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 72.040000000000006 110.856 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.7 mm -115.45 131.83 66.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 63.520000000000003 111.115 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 26.5 mtm -104.14 142.04 35.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 62.240000000000002 110.866 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 75.0 mtm -134.44 118.6 17.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 65.319999999999993 110.91 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.737 ' CG ' HD21 ' A' ' 46' ' ' LEU . 2.1 mmt -106.2 126.1 51.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 73.319999999999993 110.858 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' A' ' 43' ' ' GLN . . . 157.87 -154.65 25.72 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.754 -0.736 . . . . 63.329999999999998 112.49 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.795 0.331 . . . . 63.030000000000001 111.164 -179.863 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.746 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.811 0.339 . . . . 63.210000000000001 111.132 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.412 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 4.1 mt -111.71 109.61 55.4 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.681 0.753 . . . . 74.510000000000005 110.888 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 53.7 Cg_endo -69.75 156.34 63.61 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.652 2.234 . . . . 65.140000000000001 112.331 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.538 ' HB ' HD21 ' A' ' 28' ' ' LEU . 30.2 mt -150.34 136.81 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 62.32 111.129 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.711 HD12 ' HA ' ' A' ' 69' ' ' ASN . 3.6 mt -95.2 140.73 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 54.350000000000001 111.186 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.853 HG21 HD13 ' A' ' 32' ' ' LEU . 8.6 p -127.1 123.48 62.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 64.349999999999994 111.121 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.81 125.72 51.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 72.150000000000006 110.876 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.6 t-105 -125.01 100.74 6.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 73.120000000000005 110.911 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.22 -79.22 1.71 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.732 -0.747 . . . . 43.5 112.442 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.16 17.46 0.8 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.729 -0.748 . . . . 52.340000000000003 112.512 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -129.35 138.59 51.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.742 0.306 . . . . 70.019999999999996 110.909 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -102.94 142.28 34.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 73.209999999999994 110.94 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.58 ' CG ' HG21 ' A' ' 36' ' ' THR . 79.7 m-85 -136.69 116.15 12.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 75.219999999999999 110.867 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.86 133.87 35.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.086 -0.506 . . . . 53.229999999999997 110.858 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.529 HG21 HD23 ' A' ' 32' ' ' LEU . 89.7 t -95.71 139.55 18.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.08 -0.509 . . . . 74.409999999999997 111.091 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.3 p -149.02 92.91 2.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 71.510000000000005 111.151 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.712 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.8 OUTLIER 173.67 -28.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 44.340000000000003 111.175 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.746 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.7 mm? -85.7 151.53 23.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.447 . . . . 64.549999999999997 110.919 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.423 ' O ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.39 168.96 16.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 74.0 110.843 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.417 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 22.5 mt-10 -61.09 -22.37 64.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 71.200000000000003 110.892 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.37 -11.33 60.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 75.0 110.856 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.402 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.6 m-20 -99.94 -151.0 0.39 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 74.209999999999994 110.852 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -133.27 171.57 13.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 62.140000000000001 111.148 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.954 HG22 HD11 ' A' ' 64' ' ' LEU . 11.2 t -67.23 -42.02 87.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 63.119999999999997 111.153 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.57 -28.96 69.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.481 . . . . 74.340000000000003 110.876 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.496 ' HB3' HD11 ' A' ' 19' ' ' LEU . 10.1 t0 -70.46 -35.05 73.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.434 . . . . 70.129999999999995 110.893 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.661 HD23 HD23 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -80.67 -48.06 13.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 72.329999999999998 110.962 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.775 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.45 -56.51 19.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 61.439999999999998 110.885 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.2 -22.29 51.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 45.310000000000002 110.892 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.712 ' CZ ' HG21 ' A' ' 18' ' ' THR . 50.8 t80 -77.46 -55.14 5.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 63.210000000000001 110.858 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.853 HD13 HG21 ' A' ' 7' ' ' VAL . 2.4 pp -67.67 -43.07 81.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.176 -0.465 . . . . 64.219999999999999 110.897 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.564 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.98 -26.91 39.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 45.549999999999997 110.883 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.478 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -80.02 -23.85 41.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 72.310000000000002 111.12 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.405 HD11 ' CE2' ' A' ' 31' ' ' PHE . 13.1 mt -76.45 -59.85 2.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.456 . . . . 70.420000000000002 110.9 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.58 HG21 ' CG ' ' A' ' 14' ' ' TYR . 4.2 t -135.39 -28.09 1.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 71.109999999999999 111.131 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.52 -177.86 4.53 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.699 -0.762 . . . . 64.109999999999999 112.502 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.859 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.0 OUTLIER -113.18 139.57 37.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.898 0.38 . . . . 64.519999999999996 111.149 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 1.001 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.39 151.3 14.19 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.617 0.722 . . . . 71.040000000000006 110.898 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 53.9 Cg_endo -69.74 -21.42 33.63 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.664 2.243 . . . . 72.430000000000007 112.383 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -54.83 -38.88 67.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 74.420000000000002 110.821 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.426 ' H ' HD23 ' A' ' 39' ' ' LEU . 1.8 mtt-85 -103.73 -40.47 6.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 64.150000000000006 110.865 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.859 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.7 pp0? -98.29 157.32 16.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 73.129999999999995 110.888 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.31 141.11 51.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 64.040000000000006 110.907 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.406 ' N ' HD22 ' A' ' 45' ' ' LEU . 3.7 mm? -67.31 135.91 54.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 62.43 110.966 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.796 HD11 ' HG2' ' A' ' 75' ' ' MET . 7.0 mp -78.15 -75.09 0.23 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 73.129999999999995 110.927 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.13 58.78 1.7 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.724 -0.75 . . . . 75.120000000000005 112.446 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.649 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 3.7 pp -55.15 -24.48 26.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.86 0.362 . . . . 73.040000000000006 110.905 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.411 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -103.89 143.39 32.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 72.439999999999998 110.944 179.807 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.787 HG21 HD21 ' A' ' 66' ' ' LEU . 14.7 p -144.25 143.49 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 74.140000000000001 111.142 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.6 mttp 54.01 34.04 18.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 72.209999999999994 110.934 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.38 -15.11 42.08 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.739 -0.743 . . . . 70.129999999999995 112.499 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -81.64 149.47 64.39 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.586 0.708 . . . . 62.109999999999999 110.912 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.411 ' HA ' ' HB3' ' A' ' 49' ' ' LYS . 54.4 Cg_endo -69.72 -35.86 11.99 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.705 2.27 . . . . 61.509999999999998 112.335 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 38.98 39.51 0.37 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 61.420000000000002 111.146 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.31 -74.0 0.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 72.439999999999998 110.89 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.416 HD22 ' N ' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -157.45 -36.31 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 74.340000000000003 110.889 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.416 ' N ' HD22 ' A' ' 57' ' ' ASN . 4.0 m-20 -75.3 -1.6 24.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 72.409999999999997 110.913 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -93.55 147.65 5.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.166 -0.47 . . . . 72.219999999999999 111.104 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.407 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 12.9 mttt -89.99 147.2 23.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 70.329999999999998 110.85 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.423 HD12 ' O ' ' A' ' 20' ' ' SER . 17.3 mt -52.71 -38.3 60.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 72.319999999999993 110.895 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.61 -17.21 80.21 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.712 -0.756 . . . . 75.549999999999997 112.501 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.39 -20.08 32.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.826 0.346 . . . . 73.439999999999998 111.097 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.954 HD11 HG22 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -83.96 -20.02 33.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.435 . . . . 75.340000000000003 110.923 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.3 mmtp 52.09 43.91 30.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 74.109999999999999 110.904 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.787 HD21 HG21 ' A' ' 50' ' ' VAL . 3.4 mt -95.03 153.12 17.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 70.150000000000006 110.898 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.57 159.77 79.87 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.588 0.709 . . . . 71.230000000000004 110.876 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 -36.8 10.24 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.699 2.266 . . . . 60.399999999999999 112.354 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.711 ' HA ' HD12 ' A' ' 6' ' ' ILE . 2.4 m120 -78.45 -15.78 58.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 72.230000000000004 110.872 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.652 HG21 HD13 ' A' ' 66' ' ' LEU . 51.9 m -32.53 125.01 0.33 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 73.219999999999999 111.123 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.93 146.78 24.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 70.319999999999993 110.892 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.6 mm -115.17 129.96 70.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 74.019999999999996 111.164 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.487 ' CB ' HD13 ' A' ' 46' ' ' LEU . 41.2 mtm -101.01 142.87 31.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.478 . . . . 74.230000000000004 110.859 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.1 mtt -135.97 116.88 14.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 75.310000000000002 110.912 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.796 ' HG2' HD11 ' A' ' 46' ' ' LEU . 8.7 mmm -105.29 131.39 52.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 55.130000000000003 110.894 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 148.64 -151.9 24.02 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.71 -0.757 . . . . 73.230000000000004 112.51 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.753 0.311 . . . . 70.150000000000006 111.167 -179.932 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.745 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.822 0.344 . . . . 63.439999999999998 111.1 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.421 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 2.6 mt -111.38 109.37 56.35 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.595 0.712 . . . . 41.420000000000002 110.934 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 53.7 Cg_endo -69.8 156.41 63.33 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.651 2.234 . . . . 72.019999999999996 112.35 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.544 ' HB ' HD21 ' A' ' 28' ' ' LEU . 31.3 mt -150.58 137.02 12.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 73.010000000000005 111.135 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.648 HD12 ' HA ' ' A' ' 69' ' ' ASN . 5.1 mt -94.96 140.57 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 72.540000000000006 111.134 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.855 HG21 HD13 ' A' ' 32' ' ' LEU . 7.5 p -127.1 122.86 61.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 73.420000000000002 111.091 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.66 119.82 40.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 73.340000000000003 110.89 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 16.6 t-105 -120.85 100.62 7.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.454 . . . . 61.43 110.944 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.87 -83.39 0.92 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.797 -0.716 . . . . 63.420000000000002 112.489 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.57 21.57 1.05 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.772 -0.728 . . . . 61.229999999999997 112.501 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -129.28 175.29 8.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.775 0.322 . . . . 73.129999999999995 110.904 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -133.19 140.96 47.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 74.519999999999996 110.916 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.466 ' CD2' HG21 ' A' ' 36' ' ' THR . 41.3 m-85 -136.51 119.14 16.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.173 -0.467 . . . . 74.530000000000001 110.973 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.2 p -84.13 132.35 34.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 62.219999999999999 110.849 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.553 HG21 HD23 ' A' ' 32' ' ' LEU . 95.9 t -94.98 125.98 47.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.069 -0.514 . . . . 45.140000000000001 111.138 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.2 p -136.49 93.12 2.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 52.409999999999997 111.174 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.712 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.8 OUTLIER 173.51 -28.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 70.219999999999999 111.113 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.745 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.8 mm? -86.12 151.2 23.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.271 -0.422 . . . . 70.519999999999996 110.878 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.438 ' O ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.32 169.33 16.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 70.5 110.815 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.412 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 43.1 mt-10 -61.7 -22.18 65.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.106 -0.497 . . . . 72.099999999999994 110.922 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -70.16 -10.69 59.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 74.230000000000004 110.871 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.403 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.5 m-20 -99.2 -150.44 0.37 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 75.019999999999996 110.842 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.32 168.53 18.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 71.420000000000002 111.144 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.975 HG22 HD11 ' A' ' 64' ' ' LEU . 13.0 t -64.67 -42.85 96.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 64.200000000000003 111.137 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.14 -28.47 69.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 73.019999999999996 110.9 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.49 ' HB3' HD11 ' A' ' 19' ' ' LEU . 19.9 t0 -70.81 -35.09 72.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 73.120000000000005 110.868 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.667 HD12 ' CB ' ' A' ' 19' ' ' LEU . 0.9 OUTLIER -80.64 -47.73 13.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 75.150000000000006 110.906 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.755 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.97 -56.8 15.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 73.200000000000003 110.867 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -58.19 -22.1 50.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 74.420000000000002 110.906 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.712 ' CZ ' HG21 ' A' ' 18' ' ' THR . 54.0 t80 -77.48 -54.9 5.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 74.430000000000007 110.865 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.855 HD13 HG21 ' A' ' 7' ' ' VAL . 2.4 pp -68.28 -43.0 78.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 71.230000000000004 110.898 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.569 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -55.08 -26.91 41.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 74.120000000000005 110.909 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.82 -23.77 41.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.452 . . . . 62.219999999999999 111.141 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.7 mt -76.67 -60.26 2.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.234 -0.439 . . . . 72.400000000000006 110.87 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.466 HG21 ' CD2' ' A' ' 14' ' ' TYR . 2.8 t -135.41 -27.48 1.19 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 61.43 111.181 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.569 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.45 -178.4 4.74 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.759 -0.734 . . . . 70.420000000000002 112.521 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.875 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.2 p -112.91 139.06 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.889 0.376 . . . . 71.530000000000001 111.095 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.991 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.53 150.8 16.08 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.66 0.743 . . . . 75.420000000000002 110.92 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 53.9 Cg_endo -69.68 -21.64 33.57 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.69 2.26 . . . . 53.0 112.358 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -54.41 -38.89 66.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 53.25 110.874 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.432 ' H ' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -104.04 -40.52 6.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 63.100000000000001 110.865 -179.902 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.875 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.7 pp0? -97.87 158.27 15.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 73.439999999999998 110.929 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.36 141.73 51.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 73.510000000000005 110.898 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.36 136.04 54.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.266 -0.425 . . . . 40.420000000000002 110.868 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.723 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.1 mm? -76.74 -75.91 0.18 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 62.399999999999999 110.898 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.26 56.83 1.74 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.735 -0.745 . . . . 52.350000000000001 112.473 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.646 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 4.0 pp -50.56 -32.31 18.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.877 0.37 . . . . 63.520000000000003 110.933 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.527 ' N ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -95.59 146.19 24.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 72.25 110.927 179.802 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.705 HG21 ' CD2' ' A' ' 66' ' ' LEU . 8.5 p -142.37 138.01 29.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 74.409999999999997 111.126 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt 54.53 32.2 16.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 73.25 110.893 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.42 -15.57 56.17 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.753 -0.737 . . . . 42.43 112.485 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -80.17 149.79 70.16 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.546 0.688 . . . . 72.439999999999998 110.901 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -36.27 11.04 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.729 2.286 . . . . 70.430000000000007 112.316 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 39.54 37.05 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 71.239999999999995 111.101 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.44 -76.83 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 74.450000000000003 110.9 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -153.87 -38.96 0.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 71.129999999999995 110.866 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -71.89 -2.61 18.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 73.400000000000006 110.882 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.58 ' O ' HG23 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -92.93 147.7 5.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 71.549999999999997 111.15 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.415 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 15.4 mttp -91.27 147.84 22.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 74.409999999999997 110.916 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.438 HD12 ' O ' ' A' ' 20' ' ' SER . 17.6 mt -52.61 -38.45 60.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.248 -0.433 . . . . 51.509999999999998 110.907 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.7 -17.29 80.17 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.743 -0.741 . . . . 61.140000000000001 112.496 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.28 -19.97 32.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.854 0.359 . . . . 75.239999999999995 111.1 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.975 HD11 HG22 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -84.17 -19.27 34.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 55.32 110.944 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt 51.91 43.65 30.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 71.439999999999998 110.876 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.705 ' CD2' HG21 ' A' ' 50' ' ' VAL . 3.5 mt -94.26 152.3 18.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 71.25 110.956 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -68.45 159.79 79.38 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.595 0.712 . . . . 74.120000000000005 110.882 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -37.65 8.88 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.703 2.269 . . . . 74.530000000000001 112.333 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.648 ' HA ' HD12 ' A' ' 6' ' ' ILE . 14.8 m-20 -78.56 -15.45 58.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 74.409999999999997 110.897 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.611 HG21 HD13 ' A' ' 66' ' ' LEU . 56.3 m -33.01 126.86 0.32 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.472 . . . . 73.099999999999994 111.172 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.78 145.77 25.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 74.209999999999994 110.915 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.3 mm -115.5 128.17 72.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 73.219999999999999 111.114 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 9.2 mtp -99.76 141.65 32.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 53.439999999999998 110.923 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.0 mtt -133.77 117.32 16.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 72.049999999999997 110.862 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.723 ' CG ' HD21 ' A' ' 46' ' ' LEU . 2.7 mmt -105.25 123.28 47.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 71.439999999999998 110.849 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 160.3 -157.22 28.56 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.699 -0.762 . . . . 74.209999999999994 112.519 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 120.783 0.325 . . . . 65.219999999999999 111.135 -179.899 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.731 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.796 0.332 . . . . 73.340000000000003 111.107 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.545 HD23 ' HD2' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -106.95 110.46 63.61 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.603 0.716 . . . . 73.519999999999996 110.928 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.545 ' HD2' HD23 ' A' ' 3' ' ' LEU . 53.7 Cg_endo -69.79 156.32 63.58 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.692 2.262 . . . . 63.119999999999997 112.337 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.474 ' HB ' HD21 ' A' ' 28' ' ' LEU . 52.6 mt -150.81 136.86 12.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 74.129999999999995 111.116 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.712 HD12 ' HA ' ' A' ' 69' ' ' ASN . 3.5 mt -95.28 140.65 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 64.329999999999998 111.159 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.831 HG21 HD13 ' A' ' 32' ' ' LEU . 8.4 p -127.15 123.29 61.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 75.319999999999993 111.121 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.11 122.11 46.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 72.140000000000001 110.935 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.1 t-105 -123.18 102.89 8.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 75.299999999999997 110.899 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.76 -79.68 1.63 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.72 -0.752 . . . . 74.420000000000002 112.445 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.34 17.89 0.69 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.773 -0.727 . . . . 63.200000000000003 112.547 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -130.0 138.8 51.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.763 0.316 . . . . 62.229999999999997 110.928 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -102.71 142.37 33.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 62.520000000000003 110.867 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.542 ' CD1' HG21 ' A' ' 36' ' ' THR . 80.1 m-85 -136.36 116.69 13.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.474 . . . . 73.140000000000001 110.923 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.7 p -82.46 132.28 35.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.078 -0.51 . . . . 50.32 110.854 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.544 HG21 HD23 ' A' ' 32' ' ' LEU . 85.8 t -92.96 140.61 16.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 71.400000000000006 111.132 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.5 p -151.28 91.54 1.69 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 35.439999999999998 111.108 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.436 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.7 OUTLIER 173.17 -28.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 62.240000000000002 111.132 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.731 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.4 mm? -86.53 150.61 24.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 73.299999999999997 110.909 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.462 ' C ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -132.03 165.6 23.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 64.219999999999999 110.828 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.465 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -57.48 -20.55 31.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.5 . . . . 75.420000000000002 110.856 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -67.09 -13.2 61.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 71.549999999999997 110.874 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.406 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.8 m-20 -101.91 -145.65 0.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 72.319999999999993 110.813 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -138.28 167.13 22.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 72.340000000000003 111.176 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.639 HG22 HD11 ' A' ' 64' ' ' LEU . 97.6 t -62.1 -44.58 99.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 52.210000000000001 111.151 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.424 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -60.4 -27.75 67.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 64.420000000000002 110.944 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.477 ' HB3' HD11 ' A' ' 19' ' ' LEU . 3.2 t0 -71.74 -34.5 69.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 72.019999999999996 110.878 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.682 HD12 ' HB3' ' A' ' 19' ' ' LEU . 1.1 tt -80.16 -47.99 13.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 74.519999999999996 110.915 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.517 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.46 -55.87 26.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.198 -0.456 . . . . 74.400000000000006 110.84 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -57.28 -22.7 43.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 73.519999999999996 110.88 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.46 ' O ' HG22 ' A' ' 34' ' ' THR . 70.5 t80 -77.92 -55.37 5.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 44.25 110.875 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.831 HD13 HG21 ' A' ' 7' ' ' VAL . 2.5 pp -67.09 -43.02 83.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.476 . . . . 73.400000000000006 110.938 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.582 ' N ' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -54.61 -27.5 39.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 64.420000000000002 110.919 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.46 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.63 -23.67 42.43 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.474 . . . . 65.310000000000002 111.191 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.2 mt -76.49 -59.31 2.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 63.109999999999999 110.923 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.542 HG21 ' CD1' ' A' ' 14' ' ' TYR . 4.6 t -135.02 -28.25 1.19 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 71.430000000000007 111.167 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.53 -176.86 5.1 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.73 -0.747 . . . . 65.109999999999999 112.532 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.88 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.3 p -113.09 139.26 39.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.867 0.365 . . . . 64.030000000000001 111.115 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.993 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.52 150.25 18.06 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.568 0.699 . . . . 72.049999999999997 110.93 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -21.96 32.54 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.713 2.275 . . . . 75.540000000000006 112.297 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -54.47 -38.89 66.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 42.119999999999997 110.908 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.416 ' H ' HD23 ' A' ' 39' ' ' LEU . 3.9 mpt_? -103.91 -40.31 6.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 61.100000000000001 110.892 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.88 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.9 pp0? -97.35 158.06 15.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 64.219999999999999 110.91 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.03 142.52 51.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 75.109999999999999 110.928 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.31 135.95 54.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 71.409999999999997 110.938 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.752 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.1 mm? -77.4 -67.57 0.7 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 61.439999999999998 110.907 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.88 61.21 0.61 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.728 -0.748 . . . . 71.120000000000005 112.484 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.578 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 4.6 pp -59.2 -17.94 32.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.864 0.364 . . . . 73.319999999999993 110.897 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.71 144.16 42.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 74.430000000000007 110.904 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.781 HG21 HD21 ' A' ' 66' ' ' LEU . 10.9 p -143.82 145.63 21.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.428 . . . . 74.340000000000003 111.115 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.551 ' HG2' HG22 ' A' ' 50' ' ' VAL . 19.7 mmtp 54.67 32.32 17.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 64.349999999999994 110.887 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.25 -11.28 50.64 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.69 -0.767 . . . . 45.100000000000001 112.488 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.9 mmtp -81.4 151.45 69.03 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.551 0.691 . . . . 74.219999999999999 110.912 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.418 ' O ' ' C ' ' A' ' 55' ' ' ALA . 53.8 Cg_endo -69.68 -32.96 17.84 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.675 2.25 . . . . 75.310000000000002 112.349 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.601 ' HA ' HG21 ' A' ' 59' ' ' VAL . . . 36.42 43.65 0.25 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 64.109999999999999 111.111 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.97 -76.52 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 71.420000000000002 110.88 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -159.26 -37.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 73.219999999999999 110.922 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -67.4 -8.13 30.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 75.340000000000003 110.899 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.601 HG21 ' HA ' ' A' ' 55' ' ' ALA . 17.0 t -80.2 145.54 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 50.399999999999999 111.112 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -90.63 150.82 21.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 51.130000000000003 110.898 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.527 ' HA ' HD12 ' A' ' 64' ' ' LEU . 12.6 mt -51.74 -45.06 63.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 72.420000000000002 110.903 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.54 -11.29 85.61 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.75 -0.738 . . . . 51.210000000000001 112.473 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.9 -35.25 29.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.805 0.336 . . . . 64.540000000000006 111.116 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.639 HD11 HG22 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -73.13 -24.53 60.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 52.210000000000001 110.871 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.8 mmtp 62.38 38.04 13.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 52.539999999999999 110.881 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.781 HD21 HG21 ' A' ' 50' ' ' VAL . 4.2 mt -88.85 153.48 21.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 74.209999999999994 110.916 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.45 160.3 76.85 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.583 0.706 . . . . 61.140000000000001 110.879 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -35.62 12.22 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.678 2.252 . . . . 62.009999999999998 112.322 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.712 ' HA ' HD12 ' A' ' 6' ' ' ILE . 23.8 p30 -78.8 -15.88 57.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 64.310000000000002 110.92 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.617 HG21 HD13 ' A' ' 66' ' ' LEU . 55.4 m -32.42 120.13 0.3 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.143 -0.481 . . . . 61.409999999999997 111.151 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.72 146.39 23.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 71.519999999999996 110.924 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.9 mm -116.97 130.63 71.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 62.109999999999999 111.135 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 6.1 mtt -103.91 141.69 35.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 62.420000000000002 110.891 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 70.5 mtm -133.99 123.57 24.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.267 -0.424 . . . . 70.349999999999994 110.906 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.752 ' CG ' HD21 ' A' ' 46' ' ' LEU . 1.3 mmm -111.12 124.39 52.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 64.439999999999998 110.841 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 164.11 -153.96 24.58 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.716 -0.754 . . . . 53.210000000000001 112.45 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.9 t . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 120.838 0.352 . . . . 72.400000000000006 111.133 -179.867 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.738 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.804 0.335 . . . . 52.340000000000003 111.091 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.2 mt -110.79 109.1 57.79 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.621 0.724 . . . . 53.539999999999999 110.945 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 156.67 62.86 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.673 2.249 . . . . 70.420000000000002 112.34 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.458 ' HB ' HD21 ' A' ' 28' ' ' LEU . 38.1 mt -150.56 137.3 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.437 . . . . 75.439999999999998 111.147 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.723 HD12 ' HA ' ' A' ' 69' ' ' ASN . 4.1 mt -95.37 140.56 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 72.400000000000006 111.146 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.808 HG21 HD13 ' A' ' 32' ' ' LEU . 8.3 p -127.29 122.91 60.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 74.219999999999999 111.115 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -107.98 120.19 41.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 74.019999999999996 110.907 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.1 t-105 -122.27 100.91 7.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 75.109999999999999 110.903 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.91 -83.61 0.77 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.752 -0.737 . . . . 54.109999999999999 112.51 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.13 20.38 0.96 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.69 -0.767 . . . . 71.099999999999994 112.474 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -129.18 174.9 9.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.771 0.32 . . . . 72.409999999999997 110.902 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -132.7 140.64 48.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 55.399999999999999 110.934 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -135.92 119.1 16.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 71.349999999999994 110.925 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 89.2 p -82.75 136.05 34.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.101 -0.5 . . . . 61.420000000000002 110.892 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.527 HG21 HD23 ' A' ' 32' ' ' LEU . 87.3 t -98.87 125.23 52.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 72.310000000000002 111.108 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.4 p -135.44 93.41 2.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 63.340000000000003 111.121 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.573 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.9 OUTLIER 173.73 -28.84 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 73.140000000000001 111.133 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.738 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.9 mm? -84.92 149.85 25.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.222 -0.444 . . . . 63.109999999999999 110.893 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.572 ' C ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.77 167.68 19.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 72.420000000000002 110.854 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.43 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 56.1 mt-10 -58.58 -22.39 55.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 55.149999999999999 110.887 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.11 -11.54 59.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 70.400000000000006 110.905 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.447 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.9 m-20 -101.63 -150.24 0.4 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 60.43 110.836 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.487 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -136.53 167.57 21.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.462 . . . . 74.219999999999999 111.115 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.625 HG21 HD21 ' A' ' 64' ' ' LEU . 75.0 t -63.03 -42.26 96.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 70.540000000000006 111.143 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.417 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -61.97 -28.72 69.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.491 . . . . 70.340000000000003 110.901 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.576 ' HB3' HD11 ' A' ' 19' ' ' LEU . 1.2 t0 -72.06 -32.78 67.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 52.439999999999998 110.878 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.685 HD23 HD23 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -80.46 -48.93 12.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 53.030000000000001 110.917 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.76 -55.79 26.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 72.430000000000007 110.902 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.92 -22.64 49.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 72.329999999999998 110.918 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.573 ' CZ ' HG21 ' A' ' 18' ' ' THR . 44.5 t80 -77.76 -55.11 5.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.453 . . . . 64.340000000000003 110.87 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.808 HD13 HG21 ' A' ' 7' ' ' VAL . 2.8 pp -67.51 -41.93 83.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 60.409999999999997 110.915 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.569 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.71 -27.91 44.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 53.100000000000001 110.928 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.43 -23.84 42.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.455 . . . . 72.310000000000002 111.141 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.441 HD11 ' CE1' ' A' ' 31' ' ' PHE . 13.7 mt -76.15 -59.48 2.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.446 . . . . 75.439999999999998 110.877 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.4 t -135.38 -27.77 1.18 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 71.430000000000007 111.147 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.569 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.59 -175.34 4.36 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.766 -0.73 . . . . 53.340000000000003 112.495 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.726 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.4 p -112.56 141.38 28.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.807 0.337 . . . . 52.210000000000001 111.17 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 1.001 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -57.01 149.86 42.68 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.6 0.714 . . . . 74.010000000000005 110.885 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -21.4 33.48 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.707 2.272 . . . . 63.140000000000001 112.308 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -55.19 -39.25 69.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 71.209999999999994 110.835 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.423 ' H ' HD23 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -104.29 -41.42 5.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 72.25 110.891 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.726 ' HG2' HG13 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -96.12 158.41 15.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 61.109999999999999 110.898 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.603 ' N ' HE21 ' A' ' 43' ' ' GLN . 0.0 OUTLIER -130.14 142.45 50.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 64.439999999999998 110.902 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.52 136.38 54.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 54.43 110.881 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.734 HD11 ' CG ' ' A' ' 75' ' ' MET . 6.2 mp -86.13 -55.26 4.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 62.329999999999998 110.877 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.35 52.52 0.97 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.719 -0.753 . . . . 71.140000000000001 112.485 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.584 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 4.6 pp -61.67 -16.39 48.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.933 0.397 . . . . 75.510000000000005 110.942 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.9 pttt -116.8 143.25 45.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 72.129999999999995 110.876 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.988 HG21 HD21 ' A' ' 66' ' ' LEU . 10.6 p -143.73 145.17 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 74.409999999999997 111.137 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 55.34 31.52 16.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 71.140000000000001 110.924 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.09 -11.17 55.98 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.728 -0.749 . . . . 64.040000000000006 112.492 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -81.37 150.98 68.5 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.532 0.682 . . . . 74.140000000000001 110.938 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 55' ' ' ALA . 53.6 Cg_endo -69.79 -32.25 18.79 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.691 2.261 . . . . 74.239999999999995 112.302 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.591 ' HA ' HG21 ' A' ' 59' ' ' VAL . . . 35.99 44.34 0.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.439 . . . . 42.210000000000001 111.128 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.08 -79.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 74.430000000000007 110.919 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.04 -38.8 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 54.130000000000003 110.884 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -64.6 -9.8 21.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 74.329999999999998 110.896 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.591 HG21 ' HA ' ' A' ' 55' ' ' ALA . 16.6 t -79.55 145.69 8.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 73.409999999999997 111.159 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 29.8 mttt -91.49 152.25 20.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.446 . . . . 63.399999999999999 110.937 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.572 HD12 ' C ' ' A' ' 20' ' ' SER . 20.0 mt -49.86 -47.47 51.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 75.219999999999999 110.928 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.72 -11.71 85.18 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.775 -0.726 . . . . 51.409999999999997 112.473 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.59 -31.55 41.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.837 0.351 . . . . 52.509999999999998 111.076 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.625 HD21 HG21 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -78.17 -23.99 47.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 74.120000000000005 110.925 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.7 mmtp 63.45 35.84 11.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 72.030000000000001 110.875 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.988 HD21 HG21 ' A' ' 50' ' ' VAL . 4.7 mt -87.78 152.88 21.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.439 . . . . 64.129999999999995 110.925 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.7 160.44 77.14 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.627 0.727 . . . . 74.439999999999998 110.897 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -34.82 13.77 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.657 2.238 . . . . 74.420000000000002 112.355 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.723 ' HA ' HD12 ' A' ' 6' ' ' ILE . 12.3 m120 -78.81 -16.1 57.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 74.129999999999995 110.859 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.698 HG21 HD13 ' A' ' 66' ' ' LEU . 49.1 m -32.5 120.17 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 71.099999999999994 111.162 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.17 146.68 23.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 71.530000000000001 110.891 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.5 mm -115.37 128.95 72.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 72.549999999999997 111.147 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 30.8 mtt -99.7 142.67 30.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 72.430000000000007 110.865 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.3 mtt -134.08 132.73 40.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 72.0 110.854 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.734 ' CG ' HD11 ' A' ' 46' ' ' LEU . 2.3 mmt -124.58 123.5 40.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 74.5 110.88 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.13 -155.19 26.02 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.733 -0.746 . . . . 61.329999999999998 112.472 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.775 0.321 . . . . 72.239999999999995 111.131 -179.836 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.734 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.818 0.342 . . . . 64.049999999999997 111.112 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.663 HD12 ' HG2' ' A' ' 21' ' ' GLU . 4.4 mt -112.13 109.68 54.33 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.589 0.709 . . . . 72.329999999999998 110.927 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 156.42 63.49 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.689 2.259 . . . . 72.540000000000006 112.364 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.554 ' HB ' HD21 ' A' ' 28' ' ' LEU . 33.8 mt -150.56 137.45 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 72.439999999999998 111.134 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.681 HD12 ' HA ' ' A' ' 69' ' ' ASN . 4.3 mt -95.39 140.65 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 63.229999999999997 111.137 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.813 HG21 HD13 ' A' ' 32' ' ' LEU . 7.3 p -126.95 123.28 62.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 51.439999999999998 111.108 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.52 120.73 43.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 70.230000000000004 110.865 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 17.3 t-105 -123.87 105.03 9.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 74.129999999999995 110.878 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.88 -81.81 0.9 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.767 -0.73 . . . . 70.030000000000001 112.483 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.04 20.25 0.66 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.782 -0.723 . . . . 62.25 112.513 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -129.13 175.35 8.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.756 0.312 . . . . 74.310000000000002 110.947 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -132.74 140.12 47.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 75.510000000000005 110.899 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.528 ' CD2' HG21 ' A' ' 36' ' ' THR . 47.4 m-85 -134.7 116.33 14.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.172 -0.467 . . . . 73.510000000000005 110.913 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.0 p -82.93 130.59 35.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.504 . . . . 75.329999999999998 110.864 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.556 HG21 HD23 ' A' ' 32' ' ' LEU . 91.6 t -91.74 142.0 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 74.140000000000001 111.148 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.2 p -151.49 92.31 1.76 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 63.210000000000001 111.156 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.688 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.8 OUTLIER 173.74 -29.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 63.229999999999997 111.148 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.734 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.6 mm? -86.25 152.2 22.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 54.340000000000003 110.92 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.427 ' O ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.55 169.75 15.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 75.010000000000005 110.851 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.663 ' HG2' HD12 ' A' ' 3' ' ' LEU . 58.2 mt-10 -61.85 -22.23 65.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 63.119999999999997 110.914 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -68.8 -12.05 61.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.17 -0.468 . . . . 75.519999999999996 110.887 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.412 ' HB2' HD12 ' A' ' 19' ' ' LEU . 2.0 m-20 -99.78 -150.52 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 71.329999999999998 110.88 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -132.53 171.37 13.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 64.140000000000001 111.17 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.929 HG22 HD11 ' A' ' 64' ' ' LEU . 11.8 t -67.69 -40.96 84.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 72.519999999999996 111.119 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.19 -29.4 70.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 72.519999999999996 110.905 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.47 ' HB3' HD11 ' A' ' 19' ' ' LEU . 19.0 t0 -70.1 -35.12 73.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 71.409999999999997 110.845 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.689 HD12 ' CB ' ' A' ' 19' ' ' LEU . 1.2 tt -80.76 -47.67 13.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 51.240000000000002 110.938 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.771 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.86 -56.5 18.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 62.439999999999998 110.892 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.15 -22.75 52.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.434 . . . . 64.510000000000005 110.915 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.688 ' CZ ' HG21 ' A' ' 18' ' ' THR . 59.9 t80 -76.86 -55.48 5.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 64.25 110.864 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.813 HD13 HG21 ' A' ' 7' ' ' VAL . 2.2 pp -67.29 -43.43 81.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 75.129999999999995 110.889 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.571 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.2 tmtt? -54.81 -27.48 42.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 73.310000000000002 110.914 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.503 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.34 -23.51 43.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 75.030000000000001 111.161 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.6 mt -76.65 -59.59 2.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 53.439999999999998 110.929 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.528 HG21 ' CD2' ' A' ' 14' ' ' TYR . 2.7 t -135.01 -27.68 1.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 75.219999999999999 111.158 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.571 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.59 -176.68 5.07 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.777 -0.725 . . . . 62.009999999999998 112.457 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.883 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.4 p -112.38 138.54 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.887 0.375 . . . . 73.319999999999993 111.144 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.983 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.06 149.75 17.35 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.575 0.703 . . . . 74.099999999999994 110.947 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -21.97 32.7 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.669 2.246 . . . . 41.219999999999999 112.335 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -53.94 -38.43 64.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 61.350000000000001 110.907 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.408 ' H ' HD23 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -105.08 -39.52 6.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 63.350000000000001 110.919 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.883 ' HG2' HG13 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -96.54 158.66 15.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 71.200000000000003 110.892 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.02 139.33 52.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 73.150000000000006 110.871 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.81 135.45 54.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.257 -0.429 . . . . 73.400000000000006 110.898 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.735 HD11 ' CG ' ' A' ' 75' ' ' MET . 7.2 mp -77.45 -75.81 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.467 . . . . 73.0 110.907 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.12 59.44 1.68 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.755 -0.736 . . . . 64.510000000000005 112.508 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.64 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 3.6 pp -55.83 -24.39 36.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.874 0.369 . . . . 74.25 110.914 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.423 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 1.9 pttt -103.45 143.16 33.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 73.439999999999998 110.854 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.8 HG21 HD21 ' A' ' 66' ' ' LEU . 14.4 p -144.19 143.36 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.42 . . . . 51.25 111.126 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.6 mttm 54.04 34.17 19.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 74.209999999999994 110.865 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.38 -15.16 41.79 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.741 -0.743 . . . . 74.340000000000003 112.47 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -81.56 149.59 64.95 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.557 0.694 . . . . 72.219999999999999 110.887 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.423 ' HA ' ' HB3' ' A' ' 49' ' ' LYS . 53.8 Cg_endo -69.77 -36.4 10.85 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.714 2.276 . . . . 65.200000000000003 112.344 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 38.4 40.01 0.33 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 71.510000000000005 111.075 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -66.94 -74.37 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 71.5 110.865 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.401 HD22 ' N ' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -156.54 -37.31 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 71.099999999999994 110.87 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.401 ' N ' HD22 ' A' ' 57' ' ' ASN . 56.4 m-20 -74.67 -2.98 28.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 75.310000000000002 110.897 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.597 ' O ' HG23 ' A' ' 25' ' ' VAL . 1.3 t -91.15 146.94 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 61.43 111.13 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.465 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 24.6 mttt -89.04 146.55 24.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 70.329999999999998 110.943 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.438 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 18.3 mt -52.12 -37.58 54.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.256 -0.429 . . . . 52.399999999999999 110.906 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.93 -18.24 79.62 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.748 -0.739 . . . . 71.329999999999998 112.47 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.73 -15.56 44.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.883 0.373 . . . . 53.030000000000001 111.141 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.929 HD11 HG22 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -87.04 -18.31 30.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 71.219999999999999 110.913 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 49.66 45.08 24.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 73.109999999999999 110.924 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.8 HD21 HG21 ' A' ' 50' ' ' VAL . 3.4 mt -97.86 152.99 18.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 65.340000000000003 110.923 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.42 159.81 79.15 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.547 0.689 . . . . 63.409999999999997 110.911 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -36.57 10.51 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.682 2.255 . . . . 64.040000000000006 112.332 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.681 ' HA ' HD12 ' A' ' 6' ' ' ILE . 5.0 m120 -78.45 -15.59 58.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 75.219999999999999 110.911 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.649 HG21 HD13 ' A' ' 66' ' ' LEU . 52.2 m -32.93 125.68 0.34 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 74.140000000000001 111.126 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.88 145.29 25.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 74.340000000000003 110.887 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.3 mm -115.57 131.9 66.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 62.310000000000002 111.14 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.2 mtp -101.99 141.78 34.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 71.239999999999995 110.913 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 75.9 mtm -133.47 120.0 20.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 74.329999999999998 110.856 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.735 ' CG ' HD11 ' A' ' 46' ' ' LEU . 1.5 mmt -109.7 123.8 50.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 74.140000000000001 110.921 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 162.73 -155.56 26.94 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 70.340000000000003 112.48 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.9 t . . . . . 0 C--N 1.33 -0.266 0 CA-C-O 120.8 0.333 . . . . 74.409999999999997 111.134 -179.866 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.74 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.768 0.318 . . . . 40.530000000000001 111.121 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.409 HD23 ' HD2' ' A' ' 4' ' ' PRO . 1.9 mt -110.49 108.89 58.36 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.665 0.745 . . . . 73.109999999999999 110.892 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.409 ' HD2' HD23 ' A' ' 3' ' ' LEU . 53.6 Cg_endo -69.8 156.52 63.05 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.735 2.29 . . . . 65.209999999999994 112.33 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.461 ' HB ' HD21 ' A' ' 28' ' ' LEU . 39.0 mt -150.5 137.24 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 62.450000000000003 111.128 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.69 HD12 ' HA ' ' A' ' 69' ' ' ASN . 4.6 mt -94.96 140.57 16.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 75.329999999999998 111.143 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.814 HG21 HD13 ' A' ' 32' ' ' LEU . 8.0 p -127.28 122.88 60.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 74.310000000000002 111.153 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -107.31 118.85 37.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 73.099999999999994 110.9 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 16.8 t-105 -121.18 101.59 7.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.233 -0.44 . . . . 73.340000000000003 110.895 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.48 -83.24 0.79 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.81 -0.71 . . . . 72.140000000000001 112.524 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.85 20.55 0.89 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.756 -0.735 . . . . 54.210000000000001 112.488 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -129.2 175.83 8.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.711 0.291 . . . . 61.549999999999997 110.957 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -132.88 140.78 48.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 73.420000000000002 110.903 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -136.62 118.13 14.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.147 -0.479 . . . . 73.340000000000003 110.931 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.02 133.94 35.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 73.340000000000003 110.856 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.532 HG21 HD23 ' A' ' 32' ' ' LEU . 86.3 t -96.02 126.91 48.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 74.109999999999999 111.124 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.1 p -135.94 91.99 2.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 74.329999999999998 111.121 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.659 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 1.2 t 174.62 -29.69 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 75.319999999999993 111.125 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.74 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.9 mm? -83.4 149.62 26.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 74.299999999999997 110.91 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.518 ' C ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.5 168.01 18.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 72.120000000000005 110.844 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.401 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 36.9 mt-10 -59.24 -22.01 60.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 62.43 110.896 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -69.11 -10.7 58.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 71.299999999999997 110.873 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.465 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.5 m-20 -100.89 -150.19 0.39 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 74.549999999999997 110.855 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -137.07 167.99 20.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 75.549999999999997 111.141 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.941 HG22 HD11 ' A' ' 64' ' ' LEU . 41.8 t -62.38 -45.02 99.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 73.530000000000001 111.158 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -60.78 -28.54 68.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.475 . . . . 71.329999999999998 110.918 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.567 ' HB3' HD11 ' A' ' 19' ' ' LEU . 0.7 OUTLIER -71.05 -33.56 70.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 43.149999999999999 110.938 179.792 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.689 HD23 HD23 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -80.86 -48.97 11.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 64.310000000000002 110.902 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.592 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.4 -56.58 18.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 72.340000000000003 110.858 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -58.29 -22.04 51.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 62.009999999999998 110.93 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.659 ' CZ ' HG21 ' A' ' 18' ' ' THR . 44.9 t80 -77.88 -54.93 5.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 65.409999999999997 110.854 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.814 HD13 HG21 ' A' ' 7' ' ' VAL . 2.6 pp -67.73 -42.24 82.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 54.450000000000003 110.929 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.577 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.88 -27.39 42.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 70.439999999999998 110.889 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.484 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.77 -23.77 41.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 74.010000000000005 111.207 179.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.416 HD11 ' CE2' ' A' ' 31' ' ' PHE . 13.9 mt -76.5 -59.94 2.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 52.32 110.896 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.9 t -135.28 -27.62 1.2 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.443 . . . . 74.25 111.162 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.577 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.61 -177.81 4.61 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.729 -0.748 . . . . 72.140000000000001 112.532 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.89 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.3 p -112.66 138.56 41.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.827 0.346 . . . . 64.0 111.145 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.967 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -55.17 151.17 18.45 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.614 0.721 . . . . 71.109999999999999 110.903 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -21.61 33.51 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.718 2.279 . . . . 74.200000000000003 112.334 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -54.38 -38.91 66.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 75.430000000000007 110.869 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.447 ' H ' HD23 ' A' ' 39' ' ' LEU . 3.1 mpt_? -104.14 -40.4 6.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 74.140000000000001 110.897 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.89 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.7 pp0? -97.86 158.43 15.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 72.319999999999993 110.917 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.64 140.85 51.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 71.420000000000002 110.861 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 45' ' ' LEU . 3.8 mm? -67.35 135.75 53.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.461 . . . . 74.049999999999997 110.913 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.742 HD21 ' CG ' ' A' ' 75' ' ' MET . 3.8 mm? -81.05 -64.39 1.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 63.420000000000002 110.91 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.63 56.89 1.64 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.781 -0.723 . . . . 71.329999999999998 112.516 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.805 HD22 ' C ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -59.72 -13.4 9.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.886 0.374 . . . . 52.329999999999998 110.905 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.514 ' N ' HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -122.31 145.97 47.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 54.140000000000001 110.903 179.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.924 HG21 HD21 ' A' ' 66' ' ' LEU . 9.6 p -143.75 144.06 23.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.207 -0.451 . . . . 74.019999999999996 111.109 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.2 mttt 54.72 31.14 14.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 73.109999999999999 110.907 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.24 -9.99 59.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.763 -0.732 . . . . 70.549999999999997 112.485 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -81.04 150.25 68.18 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.576 0.703 . . . . 64.230000000000004 110.88 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.411 ' O ' ' C ' ' A' ' 55' ' ' ALA . 53.7 Cg_endo -69.76 -30.53 22.12 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.7 2.267 . . . . 62.119999999999997 112.328 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.62 ' HA ' HG21 ' A' ' 59' ' ' VAL . . . 35.5 43.28 0.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 53.200000000000003 111.102 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.33 -78.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 70.340000000000003 110.929 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -157.44 -38.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 72.540000000000006 110.845 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -66.12 -8.59 24.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.221 -0.445 . . . . 73.420000000000002 110.838 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.62 HG21 ' HA ' ' A' ' 55' ' ' ALA . 21.4 t -78.79 146.55 7.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 32.399999999999999 111.133 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 28.8 mttt -93.24 151.14 20.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 54.229999999999997 110.885 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.54 ' HA ' HD12 ' A' ' 64' ' ' LEU . 18.9 mt -50.64 -45.64 57.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.264 -0.425 . . . . 64.319999999999993 110.882 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.38 -12.02 84.59 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.79 -0.719 . . . . 52.329999999999998 112.474 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.14 -33.45 29.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.8 0.333 . . . . 53.219999999999999 111.077 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.941 HD11 HG22 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -73.09 -25.07 60.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 64.409999999999997 110.905 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt 62.63 37.75 12.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.218 -0.446 . . . . 72.530000000000001 110.891 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.924 HD21 HG21 ' A' ' 50' ' ' VAL . 5.8 mt -91.31 152.98 20.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.266 -0.424 . . . . 75.099999999999994 110.928 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -68.7 160.71 75.86 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.589 0.709 . . . . 70.409999999999997 110.909 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -35.42 12.61 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.696 2.264 . . . . 72.120000000000005 112.356 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.69 ' HA ' HD12 ' A' ' 6' ' ' ILE . 8.6 m-20 -78.86 -15.96 57.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 71.099999999999994 110.906 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.472 ' C ' ' O ' ' A' ' 69' ' ' ASN . 54.6 m -32.51 124.72 0.33 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 70.519999999999996 111.133 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.4 147.0 23.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 74.310000000000002 110.859 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.6 mm -116.93 127.5 74.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 74.319999999999993 111.128 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.4 mtt -99.22 141.87 31.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 74.239999999999995 110.838 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.9 mtt -136.14 117.22 14.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 74.200000000000003 110.864 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.742 ' CG ' HD21 ' A' ' 46' ' ' LEU . 1.4 mmt -106.19 125.78 51.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 55.310000000000002 110.863 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 160.26 -155.3 26.42 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.763 -0.732 . . . . 62.119999999999997 112.487 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.0 t . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 120.779 0.323 . . . . 74.430000000000007 111.163 -179.893 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.737 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.792 0.33 . . . . 72.510000000000005 111.116 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.411 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 3.9 mt -111.08 109.36 57.11 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.59 0.71 . . . . 65.019999999999996 110.865 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 53.9 Cg_endo -69.74 156.05 64.39 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.738 2.292 . . . . 71.340000000000003 112.356 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.431 ' HB ' HD21 ' A' ' 28' ' ' LEU . 53.4 mt -150.7 135.96 10.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.452 . . . . 62.420000000000002 111.146 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.697 HD12 ' HA ' ' A' ' 69' ' ' ASN . 3.3 mt -94.24 140.4 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 73.239999999999995 111.118 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.831 HG21 HD13 ' A' ' 32' ' ' LEU . 8.9 p -127.34 123.39 61.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 63.43 111.121 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.64 123.01 48.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 71.129999999999995 110.866 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.0 t-105 -123.87 100.49 6.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 73.540000000000006 110.9 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.23 -80.41 1.3 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.718 -0.753 . . . . 54.539999999999999 112.458 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.25 17.24 0.79 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.735 . . . . 61.43 112.48 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -129.89 139.03 51.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.774 0.321 . . . . 64.150000000000006 110.943 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -103.07 142.39 34.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 70.230000000000004 110.846 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -135.84 117.27 14.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 75.120000000000005 110.92 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 82.6 p -81.82 132.6 35.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 45.43 110.829 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.545 HG21 HD23 ' A' ' 32' ' ' LEU . 99.9 t -93.31 136.31 25.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 74.450000000000003 111.155 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.2 p -147.55 92.38 2.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 74.349999999999994 111.145 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.488 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.7 OUTLIER 173.51 -28.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 74.420000000000002 111.152 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.737 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.6 mm? -85.98 150.72 24.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 63.240000000000002 110.911 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.545 ' C ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.81 168.7 17.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.464 . . . . 74.299999999999997 110.876 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.426 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 69.9 mt-10 -59.51 -22.14 61.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 52.100000000000001 110.893 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.04 -12.57 60.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 61.210000000000001 110.883 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.423 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.9 m-20 -101.97 -148.7 0.38 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 72.239999999999995 110.874 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.499 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -136.64 168.28 19.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 71.420000000000002 111.13 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.601 HG21 HD21 ' A' ' 64' ' ' LEU . 86.9 t -63.02 -45.15 99.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 63.219999999999999 111.103 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.422 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -59.8 -27.95 67.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 65.430000000000007 110.94 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.537 ' HB3' HD11 ' A' ' 19' ' ' LEU . 2.3 t0 -71.79 -33.78 68.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.193 -0.458 . . . . 54.439999999999998 110.835 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.657 HD12 ' HB3' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -80.67 -48.28 12.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 75.510000000000005 110.907 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.503 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.64 -55.79 26.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 74.530000000000001 110.86 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.51 -22.5 44.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 74.040000000000006 110.94 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.488 ' CZ ' HG21 ' A' ' 18' ' ' THR . 45.8 t80 -77.75 -55.06 5.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 73.329999999999998 110.891 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.831 HD13 HG21 ' A' ' 7' ' ' VAL . 2.5 pp -67.76 -42.93 81.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 74.129999999999995 110.945 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.582 ' N ' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -54.62 -27.53 40.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 63.420000000000002 110.923 179.797 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.46 -23.6 42.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.465 . . . . 75.530000000000001 111.15 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.2 mt -76.58 -59.15 2.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 74.319999999999993 110.958 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.5 t -134.95 -28.09 1.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.444 . . . . 64.209999999999994 111.132 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.573 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.79 -176.52 5.21 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.727 -0.749 . . . . 63.25 112.499 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.864 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.3 p -113.39 138.28 43.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.834 0.349 . . . . 74.310000000000002 111.145 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.97 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -53.61 149.94 14.39 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.633 0.73 . . . . 74.409999999999997 110.911 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.401 ' O ' ' O ' ' A' ' 43' ' ' GLN . 53.5 Cg_endo -69.78 -21.72 33.01 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.647 2.231 . . . . 64.019999999999996 112.373 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -54.06 -38.33 65.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 63.539999999999999 110.882 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.42 ' H ' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -104.76 -40.05 6.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 73.019999999999996 110.838 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.864 ' HG2' HG13 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -96.72 158.05 15.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 65.349999999999994 110.876 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.65 140.78 51.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 73.329999999999998 110.896 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.72 135.85 54.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.434 . . . . 71.150000000000006 110.906 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.738 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.0 mm? -75.15 -70.25 0.43 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 61.210000000000001 110.911 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -99.73 61.22 0.73 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.708 -0.758 . . . . 62.329999999999998 112.455 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.587 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 4.5 pp -57.7 -19.63 28.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.879 0.371 . . . . 54.240000000000002 110.929 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.34 144.47 39.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 74.140000000000001 110.865 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.979 HG21 HD21 ' A' ' 66' ' ' LEU . 9.7 p -143.83 145.57 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 62.149999999999999 111.134 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.9 mttm 54.89 32.24 17.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 62.420000000000002 110.892 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.04 -11.16 50.04 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.749 -0.738 . . . . 72.439999999999998 112.445 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.0 mmtt -81.3 151.31 69.19 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.581 0.705 . . . . 75.25 110.878 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 55' ' ' ALA . 53.8 Cg_endo -69.81 -32.92 17.43 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.665 2.244 . . . . 71.439999999999998 112.313 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.588 ' HA ' HG21 ' A' ' 59' ' ' VAL . . . 36.6 43.51 0.27 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 73.140000000000001 111.059 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.47 -76.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.203 -0.453 . . . . 72.040000000000006 110.919 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -159.47 -37.28 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 43.240000000000002 110.913 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.27 -7.8 27.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 73.019999999999996 110.9 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.588 HG21 ' HA ' ' A' ' 55' ' ' ALA . 17.6 t -80.52 145.72 8.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 70.230000000000004 111.096 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -90.23 151.46 21.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 72.310000000000002 110.913 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.545 HD12 ' C ' ' A' ' 20' ' ' SER . 18.6 mt -49.92 -47.62 52.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 74.209999999999994 110.924 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.57 -11.95 84.98 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.739 -0.744 . . . . 42.25 112.498 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.04 -32.06 44.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.822 0.344 . . . . 62.140000000000001 111.104 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.601 HD21 HG21 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -77.83 -23.48 48.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 72.310000000000002 110.912 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt 63.39 37.2 10.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 72.25 110.916 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.979 HD21 HG21 ' A' ' 50' ' ' VAL . 6.1 mt -88.79 152.56 21.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 63.409999999999997 110.939 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -68.64 160.24 77.85 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.572 0.701 . . . . 71.420000000000002 110.878 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -35.54 12.58 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.68 2.254 . . . . 74.120000000000005 112.385 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.697 ' HA ' HD12 ' A' ' 6' ' ' ILE . 8.2 p30 -78.5 -15.78 58.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 71.519999999999996 110.908 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.445 ' C ' ' O ' ' A' ' 69' ' ' ASN . 50.1 m -32.83 119.47 0.32 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 61.5 111.14 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -91.05 146.77 23.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 71.549999999999997 110.903 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.3 mm -115.36 129.78 71.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.436 . . . . 74.120000000000005 111.106 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 41.3 mtm -101.45 141.65 34.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 74.010000000000005 110.875 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.1 mtt -130.78 130.1 43.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 64.439999999999998 110.879 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.738 ' CG ' HD21 ' A' ' 46' ' ' LEU . 2.3 mmt -122.21 127.04 49.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 72.400000000000006 110.858 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.88 -150.87 22.52 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.714 -0.755 . . . . 74.400000000000006 112.468 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.742 0.306 . . . . 73.530000000000001 111.114 -179.851 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.678 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.828 0.347 . . . . 54.399999999999999 111.131 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.411 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 2.7 mt -114.45 107.44 51.24 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.628 0.728 . . . . 75.400000000000006 110.9 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 53.8 Cg_endo -69.76 156.02 64.43 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.664 2.243 . . . . 61.399999999999999 112.364 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.94 HD12 HD22 ' A' ' 28' ' ' LEU . 19.9 mt -150.88 138.63 13.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 72.140000000000001 111.102 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.622 HD12 ' HA ' ' A' ' 69' ' ' ASN . 5.2 mt -95.13 140.72 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 71.510000000000005 111.094 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.766 HG21 HD13 ' A' ' 32' ' ' LEU . 8.8 p -126.9 123.24 62.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 70.109999999999999 111.142 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.21 118.53 37.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 64.400000000000006 110.902 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 17.4 t-105 -120.57 103.77 9.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 70.439999999999998 110.938 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.41 -83.26 0.88 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.723 -0.751 . . . . 70.109999999999999 112.481 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.06 20.18 0.86 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.678 -0.772 . . . . 71.340000000000003 112.448 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -128.84 175.69 8.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.715 0.293 . . . . 75.329999999999998 110.932 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -132.79 141.84 48.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 72.430000000000007 110.92 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -138.49 116.46 11.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 73.439999999999998 110.889 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.21 137.35 35.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 73.239999999999995 110.855 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.499 HG21 HD23 ' A' ' 32' ' ' LEU . 84.3 t -94.21 142.45 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 51.420000000000002 111.141 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.4 HG23 ' O ' ' A' ' 16' ' ' VAL . 6.4 p -155.26 90.83 1.29 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 74.430000000000007 111.198 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.671 HG21 ' CE1' ' A' ' 31' ' ' PHE . 1.8 t 177.11 -31.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 75.540000000000006 111.138 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.797 ' CB ' HD12 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -88.02 163.67 16.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.44 . . . . 74.219999999999999 110.932 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.24 173.96 11.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 73.340000000000003 110.862 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.419 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 36.6 mt-10 -63.13 -20.03 65.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.482 . . . . 73.5 110.879 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -69.42 -11.09 60.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 54.350000000000001 110.896 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.676 ' HB2' HD23 ' A' ' 19' ' ' LEU . 6.0 m-20 -97.76 -152.08 0.39 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 74.439999999999998 110.896 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -137.09 165.3 26.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 53.229999999999997 111.143 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.603 HG22 HD11 ' A' ' 64' ' ' LEU . 72.6 t -59.04 -43.87 90.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 74.319999999999993 111.091 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.42 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -63.56 -30.54 71.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 75.109999999999999 110.918 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.591 ' HB3' HD21 ' A' ' 19' ' ' LEU . 5.6 t70 -72.22 -33.85 67.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 54.530000000000001 110.864 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.94 HD22 HD12 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -78.8 -47.89 15.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 63.530000000000001 110.889 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.477 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -62.75 -54.22 42.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 74.129999999999995 110.892 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.49 -22.11 30.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 70.409999999999997 110.884 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.671 ' CE1' HG21 ' A' ' 18' ' ' THR . 61.0 t80 -77.57 -55.15 5.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 63.210000000000001 110.915 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.766 HD13 HG21 ' A' ' 7' ' ' VAL . 2.1 pp -68.45 -42.24 79.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.477 . . . . 62.350000000000001 110.872 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.574 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.65 -27.51 40.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 64.420000000000002 110.927 179.818 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.62 -23.76 42.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 63.539999999999999 111.106 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.8 mt -76.4 -59.9 2.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.42 . . . . 72.519999999999996 110.893 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.5 t -135.14 -27.8 1.21 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.203 -0.453 . . . . 73.150000000000006 111.111 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.574 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.8 -177.55 4.68 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.778 -0.725 . . . . 41.43 112.486 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.876 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.3 p -112.7 138.59 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.842 0.353 . . . . 64.409999999999997 111.137 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.952 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.78 150.93 16.67 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.632 0.73 . . . . 71.519999999999996 110.868 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 53.7 Cg_endo -69.83 -21.7 32.78 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.638 2.225 . . . . 55.329999999999998 112.355 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -54.09 -39.14 66.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 74.109999999999999 110.872 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.446 ' H ' HD23 ' A' ' 39' ' ' LEU . 23.2 mtt85 -104.04 -40.44 6.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 70.209999999999994 110.884 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.876 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.8 pp0? -97.23 157.21 16.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 72.25 110.914 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.83 143.31 50.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 74.120000000000005 110.902 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.413 ' N ' HD22 ' A' ' 45' ' ' LEU . 3.7 mm? -67.57 136.1 53.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 73.5 110.908 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.724 HD11 ' CG ' ' A' ' 75' ' ' MET . 6.3 mp -86.13 -53.0 5.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 52.509999999999998 110.904 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -104.68 53.37 0.68 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.718 -0.754 . . . . 63.549999999999997 112.474 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.58 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 4.5 pp -59.67 -17.91 37.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.855 0.359 . . . . 71.549999999999997 110.886 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.93 143.13 45.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 72.430000000000007 110.91 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.793 HG21 HD21 ' A' ' 66' ' ' LEU . 11.5 p -143.67 145.3 22.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 74.420000000000002 111.094 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.92 31.86 16.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 72.430000000000007 110.868 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.99 -10.99 56.54 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.756 -0.735 . . . . 61.439999999999998 112.494 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -81.62 150.99 67.67 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.61 0.719 . . . . 64.040000000000006 110.9 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 55' ' ' ALA . 54.3 Cg_endo -69.73 -32.74 18.1 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.709 2.273 . . . . 42.039999999999999 112.353 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.625 ' HA ' HG21 ' A' ' 59' ' ' VAL . . . 36.04 44.25 0.25 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 65.019999999999996 111.083 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.77 -80.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 64.239999999999995 110.918 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -154.65 -39.26 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 72.219999999999999 110.886 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.69 -10.39 19.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 74.439999999999998 110.864 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.625 HG21 ' HA ' ' A' ' 55' ' ' ALA . 16.6 t -79.28 146.1 8.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 74.510000000000005 111.141 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 14.6 mttt -93.02 152.16 19.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 74.120000000000005 110.892 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.539 ' CD1' HD13 ' A' ' 28' ' ' LEU . 24.3 mt -50.13 -46.56 53.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 74.019999999999996 110.939 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.22 -12.02 84.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.742 -0.742 . . . . 70.040000000000006 112.435 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.92 -33.1 34.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.883 0.373 . . . . 52.119999999999997 111.111 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.603 HD11 HG22 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -74.23 -24.6 59.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 73.420000000000002 110.917 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt 62.95 37.86 11.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 73.409999999999997 110.955 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.793 HD21 HG21 ' A' ' 50' ' ' VAL . 4.5 mt -90.76 154.11 19.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 65.439999999999998 110.905 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -68.35 160.26 76.62 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.574 0.702 . . . . 74.099999999999994 110.929 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 -35.51 12.71 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.68 2.253 . . . . 53.25 112.395 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.622 ' HA ' HD12 ' A' ' 6' ' ' ILE . 7.8 m-20 -78.83 -16.32 57.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 73.120000000000005 110.94 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.665 HG21 HD13 ' A' ' 66' ' ' LEU . 55.5 m -32.45 126.11 0.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 74.400000000000006 111.142 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.34 147.5 23.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 73.120000000000005 110.874 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.0 mm -117.54 128.64 74.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 75.340000000000003 111.168 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.406 ' HB3' HD13 ' A' ' 46' ' ' LEU . 6.5 mtt -99.02 141.87 31.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 74.340000000000003 110.863 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.7 mtt -137.03 116.96 13.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 71.530000000000001 110.883 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.724 ' CG ' HD11 ' A' ' 46' ' ' LEU . 4.2 mmm -107.14 126.13 51.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 74.409999999999997 110.893 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.83 -155.05 26.19 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.735 . . . . 75.099999999999994 112.475 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.3 t . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.764 0.316 . . . . 61.0 111.133 -179.864 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.697 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.875 0.369 . . . . 73.329999999999998 111.06 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.409 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 3.3 mt -110.9 108.11 57.74 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.644 0.735 . . . . 74.439999999999998 110.911 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 53.8 Cg_endo -69.81 155.72 65.07 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.666 2.244 . . . . 64.310000000000002 112.338 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.866 HD12 HD22 ' A' ' 28' ' ' LEU . 17.4 mt -150.95 138.68 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 73.129999999999995 111.12 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.552 HD12 ' HA ' ' A' ' 69' ' ' ASN . 6.1 mt -94.78 140.79 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 72.439999999999998 111.109 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.789 HG21 HD13 ' A' ' 32' ' ' LEU . 8.4 p -126.63 123.13 62.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.124 -0.489 . . . . 62.009999999999998 111.154 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -107.77 117.38 33.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 72.400000000000006 110.863 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 17.9 t-105 -119.84 102.07 8.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 70.120000000000005 110.902 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.09 -82.93 0.81 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.748 -0.739 . . . . 51.0 112.505 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.26 19.93 0.83 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.734 -0.745 . . . . 73.230000000000004 112.471 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -128.26 175.72 8.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.75 0.31 . . . . 73.340000000000003 110.938 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -132.99 141.7 48.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 72.420000000000002 110.875 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -138.28 118.38 13.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.16 -0.473 . . . . 63.43 110.938 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.4 p -82.62 135.38 35.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 75.319999999999993 110.898 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.526 HG21 ' CD2' ' A' ' 32' ' ' LEU . 62.3 t -94.36 130.58 43.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 64.349999999999994 111.13 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.5 p -144.37 90.55 2.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 73.310000000000002 111.123 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.764 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 2.8 t 177.68 -32.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 73.129999999999995 111.119 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.785 HD13 ' HA ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -87.86 164.12 16.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 61.109999999999999 110.898 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.42 174.82 10.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 74.519999999999996 110.877 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.404 ' HG2' HD12 ' A' ' 3' ' ' LEU . 37.8 mt-10 -64.8 -20.46 66.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 63.530000000000001 110.873 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -67.73 -20.98 65.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 72.319999999999993 110.852 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.663 ' HB2' HD23 ' A' ' 19' ' ' LEU . 1.5 m-20 -85.31 -150.36 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 73.239999999999995 110.84 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.97 162.68 33.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 75.329999999999998 111.121 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.011 HG22 HD11 ' A' ' 64' ' ' LEU . 22.0 t -55.5 -48.53 77.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.45 . . . . 74.230000000000004 111.12 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.403 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -61.29 -28.33 69.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 61.200000000000003 110.929 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.558 ' HB3' HD21 ' A' ' 19' ' ' LEU . 9.3 t70 -71.56 -36.24 70.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 74.120000000000005 110.901 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.866 HD22 HD12 ' A' ' 5' ' ' ILE . 0.9 OUTLIER -77.2 -47.72 19.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 72.0 110.894 -179.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.536 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -62.47 -55.11 30.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 73.019999999999996 110.875 179.83 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -56.62 -22.65 35.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 73.230000000000004 110.878 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.764 ' CZ ' HG21 ' A' ' 18' ' ' THR . 42.7 t80 -76.77 -55.08 5.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 73.430000000000007 110.874 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.789 HD13 HG21 ' A' ' 7' ' ' VAL . 1.8 pp -69.01 -41.86 77.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 73.349999999999994 110.875 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.569 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.2 tmtt? -54.85 -27.72 44.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 73.340000000000003 110.899 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.519 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.33 -23.41 43.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.461 . . . . 74.349999999999994 111.157 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.5 mt -76.98 -59.77 2.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 73.129999999999995 110.915 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.8 t -135.66 -27.64 1.15 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.458 . . . . 64.019999999999996 111.176 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.569 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.66 -177.77 4.64 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.704 -0.76 . . . . 73.340000000000003 112.506 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.884 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.3 p -112.31 138.88 39.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.88 0.371 . . . . 73.329999999999998 111.159 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.984 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.78 151.04 16.25 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.635 0.731 . . . . 75.329999999999998 110.913 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 53.3 Cg_endo -69.74 -21.79 33.09 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.713 2.275 . . . . 72.430000000000007 112.318 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -54.17 -39.11 66.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 63.43 110.911 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.425 ' H ' HD23 ' A' ' 39' ' ' LEU . 4.2 mpt_? -104.02 -40.21 6.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 73.519999999999996 110.855 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.884 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.7 pp0? -97.84 157.37 16.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 55.420000000000002 110.881 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.06 142.1 51.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 74.450000000000003 110.902 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.402 ' N ' HD22 ' A' ' 45' ' ' LEU . 3.7 mm? -67.45 135.95 53.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 64.209999999999994 110.916 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.733 HD11 ' CG ' ' A' ' 75' ' ' MET . 6.2 mp -85.37 -60.49 2.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 73.450000000000003 110.939 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.82 51.63 0.97 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.755 -0.736 . . . . 64.349999999999994 112.494 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.651 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 3.6 pp -55.2 -25.45 32.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.909 0.385 . . . . 75.219999999999999 110.929 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.414 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -107.34 141.76 38.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 41.299999999999997 110.88 179.832 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.977 HG21 HD11 ' A' ' 66' ' ' LEU . 23.8 t -143.95 144.97 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 61.130000000000003 111.113 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.554 ' HG2' HG12 ' A' ' 50' ' ' VAL . 0.4 OUTLIER 54.34 32.41 16.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 74.25 110.944 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.07 -14.45 49.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.716 -0.755 . . . . 64.219999999999999 112.467 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -81.55 148.74 63.04 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.6 0.714 . . . . 63.530000000000001 110.866 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.414 ' HA ' ' HB3' ' A' ' 49' ' ' LYS . 53.5 Cg_endo -69.82 -35.0 13.27 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.696 2.264 . . . . 52.219999999999999 112.341 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.651 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 37.39 41.49 0.26 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 75.030000000000001 111.132 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.73 -76.89 0.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 71.549999999999997 110.885 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -150.98 -39.44 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 63.329999999999998 110.892 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -71.96 -2.63 18.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 71.319999999999993 110.875 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.566 ' O ' HG23 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -95.78 147.44 5.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 62.030000000000001 111.155 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.473 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 30.8 mttt -93.93 149.05 21.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 74.549999999999997 110.888 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.666 ' CD1' HD13 ' A' ' 28' ' ' LEU . 17.4 mt -51.98 -39.74 59.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 74.030000000000001 110.956 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.13 -16.49 80.56 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.767 -0.73 . . . . 53.539999999999999 112.489 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.91 -19.75 31.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.814 0.34 . . . . 61.310000000000002 111.096 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.011 HD11 HG22 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -85.05 -18.89 32.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 73.099999999999994 110.899 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp 52.31 42.63 31.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 62.130000000000003 110.879 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.977 HD11 HG21 ' A' ' 50' ' ' VAL . 3.3 mt -91.12 153.64 19.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 75.409999999999997 110.921 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.47 159.13 82.74 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.6 0.714 . . . . 65.219999999999999 110.842 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -37.21 9.56 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.69 2.26 . . . . 75.109999999999999 112.339 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.552 ' HA ' HD12 ' A' ' 6' ' ' ILE . 11.7 p30 -79.42 -16.31 56.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 64.439999999999998 110.856 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.634 HG21 HD13 ' A' ' 66' ' ' LEU . 65.8 m -31.77 132.4 0.11 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 52.32 111.144 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.86 145.92 28.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 74.150000000000006 110.916 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.5 mm -115.63 128.75 72.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.245 -0.434 . . . . 62.030000000000001 111.117 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.2 mtt -99.35 141.45 32.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 71.239999999999995 110.918 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.9 mtt -136.65 116.71 13.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 75.430000000000007 110.878 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.733 ' CG ' HD11 ' A' ' 46' ' ' LEU . 3.9 mmm -106.38 127.13 53.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 73.109999999999999 110.88 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.98 -155.92 27.08 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.697 -0.764 . . . . 55.140000000000001 112.436 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.3 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.768 0.318 . . . . 71.530000000000001 111.195 -179.871 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.733 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.77 0.319 . . . . 74.319999999999993 111.143 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.447 HD23 ' HG3' ' A' ' 21' ' ' GLU . 1.7 mm? -105.66 109.82 63.58 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.608 0.718 . . . . 63.439999999999998 110.934 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 156.46 63.45 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.716 2.277 . . . . 50.520000000000003 112.356 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.551 ' HB ' HD21 ' A' ' 28' ' ' LEU . 29.1 mt -149.98 137.01 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 75.150000000000006 111.132 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.669 HD12 ' HA ' ' A' ' 69' ' ' ASN . 3.7 mt -95.33 140.58 16.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 73.310000000000002 111.134 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.807 HG21 HD13 ' A' ' 32' ' ' LEU . 7.6 p -127.42 123.5 61.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 72.340000000000003 111.142 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.35 121.44 45.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 73.450000000000003 110.9 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 17.3 t-105 -125.17 106.25 9.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 74.120000000000005 110.928 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.16 -81.29 0.86 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.744 -0.741 . . . . 71.340000000000003 112.464 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -155.12 19.83 0.56 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.745 -0.741 . . . . 75.409999999999997 112.487 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -129.3 175.23 8.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.793 0.33 . . . . 72.200000000000003 110.865 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -132.43 140.09 48.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 63.329999999999998 110.881 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.55 ' CG ' HG21 ' A' ' 36' ' ' THR . 50.0 m-85 -134.39 116.13 14.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 63.43 110.979 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.76 131.49 35.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.488 . . . . 74.109999999999999 110.858 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.539 HG21 HD23 ' A' ' 32' ' ' LEU . 90.4 t -92.79 141.43 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 64.439999999999998 111.143 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.3 p -150.58 92.62 1.87 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 75.219999999999999 111.142 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.685 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.8 OUTLIER 173.29 -28.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 73.019999999999996 111.137 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.733 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.8 mm? -86.36 150.81 24.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.248 -0.433 . . . . 65.519999999999996 110.93 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.67 167.55 19.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 51.229999999999997 110.83 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.447 ' HG3' HD23 ' A' ' 3' ' ' LEU . 40.3 mt-10 -59.41 -22.24 61.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 52.439999999999998 110.892 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.0 -11.52 60.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.144 -0.48 . . . . 72.019999999999996 110.852 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.415 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.5 m-20 -100.34 -150.37 0.38 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 75.439999999999998 110.837 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.418 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -132.94 170.09 15.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 64.040000000000006 111.15 -179.892 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.974 HG22 HD11 ' A' ' 64' ' ' LEU . 12.8 t -66.1 -43.75 92.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 62.039999999999999 111.114 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.4 -28.77 68.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 62.310000000000002 110.926 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.477 ' HB3' HD11 ' A' ' 19' ' ' LEU . 9.1 t0 -69.97 -35.62 74.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 61.100000000000001 110.869 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.664 HD12 ' HB3' ' A' ' 19' ' ' LEU . 1.2 tt -80.7 -47.94 13.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 74.310000000000002 110.903 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.735 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.28 -56.56 19.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 73.400000000000006 110.911 179.88 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.19 -22.77 53.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 71.400000000000006 110.933 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.685 ' CZ ' HG21 ' A' ' 18' ' ' THR . 49.0 t80 -76.79 -55.27 5.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 71.510000000000005 110.89 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.807 HD13 HG21 ' A' ' 7' ' ' VAL . 2.3 pp -67.73 -43.46 79.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 74.109999999999999 110.877 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.566 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.2 tmtt? -54.89 -27.14 40.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 70.0 110.898 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.502 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.52 -23.72 42.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.248 -0.433 . . . . 70.310000000000002 111.135 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.1 mt -76.59 -59.57 2.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 52.450000000000003 110.901 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.55 HG21 ' CG ' ' A' ' 14' ' ' TYR . 2.9 t -135.09 -28.07 1.2 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 74.420000000000002 111.139 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.566 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.03 -177.37 4.85 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.745 -0.741 . . . . 63.119999999999997 112.539 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.855 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.3 p -112.84 138.43 42.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.845 0.355 . . . . 72.400000000000006 111.155 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.925 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -53.73 149.72 15.59 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.639 0.733 . . . . 75.349999999999994 110.926 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.4 ' O ' ' O ' ' A' ' 43' ' ' GLN . 53.8 Cg_endo -69.78 -21.71 33.01 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.663 2.242 . . . . 72.349999999999994 112.335 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -54.19 -38.3 65.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 62.520000000000003 110.925 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.418 ' H ' HD23 ' A' ' 39' ' ' LEU . 1.3 mpt_? -104.72 -40.04 6.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 73.420000000000002 110.856 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.855 ' HG2' HG13 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -96.94 158.66 15.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 72.540000000000006 110.955 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.37 139.57 52.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 63.340000000000003 110.916 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.15 136.08 55.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 72.219999999999999 110.92 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.761 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.1 mm? -75.83 -74.96 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 60.140000000000001 110.915 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -97.52 60.06 1.07 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.731 -0.747 . . . . 43.219999999999999 112.464 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.646 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 3.8 pp -54.93 -24.2 22.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.853 0.358 . . . . 74.349999999999994 110.944 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.421 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -104.32 143.33 33.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.202 -0.453 . . . . 71.340000000000003 110.879 179.813 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.76 HG21 HD21 ' A' ' 66' ' ' LEU . 14.9 p -144.13 143.2 23.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 60.509999999999998 111.131 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.642 ' HG2' HG22 ' A' ' 50' ' ' VAL . 10.0 mmpt? 54.2 34.06 19.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 60.210000000000001 110.912 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.4 -15.18 41.76 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.758 -0.735 . . . . 74.230000000000004 112.487 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -81.5 149.28 64.53 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.628 0.727 . . . . 74.530000000000001 110.848 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.421 ' HA ' ' HB3' ' A' ' 49' ' ' LYS . 54.0 Cg_endo -69.72 -35.47 12.71 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.698 2.265 . . . . 74.120000000000005 112.384 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 38.74 39.61 0.35 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 42.140000000000001 111.117 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.49 -75.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.278 -0.419 . . . . 74.540000000000006 110.873 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -154.68 -38.63 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 75.430000000000007 110.884 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -73.09 -1.98 19.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 73.310000000000002 110.819 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.58 ' O ' HG23 ' A' ' 25' ' ' VAL . 0.8 OUTLIER -92.71 148.27 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 75.239999999999995 111.124 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.431 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 16.6 mttt -91.18 147.28 23.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 70.349999999999994 110.924 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.43 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 18.7 mt -52.29 -39.31 60.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.433 . . . . 74.519999999999996 110.902 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.66 -16.91 80.34 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.735 -0.745 . . . . 71.340000000000003 112.511 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.49 -19.31 33.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.853 0.359 . . . . 73.349999999999994 111.093 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.974 HD11 HG22 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -83.79 -19.96 34.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 74.140000000000001 110.943 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp 52.87 43.49 31.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 62.420000000000002 110.935 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.76 HD21 HG21 ' A' ' 50' ' ' VAL . 3.4 mt -96.19 152.91 18.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 71.319999999999993 110.935 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.54 159.81 79.58 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.626 0.727 . . . . 72.530000000000001 110.894 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -36.15 11.22 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.645 2.23 . . . . 74.299999999999997 112.322 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.669 ' HA ' HD12 ' A' ' 6' ' ' ILE . 82.4 m-20 -78.57 -15.72 58.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 55.530000000000001 110.868 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.628 HG21 HD13 ' A' ' 66' ' ' LEU . 52.8 m -32.58 124.78 0.33 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 74.299999999999997 111.128 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.26 146.27 24.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 60.329999999999998 110.883 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.3 mm -115.16 129.88 70.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 64.450000000000003 111.165 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 6.8 mtp -101.85 141.93 33.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 72.439999999999998 110.895 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 78.3 mtm -132.48 125.67 31.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 71.319999999999993 110.895 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.761 ' CG ' HD21 ' A' ' 46' ' ' LEU . 0.4 OUTLIER -115.01 128.9 56.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 65.409999999999997 110.886 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 150.84 -151.72 23.67 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.768 -0.729 . . . . 72.109999999999999 112.528 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.801 0.334 . . . . 72.430000000000007 111.144 -179.884 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.812 0.339 . . . . 72.150000000000006 111.105 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.521 ' O ' ' HG ' ' A' ' 3' ' ' LEU . 0.2 OUTLIER -107.22 111.78 63.17 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.594 0.711 . . . . 54.420000000000002 110.925 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 156.28 63.7 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.642 2.228 . . . . 75.049999999999997 112.366 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.528 ' HB ' HD21 ' A' ' 28' ' ' LEU . 30.8 mt -149.87 134.83 10.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 72.209999999999994 111.133 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.61 HD12 ' HA ' ' A' ' 69' ' ' ASN . 4.6 mt -94.28 140.94 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 72.230000000000004 111.151 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.848 HG21 HD13 ' A' ' 32' ' ' LEU . 7.3 p -127.26 123.22 61.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 62.32 111.101 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.64 119.06 38.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 73.430000000000007 110.906 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.9 t-105 -123.67 105.64 9.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 73.230000000000004 110.87 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.82 -81.82 0.9 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.754 -0.736 . . . . 71.019999999999996 112.478 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.76 19.92 0.59 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.729 -0.748 . . . . 52.340000000000003 112.45 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -129.28 175.85 8.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.738 0.304 . . . . 75.439999999999998 110.947 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -132.48 140.83 48.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 74.0 110.916 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.53 ' CG ' HG21 ' A' ' 36' ' ' THR . 53.7 m-85 -135.79 117.0 14.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 75.299999999999997 110.903 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.0 p -83.07 130.89 35.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 50.450000000000003 110.839 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.581 HG21 HD23 ' A' ' 32' ' ' LEU . 96.4 t -92.86 135.3 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 74.109999999999999 111.12 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.6 p -144.39 92.47 2.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 72.400000000000006 111.161 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.654 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.8 OUTLIER 173.4 -28.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 72.510000000000005 111.161 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.67 ' HB3' HD12 ' A' ' 28' ' ' LEU . 1.6 mm? -85.94 151.12 24.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 74.040000000000006 110.874 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.53 163.47 28.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 52.210000000000001 110.85 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.459 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 72.2 mt-10 -55.71 -23.79 30.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.097 -0.501 . . . . 43.240000000000002 110.876 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -66.66 -14.01 61.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.467 . . . . 64.319999999999993 110.865 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.419 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.7 m-20 -98.44 -149.77 0.35 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 75.409999999999997 110.89 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.54 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -132.8 172.92 11.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 74.439999999999998 111.132 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.93 HG22 HD11 ' A' ' 64' ' ' LEU . 10.8 t -68.53 -43.61 83.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 74.310000000000002 111.153 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.45 -28.72 68.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 74.239999999999995 110.9 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.489 ' HB3' HD11 ' A' ' 19' ' ' LEU . 9.5 t0 -70.18 -35.82 74.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.189 -0.46 . . . . 73.510000000000005 110.838 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.67 HD12 ' HB3' ' A' ' 19' ' ' LEU . 1.1 tt -80.61 -47.06 14.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 73.540000000000006 110.909 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.754 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -62.09 -56.9 14.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 74.420000000000002 110.866 179.814 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -57.8 -22.49 47.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.276 -0.42 . . . . 73.329999999999998 110.925 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.654 ' CZ ' HG21 ' A' ' 18' ' ' THR . 62.5 t80 -77.35 -55.23 5.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 44.329999999999998 110.864 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.848 HD13 HG21 ' A' ' 7' ' ' VAL . 2.3 pp -67.78 -43.06 80.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 65.140000000000001 110.93 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.565 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -55.01 -27.04 41.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 55.119999999999997 110.906 179.829 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.489 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.77 -23.54 42.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 70.239999999999995 111.121 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.4 mt -76.97 -60.16 2.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.227 -0.442 . . . . 72.239999999999995 110.9 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.53 HG21 ' CG ' ' A' ' 14' ' ' TYR . 2.9 t -134.93 -27.76 1.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 53.240000000000002 111.153 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.83 -177.76 4.84 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.76 -0.734 . . . . 61.420000000000002 112.503 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.869 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.3 p -112.29 139.26 37.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.898 0.38 . . . . 72.019999999999996 111.129 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.969 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.61 150.56 17.35 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.599 0.714 . . . . 72.129999999999995 110.919 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 -21.92 32.95 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.676 2.251 . . . . 64.230000000000004 112.333 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -54.1 -39.04 66.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 71.530000000000001 110.928 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.434 ' H ' HD23 ' A' ' 39' ' ' LEU . 5.8 mpt_? -104.25 -40.18 6.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.142 -0.481 . . . . 61.530000000000001 110.881 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.869 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.8 pp0? -97.51 158.16 15.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 73.430000000000007 110.91 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.9 141.71 51.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.438 . . . . 75.230000000000004 110.907 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.98 134.8 52.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 74.120000000000005 110.89 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.735 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.0 mm? -75.93 -75.55 0.18 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 75.409999999999997 110.898 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.83 59.84 1.47 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.737 -0.744 . . . . 61.109999999999999 112.473 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.656 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 3.7 pp -55.56 -23.55 27.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.838 0.351 . . . . 70.25 110.914 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.422 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -105.57 142.23 35.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 65.230000000000004 110.929 179.808 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.943 HG21 HD11 ' A' ' 66' ' ' LEU . 21.8 t -143.74 144.27 23.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 71.040000000000006 111.097 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.651 ' HG2' HG12 ' A' ' 50' ' ' VAL . 16.0 mmtm 54.35 33.29 18.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 71.450000000000003 110.897 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.48 -14.78 44.43 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.733 -0.746 . . . . 74.129999999999995 112.495 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -81.56 149.26 64.24 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.6 0.714 . . . . 73.519999999999996 110.886 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.422 ' HA ' ' HB3' ' A' ' 49' ' ' LYS . 54.1 Cg_endo -69.7 -35.69 12.34 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.693 2.262 . . . . 73.319999999999993 112.386 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.656 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 38.5 40.26 0.37 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.453 . . . . 74.299999999999997 111.106 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.34 -75.38 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 74.439999999999998 110.881 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -156.38 -37.84 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 64.140000000000001 110.91 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -74.41 -1.05 19.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 74.030000000000001 110.828 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.573 ' O ' HG23 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -93.04 147.81 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 52.420000000000002 111.146 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.408 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 5.8 mttp -89.49 146.18 24.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 65.25 110.878 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 15.9 mt -52.37 -38.39 58.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 62.310000000000002 110.884 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.96 -17.2 80.18 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.736 -0.745 . . . . 65.420000000000002 112.483 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.22 -19.63 33.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.829 0.347 . . . . 74.310000000000002 111.102 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.93 HD11 HG22 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -84.54 -19.53 33.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 25.34 110.907 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp 54.21 42.08 31.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 73.129999999999995 110.893 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.943 HD11 HG21 ' A' ' 50' ' ' VAL . 3.9 mt -92.71 152.05 19.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 61.229999999999997 110.906 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -68.63 160.18 78.11 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.563 0.696 . . . . 61.32 110.914 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -37.58 8.99 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.663 2.242 . . . . 61.420000000000002 112.36 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.61 ' HA ' HD12 ' A' ' 6' ' ' ILE . 55.0 m-20 -78.84 -15.92 57.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 64.329999999999998 110.877 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.701 HG21 HD13 ' A' ' 66' ' ' LEU . 66.9 m -31.31 129.44 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.155 -0.475 . . . . 63.119999999999997 111.185 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.87 145.73 26.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 61.030000000000001 110.905 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.8 mm -115.61 128.71 72.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 74.519999999999996 111.135 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 28.5 mtm -101.33 141.6 33.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 73.019999999999996 110.894 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 73.1 mtm -136.2 116.91 13.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 62.32 110.893 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.735 ' CG ' HD21 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -105.92 127.53 53.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 75.120000000000005 110.886 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.65 -154.22 25.27 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.765 -0.731 . . . . 62.539999999999999 112.489 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.2 t . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.79 0.328 . . . . 64.310000000000002 111.136 -179.829 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.753 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.854 0.359 . . . . 44.530000000000001 111.083 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.502 HD12 ' HG2' ' A' ' 21' ' ' GLU . 1.0 OUTLIER -107.37 108.98 62.51 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.604 0.716 . . . . 74.439999999999998 110.936 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 156.33 63.42 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.716 2.277 . . . . 74.510000000000005 112.295 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.477 ' HB ' HD21 ' A' ' 28' ' ' LEU . 38.1 mt -150.4 136.42 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 70.310000000000002 111.131 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.703 HD12 ' HA ' ' A' ' 69' ' ' ASN . 3.5 mt -94.93 140.13 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 73.430000000000007 111.119 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.883 HG21 HD13 ' A' ' 32' ' ' LEU . 8.3 p -127.69 123.02 60.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 72.420000000000002 111.08 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.89 120.51 42.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 73.329999999999998 110.895 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 14.1 t-105 -122.74 102.67 8.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 73.150000000000006 110.919 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.0 -78.09 1.71 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.774 -0.727 . . . . 54.420000000000002 112.484 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -155.62 18.5 0.5 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.75 -0.738 . . . . 73.230000000000004 112.5 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -130.87 139.17 50.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.738 0.304 . . . . 74.530000000000001 110.922 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -102.62 142.11 34.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 73.129999999999995 110.896 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.605 ' CD1' HG21 ' A' ' 36' ' ' THR . 82.6 m-85 -136.24 122.14 20.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.494 . . . . 70.299999999999997 110.914 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 92.7 p -84.95 133.43 34.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 51.520000000000003 110.844 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.592 HG21 HD23 ' A' ' 32' ' ' LEU . 85.5 t -96.37 111.48 26.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 51.409999999999997 111.136 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.0 p -124.05 91.42 3.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 74.439999999999998 111.174 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.618 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 1.2 t 174.83 -29.69 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 71.030000000000001 111.177 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.753 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.9 mm? -83.16 149.76 26.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 60.420000000000002 110.947 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.524 ' C ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.43 168.22 17.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 71.200000000000003 110.852 -179.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.502 ' HG2' HD12 ' A' ' 3' ' ' LEU . 51.8 mt-10 -59.8 -22.16 61.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.477 . . . . 74.420000000000002 110.891 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -69.26 -11.34 60.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 70.040000000000006 110.868 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.442 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.5 m-20 -99.52 -149.54 0.36 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 54.329999999999998 110.896 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.485 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -138.07 167.46 21.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 64.450000000000003 111.131 -179.878 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.973 HG22 HD11 ' A' ' 64' ' ' LEU . 41.4 t -61.9 -45.69 98.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 73.409999999999997 111.129 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.48 -29.15 67.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 73.340000000000003 110.914 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.553 ' HB3' HD11 ' A' ' 19' ' ' LEU . 1.3 t0 -70.69 -34.31 71.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 70.519999999999996 110.841 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.695 HD23 HD23 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -80.74 -48.45 12.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 71.420000000000002 110.904 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.592 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.6 -56.79 16.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 73.129999999999995 110.894 179.827 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.05 -22.76 51.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 65.439999999999998 110.894 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.618 ' CZ ' HG21 ' A' ' 18' ' ' THR . 58.7 t80 -76.94 -55.16 5.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 75.25 110.922 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.883 HD13 HG21 ' A' ' 7' ' ' VAL . 2.5 pp -67.59 -42.81 81.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 74.109999999999999 110.926 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.571 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.2 tmtt? -54.96 -27.14 41.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 74.340000000000003 110.926 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.99 -23.67 41.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 60.049999999999997 111.132 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.8 mt -76.96 -60.03 2.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 61.210000000000001 110.908 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.605 HG21 ' CD1' ' A' ' 14' ' ' TYR . 5.1 t -135.45 -27.35 1.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 75.519999999999996 111.166 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.571 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.48 -178.75 4.96 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.724 -0.75 . . . . 54.240000000000002 112.489 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.85 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.4 p -113.25 137.96 44.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.885 0.374 . . . . 30.440000000000001 111.132 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.984 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -53.95 149.56 17.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.615 0.721 . . . . 53.240000000000002 110.919 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -21.59 33.24 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.65 2.234 . . . . 72.439999999999998 112.389 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -54.21 -38.35 65.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 71.099999999999994 110.883 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.408 ' H ' HD23 ' A' ' 39' ' ' LEU . 2.7 mpt_? -105.05 -39.94 6.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 64.450000000000003 110.907 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.85 ' HG2' HG13 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -95.67 159.4 15.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 75.510000000000005 110.905 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.8 137.85 52.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 63.549999999999997 110.899 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 45' ' ' LEU . 3.4 mm? -66.86 132.66 48.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 71.129999999999995 110.917 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.738 HD11 ' CG ' ' A' ' 75' ' ' MET . 5.8 mp -83.05 -44.48 15.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 73.109999999999999 110.908 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -107.73 39.26 2.96 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.751 -0.738 . . . . 44.350000000000001 112.478 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.516 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 0.5 OUTLIER -44.88 -35.02 2.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.905 0.383 . . . . 70.409999999999997 110.927 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.85 146.54 33.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 55.5 110.872 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.675 HG21 HD21 ' A' ' 66' ' ' LEU . 14.1 p -143.77 145.69 21.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 71.120000000000005 111.11 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.5 mttt 54.91 31.19 15.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.47 . . . . 74.420000000000002 110.866 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.64 -10.83 54.9 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.717 -0.754 . . . . 52.539999999999999 112.518 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -81.44 149.51 65.23 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.581 0.705 . . . . 72.140000000000001 110.881 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -31.69 19.96 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.632 2.221 . . . . 75.230000000000004 112.36 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.609 ' HA ' HG21 ' A' ' 59' ' ' VAL . . . 37.36 41.91 0.28 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 51.109999999999999 111.082 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.03 -77.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 64.530000000000001 110.885 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.417 HD22 ' N ' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -157.92 -36.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 74.430000000000007 110.902 -179.942 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.417 ' N ' HD22 ' A' ' 57' ' ' ASN . 0.2 OUTLIER -68.06 -6.77 24.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 73.239999999999995 110.885 179.917 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.609 HG21 ' HA ' ' A' ' 55' ' ' ALA . 17.6 t -82.14 146.35 7.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.468 . . . . 55.149999999999999 111.12 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.2 mttp -94.46 151.61 19.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 74.109999999999999 110.871 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.553 ' HA ' HD12 ' A' ' 64' ' ' LEU . 19.5 mt -50.84 -44.63 59.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 71.450000000000003 110.944 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.54 -12.25 84.52 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.753 -0.737 . . . . 62.039999999999999 112.504 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.77 -34.42 27.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 65.439999999999998 111.097 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.973 HD11 HG22 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -70.48 -25.22 63.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 72.439999999999998 110.91 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp 62.38 36.87 14.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 61.530000000000001 110.902 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.675 HD21 HG21 ' A' ' 50' ' ' VAL . 4.2 mt -92.04 152.83 19.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 75.129999999999995 110.894 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -68.49 160.99 73.58 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.607 0.717 . . . . 63.210000000000001 110.903 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 -35.47 12.69 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.701 2.267 . . . . 42.32 112.381 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.703 ' HA ' HD12 ' A' ' 6' ' ' ILE . 23.7 p30 -78.77 -15.73 58.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 64.109999999999999 110.909 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.643 HG21 HD13 ' A' ' 66' ' ' LEU . 52.4 m -32.53 121.4 0.33 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.174 -0.467 . . . . 74.239999999999995 111.124 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -92.85 145.81 24.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 62.219999999999999 110.875 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.6 mm -115.74 129.17 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.268 -0.424 . . . . 74.319999999999993 111.149 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.455 ' CB ' HD13 ' A' ' 46' ' ' LEU . 4.6 mtp -101.33 141.92 33.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 73.329999999999998 110.891 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 76.5 mtm -135.2 119.62 17.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.438 . . . . 75.310000000000002 110.873 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.738 ' CG ' HD11 ' A' ' 46' ' ' LEU . 1.4 mmt -110.74 123.71 50.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 53.32 110.895 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 163.01 -153.9 24.63 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.756 -0.735 . . . . 71.530000000000001 112.508 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.6 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-O 120.81 0.338 . . . . 62.210000000000001 111.133 -179.864 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.87 0.367 . . . . 44.229999999999997 111.062 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.506 ' O ' ' HG ' ' A' ' 3' ' ' LEU . 0.2 OUTLIER -107.29 111.72 63.09 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.67 0.748 . . . . 62.229999999999997 110.938 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.412 ' O ' HD12 ' A' ' 3' ' ' LEU . 53.9 Cg_endo -69.77 156.34 63.59 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.713 2.275 . . . . 62.420000000000002 112.342 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.543 ' HB ' HD21 ' A' ' 28' ' ' LEU . 23.8 mt -149.17 135.62 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 74.099999999999994 111.143 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.633 HD12 ' HA ' ' A' ' 69' ' ' ASN . 4.4 mt -94.78 141.0 15.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 64.019999999999996 111.15 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.833 HG21 HD13 ' A' ' 32' ' ' LEU . 7.9 p -127.3 123.12 61.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 64.129999999999995 111.122 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.65 121.36 44.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 73.319999999999993 110.908 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 13.1 t-105 -121.74 100.9 7.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 71.420000000000002 110.939 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.01 -83.53 0.91 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.736 -0.745 . . . . 75.010000000000005 112.517 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.94 20.43 1.12 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.742 . . . . 64.430000000000007 112.497 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -128.01 174.31 9.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.739 0.304 . . . . 72.219999999999999 110.926 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -133.06 140.12 47.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 72.349999999999994 110.917 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.521 ' CD2' HG21 ' A' ' 36' ' ' THR . 38.7 m-85 -135.83 115.97 13.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.494 . . . . 73.030000000000001 110.901 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.3 p -82.19 133.41 35.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 60.310000000000002 110.873 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.521 HG21 HD23 ' A' ' 32' ' ' LEU . 91.5 t -96.01 139.72 18.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 54.43 111.123 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.5 p -148.23 93.58 2.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 73.140000000000001 111.167 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.682 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.8 OUTLIER 173.04 -28.37 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 73.25 111.169 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.657 ' HB3' HD12 ' A' ' 28' ' ' LEU . 1.7 mm? -86.52 151.78 23.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 72.349999999999994 110.944 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.77 163.57 28.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 62.5 110.858 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.448 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 49.0 mt-10 -56.16 -23.34 34.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 72.519999999999996 110.872 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -67.84 -12.53 60.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 70.340000000000003 110.873 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.405 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.6 m-20 -99.12 -150.31 0.37 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 71.040000000000006 110.842 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -132.19 171.1 14.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 74.340000000000003 111.122 -179.881 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.946 HG22 HD11 ' A' ' 64' ' ' LEU . 11.6 t -67.3 -43.78 87.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 73.400000000000006 111.109 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.77 -28.36 68.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 73.519999999999996 110.901 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.494 ' HB3' HD11 ' A' ' 19' ' ' LEU . 17.3 t0 -70.18 -35.64 74.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.475 . . . . 73.420000000000002 110.853 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.673 HD23 HD23 ' A' ' 32' ' ' LEU . 1.2 tt -80.76 -47.41 13.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 44.140000000000001 110.966 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.77 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.7 -56.6 17.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 42.130000000000003 110.91 179.81 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -58.09 -22.42 50.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 73.420000000000002 110.878 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.682 ' CZ ' HG21 ' A' ' 18' ' ' THR . 56.4 t80 -77.18 -55.2 5.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 74.439999999999998 110.867 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.833 HD13 HG21 ' A' ' 7' ' ' VAL . 2.4 pp -67.93 -43.01 80.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.14 -0.482 . . . . 73.519999999999996 110.931 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.564 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.9 -27.2 41.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.45 . . . . 74.349999999999994 110.908 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.73 -23.61 42.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.247 -0.433 . . . . 54.450000000000003 111.107 179.968 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.0 mt -76.59 -59.76 2.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 70.400000000000006 110.94 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.521 HG21 ' CD2' ' A' ' 14' ' ' TYR . 3.3 t -135.14 -27.83 1.2 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 74.540000000000006 111.119 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.29 -176.7 4.77 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.718 -0.753 . . . . 42.5 112.505 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.88 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.1 p -112.43 139.73 35.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.835 0.35 . . . . 75.519999999999996 111.16 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.983 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.76 150.2 19.41 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.584 0.707 . . . . 74.519999999999996 110.922 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -21.98 32.63 Favored 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.696 2.264 . . . . 71.400000000000006 112.308 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -54.42 -39.08 66.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.273 -0.421 . . . . 74.439999999999998 110.932 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.413 ' H ' HD23 ' A' ' 39' ' ' LEU . 9.2 mtt85 -103.76 -40.73 6.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 73.420000000000002 110.906 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.88 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.6 pp0? -97.29 157.58 15.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 65.129999999999995 110.89 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.77 142.18 51.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 72.129999999999995 110.923 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.49 136.05 54.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 74.120000000000005 110.942 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.743 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.0 mm? -77.31 -75.03 0.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 72.420000000000002 110.929 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.15 59.23 1.68 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.774 -0.727 . . . . 70.25 112.522 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.645 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 3.8 pp -56.22 -23.06 33.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 73.209999999999994 110.906 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.417 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 2.0 pttt -105.95 142.33 35.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 72.5 110.911 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.871 HG11 HD21 ' A' ' 66' ' ' LEU . 20.8 t -143.94 144.33 23.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 73.129999999999995 111.119 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.596 ' HG3' HG12 ' A' ' 50' ' ' VAL . 18.4 mttt 54.27 33.06 17.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 75.209999999999994 110.912 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.79 -14.67 46.72 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.728 -0.748 . . . . 72.5 112.504 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -81.56 148.97 63.62 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.597 0.713 . . . . 71.209999999999994 110.853 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.417 ' HA ' ' HB3' ' A' ' 49' ' ' LYS . 53.2 Cg_endo -69.82 -35.49 12.37 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.657 2.238 . . . . 64.340000000000003 112.323 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.645 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 38.03 40.69 0.32 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 61.200000000000003 111.088 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.02 -76.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 72.310000000000002 110.882 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -155.25 -38.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 61.310000000000002 110.877 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -73.55 -1.12 17.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 73.129999999999995 110.892 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.572 ' O ' HG23 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -93.45 148.37 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 70.030000000000001 111.159 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.414 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 5.6 mttt -90.32 146.7 24.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 60.340000000000003 110.874 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.448 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 16.4 mt -52.27 -38.88 59.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.447 . . . . 75.420000000000002 110.883 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.89 -17.02 80.28 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.76 -0.733 . . . . 33.210000000000001 112.508 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.15 -19.46 34.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.812 0.339 . . . . 64.310000000000002 111.128 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.946 HD11 HG22 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -84.83 -19.9 31.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 74.120000000000005 110.906 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.9 mmtp 55.13 41.47 31.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 65.209999999999994 110.923 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.871 HD21 HG11 ' A' ' 50' ' ' VAL . 3.8 mt -92.38 151.2 20.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 72.230000000000004 110.918 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -68.43 160.79 74.28 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.619 0.723 . . . . 65.239999999999995 110.944 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -37.09 9.67 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.738 2.292 . . . . 72.120000000000005 112.33 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.633 ' HA ' HD12 ' A' ' 6' ' ' ILE . 10.5 p-10 -78.81 -15.82 57.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 70.120000000000005 110.891 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.749 HG21 HD22 ' A' ' 66' ' ' LEU . 53.1 m -31.25 128.96 0.15 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 62.399999999999999 111.183 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.49 146.4 25.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.229 -0.441 . . . . 63.219999999999999 110.868 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.7 mm -115.38 127.93 72.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 73.200000000000003 111.131 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.0 mtp -100.15 141.72 32.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 65.310000000000002 110.841 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.8 mtt -134.58 127.5 31.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 73.530000000000001 110.871 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.743 ' CG ' HD21 ' A' ' 46' ' ' LEU . 0.3 OUTLIER -116.97 126.35 52.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 72.129999999999995 110.913 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.9 -154.53 25.6 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.75 -0.738 . . . . 63.219999999999999 112.51 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.33 -0.264 0 CA-C-O 120.763 0.316 . . . . 75.099999999999994 111.101 -179.84 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.691 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.877 0.37 . . . . 72.030000000000001 111.076 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.416 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 1.7 mt -113.53 107.08 53.61 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.579 0.704 . . . . 62.149999999999999 110.917 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 53.7 Cg_endo -69.78 155.68 65.24 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.665 2.243 . . . . 55.350000000000001 112.338 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.962 HD12 HD22 ' A' ' 28' ' ' LEU . 20.7 mt -151.0 138.77 13.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 75.150000000000006 111.105 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.615 HD12 ' HA ' ' A' ' 69' ' ' ASN . 4.7 mt -95.02 140.47 16.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 74.409999999999997 111.119 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.829 HG21 HD13 ' A' ' 32' ' ' LEU . 7.5 p -126.53 123.0 62.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 70.010000000000005 111.139 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.45 118.07 35.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 63.109999999999999 110.9 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.9 t-105 -122.87 106.67 11.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 73.319999999999993 110.889 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.72 -81.06 0.9 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.744 -0.741 . . . . 74.409999999999997 112.469 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -155.98 19.87 0.49 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.72 -0.752 . . . . 54.25 112.466 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -129.34 176.07 8.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.796 0.332 . . . . 52.409999999999997 110.902 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -132.51 140.83 48.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 70.010000000000005 110.901 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -136.18 119.44 16.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 73.319999999999993 110.915 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.6 p -82.89 134.22 35.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.089 -0.505 . . . . 64.319999999999993 110.857 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.535 HG21 HD23 ' A' ' 32' ' ' LEU . 87.2 t -93.46 132.81 36.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 64.530000000000001 111.152 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.4 p -147.28 92.08 2.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 71.540000000000006 111.162 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.679 HG21 ' CE1' ' A' ' 31' ' ' PHE . 1.8 t 176.99 -31.89 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 73.549999999999997 111.133 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.788 ' CB ' HD12 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -87.93 164.32 15.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 75.219999999999999 110.931 179.948 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.449 ' O ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -136.26 175.17 9.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.448 . . . . 52.0 110.848 -179.895 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.424 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 35.0 mt-10 -64.52 -20.01 65.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 54.32 110.896 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.94 -11.32 60.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.127 -0.488 . . . . 32.030000000000001 110.839 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.687 ' HB2' HD23 ' A' ' 19' ' ' LEU . 1.6 m-20 -95.99 -152.62 0.38 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 74.420000000000002 110.848 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -136.91 165.6 25.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 61.210000000000001 111.156 -179.882 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.978 HG22 HD11 ' A' ' 64' ' ' LEU . 37.9 t -58.69 -44.41 89.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 73.099999999999994 111.157 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.407 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -63.88 -30.13 71.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 61.399999999999999 110.875 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.577 ' HB3' HD21 ' A' ' 19' ' ' LEU . 3.3 t70 -71.37 -34.97 70.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 60.43 110.875 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.962 HD22 HD12 ' A' ' 5' ' ' ILE . 0.6 OUTLIER -78.72 -48.03 15.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 63.420000000000002 110.902 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.557 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -62.15 -54.73 36.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 72.430000000000007 110.902 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -56.36 -22.51 31.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 75.510000000000005 110.929 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.679 ' CE1' HG21 ' A' ' 18' ' ' THR . 56.3 t80 -77.31 -55.45 5.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 72.129999999999995 110.849 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.829 HD13 HG21 ' A' ' 7' ' ' VAL . 2.0 pp -67.68 -43.5 80.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 73.109999999999999 110.912 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.569 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.49 -27.17 35.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 74.310000000000002 110.882 179.849 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.69 -23.85 42.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 63.149999999999999 111.152 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.4 mt -76.36 -59.71 2.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.198 -0.456 . . . . 74.099999999999994 110.909 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.5 t -135.21 -28.03 1.18 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.461 . . . . 61.240000000000002 111.136 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.569 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.67 -177.51 4.51 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.757 -0.735 . . . . 55.32 112.503 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.882 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.3 p -112.83 138.71 41.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.883 0.373 . . . . 65.049999999999997 111.11 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.987 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.86 150.63 18.18 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.633 0.73 . . . . 55.219999999999999 110.852 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -21.76 32.83 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.671 2.247 . . . . 63.240000000000002 112.35 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -54.13 -38.93 66.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 74.450000000000003 110.902 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.422 ' H ' HD23 ' A' ' 39' ' ' LEU . 6.6 mpt_? -104.29 -40.4 6.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.505 . . . . 70.319999999999993 110.836 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.882 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.9 pp0? -97.21 158.09 15.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 64.099999999999994 110.876 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.09 141.97 51.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 75.0 110.854 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.406 HD22 ' N ' ' A' ' 45' ' ' LEU . 3.7 mm? -67.05 134.01 51.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 65.409999999999997 110.894 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.745 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.1 mm? -74.88 -68.03 0.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 64.129999999999995 110.926 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.39 60.03 0.69 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.707 -0.758 . . . . 24.100000000000001 112.465 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.598 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 4.6 pp -56.93 -19.81 19.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.86 0.362 . . . . 73.540000000000006 110.936 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.65 144.08 41.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 73.420000000000002 110.913 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.79 HG21 HD21 ' A' ' 66' ' ' LEU . 11.0 p -143.79 146.1 21.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 73.540000000000006 111.146 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.3 mttt 54.78 31.55 15.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 75.519999999999996 110.875 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.56 -10.87 54.33 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.71 -0.757 . . . . 34.219999999999999 112.502 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.2 mmtm -81.36 150.82 68.21 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.593 0.711 . . . . 72.129999999999995 110.869 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 55' ' ' ALA . 53.1 Cg_endo -69.81 -31.98 19.24 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.658 2.239 . . . . 73.450000000000003 112.359 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.638 ' HA ' HG21 ' A' ' 59' ' ' VAL . . . 35.93 44.63 0.25 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 44.119999999999997 111.072 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.32 -76.69 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 70.239999999999995 110.92 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -158.61 -37.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 73.329999999999998 110.887 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.85 -8.66 30.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 60.200000000000003 110.828 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.638 HG21 ' HA ' ' A' ' 55' ' ' ALA . 19.4 t -79.31 147.49 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 73.329999999999998 111.149 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.42 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 10.8 mttt -94.78 150.33 20.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 71.319999999999993 110.895 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.623 ' HA ' HD12 ' A' ' 64' ' ' LEU . 25.3 mt -51.42 -42.05 61.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 75.239999999999995 110.938 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.12 -13.34 83.33 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.768 -0.729 . . . . 71.430000000000007 112.443 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.04 -34.31 22.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.779 0.323 . . . . 54.219999999999999 111.066 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.978 HD11 HG22 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -67.84 -24.35 65.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 61.43 110.922 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp 59.88 33.08 21.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 72.439999999999998 110.859 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.79 HD21 HG21 ' A' ' 50' ' ' VAL . 5.0 mt -87.72 153.87 21.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.283 -0.417 . . . . 72.5 110.91 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.46 160.41 76.32 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.552 0.692 . . . . 73.239999999999995 110.906 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -35.3 12.81 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.641 2.227 . . . . 53.340000000000003 112.37 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.615 ' HA ' HD12 ' A' ' 6' ' ' ILE . 7.6 p30 -79.15 -16.38 56.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.431 . . . . 73.019999999999996 110.886 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.527 HG21 HD13 ' A' ' 66' ' ' LEU . 54.9 m -32.08 128.16 0.22 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 63.210000000000001 111.163 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.93 147.95 23.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 64.420000000000002 110.908 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.6 mm -118.83 127.32 75.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 63.439999999999998 111.153 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 62.9 mtp -100.41 141.79 32.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 61.020000000000003 110.837 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 73.7 mtm -134.71 117.51 16.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 71.129999999999995 110.87 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.745 ' CG ' HD21 ' A' ' 46' ' ' LEU . 2.2 mmt -105.52 124.56 49.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 72.400000000000006 110.866 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.57 -154.69 25.74 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.726 -0.749 . . . . 62.109999999999999 112.456 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.5 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.332 . . . . 71.439999999999998 111.155 -179.837 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mtt . . . . . 0 C--O 1.23 0.042 0 CA-C-O 120.793 0.33 . . . . 71.329999999999998 110.865 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.737 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . -79.83 151.43 30.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 73.349999999999994 111.135 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.5 mt -110.87 109.43 57.5 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.618 0.723 . . . . 73.140000000000001 110.907 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 156.48 63.23 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.693 2.262 . . . . 43.219999999999999 112.357 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 28' ' ' LEU . 42.9 mt -150.51 137.45 13.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 73.510000000000005 111.155 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.718 HD12 ' HA ' ' A' ' 69' ' ' ASN . 4.1 mt -94.91 140.52 16.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 63.439999999999998 111.152 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.83 HG21 HD13 ' A' ' 32' ' ' LEU . 8.3 p -126.9 123.14 62.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 61.520000000000003 111.089 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.12 119.78 40.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 65.519999999999996 110.881 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 16.8 t-105 -121.09 100.92 7.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.258 -0.428 . . . . 75.219999999999999 110.912 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.89 -83.53 0.85 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.778 -0.725 . . . . 34.020000000000003 112.515 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.68 20.45 1.02 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.693 -0.765 . . . . 70.099999999999994 112.459 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -128.43 174.83 9.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.756 0.312 . . . . 72.549999999999997 110.896 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -133.07 140.19 47.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 64.239999999999995 110.865 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -135.84 118.59 16.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 75.420000000000002 110.886 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.6 p -82.36 133.93 35.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 75.010000000000005 110.84 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.54 HG21 HD23 ' A' ' 32' ' ' LEU . 69.6 t -96.21 131.33 43.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.49 . . . . 72.439999999999998 111.137 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.2 p -141.31 93.54 2.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 52.030000000000001 111.11 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.602 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.7 OUTLIER 173.47 -28.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.462 . . . . 61.43 111.128 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.737 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.9 mm? -85.6 150.52 24.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 74.030000000000001 110.871 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.549 ' C ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.89 168.09 18.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 55.130000000000003 110.867 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.41 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 44.9 mt-10 -59.04 -21.98 59.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 63.420000000000002 110.898 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -68.59 -10.9 58.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 63.310000000000002 110.885 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.458 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.5 m-20 -102.61 -150.47 0.41 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 63.140000000000001 110.869 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.504 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -135.65 168.03 20.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 64.099999999999994 111.148 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.621 HG22 HD11 ' A' ' 64' ' ' LEU . 94.2 t -63.39 -43.15 98.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 73.319999999999993 111.124 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.407 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -61.06 -29.08 69.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.166 -0.47 . . . . 64.319999999999993 110.938 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.561 ' HB3' HD11 ' A' ' 19' ' ' LEU . 2.0 t0 -71.51 -32.67 68.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 74.420000000000002 110.845 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.642 HD23 HD23 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -80.65 -48.82 12.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 72.310000000000002 110.924 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.514 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -62.09 -56.09 22.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 71.239999999999995 110.89 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -57.6 -22.4 44.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 71.219999999999999 110.89 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.602 ' CZ ' HG21 ' A' ' 18' ' ' THR . 40.3 t80 -77.98 -54.89 5.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 73.430000000000007 110.82 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.83 HD13 HG21 ' A' ' 7' ' ' VAL . 2.5 pp -68.05 -42.13 80.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.148 -0.478 . . . . 60.0 110.92 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.568 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.76 -27.65 42.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 75.340000000000003 110.866 179.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.499 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.52 -23.62 42.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 75.150000000000006 111.155 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.432 HD11 ' CE1' ' A' ' 31' ' ' PHE . 13.8 mt -76.63 -59.7 2.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 73.430000000000007 110.914 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.7 t -135.41 -27.66 1.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 72.109999999999999 111.181 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.568 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.95 -177.46 4.8 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 55.299999999999997 112.479 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.878 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.3 p -112.72 138.24 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.856 0.36 . . . . 73.239999999999995 111.106 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.979 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.76 150.94 16.49 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.632 0.729 . . . . 74.430000000000007 110.875 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -21.59 33.39 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.715 2.277 . . . . 72.140000000000001 112.32 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -54.35 -38.79 66.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.429 . . . . 75.129999999999995 110.855 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.441 ' H ' HD23 ' A' ' 39' ' ' LEU . 2.6 mpt_? -104.15 -40.58 6.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 71.329999999999998 110.889 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.878 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.9 pp0? -97.28 157.47 15.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 73.420000000000002 110.932 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.08 142.94 51.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.435 . . . . 74.310000000000002 110.955 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.408 ' N ' HD22 ' A' ' 45' ' ' LEU . 3.7 mm? -67.7 135.9 53.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.246 -0.434 . . . . 61.450000000000003 110.885 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.748 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.0 mm? -78.0 -68.29 0.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 60.240000000000002 110.972 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.4 61.06 0.66 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.705 -0.76 . . . . 62.539999999999999 112.497 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.58 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 4.5 pp -58.96 -18.2 31.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.899 0.381 . . . . 72.430000000000007 110.907 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -112.39 144.16 42.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 64.25 110.926 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.876 HG21 HD11 ' A' ' 66' ' ' LEU . 43.0 t -143.85 145.31 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 75.150000000000006 111.119 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.0 mttt 54.87 32.51 17.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 75.329999999999998 110.858 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.25 -11.3 50.59 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.744 -0.741 . . . . 61.509999999999998 112.509 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -81.7 150.88 67.13 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.602 0.715 . . . . 71.510000000000005 110.856 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 -32.91 17.85 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.706 2.271 . . . . 54.509999999999998 112.351 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 36.78 43.48 0.28 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 74.340000000000003 111.074 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.54 -76.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.438 . . . . 65.519999999999996 110.896 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -159.36 -37.5 0.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 72.209999999999994 110.884 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -66.8 -8.68 30.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 73.400000000000006 110.862 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.575 HG21 ' HA ' ' A' ' 55' ' ' ALA . 16.9 t -79.79 145.69 8.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 73.209999999999994 111.135 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 18.9 mttp -90.27 151.44 21.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 75.040000000000006 110.858 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.549 HD12 ' C ' ' A' ' 20' ' ' SER . 19.3 mt -49.96 -47.44 52.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 75.349999999999994 110.982 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.63 -11.69 85.22 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.732 -0.747 . . . . 63.399999999999999 112.473 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.39 -32.16 42.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.783 0.325 . . . . 61.329999999999998 111.097 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.621 HD11 HG22 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -77.82 -23.55 48.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 65.200000000000003 110.943 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt 63.12 38.03 11.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 62.450000000000003 110.876 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.876 HD11 HG21 ' A' ' 50' ' ' VAL . 4.2 mt -89.66 152.62 21.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 75.420000000000002 110.899 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -68.67 160.57 76.41 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.603 0.716 . . . . 65.030000000000001 110.899 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -35.0 13.26 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.718 2.278 . . . . 74.129999999999995 112.335 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.718 ' HA ' HD12 ' A' ' 6' ' ' ILE . 10.5 p30 -78.8 -15.83 57.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 72.329999999999998 110.864 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.663 HG21 HD13 ' A' ' 66' ' ' LEU . 51.3 m -32.92 121.52 0.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 72.319999999999993 111.132 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -92.85 146.49 23.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 61.229999999999997 110.913 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.8 mm -116.4 127.46 74.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 74.230000000000004 111.087 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 23.2 mtp -99.46 141.68 31.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 63.539999999999999 110.89 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.6 mtt -134.74 118.99 17.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 72.319999999999993 110.937 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.748 ' CG ' HD21 ' A' ' 46' ' ' LEU . 4.1 mmm -107.88 123.82 49.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 74.230000000000004 110.906 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.79 -155.16 26.32 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.751 -0.738 . . . . 73.540000000000006 112.526 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.2 t -134.19 146.38 50.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.783 0.325 . . . . 73.0 111.164 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -63.22 159.97 16.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 74.319999999999993 110.846 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.01 157.56 1.26 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 72.239999999999995 110.876 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -89.93 71.05 7.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 74.150000000000006 110.919 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -165.9 -118.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 63.149999999999999 110.875 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.494 0 O-C-N 124.48 1.112 . . . . 22.43 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.778 0.323 . . . . 75.219999999999999 110.887 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.743 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . -80.6 151.58 28.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 70.140000000000001 111.119 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.404 HD23 ' HD2' ' A' ' 4' ' ' PRO . 2.4 mt -112.04 109.66 54.57 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.593 0.711 . . . . 63.520000000000003 110.89 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.404 ' HD2' HD23 ' A' ' 3' ' ' LEU . 54.1 Cg_endo -69.75 156.6 62.94 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.717 2.278 . . . . 74.030000000000001 112.345 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.547 ' HB ' HD21 ' A' ' 28' ' ' LEU . 28.0 mt -150.45 137.52 13.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 71.129999999999995 111.114 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.653 HD12 ' HA ' ' A' ' 69' ' ' ASN . 4.7 mt -95.14 140.81 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 60.350000000000001 111.162 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.823 HG21 HD13 ' A' ' 32' ' ' LEU . 8.3 p -126.92 123.44 62.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 72.030000000000001 111.12 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.78 120.9 43.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 71.340000000000003 110.931 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 12.9 t-105 -122.04 100.96 7.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.436 . . . . 73.120000000000005 110.884 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.79 -83.76 0.78 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.739 -0.744 . . . . 75.150000000000006 112.498 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.46 20.17 1.04 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.742 -0.742 . . . . 65.200000000000003 112.488 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -128.56 174.24 9.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.784 0.325 . . . . 63.200000000000003 110.875 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -132.81 140.5 48.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 75.340000000000003 110.902 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -136.67 116.14 12.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 74.200000000000003 110.96 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 80.9 p -81.62 135.03 35.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 65.340000000000003 110.854 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.518 HG21 HD23 ' A' ' 32' ' ' LEU . 97.4 t -96.26 140.28 17.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.115 -0.493 . . . . 73.439999999999998 111.077 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.5 p -148.66 93.37 2.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 63.439999999999998 111.137 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.749 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 1.0 OUTLIER 173.68 -28.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.22 -0.445 . . . . 74.150000000000006 111.137 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.743 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.7 mm? -86.61 151.92 23.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 75.219999999999999 110.908 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.416 ' O ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.6 169.47 16.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 61.219999999999999 110.882 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.413 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 36.3 mt-10 -61.78 -22.09 65.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 63.049999999999997 110.854 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -69.87 -10.76 59.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 74.010000000000005 110.852 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.417 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.6 m-20 -100.08 -150.84 0.39 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.452 . . . . 64.120000000000005 110.887 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.41 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -132.61 170.58 14.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 63.109999999999999 111.176 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.938 HG22 HD11 ' A' ' 64' ' ' LEU . 11.7 t -66.58 -43.79 90.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 72.310000000000002 111.135 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.44 -28.66 68.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 72.230000000000004 110.925 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.478 ' HB3' HD11 ' A' ' 19' ' ' LEU . 17.0 t0 -70.07 -35.16 74.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.476 . . . . 64.200000000000003 110.844 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.665 HD12 ' CB ' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -80.72 -47.82 13.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 63.530000000000001 110.911 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.717 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.78 -56.71 16.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 73.200000000000003 110.892 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.0 -22.41 49.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 73.219999999999999 110.924 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.749 ' CZ ' HG21 ' A' ' 18' ' ' THR . 40.0 t80 -77.16 -55.23 5.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 70.329999999999998 110.835 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.823 HD13 HG21 ' A' ' 7' ' ' VAL . 2.4 pp -67.92 -43.14 79.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 72.0 110.942 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.567 ' N ' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -55.02 -27.34 43.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 72.230000000000004 110.876 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.493 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.3 -23.78 43.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 65.230000000000004 111.159 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.424 HD11 ' CE1' ' A' ' 31' ' ' PHE . 12.5 mt -76.46 -59.8 2.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 54.539999999999999 110.931 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.1 t -135.25 -27.63 1.2 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 65.540000000000006 111.135 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.562 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.23 -176.63 4.66 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.699 -0.762 . . . . 54.299999999999997 112.513 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.857 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.1 p -112.29 139.73 35.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.835 0.35 . . . . 62.310000000000002 111.168 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.973 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.8 149.98 20.55 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.602 0.715 . . . . 74.420000000000002 110.927 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -22.02 32.78 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.717 2.278 . . . . 64.219999999999999 112.334 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -54.61 -39.06 67.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.443 . . . . 74.120000000000005 110.899 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.431 ' H ' HD23 ' A' ' 39' ' ' LEU . 4.0 mpt_? -103.7 -40.46 6.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 75.099999999999994 110.87 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.857 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.5 pp0? -97.57 157.2 16.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 74.25 110.921 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.17 141.32 51.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 74.319999999999993 110.908 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.02 135.96 54.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 74.530000000000001 110.973 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.74 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.0 mm? -76.54 -75.22 0.2 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 75.450000000000003 110.916 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.74 60.03 1.48 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.726 -0.75 . . . . 55.310000000000002 112.518 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.649 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 3.8 pp -56.8 -22.56 37.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.9 0.381 . . . . 74.219999999999999 110.949 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.428 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -106.29 142.43 35.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 71.129999999999995 110.932 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.898 HG11 HD21 ' A' ' 66' ' ' LEU . 21.0 t -144.04 144.37 22.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 71.239999999999995 111.07 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.449 ' HG2' HG12 ' A' ' 50' ' ' VAL . 2.1 mmmm 54.3 33.01 17.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 75.340000000000003 110.863 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.9 -15.05 45.28 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.718 -0.753 . . . . 71.230000000000004 112.462 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -81.08 148.78 64.91 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.538 0.685 . . . . 75.319999999999993 110.9 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.428 ' HA ' ' HB3' ' A' ' 49' ' ' LYS . 53.8 Cg_endo -69.71 -35.57 12.53 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.681 2.254 . . . . 64.030000000000001 112.366 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 38.14 40.67 0.34 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 61.340000000000003 111.136 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -67.81 -76.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 63.020000000000003 110.91 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -154.53 -38.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 71.150000000000006 110.889 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -73.14 -1.65 18.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 74.140000000000001 110.867 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -92.85 148.19 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 62.509999999999998 111.168 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.41 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 11.2 mttt -90.75 147.22 23.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 62.549999999999997 110.873 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 20' ' ' SER . 17.5 mt -52.47 -38.72 60.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 54.409999999999997 110.887 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.77 -17.0 80.29 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.771 -0.728 . . . . 62.299999999999997 112.451 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.53 -19.52 33.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.834 0.349 . . . . 72.329999999999998 111.128 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.938 HD11 HG22 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -84.44 -20.46 31.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 71.439999999999998 110.904 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp 53.89 42.01 31.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 74.319999999999993 110.935 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.898 HD21 HG11 ' A' ' 50' ' ' VAL . 3.6 mt -92.79 151.58 19.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.462 . . . . 52.329999999999998 110.939 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -68.4 160.01 78.06 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.564 0.697 . . . . 71.430000000000007 110.933 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -36.88 10.07 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.68 2.253 . . . . 73.310000000000002 112.311 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.653 ' HA ' HD12 ' A' ' 6' ' ' ILE . 26.4 m-80 -78.8 -15.79 57.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 75.450000000000003 110.897 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.75 HG21 HD22 ' A' ' 66' ' ' LEU . 52.0 m -32.43 128.03 0.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 60.399999999999999 111.13 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -97.66 146.51 25.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 73.019999999999996 110.837 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.0 mm -115.34 128.46 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 74.329999999999998 111.167 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 34.4 mtm -100.36 141.76 32.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 74.109999999999999 110.883 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.7 mtt -133.21 129.42 37.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 71.209999999999994 110.884 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.74 ' CG ' HD21 ' A' ' 46' ' ' LEU . 6.1 mmm -118.6 123.95 46.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.254 -0.43 . . . . 52.0 110.9 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 153.11 -155.23 26.01 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 60.049999999999997 112.459 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.0 t -133.32 139.86 47.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.794 0.331 . . . . 52.420000000000002 111.136 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.477 ' HA ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -93.55 147.46 22.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.444 . . . . 73.430000000000007 110.894 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -55.87 174.55 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 75.420000000000002 110.894 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -104.91 86.65 2.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 61.43 110.892 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.748 ' HG ' ' N ' ' A' ' 90' ' ' NH2 . 0.3 OUTLIER -172.55 179.64 2.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 73.420000000000002 110.887 -179.8 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' NH2 . . . . . 0.748 ' N ' ' HG ' ' A' ' 81' ' ' SER . . . . . . . . 0 C--N 1.325 -0.499 0 O-C-N 124.504 1.128 . . . . 64.140000000000001 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.804 0.335 . . . . 65.049999999999997 110.845 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.74 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . -88.57 151.34 22.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 62.420000000000002 111.119 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.407 HD23 ' HD2' ' A' ' 4' ' ' PRO . 2.1 mt -110.86 109.27 57.6 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.625 0.726 . . . . 64.409999999999997 110.916 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.407 ' HD2' HD23 ' A' ' 3' ' ' LEU . 53.5 Cg_endo -69.77 156.84 62.27 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.677 2.251 . . . . 72.200000000000003 112.308 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.44 ' HB ' HD21 ' A' ' 28' ' ' LEU . 42.9 mt -150.57 137.51 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 53.210000000000001 111.149 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.715 HD12 ' HA ' ' A' ' 69' ' ' ASN . 3.6 mt -95.03 140.38 16.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 73.439999999999998 111.112 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.83 HG21 HD13 ' A' ' 32' ' ' LEU . 8.7 p -127.15 122.91 61.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 73.219999999999999 111.133 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.77 122.28 46.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 73.510000000000005 110.893 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 17.5 t-105 -122.56 100.52 6.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.24 -0.436 . . . . 75.439999999999998 110.89 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.55 -78.75 1.71 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.725 -0.75 . . . . 71.150000000000006 112.488 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.11 17.94 0.71 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.727 -0.749 . . . . 74.239999999999995 112.508 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -129.94 138.98 51.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.72 0.295 . . . . 73.019999999999996 110.93 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -102.98 142.25 34.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 63.520000000000003 110.899 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -136.31 119.38 16.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.465 . . . . 74.439999999999998 110.94 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.9 p -83.29 131.96 35.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 52.509999999999998 110.895 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.546 HG21 HD23 ' A' ' 32' ' ' LEU . 66.9 t -93.95 130.94 42.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.485 . . . . 74.519999999999996 111.16 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.0 p -141.27 93.08 2.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 72.450000000000003 111.137 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.575 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.8 OUTLIER 173.23 -28.37 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 72.25 111.14 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.74 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.9 mm? -85.11 150.1 25.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.462 . . . . 33.149999999999999 110.902 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.563 ' C ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.71 167.78 18.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 64.310000000000002 110.887 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.406 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 35.3 mt-10 -58.81 -21.91 57.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 64.120000000000005 110.929 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -68.9 -10.54 57.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.13 -0.487 . . . . 73.329999999999998 110.875 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.473 ' HB2' HD12 ' A' ' 19' ' ' LEU . 2.1 m-20 -102.62 -150.76 0.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 73.329999999999998 110.867 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.489 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -135.82 167.54 20.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 55.25 111.127 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.61 HG21 HD21 ' A' ' 64' ' ' LEU . 82.5 t -63.06 -42.37 96.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 63.539999999999999 111.13 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.424 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -61.78 -28.79 69.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.48 . . . . 73.040000000000006 110.915 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.594 ' HB3' HD11 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -72.01 -32.56 67.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.174 -0.466 . . . . 71.450000000000003 110.871 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.65 HD23 HD23 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -80.59 -48.82 12.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 73.530000000000001 110.939 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.512 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.94 -55.78 26.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 71.329999999999998 110.929 179.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.6 -22.49 45.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 75.239999999999995 110.902 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.575 ' CZ ' HG21 ' A' ' 18' ' ' THR . 54.6 t80 -77.84 -54.88 5.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 75.450000000000003 110.881 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.83 HD13 HG21 ' A' ' 7' ' ' VAL . 2.5 pp -68.07 -41.96 81.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 74.099999999999994 110.927 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.564 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.85 -27.74 44.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 73.420000000000002 110.889 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.34 -23.49 43.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.25 -0.432 . . . . 64.549999999999997 111.168 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.7 mt -76.76 -59.43 2.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 64.299999999999997 110.886 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.6 t -135.47 -28.03 1.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 54.43 111.178 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.59 -177.37 4.35 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.72 -0.752 . . . . 51.219999999999999 112.498 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.848 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.4 p -112.77 137.78 44.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.864 0.364 . . . . 63.340000000000003 111.098 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.975 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -53.71 149.95 14.86 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.631 0.729 . . . . 71.310000000000002 110.915 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -21.89 32.95 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.695 2.264 . . . . 64.209999999999994 112.342 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -54.21 -38.38 65.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 73.129999999999995 110.878 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.42 ' H ' HD23 ' A' ' 39' ' ' LEU . 2.7 mpt_? -104.43 -40.3 6.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 75.209999999999994 110.885 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.848 ' HG2' HG13 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -95.96 157.41 15.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 75.299999999999997 110.877 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.09 140.05 52.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 64.519999999999996 110.91 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.403 ' N ' HD22 ' A' ' 45' ' ' LEU . 3.6 mm? -65.94 135.75 55.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 75.109999999999999 110.917 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.684 HD11 ' CG ' ' A' ' 75' ' ' MET . 6.4 mp -81.36 -63.51 1.38 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 74.340000000000003 110.901 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.91 58.72 0.68 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.703 -0.76 . . . . 65.040000000000006 112.483 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.568 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 4.5 pp -60.46 -17.34 44.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 75.540000000000006 110.899 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.96 144.15 43.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 72.010000000000005 110.885 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.893 HG21 HD21 ' A' ' 66' ' ' LEU . 11.8 p -144.0 144.95 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 70.140000000000001 111.132 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.636 ' HG2' HG22 ' A' ' 50' ' ' VAL . 11.7 mmtt 54.66 32.71 17.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 65.109999999999999 110.912 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.78 -12.17 49.42 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.725 -0.75 . . . . 21.23 112.514 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.6 mmtt -81.61 150.6 66.86 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.574 0.702 . . . . 75.430000000000007 110.896 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.403 ' O ' ' C ' ' A' ' 55' ' ' ALA . 53.6 Cg_endo -69.83 -32.39 18.39 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.648 2.232 . . . . 62.25 112.302 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.579 ' HA ' HG21 ' A' ' 59' ' ' VAL . . . 36.79 43.45 0.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.277 -0.419 . . . . 44.409999999999997 111.087 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.46 -78.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 71.319999999999993 110.85 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -157.0 -38.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 62.310000000000002 110.916 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -64.95 -9.64 22.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 71.319999999999993 110.848 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.579 HG21 ' HA ' ' A' ' 55' ' ' ALA . 16.8 t -79.25 145.6 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 73.310000000000002 111.133 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 25.7 mttp -91.0 151.65 20.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 61.030000000000001 110.92 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.563 HD12 ' C ' ' A' ' 20' ' ' SER . 20.0 mt -49.66 -47.6 49.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 71.439999999999998 110.983 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.68 -11.84 85.05 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.742 -0.742 . . . . 55.340000000000003 112.478 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.22 -32.12 43.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.826 0.346 . . . . 72.019999999999996 111.125 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.61 HD21 HG21 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -77.29 -23.91 51.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 54.240000000000002 110.9 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp 63.67 37.44 10.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 54.109999999999999 110.875 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.893 HD21 HG21 ' A' ' 50' ' ' VAL . 5.2 mt -90.2 152.68 20.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 65.140000000000001 110.941 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.61 160.86 74.75 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.558 0.694 . . . . 73.030000000000001 110.89 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -35.08 13.24 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.629 2.22 . . . . 74.120000000000005 112.319 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.715 ' HA ' HD12 ' A' ' 6' ' ' ILE . 68.7 m-20 -78.49 -15.91 58.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 51.439999999999998 110.938 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.707 HG21 HD13 ' A' ' 66' ' ' LEU . 45.6 m -32.77 122.33 0.36 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.487 . . . . 72.349999999999994 111.125 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -93.83 146.24 24.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 70.239999999999995 110.899 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 36.2 mm -115.99 131.75 67.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 61.140000000000001 111.149 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.531 ' HB3' HD13 ' A' ' 46' ' ' LEU . 46.1 mtm -101.85 142.46 33.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 75.129999999999995 110.892 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.9 mtt -133.83 119.29 19.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 61.119999999999997 110.88 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.684 ' CG ' HD11 ' A' ' 46' ' ' LEU . 2.8 mmm -108.42 121.88 45.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 75.239999999999995 110.912 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 162.85 -156.7 28.53 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.703 -0.76 . . . . 72.140000000000001 112.468 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.7 t -133.58 147.2 51.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.786 0.326 . . . . 61.240000000000002 111.114 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.87 159.35 25.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 74.299999999999997 110.879 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -82.1 179.44 7.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 72.25 110.907 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 63.37 162.59 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.464 . . . . 74.109999999999999 110.915 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.7 166.64 16.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 72.209999999999994 110.864 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.492 0 O-C-N 124.552 1.158 . . . . 72.129999999999995 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mmt . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.801 0.334 . . . . 74.129999999999995 110.89 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.736 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . -94.74 147.09 23.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 41.399999999999999 111.111 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.522 HD23 ' HD2' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -107.79 110.33 62.47 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.597 0.713 . . . . 62.240000000000002 110.921 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.522 ' HD2' HD23 ' A' ' 3' ' ' LEU . 53.2 Cg_endo -69.83 156.89 62.01 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.656 2.237 . . . . 72.140000000000001 112.287 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.549 ' HB ' HD21 ' A' ' 28' ' ' LEU . 40.3 mt -150.3 137.15 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.483 . . . . 70.329999999999998 111.125 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.692 HD12 ' HA ' ' A' ' 69' ' ' ASN . 4.6 mt -95.2 140.65 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 74.019999999999996 111.126 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.801 HG21 HD13 ' A' ' 32' ' ' LEU . 7.3 p -126.82 122.72 61.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 53.340000000000003 111.124 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.97 121.33 44.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 61.200000000000003 110.918 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 16.2 t-105 -121.43 100.78 7.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 75.239999999999995 110.891 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.59 -83.64 0.96 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.702 -0.761 . . . . 71.230000000000004 112.483 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.67 20.68 1.16 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.7 -0.762 . . . . 61.310000000000002 112.434 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.28 174.2 9.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.761 0.315 . . . . 73.510000000000005 110.944 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -132.93 140.46 47.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.268 -0.424 . . . . 74.25 110.929 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.506 ' CD2' HG21 ' A' ' 36' ' ' THR . 38.2 m-85 -135.83 116.32 13.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 74.019999999999996 110.91 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.3 p -82.51 132.17 35.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 74.140000000000001 110.851 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.551 HG21 HD23 ' A' ' 32' ' ' LEU . 96.4 t -94.68 136.93 24.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 74.439999999999998 111.12 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.6 p -146.73 93.83 2.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 74.420000000000002 111.125 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.666 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.7 OUTLIER 172.66 -28.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.219 -0.446 . . . . 75.430000000000007 111.136 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.736 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.8 mm? -87.64 150.53 23.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 65.409999999999997 110.917 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.67 165.56 23.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 65.540000000000006 110.883 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -57.78 -20.75 37.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 71.010000000000005 110.878 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.08 -11.9 61.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.179 -0.464 . . . . 74.439999999999998 110.854 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.431 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.7 m-20 -101.06 -148.84 0.37 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.266 -0.425 . . . . 73.549999999999997 110.831 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.26 167.47 20.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.191 -0.459 . . . . 74.230000000000004 111.166 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.939 HG22 HD11 ' A' ' 64' ' ' LEU . 15.9 t -63.42 -44.05 98.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 61.539999999999999 111.094 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.16 -28.39 67.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.457 . . . . 63.350000000000001 110.971 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.498 ' HB3' HD11 ' A' ' 19' ' ' LEU . 12.5 t0 -70.59 -35.52 73.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 54.32 110.857 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.693 HD12 ' CB ' ' A' ' 19' ' ' LEU . 1.2 tt -80.4 -47.82 13.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 45.140000000000001 110.904 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.747 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.57 -56.69 17.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 73.319999999999993 110.886 179.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -57.99 -22.31 48.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 63.439999999999998 110.915 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.666 ' CZ ' HG21 ' A' ' 18' ' ' THR . 64.8 t80 -77.3 -54.93 5.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 73.510000000000005 110.839 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.801 HD13 HG21 ' A' ' 7' ' ' VAL . 2.3 pp -68.23 -42.83 79.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 63.310000000000002 110.871 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.562 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -55.02 -27.12 41.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 74.099999999999994 110.901 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.503 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.77 -23.58 42.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 75.25 111.189 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.9 mt -76.7 -59.89 2.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 74.439999999999998 110.92 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.506 HG21 ' CD2' ' A' ' 14' ' ' TYR . 3.1 t -135.4 -27.42 1.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 73.099999999999994 111.194 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.562 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.99 -177.95 5.14 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.8 -0.714 . . . . 51.009999999999998 112.466 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.861 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.2 p -112.98 138.7 41.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.899 0.381 . . . . 74.109999999999999 111.098 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.963 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.42 151.1 14.74 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.593 0.711 . . . . 71.299999999999997 110.932 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 54.1 Cg_endo -69.78 -21.49 33.31 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.68 2.253 . . . . 73.420000000000002 112.354 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -54.52 -38.98 67.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 73.129999999999995 110.87 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.438 ' H ' HD23 ' A' ' 39' ' ' LEU . 8.8 mpt_? -103.89 -40.45 6.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 73.109999999999999 110.847 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.861 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.7 pp0? -98.11 158.2 15.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 75.140000000000001 110.877 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.28 141.37 51.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 75.310000000000002 110.902 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.26 135.96 54.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.262 -0.426 . . . . 63.409999999999997 110.905 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.736 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.1 mm? -76.86 -75.8 0.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 73.299999999999997 110.904 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -97.03 60.5 1.13 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.68 -0.772 . . . . 64.120000000000005 112.482 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.645 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 3.7 pp -55.4 -24.43 30.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.843 0.354 . . . . 64.219999999999999 110.923 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.421 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -103.71 143.42 32.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 72.319999999999993 110.892 179.845 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.763 HG21 HD21 ' A' ' 66' ' ' LEU . 14.9 p -144.1 143.38 23.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 73.120000000000005 111.15 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.0 mttt 54.0 34.19 19.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 44.32 110.905 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.22 -14.98 41.84 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.801 -0.714 . . . . 52.240000000000002 112.468 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.8 mmtt -81.67 149.57 64.47 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.537 0.684 . . . . 60.399999999999999 110.93 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.421 ' HA ' ' HB3' ' A' ' 49' ' ' LYS . 53.9 Cg_endo -69.73 -35.97 11.75 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.669 2.246 . . . . 73.319999999999993 112.334 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.645 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 38.97 39.3 0.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 34.119999999999997 111.096 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.89 -75.65 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 64.230000000000004 110.892 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -154.17 -38.57 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 64.040000000000006 110.875 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -72.72 -2.46 20.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 64.0 110.855 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.555 ' O ' HG23 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -93.36 148.19 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 74.230000000000004 111.137 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.408 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 35.1 mttt -91.39 147.56 22.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 64.099999999999994 110.906 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.407 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 10.6 mt -51.88 -41.95 62.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 70.150000000000006 110.916 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.63 -15.59 80.54 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.76 -0.733 . . . . 72.200000000000003 112.462 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.69 -19.94 32.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.839 0.352 . . . . 64.299999999999997 111.108 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.939 HD11 HG22 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -83.47 -20.23 34.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 70.120000000000005 110.939 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt 53.74 43.02 31.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 53.229999999999997 110.816 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.763 HD21 HG21 ' A' ' 50' ' ' VAL . 3.3 mt -95.48 153.33 17.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 70.340000000000003 110.902 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -68.25 159.75 78.87 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.626 0.727 . . . . 73.219999999999999 110.872 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -36.77 10.16 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.663 2.242 . . . . 72.230000000000004 112.329 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.692 ' HA ' HD12 ' A' ' 6' ' ' ILE . 14.8 p30 -78.44 -15.85 58.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 74.5 110.9 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.636 HG21 HD13 ' A' ' 66' ' ' LEU . 53.6 m -32.4 125.13 0.31 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 72.439999999999998 111.156 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.27 145.83 24.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 70.209999999999994 110.919 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.6 mm -115.61 128.36 72.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.27 -0.423 . . . . 71.319999999999993 111.126 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 37.0 mtt -99.71 141.74 32.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.478 . . . . 73.209999999999994 110.876 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.0 mtt -133.76 118.36 17.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 73.140000000000001 110.862 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.736 ' CG ' HD21 ' A' ' 46' ' ' LEU . 3.0 mmt -106.05 123.07 47.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 61.329999999999998 110.887 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.87 -157.16 28.87 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.765 -0.731 . . . . 62.340000000000003 112.526 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.3 t -134.27 148.89 50.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.777 0.322 . . . . 55.539999999999999 111.115 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -67.39 154.84 40.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 73.109999999999999 110.866 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.452 ' HG3' HD11 ' A' ' 39' ' ' LEU . 41.6 mt-10 -74.85 175.57 7.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 73.239999999999995 110.896 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.29 -43.57 98.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 74.329999999999998 110.855 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 55.07 -108.11 0.42 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 71.219999999999999 110.886 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.464 0 O-C-N 124.465 1.103 . . . . 2.1299999999999999 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 mtt . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.825 0.345 . . . . 74.319999999999993 110.871 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.748 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . -85.73 151.54 23.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 72.200000000000003 111.116 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.4 mt -110.99 109.54 57.22 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.653 0.739 . . . . 74.120000000000005 110.9 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 156.62 62.86 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.685 2.256 . . . . 75.219999999999999 112.359 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.443 ' HB ' HD21 ' A' ' 28' ' ' LEU . 37.8 mt -150.57 137.67 13.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.247 -0.433 . . . . 64.409999999999997 111.083 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.694 HD12 ' HA ' ' A' ' 69' ' ' ASN . 3.8 mt -95.24 140.41 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 74.329999999999998 111.116 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.838 HG21 HD13 ' A' ' 32' ' ' LEU . 8.7 p -127.46 123.71 62.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 64.030000000000001 111.138 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.21 118.98 38.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.462 . . . . 73.140000000000001 110.872 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 10.5 t-105 -122.4 102.56 8.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.205 -0.452 . . . . 63.100000000000001 110.906 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.0 -82.84 0.74 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.785 -0.721 . . . . 34.229999999999997 112.504 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.77 19.73 0.78 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.73 -0.748 . . . . 55.439999999999998 112.464 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -129.08 175.55 8.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.753 0.311 . . . . 63.310000000000002 110.941 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -132.92 140.56 47.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 54.340000000000003 110.898 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -135.01 120.26 18.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.152 -0.476 . . . . 75.420000000000002 110.941 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.4 p -83.53 133.3 34.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.499 . . . . 75.450000000000003 110.825 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.541 HG21 ' CD2' ' A' ' 32' ' ' LEU . 73.6 t -95.98 126.83 48.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 74.230000000000004 111.169 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.5 p -137.39 92.77 2.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 54.32 111.117 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.563 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.9 OUTLIER 174.03 -29.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 74.0 111.162 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.748 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.8 mm? -84.92 150.03 25.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 75.129999999999995 110.88 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.558 ' C ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.74 168.18 18.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 72.040000000000006 110.875 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.432 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 78.1 mt-10 -59.06 -22.03 60.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 63.229999999999997 110.852 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.3 -10.94 58.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.193 -0.458 . . . . 72.319999999999993 110.868 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.444 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.9 m-20 -102.79 -150.14 0.41 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 53.439999999999998 110.869 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.564 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -136.03 168.07 20.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 73.129999999999995 111.129 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.613 HG22 HD11 ' A' ' 64' ' ' LEU . 91.1 t -63.29 -42.92 98.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 61.030000000000001 111.126 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.403 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -61.19 -29.47 69.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 74.040000000000006 110.907 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.566 ' HB3' HD11 ' A' ' 19' ' ' LEU . 4.1 t0 -71.06 -32.98 69.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.459 . . . . 62.420000000000002 110.863 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.674 HD23 HD23 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -80.45 -48.95 12.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 74.349999999999994 110.871 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.509 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.99 -56.13 22.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 73.310000000000002 110.911 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -57.47 -23.01 47.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 74.409999999999997 110.913 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.563 ' CZ ' HG21 ' A' ' 18' ' ' THR . 52.5 t80 -77.27 -55.36 5.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 70.150000000000006 110.884 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.838 HD13 HG21 ' A' ' 7' ' ' VAL . 2.5 pp -67.66 -42.4 82.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.494 . . . . 62.420000000000002 110.909 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.572 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.2 tmtt? -54.81 -27.69 43.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 65.340000000000003 110.901 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.518 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.47 -23.34 43.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.24 -0.436 . . . . 73.120000000000005 111.154 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.7 mt -76.85 -59.51 2.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 41.219999999999999 110.9 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.8 t -135.27 -27.24 1.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 73.310000000000002 111.165 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.572 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.72 -176.86 5.31 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.723 -0.751 . . . . 74.319999999999993 112.513 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.873 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.4 p -112.78 137.16 46.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.845 0.355 . . . . 45.530000000000001 111.136 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.947 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -53.48 150.0 13.55 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.561 0.696 . . . . 43.020000000000003 110.946 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -21.8 33.19 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.701 2.267 . . . . 64.120000000000005 112.37 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.16 -38.09 65.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 62.439999999999998 110.868 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.423 ' H ' HD23 ' A' ' 39' ' ' LEU . 3.1 mpt_? -104.95 -40.05 6.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 63.149999999999999 110.881 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.873 ' HG2' HG13 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -96.48 158.31 15.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 63.310000000000002 110.895 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.72 140.37 51.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 73.409999999999997 110.893 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.32 135.25 54.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 74.200000000000003 110.945 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.746 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.0 mm? -75.74 -72.17 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 65.299999999999997 110.972 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.57 61.61 0.86 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.686 -0.769 . . . . 53.240000000000002 112.524 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.583 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 4.5 pp -58.19 -19.22 31.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 72.099999999999994 110.948 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.39 144.24 39.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 70.239999999999995 110.875 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.783 HG21 HD21 ' A' ' 66' ' ' LEU . 10.9 p -143.8 146.21 21.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 74.340000000000003 111.111 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt 54.77 31.92 16.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 72.530000000000001 110.914 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.16 -10.91 51.88 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.74 -0.743 . . . . 63.520000000000003 112.507 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -81.34 151.07 68.75 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.592 0.711 . . . . 73.140000000000001 110.885 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 55' ' ' ALA . 54.1 Cg_endo -69.74 -32.91 17.73 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.683 2.256 . . . . 71.209999999999994 112.347 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.585 ' HA ' HG21 ' A' ' 59' ' ' VAL . . . 35.98 44.35 0.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 74.299999999999997 111.122 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.33 -75.75 0.05 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 75.409999999999997 110.869 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.72 -37.53 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 75.299999999999997 110.909 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -67.14 -8.99 35.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 71.209999999999994 110.884 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.585 HG21 ' HA ' ' A' ' 55' ' ' ALA . 17.7 t -78.61 145.65 9.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 74.319999999999993 111.132 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -89.9 151.14 21.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 74.040000000000006 110.89 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.558 HD12 ' C ' ' A' ' 20' ' ' SER . 19.8 mt -49.83 -47.42 51.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 51.240000000000002 110.909 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.48 -12.02 84.93 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.804 -0.712 . . . . 50.409999999999997 112.461 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.14 -32.15 44.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.817 0.341 . . . . 63.140000000000001 111.061 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.613 HD11 HG22 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -77.81 -23.61 49.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 71.530000000000001 110.887 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp 63.41 37.49 10.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 64.310000000000002 110.95 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.783 HD21 HG21 ' A' ' 50' ' ' VAL . 4.2 mt -89.29 152.32 21.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 65.549999999999997 110.987 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.63 160.61 76.03 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.598 0.713 . . . . 72.310000000000002 110.882 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -34.85 13.7 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.649 2.232 . . . . 64.349999999999994 112.35 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.694 ' HA ' HD12 ' A' ' 6' ' ' ILE . 10.5 m120 -78.8 -15.68 58.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 74.310000000000002 110.883 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.66 HG21 HD13 ' A' ' 66' ' ' LEU . 47.7 m -32.97 120.82 0.36 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 61.009999999999998 111.145 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -92.5 146.43 23.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 63.340000000000003 110.926 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.0 mm -115.8 128.89 72.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 52.539999999999999 111.168 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 44.7 mtm -99.74 141.6 32.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 64.109999999999999 110.883 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.8 mtt -131.74 125.72 32.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 74.409999999999997 110.876 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.746 ' CG ' HD21 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -116.01 120.09 37.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 74.310000000000002 110.889 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 163.05 -156.41 28.16 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.765 -0.731 . . . . 73.510000000000005 112.54 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.3 t -133.96 144.85 49.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.754 0.311 . . . . 51.109999999999999 111.128 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.7 157.51 20.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 75.25 110.943 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.412 ' HB3' HD11 ' A' ' 39' ' ' LEU . 4.4 pt-20 -73.27 177.0 5.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 74.209999999999994 110.895 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.87 99.7 4.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 64.230000000000004 110.854 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.829 ' HG ' ' N ' ' A' ' 90' ' ' NH2 . 1.4 t -177.94 -103.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 72.420000000000002 110.834 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' NH2 . . . . . 0.829 ' N ' ' HG ' ' A' ' 81' ' ' SER . . . . . . . . 0 C--N 1.325 -0.474 0 O-C-N 124.513 1.133 . . . . 44.109999999999999 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.773 0.321 . . . . 73.129999999999995 110.87 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.744 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . -113.5 148.79 35.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 43.219999999999999 111.106 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.413 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 3.4 mt -109.15 109.76 60.63 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.609 0.719 . . . . 72.040000000000006 110.936 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 53.8 Cg_endo -69.79 156.13 64.07 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.698 2.265 . . . . 71.129999999999995 112.343 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.557 ' HB ' HD21 ' A' ' 28' ' ' LEU . 36.2 mt -150.51 136.08 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 62.119999999999997 111.115 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.716 HD12 ' HA ' ' A' ' 69' ' ' ASN . 3.6 mt -94.87 140.68 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 60.43 111.131 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.848 HG21 HD13 ' A' ' 32' ' ' LEU . 7.7 p -127.33 123.21 61.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 74.0 111.136 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.43 123.21 48.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.485 . . . . 52.329999999999998 110.899 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.2 t-105 -124.48 102.88 7.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.441 . . . . 72.239999999999995 110.91 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.55 -80.09 1.52 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.745 -0.74 . . . . 61.219999999999999 112.493 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.23 17.51 0.69 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.786 -0.721 . . . . 64.409999999999997 112.497 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 36.6 mm-40 -130.06 139.19 51.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.751 0.31 . . . . 64.530000000000001 110.949 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -103.1 142.06 34.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 72.510000000000005 110.903 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.634 ' CD1' HG21 ' A' ' 36' ' ' THR . 76.4 m-85 -136.28 116.54 13.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 61.200000000000003 110.947 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.4 p -82.45 131.2 35.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 61.439999999999998 110.88 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.562 HG21 HD23 ' A' ' 32' ' ' LEU . 85.9 t -92.29 138.81 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 72.329999999999998 111.136 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 p -148.76 92.42 1.99 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 74.450000000000003 111.155 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.655 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.9 OUTLIER 173.63 -28.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 63.25 111.158 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.744 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.8 mm? -85.78 151.21 24.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 65.239999999999995 110.936 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.18 168.54 17.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 74.400000000000006 110.863 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.414 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 36.2 mt-10 -60.61 -22.09 63.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 62.329999999999998 110.901 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.63 -11.23 60.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.157 -0.474 . . . . 73.400000000000006 110.81 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.415 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.5 m-20 -99.82 -151.15 0.39 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 61.100000000000001 110.838 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.64 168.86 17.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 61.409999999999997 111.114 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.961 HG22 HD11 ' A' ' 64' ' ' LEU . 12.4 t -65.62 -41.32 90.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 74.530000000000001 111.143 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.44 -28.63 69.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.141 -0.482 . . . . 72.010000000000005 110.92 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.519 ' HB3' HD11 ' A' ' 19' ' ' LEU . 19.6 t0 -70.73 -34.92 72.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 64.200000000000003 110.859 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.68 HD12 ' CB ' ' A' ' 19' ' ' LEU . 1.2 tt -80.76 -47.91 13.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 74.129999999999995 110.914 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.751 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.64 -56.57 18.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 73.129999999999995 110.911 179.812 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.15 -22.45 51.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 73.140000000000001 110.943 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.655 ' CZ ' HG21 ' A' ' 18' ' ' THR . 55.2 t80 -77.29 -55.17 5.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 74.209999999999994 110.879 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.848 HD13 HG21 ' A' ' 7' ' ' VAL . 2.3 pp -67.49 -43.45 80.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.141 -0.482 . . . . 64.25 110.902 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.579 ' N ' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -54.84 -27.03 39.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 71.109999999999999 110.924 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.46 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.78 -23.74 41.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 74.340000000000003 111.146 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.9 mt -76.46 -59.75 2.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.439 . . . . 74.400000000000006 110.859 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.634 HG21 ' CD1' ' A' ' 14' ' ' TYR . 3.5 t -135.31 -28.07 1.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 74.230000000000004 111.163 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.8 -177.58 4.7 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.717 -0.754 . . . . 63.200000000000003 112.52 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.898 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.2 p -112.56 139.22 38.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.861 0.362 . . . . 51.240000000000002 111.082 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.978 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.52 150.67 16.55 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.622 0.725 . . . . 74.150000000000006 110.88 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 53.5 Cg_endo -69.73 -21.95 32.9 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.653 2.235 . . . . 71.209999999999994 112.353 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -54.29 -38.98 66.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 63.549999999999997 110.876 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.421 ' H ' HD23 ' A' ' 39' ' ' LEU . 5.5 mtt85 -103.97 -40.27 6.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 62.520000000000003 110.889 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.898 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.7 pp0? -98.2 158.7 15.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 74.200000000000003 110.916 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.67 141.06 51.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 73.25 110.89 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.64 135.04 53.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 74.239999999999995 110.93 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.737 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.1 mm? -75.81 -75.57 0.18 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 74.030000000000001 110.906 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -96.15 60.34 1.36 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.725 -0.75 . . . . 72.319999999999993 112.459 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.635 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 3.8 pp -56.06 -23.85 36.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.905 0.383 . . . . 72.349999999999994 110.947 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.407 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -104.43 143.4 33.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 61.530000000000001 110.888 179.836 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.757 HG21 HD21 ' A' ' 66' ' ' LEU . 13.0 p -144.11 143.64 23.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 51.329999999999998 111.091 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.719 ' HG2' HG22 ' A' ' 50' ' ' VAL . 0.2 OUTLIER 54.07 33.82 18.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 72.109999999999999 110.854 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.48 -15.04 42.96 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.714 -0.755 . . . . 51.329999999999998 112.452 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.6 mmtm -81.61 149.63 64.82 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.636 0.732 . . . . 54.409999999999997 110.858 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.407 ' HA ' ' HB3' ' A' ' 49' ' ' LYS . 53.8 Cg_endo -69.73 -35.98 11.71 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.663 2.242 . . . . 71.420000000000002 112.354 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 38.92 39.31 0.35 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 41.399999999999999 111.115 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.7 -75.47 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 75.219999999999999 110.878 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -154.61 -39.51 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 64.349999999999994 110.857 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -72.16 -4.11 27.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 54.409999999999997 110.875 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.615 ' O ' HG23 ' A' ' 25' ' ' VAL . 1.4 t -90.04 147.48 5.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 73.099999999999994 111.099 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.485 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 13.4 mttp -90.35 147.13 23.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 74.030000000000001 110.933 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.414 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 16.1 mt -51.95 -38.1 55.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 71.340000000000003 110.882 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.69 -18.43 79.7 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.753 -0.736 . . . . 41.229999999999997 112.455 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.61 -14.89 47.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.857 0.36 . . . . 63.140000000000001 111.142 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.961 HD11 HG22 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -87.17 -18.02 31.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 64.299999999999997 110.944 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.16 45.65 23.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 64.109999999999999 110.914 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.757 HD21 HG21 ' A' ' 50' ' ' VAL . 3.5 mt -99.02 153.27 18.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 71.519999999999996 110.897 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.27 159.81 78.62 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.549 0.69 . . . . 63.329999999999998 110.932 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -36.71 10.32 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.707 2.271 . . . . 52.219999999999999 112.37 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.716 ' HA ' HD12 ' A' ' 6' ' ' ILE . 1.7 m-80 -78.59 -15.81 58.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 62.020000000000003 110.872 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.655 HG21 HD13 ' A' ' 66' ' ' LEU . 51.8 m -32.63 123.65 0.35 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.475 . . . . 51.200000000000003 111.163 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.68 146.26 23.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 72.040000000000006 110.856 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.7 mm -115.45 131.83 66.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 63.520000000000003 111.115 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 26.5 mtm -104.14 142.04 35.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 62.240000000000002 110.866 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 75.0 mtm -134.44 118.6 17.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 65.319999999999993 110.91 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.737 ' CG ' HD21 ' A' ' 46' ' ' LEU . 2.1 mmt -106.2 126.1 51.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 73.319999999999993 110.858 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' A' ' 43' ' ' GLN . . . 157.87 -154.65 25.72 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.754 -0.736 . . . . 63.329999999999998 112.49 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 t -134.99 150.4 50.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.795 0.331 . . . . 63.030000000000001 111.164 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.17 153.45 43.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 63.399999999999999 110.842 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -63.06 179.28 0.4 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 75.510000000000005 110.865 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -144.17 77.08 1.53 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 75.310000000000002 110.904 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 1.075 ' HG ' ' N ' ' A' ' 90' ' ' NH2 . 0.7 OUTLIER -172.35 -125.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 73.340000000000003 110.865 -179.797 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' NH2 . . . . . 1.075 ' N ' ' HG ' ' A' ' 81' ' ' SER . . . . . . . . 0 C--N 1.324 -0.511 0 O-C-N 124.512 1.133 . . . . 35.439999999999998 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.77 0.319 . . . . 71.230000000000004 110.876 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.746 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . -82.26 151.3 26.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.426 . . . . 63.210000000000001 111.132 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.412 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 4.1 mt -111.71 109.61 55.4 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.681 0.753 . . . . 74.510000000000005 110.888 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 53.7 Cg_endo -69.75 156.34 63.61 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.652 2.234 . . . . 65.140000000000001 112.331 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.538 ' HB ' HD21 ' A' ' 28' ' ' LEU . 30.2 mt -150.34 136.81 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 62.32 111.129 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.711 HD12 ' HA ' ' A' ' 69' ' ' ASN . 3.6 mt -95.2 140.73 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 54.350000000000001 111.186 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.853 HG21 HD13 ' A' ' 32' ' ' LEU . 8.6 p -127.1 123.48 62.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 64.349999999999994 111.121 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.81 125.72 51.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 72.150000000000006 110.876 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.6 t-105 -125.01 100.74 6.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 73.120000000000005 110.911 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.22 -79.22 1.71 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.732 -0.747 . . . . 43.5 112.442 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.16 17.46 0.8 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.729 -0.748 . . . . 52.340000000000003 112.512 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -129.35 138.59 51.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.742 0.306 . . . . 70.019999999999996 110.909 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -102.94 142.28 34.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 73.209999999999994 110.94 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.58 ' CG ' HG21 ' A' ' 36' ' ' THR . 79.7 m-85 -136.69 116.15 12.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 75.219999999999999 110.867 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.86 133.87 35.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.086 -0.506 . . . . 53.229999999999997 110.858 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.529 HG21 HD23 ' A' ' 32' ' ' LEU . 89.7 t -95.71 139.55 18.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.08 -0.509 . . . . 74.409999999999997 111.091 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.3 p -149.02 92.91 2.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 71.510000000000005 111.151 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.712 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.8 OUTLIER 173.67 -28.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 44.340000000000003 111.175 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.746 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.7 mm? -85.7 151.53 23.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.447 . . . . 64.549999999999997 110.919 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.423 ' O ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.39 168.96 16.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 74.0 110.843 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.417 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 22.5 mt-10 -61.09 -22.37 64.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 71.200000000000003 110.892 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.37 -11.33 60.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 75.0 110.856 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.402 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.6 m-20 -99.94 -151.0 0.39 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 74.209999999999994 110.852 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -133.27 171.57 13.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 62.140000000000001 111.148 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.954 HG22 HD11 ' A' ' 64' ' ' LEU . 11.2 t -67.23 -42.02 87.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 63.119999999999997 111.153 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.57 -28.96 69.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.481 . . . . 74.340000000000003 110.876 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.496 ' HB3' HD11 ' A' ' 19' ' ' LEU . 10.1 t0 -70.46 -35.05 73.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.434 . . . . 70.129999999999995 110.893 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.661 HD23 HD23 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -80.67 -48.06 13.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 72.329999999999998 110.962 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.775 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.45 -56.51 19.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 61.439999999999998 110.885 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.2 -22.29 51.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 45.310000000000002 110.892 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.712 ' CZ ' HG21 ' A' ' 18' ' ' THR . 50.8 t80 -77.46 -55.14 5.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 63.210000000000001 110.858 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.853 HD13 HG21 ' A' ' 7' ' ' VAL . 2.4 pp -67.67 -43.07 81.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.176 -0.465 . . . . 64.219999999999999 110.897 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.564 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.98 -26.91 39.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 45.549999999999997 110.883 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.478 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -80.02 -23.85 41.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 72.310000000000002 111.12 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.405 HD11 ' CE2' ' A' ' 31' ' ' PHE . 13.1 mt -76.45 -59.85 2.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.456 . . . . 70.420000000000002 110.9 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.58 HG21 ' CG ' ' A' ' 14' ' ' TYR . 4.2 t -135.39 -28.09 1.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 71.109999999999999 111.131 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.52 -177.86 4.53 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.699 -0.762 . . . . 64.109999999999999 112.502 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.859 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.0 OUTLIER -113.18 139.57 37.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.898 0.38 . . . . 64.519999999999996 111.149 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 1.001 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.39 151.3 14.19 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.617 0.722 . . . . 71.040000000000006 110.898 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 53.9 Cg_endo -69.74 -21.42 33.63 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.664 2.243 . . . . 72.430000000000007 112.383 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -54.83 -38.88 67.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 74.420000000000002 110.821 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.426 ' H ' HD23 ' A' ' 39' ' ' LEU . 1.8 mtt-85 -103.73 -40.47 6.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 64.150000000000006 110.865 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.859 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.7 pp0? -98.29 157.32 16.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 73.129999999999995 110.888 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.31 141.11 51.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 64.040000000000006 110.907 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.406 ' N ' HD22 ' A' ' 45' ' ' LEU . 3.7 mm? -67.31 135.91 54.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 62.43 110.966 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.796 HD11 ' HG2' ' A' ' 75' ' ' MET . 7.0 mp -78.15 -75.09 0.23 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 73.129999999999995 110.927 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.13 58.78 1.7 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.724 -0.75 . . . . 75.120000000000005 112.446 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.649 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 3.7 pp -55.15 -24.48 26.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.86 0.362 . . . . 73.040000000000006 110.905 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.411 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -103.89 143.39 32.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 72.439999999999998 110.944 179.807 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.787 HG21 HD21 ' A' ' 66' ' ' LEU . 14.7 p -144.25 143.49 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 74.140000000000001 111.142 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.6 mttp 54.01 34.04 18.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 72.209999999999994 110.934 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.38 -15.11 42.08 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.739 -0.743 . . . . 70.129999999999995 112.499 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -81.64 149.47 64.39 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.586 0.708 . . . . 62.109999999999999 110.912 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.411 ' HA ' ' HB3' ' A' ' 49' ' ' LYS . 54.4 Cg_endo -69.72 -35.86 11.99 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.705 2.27 . . . . 61.509999999999998 112.335 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 38.98 39.51 0.37 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 61.420000000000002 111.146 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.31 -74.0 0.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 72.439999999999998 110.89 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.416 HD22 ' N ' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -157.45 -36.31 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 74.340000000000003 110.889 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.416 ' N ' HD22 ' A' ' 57' ' ' ASN . 4.0 m-20 -75.3 -1.6 24.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 72.409999999999997 110.913 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -93.55 147.65 5.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.166 -0.47 . . . . 72.219999999999999 111.104 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.407 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 12.9 mttt -89.99 147.2 23.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 70.329999999999998 110.85 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.423 HD12 ' O ' ' A' ' 20' ' ' SER . 17.3 mt -52.71 -38.3 60.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 72.319999999999993 110.895 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.61 -17.21 80.21 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.712 -0.756 . . . . 75.549999999999997 112.501 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.39 -20.08 32.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.826 0.346 . . . . 73.439999999999998 111.097 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.954 HD11 HG22 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -83.96 -20.02 33.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.435 . . . . 75.340000000000003 110.923 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.3 mmtp 52.09 43.91 30.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 74.109999999999999 110.904 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.787 HD21 HG21 ' A' ' 50' ' ' VAL . 3.4 mt -95.03 153.12 17.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 70.150000000000006 110.898 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.57 159.77 79.87 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.588 0.709 . . . . 71.230000000000004 110.876 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 -36.8 10.24 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.699 2.266 . . . . 60.399999999999999 112.354 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.711 ' HA ' HD12 ' A' ' 6' ' ' ILE . 2.4 m120 -78.45 -15.78 58.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 72.230000000000004 110.872 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.652 HG21 HD13 ' A' ' 66' ' ' LEU . 51.9 m -32.53 125.01 0.33 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 73.219999999999999 111.123 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.93 146.78 24.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 70.319999999999993 110.892 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.6 mm -115.17 129.96 70.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 74.019999999999996 111.164 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.487 ' CB ' HD13 ' A' ' 46' ' ' LEU . 41.2 mtm -101.01 142.87 31.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.478 . . . . 74.230000000000004 110.859 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.1 mtt -135.97 116.88 14.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 75.310000000000002 110.912 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.796 ' HG2' HD11 ' A' ' 46' ' ' LEU . 8.7 mmm -105.29 131.39 52.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 55.130000000000003 110.894 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 148.64 -151.9 24.02 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.71 -0.757 . . . . 73.230000000000004 112.51 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 t -133.06 134.59 44.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.753 0.311 . . . . 70.150000000000006 111.167 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.507 ' HA ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -89.14 151.72 22.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 74.329999999999998 110.893 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.529 ' HG3' HD11 ' A' ' 39' ' ' LEU . 36.1 mt-10 -81.02 88.41 5.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 74.430000000000007 110.914 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -72.62 137.21 45.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 74.319999999999993 110.854 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 57.09 -142.08 0.76 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 75.129999999999995 110.832 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.511 0 O-C-N 124.56 1.163 . . . . 64.510000000000005 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 mtt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.785 0.326 . . . . 71.409999999999997 110.872 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.745 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . -81.38 151.34 27.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 63.439999999999998 111.1 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.421 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 2.6 mt -111.38 109.37 56.35 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.595 0.712 . . . . 41.420000000000002 110.934 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 53.7 Cg_endo -69.8 156.41 63.33 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.651 2.234 . . . . 72.019999999999996 112.35 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.544 ' HB ' HD21 ' A' ' 28' ' ' LEU . 31.3 mt -150.58 137.02 12.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 73.010000000000005 111.135 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.648 HD12 ' HA ' ' A' ' 69' ' ' ASN . 5.1 mt -94.96 140.57 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 72.540000000000006 111.134 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.855 HG21 HD13 ' A' ' 32' ' ' LEU . 7.5 p -127.1 122.86 61.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 73.420000000000002 111.091 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.66 119.82 40.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 73.340000000000003 110.89 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 16.6 t-105 -120.85 100.62 7.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.454 . . . . 61.43 110.944 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.87 -83.39 0.92 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.797 -0.716 . . . . 63.420000000000002 112.489 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.57 21.57 1.05 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.772 -0.728 . . . . 61.229999999999997 112.501 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -129.28 175.29 8.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.775 0.322 . . . . 73.129999999999995 110.904 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -133.19 140.96 47.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 74.519999999999996 110.916 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.466 ' CD2' HG21 ' A' ' 36' ' ' THR . 41.3 m-85 -136.51 119.14 16.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.173 -0.467 . . . . 74.530000000000001 110.973 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.2 p -84.13 132.35 34.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 62.219999999999999 110.849 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.553 HG21 HD23 ' A' ' 32' ' ' LEU . 95.9 t -94.98 125.98 47.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.069 -0.514 . . . . 45.140000000000001 111.138 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.2 p -136.49 93.12 2.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 52.409999999999997 111.174 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.712 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.8 OUTLIER 173.51 -28.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 70.219999999999999 111.113 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.745 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.8 mm? -86.12 151.2 23.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.271 -0.422 . . . . 70.519999999999996 110.878 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.438 ' O ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.32 169.33 16.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 70.5 110.815 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.412 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 43.1 mt-10 -61.7 -22.18 65.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.106 -0.497 . . . . 72.099999999999994 110.922 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -70.16 -10.69 59.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 74.230000000000004 110.871 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.403 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.5 m-20 -99.2 -150.44 0.37 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 75.019999999999996 110.842 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.32 168.53 18.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 71.420000000000002 111.144 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.975 HG22 HD11 ' A' ' 64' ' ' LEU . 13.0 t -64.67 -42.85 96.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 64.200000000000003 111.137 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.14 -28.47 69.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 73.019999999999996 110.9 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.49 ' HB3' HD11 ' A' ' 19' ' ' LEU . 19.9 t0 -70.81 -35.09 72.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 73.120000000000005 110.868 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.667 HD12 ' CB ' ' A' ' 19' ' ' LEU . 0.9 OUTLIER -80.64 -47.73 13.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 75.150000000000006 110.906 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.755 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.97 -56.8 15.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 73.200000000000003 110.867 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -58.19 -22.1 50.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 74.420000000000002 110.906 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.712 ' CZ ' HG21 ' A' ' 18' ' ' THR . 54.0 t80 -77.48 -54.9 5.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 74.430000000000007 110.865 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.855 HD13 HG21 ' A' ' 7' ' ' VAL . 2.4 pp -68.28 -43.0 78.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 71.230000000000004 110.898 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.569 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -55.08 -26.91 41.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.441 . . . . 74.120000000000005 110.909 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.82 -23.77 41.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.452 . . . . 62.219999999999999 111.141 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.7 mt -76.67 -60.26 2.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.234 -0.439 . . . . 72.400000000000006 110.87 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.466 HG21 ' CD2' ' A' ' 14' ' ' TYR . 2.8 t -135.41 -27.48 1.19 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 61.43 111.181 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.569 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.45 -178.4 4.74 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.759 -0.734 . . . . 70.420000000000002 112.521 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.875 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.2 p -112.91 139.06 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.889 0.376 . . . . 71.530000000000001 111.095 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.991 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.53 150.8 16.08 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.66 0.743 . . . . 75.420000000000002 110.92 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 53.9 Cg_endo -69.68 -21.64 33.57 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.69 2.26 . . . . 53.0 112.358 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -54.41 -38.89 66.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 53.25 110.874 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.432 ' H ' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -104.04 -40.52 6.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 63.100000000000001 110.865 -179.902 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.875 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.7 pp0? -97.87 158.27 15.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 73.439999999999998 110.929 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.36 141.73 51.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 73.510000000000005 110.898 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.36 136.04 54.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.266 -0.425 . . . . 40.420000000000002 110.868 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.723 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.1 mm? -76.74 -75.91 0.18 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 62.399999999999999 110.898 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.26 56.83 1.74 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.735 -0.745 . . . . 52.350000000000001 112.473 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.646 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 4.0 pp -50.56 -32.31 18.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.877 0.37 . . . . 63.520000000000003 110.933 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.527 ' N ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -95.59 146.19 24.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 72.25 110.927 179.802 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.705 HG21 ' CD2' ' A' ' 66' ' ' LEU . 8.5 p -142.37 138.01 29.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 74.409999999999997 111.126 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt 54.53 32.2 16.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 73.25 110.893 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.42 -15.57 56.17 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.753 -0.737 . . . . 42.43 112.485 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -80.17 149.79 70.16 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.546 0.688 . . . . 72.439999999999998 110.901 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -36.27 11.04 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.729 2.286 . . . . 70.430000000000007 112.316 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 39.54 37.05 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 71.239999999999995 111.101 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.44 -76.83 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 74.450000000000003 110.9 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -153.87 -38.96 0.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 71.129999999999995 110.866 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -71.89 -2.61 18.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 73.400000000000006 110.882 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.58 ' O ' HG23 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -92.93 147.7 5.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 71.549999999999997 111.15 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.415 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 15.4 mttp -91.27 147.84 22.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 74.409999999999997 110.916 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.438 HD12 ' O ' ' A' ' 20' ' ' SER . 17.6 mt -52.61 -38.45 60.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.248 -0.433 . . . . 51.509999999999998 110.907 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.7 -17.29 80.17 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.743 -0.741 . . . . 61.140000000000001 112.496 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.28 -19.97 32.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.854 0.359 . . . . 75.239999999999995 111.1 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.975 HD11 HG22 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -84.17 -19.27 34.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 55.32 110.944 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt 51.91 43.65 30.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 71.439999999999998 110.876 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.705 ' CD2' HG21 ' A' ' 50' ' ' VAL . 3.5 mt -94.26 152.3 18.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 71.25 110.956 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -68.45 159.79 79.38 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.595 0.712 . . . . 74.120000000000005 110.882 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -37.65 8.88 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.703 2.269 . . . . 74.530000000000001 112.333 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.648 ' HA ' HD12 ' A' ' 6' ' ' ILE . 14.8 m-20 -78.56 -15.45 58.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 74.409999999999997 110.897 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.611 HG21 HD13 ' A' ' 66' ' ' LEU . 56.3 m -33.01 126.86 0.32 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.472 . . . . 73.099999999999994 111.172 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.78 145.77 25.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 74.209999999999994 110.915 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.3 mm -115.5 128.17 72.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 73.219999999999999 111.114 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 9.2 mtp -99.76 141.65 32.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 53.439999999999998 110.923 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.0 mtt -133.77 117.32 16.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 72.049999999999997 110.862 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.723 ' CG ' HD21 ' A' ' 46' ' ' LEU . 2.7 mmt -105.25 123.28 47.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 71.439999999999998 110.849 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 160.3 -157.22 28.56 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.699 -0.762 . . . . 74.209999999999994 112.519 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 t -134.21 149.3 50.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.783 0.325 . . . . 65.219999999999999 111.135 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -66.4 153.34 43.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 75.5 110.827 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -69.53 -174.29 0.68 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 73.150000000000006 110.876 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -60.38 -32.15 71.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 71.319999999999993 110.868 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 58.57 -173.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 54.130000000000003 110.896 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.513 0 O-C-N 124.537 1.148 . . . . 31.43 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.758 0.313 . . . . 73.0 110.907 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.731 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . -79.19 146.56 33.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 73.340000000000003 111.107 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.545 HD23 ' HD2' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -106.95 110.46 63.61 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.603 0.716 . . . . 73.519999999999996 110.928 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.545 ' HD2' HD23 ' A' ' 3' ' ' LEU . 53.7 Cg_endo -69.79 156.32 63.58 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.692 2.262 . . . . 63.119999999999997 112.337 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.474 ' HB ' HD21 ' A' ' 28' ' ' LEU . 52.6 mt -150.81 136.86 12.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 74.129999999999995 111.116 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.712 HD12 ' HA ' ' A' ' 69' ' ' ASN . 3.5 mt -95.28 140.65 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 64.329999999999998 111.159 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.831 HG21 HD13 ' A' ' 32' ' ' LEU . 8.4 p -127.15 123.29 61.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 75.319999999999993 111.121 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.11 122.11 46.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 72.140000000000001 110.935 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.1 t-105 -123.18 102.89 8.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 75.299999999999997 110.899 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.76 -79.68 1.63 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.72 -0.752 . . . . 74.420000000000002 112.445 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.34 17.89 0.69 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.773 -0.727 . . . . 63.200000000000003 112.547 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -130.0 138.8 51.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.763 0.316 . . . . 62.229999999999997 110.928 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -102.71 142.37 33.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 62.520000000000003 110.867 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.542 ' CD1' HG21 ' A' ' 36' ' ' THR . 80.1 m-85 -136.36 116.69 13.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.474 . . . . 73.140000000000001 110.923 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.7 p -82.46 132.28 35.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.078 -0.51 . . . . 50.32 110.854 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.544 HG21 HD23 ' A' ' 32' ' ' LEU . 85.8 t -92.96 140.61 16.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 71.400000000000006 111.132 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.5 p -151.28 91.54 1.69 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 35.439999999999998 111.108 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.436 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.7 OUTLIER 173.17 -28.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 62.240000000000002 111.132 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.731 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.4 mm? -86.53 150.61 24.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 73.299999999999997 110.909 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.462 ' C ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -132.03 165.6 23.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 64.219999999999999 110.828 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.465 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -57.48 -20.55 31.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.5 . . . . 75.420000000000002 110.856 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -67.09 -13.2 61.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 71.549999999999997 110.874 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.406 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.8 m-20 -101.91 -145.65 0.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 72.319999999999993 110.813 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -138.28 167.13 22.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 72.340000000000003 111.176 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.639 HG22 HD11 ' A' ' 64' ' ' LEU . 97.6 t -62.1 -44.58 99.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 52.210000000000001 111.151 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.424 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -60.4 -27.75 67.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 64.420000000000002 110.944 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.477 ' HB3' HD11 ' A' ' 19' ' ' LEU . 3.2 t0 -71.74 -34.5 69.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 72.019999999999996 110.878 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.682 HD12 ' HB3' ' A' ' 19' ' ' LEU . 1.1 tt -80.16 -47.99 13.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 74.519999999999996 110.915 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.517 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.46 -55.87 26.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.198 -0.456 . . . . 74.400000000000006 110.84 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -57.28 -22.7 43.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 73.519999999999996 110.88 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.46 ' O ' HG22 ' A' ' 34' ' ' THR . 70.5 t80 -77.92 -55.37 5.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 44.25 110.875 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.831 HD13 HG21 ' A' ' 7' ' ' VAL . 2.5 pp -67.09 -43.02 83.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.476 . . . . 73.400000000000006 110.938 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.582 ' N ' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -54.61 -27.5 39.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 64.420000000000002 110.919 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.46 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.63 -23.67 42.43 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.474 . . . . 65.310000000000002 111.191 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.2 mt -76.49 -59.31 2.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 63.109999999999999 110.923 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.542 HG21 ' CD1' ' A' ' 14' ' ' TYR . 4.6 t -135.02 -28.25 1.19 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 71.430000000000007 111.167 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.53 -176.86 5.1 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.73 -0.747 . . . . 65.109999999999999 112.532 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.88 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.3 p -113.09 139.26 39.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.867 0.365 . . . . 64.030000000000001 111.115 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.993 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.52 150.25 18.06 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.568 0.699 . . . . 72.049999999999997 110.93 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -21.96 32.54 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.713 2.275 . . . . 75.540000000000006 112.297 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -54.47 -38.89 66.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 42.119999999999997 110.908 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.416 ' H ' HD23 ' A' ' 39' ' ' LEU . 3.9 mpt_? -103.91 -40.31 6.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 61.100000000000001 110.892 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.88 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.9 pp0? -97.35 158.06 15.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 64.219999999999999 110.91 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.03 142.52 51.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 75.109999999999999 110.928 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.31 135.95 54.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 71.409999999999997 110.938 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.752 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.1 mm? -77.4 -67.57 0.7 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 61.439999999999998 110.907 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.88 61.21 0.61 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.728 -0.748 . . . . 71.120000000000005 112.484 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.578 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 4.6 pp -59.2 -17.94 32.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.864 0.364 . . . . 73.319999999999993 110.897 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.71 144.16 42.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 74.430000000000007 110.904 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.781 HG21 HD21 ' A' ' 66' ' ' LEU . 10.9 p -143.82 145.63 21.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.428 . . . . 74.340000000000003 111.115 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.551 ' HG2' HG22 ' A' ' 50' ' ' VAL . 19.7 mmtp 54.67 32.32 17.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 64.349999999999994 110.887 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.25 -11.28 50.64 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.69 -0.767 . . . . 45.100000000000001 112.488 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.9 mmtp -81.4 151.45 69.03 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.551 0.691 . . . . 74.219999999999999 110.912 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.418 ' O ' ' C ' ' A' ' 55' ' ' ALA . 53.8 Cg_endo -69.68 -32.96 17.84 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.675 2.25 . . . . 75.310000000000002 112.349 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.601 ' HA ' HG21 ' A' ' 59' ' ' VAL . . . 36.42 43.65 0.25 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 64.109999999999999 111.111 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.97 -76.52 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 71.420000000000002 110.88 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -159.26 -37.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 73.219999999999999 110.922 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -67.4 -8.13 30.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 75.340000000000003 110.899 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.601 HG21 ' HA ' ' A' ' 55' ' ' ALA . 17.0 t -80.2 145.54 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 50.399999999999999 111.112 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -90.63 150.82 21.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 51.130000000000003 110.898 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.527 ' HA ' HD12 ' A' ' 64' ' ' LEU . 12.6 mt -51.74 -45.06 63.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 72.420000000000002 110.903 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.54 -11.29 85.61 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.75 -0.738 . . . . 51.210000000000001 112.473 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.9 -35.25 29.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.805 0.336 . . . . 64.540000000000006 111.116 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.639 HD11 HG22 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -73.13 -24.53 60.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 52.210000000000001 110.871 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.8 mmtp 62.38 38.04 13.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 52.539999999999999 110.881 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.781 HD21 HG21 ' A' ' 50' ' ' VAL . 4.2 mt -88.85 153.48 21.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 74.209999999999994 110.916 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.45 160.3 76.85 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.583 0.706 . . . . 61.140000000000001 110.879 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -35.62 12.22 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.678 2.252 . . . . 62.009999999999998 112.322 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.712 ' HA ' HD12 ' A' ' 6' ' ' ILE . 23.8 p30 -78.8 -15.88 57.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 64.310000000000002 110.92 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.617 HG21 HD13 ' A' ' 66' ' ' LEU . 55.4 m -32.42 120.13 0.3 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.143 -0.481 . . . . 61.409999999999997 111.151 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.72 146.39 23.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 71.519999999999996 110.924 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.9 mm -116.97 130.63 71.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 62.109999999999999 111.135 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 6.1 mtt -103.91 141.69 35.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 62.420000000000002 110.891 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 70.5 mtm -133.99 123.57 24.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.267 -0.424 . . . . 70.349999999999994 110.906 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.752 ' CG ' HD21 ' A' ' 46' ' ' LEU . 1.3 mmm -111.12 124.39 52.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 64.439999999999998 110.841 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 164.11 -153.96 24.58 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.716 -0.754 . . . . 53.210000000000001 112.45 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.9 t -134.47 143.68 47.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.838 0.352 . . . . 72.400000000000006 111.133 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -63.72 158.75 20.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 74.209999999999994 110.878 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -84.43 140.93 31.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.465 . . . . 63.43 110.894 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -64.73 -31.81 73.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 73.310000000000002 110.904 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.6 t -80.4 -63.59 1.38 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.134 -0.485 . . . . 71.010000000000005 110.874 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.478 0 O-C-N 124.487 1.117 . . . . 25.199999999999999 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.8 0.334 . . . . 61.439999999999998 110.868 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.738 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . -94.72 151.36 19.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 52.340000000000003 111.091 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.2 mt -110.79 109.1 57.79 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.621 0.724 . . . . 53.539999999999999 110.945 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 156.67 62.86 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.673 2.249 . . . . 70.420000000000002 112.34 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.458 ' HB ' HD21 ' A' ' 28' ' ' LEU . 38.1 mt -150.56 137.3 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.437 . . . . 75.439999999999998 111.147 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.723 HD12 ' HA ' ' A' ' 69' ' ' ASN . 4.1 mt -95.37 140.56 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 72.400000000000006 111.146 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.808 HG21 HD13 ' A' ' 32' ' ' LEU . 8.3 p -127.29 122.91 60.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 74.219999999999999 111.115 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -107.98 120.19 41.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 74.019999999999996 110.907 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.1 t-105 -122.27 100.91 7.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 75.109999999999999 110.903 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.91 -83.61 0.77 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.752 -0.737 . . . . 54.109999999999999 112.51 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.13 20.38 0.96 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.69 -0.767 . . . . 71.099999999999994 112.474 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -129.18 174.9 9.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.771 0.32 . . . . 72.409999999999997 110.902 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -132.7 140.64 48.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 55.399999999999999 110.934 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -135.92 119.1 16.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 71.349999999999994 110.925 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 89.2 p -82.75 136.05 34.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.101 -0.5 . . . . 61.420000000000002 110.892 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.527 HG21 HD23 ' A' ' 32' ' ' LEU . 87.3 t -98.87 125.23 52.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 72.310000000000002 111.108 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.4 p -135.44 93.41 2.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 63.340000000000003 111.121 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.573 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.9 OUTLIER 173.73 -28.84 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 73.140000000000001 111.133 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.738 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.9 mm? -84.92 149.85 25.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.222 -0.444 . . . . 63.109999999999999 110.893 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.572 ' C ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.77 167.68 19.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 72.420000000000002 110.854 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.43 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 56.1 mt-10 -58.58 -22.39 55.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 55.149999999999999 110.887 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.11 -11.54 59.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 70.400000000000006 110.905 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.447 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.9 m-20 -101.63 -150.24 0.4 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 60.43 110.836 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.487 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -136.53 167.57 21.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.462 . . . . 74.219999999999999 111.115 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.625 HG21 HD21 ' A' ' 64' ' ' LEU . 75.0 t -63.03 -42.26 96.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 70.540000000000006 111.143 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.417 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -61.97 -28.72 69.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.491 . . . . 70.340000000000003 110.901 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.576 ' HB3' HD11 ' A' ' 19' ' ' LEU . 1.2 t0 -72.06 -32.78 67.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 52.439999999999998 110.878 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.685 HD23 HD23 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -80.46 -48.93 12.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 53.030000000000001 110.917 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.76 -55.79 26.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 72.430000000000007 110.902 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.92 -22.64 49.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 72.329999999999998 110.918 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.573 ' CZ ' HG21 ' A' ' 18' ' ' THR . 44.5 t80 -77.76 -55.11 5.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.453 . . . . 64.340000000000003 110.87 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.808 HD13 HG21 ' A' ' 7' ' ' VAL . 2.8 pp -67.51 -41.93 83.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 60.409999999999997 110.915 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.569 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.71 -27.91 44.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 53.100000000000001 110.928 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.43 -23.84 42.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.455 . . . . 72.310000000000002 111.141 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.441 HD11 ' CE1' ' A' ' 31' ' ' PHE . 13.7 mt -76.15 -59.48 2.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.446 . . . . 75.439999999999998 110.877 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.4 t -135.38 -27.77 1.18 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 71.430000000000007 111.147 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.569 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.59 -175.34 4.36 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.766 -0.73 . . . . 53.340000000000003 112.495 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.726 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.4 p -112.56 141.38 28.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.807 0.337 . . . . 52.210000000000001 111.17 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 1.001 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -57.01 149.86 42.68 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.6 0.714 . . . . 74.010000000000005 110.885 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -21.4 33.48 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.707 2.272 . . . . 63.140000000000001 112.308 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -55.19 -39.25 69.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 71.209999999999994 110.835 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.423 ' H ' HD23 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -104.29 -41.42 5.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 72.25 110.891 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.726 ' HG2' HG13 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -96.12 158.41 15.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 61.109999999999999 110.898 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.603 ' N ' HE21 ' A' ' 43' ' ' GLN . 0.0 OUTLIER -130.14 142.45 50.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 64.439999999999998 110.902 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.52 136.38 54.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 54.43 110.881 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.734 HD11 ' CG ' ' A' ' 75' ' ' MET . 6.2 mp -86.13 -55.26 4.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 62.329999999999998 110.877 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.35 52.52 0.97 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.719 -0.753 . . . . 71.140000000000001 112.485 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.584 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 4.6 pp -61.67 -16.39 48.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.933 0.397 . . . . 75.510000000000005 110.942 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.9 pttt -116.8 143.25 45.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 72.129999999999995 110.876 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.988 HG21 HD21 ' A' ' 66' ' ' LEU . 10.6 p -143.73 145.17 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 74.409999999999997 111.137 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 55.34 31.52 16.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 71.140000000000001 110.924 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.09 -11.17 55.98 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.728 -0.749 . . . . 64.040000000000006 112.492 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -81.37 150.98 68.5 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.532 0.682 . . . . 74.140000000000001 110.938 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 55' ' ' ALA . 53.6 Cg_endo -69.79 -32.25 18.79 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.691 2.261 . . . . 74.239999999999995 112.302 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.591 ' HA ' HG21 ' A' ' 59' ' ' VAL . . . 35.99 44.34 0.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.439 . . . . 42.210000000000001 111.128 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.08 -79.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 74.430000000000007 110.919 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.04 -38.8 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 54.130000000000003 110.884 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -64.6 -9.8 21.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 74.329999999999998 110.896 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.591 HG21 ' HA ' ' A' ' 55' ' ' ALA . 16.6 t -79.55 145.69 8.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 73.409999999999997 111.159 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 29.8 mttt -91.49 152.25 20.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.446 . . . . 63.399999999999999 110.937 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.572 HD12 ' C ' ' A' ' 20' ' ' SER . 20.0 mt -49.86 -47.47 51.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 75.219999999999999 110.928 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.72 -11.71 85.18 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.775 -0.726 . . . . 51.409999999999997 112.473 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.59 -31.55 41.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.837 0.351 . . . . 52.509999999999998 111.076 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.625 HD21 HG21 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -78.17 -23.99 47.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 74.120000000000005 110.925 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.7 mmtp 63.45 35.84 11.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 72.030000000000001 110.875 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.988 HD21 HG21 ' A' ' 50' ' ' VAL . 4.7 mt -87.78 152.88 21.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.439 . . . . 64.129999999999995 110.925 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.7 160.44 77.14 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.627 0.727 . . . . 74.439999999999998 110.897 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -34.82 13.77 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.657 2.238 . . . . 74.420000000000002 112.355 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.723 ' HA ' HD12 ' A' ' 6' ' ' ILE . 12.3 m120 -78.81 -16.1 57.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 74.129999999999995 110.859 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.698 HG21 HD13 ' A' ' 66' ' ' LEU . 49.1 m -32.5 120.17 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 71.099999999999994 111.162 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.17 146.68 23.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 71.530000000000001 110.891 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.5 mm -115.37 128.95 72.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 72.549999999999997 111.147 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 30.8 mtt -99.7 142.67 30.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 72.430000000000007 110.865 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.3 mtt -134.08 132.73 40.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 72.0 110.854 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.734 ' CG ' HD11 ' A' ' 46' ' ' LEU . 2.3 mmt -124.58 123.5 40.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 74.5 110.88 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.13 -155.19 26.02 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.733 -0.746 . . . . 61.329999999999998 112.472 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 t -132.73 135.41 45.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.775 0.321 . . . . 72.239999999999995 111.131 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.522 ' HA ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -93.17 147.83 22.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 62.310000000000002 110.867 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.441 ' H ' HD11 ' A' ' 39' ' ' LEU . 21.6 pt-20 -54.46 167.35 0.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 74.25 110.858 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.34 108.15 19.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 72.319999999999993 110.877 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.1 m -78.58 -141.44 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 43.539999999999999 110.817 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.481 0 O-C-N 124.494 1.121 . . . . 21.41 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mtt . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.815 0.341 . . . . 71.140000000000001 110.83 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.734 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . -91.1 151.47 20.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 64.049999999999997 111.112 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.663 HD12 ' HG2' ' A' ' 21' ' ' GLU . 4.4 mt -112.13 109.68 54.33 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.589 0.709 . . . . 72.329999999999998 110.927 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 156.42 63.49 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.689 2.259 . . . . 72.540000000000006 112.364 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.554 ' HB ' HD21 ' A' ' 28' ' ' LEU . 33.8 mt -150.56 137.45 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 72.439999999999998 111.134 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.681 HD12 ' HA ' ' A' ' 69' ' ' ASN . 4.3 mt -95.39 140.65 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 63.229999999999997 111.137 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.813 HG21 HD13 ' A' ' 32' ' ' LEU . 7.3 p -126.95 123.28 62.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 51.439999999999998 111.108 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.52 120.73 43.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 70.230000000000004 110.865 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 17.3 t-105 -123.87 105.03 9.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 74.129999999999995 110.878 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.88 -81.81 0.9 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.767 -0.73 . . . . 70.030000000000001 112.483 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.04 20.25 0.66 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.782 -0.723 . . . . 62.25 112.513 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -129.13 175.35 8.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.756 0.312 . . . . 74.310000000000002 110.947 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -132.74 140.12 47.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 75.510000000000005 110.899 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.528 ' CD2' HG21 ' A' ' 36' ' ' THR . 47.4 m-85 -134.7 116.33 14.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.172 -0.467 . . . . 73.510000000000005 110.913 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.0 p -82.93 130.59 35.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.504 . . . . 75.329999999999998 110.864 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.556 HG21 HD23 ' A' ' 32' ' ' LEU . 91.6 t -91.74 142.0 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 74.140000000000001 111.148 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.2 p -151.49 92.31 1.76 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 63.210000000000001 111.156 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.688 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.8 OUTLIER 173.74 -29.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 63.229999999999997 111.148 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.734 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.6 mm? -86.25 152.2 22.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 54.340000000000003 110.92 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.427 ' O ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.55 169.75 15.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 75.010000000000005 110.851 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.663 ' HG2' HD12 ' A' ' 3' ' ' LEU . 58.2 mt-10 -61.85 -22.23 65.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 63.119999999999997 110.914 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -68.8 -12.05 61.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.17 -0.468 . . . . 75.519999999999996 110.887 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.412 ' HB2' HD12 ' A' ' 19' ' ' LEU . 2.0 m-20 -99.78 -150.52 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 71.329999999999998 110.88 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -132.53 171.37 13.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 64.140000000000001 111.17 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.929 HG22 HD11 ' A' ' 64' ' ' LEU . 11.8 t -67.69 -40.96 84.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 72.519999999999996 111.119 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.19 -29.4 70.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 72.519999999999996 110.905 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.47 ' HB3' HD11 ' A' ' 19' ' ' LEU . 19.0 t0 -70.1 -35.12 73.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 71.409999999999997 110.845 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.689 HD12 ' CB ' ' A' ' 19' ' ' LEU . 1.2 tt -80.76 -47.67 13.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 51.240000000000002 110.938 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.771 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.86 -56.5 18.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 62.439999999999998 110.892 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.15 -22.75 52.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.434 . . . . 64.510000000000005 110.915 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.688 ' CZ ' HG21 ' A' ' 18' ' ' THR . 59.9 t80 -76.86 -55.48 5.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 64.25 110.864 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.813 HD13 HG21 ' A' ' 7' ' ' VAL . 2.2 pp -67.29 -43.43 81.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 75.129999999999995 110.889 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.571 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.2 tmtt? -54.81 -27.48 42.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 73.310000000000002 110.914 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.503 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.34 -23.51 43.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 75.030000000000001 111.161 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.6 mt -76.65 -59.59 2.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 53.439999999999998 110.929 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.528 HG21 ' CD2' ' A' ' 14' ' ' TYR . 2.7 t -135.01 -27.68 1.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 75.219999999999999 111.158 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.571 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.59 -176.68 5.07 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.777 -0.725 . . . . 62.009999999999998 112.457 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.883 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.4 p -112.38 138.54 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.887 0.375 . . . . 73.319999999999993 111.144 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.983 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.06 149.75 17.35 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.575 0.703 . . . . 74.099999999999994 110.947 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -21.97 32.7 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.669 2.246 . . . . 41.219999999999999 112.335 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -53.94 -38.43 64.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 61.350000000000001 110.907 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.408 ' H ' HD23 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -105.08 -39.52 6.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 63.350000000000001 110.919 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.883 ' HG2' HG13 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -96.54 158.66 15.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 71.200000000000003 110.892 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.02 139.33 52.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 73.150000000000006 110.871 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.81 135.45 54.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.257 -0.429 . . . . 73.400000000000006 110.898 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.735 HD11 ' CG ' ' A' ' 75' ' ' MET . 7.2 mp -77.45 -75.81 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.467 . . . . 73.0 110.907 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.12 59.44 1.68 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.755 -0.736 . . . . 64.510000000000005 112.508 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.64 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 3.6 pp -55.83 -24.39 36.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.874 0.369 . . . . 74.25 110.914 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.423 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 1.9 pttt -103.45 143.16 33.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 73.439999999999998 110.854 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.8 HG21 HD21 ' A' ' 66' ' ' LEU . 14.4 p -144.19 143.36 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.42 . . . . 51.25 111.126 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.6 mttm 54.04 34.17 19.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 74.209999999999994 110.865 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.38 -15.16 41.79 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.741 -0.743 . . . . 74.340000000000003 112.47 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -81.56 149.59 64.95 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.557 0.694 . . . . 72.219999999999999 110.887 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.423 ' HA ' ' HB3' ' A' ' 49' ' ' LYS . 53.8 Cg_endo -69.77 -36.4 10.85 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.714 2.276 . . . . 65.200000000000003 112.344 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 38.4 40.01 0.33 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 71.510000000000005 111.075 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -66.94 -74.37 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 71.5 110.865 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.401 HD22 ' N ' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -156.54 -37.31 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 71.099999999999994 110.87 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.401 ' N ' HD22 ' A' ' 57' ' ' ASN . 56.4 m-20 -74.67 -2.98 28.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 75.310000000000002 110.897 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.597 ' O ' HG23 ' A' ' 25' ' ' VAL . 1.3 t -91.15 146.94 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 61.43 111.13 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.465 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 24.6 mttt -89.04 146.55 24.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 70.329999999999998 110.943 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.438 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 18.3 mt -52.12 -37.58 54.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.256 -0.429 . . . . 52.399999999999999 110.906 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.93 -18.24 79.62 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.748 -0.739 . . . . 71.329999999999998 112.47 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.73 -15.56 44.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.883 0.373 . . . . 53.030000000000001 111.141 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.929 HD11 HG22 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -87.04 -18.31 30.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 71.219999999999999 110.913 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 49.66 45.08 24.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 73.109999999999999 110.924 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.8 HD21 HG21 ' A' ' 50' ' ' VAL . 3.4 mt -97.86 152.99 18.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 65.340000000000003 110.923 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.42 159.81 79.15 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.547 0.689 . . . . 63.409999999999997 110.911 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -36.57 10.51 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.682 2.255 . . . . 64.040000000000006 112.332 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.681 ' HA ' HD12 ' A' ' 6' ' ' ILE . 5.0 m120 -78.45 -15.59 58.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 75.219999999999999 110.911 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.649 HG21 HD13 ' A' ' 66' ' ' LEU . 52.2 m -32.93 125.68 0.34 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 74.140000000000001 111.126 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.88 145.29 25.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 74.340000000000003 110.887 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.3 mm -115.57 131.9 66.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 62.310000000000002 111.14 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.2 mtp -101.99 141.78 34.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 71.239999999999995 110.913 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 75.9 mtm -133.47 120.0 20.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 74.329999999999998 110.856 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.735 ' CG ' HD11 ' A' ' 46' ' ' LEU . 1.5 mmt -109.7 123.8 50.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 74.140000000000001 110.921 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 162.73 -155.56 26.94 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 70.340000000000003 112.48 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.9 t -134.09 144.04 48.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.8 0.333 . . . . 74.409999999999997 111.134 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -64.22 156.05 29.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 75.129999999999995 110.889 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -81.38 141.94 33.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 74.219999999999999 110.852 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.625 ' O ' ' N ' ' A' ' 90' ' ' NH2 . 0.2 OUTLIER 58.27 89.02 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 63.310000000000002 110.877 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.76 -38.32 0.12 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 53.130000000000003 110.895 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' NH2 . . . . . 0.625 ' N ' ' O ' ' A' ' 80' ' ' GLU . . . . . . . . 0 C--N 1.324 -0.513 0 O-C-N 124.55 1.156 . . . . 35.119999999999997 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.78 0.324 . . . . 74.209999999999994 110.864 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.74 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . -90.8 151.13 21.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 40.530000000000001 111.121 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.409 HD23 ' HD2' ' A' ' 4' ' ' PRO . 1.9 mt -110.49 108.89 58.36 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.665 0.745 . . . . 73.109999999999999 110.892 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.409 ' HD2' HD23 ' A' ' 3' ' ' LEU . 53.6 Cg_endo -69.8 156.52 63.05 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.735 2.29 . . . . 65.209999999999994 112.33 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.461 ' HB ' HD21 ' A' ' 28' ' ' LEU . 39.0 mt -150.5 137.24 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 62.450000000000003 111.128 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.69 HD12 ' HA ' ' A' ' 69' ' ' ASN . 4.6 mt -94.96 140.57 16.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 75.329999999999998 111.143 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.814 HG21 HD13 ' A' ' 32' ' ' LEU . 8.0 p -127.28 122.88 60.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 74.310000000000002 111.153 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -107.31 118.85 37.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 73.099999999999994 110.9 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 16.8 t-105 -121.18 101.59 7.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.233 -0.44 . . . . 73.340000000000003 110.895 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.48 -83.24 0.79 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.81 -0.71 . . . . 72.140000000000001 112.524 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.85 20.55 0.89 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.756 -0.735 . . . . 54.210000000000001 112.488 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -129.2 175.83 8.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.711 0.291 . . . . 61.549999999999997 110.957 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -132.88 140.78 48.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 73.420000000000002 110.903 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -136.62 118.13 14.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.147 -0.479 . . . . 73.340000000000003 110.931 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.02 133.94 35.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.104 -0.498 . . . . 73.340000000000003 110.856 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.532 HG21 HD23 ' A' ' 32' ' ' LEU . 86.3 t -96.02 126.91 48.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 74.109999999999999 111.124 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.1 p -135.94 91.99 2.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 74.329999999999998 111.121 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.659 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 1.2 t 174.62 -29.69 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 75.319999999999993 111.125 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.74 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.9 mm? -83.4 149.62 26.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 74.299999999999997 110.91 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.518 ' C ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.5 168.01 18.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 72.120000000000005 110.844 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.401 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 36.9 mt-10 -59.24 -22.01 60.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 62.43 110.896 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -69.11 -10.7 58.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 71.299999999999997 110.873 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.465 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.5 m-20 -100.89 -150.19 0.39 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 74.549999999999997 110.855 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -137.07 167.99 20.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 75.549999999999997 111.141 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.941 HG22 HD11 ' A' ' 64' ' ' LEU . 41.8 t -62.38 -45.02 99.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 73.530000000000001 111.158 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -60.78 -28.54 68.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.475 . . . . 71.329999999999998 110.918 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.567 ' HB3' HD11 ' A' ' 19' ' ' LEU . 0.7 OUTLIER -71.05 -33.56 70.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 43.149999999999999 110.938 179.792 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.689 HD23 HD23 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -80.86 -48.97 11.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 64.310000000000002 110.902 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.592 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.4 -56.58 18.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 72.340000000000003 110.858 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -58.29 -22.04 51.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 62.009999999999998 110.93 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.659 ' CZ ' HG21 ' A' ' 18' ' ' THR . 44.9 t80 -77.88 -54.93 5.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 65.409999999999997 110.854 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.814 HD13 HG21 ' A' ' 7' ' ' VAL . 2.6 pp -67.73 -42.24 82.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 54.450000000000003 110.929 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.577 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.88 -27.39 42.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 70.439999999999998 110.889 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.484 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.77 -23.77 41.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 74.010000000000005 111.207 179.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.416 HD11 ' CE2' ' A' ' 31' ' ' PHE . 13.9 mt -76.5 -59.94 2.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 52.32 110.896 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.9 t -135.28 -27.62 1.2 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.443 . . . . 74.25 111.162 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.577 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.61 -177.81 4.61 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.729 -0.748 . . . . 72.140000000000001 112.532 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.89 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.3 p -112.66 138.56 41.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.827 0.346 . . . . 64.0 111.145 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.967 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -55.17 151.17 18.45 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.614 0.721 . . . . 71.109999999999999 110.903 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -21.61 33.51 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.718 2.279 . . . . 74.200000000000003 112.334 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -54.38 -38.91 66.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 75.430000000000007 110.869 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.447 ' H ' HD23 ' A' ' 39' ' ' LEU . 3.1 mpt_? -104.14 -40.4 6.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 74.140000000000001 110.897 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.89 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.7 pp0? -97.86 158.43 15.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 72.319999999999993 110.917 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.64 140.85 51.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 71.420000000000002 110.861 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 45' ' ' LEU . 3.8 mm? -67.35 135.75 53.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.461 . . . . 74.049999999999997 110.913 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.742 HD21 ' CG ' ' A' ' 75' ' ' MET . 3.8 mm? -81.05 -64.39 1.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 63.420000000000002 110.91 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.63 56.89 1.64 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.781 -0.723 . . . . 71.329999999999998 112.516 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.805 HD22 ' C ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -59.72 -13.4 9.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.886 0.374 . . . . 52.329999999999998 110.905 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.514 ' N ' HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -122.31 145.97 47.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 54.140000000000001 110.903 179.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.924 HG21 HD21 ' A' ' 66' ' ' LEU . 9.6 p -143.75 144.06 23.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.207 -0.451 . . . . 74.019999999999996 111.109 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.2 mttt 54.72 31.14 14.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 73.109999999999999 110.907 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.24 -9.99 59.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.763 -0.732 . . . . 70.549999999999997 112.485 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -81.04 150.25 68.18 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.576 0.703 . . . . 64.230000000000004 110.88 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.411 ' O ' ' C ' ' A' ' 55' ' ' ALA . 53.7 Cg_endo -69.76 -30.53 22.12 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.7 2.267 . . . . 62.119999999999997 112.328 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.62 ' HA ' HG21 ' A' ' 59' ' ' VAL . . . 35.5 43.28 0.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 53.200000000000003 111.102 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.33 -78.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 70.340000000000003 110.929 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -157.44 -38.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 72.540000000000006 110.845 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -66.12 -8.59 24.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.221 -0.445 . . . . 73.420000000000002 110.838 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.62 HG21 ' HA ' ' A' ' 55' ' ' ALA . 21.4 t -78.79 146.55 7.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 32.399999999999999 111.133 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 28.8 mttt -93.24 151.14 20.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 54.229999999999997 110.885 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.54 ' HA ' HD12 ' A' ' 64' ' ' LEU . 18.9 mt -50.64 -45.64 57.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.264 -0.425 . . . . 64.319999999999993 110.882 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.38 -12.02 84.59 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.79 -0.719 . . . . 52.329999999999998 112.474 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.14 -33.45 29.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.8 0.333 . . . . 53.219999999999999 111.077 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.941 HD11 HG22 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -73.09 -25.07 60.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 64.409999999999997 110.905 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt 62.63 37.75 12.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.218 -0.446 . . . . 72.530000000000001 110.891 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.924 HD21 HG21 ' A' ' 50' ' ' VAL . 5.8 mt -91.31 152.98 20.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.266 -0.424 . . . . 75.099999999999994 110.928 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -68.7 160.71 75.86 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.589 0.709 . . . . 70.409999999999997 110.909 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -35.42 12.61 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.696 2.264 . . . . 72.120000000000005 112.356 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.69 ' HA ' HD12 ' A' ' 6' ' ' ILE . 8.6 m-20 -78.86 -15.96 57.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 71.099999999999994 110.906 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.472 ' C ' ' O ' ' A' ' 69' ' ' ASN . 54.6 m -32.51 124.72 0.33 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 70.519999999999996 111.133 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.4 147.0 23.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 74.310000000000002 110.859 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.6 mm -116.93 127.5 74.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 74.319999999999993 111.128 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.4 mtt -99.22 141.87 31.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 74.239999999999995 110.838 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.9 mtt -136.14 117.22 14.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 74.200000000000003 110.864 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.742 ' CG ' HD21 ' A' ' 46' ' ' LEU . 1.4 mmt -106.19 125.78 51.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 55.310000000000002 110.863 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 160.26 -155.3 26.42 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.763 -0.732 . . . . 62.119999999999997 112.487 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.0 t -134.52 147.82 50.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.779 0.323 . . . . 74.430000000000007 111.163 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -64.95 157.0 29.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 50.509999999999998 110.849 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.56 165.69 0.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 74.310000000000002 110.89 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.03 148.89 43.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 65.420000000000002 110.905 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.3 p -152.11 -165.58 2.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 62.539999999999999 110.882 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.472 0 O-C-N 124.508 1.13 . . . . 72.140000000000001 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mtt . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.774 0.321 . . . . 71.430000000000007 110.879 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.737 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . -85.42 151.46 23.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 72.510000000000005 111.116 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.411 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 3.9 mt -111.08 109.36 57.11 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.59 0.71 . . . . 65.019999999999996 110.865 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 53.9 Cg_endo -69.74 156.05 64.39 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.738 2.292 . . . . 71.340000000000003 112.356 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.431 ' HB ' HD21 ' A' ' 28' ' ' LEU . 53.4 mt -150.7 135.96 10.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.452 . . . . 62.420000000000002 111.146 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.697 HD12 ' HA ' ' A' ' 69' ' ' ASN . 3.3 mt -94.24 140.4 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 73.239999999999995 111.118 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.831 HG21 HD13 ' A' ' 32' ' ' LEU . 8.9 p -127.34 123.39 61.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 63.43 111.121 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.64 123.01 48.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 71.129999999999995 110.866 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 9.0 t-105 -123.87 100.49 6.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 73.540000000000006 110.9 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.23 -80.41 1.3 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.718 -0.753 . . . . 54.539999999999999 112.458 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.25 17.24 0.79 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.735 . . . . 61.43 112.48 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -129.89 139.03 51.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.774 0.321 . . . . 64.150000000000006 110.943 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -103.07 142.39 34.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 70.230000000000004 110.846 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -135.84 117.27 14.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 75.120000000000005 110.92 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 82.6 p -81.82 132.6 35.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 45.43 110.829 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.545 HG21 HD23 ' A' ' 32' ' ' LEU . 99.9 t -93.31 136.31 25.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 74.450000000000003 111.155 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.2 p -147.55 92.38 2.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 74.349999999999994 111.145 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.488 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.7 OUTLIER 173.51 -28.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 74.420000000000002 111.152 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.737 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.6 mm? -85.98 150.72 24.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 63.240000000000002 110.911 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.545 ' C ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.81 168.7 17.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.464 . . . . 74.299999999999997 110.876 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.426 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 69.9 mt-10 -59.51 -22.14 61.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 52.100000000000001 110.893 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.04 -12.57 60.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 61.210000000000001 110.883 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.423 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.9 m-20 -101.97 -148.7 0.38 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 72.239999999999995 110.874 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.499 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -136.64 168.28 19.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 71.420000000000002 111.13 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.601 HG21 HD21 ' A' ' 64' ' ' LEU . 86.9 t -63.02 -45.15 99.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 63.219999999999999 111.103 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.422 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -59.8 -27.95 67.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 65.430000000000007 110.94 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.537 ' HB3' HD11 ' A' ' 19' ' ' LEU . 2.3 t0 -71.79 -33.78 68.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.193 -0.458 . . . . 54.439999999999998 110.835 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.657 HD12 ' HB3' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -80.67 -48.28 12.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 75.510000000000005 110.907 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.503 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.64 -55.79 26.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 74.530000000000001 110.86 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.51 -22.5 44.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 74.040000000000006 110.94 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.488 ' CZ ' HG21 ' A' ' 18' ' ' THR . 45.8 t80 -77.75 -55.06 5.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 73.329999999999998 110.891 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.831 HD13 HG21 ' A' ' 7' ' ' VAL . 2.5 pp -67.76 -42.93 81.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 74.129999999999995 110.945 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.582 ' N ' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -54.62 -27.53 40.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 63.420000000000002 110.923 179.797 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.46 -23.6 42.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.465 . . . . 75.530000000000001 111.15 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.2 mt -76.58 -59.15 2.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 74.319999999999993 110.958 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.5 t -134.95 -28.09 1.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.444 . . . . 64.209999999999994 111.132 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.573 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.79 -176.52 5.21 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.727 -0.749 . . . . 63.25 112.499 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.864 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.3 p -113.39 138.28 43.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.834 0.349 . . . . 74.310000000000002 111.145 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.97 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -53.61 149.94 14.39 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.633 0.73 . . . . 74.409999999999997 110.911 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.401 ' O ' ' O ' ' A' ' 43' ' ' GLN . 53.5 Cg_endo -69.78 -21.72 33.01 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.647 2.231 . . . . 64.019999999999996 112.373 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -54.06 -38.33 65.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 63.539999999999999 110.882 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.42 ' H ' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -104.76 -40.05 6.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 73.019999999999996 110.838 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.864 ' HG2' HG13 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -96.72 158.05 15.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 65.349999999999994 110.876 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.65 140.78 51.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 73.329999999999998 110.896 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.72 135.85 54.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.434 . . . . 71.150000000000006 110.906 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.738 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.0 mm? -75.15 -70.25 0.43 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 61.210000000000001 110.911 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -99.73 61.22 0.73 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.708 -0.758 . . . . 62.329999999999998 112.455 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.587 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 4.5 pp -57.7 -19.63 28.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.879 0.371 . . . . 54.240000000000002 110.929 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.34 144.47 39.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 74.140000000000001 110.865 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.979 HG21 HD21 ' A' ' 66' ' ' LEU . 9.7 p -143.83 145.57 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 62.149999999999999 111.134 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.9 mttm 54.89 32.24 17.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 62.420000000000002 110.892 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.04 -11.16 50.04 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.749 -0.738 . . . . 72.439999999999998 112.445 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.0 mmtt -81.3 151.31 69.19 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.581 0.705 . . . . 75.25 110.878 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 55' ' ' ALA . 53.8 Cg_endo -69.81 -32.92 17.43 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.665 2.244 . . . . 71.439999999999998 112.313 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.588 ' HA ' HG21 ' A' ' 59' ' ' VAL . . . 36.6 43.51 0.27 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 73.140000000000001 111.059 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.47 -76.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.203 -0.453 . . . . 72.040000000000006 110.919 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -159.47 -37.28 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 43.240000000000002 110.913 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.27 -7.8 27.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 73.019999999999996 110.9 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.588 HG21 ' HA ' ' A' ' 55' ' ' ALA . 17.6 t -80.52 145.72 8.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 70.230000000000004 111.096 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -90.23 151.46 21.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 72.310000000000002 110.913 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.545 HD12 ' C ' ' A' ' 20' ' ' SER . 18.6 mt -49.92 -47.62 52.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 74.209999999999994 110.924 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.57 -11.95 84.98 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.739 -0.744 . . . . 42.25 112.498 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.04 -32.06 44.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.822 0.344 . . . . 62.140000000000001 111.104 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.601 HD21 HG21 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -77.83 -23.48 48.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 72.310000000000002 110.912 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt 63.39 37.2 10.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 72.25 110.916 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.979 HD21 HG21 ' A' ' 50' ' ' VAL . 6.1 mt -88.79 152.56 21.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 63.409999999999997 110.939 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -68.64 160.24 77.85 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.572 0.701 . . . . 71.420000000000002 110.878 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -35.54 12.58 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.68 2.254 . . . . 74.120000000000005 112.385 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.697 ' HA ' HD12 ' A' ' 6' ' ' ILE . 8.2 p30 -78.5 -15.78 58.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 71.519999999999996 110.908 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.445 ' C ' ' O ' ' A' ' 69' ' ' ASN . 50.1 m -32.83 119.47 0.32 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 61.5 111.14 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -91.05 146.77 23.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 71.549999999999997 110.903 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.3 mm -115.36 129.78 71.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.436 . . . . 74.120000000000005 111.106 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 41.3 mtm -101.45 141.65 34.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 74.010000000000005 110.875 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.1 mtt -130.78 130.1 43.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 64.439999999999998 110.879 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.738 ' CG ' HD21 ' A' ' 46' ' ' LEU . 2.3 mmt -122.21 127.04 49.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 72.400000000000006 110.858 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.88 -150.87 22.52 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.714 -0.755 . . . . 74.400000000000006 112.468 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 t -132.92 125.17 29.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.742 0.306 . . . . 73.530000000000001 111.114 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.513 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -83.82 148.22 27.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 72.349999999999994 110.836 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -69.68 -172.49 0.5 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.465 . . . . 74.329999999999998 110.905 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -98.1 -59.29 1.79 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 71.239999999999995 110.884 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.9 t -135.39 -40.27 0.73 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.098 -0.501 . . . . 74.400000000000006 110.854 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.497 0 O-C-N 124.519 1.137 . . . . 41.240000000000002 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mmt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.781 0.324 . . . . 72.430000000000007 110.872 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.678 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . -101.73 151.34 22.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 54.399999999999999 111.131 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.411 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 2.7 mt -114.45 107.44 51.24 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.628 0.728 . . . . 75.400000000000006 110.9 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 53.8 Cg_endo -69.76 156.02 64.43 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.664 2.243 . . . . 61.399999999999999 112.364 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.94 HD12 HD22 ' A' ' 28' ' ' LEU . 19.9 mt -150.88 138.63 13.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 72.140000000000001 111.102 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.622 HD12 ' HA ' ' A' ' 69' ' ' ASN . 5.2 mt -95.13 140.72 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 71.510000000000005 111.094 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.766 HG21 HD13 ' A' ' 32' ' ' LEU . 8.8 p -126.9 123.24 62.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 70.109999999999999 111.142 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.21 118.53 37.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 64.400000000000006 110.902 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 17.4 t-105 -120.57 103.77 9.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 70.439999999999998 110.938 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.41 -83.26 0.88 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.723 -0.751 . . . . 70.109999999999999 112.481 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.06 20.18 0.86 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.678 -0.772 . . . . 71.340000000000003 112.448 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -128.84 175.69 8.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.715 0.293 . . . . 75.329999999999998 110.932 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -132.79 141.84 48.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 72.430000000000007 110.92 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -138.49 116.46 11.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 73.439999999999998 110.889 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.21 137.35 35.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 73.239999999999995 110.855 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.499 HG21 HD23 ' A' ' 32' ' ' LEU . 84.3 t -94.21 142.45 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 51.420000000000002 111.141 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.4 HG23 ' O ' ' A' ' 16' ' ' VAL . 6.4 p -155.26 90.83 1.29 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 74.430000000000007 111.198 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.671 HG21 ' CE1' ' A' ' 31' ' ' PHE . 1.8 t 177.11 -31.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 75.540000000000006 111.138 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.797 ' CB ' HD12 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -88.02 163.67 16.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.44 . . . . 74.219999999999999 110.932 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.24 173.96 11.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 73.340000000000003 110.862 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.419 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 36.6 mt-10 -63.13 -20.03 65.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.482 . . . . 73.5 110.879 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -69.42 -11.09 60.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 54.350000000000001 110.896 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.676 ' HB2' HD23 ' A' ' 19' ' ' LEU . 6.0 m-20 -97.76 -152.08 0.39 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 74.439999999999998 110.896 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -137.09 165.3 26.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 53.229999999999997 111.143 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.603 HG22 HD11 ' A' ' 64' ' ' LEU . 72.6 t -59.04 -43.87 90.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 74.319999999999993 111.091 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.42 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -63.56 -30.54 71.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 75.109999999999999 110.918 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.591 ' HB3' HD21 ' A' ' 19' ' ' LEU . 5.6 t70 -72.22 -33.85 67.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 54.530000000000001 110.864 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.94 HD22 HD12 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -78.8 -47.89 15.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 63.530000000000001 110.889 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.477 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -62.75 -54.22 42.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 74.129999999999995 110.892 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.49 -22.11 30.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 70.409999999999997 110.884 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.671 ' CE1' HG21 ' A' ' 18' ' ' THR . 61.0 t80 -77.57 -55.15 5.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 63.210000000000001 110.915 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.766 HD13 HG21 ' A' ' 7' ' ' VAL . 2.1 pp -68.45 -42.24 79.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.477 . . . . 62.350000000000001 110.872 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.574 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.65 -27.51 40.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 64.420000000000002 110.927 179.818 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.62 -23.76 42.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 63.539999999999999 111.106 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.8 mt -76.4 -59.9 2.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.42 . . . . 72.519999999999996 110.893 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.5 t -135.14 -27.8 1.21 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.203 -0.453 . . . . 73.150000000000006 111.111 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.574 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.8 -177.55 4.68 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.778 -0.725 . . . . 41.43 112.486 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.876 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.3 p -112.7 138.59 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.842 0.353 . . . . 64.409999999999997 111.137 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.952 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.78 150.93 16.67 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.632 0.73 . . . . 71.519999999999996 110.868 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 53.7 Cg_endo -69.83 -21.7 32.78 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.638 2.225 . . . . 55.329999999999998 112.355 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -54.09 -39.14 66.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 74.109999999999999 110.872 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.446 ' H ' HD23 ' A' ' 39' ' ' LEU . 23.2 mtt85 -104.04 -40.44 6.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 70.209999999999994 110.884 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.876 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.8 pp0? -97.23 157.21 16.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 72.25 110.914 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.83 143.31 50.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 74.120000000000005 110.902 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.413 ' N ' HD22 ' A' ' 45' ' ' LEU . 3.7 mm? -67.57 136.1 53.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 73.5 110.908 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.724 HD11 ' CG ' ' A' ' 75' ' ' MET . 6.3 mp -86.13 -53.0 5.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 52.509999999999998 110.904 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -104.68 53.37 0.68 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.718 -0.754 . . . . 63.549999999999997 112.474 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.58 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 4.5 pp -59.67 -17.91 37.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.855 0.359 . . . . 71.549999999999997 110.886 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.93 143.13 45.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 72.430000000000007 110.91 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.793 HG21 HD21 ' A' ' 66' ' ' LEU . 11.5 p -143.67 145.3 22.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 74.420000000000002 111.094 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.92 31.86 16.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 72.430000000000007 110.868 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.99 -10.99 56.54 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.756 -0.735 . . . . 61.439999999999998 112.494 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -81.62 150.99 67.67 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.61 0.719 . . . . 64.040000000000006 110.9 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 55' ' ' ALA . 54.3 Cg_endo -69.73 -32.74 18.1 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.709 2.273 . . . . 42.039999999999999 112.353 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.625 ' HA ' HG21 ' A' ' 59' ' ' VAL . . . 36.04 44.25 0.25 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 65.019999999999996 111.083 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.77 -80.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 64.239999999999995 110.918 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -154.65 -39.26 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 72.219999999999999 110.886 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.69 -10.39 19.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 74.439999999999998 110.864 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.625 HG21 ' HA ' ' A' ' 55' ' ' ALA . 16.6 t -79.28 146.1 8.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 74.510000000000005 111.141 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 14.6 mttt -93.02 152.16 19.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 74.120000000000005 110.892 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.539 ' CD1' HD13 ' A' ' 28' ' ' LEU . 24.3 mt -50.13 -46.56 53.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 74.019999999999996 110.939 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.22 -12.02 84.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.742 -0.742 . . . . 70.040000000000006 112.435 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.92 -33.1 34.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.883 0.373 . . . . 52.119999999999997 111.111 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.603 HD11 HG22 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -74.23 -24.6 59.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 73.420000000000002 110.917 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt 62.95 37.86 11.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 73.409999999999997 110.955 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.793 HD21 HG21 ' A' ' 50' ' ' VAL . 4.5 mt -90.76 154.11 19.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 65.439999999999998 110.905 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -68.35 160.26 76.62 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.574 0.702 . . . . 74.099999999999994 110.929 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 -35.51 12.71 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.68 2.253 . . . . 53.25 112.395 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.622 ' HA ' HD12 ' A' ' 6' ' ' ILE . 7.8 m-20 -78.83 -16.32 57.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 73.120000000000005 110.94 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.665 HG21 HD13 ' A' ' 66' ' ' LEU . 55.5 m -32.45 126.11 0.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 74.400000000000006 111.142 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.34 147.5 23.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 73.120000000000005 110.874 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.0 mm -117.54 128.64 74.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 75.340000000000003 111.168 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.406 ' HB3' HD13 ' A' ' 46' ' ' LEU . 6.5 mtt -99.02 141.87 31.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 74.340000000000003 110.863 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.7 mtt -137.03 116.96 13.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 71.530000000000001 110.883 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.724 ' CG ' HD11 ' A' ' 46' ' ' LEU . 4.2 mmm -107.14 126.13 51.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 74.409999999999997 110.893 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.83 -155.05 26.19 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.735 . . . . 75.099999999999994 112.475 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.3 t -134.65 143.83 47.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.764 0.316 . . . . 61.0 111.133 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -61.72 159.56 13.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 74.519999999999996 110.891 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -52.07 157.25 1.36 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 74.209999999999994 110.853 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -165.46 32.0 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 73.519999999999996 110.877 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.6 t -168.5 -128.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 72.510000000000005 110.86 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.454 0 O-C-N 124.504 1.128 . . . . 32.299999999999997 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.77 0.319 . . . . 73.099999999999994 110.848 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.697 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . -113.39 146.7 39.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 73.329999999999998 111.06 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.409 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 3.3 mt -110.9 108.11 57.74 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.644 0.735 . . . . 74.439999999999998 110.911 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 53.8 Cg_endo -69.81 155.72 65.07 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.666 2.244 . . . . 64.310000000000002 112.338 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.866 HD12 HD22 ' A' ' 28' ' ' LEU . 17.4 mt -150.95 138.68 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 73.129999999999995 111.12 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.552 HD12 ' HA ' ' A' ' 69' ' ' ASN . 6.1 mt -94.78 140.79 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 72.439999999999998 111.109 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.789 HG21 HD13 ' A' ' 32' ' ' LEU . 8.4 p -126.63 123.13 62.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.124 -0.489 . . . . 62.009999999999998 111.154 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -107.77 117.38 33.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 72.400000000000006 110.863 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 17.9 t-105 -119.84 102.07 8.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 70.120000000000005 110.902 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.09 -82.93 0.81 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.748 -0.739 . . . . 51.0 112.505 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.26 19.93 0.83 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.734 -0.745 . . . . 73.230000000000004 112.471 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -128.26 175.72 8.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.75 0.31 . . . . 73.340000000000003 110.938 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -132.99 141.7 48.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 72.420000000000002 110.875 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -138.28 118.38 13.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.16 -0.473 . . . . 63.43 110.938 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.4 p -82.62 135.38 35.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 75.319999999999993 110.898 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.526 HG21 ' CD2' ' A' ' 32' ' ' LEU . 62.3 t -94.36 130.58 43.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 64.349999999999994 111.13 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.5 p -144.37 90.55 2.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 73.310000000000002 111.123 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.764 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 2.8 t 177.68 -32.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 73.129999999999995 111.119 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.785 HD13 ' HA ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -87.86 164.12 16.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 61.109999999999999 110.898 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.42 174.82 10.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 74.519999999999996 110.877 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.404 ' HG2' HD12 ' A' ' 3' ' ' LEU . 37.8 mt-10 -64.8 -20.46 66.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 63.530000000000001 110.873 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -67.73 -20.98 65.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 72.319999999999993 110.852 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.663 ' HB2' HD23 ' A' ' 19' ' ' LEU . 1.5 m-20 -85.31 -150.36 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 73.239999999999995 110.84 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.97 162.68 33.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 75.329999999999998 111.121 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.011 HG22 HD11 ' A' ' 64' ' ' LEU . 22.0 t -55.5 -48.53 77.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.45 . . . . 74.230000000000004 111.12 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.403 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -61.29 -28.33 69.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 61.200000000000003 110.929 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.558 ' HB3' HD21 ' A' ' 19' ' ' LEU . 9.3 t70 -71.56 -36.24 70.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 74.120000000000005 110.901 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.866 HD22 HD12 ' A' ' 5' ' ' ILE . 0.9 OUTLIER -77.2 -47.72 19.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 72.0 110.894 -179.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.536 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -62.47 -55.11 30.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 73.019999999999996 110.875 179.83 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -56.62 -22.65 35.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 73.230000000000004 110.878 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.764 ' CZ ' HG21 ' A' ' 18' ' ' THR . 42.7 t80 -76.77 -55.08 5.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 73.430000000000007 110.874 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.789 HD13 HG21 ' A' ' 7' ' ' VAL . 1.8 pp -69.01 -41.86 77.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 73.349999999999994 110.875 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.569 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.2 tmtt? -54.85 -27.72 44.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 73.340000000000003 110.899 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.519 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.33 -23.41 43.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.461 . . . . 74.349999999999994 111.157 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.5 mt -76.98 -59.77 2.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 73.129999999999995 110.915 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.8 t -135.66 -27.64 1.15 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.458 . . . . 64.019999999999996 111.176 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.569 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.66 -177.77 4.64 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.704 -0.76 . . . . 73.340000000000003 112.506 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.884 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.3 p -112.31 138.88 39.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.88 0.371 . . . . 73.329999999999998 111.159 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.984 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.78 151.04 16.25 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.635 0.731 . . . . 75.329999999999998 110.913 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 53.3 Cg_endo -69.74 -21.79 33.09 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.713 2.275 . . . . 72.430000000000007 112.318 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -54.17 -39.11 66.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 63.43 110.911 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.425 ' H ' HD23 ' A' ' 39' ' ' LEU . 4.2 mpt_? -104.02 -40.21 6.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 73.519999999999996 110.855 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.884 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.7 pp0? -97.84 157.37 16.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 55.420000000000002 110.881 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.06 142.1 51.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 74.450000000000003 110.902 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.402 ' N ' HD22 ' A' ' 45' ' ' LEU . 3.7 mm? -67.45 135.95 53.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 64.209999999999994 110.916 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.733 HD11 ' CG ' ' A' ' 75' ' ' MET . 6.2 mp -85.37 -60.49 2.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 73.450000000000003 110.939 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.82 51.63 0.97 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.755 -0.736 . . . . 64.349999999999994 112.494 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.651 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 3.6 pp -55.2 -25.45 32.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.909 0.385 . . . . 75.219999999999999 110.929 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.414 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -107.34 141.76 38.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 41.299999999999997 110.88 179.832 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.977 HG21 HD11 ' A' ' 66' ' ' LEU . 23.8 t -143.95 144.97 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 61.130000000000003 111.113 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.554 ' HG2' HG12 ' A' ' 50' ' ' VAL . 0.4 OUTLIER 54.34 32.41 16.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 74.25 110.944 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.07 -14.45 49.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.716 -0.755 . . . . 64.219999999999999 112.467 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -81.55 148.74 63.04 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.6 0.714 . . . . 63.530000000000001 110.866 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.414 ' HA ' ' HB3' ' A' ' 49' ' ' LYS . 53.5 Cg_endo -69.82 -35.0 13.27 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.696 2.264 . . . . 52.219999999999999 112.341 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.651 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 37.39 41.49 0.26 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 75.030000000000001 111.132 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.73 -76.89 0.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 71.549999999999997 110.885 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -150.98 -39.44 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 63.329999999999998 110.892 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -71.96 -2.63 18.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 71.319999999999993 110.875 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.566 ' O ' HG23 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -95.78 147.44 5.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 62.030000000000001 111.155 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.473 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 30.8 mttt -93.93 149.05 21.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 74.549999999999997 110.888 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.666 ' CD1' HD13 ' A' ' 28' ' ' LEU . 17.4 mt -51.98 -39.74 59.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 74.030000000000001 110.956 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.13 -16.49 80.56 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.767 -0.73 . . . . 53.539999999999999 112.489 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.91 -19.75 31.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.814 0.34 . . . . 61.310000000000002 111.096 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.011 HD11 HG22 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -85.05 -18.89 32.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 73.099999999999994 110.899 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp 52.31 42.63 31.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 62.130000000000003 110.879 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.977 HD11 HG21 ' A' ' 50' ' ' VAL . 3.3 mt -91.12 153.64 19.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 75.409999999999997 110.921 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.47 159.13 82.74 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.6 0.714 . . . . 65.219999999999999 110.842 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -37.21 9.56 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.69 2.26 . . . . 75.109999999999999 112.339 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.552 ' HA ' HD12 ' A' ' 6' ' ' ILE . 11.7 p30 -79.42 -16.31 56.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 64.439999999999998 110.856 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.634 HG21 HD13 ' A' ' 66' ' ' LEU . 65.8 m -31.77 132.4 0.11 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 52.32 111.144 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.86 145.92 28.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 74.150000000000006 110.916 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.5 mm -115.63 128.75 72.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.245 -0.434 . . . . 62.030000000000001 111.117 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.2 mtt -99.35 141.45 32.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 71.239999999999995 110.918 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.9 mtt -136.65 116.71 13.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 75.430000000000007 110.878 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.733 ' CG ' HD11 ' A' ' 46' ' ' LEU . 3.9 mmm -106.38 127.13 53.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 73.109999999999999 110.88 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.98 -155.92 27.08 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.697 -0.764 . . . . 55.140000000000001 112.436 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.3 t -134.71 146.59 49.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.768 0.318 . . . . 71.530000000000001 111.195 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -64.12 160.58 17.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 70.209999999999994 110.848 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.79 177.97 5.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 61.439999999999998 110.88 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -130.14 -48.99 1.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 72.200000000000003 110.883 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.19 162.84 13.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 75.340000000000003 110.874 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.489 0 O-C-N 124.494 1.121 . . . . 71.299999999999997 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mtt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.771 0.319 . . . . 71.319999999999993 110.86 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.733 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . -87.0 145.46 26.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 74.319999999999993 111.143 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.447 HD23 ' HG3' ' A' ' 21' ' ' GLU . 1.7 mm? -105.66 109.82 63.58 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.608 0.718 . . . . 63.439999999999998 110.934 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 156.46 63.45 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.716 2.277 . . . . 50.520000000000003 112.356 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.551 ' HB ' HD21 ' A' ' 28' ' ' LEU . 29.1 mt -149.98 137.01 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 75.150000000000006 111.132 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.669 HD12 ' HA ' ' A' ' 69' ' ' ASN . 3.7 mt -95.33 140.58 16.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 73.310000000000002 111.134 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.807 HG21 HD13 ' A' ' 32' ' ' LEU . 7.6 p -127.42 123.5 61.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 72.340000000000003 111.142 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.35 121.44 45.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 73.450000000000003 110.9 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 17.3 t-105 -125.17 106.25 9.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 74.120000000000005 110.928 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.16 -81.29 0.86 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.744 -0.741 . . . . 71.340000000000003 112.464 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -155.12 19.83 0.56 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.745 -0.741 . . . . 75.409999999999997 112.487 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -129.3 175.23 8.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.793 0.33 . . . . 72.200000000000003 110.865 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -132.43 140.09 48.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 63.329999999999998 110.881 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.55 ' CG ' HG21 ' A' ' 36' ' ' THR . 50.0 m-85 -134.39 116.13 14.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 63.43 110.979 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.76 131.49 35.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.488 . . . . 74.109999999999999 110.858 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.539 HG21 HD23 ' A' ' 32' ' ' LEU . 90.4 t -92.79 141.43 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 64.439999999999998 111.143 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.3 p -150.58 92.62 1.87 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 75.219999999999999 111.142 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.685 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.8 OUTLIER 173.29 -28.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 73.019999999999996 111.137 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.733 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.8 mm? -86.36 150.81 24.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.248 -0.433 . . . . 65.519999999999996 110.93 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.67 167.55 19.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 51.229999999999997 110.83 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.447 ' HG3' HD23 ' A' ' 3' ' ' LEU . 40.3 mt-10 -59.41 -22.24 61.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 52.439999999999998 110.892 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.0 -11.52 60.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.144 -0.48 . . . . 72.019999999999996 110.852 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.415 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.5 m-20 -100.34 -150.37 0.38 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 75.439999999999998 110.837 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.418 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -132.94 170.09 15.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 64.040000000000006 111.15 -179.892 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.974 HG22 HD11 ' A' ' 64' ' ' LEU . 12.8 t -66.1 -43.75 92.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 62.039999999999999 111.114 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.4 -28.77 68.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 62.310000000000002 110.926 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.477 ' HB3' HD11 ' A' ' 19' ' ' LEU . 9.1 t0 -69.97 -35.62 74.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 61.100000000000001 110.869 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.664 HD12 ' HB3' ' A' ' 19' ' ' LEU . 1.2 tt -80.7 -47.94 13.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 74.310000000000002 110.903 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.735 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.28 -56.56 19.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 73.400000000000006 110.911 179.88 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.19 -22.77 53.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 71.400000000000006 110.933 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.685 ' CZ ' HG21 ' A' ' 18' ' ' THR . 49.0 t80 -76.79 -55.27 5.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 71.510000000000005 110.89 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.807 HD13 HG21 ' A' ' 7' ' ' VAL . 2.3 pp -67.73 -43.46 79.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 74.109999999999999 110.877 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.566 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.2 tmtt? -54.89 -27.14 40.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 70.0 110.898 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.502 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.52 -23.72 42.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.248 -0.433 . . . . 70.310000000000002 111.135 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.1 mt -76.59 -59.57 2.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 52.450000000000003 110.901 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.55 HG21 ' CG ' ' A' ' 14' ' ' TYR . 2.9 t -135.09 -28.07 1.2 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 74.420000000000002 111.139 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.566 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.03 -177.37 4.85 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.745 -0.741 . . . . 63.119999999999997 112.539 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.855 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.3 p -112.84 138.43 42.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.845 0.355 . . . . 72.400000000000006 111.155 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.925 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -53.73 149.72 15.59 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.639 0.733 . . . . 75.349999999999994 110.926 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.4 ' O ' ' O ' ' A' ' 43' ' ' GLN . 53.8 Cg_endo -69.78 -21.71 33.01 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.663 2.242 . . . . 72.349999999999994 112.335 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -54.19 -38.3 65.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 62.520000000000003 110.925 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.418 ' H ' HD23 ' A' ' 39' ' ' LEU . 1.3 mpt_? -104.72 -40.04 6.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 73.420000000000002 110.856 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.855 ' HG2' HG13 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -96.94 158.66 15.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 72.540000000000006 110.955 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.37 139.57 52.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 63.340000000000003 110.916 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.15 136.08 55.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 72.219999999999999 110.92 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.761 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.1 mm? -75.83 -74.96 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 60.140000000000001 110.915 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -97.52 60.06 1.07 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.731 -0.747 . . . . 43.219999999999999 112.464 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.646 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 3.8 pp -54.93 -24.2 22.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.853 0.358 . . . . 74.349999999999994 110.944 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.421 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -104.32 143.33 33.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.202 -0.453 . . . . 71.340000000000003 110.879 179.813 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.76 HG21 HD21 ' A' ' 66' ' ' LEU . 14.9 p -144.13 143.2 23.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 60.509999999999998 111.131 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.642 ' HG2' HG22 ' A' ' 50' ' ' VAL . 10.0 mmpt? 54.2 34.06 19.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 60.210000000000001 110.912 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.4 -15.18 41.76 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.758 -0.735 . . . . 74.230000000000004 112.487 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -81.5 149.28 64.53 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.628 0.727 . . . . 74.530000000000001 110.848 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.421 ' HA ' ' HB3' ' A' ' 49' ' ' LYS . 54.0 Cg_endo -69.72 -35.47 12.71 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.698 2.265 . . . . 74.120000000000005 112.384 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 38.74 39.61 0.35 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 42.140000000000001 111.117 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.49 -75.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.278 -0.419 . . . . 74.540000000000006 110.873 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -154.68 -38.63 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 75.430000000000007 110.884 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -73.09 -1.98 19.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 73.310000000000002 110.819 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.58 ' O ' HG23 ' A' ' 25' ' ' VAL . 0.8 OUTLIER -92.71 148.27 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 75.239999999999995 111.124 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.431 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 16.6 mttt -91.18 147.28 23.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 70.349999999999994 110.924 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.43 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 18.7 mt -52.29 -39.31 60.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.433 . . . . 74.519999999999996 110.902 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.66 -16.91 80.34 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.735 -0.745 . . . . 71.340000000000003 112.511 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.49 -19.31 33.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.853 0.359 . . . . 73.349999999999994 111.093 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.974 HD11 HG22 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -83.79 -19.96 34.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 74.140000000000001 110.943 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp 52.87 43.49 31.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 62.420000000000002 110.935 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.76 HD21 HG21 ' A' ' 50' ' ' VAL . 3.4 mt -96.19 152.91 18.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 71.319999999999993 110.935 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.54 159.81 79.58 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.626 0.727 . . . . 72.530000000000001 110.894 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -36.15 11.22 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.645 2.23 . . . . 74.299999999999997 112.322 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.669 ' HA ' HD12 ' A' ' 6' ' ' ILE . 82.4 m-20 -78.57 -15.72 58.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 55.530000000000001 110.868 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.628 HG21 HD13 ' A' ' 66' ' ' LEU . 52.8 m -32.58 124.78 0.33 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 74.299999999999997 111.128 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.26 146.27 24.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 60.329999999999998 110.883 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.3 mm -115.16 129.88 70.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 64.450000000000003 111.165 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 6.8 mtp -101.85 141.93 33.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 72.439999999999998 110.895 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 78.3 mtm -132.48 125.67 31.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 71.319999999999993 110.895 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.761 ' CG ' HD21 ' A' ' 46' ' ' LEU . 0.4 OUTLIER -115.01 128.9 56.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 65.409999999999997 110.886 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 150.84 -151.72 23.67 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.768 -0.729 . . . . 72.109999999999999 112.528 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 t -133.02 134.42 44.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.801 0.334 . . . . 72.430000000000007 111.144 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.517 ' HB3' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -92.1 149.09 21.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 75.219999999999999 110.901 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -60.45 -175.16 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 65.109999999999999 110.893 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -99.22 88.61 3.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.484 . . . . 73.400000000000006 110.893 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.01 168.63 21.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 65.340000000000003 110.897 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.507 0 O-C-N 124.518 1.136 . . . . 32.210000000000001 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mtt . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.787 0.327 . . . . 74.010000000000005 110.889 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.54 137.07 37.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 72.150000000000006 111.105 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.521 ' O ' ' HG ' ' A' ' 3' ' ' LEU . 0.2 OUTLIER -107.22 111.78 63.17 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.594 0.711 . . . . 54.420000000000002 110.925 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 156.28 63.7 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.642 2.228 . . . . 75.049999999999997 112.366 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.528 ' HB ' HD21 ' A' ' 28' ' ' LEU . 30.8 mt -149.87 134.83 10.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 72.209999999999994 111.133 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.61 HD12 ' HA ' ' A' ' 69' ' ' ASN . 4.6 mt -94.28 140.94 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 72.230000000000004 111.151 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.848 HG21 HD13 ' A' ' 32' ' ' LEU . 7.3 p -127.26 123.22 61.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 62.32 111.101 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.64 119.06 38.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 73.430000000000007 110.906 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.9 t-105 -123.67 105.64 9.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 73.230000000000004 110.87 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.82 -81.82 0.9 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.754 -0.736 . . . . 71.019999999999996 112.478 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.76 19.92 0.59 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.729 -0.748 . . . . 52.340000000000003 112.45 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -129.28 175.85 8.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.738 0.304 . . . . 75.439999999999998 110.947 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -132.48 140.83 48.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 74.0 110.916 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.53 ' CG ' HG21 ' A' ' 36' ' ' THR . 53.7 m-85 -135.79 117.0 14.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 75.299999999999997 110.903 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.0 p -83.07 130.89 35.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 50.450000000000003 110.839 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.581 HG21 HD23 ' A' ' 32' ' ' LEU . 96.4 t -92.86 135.3 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 74.109999999999999 111.12 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.6 p -144.39 92.47 2.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 72.400000000000006 111.161 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.654 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.8 OUTLIER 173.4 -28.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 72.510000000000005 111.161 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.67 ' HB3' HD12 ' A' ' 28' ' ' LEU . 1.6 mm? -85.94 151.12 24.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 74.040000000000006 110.874 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.53 163.47 28.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 52.210000000000001 110.85 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.459 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 72.2 mt-10 -55.71 -23.79 30.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.097 -0.501 . . . . 43.240000000000002 110.876 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -66.66 -14.01 61.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.467 . . . . 64.319999999999993 110.865 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.419 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.7 m-20 -98.44 -149.77 0.35 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 75.409999999999997 110.89 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.54 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -132.8 172.92 11.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 74.439999999999998 111.132 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.93 HG22 HD11 ' A' ' 64' ' ' LEU . 10.8 t -68.53 -43.61 83.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 74.310000000000002 111.153 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.45 -28.72 68.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 74.239999999999995 110.9 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.489 ' HB3' HD11 ' A' ' 19' ' ' LEU . 9.5 t0 -70.18 -35.82 74.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.189 -0.46 . . . . 73.510000000000005 110.838 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.67 HD12 ' HB3' ' A' ' 19' ' ' LEU . 1.1 tt -80.61 -47.06 14.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 73.540000000000006 110.909 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.754 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -62.09 -56.9 14.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 74.420000000000002 110.866 179.814 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -57.8 -22.49 47.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.276 -0.42 . . . . 73.329999999999998 110.925 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.654 ' CZ ' HG21 ' A' ' 18' ' ' THR . 62.5 t80 -77.35 -55.23 5.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 44.329999999999998 110.864 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.848 HD13 HG21 ' A' ' 7' ' ' VAL . 2.3 pp -67.78 -43.06 80.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 65.140000000000001 110.93 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.565 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -55.01 -27.04 41.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 55.119999999999997 110.906 179.829 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.489 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.77 -23.54 42.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 70.239999999999995 111.121 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.4 mt -76.97 -60.16 2.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.227 -0.442 . . . . 72.239999999999995 110.9 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.53 HG21 ' CG ' ' A' ' 14' ' ' TYR . 2.9 t -134.93 -27.76 1.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 53.240000000000002 111.153 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.83 -177.76 4.84 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.76 -0.734 . . . . 61.420000000000002 112.503 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.869 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.3 p -112.29 139.26 37.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.898 0.38 . . . . 72.019999999999996 111.129 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.969 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.61 150.56 17.35 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.599 0.714 . . . . 72.129999999999995 110.919 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 -21.92 32.95 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.676 2.251 . . . . 64.230000000000004 112.333 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -54.1 -39.04 66.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 71.530000000000001 110.928 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.434 ' H ' HD23 ' A' ' 39' ' ' LEU . 5.8 mpt_? -104.25 -40.18 6.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.142 -0.481 . . . . 61.530000000000001 110.881 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.869 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.8 pp0? -97.51 158.16 15.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 73.430000000000007 110.91 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.9 141.71 51.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.438 . . . . 75.230000000000004 110.907 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.98 134.8 52.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 74.120000000000005 110.89 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.735 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.0 mm? -75.93 -75.55 0.18 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 75.409999999999997 110.898 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.83 59.84 1.47 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.737 -0.744 . . . . 61.109999999999999 112.473 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.656 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 3.7 pp -55.56 -23.55 27.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.838 0.351 . . . . 70.25 110.914 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.422 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -105.57 142.23 35.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 65.230000000000004 110.929 179.808 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.943 HG21 HD11 ' A' ' 66' ' ' LEU . 21.8 t -143.74 144.27 23.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 71.040000000000006 111.097 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.651 ' HG2' HG12 ' A' ' 50' ' ' VAL . 16.0 mmtm 54.35 33.29 18.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 71.450000000000003 110.897 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.48 -14.78 44.43 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.733 -0.746 . . . . 74.129999999999995 112.495 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -81.56 149.26 64.24 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.6 0.714 . . . . 73.519999999999996 110.886 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.422 ' HA ' ' HB3' ' A' ' 49' ' ' LYS . 54.1 Cg_endo -69.7 -35.69 12.34 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.693 2.262 . . . . 73.319999999999993 112.386 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.656 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 38.5 40.26 0.37 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.453 . . . . 74.299999999999997 111.106 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.34 -75.38 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 74.439999999999998 110.881 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -156.38 -37.84 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 64.140000000000001 110.91 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -74.41 -1.05 19.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 74.030000000000001 110.828 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.573 ' O ' HG23 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -93.04 147.81 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 52.420000000000002 111.146 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.408 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 5.8 mttp -89.49 146.18 24.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 65.25 110.878 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 15.9 mt -52.37 -38.39 58.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 62.310000000000002 110.884 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.96 -17.2 80.18 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.736 -0.745 . . . . 65.420000000000002 112.483 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.22 -19.63 33.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.829 0.347 . . . . 74.310000000000002 111.102 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.93 HD11 HG22 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -84.54 -19.53 33.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 25.34 110.907 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp 54.21 42.08 31.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 73.129999999999995 110.893 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.943 HD11 HG21 ' A' ' 50' ' ' VAL . 3.9 mt -92.71 152.05 19.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 61.229999999999997 110.906 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -68.63 160.18 78.11 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.563 0.696 . . . . 61.32 110.914 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -37.58 8.99 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.663 2.242 . . . . 61.420000000000002 112.36 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.61 ' HA ' HD12 ' A' ' 6' ' ' ILE . 55.0 m-20 -78.84 -15.92 57.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 64.329999999999998 110.877 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.701 HG21 HD13 ' A' ' 66' ' ' LEU . 66.9 m -31.31 129.44 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.155 -0.475 . . . . 63.119999999999997 111.185 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.87 145.73 26.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 61.030000000000001 110.905 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.8 mm -115.61 128.71 72.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 74.519999999999996 111.135 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 28.5 mtm -101.33 141.6 33.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 73.019999999999996 110.894 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 73.1 mtm -136.2 116.91 13.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 62.32 110.893 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.735 ' CG ' HD21 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -105.92 127.53 53.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 75.120000000000005 110.886 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.65 -154.22 25.27 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.765 -0.731 . . . . 62.539999999999999 112.489 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.2 t -134.84 146.22 49.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.79 0.328 . . . . 64.310000000000002 111.136 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.22 158.04 24.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 75.450000000000003 110.877 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.7 ' OE1' ' N ' ' A' ' 90' ' ' NH2 . 5.0 pt-20 -51.15 133.68 27.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 72.430000000000007 110.885 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -57.42 -32.85 67.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 71.510000000000005 110.844 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.51 -14.36 0.11 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.491 . . . . 74.409999999999997 110.833 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' NH2 . . . . . 0.7 ' N ' ' OE1' ' A' ' 79' ' ' GLU . . . . . . . . 0 C--N 1.324 -0.514 0 O-C-N 124.493 1.12 . . . . 10.43 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.8 mmt . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.75 0.31 . . . . 72.310000000000002 110.882 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.753 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . -81.43 148.27 29.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 44.530000000000001 111.083 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.502 HD12 ' HG2' ' A' ' 21' ' ' GLU . 1.0 OUTLIER -107.37 108.98 62.51 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.604 0.716 . . . . 74.439999999999998 110.936 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 156.33 63.42 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.716 2.277 . . . . 74.510000000000005 112.295 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.477 ' HB ' HD21 ' A' ' 28' ' ' LEU . 38.1 mt -150.4 136.42 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 70.310000000000002 111.131 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.703 HD12 ' HA ' ' A' ' 69' ' ' ASN . 3.5 mt -94.93 140.13 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 73.430000000000007 111.119 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.883 HG21 HD13 ' A' ' 32' ' ' LEU . 8.3 p -127.69 123.02 60.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 72.420000000000002 111.08 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.89 120.51 42.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 73.329999999999998 110.895 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 14.1 t-105 -122.74 102.67 8.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 73.150000000000006 110.919 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.0 -78.09 1.71 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.774 -0.727 . . . . 54.420000000000002 112.484 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -155.62 18.5 0.5 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.75 -0.738 . . . . 73.230000000000004 112.5 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -130.87 139.17 50.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.738 0.304 . . . . 74.530000000000001 110.922 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -102.62 142.11 34.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 73.129999999999995 110.896 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.605 ' CD1' HG21 ' A' ' 36' ' ' THR . 82.6 m-85 -136.24 122.14 20.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.494 . . . . 70.299999999999997 110.914 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 92.7 p -84.95 133.43 34.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 51.520000000000003 110.844 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.592 HG21 HD23 ' A' ' 32' ' ' LEU . 85.5 t -96.37 111.48 26.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 51.409999999999997 111.136 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.0 p -124.05 91.42 3.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 74.439999999999998 111.174 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.618 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 1.2 t 174.83 -29.69 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 71.030000000000001 111.177 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.753 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 1.9 mm? -83.16 149.76 26.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 60.420000000000002 110.947 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.524 ' C ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.43 168.22 17.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 71.200000000000003 110.852 -179.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.502 ' HG2' HD12 ' A' ' 3' ' ' LEU . 51.8 mt-10 -59.8 -22.16 61.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.477 . . . . 74.420000000000002 110.891 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -69.26 -11.34 60.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 70.040000000000006 110.868 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.442 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.5 m-20 -99.52 -149.54 0.36 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 54.329999999999998 110.896 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.485 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -138.07 167.46 21.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 64.450000000000003 111.131 -179.878 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.973 HG22 HD11 ' A' ' 64' ' ' LEU . 41.4 t -61.9 -45.69 98.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 73.409999999999997 111.129 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.48 -29.15 67.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 73.340000000000003 110.914 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.553 ' HB3' HD11 ' A' ' 19' ' ' LEU . 1.3 t0 -70.69 -34.31 71.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 70.519999999999996 110.841 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.695 HD23 HD23 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -80.74 -48.45 12.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 71.420000000000002 110.904 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.592 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.6 -56.79 16.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 73.129999999999995 110.894 179.827 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.05 -22.76 51.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 65.439999999999998 110.894 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.618 ' CZ ' HG21 ' A' ' 18' ' ' THR . 58.7 t80 -76.94 -55.16 5.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 75.25 110.922 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.883 HD13 HG21 ' A' ' 7' ' ' VAL . 2.5 pp -67.59 -42.81 81.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 74.109999999999999 110.926 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.571 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.2 tmtt? -54.96 -27.14 41.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 74.340000000000003 110.926 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.99 -23.67 41.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 60.049999999999997 111.132 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.8 mt -76.96 -60.03 2.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 61.210000000000001 110.908 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.605 HG21 ' CD1' ' A' ' 14' ' ' TYR . 5.1 t -135.45 -27.35 1.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 75.519999999999996 111.166 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.571 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.48 -178.75 4.96 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.724 -0.75 . . . . 54.240000000000002 112.489 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.85 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.4 p -113.25 137.96 44.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.885 0.374 . . . . 30.440000000000001 111.132 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.984 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -53.95 149.56 17.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.615 0.721 . . . . 53.240000000000002 110.919 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -21.59 33.24 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.65 2.234 . . . . 72.439999999999998 112.389 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -54.21 -38.35 65.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 71.099999999999994 110.883 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.408 ' H ' HD23 ' A' ' 39' ' ' LEU . 2.7 mpt_? -105.05 -39.94 6.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 64.450000000000003 110.907 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.85 ' HG2' HG13 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -95.67 159.4 15.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 75.510000000000005 110.905 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.8 137.85 52.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 63.549999999999997 110.899 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 45' ' ' LEU . 3.4 mm? -66.86 132.66 48.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 71.129999999999995 110.917 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.738 HD11 ' CG ' ' A' ' 75' ' ' MET . 5.8 mp -83.05 -44.48 15.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 73.109999999999999 110.908 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -107.73 39.26 2.96 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.751 -0.738 . . . . 44.350000000000001 112.478 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.516 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 0.5 OUTLIER -44.88 -35.02 2.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.905 0.383 . . . . 70.409999999999997 110.927 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.85 146.54 33.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 55.5 110.872 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.675 HG21 HD21 ' A' ' 66' ' ' LEU . 14.1 p -143.77 145.69 21.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 71.120000000000005 111.11 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.5 mttt 54.91 31.19 15.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.47 . . . . 74.420000000000002 110.866 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.64 -10.83 54.9 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.717 -0.754 . . . . 52.539999999999999 112.518 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -81.44 149.51 65.23 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.581 0.705 . . . . 72.140000000000001 110.881 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -31.69 19.96 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.632 2.221 . . . . 75.230000000000004 112.36 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.609 ' HA ' HG21 ' A' ' 59' ' ' VAL . . . 37.36 41.91 0.28 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 51.109999999999999 111.082 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.03 -77.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 64.530000000000001 110.885 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.417 HD22 ' N ' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -157.92 -36.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 74.430000000000007 110.902 -179.942 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.417 ' N ' HD22 ' A' ' 57' ' ' ASN . 0.2 OUTLIER -68.06 -6.77 24.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 73.239999999999995 110.885 179.917 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.609 HG21 ' HA ' ' A' ' 55' ' ' ALA . 17.6 t -82.14 146.35 7.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.468 . . . . 55.149999999999999 111.12 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.2 mttp -94.46 151.61 19.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 74.109999999999999 110.871 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.553 ' HA ' HD12 ' A' ' 64' ' ' LEU . 19.5 mt -50.84 -44.63 59.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 71.450000000000003 110.944 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.54 -12.25 84.52 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.753 -0.737 . . . . 62.039999999999999 112.504 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.77 -34.42 27.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 65.439999999999998 111.097 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.973 HD11 HG22 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -70.48 -25.22 63.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 72.439999999999998 110.91 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp 62.38 36.87 14.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 61.530000000000001 110.902 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.675 HD21 HG21 ' A' ' 50' ' ' VAL . 4.2 mt -92.04 152.83 19.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 75.129999999999995 110.894 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -68.49 160.99 73.58 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.607 0.717 . . . . 63.210000000000001 110.903 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 -35.47 12.69 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.701 2.267 . . . . 42.32 112.381 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.703 ' HA ' HD12 ' A' ' 6' ' ' ILE . 23.7 p30 -78.77 -15.73 58.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 64.109999999999999 110.909 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.643 HG21 HD13 ' A' ' 66' ' ' LEU . 52.4 m -32.53 121.4 0.33 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.174 -0.467 . . . . 74.239999999999995 111.124 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -92.85 145.81 24.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 62.219999999999999 110.875 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.6 mm -115.74 129.17 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.268 -0.424 . . . . 74.319999999999993 111.149 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.455 ' CB ' HD13 ' A' ' 46' ' ' LEU . 4.6 mtp -101.33 141.92 33.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 73.329999999999998 110.891 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 76.5 mtm -135.2 119.62 17.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.438 . . . . 75.310000000000002 110.873 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.738 ' CG ' HD11 ' A' ' 46' ' ' LEU . 1.4 mmt -110.74 123.71 50.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 53.32 110.895 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 163.01 -153.9 24.63 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.756 -0.735 . . . . 71.530000000000001 112.508 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.6 t -134.17 142.12 47.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.81 0.338 . . . . 62.210000000000001 111.133 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -61.59 160.33 11.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 73.319999999999993 110.846 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.04 138.81 24.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 53.539999999999999 110.91 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 58.33 -172.12 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 61.5 110.864 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -108.5 -29.14 8.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.488 . . . . 75.209999999999994 110.829 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.505 0 O-C-N 124.495 1.122 . . . . 65.120000000000005 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mtm . . . . . 0 N--CA 1.458 -0.062 0 CA-C-O 120.749 0.309 . . . . 74.219999999999999 110.889 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.24 137.06 50.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 44.229999999999997 111.062 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.506 ' O ' ' HG ' ' A' ' 3' ' ' LEU . 0.2 OUTLIER -107.29 111.72 63.09 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.67 0.748 . . . . 62.229999999999997 110.938 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.412 ' O ' HD12 ' A' ' 3' ' ' LEU . 53.9 Cg_endo -69.77 156.34 63.59 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.713 2.275 . . . . 62.420000000000002 112.342 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.543 ' HB ' HD21 ' A' ' 28' ' ' LEU . 23.8 mt -149.17 135.62 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 74.099999999999994 111.143 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.633 HD12 ' HA ' ' A' ' 69' ' ' ASN . 4.4 mt -94.78 141.0 15.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 64.019999999999996 111.15 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.833 HG21 HD13 ' A' ' 32' ' ' LEU . 7.9 p -127.3 123.12 61.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 64.129999999999995 111.122 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.65 121.36 44.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 73.319999999999993 110.908 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 13.1 t-105 -121.74 100.9 7.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 71.420000000000002 110.939 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.01 -83.53 0.91 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.736 -0.745 . . . . 75.010000000000005 112.517 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.94 20.43 1.12 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.742 . . . . 64.430000000000007 112.497 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -128.01 174.31 9.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.739 0.304 . . . . 72.219999999999999 110.926 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -133.06 140.12 47.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 72.349999999999994 110.917 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.521 ' CD2' HG21 ' A' ' 36' ' ' THR . 38.7 m-85 -135.83 115.97 13.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.494 . . . . 73.030000000000001 110.901 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.3 p -82.19 133.41 35.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 60.310000000000002 110.873 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.521 HG21 HD23 ' A' ' 32' ' ' LEU . 91.5 t -96.01 139.72 18.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 54.43 111.123 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.5 p -148.23 93.58 2.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 73.140000000000001 111.167 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.682 HG21 ' CZ ' ' A' ' 31' ' ' PHE . 0.8 OUTLIER 173.04 -28.37 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 73.25 111.169 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.657 ' HB3' HD12 ' A' ' 28' ' ' LEU . 1.7 mm? -86.52 151.78 23.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 72.349999999999994 110.944 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.77 163.57 28.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 62.5 110.858 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.448 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 49.0 mt-10 -56.16 -23.34 34.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 72.519999999999996 110.872 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -67.84 -12.53 60.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 70.340000000000003 110.873 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.405 ' HB2' HD12 ' A' ' 19' ' ' LEU . 1.6 m-20 -99.12 -150.31 0.37 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 71.040000000000006 110.842 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -132.19 171.1 14.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 74.340000000000003 111.122 -179.881 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.946 HG22 HD11 ' A' ' 64' ' ' LEU . 11.6 t -67.3 -43.78 87.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 73.400000000000006 111.109 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.77 -28.36 68.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 73.519999999999996 110.901 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.494 ' HB3' HD11 ' A' ' 19' ' ' LEU . 17.3 t0 -70.18 -35.64 74.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.475 . . . . 73.420000000000002 110.853 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.673 HD23 HD23 ' A' ' 32' ' ' LEU . 1.2 tt -80.76 -47.41 13.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 44.140000000000001 110.966 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.77 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -61.7 -56.6 17.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 42.130000000000003 110.91 179.81 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -58.09 -22.42 50.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 73.420000000000002 110.878 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.682 ' CZ ' HG21 ' A' ' 18' ' ' THR . 56.4 t80 -77.18 -55.2 5.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 74.439999999999998 110.867 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.833 HD13 HG21 ' A' ' 7' ' ' VAL . 2.4 pp -67.93 -43.01 80.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.14 -0.482 . . . . 73.519999999999996 110.931 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.564 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.9 -27.2 41.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.45 . . . . 74.349999999999994 110.908 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.73 -23.61 42.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.247 -0.433 . . . . 54.450000000000003 111.107 179.968 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.0 mt -76.59 -59.76 2.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 70.400000000000006 110.94 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.521 HG21 ' CD2' ' A' ' 14' ' ' TYR . 3.3 t -135.14 -27.83 1.2 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 74.540000000000006 111.119 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -64.29 -176.7 4.77 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.718 -0.753 . . . . 42.5 112.505 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.88 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.1 p -112.43 139.73 35.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.835 0.35 . . . . 75.519999999999996 111.16 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.983 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.76 150.2 19.41 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.584 0.707 . . . . 74.519999999999996 110.922 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -21.98 32.63 Favored 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.696 2.264 . . . . 71.400000000000006 112.308 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -54.42 -39.08 66.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.273 -0.421 . . . . 74.439999999999998 110.932 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.413 ' H ' HD23 ' A' ' 39' ' ' LEU . 9.2 mtt85 -103.76 -40.73 6.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 73.420000000000002 110.906 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.88 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.6 pp0? -97.29 157.58 15.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 65.129999999999995 110.89 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.77 142.18 51.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 72.129999999999995 110.923 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.49 136.05 54.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 74.120000000000005 110.942 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.743 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.0 mm? -77.31 -75.03 0.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 72.420000000000002 110.929 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.15 59.23 1.68 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.774 -0.727 . . . . 70.25 112.522 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.645 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 3.8 pp -56.22 -23.06 33.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 73.209999999999994 110.906 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.417 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 2.0 pttt -105.95 142.33 35.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 72.5 110.911 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.871 HG11 HD21 ' A' ' 66' ' ' LEU . 20.8 t -143.94 144.33 23.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 73.129999999999995 111.119 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.596 ' HG3' HG12 ' A' ' 50' ' ' VAL . 18.4 mttt 54.27 33.06 17.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 75.209999999999994 110.912 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.79 -14.67 46.72 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.728 -0.748 . . . . 72.5 112.504 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -81.56 148.97 63.62 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.597 0.713 . . . . 71.209999999999994 110.853 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.417 ' HA ' ' HB3' ' A' ' 49' ' ' LYS . 53.2 Cg_endo -69.82 -35.49 12.37 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.657 2.238 . . . . 64.340000000000003 112.323 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.645 ' HB3' ' O ' ' A' ' 48' ' ' LEU . . . 38.03 40.69 0.32 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 61.200000000000003 111.088 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.02 -76.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 72.310000000000002 110.882 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -155.25 -38.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 61.310000000000002 110.877 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -73.55 -1.12 17.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 73.129999999999995 110.892 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.572 ' O ' HG23 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -93.45 148.37 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 70.030000000000001 111.159 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.414 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 5.6 mttt -90.32 146.7 24.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 60.340000000000003 110.874 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.448 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 16.4 mt -52.27 -38.88 59.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.447 . . . . 75.420000000000002 110.883 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.89 -17.02 80.28 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.76 -0.733 . . . . 33.210000000000001 112.508 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.15 -19.46 34.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.812 0.339 . . . . 64.310000000000002 111.128 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.946 HD11 HG22 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -84.83 -19.9 31.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 74.120000000000005 110.906 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.9 mmtp 55.13 41.47 31.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 65.209999999999994 110.923 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.871 HD21 HG11 ' A' ' 50' ' ' VAL . 3.8 mt -92.38 151.2 20.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 72.230000000000004 110.918 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -68.43 160.79 74.28 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.619 0.723 . . . . 65.239999999999995 110.944 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -37.09 9.67 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.738 2.292 . . . . 72.120000000000005 112.33 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.633 ' HA ' HD12 ' A' ' 6' ' ' ILE . 10.5 p-10 -78.81 -15.82 57.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 70.120000000000005 110.891 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.749 HG21 HD22 ' A' ' 66' ' ' LEU . 53.1 m -31.25 128.96 0.15 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 62.399999999999999 111.183 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.49 146.4 25.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.229 -0.441 . . . . 63.219999999999999 110.868 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.7 mm -115.38 127.93 72.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 73.200000000000003 111.131 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.0 mtp -100.15 141.72 32.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 65.310000000000002 110.841 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.8 mtt -134.58 127.5 31.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 73.530000000000001 110.871 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.743 ' CG ' HD21 ' A' ' 46' ' ' LEU . 0.3 OUTLIER -116.97 126.35 52.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 72.129999999999995 110.913 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.9 -154.53 25.6 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.75 -0.738 . . . . 63.219999999999999 112.51 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 t -133.52 140.12 47.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.763 0.316 . . . . 75.099999999999994 111.101 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.479 ' HA ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -93.88 150.34 20.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 64.099999999999994 110.907 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.12 174.55 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 75.430000000000007 110.901 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.17 -59.55 4.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 65.310000000000002 110.858 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.2 t -67.62 -104.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 64.239999999999995 110.889 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.452 0 O-C-N 124.447 1.092 . . . . 45.140000000000001 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.76 0.314 . . . . 73.209999999999994 110.864 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.691 ' HB1' ' O ' ' A' ' 19' ' ' LEU . . . -80.76 150.98 29.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 72.030000000000001 111.076 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.416 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 1.7 mt -113.53 107.08 53.61 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.579 0.704 . . . . 62.149999999999999 110.917 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 53.7 Cg_endo -69.78 155.68 65.24 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.665 2.243 . . . . 55.350000000000001 112.338 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.962 HD12 HD22 ' A' ' 28' ' ' LEU . 20.7 mt -151.0 138.77 13.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 75.150000000000006 111.105 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.615 HD12 ' HA ' ' A' ' 69' ' ' ASN . 4.7 mt -95.02 140.47 16.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 74.409999999999997 111.119 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.829 HG21 HD13 ' A' ' 32' ' ' LEU . 7.5 p -126.53 123.0 62.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 70.010000000000005 111.139 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.45 118.07 35.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 63.109999999999999 110.9 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 15.9 t-105 -122.87 106.67 11.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 73.319999999999993 110.889 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.72 -81.06 0.9 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.744 -0.741 . . . . 74.409999999999997 112.469 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -155.98 19.87 0.49 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.72 -0.752 . . . . 54.25 112.466 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -129.34 176.07 8.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.796 0.332 . . . . 52.409999999999997 110.902 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -132.51 140.83 48.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 70.010000000000005 110.901 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -136.18 119.44 16.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 73.319999999999993 110.915 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.6 p -82.89 134.22 35.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.089 -0.505 . . . . 64.319999999999993 110.857 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.535 HG21 HD23 ' A' ' 32' ' ' LEU . 87.2 t -93.46 132.81 36.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 64.530000000000001 111.152 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.4 p -147.28 92.08 2.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 71.540000000000006 111.162 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.679 HG21 ' CE1' ' A' ' 31' ' ' PHE . 1.8 t 176.99 -31.89 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 73.549999999999997 111.133 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.788 ' CB ' HD12 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -87.93 164.32 15.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 75.219999999999999 110.931 179.948 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.449 ' O ' HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -136.26 175.17 9.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.448 . . . . 52.0 110.848 -179.895 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.424 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 35.0 mt-10 -64.52 -20.01 65.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 54.32 110.896 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.94 -11.32 60.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.127 -0.488 . . . . 32.030000000000001 110.839 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.687 ' HB2' HD23 ' A' ' 19' ' ' LEU . 1.6 m-20 -95.99 -152.62 0.38 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 74.420000000000002 110.848 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -136.91 165.6 25.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 61.210000000000001 111.156 -179.882 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.978 HG22 HD11 ' A' ' 64' ' ' LEU . 37.9 t -58.69 -44.41 89.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 73.099999999999994 111.157 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.407 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -63.88 -30.13 71.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 61.399999999999999 110.875 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.577 ' HB3' HD21 ' A' ' 19' ' ' LEU . 3.3 t70 -71.37 -34.97 70.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 60.43 110.875 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.962 HD22 HD12 ' A' ' 5' ' ' ILE . 0.6 OUTLIER -78.72 -48.03 15.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 63.420000000000002 110.902 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.557 ' HD2' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -62.15 -54.73 36.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 72.430000000000007 110.902 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -56.36 -22.51 31.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 75.510000000000005 110.929 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.679 ' CE1' HG21 ' A' ' 18' ' ' THR . 56.3 t80 -77.31 -55.45 5.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 72.129999999999995 110.849 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.829 HD13 HG21 ' A' ' 7' ' ' VAL . 2.0 pp -67.68 -43.5 80.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 73.109999999999999 110.912 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.569 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -54.49 -27.17 35.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 74.310000000000002 110.882 179.849 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -79.69 -23.85 42.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 63.149999999999999 111.152 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.4 mt -76.36 -59.71 2.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.198 -0.456 . . . . 74.099999999999994 110.909 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.5 t -135.21 -28.03 1.18 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.461 . . . . 61.240000000000002 111.136 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.569 ' HA3' ' HA ' ' A' ' 33' ' ' LYS . . . -63.67 -177.51 4.51 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.757 -0.735 . . . . 55.32 112.503 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.882 HG13 ' HG2' ' A' ' 43' ' ' GLN . 1.3 p -112.83 138.71 41.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.883 0.373 . . . . 65.049999999999997 111.11 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.987 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -54.86 150.63 18.18 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.633 0.73 . . . . 55.219999999999999 110.852 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -21.76 32.83 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.671 2.247 . . . . 63.240000000000002 112.35 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -54.13 -38.93 66.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 74.450000000000003 110.902 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.422 ' H ' HD23 ' A' ' 39' ' ' LEU . 6.6 mpt_? -104.29 -40.4 6.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.505 . . . . 70.319999999999993 110.836 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.882 ' HG2' HG13 ' A' ' 38' ' ' VAL . 1.9 pp0? -97.21 158.09 15.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 64.099999999999994 110.876 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.09 141.97 51.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 75.0 110.854 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.406 HD22 ' N ' ' A' ' 45' ' ' LEU . 3.7 mm? -67.05 134.01 51.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 65.409999999999997 110.894 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.745 HD21 ' CG ' ' A' ' 75' ' ' MET . 4.1 mm? -74.88 -68.03 0.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 64.129999999999995 110.926 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.39 60.03 0.69 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.707 -0.758 . . . . 24.100000000000001 112.465 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.598 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 4.6 pp -56.93 -19.81 19.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.86 0.362 . . . . 73.540000000000006 110.936 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.65 144.08 41.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 73.420000000000002 110.913 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.79 HG21 HD21 ' A' ' 66' ' ' LEU . 11.0 p -143.79 146.1 21.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 73.540000000000006 111.146 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.3 mttt 54.78 31.55 15.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 75.519999999999996 110.875 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.56 -10.87 54.33 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.71 -0.757 . . . . 34.219999999999999 112.502 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.2 mmtm -81.36 150.82 68.21 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.593 0.711 . . . . 72.129999999999995 110.869 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 55' ' ' ALA . 53.1 Cg_endo -69.81 -31.98 19.24 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.658 2.239 . . . . 73.450000000000003 112.359 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.638 ' HA ' HG21 ' A' ' 59' ' ' VAL . . . 35.93 44.63 0.25 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 44.119999999999997 111.072 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.32 -76.69 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 70.239999999999995 110.92 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -158.61 -37.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 73.329999999999998 110.887 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.85 -8.66 30.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 60.200000000000003 110.828 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.638 HG21 ' HA ' ' A' ' 55' ' ' ALA . 19.4 t -79.31 147.49 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 73.329999999999998 111.149 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.42 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 10.8 mttt -94.78 150.33 20.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 71.319999999999993 110.895 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.623 ' HA ' HD12 ' A' ' 64' ' ' LEU . 25.3 mt -51.42 -42.05 61.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 75.239999999999995 110.938 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.12 -13.34 83.33 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.768 -0.729 . . . . 71.430000000000007 112.443 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.04 -34.31 22.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.779 0.323 . . . . 54.219999999999999 111.066 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.978 HD11 HG22 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -67.84 -24.35 65.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 61.43 110.922 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp 59.88 33.08 21.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 72.439999999999998 110.859 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.79 HD21 HG21 ' A' ' 50' ' ' VAL . 5.0 mt -87.72 153.87 21.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.283 -0.417 . . . . 72.5 110.91 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.46 160.41 76.32 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.552 0.692 . . . . 73.239999999999995 110.906 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -35.3 12.81 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.641 2.227 . . . . 53.340000000000003 112.37 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.615 ' HA ' HD12 ' A' ' 6' ' ' ILE . 7.6 p30 -79.15 -16.38 56.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.431 . . . . 73.019999999999996 110.886 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.527 HG21 HD13 ' A' ' 66' ' ' LEU . 54.9 m -32.08 128.16 0.22 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 63.210000000000001 111.163 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.93 147.95 23.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 64.420000000000002 110.908 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.6 mm -118.83 127.32 75.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 63.439999999999998 111.153 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 62.9 mtp -100.41 141.79 32.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 61.020000000000003 110.837 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 73.7 mtm -134.71 117.51 16.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 71.129999999999995 110.87 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.745 ' CG ' HD21 ' A' ' 46' ' ' LEU . 2.2 mmt -105.52 124.56 49.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 72.400000000000006 110.866 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.57 -154.69 25.74 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.726 -0.749 . . . . 62.109999999999999 112.456 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.5 t -135.15 144.16 46.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.332 . . . . 71.439999999999998 111.155 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -60.99 160.55 9.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 71.430000000000007 110.838 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.04 143.72 13.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 62.149999999999999 110.896 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -82.91 -55.05 4.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 54.539999999999999 110.906 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -176.81 11.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 50.549999999999997 110.9 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.477 0 O-C-N 124.519 1.137 . . . . 20.440000000000001 . . . . . . . . . . 0 0 . 1 stop_ save_